Query ID;Target ID;Affinity Threshold (nM);P-Value;Max Tc;Cut Sum;Z-Score;Name;Description;Query Smiles;InChi Key
96814;NPFFR1;7;3.0570000000000002e-87;0.4151;7.4504;154.8715;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
152198;CAPN1;6;6.97e-72;0.5306;41.5916;127.299;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
13783081;TYR;6;1.269e-46;0.6176;2.4275;81.9486;TYR;Tyrosinase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7010506;AMP1_PLAFQ;6;1.4030000000000001e-43;0.54;5.5393;76.4847;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
52924465;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QCCKXFCODQEYIW-UHFFFAOYSA-N
6992643;ENPEP;7;3.357e-71;0.4545;5.5756;126.0733;ENPEP;Glutamyl aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
135398728;HPRT1;6;1.585e-62;0.4219;5.8747;110.5008;HPRT1;Hypoxanthine-guanine phosphoribosyltransferase (pKi >= 6);C1=NC2=C(N1C3C4C(C(O3)CO)OP(=O)(O4)O)N=C(NC2=O)N;UASRYODFRYWBRC-UHFFFAOYSA-N
5282942;CQSS;6;7.223e-64;0.4;1.8679;112.9087;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(CC=CCCCCCCCC(=O)O)O;WBHHMMIMDMUBKC-UHFFFAOYSA-N
3421919;MME;6;4.616e-227;0.6744;194.3423;405.8946;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4466134;CAPN2;6;5.193e-168;0.52;48.9571;299.8789;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
193508;NPR;6;1.225e-91;0.4167;13.2154;162.7659;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
131760520;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WZQHACRHKQJTGS-UHFFFAOYSA-N
96814;ECE1;6;9.957e-117;0.5581;50.5144;207.8102;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
9543878;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;BNNRAXXNNFEFAX-UHFFFAOYSA-N
53480247;LPAR3;6;4.0229999999999994e-88;0.5556;13.4609;156.4527;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;GSQABQVBVQXYJH-UHFFFAOYSA-N
97415;GRIA1;6;2.2850000000000002e-57;0.4423;12.6703;101.2389;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
14409732;CCKBR;6;1.342e-82;0.5065;83.6931;146.5369;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
53481871;LPAR3;6;4.658e-119;0.7308;18.2183;211.9932;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;UZDPEBGNSKBQGX-UHFFFAOYSA-N
9700;P2RY14;6;1.1769999999999999e-66;0.4516;12.1989;117.9141;P2RY14;P2Y purinoceptor 14 (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
10445608;MME;6;4.9950000000000005e-180;0.7105;154.0771;321.4532;MME;Neprilysin (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
4128305;HLA-A;6;5.352999999999999e-66;0.45;10.1698;116.7328;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CC(=O)N)C(=O)O)N;MLTRLIITQPXHBJ-UHFFFAOYSA-N
11579826;ACE2;6;4.807e-86;0.4419;12.1019;152.7231;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
7010506;MMP1;6;1.3549999999999999e-44;0.463;56.1886;78.3068;MMP1;Interstitial collagenase (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
53480967;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(CO)CO;FHCHFKIVIFQBSC-UHFFFAOYSA-N
111299;CTSB;6;7.442e-50;0.5;29.3672;87.7509;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
52924901;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HNFSZKRUPTYBOQ-UHFFFAOYSA-N
4657542;MMP3;6;4.336e-49;0.5;57.5441;86.3767;MMP3;Stromelysin-1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
131765702;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;QLJCFMWAJRKWEQ-UHFFFAOYSA-N
7010566;ACE2;6;1.609e-116;0.5319;16.4185;207.4359;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
134906;MC4R;6;5.205e-76;0.6452;112.1942;134.708;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53481900;FABP3;7;6.51e-50;0.5556;1.6418;87.8553;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(COP(=O)(O)O)O;YGJPTGGFWWXCQF-UHFFFAOYSA-N
131801928;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;KYTZSBQBUCWGRJ-UHFFFAOYSA-N
131801916;FABP3;7;2.4999999999999997e-55;0.55;1.8228;97.578;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;GHJOXQFLZDFHBM-UHFFFAOYSA-N
92829;ECE1;6;5.1629999999999994e-51;0.4314;21.998;89.8312;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
323786;SSTR2;7;1.4769999999999999e-83;0.4384;20.2242;148.2574;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
151008;CQSS;6;6.174e-67;0.4062;1.9588;118.4169;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NCC(=O)O;KVTFEOAKFFQCCX-UHFFFAOYSA-N
7010580;OPRM1;6;9.991e-81;0.5;233.2161;143.1761;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7016103;NPR;6;3.27e-78;0.4035;11.2663;138.6609;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7010566;HLA-DRB1;6;1.315e-94;0.4237;9.3255;168.0962;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
12599;ADCY5;6;6.866e-51;0.5;2.1918;89.609;ADCY5;Adenylate cyclase type 5 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
92021849;P2RX1;7;1.8e-48;0.4026;1.4119;85.2668;P2RX1;P2X purinoceptor 1 (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
10634;SHBG;9;4.187e-99;1.0;6.5584;176.1699;SHBG;Sex hormone-binding globulin (pKi >= 9);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
5259590;ENPEP;6;7.488e-70;0.4314;8.4035;123.6524;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
7010588;NOD1;9;6.286e-91;0.4167;6.4741;161.4906;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CC(=O)N)C(C(=O)NC(CCC(=O)N)C(=O)O)N;LOJYQMFIIJVETK-UHFFFAOYSA-N
52924162;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ADCNXGARWPJRBV-UHFFFAOYSA-N
9856500;NPR;6;1.591e-84;0.4182;12.1828;149.9948;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
12741;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
7010506;OPRD1;6;9.732000000000001e-98;0.6727;231.9287;173.717;OPRD1;Delta-type opioid receptor (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
7010506;ACE2;6;3.071e-113;0.451;15.9538;201.5462;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
5283956;SLC10A1;6;9.975e-57;0.4337;2.263;100.0897;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(=O)C4)C)O)O)C;OEKUSRBIIZNLHZ-UHFFFAOYSA-N
9546825;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;CLPMAPXZURYSNH-UHFFFAOYSA-N
19816755;SSTR2;7;3.567e-78;0.4079;18.9136;138.5931;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
435728;FPR1;6;1.325e-105;0.587;20.0331;187.8391;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
25200879;EDNRA;6;2.2189999999999999e-44;0.4286;66.217;77.9224;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
53479719;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPPCXIJSFVQDL-UHFFFAOYSA-N
52924564;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VPDGQGZVNVFJGD-UHFFFAOYSA-N
53480925;LPAR3;6;2.219e-101;0.6226;15.4998;180.2556;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NOVZJYYJYIFXJC-UHFFFAOYSA-N
52924353;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIWMKSHLSCQARO-UHFFFAOYSA-N
131763523;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;JULFTYLLKSHNRK-UHFFFAOYSA-N
12366;LPAR3;6;2.1619999999999997e-53;0.5;8.12;94.1007;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
131753929;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HCFBZCCMOSAJDD-UHFFFAOYSA-N
131753287;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DBIJZZLMYBLAQP-UHFFFAOYSA-N
4657542;NPR;6;7.037000000000001e-76;0.4186;10.9277;134.4728;NPR;Thermolysin (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
3038501;CCKAR;6;2.1249999999999997e-139;0.5156;137.9222;248.5115;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
47579;CTSL;6;2.894e-68;0.6316;52.4485;120.803;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
4427709;MMP1;6;9.986e-55;0.5556;68.9127;96.4982;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131801877;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;JWCNGONSUJKGDO-UHFFFAOYSA-N
4427709;OPRD1;6;9.927e-80;0.6364;189.4463;141.3858;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
22556;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
6992643;ACE;6;3.0230000000000003e-124;0.55;123.4249;221.307;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
800;MPO;6;8.771e-49;0.5455;7.9762;85.8275;MPO;Myeloperoxidase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC=O;WHOOUMGHGSPMGR-UHFFFAOYSA-N
131759263;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MDXVSMKNQLMYQZ-UHFFFAOYSA-N
7020642;TRY1_BOVIN;8;4.054e-110;0.4857;22.6943;195.9436;TRY1_BOVIN;Cationic trypsin (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
131750945;CYP17A1;6;3.185e-65;0.6909;29.2009;115.3424;CYP17A1;Steroid 17-alpha-hydroxylase/17,20 lyase (pKi >= 6);CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C;OSELKOCHBMDKEJ-UHFFFAOYSA-N
7359122;CAPNS1;6;8.150999999999999e-93;0.4107;6.3765;164.8787;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131801943;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;PPTFPPBZILRDOI-UHFFFAOYSA-N
52925087;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HLSDKIUXCZPFLL-UHFFFAOYSA-N
6993120;MMP9;6;4.4709999999999997e-45;0.4898;65.0639;79.1716;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131754096;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;MLEFRDDBNGCWLN-UHFFFAOYSA-N
47579;GRIA1;6;7.369e-48;0.4898;10.5514;84.168;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CTSK;6;3.7859999999999997e-47;0.4464;56.5686;82.8919;CTSK;Cathepsin K (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
12591;PLA2G4B;6;2.175e-68;0.4595;5.9815;121.0259;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
96814;BLA1_STEMA;6;1.037e-99;0.5;8.9706;177.2581;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
53478438;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWHGFSHXNNIITD-UHFFFAOYSA-N
96814;HLA-DRB1;6;6.738e-99;0.4364;9.7515;175.799;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
5488196;CYSP_TRYCR;7;3.189e-77;0.4151;18.7854;136.8852;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
151134;CAPNS1;6;3.9330000000000003e-69;0.4211;4.7367;122.3592;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
4427709;OPRM1;6;6.22e-87;0.6364;250.9819;154.3176;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53479939;FABP3;7;2.996e-45;0.4844;1.4859;79.4836;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PCKXGFCVDCVIHH-UHFFFAOYSA-N
263475;OPRD1;6;6.923e-43;0.5938;102.5322;75.24;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
134906;ACE2;6;9.589e-101;0.4259;14.1841;179.1145;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
131754749;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DCEIEGPNDFHINJ-UHFFFAOYSA-N
14409732;MME;6;7.376e-46;0.6212;39.2172;80.5766;MME;Neprilysin (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
273262;OPRD1;6;1.762e-110;0.6071;261.9878;196.5935;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
11579826;FURIN;6;4.641e-67;0.4737;12.2735;118.6395;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
150964;MC1R;6;8.396000000000001e-120;0.5077;60.9439;213.3292;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
53480059;LPAR3;6;1.612e-89;0.5667;13.6757;158.9608;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O;BZUNGYVNIWPISD-UHFFFAOYSA-N
97415;QRFPR;6;7.056e-52;0.4386;6.3195;91.383;QRFPR;Pyroglutamylated RFamide peptide receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7021828;LAP3;6;3.241e-50;0.697;5.73;88.3989;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
3421919;FCER2;6;1.634e-107;0.4655;13.18;191.2662;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
92946;PAPA1_CARPA;6;2.864e-64;0.4423;9.684;113.6298;PAPA1_CARPA;Papain (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
3038501;MME;6;2.8000000000000003e-80;0.6071;68.684;142.3725;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
152198;ANPEP;8;4.18e-119;0.4909;16.1479;212.0776;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
9700;TK;6;2.178e-59;0.7021;8.4304;104.8667;TK;Thymidine kinase (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
4466134;NTSR2;8;6.023e-110;0.4487;10.6147;195.6349;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53479658;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UJKZLJHORBRGNZ-UHFFFAOYSA-N
131763089;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LPABDPJNNDGDTQ-UHFFFAOYSA-N
151134;ACE2;6;1.785e-117;0.4694;16.5538;209.1505;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
342468;ENPEP;7;1.493e-91;0.4737;7.1852;162.6116;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
7009598;CAPNS1;6;4.1299999999999997e-81;0.5;5.5661;143.865;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
263471;MC1R;6;6.577000000000001e-117;0.4848;59.4685;208.1336;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
14282475;NPR;6;1.476e-52;0.4516;7.5422;92.603;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
263471;GHSR;6;5.833e-69;0.5932;71.0518;122.0519;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
7010566;AMP1_PLAFQ;6;7.490000000000001e-58;0.46;7.3797;102.1084;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
89567;LPAR3;6;3.991e-130;1.0;19.9203;231.8621;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;LAYXSTYJRSVXIH-UHFFFAOYSA-N
19816755;CCKAR;6;1.1040000000000001e-131;0.5;130.2894;234.6593;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MC5R;7;8.867e-85;0.48;21.0861;150.4504;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
102763;CCKBR;6;8.631e-130;0.5625;131.49;231.2608;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
168182;MME;6;1.015e-137;0.7255;117.858;245.4968;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
11579826;FOLH1;6;4.9e-125;0.6061;39.5479;222.7256;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
318292;MMP8;9;3.396e-52;0.5;10.7753;91.9532;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
52922765;FABP3;7;3.359e-50;0.65;1.6514;88.3711;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCC;NPXTVNLLGVNVDJ-UHFFFAOYSA-N
131753463;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;FICVIOYVXOEZEN-UHFFFAOYSA-N
131755321;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVLMVUOWVUUAHL-UHFFFAOYSA-N
14282475;ACE;6;2.376e-47;0.5769;47.0526;83.255;ACE;Angiotensin-converting enzyme (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
102763;MC4R;6;5.528e-61;0.5167;90.0864;107.7313;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
76807;CAPN2;6;1.619e-120;0.4;35.0815;214.6125;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
131763089;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LPABDPJNNDGDTQ-UHFFFAOYSA-N
24779494;LPAR3;6;1.6e-72;0.5614;11.062;128.4463;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)([O-])OCC[N+](C)(C)C;SULIDBRAXVDKBU-UHFFFAOYSA-N
131755479;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MBOXBOYLRVJTGJ-UHFFFAOYSA-N
9546800;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DRIVXEVMDWCWLI-UHFFFAOYSA-N
11622;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
53479804;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JUYYWEDATPYDSS-UHFFFAOYSA-N
7010580;ACE;6;8.718e-129;0.6;127.934;229.4576;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
52924378;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;ODKCSLGCTVUPMX-UHFFFAOYSA-N
7359122;PGA;8;4.554e-48;0.4444;6.1181;84.5431;PGA;Pepsin A (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4466134;ECE1;6;1.052e-70;0.4286;30.5428;125.1828;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
7009598;C3AR1;6;2.594e-49;0.4746;8.1436;86.7772;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
7010566;CPA1;6;4.1680000000000003e-78;0.5319;9.7008;138.4718;CPA1;Carboxypeptidase A1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
131755020;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SHZPWJWHCSZOEX-UHFFFAOYSA-N
7021820;ANPEP;8;3.879e-78;0.4138;10.5649;138.5278;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
4657542;FCER2;6;4.1589999999999997e-103;0.4255;12.6367;183.3565;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
4078684;OPRM1;6;6.730999999999999e-113;0.6944;325.3152;200.9343;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
53479856;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;CUUQTWOJYKCYRS-UHFFFAOYSA-N
7015683;HLA-A;6;3.1119999999999998e-47;0.4348;7.2523;83.0447;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
323786;GHSR;6;3.0000000000000004e-81;0.7455;83.7053;144.114;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
4078684;ACE2;6;2.6119999999999996e-88;0.4792;12.4227;156.7893;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
263471;MC5R;7;6.5459999999999996e-83;0.4211;20.6188;147.0965;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
131753498;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JPNVFKJWXNFOKV-UHFFFAOYSA-N
9543841;LPAR3;6;2.6120000000000003e-63;0.549;9.6452;111.9065;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NSVJKGBXOPSAKL-UHFFFAOYSA-N
4427709;BLA1_STEMA;6;1.829e-86;0.4333;7.7706;153.4766;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
92946;ACE;6;1.613e-88;0.6512;87.9407;157.1651;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
193508;HLA-A;7;6.0970000000000004e-65;0.4138;6.7845;114.8361;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
134906;MMP8;7;2.805e-59;0.5254;39.049;104.6696;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
131753587;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VHTASOICTBAXTL-UHFFFAOYSA-N
545258;EST1_PIG;6;6.551e-72;0.4667;5.6317;127.3473;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
14282475;HLA-A;7;3.5530000000000002e-102;0.4531;10.7141;181.684;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
537297;CQSS;6;5.057e-72;0.4375;2.1095;127.5491;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(CO)CO;SJUYTIGRIZBTCI-UHFFFAOYSA-N
3038501;MMP11;6;1.58e-112;0.4211;11.341;200.2691;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
193508;ANPEP;8;4.0909999999999996e-134;0.5333;18.1933;239.0243;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
92021849;AHCY;6;1.559e-56;0.4324;11.68;99.7416;AHCY;Adenosylhomocysteinase (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
515717;ACE;6;4.129e-71;0.5417;70.651;125.9119;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
131755016;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RBJMAKBTUZSIDN-UHFFFAOYSA-N
131755173;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UOSXDBUYARIRPO-UHFFFAOYSA-N
6993118;RIR1_HHV11;6;1.762e-90;0.4038;5.9835;160.687;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
53480012;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MTYZXHQAIRJTJM-UHFFFAOYSA-N
7009555;FPR1;6;4.525e-90;0.5;17.0711;159.9516;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
19816755;MC3R;6;9.499e-73;0.4198;35.6656;128.8529;MC3R;Melanocortin receptor 3 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
25200879;MC1R;6;1.244e-114;0.4384;58.3078;204.0463;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
3081383;P2RX1;7;2.368e-74;0.4946;2.1785;131.7315;P2RX1;P2X purinoceptor 1 (pKi >= 7);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
9797038;ANPEP;8;1.132e-64;0.4068;8.7299;114.3538;ANPEP;Aminopeptidase N (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
151410;CPA1;6;2.0159999999999998e-67;0.5106;8.363;119.2896;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53480963;LPAR3;6;6.34e-73;0.6279;11.1238;129.1682;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)CO;YRAZXZXQMMJRRV-UHFFFAOYSA-N
53479908;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PIRVOZHXFFFFFG-UHFFFAOYSA-N
7009650;MC4R;6;3.287e-62;0.6528;91.8899;109.9319;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53480249;LPAR1;6;1.312e-43;0.541;8.1455;76.5367;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;SJLOPHYYGZLTGX-UHFFFAOYSA-N
53479829;FABP3;7;1.76e-48;0.5077;1.5939;85.2846;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;ZRQPYJXAEPDRDM-UHFFFAOYSA-N
52924653;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BUIZMIHPZOBMLF-UHFFFAOYSA-N
76041074;LPAR1;6;2.912e-55;0.7692;10.3499;97.459;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;RPAOEHFOGLEBTJ-UHFFFAOYSA-N
13817313;ANPEP;6;9.032e-42;0.4889;14.6001;73.2374;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
342468;OPRD1;6;3.1839999999999995e-88;0.4909;209.4833;156.6349;OPRD1;Delta-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
131758666;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RFMPQNSSBPXIIY-UHFFFAOYSA-N
7020642;OPRM1;6;7.046e-88;0.6415;253.6895;156.0156;OPRM1;Mu-type opioid receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
13783081;TMPRSS6;8;1.41e-52;0.55;2.2656;92.6387;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131753660;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GZLQQXVVOPFZRE-UHFFFAOYSA-N
10445608;OPRM1;6;4.6919999999999995e-89;0.6071;257.0579;158.128;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
435728;ACE;6;2.218e-141;0.7143;140.4427;252.0686;ACE;Angiotensin-converting enzyme (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
7010566;CTSL;6;2.684e-71;0.4545;54.7819;126.2477;CTSL;Cathepsin L1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
150964;F2R;6;1.766e-61;0.6316;37.1353;108.6209;F2R;Proteinase-activated receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
53481872;LPAR3;6;1.2349999999999999e-114;0.6909;17.5381;204.0514;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCCCCC=CCC=CCC=CCC;OKSGKZRUQJEAKX-UHFFFAOYSA-N
44232492;CAPN1;6;3.741e-77;0.5;44.6501;136.7608;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
515709;CAPN1;6;9.55e-123;0.619;71.1094;218.6147;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
14304554;ENPEP;7;6.345e-106;0.5435;8.3218;188.4131;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
151003;NPFFR2;7;8.671e-41;0.5072;3.3593;71.4739;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
23274411;BHMT;6;9.612e-58;0.4048;1.6865;101.9139;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCSC)N;BJFJQOMZCSHBMY-UHFFFAOYSA-N
11551966;PLA2G4B;6;1.3850000000000001e-106;0.4667;9.3559;189.5998;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1;RAMRROOXFMYSNA-UHFFFAOYSA-N
318292;OPRM1;6;3.491e-44;0.5818;128.6017;77.5692;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
52924785;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;JCZXAXBRLLOCPM-UHFFFAOYSA-N
131760624;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;QBTDCDJQWFFVGF-UHFFFAOYSA-N
9546841;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DBYSGBYABPVNGO-UHFFFAOYSA-N
53479623;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MKMUWJJSVUOCQC-UHFFFAOYSA-N
759256;ACE;6;1.467e-88;0.5405;87.9816;157.239;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
7016045;NOD1;9;2.542e-91;0.4043;6.5023;162.1966;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)C(C(=O)NC(CCC(=O)N)C(=O)O)N;XXDVDTMEVBYRPK-UHFFFAOYSA-N
3081383;RNASE1;6;2.3619999999999998e-60;0.4775;1.7638;106.599;RNASE1;Ribonuclease pancreatic (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
151134;FURIN;6;3.884e-45;0.4068;8.2278;79.2813;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131801772;LPAR1;6;3.626e-43;0.7045;8.062;75.7442;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;XIZKIPQKOHUAHX-UHFFFAOYSA-N
7009598;FCER2;6;2.275e-106;0.4151;13.039;189.2128;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
8180;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
53479588;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQIMLWFRWGTTOZ-UHFFFAOYSA-N
131801858;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;YWYQODJQQTZXGP-UHFFFAOYSA-N
92021849;ADORA3;6;1.335e-154;0.5538;56.4505;275.8034;ADORA3;Adenosine receptor A3 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
131755337;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MZFQLGNBXGADLH-UHFFFAOYSA-N
12575964;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCC(C(=O)O)O;JGHSBPIZNUXPLA-UHFFFAOYSA-N
131801919;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;MARDKHBEDGKFMD-UHFFFAOYSA-N
323786;MME;6;7.895e-129;0.6667;110.2467;229.535;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
3081383;DOT1L;6;5.469e-106;0.4167;10.0026;188.5289;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
134906;CCKBR;6;1.797e-112;0.6154;113.9495;200.1687;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
134906;ACE;6;2.397e-77;0.7115;76.8447;137.1078;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
263475;ACE;6;3.078e-42;0.6078;41.9749;74.0766;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9547243;VDR;6;2.117e-229;0.7742;77.1778;410.0929;VDR;Vitamin D3 receptor (pKi >= 6);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
4418533;MAG;6;9.382e-75;0.5327;2.4721;132.4532;MAG;Myelin-associated glycoprotein (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)NC(=O)C)OC4C(C(OC(C4O)OC(C(CO)O)C(C(C=O)O)O)CO)O)CO)O)O)O)O;SXMGGNXBTZBGLU-UHFFFAOYSA-N
7010506;CPA1;6;3.3179999999999996e-73;0.451;9.0872;129.6731;CPA1;Carboxypeptidase A1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
97415;OPRD1;6;9.691999999999999e-51;0.4286;121.0596;89.3403;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
5488196;MMP1;6;2.2789999999999998e-45;0.5;57.161;79.6969;MMP1;Interstitial collagenase (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13783081;MC1R;6;1.0320000000000001e-131;0.5588;67.0161;234.712;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131802016;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;ZLEJYIVDPRFANO-UHFFFAOYSA-N
4427709;CTSL;6;9.871e-61;0.5636;46.6527;107.2791;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131753836;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;POWNQYNUJQKIJN-UHFFFAOYSA-N
263471;ERAP2;6;6.177e-51;0.4384;1.676;89.6914;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
10459;KDM2A;6;9.509e-48;0.4074;1.8998;83.9692;KDM2A;Lysine-specific demethylase 2A (pKi >= 6);C(CCCCCCCC(=O)O)CCCCCCC(=O)O;QQHJDPROMQRDLA-UHFFFAOYSA-N
53479812;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;IZEJYRQAFUAOSD-UHFFFAOYSA-N
323786;CTSL;8;4.475e-47;0.5152;13.1611;82.7614;CTSL;Cathepsin L1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7020642;LAP3;6;3.42e-41;0.4918;4.6871;72.1993;LAP3;Cytosol aminopeptidase (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
19421321;NAALAD2;6;4.684e-64;0.5652;3.7112;113.2463;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
53480018;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;LYQNHUUXGYHXPH-UHFFFAOYSA-N
9948926;ACE2;6;1.702e-69;0.4138;9.7578;123.0123;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
53479710;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MIPOZDXFSKBSGM-UHFFFAOYSA-N
131759456;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FXVLQYFZVVLQJO-UHFFFAOYSA-N
53480966;LPAR3;6;1.5240000000000002e-57;0.5532;8.7585;101.5545;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)CO;CRSKSGIHJXUIHD-UHFFFAOYSA-N
131754775;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BWUZGPYYZXQIFD-UHFFFAOYSA-N
12599;ADORA1;6;8.934000000000001e-65;0.7222;167.0766;114.5382;ADORA1;Adenosine receptor A1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
4466134;OPRM1;6;1.62e-120;0.6981;347.125;214.6119;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53477837;FABP3;7;4.646e-48;0.4318;1.5798;84.5275;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C;IPOLTUVFXFHAHI-UHFFFAOYSA-N
52926034;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;QPLGPOYWQGNODB-UHFFFAOYSA-N
100048;CAPNS1;6;3.194e-83;0.5273;5.7123;147.6559;CAPNS1;Calpain small subunit 1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
9546836;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XMJSNHMFTISTET-UHFFFAOYSA-N
7359122;FPR1;6;1.189e-85;0.4583;16.2284;152.0171;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4078684;LAP3;6;1.1540000000000001e-46;0.4;5.3195;82.023;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
263475;CCKBR;6;1.751e-116;0.5385;118.0122;207.3703;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
7009555;ACE;6;2.267e-84;0.6222;83.8212;149.7186;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
5488196;ANPEP;8;1.467e-137;0.5952;18.6628;245.2095;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
5281516;GGPS1;6;3.2279999999999996e-45;0.4054;4.7028;79.4257;GGPS1;Geranylgeranyl pyrophosphate synthase (pKi >= 6);CC(=CCCC(=CCC=C(C)C=C)C)C;CXENHBSYCFFKJS-UHFFFAOYSA-N
7009598;CTSC;6;6.694e-48;0.5116;7.3561;84.2428;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
259327;NPR;6;3.3360000000000003e-108;0.5;15.62;192.505;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
53480248;LPAR1;6;1.312e-43;0.541;8.1455;76.5367;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;VFLPHYZOQHTWTQ-UHFFFAOYSA-N
96814;HLA-A;6;2.0259999999999997e-66;0.5882;10.2354;117.4905;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
332962;LAP3;6;6.485e-45;0.6471;5.1173;78.8816;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
131755894;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QXJSFSDQSFDVAT-UHFFFAOYSA-N
92946;CAPNS1;6;2.956e-76;0.463;5.23;135.1491;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
131755391;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YRHHWDQMQNTGFU-UHFFFAOYSA-N
435728;QRFPR;6;3.3100000000000003e-43;0.4118;5.2502;75.8153;QRFPR;Pyroglutamylated RFamide peptide receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
4656408;GHSR;6;1.692e-74;0.4444;76.7536;131.9933;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
100094;GRPR;8;3.564e-82;0.4;6.6365;145.7751;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
4078684;CAPN2;6;1.153e-62;0.4694;18.1794;110.7486;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
4128305;FPR1;6;1.5570000000000002e-58;0.4255;11.0576;103.333;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC(=O)N)C(=O)O)N;MLTRLIITQPXHBJ-UHFFFAOYSA-N
53479727;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;XEWZHCLDUCWNLB-UHFFFAOYSA-N
5259590;NOD1;9;3.112e-94;0.4255;6.7113;167.4246;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
131750324;SLC10A1;6;1.5570000000000002e-46;0.4286;1.8507;81.7896;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C;DKPMWHFRUGMUKF-UHFFFAOYSA-N
18986;TUBB2B;6;9.488e-43;0.4043;4.9497;74.9943;TUBB2B;Tubulin beta-2B chain (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
131801991;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;JODFYBIHEFCIFI-UHFFFAOYSA-N
515709;MME;6;4.616e-227;0.6744;194.3423;405.8946;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
435718;ENPEP;7;7.786999999999999e-88;0.5;6.8912;155.9377;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
92021849;DOT1L;6;6.645e-120;0.4933;11.3243;213.5115;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
53479569;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;IPBXKYJWPCRPLD-UHFFFAOYSA-N
168182;NPR;8;1.134e-86;0.7255;5.0368;153.849;NPR;Thermolysin (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
97415;NPR;6;3.074e-62;0.413;8.9476;109.9841;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
13817313;NPR;6;1.014e-81;0.4364;11.7757;144.9599;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
152198;OPRM1;6;6.602e-75;0.4355;216.5548;132.7273;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
7010506;CTSL;6;3.7219999999999996e-66;0.4576;50.8256;117.0163;CTSL;Cathepsin L1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
323786;KISS1R;8;8.214e-97;0.4557;12.582;172.0539;KISS1R;KiSS-1 receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
131755759;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;XBEBXEQYPIBWCY-UHFFFAOYSA-N
92829;MME;6;1.76e-139;0.6047;119.3656;248.6585;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
53480884;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DZPHTQGGRSWHLG-UHFFFAOYSA-N
131755167;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NJWLXJXDVKOEOP-UHFFFAOYSA-N
53480059;FABP3;7;9.344e-48;0.5469;1.5697;83.9828;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O;BZUNGYVNIWPISD-UHFFFAOYSA-N
53479700;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;RQRUBEBOUYHPDW-UHFFFAOYSA-N
131760022;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;SEJBPZVTMDKZMT-UHFFFAOYSA-N
47579;FURIN;6;6.326e-64;0.4286;11.695;113.012;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
19816756;MME;6;5.643e-72;0.5893;61.5749;127.4637;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
7009650;EDNRB;9;7.57e-61;0.4533;5.8454;107.4861;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
8164;EST1_PIG;7;1.176e-68;0.4516;4.5286;121.5052;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCOC(=O)C;YLYBTZIQSIBWLI-UHFFFAOYSA-N
7016103;FPR1;6;1.905e-66;0.4655;12.5664;117.5385;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
53480484;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGZSJHAMIMLPBP-UHFFFAOYSA-N
5488196;OPRM1;6;6.395e-105;0.6078;302.4769;186.6116;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
53480976;FABP3;7;1.61e-51;0.5;1.6955;90.7399;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(CO)O;KVYUBFKSKZWZSV-UHFFFAOYSA-N
53478215;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ADQHTXPTSHXNKF-UHFFFAOYSA-N
515709;YARS;6;1.012e-115;0.6905;6.7395;206.0021;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
6993120;ACE;6;1.139e-136;0.6154;135.7641;243.6115;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53479700;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;RQRUBEBOUYHPDW-UHFFFAOYSA-N
6992643;CAPN2;6;1.0370000000000001e-128;0.5581;37.4753;229.3223;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
61030;NOD1;9;5.502e-51;0.4545;3.6077;89.7817;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
10373084;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;YIGARKIIFOHVPF-UHFFFAOYSA-N
131801934;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;MGNMWMMQKHUXCT-UHFFFAOYSA-N
18218220;ENPEP;7;2.833e-83;0.4468;6.5305;147.7495;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(C(C)O)C(=O)O)N;DRCKHKZYDLJYFQ-UHFFFAOYSA-N
4078684;OPRD1;6;4.568e-112;0.6383;265.7297;199.4412;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
131754079;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;VMJJCASFGIUXQS-UHFFFAOYSA-N
263471;GRPR;6;1.9260000000000002e-99;0.4103;12.1847;176.7755;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
7010506;FURIN;6;6.864e-42;0.4179;7.6286;73.4514;FURIN;Furin (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
5283496;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;FHQVHHIBKUMWTI-UHFFFAOYSA-N
263471;EDNRA;6;1.888e-42;0.5;63.3538;74.4576;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
131755148;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QDDBVRCUCSETRT-UHFFFAOYSA-N
102763;EDNRA;6;7.556e-48;0.5077;71.3622;84.1484;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
131753292;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PDOWBMFLISSQRT-UHFFFAOYSA-N
53479616;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;XJRBLUARQNXNQS-UHFFFAOYSA-N
323786;ANPEP;6;3.294e-75;0.5283;26.3967;133.2693;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
168182;MMP11;6;1.216e-116;0.4789;11.758;207.6542;MMP11;Stromelysin-3 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
12741;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
52925126;LPAR3;6;6.91e-77;0.5333;11.7332;136.2823;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UUYSKERSKRMYME-UHFFFAOYSA-N
7359122;MME;6;6.325e-196;0.7297;167.6866;349.9941;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
323786;MMP2;6;8.765e-55;0.5965;88.6127;96.5999;MMP2;72 kDa type IV collagenase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
52924593;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KSAJIJQUJUOZKJ-UHFFFAOYSA-N
97415;PAPA1_CARPA;6;1.7049999999999998e-66;0.4318;10.0224;117.6247;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
5488196;CTSB;6;1.255e-95;0.6429;56.4428;169.9283;CTSB;Cathepsin B (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
100048;OPRD1;6;8.222e-85;0.5932;201.4343;150.5093;OPRD1;Delta-type opioid receptor (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
4427709;MMP9;6;6.403e-55;0.5088;79.2006;96.8447;MMP9;Matrix metalloproteinase-9 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
439887;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCC(C(=O)O)O;KIHBGTRZFAVZRV-UHFFFAOYSA-N
131801915;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;QPKXQZITTOAAKY-UHFFFAOYSA-N
5488196;C3AR1;6;3.588e-49;0.5357;8.1201;86.5244;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
263471;MC4R;6;1.0520000000000001e-57;0.4848;85.2615;101.8436;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
47579;ECE1;6;1.507e-110;0.5366;47.8327;196.7152;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
5057430;BLA1_STEMA;6;2.2960000000000003e-84;0.4182;7.5805;149.7086;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
13783081;MMP1;6;5.2570000000000005e-42;0.5;52.938;73.6593;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7021456;OPRM1;6;6.1729999999999995e-89;0.65;256.7167;157.914;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
131754546;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LBTCQHAIXPLSSD-UHFFFAOYSA-N
4427709;ERAP2;6;2.039e-59;0.5072;1.9595;104.9181;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
7010566;CTRB1;6;7.93e-44;0.4783;5.2439;76.9295;CTRB1;Chymotrypsinogen B (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
96814;LAP3;6;2.178e-96;0.619;11.0669;171.2935;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
135398728;ADORA1;6;5.441e-79;0.4516;203.3827;140.0593;ADORA1;Adenosine receptor A1 (pKi >= 6);C1=NC2=C(N1C3C4C(C(O3)CO)OP(=O)(O4)O)N=C(NC2=O)N;UASRYODFRYWBRC-UHFFFAOYSA-N
131801904;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;BWPPXWXSNNMLOW-UHFFFAOYSA-N
53480981;CQSS;6;9.049e-73;0.4412;2.1317;128.8908;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;UMEKPPOFCOUEDT-UHFFFAOYSA-N
53479718;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;GKXLKICEHUALBW-UHFFFAOYSA-N
4305457;NOD1;9;3.711e-93;0.4167;6.634;165.4922;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
131754999;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YQQLYNBUCCDBQS-UHFFFAOYSA-N
7021820;NPFFR2;6;3.328e-56;0.4032;8.8347;99.1502;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
131763181;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JKLVWHFEADJCSE-UHFFFAOYSA-N
131754524;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOTJQCORLIFPLC-UHFFFAOYSA-N
13817313;CAPN1;6;2.335e-85;0.4889;49.4116;151.491;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
52924528;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;KZMQZJZTKYKTJQ-UHFFFAOYSA-N
3038501;NMBR;6;3.5350000000000006e-42;0.4677;6.6765;73.9689;NMBR;Neuromedin-B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
100094;NPR;8;5.107e-70;0.6071;4.0607;123.9508;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
102763;SSTR2;6;1.813e-69;0.4493;21.1738;122.9629;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
7009555;LAP3;6;1.648e-45;0.4694;5.186;79.9497;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
6992304;RNPEP;6;1.7599999999999998e-46;0.4043;2.2841;81.6938;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
7010580;FCER2;6;2.412e-118;0.4528;14.5156;210.7111;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
52924537;LPAR3;6;2.8250000000000003e-78;0.5862;11.9467;138.7751;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MWDRGYRNYDLFKA-UHFFFAOYSA-N
100094;MC4R;6;1.857e-62;0.5294;92.2548;110.3772;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
19816755;MC4R;6;1.382e-51;0.4583;76.2594;90.859;MC4R;Melanocortin receptor 4 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
18218238;EDNRB;9;1.071e-62;0.4722;6.025;110.8061;EDNRB;Endothelin B receptor (pKi >= 9);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
151134;CPA1;6;1.6510000000000001e-84;0.4681;10.5024;149.9657;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
12591;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
7010566;ANPEP;6;2.053e-121;0.46;42.6974;216.2227;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
53480949;LPAR3;6;2.079e-106;0.75;16.2731;189.2832;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;WAYKKNOEMJFLDI-UHFFFAOYSA-N
131801901;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;FYYBTKGJGCSNCV-UHFFFAOYSA-N
329275;HLA-A;6;8.988e-53;0.4149;8.1136;92.9897;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
52925065;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LYFMZJCIGLZMJF-UHFFFAOYSA-N
131755016;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RBJMAKBTUZSIDN-UHFFFAOYSA-N
151134;CTSL;6;1.1079999999999999e-60;0.4231;46.614;107.189;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
13783081;YARS;6;4.8549999999999995e-90;0.5091;5.2342;159.8966;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131758821;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YMPDPPQASWDPRK-UHFFFAOYSA-N
4657542;AMP1_PLAFQ;6;7.155e-62;0.4762;7.8981;109.3254;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
53479855;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;URRUJVMBYGYWNL-UHFFFAOYSA-N
6992643;FOLH1;6;4.2470000000000004e-42;0.4762;13.2277;73.8258;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
131755130;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RHYGXFNQVVYIJD-UHFFFAOYSA-N
52924644;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FKCXXHSNNJJOHT-UHFFFAOYSA-N
65254;FURIN;6;8.646e-45;0.463;8.1637;78.6573;FURIN;Furin (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
9948926;CCKBR;6;3.033e-107;0.5758;108.655;190.7838;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
17525;CES2;7;2.662e-50;0.4242;2.905;88.5526;CES2;Cocaine esterase (pKi >= 7);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
96814;NPPA;7;1.855e-44;0.5417;1.4594;78.0621;NPPA;Natriuretic peptides A (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
111299;ECE1;6;1.565e-70;0.4583;30.4679;124.873;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
150964;CYSP_TRYCR;7;1.0280000000000001e-63;0.4262;15.4785;112.6334;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7010566;CAPNS1;6;2.485e-95;0.4138;6.5507;169.3955;CAPNS1;Calpain small subunit 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
19816756;EDNRA;6;1.316e-50;0.4935;75.4554;89.1016;EDNRA;Endothelin-1 receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
92946;GRIA1;6;2.7350000000000002e-70;0.451;15.5498;124.4377;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
7021820;HLA-A;6;2.0359999999999998e-67;0.44;10.3905;119.2818;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
102763;ACE;6;6.697999999999999e-47;0.7727;46.6056;82.447;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
12599;PANC;6;2.2860000000000003e-42;0.4384;3.2953;74.3086;PANC;Pantothenate synthetase (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
52925126;FABP3;7;3.6259999999999995e-45;0.5156;1.4831;79.335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UUYSKERSKRMYME-UHFFFAOYSA-N
152322;ACE;6;3.0209999999999998e-61;0.5417;60.8538;108.2023;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CN=CN2)N)C(=O)O;LNCFUHAPNTYMJB-UHFFFAOYSA-N
131754010;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XDVVZXAIBRKPCM-UHFFFAOYSA-N
12591;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
12599;P2RX1;7;1.268e-81;0.6066;2.3939;144.7858;P2RX1;P2X purinoceptor 1 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
52925214;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FGWZGYGIIUCSFO-UHFFFAOYSA-N
52925434;LPAR1;6;1.043e-45;0.6154;8.5427;80.3066;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCC;GKXJCTQSLVKTAV-UHFFFAOYSA-N
52926076;FABP3;7;4.666e-52;0.5556;1.7135;91.7055;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCC=CCC;GRXQVLCZJYBDDD-UHFFFAOYSA-N
151410;ECE1;6;6.307e-81;0.4898;34.9786;143.5348;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
9547070;LPAR3;6;4.283e-69;0.7143;10.5349;122.2927;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;RPXHXZNGZBHSMJ-UHFFFAOYSA-N
53479558;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PHNTZMYSEVOGFP-UHFFFAOYSA-N
53480979;FABP3;7;3.402e-49;0.5366;1.6178;86.5658;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(CO)O;GGJRAQULURVTAJ-UHFFFAOYSA-N
435718;HLA-A;6;1.585e-86;0.5098;13.3615;153.5883;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
134906;ERAP2;6;5.983e-62;0.5294;2.0441;109.4649;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924554;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;BUCLJVJCFFPNPB-UHFFFAOYSA-N
14767562;CAPN1;6;4.0349999999999995e-47;0.4468;27.221;82.8423;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
100094;ECE1;6;1.058e-95;0.6296;41.3903;170.0616;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;NMBR;6;4.578e-58;0.5167;9.2265;102.4923;NMBR;Neuromedin-B receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7800;CQSS;6;7.424e-77;0.5;2.2527;136.2264;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
111299;GLO1;6;1.1689999999999998e-53;0.4821;4.6801;94.5802;GLO1;Lactoylglutathione lyase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
14767562;ACE2;6;2.611e-81;0.46;11.4312;144.2223;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
44232492;FPR1;6;2.944e-64;0.4375;12.149;113.6085;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
6351946;NPFFR2;7;7.028e-61;0.5556;5.0426;107.544;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
100048;CTSB;6;2.494e-92;0.587;54.4918;164.0066;CTSB;Cathepsin B (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7021828;CAPN1;6;7.02e-71;0.4773;41.0095;125.4981;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
12741;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
11622;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
92946;CAPN2;6;3.31e-94;0.6;27.3947;167.3766;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
53478106;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BYLXXZYUDXCZFN-UHFFFAOYSA-N
6993120;CTSL;6;1.956e-77;0.46;59.5042;137.2664;CTSL;Cathepsin L1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131753287;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DBIJZZLMYBLAQP-UHFFFAOYSA-N
3038501;MC1R;6;3.999e-116;0.4714;59.0689;206.7262;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
53479739;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;SSVPEUWHHFKSEB-UHFFFAOYSA-N
53480867;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;URRCZPXKAKNTHV-UHFFFAOYSA-N
454064;CQSS;6;1.636e-73;0.4483;2.1537;130.2241;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
53478149;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;QBTJRRWTWAXKSO-UHFFFAOYSA-N
150964;CAPNS1;6;5.18e-71;0.45;4.8669;125.7351;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7021456;F2R;6;2.097e-55;0.5323;33.4541;97.7149;F2R;Proteinase-activated receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515717;ECE1;6;2.483e-52;0.4375;22.5699;92.1973;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
111299;BLA1_STEMA;6;1.0949999999999999e-94;0.5294;8.5155;168.2394;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992567;DLG4;6;9.434e-78;0.4444;2.8494;137.8349;DLG4;Disks large homolog 4 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SITLTJHOQZFJGG-UHFFFAOYSA-N
5282761;CQSS;6;5.429e-69;0.4194;2.0197;122.1078;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
53480012;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MTYZXHQAIRJTJM-UHFFFAOYSA-N
96814;CPA1;6;1.12e-114;0.6341;14.2797;204.1278;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131753718;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CJNBEPRDDYRSPK-UHFFFAOYSA-N
131759301;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;NTANLNVWSGZVNG-UHFFFAOYSA-N
131801964;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;QWBJFHUMPKVXOT-UHFFFAOYSA-N
12741;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
189008;HLA-A;6;8.917999999999999e-94;0.4267;14.4886;166.6039;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
12530;FABP3;7;6.518e-57;0.7391;1.8757;100.4214;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
7020642;LGMN;6;3.4039999999999995e-54;0.4032;7.0076;95.5419;LGMN;Legumain (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
151410;FPR1;6;4.722e-96;0.5614;18.2117;170.6903;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4656408;MC4R;6;1.75e-50;0.4355;74.6374;88.8797;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
4466134;ACE2;6;1.234e-104;0.5306;14.7352;186.0994;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
323786;ECE1;6;2.9809999999999998e-105;0.6727;45.5344;187.2067;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
13890535;CTRB1;6;1.248e-48;0.4314;5.827;85.5525;CTRB1;Chymotrypsinogen B (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
259327;CAPN1;6;1.056e-111;0.5854;64.7003;198.7877;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
131750529;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;VUYXIQLBLBPRDY-UHFFFAOYSA-N
7076347;GALR1;7;5.987e-82;0.6486;3.2832;145.3707;GALR1;Galanin receptor type 1 (pKi >= 7);CC(C)CC1C(=O)NC(C(=O)N1)CC2=CC=CC=C2;QPDMOMIYLJMOQJ-UHFFFAOYSA-N
7010580;HLA-DRB1;6;2.1249999999999997e-93;0.4386;9.2056;165.9269;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
52924717;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;QMQLZZVQOMZDCN-UHFFFAOYSA-N
53478393;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXPLJLDIGVRTRM-UHFFFAOYSA-N
435728;PAPA1_CARPA;6;2.119e-100;0.4464;15.1787;178.4964;PAPA1_CARPA;Papain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
131753516;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNKDMZBYGADBFP-UHFFFAOYSA-N
131764015;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RJJPSRSFWRKXGV-UHFFFAOYSA-N
53479811;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QIMXBAASHOXOCT-UHFFFAOYSA-N
7021820;ERAP2;6;3.539e-55;0.4688;1.8177;97.307;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NPR;7;6.19e-45;0.4032;5.1196;78.918;NPR;Thermolysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
435728;CTSB;6;7.484e-111;0.5778;65.4484;197.2609;CTSB;Cathepsin B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
52924583;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;FRVWPWGGHGGKMD-UHFFFAOYSA-N
3634442;CCKAR;6;2.669e-144;0.5571;142.7705;257.3104;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
329275;OPRM1;6;3.966e-45;0.569;131.306;79.2651;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
3038501;ACE;6;4.046e-43;0.6939;42.8503;75.6589;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
7020642;CMA1;8;3.957e-43;0.4;4.3943;75.6762;CMA1;Chymase (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
168182;GRPR;6;3.898e-87;0.4359;10.6672;154.6819;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
9546757;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;MWRBNPKJOOWZPW-UHFFFAOYSA-N
14767562;YARS;6;5.3540000000000004e-117;0.6136;6.8143;208.294;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
53477864;CD22;6;3.728e-88;0.4752;4.0983;156.5121;CD22;B-cell receptor CD22 (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC(C(CO)O)C(C(C=O)O)O)CO)O)NC(=O)C)OC4C(C(C(C(O4)CO)O)O)O)O)O;SFMRPVLZMVJKGZ-UHFFFAOYSA-N
14767562;MME;6;1.536e-124;0.5714;106.5748;221.8345;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
100048;CTSC;6;1.86e-45;0.4746;6.9761;79.8552;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
759256;BLA1_STEMA;6;1.1749999999999998e-81;0.4;7.3351;144.8449;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
5312554;FABP3;7;6.644e-81;1.0;2.6777;143.4942;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
53479717;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;KRZKEZVISPYOPJ-UHFFFAOYSA-N
445468;LPAR3;6;2.4939999999999997e-67;0.7391;10.2634;119.1238;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCCC;SLKDGVPOSSLUAI-UHFFFAOYSA-N
10851;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC;VMPHSYLJUKZBJJ-UHFFFAOYSA-N
7021456;OPRD1;6;6.6e-87;0.623;206.3774;154.2712;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
17863274;HLA-A;6;7.268e-64;0.4727;9.8382;112.9038;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CCSC)C(=O)O)N;TUYOFUHICRWDGA-UHFFFAOYSA-N
9813855;HLA-A;6;2.009e-60;0.4364;9.3031;106.7253;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SNFUTDLOCQQRQD-UHFFFAOYSA-N
193508;CAPN1;6;5.012e-124;0.5854;71.8522;220.9126;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52924653;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BUIZMIHPZOBMLF-UHFFFAOYSA-N
13890535;NPPA;7;9.439e-42;0.434;1.3689;73.203;NPPA;Natriuretic peptides A (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
7010566;MME;6;3.0529999999999998e-179;0.675;153.4041;320.0417;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
131755130;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RHYGXFNQVVYIJD-UHFFFAOYSA-N
193508;MME;6;2.6e-207;0.7027;177.4341;370.4359;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
150964;NPFFR1;7;2.6360000000000003e-84;0.4167;7.1977;149.601;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9948926;NPR;8;3.5430000000000004e-72;0.6415;4.1872;127.8265;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
323786;ERAP2;6;9.380000000000001e-59;0.5294;1.9373;103.7283;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
8163;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
7010566;CAPN2;6;2.804e-147;0.449;42.9;262.6578;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
151410;CYSP_TRYCR;7;4.4200000000000005e-73;0.4364;17.7715;129.4495;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
96814;CTSB;6;3.34e-108;0.6098;63.8811;192.504;CTSB;Cathepsin B (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131755736;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;GGCGDJPSQJXGBG-UHFFFAOYSA-N
5284499;LPAR3;6;8.557e-43;0.4516;6.4903;75.0748;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCO;ALSTYHKOOCGGFT-UHFFFAOYSA-N
9546726;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LYJWNHGFGVVCAO-UHFFFAOYSA-N
53479738;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;MPCVLWFEQHTFHH-UHFFFAOYSA-N
332962;RIR1_HHV11;6;7.453e-95;0.4231;6.275;168.5391;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
80108;CES1;6;4.201e-90;0.4;20.217;160.0095;CES1;Liver carboxylesterase 1 (pKi >= 6);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
3634442;NAALAD2;6;1.2229999999999999e-68;0.4528;3.9798;121.4746;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
515709;HLA-A;7;1.215e-69;0.4167;7.2805;123.2749;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
100094;TACR1;6;1.368e-44;0.5161;77.1507;78.2995;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
134906;EDNRA;6;1.175e-53;0.6032;79.9795;94.5761;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924814;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WALILJXJZOCRCD-UHFFFAOYSA-N
14409732;ECE1;6;1.479e-57;0.4062;24.8373;101.5778;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
131758755;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;ARRWAWFZJHRGLN-UHFFFAOYSA-N
323786;CCKAR;6;2.463e-138;0.5429;136.8695;246.601;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
131753587;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VHTASOICTBAXTL-UHFFFAOYSA-N
97415;CAPN2;6;9.055e-70;0.561;20.2552;123.5043;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
323786;EDNRA;6;1.126e-71;0.5692;106.7123;126.9247;EDNRA;Endothelin-1 receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
9797038;MMP11;6;1.532e-116;0.4795;11.7479;207.4742;MMP11;Stromelysin-3 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
7010506;CTSB;6;3.6649999999999995e-73;0.4898;43.1541;129.5956;CTSB;Cathepsin B (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
323786;FPR1;6;6.235e-93;0.5968;17.6166;165.0875;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7016103;NTSR2;7;7.052e-71;0.4342;11.0473;125.4946;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
131758820;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;HWXYJCBLRIWFEE-UHFFFAOYSA-N
52925140;FABP3;7;3.395e-49;0.4839;1.6178;86.5676;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;QJHRNPQXCMXOOH-UHFFFAOYSA-N
19816755;LNPEP;6;6.168999999999999e-41;0.4675;4.5776;71.7393;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
52924408;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;GMXIUCLINHXQQD-UHFFFAOYSA-N
131758800;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UAXBSAJQKYIKRG-UHFFFAOYSA-N
131765707;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;RIDIILYYYNCBPC-UHFFFAOYSA-N
151410;CAPNS1;6;8.812e-80;0.4821;5.4741;141.4787;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
439887;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCC(C(=O)O)O;KIHBGTRZFAVZRV-UHFFFAOYSA-N
7021456;RNPEP;8;1.661e-43;0.4333;1.4276;76.3528;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
7359122;FCER2;6;5.627e-111;0.4074;13.607;197.4833;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
53479855;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;URRUJVMBYGYWNL-UHFFFAOYSA-N
151410;OPRD1;6;4.084e-82;0.5397;195.0742;145.6689;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131758733;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCC;DTWPBANPCJFNIA-UHFFFAOYSA-N
6351946;TRHR;6;4.2479999999999996e-45;0.4754;2.215;79.2116;TRHR;Thyrotropin-releasing hormone receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
3634442;MC3R;6;5.715e-87;0.4805;42.664;154.3836;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
52924593;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KSAJIJQUJUOZKJ-UHFFFAOYSA-N
273262;LAP3;6;2.375e-48;0.5417;5.5145;85.0509;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
76807;CAPNS1;6;1.105e-61;0.4118;4.221;108.9865;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
53480914;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PQEYJXRJLFZSPT-UHFFFAOYSA-N
7010506;MMP3;6;2.064e-52;0.4909;61.43;92.3416;MMP3;Stromelysin-1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
52924652;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WLTBPSUTBXIPBI-UHFFFAOYSA-N
150964;YARS;6;6.383e-49;0.4;2.8241;86.0753;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
52926076;LPAR1;6;3.639e-44;0.5614;8.2509;77.5369;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCC=CCC;GRXQVLCZJYBDDD-UHFFFAOYSA-N
131755705;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FBJIMBUHNICHHH-UHFFFAOYSA-N
4427709;FURIN;6;5.112e-45;0.4583;8.2058;79.0671;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
4427709;KISS1R;8;7.388e-95;0.443;12.3264;168.5459;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53479624;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;FXSMMNUNFDTUMS-UHFFFAOYSA-N
19421321;NTSR1;7;5.99e-110;0.411;20.6943;195.6392;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
4078684;ACE;6;4.583e-65;0.5238;64.6468;115.0587;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
9700;P2RY4;6;8.182e-102;0.4384;14.6925;181.0335;P2RY4;P2Y purinoceptor 4 (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
131753836;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;POWNQYNUJQKIJN-UHFFFAOYSA-N
131759889;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;COWOCJLJJIQXGS-UHFFFAOYSA-N
53480868;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VXAQICWVKHYAOM-UHFFFAOYSA-N
53478491;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RMUBRZSHPSLPPN-UHFFFAOYSA-N
7427;SLC5A2;6;1.027e-49;0.4222;36.8906;87.4998;SLC5A2;Sodium/glucose cotransporter 2 (pKi >= 6);C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O;HDTRYLNUVZCQOY-UHFFFAOYSA-N
131753660;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GZLQQXVVOPFZRE-UHFFFAOYSA-N
9547010;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;CCIRMRKPMPEIFZ-UHFFFAOYSA-N
152198;MC3R;6;2.254e-46;0.5417;22.6856;81.5009;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
131759098;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DSZMYGQJZQQSEL-UHFFFAOYSA-N
25200879;MC5R;7;2.883e-92;0.4024;22.9591;163.8938;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
53479853;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;XOTZQQUUCAOSLB-UHFFFAOYSA-N
131758920;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHMSYFQZXWGGAR-UHFFFAOYSA-N
131754999;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YQQLYNBUCCDBQS-UHFFFAOYSA-N
273262;ANPEP;6;1.76e-101;0.5417;35.6652;180.4365;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7021456;FPR1;6;2.457e-61;0.4035;11.5919;108.3636;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
9797038;CCKBR;6;1.064e-118;0.5;120.2571;211.3495;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
56960317;ENPP2;6;1.422e-48;0.6585;7.1315;85.4509;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;LPQBQFLKBCPNAV-UHFFFAOYSA-N
14282475;ENPEP;7;5.8310000000000005e-96;0.4259;7.5338;170.5258;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
6781;CACNA1C;6;3.728e-46;0.4857;18.3805;81.1087;CACNA1C;Voltage-dependent L-type calcium channel subunit alpha-1C (pKi >= 6);CCOC(=O)C1=CC=CC=C1C(=O)OCC;FLKPEMZONWLCSK-UHFFFAOYSA-N
7009555;ANPEP;8;3.062e-93;0.4902;12.6231;165.6419;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
7009650;EDNRA;6;2.5799999999999997e-45;0.5;67.6035;79.6002;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53479650;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZTSRQLQWGSDQGP-UHFFFAOYSA-N
131766679;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;IAFKLCDFTGOUGB-UHFFFAOYSA-N
342468;NPR;6;1.1669999999999999e-68;0.4194;9.8797;121.5113;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
52924563;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXLWNJDUZUKLO-UHFFFAOYSA-N
8048;CES2;7;3.9539999999999995e-51;0.4483;2.9535;90.0394;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
168182;EDNRB;9;8.423e-70;0.5224;6.7151;123.5607;EDNRB;Endothelin B receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
22556;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
131801942;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)O;IGVSZJYOSQMZTC-UHFFFAOYSA-N
7020642;DPP4;6;3.194e-61;0.6889;122.4292;108.1589;DPP4;Dipeptidyl peptidase 4 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
25200879;FURIN;6;9.641e-62;0.4648;11.2922;109.0929;FURIN;Furin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
69421;CQSS;6;1.491e-86;0.5385;2.5399;153.6359;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
66066;NPC1L1;6;1.794e-43;0.4853;3.175;76.2929;NPC1L1;Niemann-Pick C1-like 1 protein (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
101227804;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FSTOZAMDIJDRCH-UHFFFAOYSA-N
7021820;ECE1;6;1.9149999999999998e-52;0.4242;22.6189;92.3999;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
53478349;FABP3;7;5.947e-52;0.4468;1.7099;91.5164;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RIRRWYKZEDZUDS-UHFFFAOYSA-N
8180;FABP3;7;6.518e-57;0.7391;1.8757;100.4214;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
100048;MMP3;6;3.344e-55;0.4821;64.6937;97.3513;MMP3;Stromelysin-1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
53479631;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;UKRAYYYOKQQQKZ-UHFFFAOYSA-N
13783081;GHSR;6;1.291e-76;0.65;78.934;135.7949;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
6992563;HLA-A;6;8.034e-55;0.4528;8.4321;96.6678;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
3634442;MMP11;6;3.378e-120;0.4533;12.1186;214.0391;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
131756654;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SGNGDCVKDGTDQC-UHFFFAOYSA-N
9543847;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CPEWURNZWJEDDC-UHFFFAOYSA-N
52924614;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;AYXGHIQPMDYMJC-UHFFFAOYSA-N
273262;CTSL;6;6.171e-52;0.4333;39.8849;91.4875;CTSL;Cathepsin L1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131755894;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QXJSFSDQSFDVAT-UHFFFAOYSA-N
13890535;PAPA1_CARPA;6;1.488e-69;0.4545;10.4877;123.1172;PAPA1_CARPA;Papain (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131802002;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;UFKFDATWXJRMOS-UHFFFAOYSA-N
131801910;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;JOJJIWNPSBTCRD-UHFFFAOYSA-N
6993120;REN;6;1.6959999999999998e-47;0.4138;79.7577;83.5179;REN;Renin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
273262;NPR;6;1.115e-115;0.5263;16.7053;205.9268;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
515709;CTSC;6;4.248e-50;0.5455;7.6978;88.188;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
53478054;FABP3;7;4.433e-53;0.4889;1.7476;93.5408;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LTTZSZYLXABAOL-UHFFFAOYSA-N
134906;NPR;8;3.062e-84;0.6296;4.8943;149.4842;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
342468;ECE1;6;1.083e-70;0.4426;30.5372;125.1598;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
17525;CES2C;6;1.437e-58;0.4242;1.9311;103.3959;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
189008;ANPEP;8;7.214e-48;0.4717;6.4399;84.1845;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
131756490;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VNKAHKVFGRGTQD-UHFFFAOYSA-N
10957631;CQSS;6;9.049e-73;0.4412;2.1317;128.8908;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(CO)O;DCBSHORRWZKAKO-UHFFFAOYSA-N
131753518;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ITNUXAAETYEROX-UHFFFAOYSA-N
97415;CMA1;6;1.69e-45;0.5;18.1644;79.9301;CMA1;Chymase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
47579;FPR1;6;4.804e-94;0.5238;17.8289;167.0862;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131753413;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;FSNNOULJUSMJGI-UHFFFAOYSA-N
53479897;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;SQWAGNNCWNPIQG-UHFFFAOYSA-N
7643;FFAR1;6;1.698e-73;0.4722;41.1152;130.1955;FFAR1;Free fatty acid receptor 1 (pKi >= 6);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
329275;CTSB;6;3.487e-58;0.4857;34.294;102.7045;CTSB;Cathepsin B (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7020642;TPP2;6;6.686e-45;0.4783;5.2027;78.8578;TPP2;Tripeptidyl-peptidase 2 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
131754580;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CDADMZPLSYSPIH-UHFFFAOYSA-N
6993120;NPPA;7;5.245e-43;0.52;1.4109;75.4564;NPPA;Natriuretic peptides A (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
6992304;MME;6;2.6320000000000005e-178;0.6765;152.6032;318.3622;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
10445608;OPRD1;6;8.023e-92;0.6071;217.9724;163.0956;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
52922765;LPAR3;6;7.273e-67;0.5254;10.1919;118.2892;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCC;NPXTVNLLGVNVDJ-UHFFFAOYSA-N
13783081;MMP9;6;4.581e-47;0.493;67.9209;82.7433;MMP9;Matrix metalloproteinase-9 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
53479719;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPPCXIJSFVQDL-UHFFFAOYSA-N
53480932;LPAR3;6;3.013e-98;0.5893;15.018;174.631;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NHBRVTKHMMOYTG-UHFFFAOYSA-N
10468;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
13783081;ERAP2;6;4.468e-74;0.4795;2.4495;131.2364;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7010566;ENPEP;7;7.602e-87;0.4423;6.8129;154.1611;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
9547071;FABP3;7;3.0419999999999995e-47;0.5085;1.5525;83.0624;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;PYVRVRFVLRNJLY-UHFFFAOYSA-N
435728;HLA-DRB1;6;7.896e-100;0.4483;9.8439;177.4706;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
7009650;CCKAR;6;1.317e-117;0.5;116.3643;209.3876;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
318292;MMP11;6;2.955e-124;0.4783;12.53;221.3247;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
329275;MME;6;3.584e-139;0.7308;119.1011;248.1039;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
76807;NPR;6;1.116e-98;0.46;14.2374;175.4053;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
14035030;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;VJLLLMIZEJJZTE-UHFFFAOYSA-N
131758820;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;HWXYJCBLRIWFEE-UHFFFAOYSA-N
9948926;EDNRA;6;2.282e-57;0.5625;85.4865;101.2399;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
9797038;CTSB;6;8.477e-48;0.5312;28.1507;84.0588;CTSB;Cathepsin B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
7020642;FKBP1A;6;2.059e-76;0.4138;36.3823;135.4311;FKBP1A;Peptidyl-prolyl cis-trans isomerase FKBP1A (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
53480922;LPAR3;6;1.22e-61;0.6;9.3885;108.9095;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;CKPBBEOJHAPPBT-UHFFFAOYSA-N
150964;CTSB;6;2.1479999999999997e-66;0.551;39.1507;117.4449;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9543869;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XLFXOFMAQPNCDB-UHFFFAOYSA-N
7015704;NOD1;9;1.008e-96;0.4889;6.8899;171.8942;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
91498;CDC25A;6;1.259e-62;0.4706;2.9011;110.6803;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)O)C;YMMFNKXZULYSOQ-UHFFFAOYSA-N
53480990;FABP3;7;1.61e-51;0.5;1.6955;90.7399;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)O;ZXNAIPHYBVMMPY-UHFFFAOYSA-N
131801983;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;DQSHOTZVAMTFFY-UHFFFAOYSA-N
6993120;TIMP3;6;5.387e-80;0.4231;7.0068;141.8624;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53480981;LPAR3;6;1.1399999999999998e-52;0.6486;8.009;92.8043;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;UMEKPPOFCOUEDT-UHFFFAOYSA-N
14767562;PAPA1_CARPA;7;1.138e-74;0.4364;8.2626;132.3028;PAPA1_CARPA;Papain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
3421919;AMP1_PLAFQ;6;8.51e-47;0.5;5.9541;82.2604;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131753929;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HCFBZCCMOSAJDD-UHFFFAOYSA-N
152198;ACE2;6;1.603e-113;0.4638;15.9938;202.0528;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
4427709;C3AR1;6;4.3959999999999996e-41;0.5556;6.7687;72.0035;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
52924578;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;NWJGEXWORFCRSI-UHFFFAOYSA-N
7010580;MMP1;6;1.281e-60;0.5;76.3114;107.0762;MMP1;Interstitial collagenase (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53481050;CQSS;6;3.5559999999999996e-67;0.4211;1.9659;118.8471;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;HCDLRJUFVJOBJP-UHFFFAOYSA-N
329275;CCKAR;6;6.759e-144;0.541;142.3713;256.5859;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
53479630;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;HPHYBSPOEJMPAN-UHFFFAOYSA-N
9948926;GRPR;8;1.037e-81;0.4051;6.5987;144.9426;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
259327;CTSB;6;2.204e-52;0.5333;30.8628;92.2902;CTSB;Cathepsin B (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
111299;CAPN2;6;2.87e-71;0.5;20.6932;126.1956;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
52924223;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QHNWICFFSBJICC-UHFFFAOYSA-N
329275;TACR1;6;2.219e-50;0.55;87.0916;88.6945;TACR1;Substance-P receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
131755148;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QDDBVRCUCSETRT-UHFFFAOYSA-N
4427709;EDNRA;6;3.0989999999999997e-51;0.5781;76.3873;90.2292;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
19816756;MMP8;7;1.338e-43;0.5;28.6924;76.5216;MMP8;Neutrophil collagenase (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
134906;PSMB8;7;9.082e-45;0.48;4.4714;78.6191;PSMB8;Proteasome subunit beta type-8 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53480484;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGZSJHAMIMLPBP-UHFFFAOYSA-N
9948926;SSTR2;6;7.328e-56;0.4507;17.001;98.5348;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
100048;TIMP3;6;4.469e-54;0.463;4.717;95.3298;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
150964;MC5R;7;8.648e-66;0.4865;16.3362;116.3589;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7021820;MME;6;1.0220000000000002e-123;0.52;105.8704;220.3572;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
52924644;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FKCXXHSNNJJOHT-UHFFFAOYSA-N
259327;LAP3;6;2.544e-50;0.6471;5.7422;88.5879;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
329275;CAPN2;6;1.8329999999999999e-127;0.4857;37.1109;227.0831;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9813855;ENPEP;6;9.137e-101;0.5417;12.1565;179.1521;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SNFUTDLOCQQRQD-UHFFFAOYSA-N
131801904;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;BWPPXWXSNNMLOW-UHFFFAOYSA-N
151410;C3AR1;6;8.385e-56;0.4375;9.2281;98.4298;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
100094;ACE;6;2.5050000000000001e-57;0.6538;56.9618;101.1671;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
96814;PSMB5;7;1.839e-50;0.449;11.2722;88.8406;PSMB5;Proteasome subunit beta type-5 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010499;NOD1;9;4.919e-79;0.4082;5.6206;140.1379;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
7020642;BRCA1;6;1.102e-73;0.4028;2.9489;130.5323;BRCA1;Breast cancer type 1 susceptibility protein (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
18218218;NOD1;9;9.034e-96;0.4167;6.8216;170.1844;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
131758777;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QGLNBMRMNJAFOO-UHFFFAOYSA-N
7016045;NAALAD2;6;2.605e-57;0.4167;3.3158;101.1367;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)N)C(=O)O)N;XXDVDTMEVBYRPK-UHFFFAOYSA-N
52924787;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;QISXRGLAZUIPCG-UHFFFAOYSA-N
53479756;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PYFNLOPDTZXGTN-UHFFFAOYSA-N
6992654;FURIN;6;1.3529999999999998e-41;0.6429;7.5742;72.9225;FURIN;Furin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;DAQIJMOLTMGJLO-UHFFFAOYSA-N
102763;NPR;8;4.505e-44;0.6154;2.5399;77.3703;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
7359122;CAPN1;6;6.008e-127;0.5714;73.5476;226.1573;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
3421919;CAPNS1;6;1.912e-82;0.5;5.6585;146.2605;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
13890535;CAPN2;6;2.389e-90;0.5094;26.2674;160.4495;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
52924894;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DXXUYBAISOHOLM-UHFFFAOYSA-N
53480858;LPAR3;6;9.267e-76;0.5323;11.5598;134.2582;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QIJJGYHBXLEBJV-UHFFFAOYSA-N
10445608;RNPEP;6;1.531e-49;0.5106;2.437;87.1882;RNPEP;Aminopeptidase B (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
3421919;HLA-A;7;1.215e-69;0.4167;7.2805;123.2749;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4657542;ACE2;6;1.8309999999999998e-127;0.525;17.9686;227.0836;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
4466134;LAP3;6;1.158e-47;0.6087;5.4349;83.8155;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
52924786;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;BRZHNCZGBULDIZ-UHFFFAOYSA-N
18218218;HLA-A;6;4.8940000000000003e-70;0.4237;10.7977;123.984;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
70694;NOD1;9;1.077e-77;0.5238;5.5244;137.7315;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
131750529;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;VUYXIQLBLBPRDY-UHFFFAOYSA-N
515709;GRIA1;6;1.2450000000000002e-69;0.4727;15.4032;123.2563;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
5280666;CYP1A1;6;1.6000000000000001e-74;1.0;16.3884;132.0369;CYP1A1;Cytochrome P450 1A1 (pKi >= 6);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
19816756;ERAP2;6;5.304e-54;0.4648;1.7784;95.1962;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
53480983;FABP3;7;4.2039999999999997e-54;0.5366;1.7818;95.3774;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)O;QRBGFYBOCBYOSN-UHFFFAOYSA-N
9546824;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WYDGEVICLIVPEG-UHFFFAOYSA-N
131754666;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;PBXBPMVNZAGNPS-UHFFFAOYSA-N
134906;GRPR;7;1.6409999999999998e-81;0.4074;9.0262;144.5843;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3634442;MME;6;4.055e-101;0.5614;86.5241;179.7856;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
131763537;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZGXRJWDPYLJJFG-UHFFFAOYSA-N
52926061;LPAR3;6;3.06e-90;0.5763;13.7867;160.2566;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(C(=O)O)N;MGXXGWZPTJJSOQ-UHFFFAOYSA-N
52924125;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUEUPCHAIFZTKH-UHFFFAOYSA-N
5057430;ANPEP;8;4.38e-93;0.4694;12.6019;165.363;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
131758800;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UAXBSAJQKYIKRG-UHFFFAOYSA-N
10468;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
273262;PSMB2;7;9.704e-41;0.4559;1.1828;71.3861;PSMB2;Proteasome subunit beta type-2 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131754362;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MODDNOQSVMCAIA-UHFFFAOYSA-N
4078684;GRIA1;6;3.445e-72;0.451;15.9732;127.8485;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
92946;FPR1;6;4.1549999999999995e-93;0.5217;17.6502;165.4039;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
92829;YARS;6;9.481e-86;0.4565;4.9827;152.1935;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
134906;TACR1;6;1.669e-58;0.5714;101.0392;103.2792;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924233;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;RPYIJSOTHVJLOR-UHFFFAOYSA-N
53480848;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OSDKOUUHCQCQEG-UHFFFAOYSA-N
14325553;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCABCCITBXMTKG-UHFFFAOYSA-N
9546826;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UITCASPZWUAJBW-UHFFFAOYSA-N
47579;PAPA1_CARPA;6;2.705e-74;0.4524;11.2086;131.6277;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
151410;AMP1_PLAFQ;6;4.0979999999999995e-41;0.52;5.2214;72.0583;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131753492;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMPQNKRQIPPNFC-UHFFFAOYSA-N
7009650;MMP11;6;7.165e-100;0.4359;10.0578;177.5464;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53479554;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RETPVUGMYRRYPF-UHFFFAOYSA-N
131756087;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TZMQOSMAJITOAT-UHFFFAOYSA-N
131763181;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JKLVWHFEADJCSE-UHFFFAOYSA-N
53481885;LPAR3;6;4.658e-119;0.7308;18.2183;211.9932;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(COP(=O)(O)O)O;OYWQLEFQIHHFDV-UHFFFAOYSA-N
6992643;AMP1_PLAFQ;6;4.2520000000000004e-55;0.5333;7.0246;97.1639;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480873;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QEDROTQEMCQUNE-UHFFFAOYSA-N
100094;SSTR2;7;7.637e-57;0.4521;13.7205;100.298;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
6435901;ENPP2;6;7.85e-42;0.4444;6.1293;73.3467;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
131754934;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;POAVLZRSJOCQEL-UHFFFAOYSA-N
52924728;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCPNXDHEZUMTLB-UHFFFAOYSA-N
13783081;MC5R;7;1.685e-88;0.4872;22.0169;157.1312;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
53478164;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QSEJQXZIIUGBTF-UHFFFAOYSA-N
8201;CQSS;6;5.2580000000000004e-76;0.4643;2.2275;134.7;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
5282761;EST1_PIG;7;2.519e-63;0.4194;4.1732;111.9348;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
53479718;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;GKXLKICEHUALBW-UHFFFAOYSA-N
7021820;CAPNS1;6;1.667e-65;0.4167;4.4856;115.8471;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
520710;CES2;7;2.362e-48;0.4194;2.7908;85.0549;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
4657542;ECE1;6;4.6889999999999996e-73;0.4878;31.5629;129.4033;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
57281443;HLA-A;6;4.666e-73;0.5192;11.2674;129.4072;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(C(C)O)N;LUMXICQAOKVQOB-UHFFFAOYSA-N
273262;NTSR2;8;6.998000000000001e-102;0.4304;9.8313;181.1554;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
150964;CPA1;6;3.487e-58;0.4706;7.2064;102.7046;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
131801935;FABP3;7;5.697e-56;0.5238;1.8443;98.7311;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;JADWQWJGAYXZKD-UHFFFAOYSA-N
13890535;FOLH1;6;8.694e-49;0.4651;15.3504;85.8344;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
193508;CAPN2;6;1.762e-129;0.5581;37.7002;230.7045;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
53480985;LPAR3;6;8.233999999999999e-54;0.617;8.1845;94.8533;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(CO)O;NXOGCYSVLAIYAP-UHFFFAOYSA-N
4427709;CAPN1;6;1.0490000000000001e-79;0.52;46.1311;141.3424;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
520710;EST1_PIG;6;1.046e-64;0.4194;5.062;114.4154;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
53480897;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CFANDHZPOSNKNO-UHFFFAOYSA-N
131755698;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HTFZBWPHGZEFJU-UHFFFAOYSA-N
9797038;MMP8;9;1.217e-52;0.5;10.8682;92.7531;MMP8;Neutrophil collagenase (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
3081383;P2RY2;6;2.4639999999999997e-47;0.4946;11.4687;83.2268;P2RY2;P2Y purinoceptor 2 (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
52924815;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PQCDVFVOQBZXJA-UHFFFAOYSA-N
53478177;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MLKOWSFMVFMITR-UHFFFAOYSA-N
10445608;YARS;6;9.849e-91;0.5217;5.2748;161.1404;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
53478416;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;KVDLGXAZPYNPJG-UHFFFAOYSA-N
6993120;HLA-A;6;3.912e-64;0.5439;9.88;113.3868;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
14282475;CAPN2;6;9.034999999999999e-89;0.4528;25.8065;157.6171;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
152198;YARS;6;2.029e-50;0.4444;2.9119;88.7643;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
53478149;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;QBTJRRWTWAXKSO-UHFFFAOYSA-N
10445608;KLK3;7;6.91e-44;0.4032;4.6513;77.0368;KLK3;Prostate-specific antigen (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
131761056;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HAGMTXDICLFDOC-UHFFFAOYSA-N
151134;AMP1_PLAFQ;6;1.222e-46;0.5417;5.9339;81.9782;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;ACE2;6;3.8620000000000003e-121;0.5;17.0729;215.7299;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
318292;SSTR2;7;2.173e-59;0.4638;14.3403;104.8687;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
168182;ACE2;6;6.062e-80;0.4561;11.2378;141.7703;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
52925079;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;XVXISDREVDGQPX-UHFFFAOYSA-N
131801877;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;JWCNGONSUJKGDO-UHFFFAOYSA-N
6992304;OPRM1;6;3.626e-85;0.5714;245.9272;151.1476;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
14767562;HLA-A;6;3.116e-110;0.4605;17.0472;196.1488;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
131759399;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDWAIWYOHVLVMF-UHFFFAOYSA-N
9546826;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UITCASPZWUAJBW-UHFFFAOYSA-N
52924549;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;UBTNBSZLGQJLPI-UHFFFAOYSA-N
7359122;HLA-DRB1;6;4.5909999999999995e-105;0.4464;10.3636;186.87;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;LTA4H;6;3.05e-43;0.619;23.7162;75.8793;LTA4H;Leukotriene A-4 hydrolase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
515717;NTSR1;6;1.2260000000000001e-108;0.4366;26.3304;193.2858;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
435728;MMP3;6;7.581e-59;0.4464;68.9562;103.8944;MMP3;Stromelysin-1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
97415;BLA1_STEMA;6;5.1550000000000004e-96;0.5;8.6357;170.6219;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
97415;AMP1_PLAFQ;6;2.848e-48;0.4667;6.1444;84.9093;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
515717;CAPN2;6;4.714e-63;0.617;18.2929;111.4461;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
131764015;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RJJPSRSFWRKXGV-UHFFFAOYSA-N
4427709;MME;6;1.2899999999999999e-176;0.7115;151.1561;315.3273;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP2;6;1.2639999999999999e-45;0.5789;73.8794;80.1565;MMP2;72 kDa type IV collagenase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
8201;EST1_PIG;7;2.2180000000000002e-69;0.4643;4.5769;122.8059;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
13783081;CAPN1;6;1.4399999999999997e-54;0.4857;31.5429;96.2126;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
52924878;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CIXWKDHTFXYVTC-UHFFFAOYSA-N
13890535;CPA1;6;1.271e-92;0.5333;11.5183;164.5325;CPA1;Carboxypeptidase A1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131801910;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;JOJJIWNPSBTCRD-UHFFFAOYSA-N
18218238;MC3R;6;1.005e-91;0.4146;45.0039;162.9197;MC3R;Melanocortin receptor 3 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
151410;CTSB;6;2.4249999999999997e-80;0.6;47.4008;142.4847;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53479648;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;BIYXBOGKCFGRKR-UHFFFAOYSA-N
9546843;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;VOSQJLVNDRUECW-UHFFFAOYSA-N
9700;TK1;6;4.345e-66;0.7021;3.4577;116.8956;TK1;Thymidine kinase, cytosolic (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
53479554;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RETPVUGMYRRYPF-UHFFFAOYSA-N
131754603;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KFJPYNZNXSQRNB-UHFFFAOYSA-N
12599;P2RY1;6;3.6680000000000003e-78;0.6393;38.1824;138.5714;P2RY1;P2Y purinoceptor 1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
13783081;KISS1R;8;5.451e-89;0.4524;11.5589;158.0111;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
329275;EDNRB;9;3.8410000000000003e-69;0.5147;6.6511;122.3776;EDNRB;Endothelin B receptor (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
6992563;CAPN1;6;2.193e-57;0.7045;33.178;101.2708;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
6992643;NPR;6;1.4160000000000001e-95;0.4386;13.7869;169.834;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480701;LPAR3;6;1.5209999999999998e-47;0.5167;7.2208;83.6029;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C;GADWRGZCWDFELP-UHFFFAOYSA-N
20057356;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;DFELABABMXOKTD-UHFFFAOYSA-N
329275;ACE2;6;5.692e-84;0.4483;11.8082;149.0007;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
96814;MMP9;6;3.28e-50;0.5319;72.4375;88.3898;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
18218238;MME;6;8.793e-46;0.5424;39.1518;80.4395;MME;Neprilysin (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
102763;TACR1;6;2.725e-45;0.5273;78.3539;79.5577;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
131755736;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;GGCGDJPSQJXGBG-UHFFFAOYSA-N
13783081;MC4R;6;4.591e-68;0.5588;100.5041;120.4433;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
6993120;CAPN1;6;9.172e-145;1.0;83.887;258.1431;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
3634442;SSTR2;7;1.504e-65;0.4324;15.8399;115.9272;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
7359122;XIAP;6;2.102e-45;0.4915;18.5493;79.7602;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
14409732;MC5R;8;9.693000000000001e-55;0.4225;8.048;96.5215;MC5R;Melanocortin receptor 5 (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
151134;CAPN1;6;8.088000000000001e-109;0.549;63.0266;193.6098;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
329275;MMP9;7;5.825e-54;0.625;64.754;95.1232;MMP9;Matrix metalloproteinase-9 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7009598;CAPN2;6;1.124e-134;0.6341;39.218;240.0318;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
150964;RNPEP;6;5.4599999999999994e-48;0.4444;2.3594;84.4017;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
53480895;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;OBAAWAYLQLYWNN-UHFFFAOYSA-N
168058;POLG_WNV;6;5.074e-74;0.451;6.479;131.1372;POLG_WNV;Genome polyprotein (pKi >= 6);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
9797038;FPR1;6;1.0689999999999998e-81;0.5781;15.4744;144.9187;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
5057430;RNPEP;6;7.103e-45;0.4375;2.2039;78.8107;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
10445608;CTSL;6;3.946e-59;0.4231;45.4203;104.4035;CTSL;Cathepsin L1 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
52924623;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CVPHRRKVQKYWSZ-UHFFFAOYSA-N
7009555;CPA1;6;8.196e-45;0.6222;5.5322;78.6991;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
3081383;AANAT;7;7.289e-123;0.6937;4.0803;218.8253;AANAT;Serotonin N-acetyltransferase (pKi >= 7);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
89566;LPAR3;6;3.991e-130;1.0;19.9203;231.8621;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;YNDYKPRNFWPPFU-UHFFFAOYSA-N
221122;SRD5A1;8;2.918e-43;0.5893;8.6604;75.9138;SRD5A1;3-oxo-5-alpha-steroid 4-dehydrogenase 1 (pKi >= 8);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
6993120;CTSC;6;7.391e-42;0.4375;6.4166;73.3937;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4427709;GHSR;6;9.329e-87;0.7273;89.3762;154.0015;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53479609;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZBKSDVGXOOCETO-UHFFFAOYSA-N
96814;NAALAD2;6;7.009e-43;0.5366;2.47;75.2305;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
13890535;ANPEP;8;6.918e-92;0.4615;12.4386;163.2112;ANPEP;Aminopeptidase N (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
52925230;LPAR3;6;5.122e-95;0.6296;14.5212;168.8316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCC(C(=O)O)N;QBNCFMDNNPQYIL-UHFFFAOYSA-N
57315376;ENPEP;7;4.403e-90;0.5;7.0689;159.9729;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)N)N;XITLYYAIPBBHPX-UHFFFAOYSA-N
168182;MC5R;7;2.067e-84;0.4459;20.9942;149.7906;MC5R;Melanocortin receptor 5 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
13783081;SSTR2;7;2.1079999999999996e-53;0.4026;12.8827;94.1202;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
52926034;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;QPLGPOYWQGNODB-UHFFFAOYSA-N
151134;C3AR1;6;3.4179999999999997e-82;0.5;13.6373;145.8078;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
22556;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
97415;CTSL;6;1.7800000000000001e-63;0.4884;48.7638;112.2052;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
6992643;CASP1;6;6.094e-48;0.52;25.9652;84.3161;CASP1;Caspase-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
131801777;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DRUQEDUMAQZVOU-UHFFFAOYSA-N
7016103;RNPEP;6;1.937e-45;0.4583;2.232;79.8237;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
3038501;EDNRB;9;1.945e-62;0.4714;5.9998;110.3408;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
131766702;LPAR3;6;2.791e-80;0.6977;12.2551;142.3752;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)O;GOLRHKZVCRTBFW-UHFFFAOYSA-N
25200879;MC3R;6;3.623e-96;0.4487;47.1905;170.8968;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4466134;RNPEP;6;3.066e-46;0.6087;2.272;81.2611;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
47579;FCER2;6;2.6310000000000002e-98;0.4151;12.0447;174.737;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
52925079;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;XVXISDREVDGQPX-UHFFFAOYSA-N
131801990;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;VLJNBDVONLLDHB-UHFFFAOYSA-N
53479647;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;ANRCNDSZUNAAEU-UHFFFAOYSA-N
92946;OPRM1;6;5.154e-105;0.54;302.7452;186.7799;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
52924125;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUEUPCHAIFZTKH-UHFFFAOYSA-N
52926071;LPAR3;6;4.94e-100;0.6415;15.2926;177.8363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCCCC;SYAYTZJXUCQTMJ-UHFFFAOYSA-N
131759098;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DSZMYGQJZQQSEL-UHFFFAOYSA-N
7009650;CCKBR;6;4.838e-79;0.5139;80.0905;140.1509;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
7009598;TIMP3;6;1.114e-57;0.4038;5.0353;101.799;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
7010506;HLA-A;7;1.5100000000000002e-58;0.4407;6.1097;103.3571;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
134906;MC1R;6;7.838e-144;0.6452;73.195;256.4703;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924624;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BYVQCOREHGDXRD-UHFFFAOYSA-N
6992643;CTSL;6;3.246e-65;0.449;50.102;115.3276;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
259327;HLA-A;6;2.928e-104;0.549;16.1186;185.4254;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
151134;FOLH1;6;5.347e-98;0.6486;30.9675;174.184;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
6351946;MME;6;6.88e-167;0.48;142.829;297.8644;MME;Neprilysin (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
329275;NTSR1;10;2.917e-44;0.4545;1.2872;77.7091;NTSR1;Neurotensin receptor type 1 (pKi >= 10);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
6351946;ECE1;6;5.242e-73;0.4231;31.5419;129.3164;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
7021456;NTSR1;6;1.064e-127;0.6269;30.9711;227.507;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
131754603;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KFJPYNZNXSQRNB-UHFFFAOYSA-N
193508;CAPNS1;6;9.552e-86;0.4444;5.8871;152.1877;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
5488196;ACE;6;1.07e-111;0.6757;110.9614;198.7776;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
14282475;ACE2;7;1.414e-91;0.551;11.3873;162.6537;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
131754962;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;YLDIXESVFMDKJA-UHFFFAOYSA-N
9546841;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DBYSGBYABPVNGO-UHFFFAOYSA-N
52925128;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ZVVYJAAMWXATNY-UHFFFAOYSA-N
13890535;NPR;6;1.8239999999999998e-66;0.4082;9.5612;117.5722;NPR;Thermolysin (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
92021849;GPR17;7;9.272e-57;0.4125;1.6574;100.1467;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
63842847;YARS;6;1.177e-91;0.4333;5.3289;162.7966;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
5282761;SLCO2A1;6;6.520000000000001e-58;0.4043;1.9092;102.2166;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
1549040;CYP1A1;6;3.169e-58;0.6154;12.7799;102.7791;CYP1A1;Cytochrome P450 1A1 (pKi >= 6);CC=CC1=CC=C(C=C1)OC;RUVINXPYWBROJD-UHFFFAOYSA-N
53478597;LPAR3;6;2.184e-76;0.5957;11.6563;135.3851;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;YUFFMVIZZQIBPN-UHFFFAOYSA-N
10257;MPO;6;5.7360000000000004e-102;0.6842;16.7756;181.3104;MPO;Myeloperoxidase (pKi >= 6);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
7009555;MME;6;1.0340000000000002e-180;0.6222;154.6625;322.6809;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
53480853;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;HUHQLMQCUTXEIJ-UHFFFAOYSA-N
7009555;CTSB;6;1.354e-45;0.5745;26.8474;80.1031;CTSB;Cathepsin B (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
323786;NTSR1;6;6.822e-74;0.5;17.8712;130.9063;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
9546824;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WYDGEVICLIVPEG-UHFFFAOYSA-N
3038501;GLO1;6;1.862e-43;0.4091;3.7787;76.264;GLO1;Lactoylglutathione lyase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
3421919;LAP3;6;5.322e-79;0.5;9.0571;140.0766;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
318292;FPR1;6;9.049e-71;0.5574;13.3907;125.3001;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
52924894;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DXXUYBAISOHOLM-UHFFFAOYSA-N
168182;CCKAR;6;5.829e-143;0.5246;141.4456;254.9059;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
31292;FABP3;7;5.498e-47;0.4815;1.5439;82.601;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
53480895;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;OBAAWAYLQLYWNN-UHFFFAOYSA-N
131753543;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UOGFRTWKEGEEJU-UHFFFAOYSA-N
150964;CAPN1;6;4.963e-101;0.5417;58.5069;179.6279;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
47579;MME;6;2.288e-234;0.6389;200.5959;419.0092;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
342468;CAPN1;6;3.183e-92;0.6136;53.3959;163.8166;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
52924785;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;JCZXAXBRLLOCPM-UHFFFAOYSA-N
4078684;NPR;6;4.004e-57;0.4681;8.2052;100.8015;NPR;Thermolysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
435728;RNPEP;6;1.084e-43;0.5532;2.1447;76.6855;RNPEP;Aminopeptidase B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
131755699;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JPBYHVQUOOKCGQ-UHFFFAOYSA-N
52923736;LPAR3;6;2.23e-73;0.5424;11.1936;129.9829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCC;YMBXMIQDISYIFB-UHFFFAOYSA-N
131802010;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;ODIFDYMVTZMQLS-UHFFFAOYSA-N
53478321;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UCEIHNHHMYDTNZ-UHFFFAOYSA-N
44232492;PSMB2;7;7.158e-50;0.4091;1.4533;87.7812;PSMB2;Proteasome subunit beta type-2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
52923844;LPAR3;6;2.689e-48;0.5094;7.3365;84.954;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC;OZQMKPUQMDJPII-UHFFFAOYSA-N
3421919;CTSB;6;7.634e-91;0.7209;53.6129;161.3391;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
7020642;NPFFR2;8;6.809e-43;0.4444;1.5588;75.253;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
168182;NTSR1;10;4.6870000000000005e-42;0.4253;1.2218;73.7488;NTSR1;Neurotensin receptor type 1 (pKi >= 10);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7010580;MMP9;6;6.295e-43;0.46;61.9784;75.3142;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53480903;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CJTMZOOUZQGAPV-UHFFFAOYSA-N
12530;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
52924232;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;DWDUPRRUGYDGQF-UHFFFAOYSA-N
131758887;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCC;GEDOOJBTRRNYEP-UHFFFAOYSA-N
168182;CAPN2;6;9.195e-48;0.4306;13.8258;83.9953;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
56991460;ENPEP;7;9.721e-91;0.4894;7.1208;161.1507;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC(=O)N)N;MQLZLIYPFDIDMZ-UHFFFAOYSA-N
19816755;CCKBR;6;2.126e-112;0.5217;113.8755;200.0376;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
7010506;ANPEP;8;1.565e-125;0.5926;17.0237;223.6156;ANPEP;Aminopeptidase N (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
53479605;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VNAHWIQCBOQKAJ-UHFFFAOYSA-N
52924408;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;GMXIUCLINHXQQD-UHFFFAOYSA-N
53479650;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZTSRQLQWGSDQGP-UHFFFAOYSA-N
13783081;EDNRA;6;9.521e-44;0.5857;65.2786;76.7869;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
342468;NTSR2;8;5.367e-104;0.425;10.0368;184.9529;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4656408;ERAP2;6;4.512e-47;0.4203;1.5468;82.7551;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
5282761;PLA2G4B;6;4.593999999999999e-47;0.4857;4.0975;82.741;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
150964;QRFPR;6;2.097e-51;0.44;6.2611;90.5338;QRFPR;Pyroglutamylated RFamide peptide receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
52924623;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CVPHRRKVQKYWSZ-UHFFFAOYSA-N
12599;SLC29A1;6;1.066e-54;0.4247;17.5455;96.4473;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
7009553;ENPEP;7;1.101e-85;0.4808;6.7211;152.077;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
9797038;MC4R;6;6.391999999999999e-60;0.4648;88.5224;105.8227;MC4R;Melanocortin receptor 4 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
4657542;CPA1;6;1.117e-124;0.5882;15.5319;222.0831;CPA1;Carboxypeptidase A1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7010506;HLA-DRB1;6;1.414e-66;0.4615;6.5428;117.7709;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6992304;CTSC;6;1.336e-47;0.55;7.3094;83.7038;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
515709;MMP1;6;2.037e-45;0.4902;57.2221;79.7844;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
4466134;ACE;6;1.052e-73;0.6122;73.2272;130.5687;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53479720;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DVFTWBPPIMYUEN-UHFFFAOYSA-N
131753741;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MFFDRCAJUNCFIE-UHFFFAOYSA-N
47579;NPFFR1;7;2.0179999999999998e-68;0.5106;5.8304;121.0843;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131753311;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYFACDKCDVPZSE-UHFFFAOYSA-N
6992643;ECE1;6;1.7360000000000002e-71;0.4783;30.8823;126.5875;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
9948926;MC3R;6;6.282e-88;0.48;43.1359;156.1051;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
70694;CES2;7;2.662e-50;0.4242;2.905;88.5526;CES2;Cocaine esterase (pKi >= 7);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
131753215;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCC;DOEBPNOTMREOMP-UHFFFAOYSA-N
52924681;LPAR3;6;2.8250000000000003e-78;0.5862;11.9467;138.7751;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;HDCWJEDGPFQUKG-UHFFFAOYSA-N
80108;CDC25B;6;9.374e-87;0.4375;8.9082;153.9977;CDC25B;M-phase inducer phosphatase 2 (pKi >= 6);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
13783081;FPR1;6;4.2e-84;0.5584;15.9332;149.2377;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
76041074;ENPP2;6;1.422e-48;0.6585;7.1315;85.4509;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;RPAOEHFOGLEBTJ-UHFFFAOYSA-N
47579;NPFFR2;6;1.263e-49;0.5106;7.7896;87.3384;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
164672;SLC10A1;6;1.5209999999999998e-53;0.4151;2.1343;94.375;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCCC4)C)O)O)C;ZHCAAZIHTDCFJX-UHFFFAOYSA-N
92946;ECE1;6;4.116e-83;0.4681;35.9269;147.4581;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
13783081;CCKAR;6;4.658e-140;0.5658;138.5743;249.6949;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131753305;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RVRHSALQSYBGAG-UHFFFAOYSA-N
6993120;CPA1;6;2.7149999999999996e-94;0.6047;11.7274;167.531;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53480971;FABP3;7;1.2469999999999999e-52;0.5789;1.7326;92.7343;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(CO)CO;LRBJILYYDLUADN-UHFFFAOYSA-N
342468;CTSB;6;4.716e-62;0.5714;36.5826;109.6504;CTSB;Cathepsin B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
53479852;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;AHVVIUYIKIQVDO-UHFFFAOYSA-N
9543752;LPAR3;6;1.3890000000000001e-55;0.5185;8.4571;98.0363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MUYDIVLBRBWUDW-UHFFFAOYSA-N
151410;NPFFR1;7;2.788e-84;0.4211;7.1956;149.5573;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
273262;CACNA1B;6;4.4810000000000005e-46;0.4058;13.3889;80.9651;CACNA1B;Voltage-dependent N-type calcium channel subunit alpha-1B (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
14767562;ACE;6;1.374e-56;0.5294;56.2275;99.8399;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
53480139;LPAR1;6;4.63e-44;0.541;8.2311;77.349;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;SNVHCYWMCGHCMU-UHFFFAOYSA-N
53480874;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VQMPZNPOSKPGTN-UHFFFAOYSA-N
4466134;MME;6;1.5480000000000002e-165;0.6122;141.6715;295.4369;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
11674746;FABP3;7;1.2469999999999999e-52;0.5789;1.7326;92.7343;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OC(CO)CO;ZCCLDKGWJIREQF-UHFFFAOYSA-N
131759473;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MONMKVNVVBWTKM-UHFFFAOYSA-N
13817313;FPR1;6;2.226e-74;0.4255;14.0789;131.7796;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
10458;KDM2A;6;9.509e-48;0.4074;1.8998;83.9692;KDM2A;Lysine-specific demethylase 2A (pKi >= 6);C(CCCCCC(=O)O)CCCCCC(=O)O;DXNCZXXFRKPEPY-UHFFFAOYSA-N
6992643;OPRD1;6;9.673000000000001e-104;0.58;246.089;184.4937;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
52924901;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HNFSZKRUPTYBOQ-UHFFFAOYSA-N
53478458;LPAR3;6;8.788999999999999e-60;0.5283;9.1028;105.5744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCC;YDNAPGXYBAGJKV-UHFFFAOYSA-N
193508;MMP3;6;1.599e-49;0.52;58.0507;87.1544;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
53479852;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;AHVVIUYIKIQVDO-UHFFFAOYSA-N
6992304;YARS;6;2.812e-75;0.4773;4.3689;133.3928;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
7789;CQSS;6;4.2049999999999997e-82;0.5161;2.4081;145.6461;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(CCCCCCCCCCC(=O)O)O;ULQISTXYYBZJSJ-UHFFFAOYSA-N
53478437;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCHJOJAVIATUSR-UHFFFAOYSA-N
9948926;GHSR;6;1.227e-76;0.6842;78.9568;135.8348;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
25200879;TACR1;6;5.73e-45;0.4789;77.7997;78.9781;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
18986;MPO;6;4.079e-87;0.4043;14.3183;154.6465;MPO;Myeloperoxidase (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
5488196;CAPN2;6;6.573999999999999e-138;0.4667;40.1625;245.8356;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
131759281;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WVBFGMOFOIEXMP-UHFFFAOYSA-N
131758647;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LMDMXKYAEKPMRJ-UHFFFAOYSA-N
263475;NMBR;6;2.234e-64;0.5172;10.2395;113.8236;NMBR;Neuromedin-B receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
4418533;CD22;6;5.828e-84;0.4476;3.9016;148.9823;CD22;B-cell receptor CD22 (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)NC(=O)C)OC4C(C(OC(C4O)OC(C(CO)O)C(C(C=O)O)O)CO)O)CO)O)O)O)O;SXMGGNXBTZBGLU-UHFFFAOYSA-N
52925230;FABP3;7;5.279e-50;0.6034;1.6448;88.0186;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCC(C(=O)O)N;QBNCFMDNNPQYIL-UHFFFAOYSA-N
52924578;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;NWJGEXWORFCRSI-UHFFFAOYSA-N
171204;ACE;6;6.021e-80;0.65;79.427;141.7756;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
9543745;FABP3;7;2.47e-50;0.5116;1.6558;88.6109;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;RAPBJBKXYYMYAY-UHFFFAOYSA-N
92946;BLA1_STEMA;6;5.166e-84;0.4107;7.5486;149.0764;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
52924644;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FKCXXHSNNJJOHT-UHFFFAOYSA-N
12051354;S1PR2;9;4.518e-50;0.4667;1.6471;88.14;S1PR2;Sphingosine 1-phosphate receptor 2 (pKi >= 9);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
131802041;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;WGCCNBRJWHJBEZ-UHFFFAOYSA-N
150964;OPRD1;6;6.969e-77;0.6032;182.7317;136.2757;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
8163;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
19816756;NMBR;6;3.699e-59;0.4754;9.4018;104.4539;NMBR;Neuromedin-B receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
18986;MTNR1B;6;1.185e-91;0.6512;61.986;162.7916;MTNR1B;Melatonin receptor type 1B (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
13879965;HLA-A;6;6.914000000000001e-63;0.5;9.6861;111.1474;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)N;BCVIOZZGJNOEQS-UHFFFAOYSA-N
329275;MC4R;6;1.153e-62;0.5147;92.5594;110.7489;MC4R;Melanocortin receptor 4 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
323786;CAPN1;6;1.78e-103;0.5965;59.926;184.018;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7021456;MC4R;6;1.794e-45;0.5312;67.2649;79.8834;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
100094;MC5R;7;6.658e-86;0.4805;21.3674;152.4692;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7010566;HLA-A;6;1.291e-101;0.5424;15.7075;180.6781;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
53480857;LPAR3;6;2.389e-75;0.5082;11.4965;133.5198;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HHQFKPJXVYWLLJ-UHFFFAOYSA-N
3634442;EDNRB;9;3.288e-62;0.4444;5.9777;109.9317;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
52924776;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;KXVQBSORIXQSRP-UHFFFAOYSA-N
52924213;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UDBXKKKIEXMSEA-UHFFFAOYSA-N
53479612;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KYERVKWKQQBRQB-UHFFFAOYSA-N
18218238;GHSR;6;1.8e-74;0.6308;76.726;131.9451;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
13890535;MMP3;6;6.185e-53;0.4706;62.0421;93.2812;MMP3;Stromelysin-1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131754967;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;DHISSBAEVLDFEV-UHFFFAOYSA-N
7010506;CAPN2;6;1.0969999999999999e-114;0.4898;33.378;204.1441;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
151003;ACE;6;9.526e-61;0.6279;60.3584;107.3069;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
53480924;LPAR1;6;1.571e-45;0.5185;8.509;79.9868;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;CZYOFWNORPEFDG-UHFFFAOYSA-N
7010566;XIAP;6;1.752e-45;0.4127;18.5819;79.9021;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
131763207;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HXJRHBUXUMSJKX-UHFFFAOYSA-N
9561835;NOD1;9;3.106e-95;0.4595;6.7831;169.2214;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCC(CCCCCCCCC(=O)O)O;PAZZVPKITDJCPV-UHFFFAOYSA-N
7021456;ACE;6;5.2749999999999997e-51;0.4833;50.6814;89.8145;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
131759473;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MONMKVNVVBWTKM-UHFFFAOYSA-N
53480983;LPAR3;6;1.377e-75;0.6522;11.5333;133.9492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)O;QRBGFYBOCBYOSN-UHFFFAOYSA-N
52925094;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVTRPEJBOGUHBJ-UHFFFAOYSA-N
7009598;LAP3;6;1.8600000000000001e-85;0.5333;9.8034;151.6681;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
131801884;FABP3;7;5.697e-56;0.5238;1.8443;98.7311;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;XJJBSSJHWZLHHT-UHFFFAOYSA-N
53479739;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;SSVPEUWHHFKSEB-UHFFFAOYSA-N
131801915;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;QPKXQZITTOAAKY-UHFFFAOYSA-N
131758920;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHMSYFQZXWGGAR-UHFFFAOYSA-N
5057430;FPR1;6;3.276e-85;0.4681;16.1444;151.2267;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
53479600;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;SMHQICHVYVREKX-UHFFFAOYSA-N
53478393;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXPLJLDIGVRTRM-UHFFFAOYSA-N
3634442;NPR;8;2.222e-61;0.5517;3.5543;108.4418;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
53479939;LPAR3;6;6.546e-87;0.4754;13.2746;154.2777;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PCKXGFCVDCVIHH-UHFFFAOYSA-N
53481000;SELP;6;1.182e-77;0.7286;6.086;137.659;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O;FGJIXPPBZNPEHW-UHFFFAOYSA-N
102763;MMP11;6;5.516e-115;0.4225;11.5901;204.6801;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
52927174;LPAR3;6;2.759e-100;0.6415;15.3315;178.2906;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCC;NOFOTAHTYLXZNV-UHFFFAOYSA-N
5280666;CYP1B1;7;8.586999999999999e-91;1.0;12.2895;161.2473;CYP1B1;Cytochrome P450 1B1 (pKi >= 7);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
100048;PAPA1_CARPA;7;2.271e-85;0.4138;9.4569;151.5125;PAPA1_CARPA;Papain (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
70694;CQSS;6;3.475e-65;0.4062;1.907;115.2744;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
53478106;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BYLXXZYUDXCZFN-UHFFFAOYSA-N
11622;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
65254;GLO1;6;1.839e-48;0.4035;4.221;85.2502;GLO1;Lactoylglutathione lyase (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
9546747;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;HBZNVZIRJWODIB-UHFFFAOYSA-N
131755191;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QJRAIXUZRUZYSD-UHFFFAOYSA-N
9547069;LPAR3;6;4.283e-69;0.7143;10.5349;122.2927;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;YVYMBNSKXOXSKW-UHFFFAOYSA-N
5488196;PAPA1_CARPA;7;6.3499999999999996e-83;0.4423;9.1838;147.1201;PAPA1_CARPA;Papain (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7775;CQSS;6;7e-70;0.4516;2.0461;123.705;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)OCC(C)C;UXUPPWPIGVTVQI-UHFFFAOYSA-N
47579;CPA1;6;2.9030000000000002e-123;0.575;15.3548;219.5432;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
9856500;FOLH1;6;1.408e-50;0.7273;15.9186;89.049;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
151134;MMP3;6;8.706e-58;0.5192;67.7163;101.9911;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
342468;ACE2;7;4.321e-123;0.7273;15.3331;219.233;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
53479988;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;UJDHYDGXZXDWNT-UHFFFAOYSA-N
9948926;MMP11;6;3.2319999999999997e-118;0.4648;11.9178;210.4829;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
152198;MC1R;6;6.202000000000001e-78;0.5417;39.5983;138.1619;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
6427003;POLG_WNV;6;4.926e-72;0.46;6.3035;127.5697;POLG_WNV;Genome polyprotein (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
18218218;ENPEP;6;9.483e-100;0.5417;12.0332;177.3278;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
4656408;NPR;8;1.756e-42;0.5185;2.4467;74.5142;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
131754603;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KFJPYNZNXSQRNB-UHFFFAOYSA-N
342468;ANPEP;8;3.481e-83;0.4727;11.2527;147.5888;ANPEP;Aminopeptidase N (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
11579826;MME;6;2.267e-158;0.4773;135.537;282.572;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
6992643;ANPEP;8;1.9129999999999997e-133;0.5333;18.102;237.8215;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480140;FABP3;7;7.184999999999999e-45;0.5147;1.4732;78.8017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;XDPWHDYPIVOSGA-UHFFFAOYSA-N
14304554;ACE2;7;2.8250000000000003e-71;0.413;8.8455;126.2079;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
53480993;FABP3;7;3.864e-47;0.4762;1.5491;82.876;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(CO)O;HDIQCISTZKHUDO-UHFFFAOYSA-N
131801899;FABP3;7;2.4999999999999997e-55;0.55;1.8228;97.578;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;RJUNCJKUOOBPGW-UHFFFAOYSA-N
7010580;CTSB;6;1.617e-101;0.5682;59.9269;180.5026;CTSB;Cathepsin B (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
14282475;MME;6;1.443e-112;0.5769;96.3252;200.3398;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
134906;SSTR2;6;6.124000000000001e-69;0.4444;21.0117;122.0139;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
65254;NOD1;9;8.996e-140;0.65;9.9793;249.1817;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
545258;CQSS;6;4.699e-72;0.4516;2.1105;127.6064;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
11622;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
131801777;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DRUQEDUMAQZVOU-UHFFFAOYSA-N
53479755;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;RUOGJLKOZLGYHK-UHFFFAOYSA-N
92946;CTSB;6;1.9259999999999998e-51;0.6;30.3059;90.6;CTSB;Cathepsin B (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
4657542;CTSL;6;6.196e-60;0.4634;46.0389;105.847;CTSL;Cathepsin L1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
100048;CAPN1;6;2.948e-124;0.6136;71.986;221.3265;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
3421919;KLK3;7;1.3280000000000002e-69;0.4058;7.418;123.2055;KLK3;Prostate-specific antigen (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4466134;NTSR1;6;3.629e-153;0.5224;37.1713;273.2287;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
151134;HLA-A;6;3.703e-68;0.4211;10.5056;120.6108;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131755168;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BUBKDTQRUWZQHX-UHFFFAOYSA-N
100048;C3AR1;6;3.276e-49;0.4308;8.1267;86.5954;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
131753492;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMPQNKRQIPPNFC-UHFFFAOYSA-N
12599;RNASE1;6;5.812e-76;0.5921;2.2262;134.622;RNASE1;Ribonuclease pancreatic (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
131754962;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;YLDIXESVFMDKJA-UHFFFAOYSA-N
52925214;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FGWZGYGIIUCSFO-UHFFFAOYSA-N
273262;ECE1;6;1.221e-91;0.4333;39.6274;162.7679;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
6351946;CPA1;6;6.742999999999999e-66;0.4565;8.1722;116.5529;CPA1;Carboxypeptidase A1 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
25200879;GHSR;6;2.531e-79;0.5;81.7221;140.6561;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
97415;TIMP3;6;1.841e-53;0.4286;4.6626;94.2259;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
96814;MMP1;6;5.138e-69;0.5319;86.8553;122.1508;MMP1;Interstitial collagenase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
111299;FPR1;6;7.534e-90;0.5106;17.0289;159.5541;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
52924370;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DPTUTWFSXXDMEO-UHFFFAOYSA-N
6992304;CPA1;6;1.0670000000000001e-71;0.4324;8.8984;126.9668;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
3085216;CD22;6;3.233e-87;0.4639;4.0543;154.8277;CD22;B-cell receptor CD22 (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC4C(OC(C(C4O)O)O)CO)CO)O)NC(=O)C)OC5C(C(C(C(O5)CO)O)OC6(CC(C(C(O6)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O;FCIROHDMPFOSFG-UHFFFAOYSA-N
9543842;FABP3;7;5.947e-52;0.4468;1.7099;91.5164;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QEOYMVJQPHELJB-UHFFFAOYSA-N
152198;OPRD1;6;8.760000000000001e-77;0.4658;182.4973;136.0973;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
97415;ITGA4;6;5.659e-44;0.4151;13.3027;77.1925;ITGA4;Integrin alpha-4 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
131758666;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RFMPQNSSBPXIIY-UHFFFAOYSA-N
13783081;CAPN2;6;6.996e-63;0.5357;18.2428;111.1382;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
4225619;SRD5A1;8;2.162e-50;0.52;10.1055;88.7147;SRD5A1;3-oxo-5-alpha-steroid 4-dehydrogenase 1 (pKi >= 8);CCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C;LJGMGXXCKVFFIS-UHFFFAOYSA-N
53479856;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;CUUQTWOJYKCYRS-UHFFFAOYSA-N
7020642;F2;7;1.387e-90;0.6296;128.0636;160.8733;F2;Prothrombin (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
53479747;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;VFSMZSWKKPWQQW-UHFFFAOYSA-N
4078684;CAPN1;6;3.051e-52;0.4348;30.193;92.0366;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
102763;KISS1R;8;7.379e-87;0.4103;11.2801;154.1843;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
263475;ECE1;6;1.9500000000000003e-80;0.5636;34.7659;142.6548;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
7020642;PREP;7;2.006e-122;0.5179;42.5071;218.036;PREP;Prolyl endopeptidase (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
53479594;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;LAFTYABRLNPQHQ-UHFFFAOYSA-N
329275;MMP1;6;1.699e-55;0.625;69.8784;97.879;MMP1;Interstitial collagenase (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9948926;CCKAR;6;4.806e-145;0.5588;143.507;258.647;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
9797038;CCKAR;6;1.664e-144;0.5238;142.9735;257.6788;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
7010580;CPA1;6;3.362e-95;0.5909;11.841;169.1598;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131802009;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;IVASVZFPDOWZBQ-UHFFFAOYSA-N
9797038;CAPN2;6;7.256e-98;0.4722;28.4637;173.9459;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
259327;MME;6;3.643e-67;0.525;57.4571;118.8282;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
53481900;LPAR3;6;1.2349999999999999e-114;0.6909;17.5381;204.0514;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(COP(=O)(O)O)O;YGJPTGGFWWXCQF-UHFFFAOYSA-N
53480989;CQSS;6;9.049e-73;0.4412;2.1317;128.8908;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;OKMWKBLSFKFYGZ-UHFFFAOYSA-N
80108;PLA2G4B;6;8.197999999999999e-94;0.4;8.2276;166.6695;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
318292;CCKBR;6;5.919e-111;0.5938;112.4122;197.4438;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
5283853;CDC25A;6;5.265e-58;0.4545;2.6844;102.3833;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C;DKPMWHFRUGMUKF-UHFFFAOYSA-N
5057430;GRIA1;6;3.998e-74;0.46;16.4044;131.3231;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
8163;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
3421919;ANPEP;8;1.753e-133;0.5306;18.1072;237.8895;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
53479611;LPAR3;6;3.147e-100;0.5965;15.3227;178.1878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DPRXQVIZBLENFV-UHFFFAOYSA-N
24779336;LPAR3;6;2.689e-48;0.5094;7.3365;84.954;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C;UWZMUJQZEJOLID-UHFFFAOYSA-N
13783081;GRIA1;6;1.5160000000000002e-76;0.4308;16.944;135.6698;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
273262;MMP1;6;9.109999999999999e-54;0.5918;67.707;94.7745;MMP1;Interstitial collagenase (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
4466134;C3AR1;6;2.542e-43;0.5455;7.1426;76.0211;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
131758625;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QZRITKSXWHDXFB-UHFFFAOYSA-N
323786;MMP9;7;3.7540000000000002e-56;0.5965;67.3768;99.0563;MMP9;Matrix metalloproteinase-9 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7020642;DPP8;6;6.397e-63;0.6739;25.5645;111.208;DPP8;Dipeptidyl peptidase 8 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
18218238;ERAP2;6;1.346e-48;0.44;1.5978;85.4936;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
131753498;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JPNVFKJWXNFOKV-UHFFFAOYSA-N
131759870;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PSHWARYKXDUDSM-UHFFFAOYSA-N
7010580;PSMB5;7;7.223000000000001e-55;0.451;12.2664;96.7507;PSMB5;Proteasome subunit beta type-5 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
9797038;MME;6;3.981e-126;0.6545;107.933;224.6828;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
131756087;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TZMQOSMAJITOAT-UHFFFAOYSA-N
454064;NOD1;9;1.576e-69;0.4167;4.9384;123.072;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
318292;GHSR;6;3.588e-81;0.6727;83.6254;143.9746;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7021820;SORT1;6;2.569e-54;0.4045;3.711;95.7614;SORT1;Sortilin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
18218218;FOLH1;9;3.728e-69;0.5;5.4138;122.4009;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
66066;SRD5A1;8;2.918e-43;0.5893;8.6604;75.9138;SRD5A1;3-oxo-5-alpha-steroid 4-dehydrogenase 1 (pKi >= 8);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
7020642;TRHR;6;3.547e-75;0.4833;3.7176;133.2115;TRHR;Thyrotropin-releasing hormone receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
100094;EDNRA;6;2.4620000000000003e-55;0.56;82.4701;97.5899;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
111299;OPRD1;6;1.1309999999999999e-75;0.4655;179.8769;134.103;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
53479625;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VHHMKXOBDPAFKC-UHFFFAOYSA-N
53480927;FABP3;7;1.5189999999999998e-47;0.5246;1.5626;83.6037;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COP(=O)(O)OCCN;QYXNIRQICOBIAE-UHFFFAOYSA-N
9546838;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;XYHIPPZFNNOMQL-UHFFFAOYSA-N
131758821;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YMPDPPQASWDPRK-UHFFFAOYSA-N
5488196;FPR1;6;5.254e-85;0.4783;16.1053;150.8585;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
323786;HLA-A;6;2.688e-80;0.4615;12.3929;142.4045;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
53477996;LPAR3;6;8.788999999999999e-60;0.5283;9.1028;105.5744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCCCC;VJQIPMXNHWLHEJ-UHFFFAOYSA-N
7010580;ANPEP;8;6.8190000000000005e-143;0.6136;19.3896;254.7836;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
19816750;C3AR1;6;2.5279999999999997e-45;0.4571;7.4771;79.616;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
53479670;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;PTTOPPWTEHEDTA-UHFFFAOYSA-N
435728;LAP3;6;2.689e-86;0.5532;9.9005;153.1761;LAP3;Cytosol aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
131759456;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FXVLQYFZVVLQJO-UHFFFAOYSA-N
13890535;ACE;6;2.1260000000000002e-102;0.6842;101.7264;182.0843;ACE;Angiotensin-converting enzyme (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
3800205;F2R;6;6.839e-46;0.5614;27.6893;80.6355;F2R;Proteinase-activated receptor 1 (pKi >= 6);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
18218238;EDNRA;6;1.954e-52;0.4737;78.1682;92.3843;EDNRA;Endothelin-1 receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
111299;MMP1;6;1.0459999999999999e-41;0.4423;52.563;73.1232;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
515709;MC1R;6;2.827e-49;0.403;24.9873;86.7104;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
52924624;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BYVQCOREHGDXRD-UHFFFAOYSA-N
121658;CQSS;6;5.057e-72;0.4375;2.1095;127.5491;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;DNULQWTYMFQUHB-UHFFFAOYSA-N
25200879;CCKAR;6;2.123e-136;0.45;134.9548;243.1262;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
52925434;FABP3;7;5.279e-50;0.6034;1.6448;88.0186;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCC;GKXJCTQSLVKTAV-UHFFFAOYSA-N
18218182;NPR;6;1.039e-88;0.4259;12.7903;157.508;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
53481816;FABP3;7;1.686e-49;0.5738;1.6279;87.1133;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NTQLGVPKRSFHIQ-UHFFFAOYSA-N
100048;FPR1;6;3.379e-110;0.6154;20.9089;196.0856;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
131758937;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PHSOZYZQNQNQAK-UHFFFAOYSA-N
131750653;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFUGNQFGFOCTMS-UHFFFAOYSA-N
12599;ITPR1;8;2.796e-46;0.5294;2.4094;81.3329;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 8);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
323786;MMP1;6;4.671e-58;0.5965;73.0942;102.4766;MMP1;Interstitial collagenase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
515717;RNPEP;8;2.388e-42;0.4035;1.3889;74.2745;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
4656408;EDNRA;6;4.395e-46;0.4844;68.744;80.9802;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
92829;OPRM1;6;1.069e-66;0.4643;193.0531;117.9886;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
53479640;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OPJHRPGFKUCTOK-UHFFFAOYSA-N
515709;CAPN2;6;4.659e-137;0.7209;39.9141;244.3088;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
6351946;BLA1_STEMA;6;3.278e-79;0.4333;7.1136;140.4544;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
111299;SLC1A2;6;6.902e-77;0.4255;6.9031;136.2832;SLC1A2;Excitatory amino acid transporter 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
9543752;FABP3;7;1.195e-53;0.4681;1.7667;94.563;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MUYDIVLBRBWUDW-UHFFFAOYSA-N
131753346;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LIMGVWSRPUIYTD-UHFFFAOYSA-N
10445608;LAP3;6;4.7149999999999995e-94;0.5106;10.797;167.1008;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
53479600;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;SMHQICHVYVREKX-UHFFFAOYSA-N
13783081;TACR1;6;1.031e-49;0.5385;85.9463;87.4968;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131753339;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AWDHZZVHWUIZSY-UHFFFAOYSA-N
53480896;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;CCSPRYPUMQZSKU-UHFFFAOYSA-N
7009598;OPRM1;6;3.004e-87;0.5088;251.8866;154.8849;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
20835023;FABP3;7;2.532e-51;0.4783;1.6889;90.3867;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
10445608;CAPNS1;6;2.804e-87;0.4035;5.9932;154.9388;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
131758776;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGUXHCYCFLVGES-UHFFFAOYSA-N
12599;DOT1L;6;4.041e-79;0.4203;7.4507;140.2913;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
7010580;ECE1;6;8.325999999999999e-103;0.5217;44.473;182.8153;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131750486;FABP3;7;7.184999999999999e-45;0.5147;1.4732;78.8017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;IQIUZAVCJONSBD-UHFFFAOYSA-N
52924152;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;BSVQKPRGDPWRBO-UHFFFAOYSA-N
7359122;MMP3;6;2.0559999999999998e-52;0.5098;61.4318;92.3443;MMP3;Stromelysin-1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
52929772;LPAR3;6;1.557e-120;0.6444;18.4453;214.6428;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)O)O;LBGSRVIXIVDRQM-UHFFFAOYSA-N
9797038;GHSR;6;2.443e-80;0.5645;82.7675;142.4789;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
69421;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
53479676;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;JLYDNXJQTBLQKZ-UHFFFAOYSA-N
131758647;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LMDMXKYAEKPMRJ-UHFFFAOYSA-N
7021820;CAPN1;6;2.541e-50;0.4694;29.0785;88.5886;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
6993120;ECE1;6;6.502e-108;0.5333;46.6893;191.9847;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
537294;LPAR3;6;9.02e-53;0.5385;8.0246;92.9869;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;KECCPKLXQUOWMI-UHFFFAOYSA-N
131755699;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JPBYHVQUOOKCGQ-UHFFFAOYSA-N
6993120;MME;6;2.6490000000000002e-244;0.6154;209.1022;436.848;MME;Neprilysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
13817313;CAPN2;6;2.62e-119;0.44;34.7282;212.4417;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
131756654;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SGNGDCVKDGTDQC-UHFFFAOYSA-N
53479907;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FISVEBQJGBZOPW-UHFFFAOYSA-N
76807;FPR1;6;1.914e-78;0.4651;14.8542;139.0785;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
7016103;FURIN;6;7.406e-46;0.5769;8.3607;80.5734;FURIN;Furin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
53480011;LPAR3;6;2.4939999999999997e-67;0.7391;10.2634;119.1238;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC;BZUNRSOACSOEBT-UHFFFAOYSA-N
7359122;OPRM1;6;7.006999999999999e-94;0.5769;270.8729;166.7918;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
7017195;NOD1;9;7.238e-92;0.4423;6.5414;163.1759;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C1=C(NC=N1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;PXVCMZCJAUJLJP-UHFFFAOYSA-N
3421919;NTSR1;6;4.7330000000000006e-102;0.4156;24.7268;181.4603;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131754096;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;MLEFRDDBNGCWLN-UHFFFAOYSA-N
44232492;NOD1;9;2.8030000000000003e-84;0.4038;5.9969;149.5531;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
131760631;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NRVWPUNQTJDNID-UHFFFAOYSA-N
131758806;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CGPMDMDZQFZLHH-UHFFFAOYSA-N
47579;LAP3;6;7.069e-62;0.4565;7.0779;109.3348;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
4466134;CTSL;6;1.7439999999999999e-53;0.4426;41.0767;94.2684;CTSL;Cathepsin L1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53479947;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;WQHSMYBPCGOJLV-UHFFFAOYSA-N
96814;ACE2;6;7.072e-151;0.6341;21.285;269.1178;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010580;NPPA;6;3.423e-52;0.5098;2.5694;91.9472;NPPA;Natriuretic peptides A (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
13890535;OPRM1;6;3.191e-44;0.4426;128.7133;77.6392;OPRM1;Mu-type opioid receptor (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
9546800;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DRIVXEVMDWCWLI-UHFFFAOYSA-N
19816756;CCKAR;6;3.302e-132;0.5;130.8081;235.6006;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
11579826;C3AR1;7;2.9470000000000003e-71;0.42;6.0745;126.175;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
7009555;CAPN2;6;6.287e-82;0.5745;23.8074;145.3326;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
9543847;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CPEWURNZWJEDDC-UHFFFAOYSA-N
263475;OPRM1;6;1.324e-44;0.5938;129.8073;78.3252;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
4657542;RNPEP;6;1.485e-41;0.4762;2.038;72.8497;RNPEP;Aminopeptidase B (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
121658;LPAR3;6;9.02e-53;0.5385;8.0246;92.9869;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;DNULQWTYMFQUHB-UHFFFAOYSA-N
7009555;CAPNS1;6;7.572000000000001e-69;0.4464;4.717;121.8485;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
131801899;LPAR1;6;3.626e-43;0.7045;8.062;75.7442;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;RJUNCJKUOOBPGW-UHFFFAOYSA-N
96814;TIMP3;6;9.249e-86;0.44;7.5162;152.2129;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131760625;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SXSRTUPMLATBNN-UHFFFAOYSA-N
189008;FPR1;6;5.642e-76;0.4182;14.3833;134.645;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
515717;OPRD1;6;5.088e-96;0.5246;227.8752;170.6321;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
515717;ACE2;6;2.097e-100;0.5306;14.1359;178.5044;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
53480960;LPAR3;6;6.34e-73;0.6279;11.1238;129.1682;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(CO)CO;CXUXMSACCLYMBI-UHFFFAOYSA-N
47579;ACE;6;1.793e-123;0.7059;122.657;219.9188;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
52925127;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;LJVXDBWIBQQKFU-UHFFFAOYSA-N
263475;GHSR;6;1.325e-82;0.6316;85.1007;146.5469;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
53479623;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MKMUWJJSVUOCQC-UHFFFAOYSA-N
4427709;ANPEP;8;1.733e-101;0.4561;13.747;180.4484;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131755553;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OAJGGPOBXCODBI-UHFFFAOYSA-N
53478300;LPAR3;6;2.6120000000000003e-63;0.549;9.6452;111.9065;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTSLGWIGCLOQRX-UHFFFAOYSA-N
6992304;CAPN1;6;2.704e-62;0.46;36.0268;110.084;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
53478491;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RMUBRZSHPSLPPN-UHFFFAOYSA-N
273262;CAPN2;6;8.682000000000001e-160;0.5833;46.5547;285.1157;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
18986;NQO2;6;5.627e-45;0.6512;11.011;78.9923;NQO2;Ribosyldihydronicotinamide dehydrogenase [quinone] (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
63842847;ACE;7;9.431999999999998e-47;0.4915;37.2938;82.1802;ACE;Angiotensin-converting enzyme (pKi >= 7);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
52925065;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LYFMZJCIGLZMJF-UHFFFAOYSA-N
131753311;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYFACDKCDVPZSE-UHFFFAOYSA-N
4128305;CAPN1;6;1.6830000000000002e-58;0.4565;33.825;103.2725;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC(=O)N)C(=O)O)N;MLTRLIITQPXHBJ-UHFFFAOYSA-N
5312378;SLCO2A1;6;5.690000000000001e-66;0.4286;2.1786;116.6853;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
4656408;MC1R;6;9.129e-95;0.4355;48.1797;168.3809;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
131763523;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;JULFTYLLKSHNRK-UHFFFAOYSA-N
7010566;NTSR1;6;7.042999999999999e-94;0.4028;22.7371;166.7879;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
92021849;OXGR1;6;4.5059999999999996e-135;0.4595;14.7344;240.7441;OXGR1;2-oxoglutarate receptor 1 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
52924174;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZHZTYDTVUSPVLX-UHFFFAOYSA-N
52924553;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;FMYXHSVUQFRMGW-UHFFFAOYSA-N
7359122;PAPA1_CARPA;7;1.355e-108;0.5098;12.0492;193.2073;PAPA1_CARPA;Papain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
52924717;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;QMQLZZVQOMZDCN-UHFFFAOYSA-N
52927171;LPAR3;6;3.8200000000000003e-97;0.6071;14.8484;172.6509;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;MVHBCRUZHMRQHX-UHFFFAOYSA-N
7009555;HLA-A;6;4.339e-86;0.4516;13.2935;152.803;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
53481816;LPAR3;6;3.408e-117;0.717;17.9317;208.6462;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NTQLGVPKRSFHIQ-UHFFFAOYSA-N
7010506;RNPEP;6;2.6930000000000002e-55;0.5;2.7244;97.5199;RNPEP;Aminopeptidase B (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
4427709;LAP3;6;9.217e-56;0.4545;6.3711;98.356;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
9797038;MMP2;6;1.057e-42;0.55;69.1786;74.9101;MMP2;72 kDa type IV collagenase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
7789;SLCO2A1;6;4.234e-62;0.4565;2.0491;109.7345;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCCC(CCCCCCCCCCC(=O)O)O;ULQISTXYYBZJSJ-UHFFFAOYSA-N
131754985;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HZWGBWWUMHOOAG-UHFFFAOYSA-N
352038;HLA-A;6;2.0349999999999997e-94;0.4792;14.5884;167.7558;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(C(C)C)C(=O)O)N;MDSUKZSLOATHMH-UHFFFAOYSA-N
4427709;MC5R;7;9.094000000000001e-102;0.5342;25.3357;180.9511;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
263475;MC3R;6;7.798999999999999e-81;0.4286;39.6448;143.3693;MC3R;Melanocortin receptor 3 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
131759263;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MDXVSMKNQLMYQZ-UHFFFAOYSA-N
131758645;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;FSTDLLFKLQLNCY-UHFFFAOYSA-N
52924548;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;APTOFTJOCNPNQP-UHFFFAOYSA-N
131760022;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;SEJBPZVTMDKZMT-UHFFFAOYSA-N
515717;MME;6;1.693e-159;0.56;136.5016;284.5951;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
91498;NPC1L1;6;1.3899999999999999e-68;0.7258;5.0393;121.375;NPC1L1;Niemann-Pick C1-like 1 protein (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)O)C;YMMFNKXZULYSOQ-UHFFFAOYSA-N
10257;HTR1D;7;1.936e-117;0.7368;103.2363;209.087;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 7);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
10373084;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;YIGARKIIFOHVPF-UHFFFAOYSA-N
131753292;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PDOWBMFLISSQRT-UHFFFAOYSA-N
92946;YARS;6;4.23e-96;0.5;5.5894;170.7761;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
11579826;BLA1_STEMA;6;1.318e-80;0.4898;7.24;142.9604;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
6992643;CAPN1;6;7.377e-120;0.5854;69.4335;213.43;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480932;LPAR1;6;2.8860000000000002e-46;0.4912;8.6482;81.3082;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NHBRVTKHMMOYTG-UHFFFAOYSA-N
131755530;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KKBIJNWSACWOQA-UHFFFAOYSA-N
131753215;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCC;DOEBPNOTMREOMP-UHFFFAOYSA-N
19421321;PSMB2;7;9.567000000000001e-57;0.5385;1.657;100.1223;PSMB2;Proteasome subunit beta type-2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
9797038;EDNRB;9;2.798e-68;0.5;6.5673;120.8293;EDNRB;Endothelin B receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
52924232;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;DWDUPRRUGYDGQF-UHFFFAOYSA-N
49786976;LPAR3;6;2.4939999999999997e-67;0.7391;10.2634;119.1238;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCCN;AUSLLMXXJBCZGL-UHFFFAOYSA-N
131754079;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;VMJJCASFGIUXQS-UHFFFAOYSA-N
14767562;NTSR1;6;9.177e-100;0.4085;24.1698;177.3534;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
263475;MMP11;6;6.192000000000001e-116;0.4507;11.6864;206.3853;MMP11;Stromelysin-3 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9797038;TACR1;6;7.038e-45;0.5323;77.6464;78.8179;TACR1;Substance-P receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
102763;MC3R;6;3.73e-84;0.4571;41.2787;149.3302;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13932172;LPAR3;6;2.828e-61;0.413;9.3323;108.2537;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
7020642;ELANE;8;1.148e-58;0.4355;27.5638;103.571;ELANE;Neutrophil elastase (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
5282942;SLCO2A1;6;8.228000000000001e-72;0.434;2.3738;127.1697;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCCC(CC=CCCCCCCCC(=O)O)O;WBHHMMIMDMUBKC-UHFFFAOYSA-N
52926008;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;DWNFLQISNVMTDP-UHFFFAOYSA-N
53479988;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;UJDHYDGXZXDWNT-UHFFFAOYSA-N
53480978;LPAR3;6;1.807e-56;0.6304;8.5933;99.6262;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)O;XQBHBEXBUZDCRY-UHFFFAOYSA-N
6992567;HLA-A;6;2.3179999999999997e-60;0.4468;9.2934;106.6135;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SITLTJHOQZFJGG-UHFFFAOYSA-N
4427709;CAPNS1;6;4.385e-68;0.4355;4.6642;120.479;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
4414300;ENPEP;7;4.7720000000000004e-85;0.46;6.6707;150.9336;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CC(=O)N)C(=O)O)N;HZYHBDVRCBDJJV-UHFFFAOYSA-N
4078684;ANPEP;8;5.388e-87;0.4902;11.772;154.4295;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
7020642;XIAP;6;8.114e-70;0.5;28.5978;123.5899;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
5488196;CTSC;6;2.354e-71;0.6;11.0026;126.3502;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
5057430;ECE1;6;4.057e-73;0.4783;31.5902;129.5163;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9543989;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SKGWNZXOCSYJQL-UHFFFAOYSA-N
7009623;NOD1;9;2.206e-92;0.413;6.5785;164.1023;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
4657542;TIMP3;6;4.445e-77;0.4348;6.7491;136.6263;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
131802009;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;IVASVZFPDOWZBQ-UHFFFAOYSA-N
4427709;TIMP3;6;5.2629999999999995e-45;0.4677;3.9156;79.0445;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
52924213;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UDBXKKKIEXMSEA-UHFFFAOYSA-N
131753238;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;ROBJWPSKKQDYDD-UHFFFAOYSA-N
53479676;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;JLYDNXJQTBLQKZ-UHFFFAOYSA-N
53481885;FABP3;7;2.379e-50;0.5833;1.6564;88.64;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(COP(=O)(O)O)O;OYWQLEFQIHHFDV-UHFFFAOYSA-N
56991460;HLA-A;6;5.623e-57;0.5439;8.7672;100.5366;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC(=O)N)N;MQLZLIYPFDIDMZ-UHFFFAOYSA-N
7015683;GRIK1;6;5.651999999999999e-45;0.5;12.06;78.9888;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
53481871;LPAR1;6;1.331e-54;0.7308;10.225;96.274;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;UZDPEBGNSKBQGX-UHFFFAOYSA-N
131758625;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QZRITKSXWHDXFB-UHFFFAOYSA-N
8180;PLA2G4B;6;2.175e-68;0.4595;5.9815;121.0259;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
131763497;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FWLOAHZIIPEDQA-UHFFFAOYSA-N
52924162;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ADCNXGARWPJRBV-UHFFFAOYSA-N
7359122;CTSB;6;4.097e-97;0.5;57.3219;172.5963;CTSB;Cathepsin B (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4466134;ANPEP;6;2.175e-100;0.6087;35.28;178.476;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
131753695;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QQZZZCIYMICCKG-UHFFFAOYSA-N
10468;NOD1;9;1.62e-69;0.4242;4.9375;123.0506;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
52924594;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JIEASZUPMDFVLW-UHFFFAOYSA-N
69421;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
193508;OPRD1;6;7.493e-100;0.5636;236.9145;177.5115;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
7021456;MME;6;5.332e-102;0.4833;87.2785;181.3675;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
134906;BLA1_STEMA;6;7.793e-82;0.4098;7.3513;145.1652;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
6992643;YARS;6;1.007e-90;0.5455;5.2743;161.1233;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
131801744;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;SYTLTRZEHNVTSX-UHFFFAOYSA-N
323786;OPRM1;6;2.7349999999999995e-53;0.5735;154.67;93.9174;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
4427709;ECE1;6;1.022e-130;0.72;56.5847;232.9244;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
193508;AMP1_PLAFQ;6;4.2520000000000004e-55;0.5333;7.0246;97.1639;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
53480991;LPAR3;6;1.377e-75;0.6522;11.5333;133.9492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)O;UCYPOAPUDLUXQX-UHFFFAOYSA-N
19421321;ACE2;6;8.574e-82;0.4615;11.4997;145.0906;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
53480959;FABP3;7;4.075e-52;0.5;1.7154;91.8112;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(CO)CO;UETKPVCPWANBPE-UHFFFAOYSA-N
131758887;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCC;GEDOOJBTRRNYEP-UHFFFAOYSA-N
7010566;FPR1;6;5.905e-83;0.4314;15.7143;147.1768;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
7021820;RNPEP;8;5.805e-59;0.4706;1.9443;104.1024;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
42607457;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;XVYPOHCSLJZFED-UHFFFAOYSA-N
7009598;QRFPR;6;6.575e-53;0.4167;6.4465;93.2334;QRFPR;Pyroglutamylated RFamide peptide receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
19816750;RNPEP;8;2.388e-42;0.4035;1.3889;74.2745;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
6351946;REN;6;4.877e-47;0.473;78.9926;82.6944;REN;Renin (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
15061532;LPAR3;6;1.437e-46;0.4906;7.0708;81.8519;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)([O-])OCC[N+](C)(C)C;NEGQHKSYEYVFTD-UHFFFAOYSA-N
131801988;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;RSFDYJRKLOLHJO-UHFFFAOYSA-N
6993120;C3AR1;6;2.499e-46;0.4194;7.6451;81.4206;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
151410;YARS;6;2e-51;0.4314;2.9709;90.5709;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
52925452;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;LZBAIACFBSMXFQ-UHFFFAOYSA-N
14409732;F2;7;4.7680000000000003e-57;0.4627;80.7666;100.6652;F2;Prothrombin (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
7016103;NTSR1;6;6.482e-106;0.4342;25.6674;188.3964;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
6993039;FPR1;8;1.082e-42;0.4259;1.5514;74.8917;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C)C(C(=O)NC(CCSC)C(=O)O)N;YSGSDAIMSCVPHG-UHFFFAOYSA-N
4656408;NMBR;6;4.747e-48;0.4237;7.6189;84.5109;NMBR;Neuromedin-B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
6992643;CYSP_TRYCR;7;1.9430000000000001e-78;0.4231;19.0829;139.0669;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
131801964;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;QWBJFHUMPKVXOT-UHFFFAOYSA-N
152198;CTSB;6;1.561e-43;0.5098;25.6277;76.4012;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
7010506;FPR1;6;4.02e-101;0.5926;19.1784;179.7923;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
7010588;NAALAD2;6;6.094e-65;0.4545;3.7631;114.8365;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C(CC(=O)N)C(C(=O)NC(CCC(=O)N)C(=O)O)N;LOJYQMFIIJVETK-UHFFFAOYSA-N
52927174;LPAR1;6;4.697e-47;0.6415;8.7974;82.7238;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCC;NOFOTAHTYLXZNV-UHFFFAOYSA-N
96814;CAPNS1;6;2.94e-97;0.54;6.6841;172.8549;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
329275;GRPR;6;4.2860000000000003e-95;0.4487;11.6486;168.9705;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9546757;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;MWRBNPKJOOWZPW-UHFFFAOYSA-N
273262;ACE2;6;6.612e-117;0.5957;16.4732;208.1294;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
53479595;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;FCPBFHHIKXPHHN-UHFFFAOYSA-N
53478321;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UCEIHNHHMYDTNZ-UHFFFAOYSA-N
53477693;CA4;6;8.649e-43;0.4865;48.746;75.0665;CA4;Carbonic anhydrase 4 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(=O)CC4C3(CCC(C4)O)C)C;DXOCDBGWDZAYRQ-UHFFFAOYSA-N
329275;MC5R;7;2.503e-81;0.4487;20.223;144.2554;MC5R;Melanocortin receptor 5 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
52925087;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HLSDKIUXCZPFLL-UHFFFAOYSA-N
11579826;ACE;6;2.4380000000000003e-108;0.525;107.6265;192.7494;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
6993118;FPR1;6;4.928000000000001e-72;0.4545;13.6318;127.5693;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
9547071;LPAR1;6;1.892e-49;0.75;9.2504;87.0232;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;PYVRVRFVLRNJLY-UHFFFAOYSA-N
131755915;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBYJHYPJVAOSBP-UHFFFAOYSA-N
9948926;ECE1;6;1.544e-102;0.6667;44.3565;182.3335;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
6435901;CQSS;6;1.732e-64;0.4;1.8863;114.0221;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
3421919;NPPA;7;1.3249999999999999e-52;0.4717;1.7317;92.6871;NPPA;Natriuretic peptides A (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4427709;SSTR2;6;5.914e-68;0.4247;20.7097;120.2458;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53479609;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZBKSDVGXOOCETO-UHFFFAOYSA-N
52925059;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NRDJGXANLABPHN-UHFFFAOYSA-N
131802042;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;GRJUVGUIQWBDLN-UHFFFAOYSA-N
134906;CTSL;7;2.9869999999999997e-54;0.5636;25.2175;95.6439;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
7021456;NPFFR2;7;2.6090000000000003e-78;0.4286;6.5029;138.8371;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
9546825;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;CLPMAPXZURYSNH-UHFFFAOYSA-N
515709;BLA1_STEMA;6;5.63e-96;0.4727;8.6322;170.5531;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
13890535;ACE2;6;2.77e-127;0.5532;17.9432;226.7611;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
53479630;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;HPHYBSPOEJMPAN-UHFFFAOYSA-N
759256;CPA1;6;7.361e-104;0.5556;12.9253;184.7066;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
7009598;ACE;6;8.977e-120;0.6316;118.9826;213.2769;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
100094;MME;6;3.45e-112;0.6182;96.0012;199.6601;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
97415;ANPEP;8;9.159e-129;0.5;17.4642;229.4192;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
435728;AMP1_PLAFQ;6;9.357e-58;0.5532;7.3673;101.9349;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
151410;FURIN;6;9.61e-75;0.42;13.6915;132.4345;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
19816756;HLA-A;6;2.57e-71;0.4505;10.9967;126.2817;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
101227803;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZDZVWVCNWRMGLA-UHFFFAOYSA-N
188292;CA4;6;2.2539999999999999e-41;0.4937;47.1366;72.5244;CA4;Carbonic anhydrase 4 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(=O)CC4C3(CCC(C4)O)C)O)C;RHCPKKNRWFXMAT-UHFFFAOYSA-N
53479829;LPAR3;6;3.06e-87;0.5;13.3254;154.8707;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;ZRQPYJXAEPDRDM-UHFFFAOYSA-N
13890535;BLA1_STEMA;6;5.356999999999999e-94;0.54;8.453;167.0011;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
7009598;RNPEP;6;6.226999999999999e-51;0.5333;2.5064;89.6852;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
7015704;POLG_WNV;6;4.2e-67;0.4423;5.8679;118.7173;POLG_WNV;Genome polyprotein (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
52924623;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CVPHRRKVQKYWSZ-UHFFFAOYSA-N
193508;C3AR1;6;5.5299999999999995e-53;0.5536;8.757;93.3684;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52924583;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;FRVWPWGGHGGKMD-UHFFFAOYSA-N
134906;CCKAR;6;3.037e-156;0.5763;154.5859;278.7535;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
515709;CAPNS1;6;1.912e-82;0.5;5.6585;146.2605;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
4657542;FPR1;6;1.4309999999999999e-90;0.5122;17.1665;160.8494;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
131761603;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CSHNWGMOFDDION-UHFFFAOYSA-N
131755369;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KJRMVHBWNRWOEF-UHFFFAOYSA-N
7009598;MMP3;6;1.414e-48;0.4615;56.9438;85.4552;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
9546747;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;HBZNVZIRJWODIB-UHFFFAOYSA-N
131755752;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SAZSVOQHSUNCSC-UHFFFAOYSA-N
7009598;BLA1_STEMA;6;1.3270000000000001e-96;0.4706;8.6891;171.6798;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
14409732;C5AR1;6;3.785e-41;0.4535;11.8431;72.1203;C5AR1;C5a anaphylatoxin chemotactic receptor 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
9546755;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;LICSIKXBSOVGBP-UHFFFAOYSA-N
7010499;HLA-A;6;3.8240000000000006e-71;0.5882;10.9698;125.9717;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
111299;ACE;6;1.523e-100;0.6667;99.8838;178.7535;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
131801916;LPAR3;6;3.449e-87;0.7045;13.3174;154.7773;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;GHJOXQFLZDFHBM-UHFFFAOYSA-N
131760503;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADOAWMSGAVKGKY-UHFFFAOYSA-N
10445608;ACE;6;8.227000000000001e-78;0.4773;77.306;137.9416;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
263475;GRPR;6;2.145e-98;0.4359;12.0556;174.8961;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
100048;HLA-DRB1;6;2.95e-69;0.4615;6.8089;122.5833;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
134906;C3AR1;6;3.668e-43;0.6;7.116;75.7354;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
435728;NPPA;7;4.057e-42;0.4906;1.3812;73.8613;NPPA;Natriuretic peptides A (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
3634442;ACE;6;2.1589999999999998e-54;0.5926;54.0462;95.8969;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
52924167;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DAZYZDVAACSMFA-UHFFFAOYSA-N
3634442;MMP8;7;3.2559999999999997e-47;0.5082;31.0795;83.0095;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
53481449;FABP3;7;6.180999999999999e-41;0.5;1.3417;71.7378;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC(CCC=CC=CC(CCCC(=O)O)O)O;NKUPFHTVILUPKF-UHFFFAOYSA-N
3421919;ACE;6;1.763e-113;0.6744;112.7324;201.979;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131753413;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;FSNNOULJUSMJGI-UHFFFAOYSA-N
53479893;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;WMGNZOBBKTUGGQ-UHFFFAOYSA-N
4466134;MMP1;6;5.782e-50;0.5294;62.932;87.9477;MMP1;Interstitial collagenase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53478233;FABP3;7;3.532e-54;0.5;1.7843;95.5133;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SPGHLBKMJHHORH-UHFFFAOYSA-N
329275;ANPEP;6;2.643e-73;0.4727;25.7248;129.8502;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
94235;SLC10A1;6;9.468e-56;0.4444;2.2235;98.335;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(C(=O)CC3C2C(CC4C3(CCC(C4)O)C)O)C;MIHNUBCEFJLAGN-UHFFFAOYSA-N
53480845;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;IMGJLLXZPUDFFN-UHFFFAOYSA-N
13890535;MME;6;6.947e-207;0.5556;177.0687;369.6696;MME;Neprilysin (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
9546755;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;LICSIKXBSOVGBP-UHFFFAOYSA-N
53477996;FABP3;7;5.019e-52;0.4783;1.7124;91.6487;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCCCC;VJQIPMXNHWLHEJ-UHFFFAOYSA-N
131759242;LPAR3;6;4.587999999999999e-81;0.5294;12.3757;143.7829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;OYGBKABOKBWAOA-UHFFFAOYSA-N
53479738;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;MPCVLWFEQHTFHH-UHFFFAOYSA-N
53479566;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;CUUIBVDVVFLYGA-UHFFFAOYSA-N
151134;BLA1_STEMA;6;7.533999999999999e-88;0.4364;7.8961;155.9634;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
53480017;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;HNZTVXMGKFBWNB-UHFFFAOYSA-N
150964;HLA-DRB1;6;5.468e-78;0.5077;7.6758;138.2602;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
100094;ERAP2;6;3.579e-62;0.5588;2.0516;109.8656;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
151134;CTSC;6;1.8709999999999997e-51;0.5455;7.9086;90.6227;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
515717;FPR1;6;1.833e-75;0.4231;14.2857;133.7264;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
131755698;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HTFZBWPHGZEFJU-UHFFFAOYSA-N
53478252;FABP3;7;3.532e-54;0.5;1.7843;95.5133;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VSVITRIWEUGRGY-UHFFFAOYSA-N
131758799;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RYWWBXHDEGSCOG-UHFFFAOYSA-N
52925058;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;MFRYWKSWYSTLOB-UHFFFAOYSA-N
263471;CCKAR;6;6.274e-132;0.4833;130.5323;235.1002;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
52924216;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OONVIPGPMOPRTM-UHFFFAOYSA-N
18218222;LAP3;6;2.152e-45;0.4737;5.1726;79.7416;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(C(C)O)C(=O)O)N;LRKCBIUDWAXNEG-UHFFFAOYSA-N
7010566;CAPN1;6;4.668e-128;0.5094;74.1915;228.1493;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
6992304;LAP3;6;1.445e-74;0.4545;8.5446;132.1162;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
7010580;RNPEP;6;3.538e-46;0.6136;2.2689;81.1494;RNPEP;Aminopeptidase B (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131754085;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;STLRCTZSDOQPTC-UHFFFAOYSA-N
47579;CAPN1;6;3.407e-106;0.5789;61.5034;188.8978;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131755131;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RXJPMHUSUSIBKN-UHFFFAOYSA-N
52924778;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XNZHFYSLNIZKJP-UHFFFAOYSA-N
515717;FOLH1;6;3.838e-61;0.6154;19.2713;108.0157;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
515709;PAPA1_CARPA;7;5.967e-80;0.4364;8.852;141.7827;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
131801898;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;IKSWSKJAXUGKHC-UHFFFAOYSA-N
92021849;ADORA2A;6;1.8130000000000001e-72;0.5634;162.9989;128.349;ADORA2A;Adenosine receptor A2a (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
101227804;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FSTOZAMDIJDRCH-UHFFFAOYSA-N
131761617;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;YSTMVIOAKCDXEL-UHFFFAOYSA-N
13783081;NPR;8;1.019e-67;0.5593;3.9258;119.8212;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
5312869;CQSS;6;4.449e-69;0.4375;2.0223;122.2631;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCC(CC(=O)O)O;ATRNZOYKSNPPBF-UHFFFAOYSA-N
342468;ACE;6;1.041e-82;0.7273;82.1704;146.7346;ACE;Angiotensin-converting enzyme (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
151134;LTA4H;6;1.824e-42;0.5;23.2878;74.4845;LTA4H;Leukotriene A-4 hydrolase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
11622;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
3634442;FPR1;6;9.708999999999998e-41;0.4706;7.6644;71.3857;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
53479804;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JUYYWEDATPYDSS-UHFFFAOYSA-N
52925086;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;HXUHHWPZGOIBGO-UHFFFAOYSA-N
131802016;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;ZLEJYIVDPRFANO-UHFFFAOYSA-N
131754085;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;STLRCTZSDOQPTC-UHFFFAOYSA-N
66066;CDC25A;6;1.371e-74;0.6786;3.4621;132.1572;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
5312378;LPAR3;6;2.658e-49;0.4412;7.4911;86.7582;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
19421321;OPRM1;6;3.878e-115;0.6271;331.7261;204.9547;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
323786;OPRD1;6;1.956e-51;0.5441;122.6993;90.5881;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
53479972;LPAR1;6;8.126e-42;0.5;7.8065;73.3198;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DHZUMZVZAZYQIW-UHFFFAOYSA-N
53477864;MAG;6;1.561e-78;0.5631;2.5985;139.2377;MAG;Myelin-associated glycoprotein (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC(C(CO)O)C(C(C=O)O)O)CO)O)NC(=O)C)OC4C(C(C(C(O4)CO)O)O)O)O)O;SFMRPVLZMVJKGZ-UHFFFAOYSA-N
131760520;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WZQHACRHKQJTGS-UHFFFAOYSA-N
131758733;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCC;DTWPBANPCJFNIA-UHFFFAOYSA-N
18218238;CCKBR;6;2.382e-112;0.4321;113.8254;199.9488;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
100048;HLA-A;7;4.972e-52;0.4194;5.4218;91.656;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
168182;ANPEP;8;4.926e-67;0.4286;9.0517;118.593;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131801711;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;YEUGSVVCGREBDT-UHFFFAOYSA-N
6992643;MMP3;6;7.541e-52;0.551;60.7718;91.3312;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
4427709;EDNRB;9;1.222e-69;0.5224;6.6994;123.2704;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
515709;TMPRSS6;8;7.841e-45;0.4167;1.9269;78.7336;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
131753346;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LIMGVWSRPUIYTD-UHFFFAOYSA-N
435728;REN;6;1.972e-64;0.5;108.0004;113.921;REN;Renin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
4656408;MMP8;7;4.756e-41;0.5;27.0075;71.9421;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
7010506;MME;6;1.3630000000000001e-191;0.6957;163.9769;342.2142;MME;Neprilysin (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
52926008;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;DWNFLQISNVMTDP-UHFFFAOYSA-N
13817313;ENPEP;7;5.959e-78;0.4118;6.1095;138.1931;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
47579;NAALAD2;6;7.856e-52;0.5946;2.9947;91.2994;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
111299;NPFFR1;7;5.1240000000000004e-76;0.4182;6.4842;134.7201;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
4657542;ANPEP;8;6.677e-119;0.4762;16.1201;211.7124;ANPEP;Aminopeptidase N (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
4657542;CAPNS1;6;1.642e-89;0.449;6.1477;158.9467;CAPNS1;Calpain small subunit 1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
515717;BLA1_STEMA;6;3.113e-83;0.4068;7.478;147.6758;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
137938;LPAR3;6;9.02e-53;0.5385;8.0246;92.9869;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(CO)CO;TVIMZSOUQXNWHO-UHFFFAOYSA-N
56960317;LPAR1;6;2.912e-55;0.7692;10.3499;97.459;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;LPQBQFLKBCPNAV-UHFFFAOYSA-N
7800;EST1_PIG;7;7.052e-67;0.4483;4.4101;118.3133;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
13783081;OPRM1;6;9.029e-117;0.6615;336.4009;207.8865;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
515717;GRIA1;6;5.444e-88;0.4103;19.4943;156.2167;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
329275;MMP11;6;8.87e-120;0.5139;12.0761;213.2863;MMP11;Stromelysin-3 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
131753806;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUCYHIOFVUWJDD-UHFFFAOYSA-N
10445608;PAPA1_CARPA;7;2.663e-84;0.4444;9.3376;149.5931;PAPA1_CARPA;Papain (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
7010532;ENPEP;7;9.948e-92;0.5227;7.1991;162.9279;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C(C)C)N;PNVLWFYAPWAQMU-UHFFFAOYSA-N
9856500;HLA-A;6;1.604e-86;0.4792;13.3607;153.5791;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
52924652;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WLTBPSUTBXIPBI-UHFFFAOYSA-N
53479670;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;PTTOPPWTEHEDTA-UHFFFAOYSA-N
13783081;CCKBR;6;4.979e-98;0.5821;99.3216;174.2396;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7359122;NPR;6;7.514e-98;0.4821;14.1172;173.9186;NPR;Thermolysin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
193508;CTSB;6;4.421e-83;0.5581;49.0211;147.4025;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
263475;MC5R;7;3.334e-81;0.4286;20.1918;144.0318;MC5R;Melanocortin receptor 5 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
435728;CPA1;6;3.8109999999999996e-89;0.7143;11.083;158.2902;CPA1;Carboxypeptidase A1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
52924238;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;XUUQFFVLEYTYES-UHFFFAOYSA-N
168058;HLA-A;6;4.438e-58;0.5556;8.9386;102.5164;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
134906;GHSR;6;6.201e-87;0.6964;89.5588;154.3199;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
18218182;HLA-A;6;1.098e-72;0.4746;11.2096;128.7401;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
7015683;BHMT;6;5.385e-60;0.4103;1.7532;105.9563;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
131755026;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QRLNWUKVSNTXQG-UHFFFAOYSA-N
151410;GRIA1;6;5.072e-66;0.431;14.5987;116.775;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131801934;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;MGNMWMMQKHUXCT-UHFFFAOYSA-N
151134;YARS;6;1.6289999999999998e-88;0.5106;5.1448;157.1577;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131758602;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QGSFHGSYPKDCBO-UHFFFAOYSA-N
100094;MC1R;6;2.9810000000000003e-123;0.5294;62.7027;219.5225;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
19421321;C3AR1;6;2.855e-64;0.4714;10.6429;113.6323;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
1549040;AHR;7;2.558e-50;0.6154;6.7738;88.5835;AHR;Aryl hydrocarbon receptor (pKi >= 7);CC=CC1=CC=C(C=C1)OC;RUVINXPYWBROJD-UHFFFAOYSA-N
131760503;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADOAWMSGAVKGKY-UHFFFAOYSA-N
56938633;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AYBNKZOBZIRMHJ-UHFFFAOYSA-N
131801883;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;RESRNMIXCOXYHQ-UHFFFAOYSA-N
759256;ANPEP;8;5.047e-107;0.4255;14.5014;190.3868;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
61030;CQSS;6;3.475e-65;0.4062;1.907;115.2744;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
131755167;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NJWLXJXDVKOEOP-UHFFFAOYSA-N
76807;LAP3;6;1.447e-46;0.6875;5.3082;81.8467;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
5488196;CAPNS1;6;1.636e-91;0.4259;6.2863;162.5402;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
12591;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
131758865;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;WUUWBWLVYRBSQT-UHFFFAOYSA-N
515709;CTSB;6;7.634e-91;0.7209;53.6129;161.3391;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
52922883;FABP3;7;1.635e-50;0.629;1.6618;88.9325;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)([O-])OCC[N+](C)(C)C;LFNLJXLPGIASGV-UHFFFAOYSA-N
545606;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NSQZMMPMMBEIIA-UHFFFAOYSA-N
53479906;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;OJCHOVMLEHFBOD-UHFFFAOYSA-N
10851;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC;VMPHSYLJUKZBJJ-UHFFFAOYSA-N
9546749;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;YDTWOEYVDRKKCR-UHFFFAOYSA-N
53480247;FABP3;7;3.2589999999999997e-44;0.4928;1.4512;77.6227;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;GSQABQVBVQXYJH-UHFFFAOYSA-N
131754163;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PZPSHGGBTBOCBZ-UHFFFAOYSA-N
5057430;NTSR1;6;5.765000000000001e-109;0.4265;26.4101;193.8738;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
52924554;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;BUCLJVJCFFPNPB-UHFFFAOYSA-N
150964;ECE1;6;1.029e-58;0.4528;25.3396;103.6561;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
11579826;DHFR;9;4.081e-45;0.4035;5.6541;79.2428;DHFR;Dihydrofolate reductase (pKi >= 9);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
53479862;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;YHKHZYNNNXVJRS-UHFFFAOYSA-N
131801943;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;PPTFPPBZILRDOI-UHFFFAOYSA-N
6992341;FURIN;6;3.974e-55;0.5;10.0714;97.2167;FURIN;Furin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCCCN)N;YQAIUOWPSUOINN-UHFFFAOYSA-N
12599;AHCY;6;8.549e-112;0.5;23.2039;198.9525;AHCY;Adenosylhomocysteinase (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
14282475;NTSR2;8;7.05e-104;0.425;10.0253;184.7403;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
168182;ECE1;6;2.9060000000000003e-115;0.7255;49.8786;205.1797;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
52924152;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;BSVQKPRGDPWRBO-UHFFFAOYSA-N
131801706;LPAR1;6;3.626e-43;0.7045;8.062;75.7442;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;TUHWKCBRUXQIHQ-UHFFFAOYSA-N
515717;OPRM1;6;3.412e-95;0.5;274.6302;169.1482;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
53479720;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DVFTWBPPIMYUEN-UHFFFAOYSA-N
19816755;MC1R;6;6.306e-101;0.4583;51.3206;179.4413;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
52924238;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;XUUQFFVLEYTYES-UHFFFAOYSA-N
3421919;MMP3;6;1.5500000000000002e-43;0.4906;51.0492;76.407;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
13783081;MMP8;7;1.3730000000000001e-55;0.493;36.6116;98.0451;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
53479569;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;IPBXKYJWPCRPLD-UHFFFAOYSA-N
151410;ST14;9;3.8299999999999995e-45;0.4085;3.5148;79.2922;ST14;Suppressor of tumorigenicity 14 protein (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
57281443;ENPEP;7;1.802e-89;0.5111;7.0205;158.8739;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C(C)O)N;LUMXICQAOKVQOB-UHFFFAOYSA-N
131754192;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OGNCECWXMXWFGY-UHFFFAOYSA-N
52924721;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;ZNMZYHOEYPCVMP-UHFFFAOYSA-N
9700;TYMP;6;2.572e-65;0.5091;6.5546;115.5092;TYMP;Thymidine phosphorylase (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
131755321;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVLMVUOWVUUAHL-UHFFFAOYSA-N
759256;CTSB;7;1.993e-43;0.4762;14.2532;76.2109;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
273262;FCER2;6;6.056e-93;0.4355;11.3835;165.1102;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
6992304;TPH1;6;3.6649999999999997e-93;0.4118;12.1047;165.5018;TPH1;Tryptophan 5-hydroxylase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
4657542;PAPA1_CARPA;6;1.3430000000000002e-69;0.475;10.4944;123.197;PAPA1_CARPA;Papain (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7010580;BLA1_STEMA;6;2.416e-96;0.5;8.6655;171.2126;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
4305457;HLA-A;6;3.466e-67;0.4912;10.3546;118.8672;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
53480989;LPAR3;6;1.1399999999999998e-52;0.6486;8.009;92.8043;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;OKMWKBLSFKFYGZ-UHFFFAOYSA-N
318292;NMBR;6;1.123e-45;0.5263;7.2379;80.2487;NMBR;Neuromedin-B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
53478008;LPAR3;6;2.184e-76;0.5957;11.6563;135.3851;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCCCC;DICYCLUXEYFAQX-UHFFFAOYSA-N
53481871;FABP3;7;2.379e-50;0.5833;1.6564;88.64;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;UZDPEBGNSKBQGX-UHFFFAOYSA-N
515709;NPPA;7;1.3249999999999999e-52;0.4717;1.7317;92.6871;NPPA;Natriuretic peptides A (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
10445608;CPA1;6;6.02e-81;0.4286;10.0564;143.5711;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
100048;CYSP_TRYCR;7;6.477e-88;0.4912;21.4029;156.0813;CYSP_TRYCR;Cruzipain (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
515717;ERAP2;6;2.4659999999999996e-41;0.4154;1.355;72.4542;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
13890535;GRIA1;6;9.113e-64;0.4545;14.0963;112.7274;GRIA1;Glutamate receptor 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
53479716;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;UAPYZCDNFGJZSC-UHFFFAOYSA-N
131765707;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;RIDIILYYYNCBPC-UHFFFAOYSA-N
131801755;LPAR3;6;2.703e-63;0.6522;9.6429;111.8798;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;OSXMEYNKEVXBGM-UHFFFAOYSA-N
131754546;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LBTCQHAIXPLSSD-UHFFFAOYSA-N
131753741;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MFFDRCAJUNCFIE-UHFFFAOYSA-N
332962;HLA-A;6;3.553e-77;0.4783;11.9077;136.8011;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
53480970;FABP3;7;2.046e-50;0.5128;1.6586;88.7577;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(CO)CO;NPZWSBAEZZLYQU-UHFFFAOYSA-N
342468;YARS;6;2.488e-92;0.451;5.3685;164.0084;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
100094;MMP8;9;1.456e-48;0.4861;10.0179;85.4324;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7010580;LAP3;6;6.119e-96;0.6136;11.0151;170.4881;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131756497;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;CHGVHAOSWOJCHZ-UHFFFAOYSA-N
131755233;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WQVLEJVLEGNDEG-UHFFFAOYSA-N
7016103;CAPN1;6;1.053e-79;0.4894;46.1302;141.3396;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7359122;CAPN2;6;2.8640000000000003e-122;0.5;35.5934;217.7585;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4305457;KLK3;7;4.1059999999999996e-41;0.4237;4.3528;72.0567;KLK3;Prostate-specific antigen (pKi >= 7);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
13783081;CTSB;6;8.234000000000001e-46;0.5357;26.9751;80.4908;CTSB;Cathepsin B (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
97045147;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AMXRERGJDVUTMF-UHFFFAOYSA-N
56938582;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SESIDPZYQNXGDB-UHFFFAOYSA-N
131759262;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPLCXIXCJSJOOR-UHFFFAOYSA-N
53479558;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PHNTZMYSEVOGFP-UHFFFAOYSA-N
53478233;LPAR3;6;2.6120000000000003e-63;0.549;9.6452;111.9065;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SPGHLBKMJHHORH-UHFFFAOYSA-N
9700;RNASE1;6;7.152e-56;0.5526;1.6311;98.5538;RNASE1;Ribonuclease pancreatic (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
7009598;CTSB;6;2.011e-83;0.6341;49.2234;148.0167;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
53479784;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CWPKVJPBYGQUHE-UHFFFAOYSA-N
6992341;HLA-A;6;5.425e-63;0.6279;9.7024;111.3366;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCCCN)N;YQAIUOWPSUOINN-UHFFFAOYSA-N
329275;C3AR1;6;2.054e-41;0.5694;6.8239;72.5967;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
759256;PAPA1_CARPA;7;5.966e-47;0.4167;5.1684;82.5373;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
53480248;FABP3;7;3.2589999999999997e-44;0.4928;1.4512;77.6227;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;VFLPHYZOQHTWTQ-UHFFFAOYSA-N
7010580;CTSL;6;3.82e-77;0.451;59.2805;136.7445;CTSL;Cathepsin L1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
323786;CTSB;6;4.957e-67;0.5072;39.5274;118.5882;CTSB;Cathepsin B (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
47579;MMP1;6;1.984e-50;0.4894;63.5153;88.7817;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131753319;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JYQXYTFYWDKLPT-UHFFFAOYSA-N
53479617;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ZTGVBXDPMCYOEV-UHFFFAOYSA-N
53480996;CQSS;6;9.049e-73;0.4412;2.1317;128.8908;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;KIWLCEXSSGNBJU-UHFFFAOYSA-N
131761186;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YZEITGDSYFHHEK-UHFFFAOYSA-N
19421321;ST14;9;5.059e-53;0.4507;4.1379;93.4378;ST14;Suppressor of tumorigenicity 14 protein (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
52924786;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;BRZHNCZGBULDIZ-UHFFFAOYSA-N
52925130;LPAR3;6;1.053e-104;0.7059;16.0109;186.2226;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;DBHKHNGBVGWQJE-UHFFFAOYSA-N
150964;MC3R;6;4.7980000000000004e-79;0.4865;38.7643;140.1573;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;ECE1;6;2.3379999999999998e-45;0.4651;19.5437;79.6772;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
329275;CAPN1;6;7.211e-91;0.5781;52.6094;161.3836;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
53478598;FABP3;7;4.9e-53;0.4815;1.7462;93.4627;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SOWAPPIVBQCDGN-UHFFFAOYSA-N
111299;NAALAD2;6;3.351e-55;0.5714;3.1922;97.3495;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
4427709;CCKBR;6;5.0699999999999995e-112;0.6452;113.4932;199.3599;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
515709;ACE;6;1.763e-113;0.6744;112.7324;201.979;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
11736661;DPP7;7;3.998e-45;0.4565;8.7041;79.2588;DPP7;Dipeptidyl peptidase 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CCC(=O)N)N)C(=O)O;NJMYZEJORPYOTO-UHFFFAOYSA-N
6993120;RNPEP;6;2.119e-46;0.5909;2.2801;81.5491;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
3421919;GRIA1;6;1.2450000000000002e-69;0.4727;15.4032;123.2563;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
52924370;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DPTUTWFSXXDMEO-UHFFFAOYSA-N
6993120;MMP2;6;5.510000000000001e-43;0.4694;69.6336;75.418;MMP2;72 kDa type IV collagenase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
14035030;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;VJLLLMIZEJJZTE-UHFFFAOYSA-N
131754010;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XDVVZXAIBRKPCM-UHFFFAOYSA-N
100048;ECE1;6;3.528e-84;0.5;36.3899;149.3736;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7359122;MMP1;6;9.065e-47;0.48;58.9195;82.2111;MMP1;Interstitial collagenase (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4427709;MMP11;6;6.398e-131;0.5;13.2057;233.2896;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131754941;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CABYGZXBJNUBCV-UHFFFAOYSA-N
13890535;CAPN1;6;9.83e-133;0.5349;76.9055;236.5453;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
53478513;FABP3;7;2.752e-49;0.4333;1.6208;86.7312;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LLOBOJAKMZHEKH-UHFFFAOYSA-N
97415;NPFFR2;6;6.916e-55;0.4314;8.6254;96.7847;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
53478341;LPAR3;6;1.3890000000000001e-55;0.5185;8.4571;98.0363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CQHRDRZMSJCJBX-UHFFFAOYSA-N
7021456;ACE2;6;1.968e-83;0.4727;11.7319;148.0334;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
545606;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NSQZMMPMMBEIIA-UHFFFAOYSA-N
151134;CAPN2;6;1.772e-114;0.5217;33.3171;203.7701;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
111299;HLA-DRB1;6;1.197e-61;0.4032;6.0537;108.9244;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
150964;Q9NAW4_PLAFA;6;9.013e-49;0.4906;1.4208;85.8063;Q9NAW4_PLAFA;Cysteine protease falcipain-3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
53479649;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MTYMMKBRSNPIPR-UHFFFAOYSA-N
131801744;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;SYTLTRZEHNVTSX-UHFFFAOYSA-N
7359122;CTSL;6;7.479e-66;0.4314;50.5924;116.4721;CTSL;Cathepsin L1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131801745;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;SFMJHWFZJBATQB-UHFFFAOYSA-N
7010506;OPRM1;6;1.573e-95;0.6727;275.5929;169.7519;OPRM1;Mu-type opioid receptor (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
131759281;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WVBFGMOFOIEXMP-UHFFFAOYSA-N
6993120;OPRD1;6;8.101e-81;0.4808;192.0135;143.3396;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
13783081;BLA1_STEMA;6;2.034e-80;0.4062;7.2229;142.6218;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
53479660;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ANVMSBIGOHYJFD-UHFFFAOYSA-N
6992643;FPR1;6;5.981e-90;0.5;17.048;159.734;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
52924233;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;RPYIJSOTHVJLOR-UHFFFAOYSA-N
52925140;LPAR3;6;1.053e-104;0.7059;16.0109;186.2226;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;QJHRNPQXCMXOOH-UHFFFAOYSA-N
12294;NOD1;9;6.42e-49;0.4318;3.4593;86.0707;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCC(=O)OCCCC;RPRPDTXKGSIXMD-UHFFFAOYSA-N
53478080;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NKDHOYXNDMODDX-UHFFFAOYSA-N
96814;FPR1;6;7.075e-113;0.6585;21.4198;200.8954;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
10468;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
70694;CES2C;6;1.437e-58;0.4242;1.9311;103.3959;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
168182;MC3R;6;1.3120000000000002e-84;0.4658;41.5021;150.1449;MC3R;Melanocortin receptor 3 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
100048;BLA1_STEMA;6;3.9589999999999997e-94;0.4643;8.4649;167.237;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
134906;MC5R;7;8.28e-102;0.5342;25.3459;181.0243;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
7021828;ANPEP;6;2.512e-43;0.5476;15.149;76.0306;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
19421321;OPRD1;6;9.937000000000001e-115;0.6271;272.0105;204.2212;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7010580;ACE2;6;1.1449999999999999e-140;0.5909;19.8389;250.7887;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
12530;PLA2G4B;6;2.175e-68;0.4595;5.9815;121.0259;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
111299;FOLH1;6;6.382e-52;0.4545;16.345;91.4614;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
3038501;EDNRA;6;2.4599999999999998e-48;0.4795;72.0853;85.0235;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
53479914;LPAR1;6;3.382e-45;0.5818;8.446;79.3892;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;NCWMYSRFLUIVBC-UHFFFAOYSA-N
20835023;LPAR3;6;7.551e-136;0.9286;20.8004;242.1369;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
19816756;MC4R;6;2.203e-51;0.4783;75.9614;90.4953;MC4R;Melanocortin receptor 4 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
131755752;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SAZSVOQHSUNCSC-UHFFFAOYSA-N
19816750;CAPN2;6;4.234e-43;0.52;12.4634;75.6234;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
9700;POLB;6;1.508e-83;0.7885;2.4509;148.2411;POLB;DNA polymerase beta (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
131755915;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBYJHYPJVAOSBP-UHFFFAOYSA-N
131755728;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;PODGNDQRHPDVSY-UHFFFAOYSA-N
7643;CES1;6;5.152e-80;0.413;17.9406;141.8972;CES1;Liver carboxylesterase 1 (pKi >= 6);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
52924787;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;QISXRGLAZUIPCG-UHFFFAOYSA-N
96814;NPR;6;1.372e-116;0.5;16.8374;207.5605;NPR;Thermolysin (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131758887;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCC;GEDOOJBTRRNYEP-UHFFFAOYSA-N
6435901;FABP3;7;6.593e-59;0.7333;1.9424;104.0032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
150964;FPR1;6;2.544e-87;0.5;16.5467;155.0145;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9797038;SSTR2;7;7.169e-85;0.4658;20.544;150.6161;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
53480847;FABP3;7;1.275e-47;0.5152;1.5652;83.7407;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YITZQGLIICATLN-UHFFFAOYSA-N
12599;OXGR1;6;7.642999999999999e-137;0.4615;14.9285;243.9228;OXGR1;2-oxoglutarate receptor 1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
131755233;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WQVLEJVLEGNDEG-UHFFFAOYSA-N
96814;PIN1;6;2.237e-43;0.4;5.6716;76.121;PIN1;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131753767;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UUHNNGQNNNMIKK-UHFFFAOYSA-N
7009650;MME;6;1.157e-72;0.5667;62.1639;128.6988;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53479863;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IZWPZNGYCMMGHU-UHFFFAOYSA-N
151134;ACE;6;1.403e-150;0.5926;149.5791;268.5836;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
3634442;OPRD1;6;5.6850000000000006e-42;0.5132;100.3752;73.5984;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
52924774;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XJLGATDALCZXFX-UHFFFAOYSA-N
7021456;NTSR2;8;1.065e-96;0.4396;9.3279;171.8512;NTSR2;Neurotensin receptor type 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
131759908;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PIYNNEKPAVFCLZ-UHFFFAOYSA-N
9948926;FPR1;6;3.6040000000000003e-65;0.5397;12.3229;115.246;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
9797038;NTSR1;10;2.043e-43;0.4773;1.2621;76.1916;NTSR1;Neurotensin receptor type 1 (pKi >= 10);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
19816756;MC5R;8;2.351e-71;0.4359;10.5177;126.3511;MC5R;Melanocortin receptor 5 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
52922266;FABP3;7;3.359e-50;0.65;1.6514;88.3711;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)([O-])OCC[N+](C)(C)C;MVGBUJJTKGIFFM-UHFFFAOYSA-N
329275;NPR;6;1.672e-117;0.7308;16.97;209.2012;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
168182;GHSR;6;9.561999999999999e-81;0.5932;83.187;143.2103;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
3421919;FPR1;6;7.583e-97;0.5319;18.3631;172.1162;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
273262;FPR1;6;5.193e-104;0.5745;19.7293;184.9786;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
53479853;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;XOTZQQUUCAOSLB-UHFFFAOYSA-N
131753666;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KRVDGBILMBJWGW-UHFFFAOYSA-N
152198;CPA1;6;9.168000000000001e-63;0.48;7.7799;110.9274;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
131754335;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NAFMESDUMVNTKX-UHFFFAOYSA-N
3081383;P2RY1;6;9.233000000000001e-57;0.4946;27.6906;100.15;P2RY1;P2Y purinoceptor 1 (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
156907995;FABP3;7;4.646e-48;0.4318;1.5798;84.5275;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C;QGIHQXKFCAACHN-UHFFFAOYSA-N
24778627;LPAR3;6;1.952e-58;0.5082;8.8957;103.1567;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SZQBOFQJPDNGHN-UHFFFAOYSA-N
14767562;GRIA1;6;4.465e-62;0.4074;13.7197;109.6931;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
151134;OPRD1;6;2.2039999999999998e-105;0.5192;249.9633;187.4422;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
323786;MC3R;6;3.5939999999999997e-91;0.4487;44.7316;161.9265;MC3R;Melanocortin receptor 3 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
4466134;FPR1;6;1.342e-99;0.5417;18.8879;177.0568;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53478121;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;OGEVDGPPHTZMPM-UHFFFAOYSA-N
7021820;GRIA1;6;4.602e-95;0.4815;21.0704;168.915;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
318292;EDNRB;9;3.219e-69;0.5231;6.6585;122.5153;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010580;TIMP3;6;1.653e-82;0.4151;7.2288;146.3743;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53478462;FABP3;7;4.433e-53;0.4889;1.7476;93.5408;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PXCOILRYJJUSSX-UHFFFAOYSA-N
9546836;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XMJSNHMFTISTET-UHFFFAOYSA-N
131755773;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;HFPMGYAXBUYRKI-UHFFFAOYSA-N
342468;CAPN2;6;1.452e-129;0.5714;37.7247;230.8553;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
47579;ANPEP;8;1.1180000000000001e-117;0.4889;15.9534;209.5154;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
52925456;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;QFGBUBRLCJWGHL-UHFFFAOYSA-N
7009598;NPR;6;2.611e-95;0.4643;13.7483;169.3568;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
13890535;AMP1_PLAFQ;6;2.4679999999999998e-54;0.5319;6.9261;95.7928;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131801991;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;JODFYBIHEFCIFI-UHFFFAOYSA-N
150964;TRY1_BOVIN;8;1.8700000000000002e-49;0.4648;10.1321;87.0326;TRY1_BOVIN;Cationic trypsin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9948926;MMP8;9;3.8859999999999996e-53;0.5082;10.9716;93.6435;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
4466134;PSMB2;7;5.562e-43;0.5;1.2492;75.4107;PSMB2;Proteasome subunit beta type-2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
7009555;NTSR1;6;3.598e-116;0.4085;28.1642;206.8086;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
53479906;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;OJCHOVMLEHFBOD-UHFFFAOYSA-N
13890535;PIN1;6;4.9869999999999994e-51;0.5357;6.6865;89.8583;PIN1;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
6351946;OPRM1;6;2.186e-43;0.4667;126.3208;76.1388;OPRM1;Mu-type opioid receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
5280666;CYP1A2;7;1.1370000000000002e-46;0.7273;9.4877;82.0341;CYP1A2;Cytochrome P450 1A2 (pKi >= 7);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
515717;CAPN1;6;4.597e-54;0.4894;31.2504;95.3078;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
19816755;EDNRB;9;5.464e-58;0.4189;5.5677;102.3544;EDNRB;Endothelin B receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
150964;NPR1;6;2.237e-47;0.4054;1.7248;83.3022;NPR1;Atrial natriuretic peptide receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
5259590;FOLH1;6;3.0799999999999996e-67;0.7273;21.2057;118.9592;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
19816750;OPRM1;6;1.353e-111;0.5484;321.5843;198.5945;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
131760624;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;QBTDCDJQWFFVGF-UHFFFAOYSA-N
131759399;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDWAIWYOHVLVMF-UHFFFAOYSA-N
323786;MC1R;6;2.0530000000000002e-116;0.5147;59.2165;207.2461;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
6351946;ACE;6;7.198e-106;0.4783;105.1731;188.3147;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
131755168;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BUBKDTQRUWZQHX-UHFFFAOYSA-N
131750653;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFUGNQFGFOCTMS-UHFFFAOYSA-N
10445608;AMP1_PLAFQ;6;1.491e-59;0.5106;7.5991;105.1621;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
53479881;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;MVASPAIFCLTHSN-UHFFFAOYSA-N
342468;OPRM1;6;4.0479999999999997e-91;0.4909;262.967;161.8338;OPRM1;Mu-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
5057430;LAP3;6;5.215e-45;0.4375;5.1282;79.0515;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
53478438;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWHGFSHXNNIITD-UHFFFAOYSA-N
131754525;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QZSQJRGOJCTPHI-UHFFFAOYSA-N
53480996;LPAR3;6;1.1399999999999998e-52;0.6486;8.009;92.8043;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O;KIWLCEXSSGNBJU-UHFFFAOYSA-N
53478487;FABP3;7;3.438e-52;0.4783;1.7179;91.9436;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XJELJGCMEUSYKS-UHFFFAOYSA-N
53480927;LPAR3;6;2.484e-87;0.5714;13.3393;155.0333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COP(=O)(O)OCCN;QYXNIRQICOBIAE-UHFFFAOYSA-N
131801864;FABP3;7;5.697e-56;0.5238;1.8443;98.7311;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DSPKXVYJORTNRJ-UHFFFAOYSA-N
44232492;NPR;6;3.2070000000000003e-85;0.4107;12.2837;151.2435;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
9546742;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;JQKOHRZNEOQNJE-UHFFFAOYSA-N
5282761;LPAR3;6;8.049000000000001e-72;0.4419;10.9541;127.1868;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
53479726;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;RZGFDECXQULSLM-UHFFFAOYSA-N
4305457;PSMB2;7;1.388e-52;0.4308;1.5337;92.6506;PSMB2;Proteasome subunit beta type-2 (pKi >= 7);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
9797038;EDNRA;6;1.309e-63;0.625;94.7462;112.4449;EDNRA;Endothelin-1 receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
273262;KLK3;7;1.0089999999999999e-83;0.4348;8.937;148.5543;KLK3;Prostate-specific antigen (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
318292;ANPEP;8;1.461e-56;0.4;7.6246;99.7923;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
102763;MC5R;7;8.716e-82;0.4125;20.3376;145.0779;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
53479688;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DSZLDVIMYQKWGY-UHFFFAOYSA-N
131750646;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NVBSJAZGISYRIW-UHFFFAOYSA-N
150964;ST14;9;1.711e-54;0.4247;4.2543;96.0784;ST14;Suppressor of tumorigenicity 14 protein (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
259327;FPR1;6;4.0009999999999996e-88;0.5116;16.6999;156.4568;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
92021849;Q4VQ11_PIG;8;1.7e-78;0.5538;2.5972;139.1712;Q4VQ11_PIG;Adenosine receptor A1 (pKi >= 8);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
131750486;LPAR3;6;4.4e-89;0.5556;13.6087;158.1781;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;IQIUZAVCJONSBD-UHFFFAOYSA-N
545258;LPAR3;6;3.858e-45;0.4;6.8511;79.2865;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
131755020;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SHZPWJWHCSZOEX-UHFFFAOYSA-N
53478281;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXZEPDSGFSCPJ-UHFFFAOYSA-N
47579;PIN1;6;5.089e-61;0.4423;8.0117;107.7957;PIN1;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
4427709;MC3R;6;2.477e-104;0.5342;51.2088;185.5558;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131750646;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NVBSJAZGISYRIW-UHFFFAOYSA-N
4466134;GRIA1;6;6.153e-65;0.4182;14.3572;114.8289;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
52924162;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ADCNXGARWPJRBV-UHFFFAOYSA-N
151410;NPFFR2;7;2.025e-78;0.4138;6.5121;139.0345;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53477997;LPAR3;6;1.349e-48;0.5;7.3826;85.492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QSZQNXRKRGRBGH-UHFFFAOYSA-N
134906;OPRD1;6;2.0809999999999998e-81;0.6667;193.4059;144.3993;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
8180;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
10459;BBOX1;6;1.619e-47;0.4;1.8905;83.5544;BBOX1;Gamma-butyrobetaine dioxygenase (pKi >= 6);C(CCCCCCCC(=O)O)CCCCCCC(=O)O;QQHJDPROMQRDLA-UHFFFAOYSA-N
53479609;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZBKSDVGXOOCETO-UHFFFAOYSA-N
131760520;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WZQHACRHKQJTGS-UHFFFAOYSA-N
435728;ANPEP;6;5.9269999999999995e-137;0.58;48.1795;244.121;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
53480247;LPAR1;6;1.312e-43;0.541;8.1455;76.5367;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;GSQABQVBVQXYJH-UHFFFAOYSA-N
7021828;FPR1;6;7.047e-68;0.4444;12.8394;120.1091;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
263475;SSTR2;7;9.476e-84;0.4167;20.2711;148.6034;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
352038;LAP3;6;3.225e-41;0.5;4.69;72.2449;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(C(C)C)C(=O)O)N;MDSUKZSLOATHMH-UHFFFAOYSA-N
7359122;HLA-A;6;7.858e-107;0.4821;16.5184;190.0417;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
20835023;ENPP2;6;6.624e-56;0.9286;8.2212;98.6136;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
134906;MMP2;6;2.308e-50;0.5357;81.5019;88.6638;MMP2;72 kDa type IV collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
74328989;SLC5A2;6;1.239e-90;0.4355;67.3229;160.9617;SLC5A2;Sodium/glucose cotransporter 2 (pKi >= 6);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
131753717;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZMOOAMBHOJSHY-UHFFFAOYSA-N
20057356;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;DFELABABMXOKTD-UHFFFAOYSA-N
5488196;CAPN1;6;2.1429999999999997e-133;0.561;77.2894;237.7329;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
273262;PSMB5;9;3.904e-45;0.4444;2.7243;79.2773;PSMB5;Proteasome subunit beta type-5 (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7010566;PAPA1_CARPA;7;1.928e-100;0.4545;11.1392;178.5699;PAPA1_CARPA;Papain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
12599;POLB;6;1.842e-74;0.5522;2.1818;131.9272;POLB;DNA polymerase beta (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
19816756;TACR1;6;1.891e-45;0.5082;78.6262;79.8424;TACR1;Substance-P receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
53479575;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LKUKJIYAXQFZTD-UHFFFAOYSA-N
12051354;LPAR3;6;2.667e-106;0.6944;16.2564;189.0889;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
329275;ECE1;6;3.534e-114;0.7308;49.4078;203.2319;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
53480986;LPAR3;6;1.377e-75;0.6522;11.5333;133.9492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(CO)O;LERKRWCYZNDWFH-UHFFFAOYSA-N
4657542;MMP1;6;1.145e-53;0.4348;67.5822;94.5961;MMP1;Interstitial collagenase (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
17525;EST1_PIG;7;1.372e-65;0.4242;4.3241;115.999;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
7009598;PAPA1_CARPA;7;6.678000000000001e-78;0.4167;8.6233;138.1043;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
111299;LAP3;6;7.600000000000001e-80;0.48;9.1548;141.594;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
61030;CES2C;6;1.437e-58;0.4242;1.9311;103.3959;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
6427003;FURIN;6;4.833e-41;0.5294;7.4722;71.9296;FURIN;Furin (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
151410;MMP1;6;3.767e-44;0.5;55.6312;77.5099;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131802016;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;ZLEJYIVDPRFANO-UHFFFAOYSA-N
5488196;CPA1;6;7.507999999999999e-103;0.4565;12.799;182.8959;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
150964;OPRM1;6;8.716000000000001e-78;0.6429;224.7976;137.8966;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
5057430;CTSB;6;4.892e-41;0.6512;24.1512;71.9201;CTSB;Cathepsin B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
193508;ECE1;6;1.104e-70;0.4783;30.5337;125.1454;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
131801706;FABP3;7;2.4999999999999997e-55;0.55;1.8228;97.578;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;TUHWKCBRUXQIHQ-UHFFFAOYSA-N
4427709;ACE2;6;1.166e-104;0.4545;14.7386;186.1433;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131754525;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QZSQJRGOJCTPHI-UHFFFAOYSA-N
53480963;FABP3;7;2.642e-55;0.5429;1.822;97.5349;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)CO;YRAZXZXQMMJRRV-UHFFFAOYSA-N
131755451;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NPRADIIHNTWIBW-UHFFFAOYSA-N
7009555;ECE1;6;1.415e-79;0.449;34.3924;141.1096;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
1549040;CYP1B1;6;3.571e-61;0.6154;12.1104;108.072;CYP1B1;Cytochrome P450 1B1 (pKi >= 6);CC=CC1=CC=C(C=C1)OC;RUVINXPYWBROJD-UHFFFAOYSA-N
100048;NPR;6;8.023e-95;0.4667;13.6776;168.4816;NPR;Thermolysin (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
3634442;EDNRA;6;6.61e-57;0.5352;84.8011;100.4105;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
7009598;ANPEP;8;1.8329999999999998e-137;0.5652;18.6496;245.036;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
9856500;FPR1;6;1.663e-69;0.4167;13.1496;123.0301;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
9546825;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;CLPMAPXZURYSNH-UHFFFAOYSA-N
134906;CAPNS1;6;3.7860000000000003e-65;0.4127;4.4609;115.2076;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
96814;ENPEP;7;5.5969999999999996e-68;0.4;5.3208;120.2888;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010506;CAPN1;6;5.3599999999999995e-104;0.5472;60.2286;184.9539;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
193508;LAP3;6;1.925e-87;0.5333;10.0329;155.2321;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
13783081;ANPEP;8;1.3909999999999998e-67;0.4032;9.1266;119.5788;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
52924564;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VPDGQGZVNVFJGD-UHFFFAOYSA-N
19421321;NPFFR2;7;2.517e-75;0.4;6.2529;133.4792;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
53480925;LPAR1;6;1.571e-45;0.5185;8.509;79.9868;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NOVZJYYJYIFXJC-UHFFFAOYSA-N
52924353;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIWMKSHLSCQARO-UHFFFAOYSA-N
9797038;MC5R;7;8.834e-82;0.4286;20.3361;145.0674;MC5R;Melanocortin receptor 5 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
131753659;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DQXQIWIQYYEGLG-UHFFFAOYSA-N
31292;LPAR3;6;1.0399999999999999e-45;0.4;6.9386;80.3085;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
152198;MME;6;2.45e-170;0.5;145.7811;304.0552;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
151134;MME;6;1.1989999999999998e-227;0.6098;194.8433;406.9454;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
53479728;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;OHBRNOPVIZLBBE-UHFFFAOYSA-N
70694;EST1_PIG;7;1.372e-65;0.4242;4.3241;115.999;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
7643;FAAH;8;1.196e-84;0.4783;56.4241;150.2172;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 8);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
53479897;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;SQWAGNNCWNPIQG-UHFFFAOYSA-N
17525;NOD1;9;5.502e-51;0.4545;3.6077;89.7817;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
5057430;ACE2;6;1.2819999999999999e-111;0.5909;15.7243;198.6369;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
31292;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
161234;FIMH;6;3.891e-81;0.4314;10.3823;143.9113;FIMH;FimH (pKi >= 6);C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)O;PUEDDPCUCPRQNY-UHFFFAOYSA-O
318292;MC3R;6;5.271e-90;0.4932;44.1576;159.8325;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
131759263;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MDXVSMKNQLMYQZ-UHFFFAOYSA-N
131801898;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;IKSWSKJAXUGKHC-UHFFFAOYSA-N
131759294;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XYKBFKVMVVJQIJ-UHFFFAOYSA-N
131801943;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;PPTFPPBZILRDOI-UHFFFAOYSA-N
9561835;FABP3;7;8.525999999999999e-45;0.5667;1.4707;78.6683;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC(CCCCCCCCC(=O)O)O;PAZZVPKITDJCPV-UHFFFAOYSA-N
53479907;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FISVEBQJGBZOPW-UHFFFAOYSA-N
74819135;LPAR3;6;2.3370000000000002e-63;0.6977;9.6526;111.9931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)O;ZPDQFUYPBVXUKS-UHFFFAOYSA-N
53479649;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MTYMMKBRSNPIPR-UHFFFAOYSA-N
11958364;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;YMYQEDCYNANIPI-UHFFFAOYSA-N
19421321;YARS;6;4.175e-111;0.5745;6.469;197.716;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7009598;NPFFR2;7;1.391e-76;0.4103;6.3583;135.7367;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
150964;ANPEP;8;1.763e-111;0.4737;15.1087;198.3881;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
14409732;TACR1;6;7.36e-46;0.4457;79.3299;80.5783;TACR1;Substance-P receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
3421919;CTSC;6;4.248e-50;0.5455;7.6978;88.188;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
329275;OPRD1;6;2.761e-42;0.569;101.1149;74.1614;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
168182;CAPN1;6;2.7630000000000002e-42;0.617;24.4147;74.1609;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
9856500;RIR1_HHV11;6;3.701e-92;0.4068;6.0953;163.6989;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
24778743;LPAR3;6;3.419e-52;0.6327;7.9356;91.948;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C;UEWKKZXJWBVMLY-UHFFFAOYSA-N
53480059;LPAR1;6;1.2770000000000001e-42;0.5517;7.9586;74.7627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O;BZUNGYVNIWPISD-UHFFFAOYSA-N
4427709;CTSB;6;1.107e-57;0.5;33.9972;101.8035;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53478487;LPAR3;6;1.349e-48;0.5;7.3826;85.492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XJELJGCMEUSYKS-UHFFFAOYSA-N
520710;LPAR3;6;4.451e-52;0.4872;7.918;91.7424;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
131753806;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUCYHIOFVUWJDD-UHFFFAOYSA-N
318292;ECE1;6;9.917e-113;0.6939;48.7794;200.6321;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010506;KLK3;7;1.657e-82;0.4531;8.8062;146.3724;KLK3;Prostate-specific antigen (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
342468;NTSR1;6;7.489e-137;0.4714;33.1994;243.9387;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
53480969;LPAR3;6;2.448e-75;0.587;11.4949;133.5009;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(CO)CO;DVYDCUGIJCYIQN-UHFFFAOYSA-N
12530;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
47579;MMP9;6;3.19e-44;0.5;63.8384;77.6395;MMP9;Matrix metalloproteinase-9 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131758777;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QGLNBMRMNJAFOO-UHFFFAOYSA-N
6993120;PGA;6;3.406e-44;0.4098;10.0413;77.5884;PGA;Pepsin A (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
52924223;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QHNWICFFSBJICC-UHFFFAOYSA-N
10445608;FPR1;6;2.436e-81;0.449;15.4062;144.2765;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
151134;CYSP_TRYCR;7;4.981e-79;0.4259;19.2276;140.1282;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
9797038;CTSL;8;8.198e-44;0.5312;12.2401;76.9035;CTSL;Cathepsin L1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
131759908;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PIYNNEKPAVFCLZ-UHFFFAOYSA-N
131759435;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGFTVBFRGRHBJX-UHFFFAOYSA-N
102763;MC1R;6;4.8940000000000003e-116;0.5167;59.0241;206.5686;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
53480986;FABP3;7;4.2039999999999997e-54;0.5366;1.7818;95.3774;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(CO)O;LERKRWCYZNDWFH-UHFFFAOYSA-N
12591;FABP3;7;6.518e-57;0.7391;1.8757;100.4214;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
332962;CAPN1;6;6.924000000000001e-84;0.5116;48.5573;148.8479;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
151410;CAPN2;6;4.948e-136;0.6;39.6143;242.4665;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53480949;FABP3;7;3.0419999999999995e-47;0.5085;1.5525;83.0624;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;WAYKKNOEMJFLDI-UHFFFAOYSA-N
18986;HTR1B;7;8.089e-47;0.641;34.0507;82.2999;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 7);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
131753490;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BVZUJVWCCYACND-UHFFFAOYSA-N
100048;ACE;6;3.553e-115;0.625;114.4164;205.0231;ACE;Angiotensin-converting enzyme (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
3800205;NTSR1;6;2.516e-48;0.4928;11.6468;85.0059;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
89567;LPAR1;6;2.4769999999999998e-60;1.0;11.309;106.5617;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;LAYXSTYJRSVXIH-UHFFFAOYSA-N
53479731;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;HCQUFOLAJNWIDV-UHFFFAOYSA-N
7016103;HLA-A;6;1.205e-82;0.6591;12.7581;146.6208;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
14282475;SORT1;6;6.2000000000000005e-58;0.4048;3.9614;102.2558;SORT1;Sortilin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
22556;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
131755321;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVLMVUOWVUUAHL-UHFFFAOYSA-N
150964;NTSR1;6;4.3660000000000005e-69;0.5333;16.7011;122.2777;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
131763089;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LPABDPJNNDGDTQ-UHFFFAOYSA-N
131760029;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OFXPDVFCVMOXOI-UHFFFAOYSA-N
759256;LAP3;6;8.335000000000001e-58;0.4255;6.6073;102.0251;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
53479729;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;USEKWJQLASGHIH-UHFFFAOYSA-N
131760023;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;OYVIPANDVFEMEV-UHFFFAOYSA-N
13783081;MMP11;6;2.9070000000000002e-124;0.473;12.5307;221.3374;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
96814;MMP2;6;2.3210000000000003e-46;0.5319;75.0633;81.4779;MMP2;72 kDa type IV collagenase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
515709;LAP3;6;5.322e-79;0.5;9.0571;140.0766;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
4466134;HLA-A;6;1.07e-117;0.4746;18.2078;209.5497;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53480018;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;LYQNHUUXGYHXPH-UHFFFAOYSA-N
19816755;MMP11;6;4.909e-109;0.44;10.9869;193.9992;MMP11;Stromelysin-3 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
131756497;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;CHGVHAOSWOJCHZ-UHFFFAOYSA-N
52924378;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;ODKCSLGCTVUPMX-UHFFFAOYSA-N
329275;MMP2;6;1.2659999999999999e-54;0.625;88.3557;96.3131;MMP2;72 kDa type IV collagenase (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7021820;FPR1;6;1.259e-72;0.4677;13.7448;128.6333;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
131763207;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HXJRHBUXUMSJKX-UHFFFAOYSA-N
53480650;CQSS;6;7.223e-64;0.4;1.8679;112.9087;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NC(CO)C(C(CCCCCCCCCCCCCC)O)O;IVBULNXGVIHEKN-UHFFFAOYSA-N
12741;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
9797038;CAPN1;6;2.362e-64;0.5147;37.2216;113.7801;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
52924465;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QCCKXFCODQEYIW-UHFFFAOYSA-N
318292;ERAP2;6;4.9799999999999995e-62;0.5538;2.0468;109.6079;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
52924721;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;ZNMZYHOEYPCVMP-UHFFFAOYSA-N
90659830;SELP;6;6.737e-77;0.7183;6.0262;136.302;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)NC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)O;MKOKWBRPIBQYJJ-UHFFFAOYSA-N
96814;YARS;6;1.201e-49;0.4255;2.8666;87.3774;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;MC4R;6;9.151e-63;0.6;92.7069;110.9288;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
6992567;ENPEP;6;3.239e-71;0.42;8.5691;126.1011;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SITLTJHOQZFJGG-UHFFFAOYSA-N
435728;MME;6;1.8e-240;0.7143;205.8215;429.9681;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
435728;CAPNS1;6;1.087e-90;0.5185;6.2294;161.0637;CAPNS1;Calpain small subunit 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
46879024;CQSS;6;9.049e-73;0.4412;2.1317;128.8908;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(CO)O;QSKPZDMBULYMDQ-UHFFFAOYSA-N
4656408;FURIN;7;3.751e-49;0.4348;6.7898;86.4897;FURIN;Furin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
100094;GHSR;6;1.6160000000000002e-71;0.619;73.6852;126.6434;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
52924894;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DXXUYBAISOHOLM-UHFFFAOYSA-N
53479731;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;HCQUFOLAJNWIDV-UHFFFAOYSA-N
131758653;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DAAWWDSQUNUMHY-UHFFFAOYSA-N
168182;MMP8;9;4.451e-57;0.5246;11.7935;100.7188;MMP8;Neutrophil collagenase (pKi >= 9);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
4225619;CDC25A;6;7.619999999999999e-61;0.4737;2.8175;107.481;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C;LJGMGXXCKVFFIS-UHFFFAOYSA-N
97415;NAALAD2;6;1.2079999999999998e-44;0.5641;2.5734;78.3963;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
92946;XIAP;6;4.986e-42;0.6226;17.1601;73.7006;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
5312554;LPAR3;6;2.828e-61;0.413;9.3323;108.2537;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
4078684;HLA-A;7;9.38e-78;0.4286;8.1367;137.8393;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
168058;NOD1;9;1.513e-93;0.5349;6.662;166.1914;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
97415;CAPNS1;6;9.252e-72;0.4423;4.9187;127.0781;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
100094;EDNRB;9;1.48e-65;0.4857;6.3028;115.9402;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7021456;YARS;6;1.322e-91;0.463;5.326;162.7065;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
53479624;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;FXSMMNUNFDTUMS-UHFFFAOYSA-N
52925130;FABP3;7;3.395e-49;0.4839;1.6178;86.5676;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;DBHKHNGBVGWQJE-UHFFFAOYSA-N
56938582;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SESIDPZYQNXGDB-UHFFFAOYSA-N
12051354;S1PR3;8;1.0359999999999999e-53;0.4667;6.8458;94.6741;S1PR3;Sphingosine 1-phosphate receptor 3 (pKi >= 8);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
151410;POLG_WNV;7;1.8119999999999999e-93;0.4444;5.9388;166.0512;POLG_WNV;Genome polyprotein (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
151134;LAP3;6;6.322e-87;0.5;9.9732;154.3049;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131755016;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RBJMAKBTUZSIDN-UHFFFAOYSA-N
131755173;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UOSXDBUYARIRPO-UHFFFAOYSA-N
131801928;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;KYTZSBQBUCWGRJ-UHFFFAOYSA-N
9856500;NOD1;9;3.4290000000000004e-85;0.4118;6.0624;151.1912;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
19816756;HLA-DRB1;6;1.0450000000000001e-55;0.4691;5.4639;98.2581;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
12294;CQSS;6;2.902e-67;0.4194;1.9685;119.0056;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)OCCCC;RPRPDTXKGSIXMD-UHFFFAOYSA-N
13932172;FABP3;7;6.644e-81;1.0;2.6777;143.4942;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
6992304;ACE;6;3.0920000000000004e-70;0.6216;69.7825;124.342;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
18986;MTNR1A;6;7.648000000000001e-108;0.6667;76.2001;191.858;MTNR1A;Melatonin receptor type 1A (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
6993120;HLA-DRB1;6;4.432e-100;0.4464;9.8688;177.9209;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131753524;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMAGTKGPGZLWKS-UHFFFAOYSA-N
53480248;LPAR3;6;4.0229999999999994e-88;0.5556;13.4609;156.4527;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;VFLPHYZOQHTWTQ-UHFFFAOYSA-N
323786;CAPN2;6;1.465e-142;0.5072;41.5216;254.1874;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263471;CCKBR;6;7.196e-110;0.5077;111.3135;195.4962;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
53480249;LPAR3;6;4.0229999999999994e-88;0.5556;13.4609;156.4527;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;SJLOPHYYGZLTGX-UHFFFAOYSA-N
53480967;LPAR3;6;2.448e-75;0.587;11.4949;133.5009;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(CO)CO;FHCHFKIVIFQBSC-UHFFFAOYSA-N
44232492;HLA-A;6;2.006e-77;0.4912;11.9463;137.2465;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
1563;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCC(C(=O)O)O;JYZJYKOZGGEXSX-UHFFFAOYSA-N
100094;NAALAD2;6;1.6219999999999999e-52;0.4259;3.0348;92.5292;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7021820;NTSR2;8;1.324e-99;0.4935;9.6101;177.0674;NTSR2;Neurotensin receptor type 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
131755391;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YRHHWDQMQNTGFU-UHFFFAOYSA-N
14325553;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCABCCITBXMTKG-UHFFFAOYSA-N
4657542;MME;6;2.563e-226;0.5714;193.705;404.5581;MME;Neprilysin (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
52924815;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PQCDVFVOQBZXJA-UHFFFAOYSA-N
80108;FAAH;7;2.238e-115;0.5238;123.5162;205.3834;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 7);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
5057430;YARS;6;5.2670000000000005e-121;0.6585;7.0492;215.488;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
52925059;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NRDJGXANLABPHN-UHFFFAOYSA-N
4656408;EDNRB;9;5.318e-52;0.4328;4.9861;91.6036;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
13783081;LNPEP;6;1.084e-54;0.473;6.1404;96.4344;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
17863274;ENPEP;7;1.973e-77;0.4074;6.0684;137.2595;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CCSC)C(=O)O)N;TUYOFUHICRWDGA-UHFFFAOYSA-N
4078684;YARS;6;6.083000000000001e-122;0.6429;7.1041;217.1711;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
9546742;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;JQKOHRZNEOQNJE-UHFFFAOYSA-N
14304554;HLA-A;6;1.962e-64;0.4464;9.9266;113.9249;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
6992643;C3AR1;6;5.119e-52;0.4746;8.5955;91.6333;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
92021849;DNMT3B;6;9.125e-84;0.439;3.8925;148.6328;DNMT3B;DNA (cytosine-5)-methyltransferase 3B (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
4427709;MC4R;6;9.888e-77;0.619;113.2554;136.0029;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
515709;RNPEP;6;2.606e-50;0.5;2.4754;88.569;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
131801884;LPAR3;6;4.274e-76;0.6739;11.6115;134.8617;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;XJJBSSJHWZLHHT-UHFFFAOYSA-N
131801877;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;JWCNGONSUJKGDO-UHFFFAOYSA-N
235009;HLA-A;6;5.336e-55;0.4898;8.4597;96.9869;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)O)N;LSLXWOCIIFUZCQ-UHFFFAOYSA-N
435728;CAPN1;6;2.023e-158;0.7692;91.8124;282.661;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
134906;C5AR1;6;5.2899999999999997e-45;0.4253;12.9645;79.0404;C5AR1;C5a anaphylatoxin chemotactic receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
47579;ACE2;6;4.622e-140;0.6389;19.7531;249.701;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131801772;LPAR3;6;3.449e-87;0.7045;13.3174;154.7773;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;XIZKIPQKOHUAHX-UHFFFAOYSA-N
53478281;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXZEPDSGFSCPJ-UHFFFAOYSA-N
10445608;HLA-A;6;2.8920000000000003e-102;0.4493;15.8085;181.8444;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
131802042;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;GRJUVGUIQWBDLN-UHFFFAOYSA-N
53479588;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQIMLWFRWGTTOZ-UHFFFAOYSA-N
152198;ECE1;6;5.369000000000001e-78;0.4444;33.7071;138.2744;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
100048;AMP1_PLAFQ;6;2.3769999999999996e-41;0.5098;5.2519;72.4829;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
131754524;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOTJQCORLIFPLC-UHFFFAOYSA-N
96814;CTSL;6;6.434000000000001e-84;0.4792;64.4921;148.9052;CTSL;Cathepsin L1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131755026;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QRLNWUKVSNTXQG-UHFFFAOYSA-N
92829;BLA1_STEMA;6;2.372e-80;0.4231;7.2169;142.502;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
131755337;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MZFQLGNBXGADLH-UHFFFAOYSA-N
6992304;OPRD1;6;5.116e-86;0.5455;204.2794;152.6745;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
131801919;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;MARDKHBEDGKFMD-UHFFFAOYSA-N
92829;CPA1;6;2.2369999999999998e-54;0.5333;6.7297;95.8695;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
53480017;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;HNZTVXMGKFBWNB-UHFFFAOYSA-N
13890535;CTSB;6;2.479e-68;0.5094;40.2968;120.9236;CTSB;Cathepsin B (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
9547010;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;CCIRMRKPMPEIFZ-UHFFFAOYSA-N
99647664;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SDNYRTVJOFMYIW-UHFFFAOYSA-N
131755915;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBYJHYPJVAOSBP-UHFFFAOYSA-N
193508;KLK3;7;7.809e-102;0.4182;10.8855;181.0699;KLK3;Prostate-specific antigen (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
13783081;ACE;6;4.625e-78;0.6316;77.5544;138.3907;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
74328989;SLC5A1;6;6.602e-71;0.4091;17.2392;125.546;SLC5A1;Sodium/glucose cotransporter 1 (pKi >= 6);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
19816756;SSTR2;7;3.763e-76;0.4054;18.4211;134.9609;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
7427;FIMH;6;2.316e-119;0.5455;15.3114;212.5379;FIMH;FimH (pKi >= 6);C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O;HDTRYLNUVZCQOY-UHFFFAOYSA-N
6435901;LPAR3;6;2.572e-68;0.4444;10.4152;120.8952;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
168182;TACR1;6;6.344999999999999e-45;0.5333;77.7236;78.8986;TACR1;Substance-P receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
318292;NPR;8;2.6959999999999998e-73;0.6667;4.2528;129.8348;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
53479617;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ZTGVBXDPMCYOEV-UHFFFAOYSA-N
6992304;AMP1_PLAFQ;6;4.37e-64;0.439;8.1836;113.3005;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
97415;MMP1;6;7.560999999999999e-41;0.5;51.4841;71.5807;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
3421919;CYSP_TRYCR;7;7.569e-82;0.4528;19.9175;145.1879;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131759456;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FXVLQYFZVVLQJO-UHFFFAOYSA-N
13890535;TIMP3;6;1.683e-76;0.4231;6.6981;135.5881;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
7009650;AKT1;6;8.086e-41;0.4648;39.4151;71.5283;AKT1;RAC-alpha serine/threonine-protein kinase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
100048;CAPN2;6;1.978e-142;0.587;41.4835;253.9531;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
318292;MC4R;6;1.111e-63;0.5714;94.054;112.5726;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
131801901;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;FYYBTKGJGCSNCV-UHFFFAOYSA-N
7009650;GRPR;6;1.574e-82;0.5316;10.0992;146.4126;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53479658;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UJKZLJHORBRGNZ-UHFFFAOYSA-N
131758755;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;ARRWAWFZJHRGLN-UHFFFAOYSA-N
4427709;ACE;6;9.27e-81;0.7115;80.2341;143.2345;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53478252;LPAR3;6;2.6120000000000003e-63;0.549;9.6452;111.9065;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VSVITRIWEUGRGY-UHFFFAOYSA-N
52924353;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIWMKSHLSCQARO-UHFFFAOYSA-N
53478080;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NKDHOYXNDMODDX-UHFFFAOYSA-N
131753463;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;FICVIOYVXOEZEN-UHFFFAOYSA-N
52924878;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CIXWKDHTFXYVTC-UHFFFAOYSA-N
515709;OPRM1;6;1.414e-147;0.6809;424.5886;263.1917;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
6993120;OPRM1;6;5.4389999999999995e-80;0.4808;231.1095;141.855;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
47579;BLA1_STEMA;6;1.353e-101;0.6279;9.1413;180.6413;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
13932172;OXER1;6;1.178e-45;0.6667;3.7671;80.2116;OXER1;Oxoeicosanoid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
6992643;OPRM1;6;2.594e-101;0.58;292.1475;180.1338;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53479727;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;XEWZHCLDUCWNLB-UHFFFAOYSA-N
92829;OPRD1;6;2.8040000000000002e-58;0.4643;138.8434;102.8746;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
19816750;MME;6;8.617e-148;0.5091;126.4797;263.5778;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
156907995;LPAR3;6;5.843e-42;0.549;6.362;73.577;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C;QGIHQXKFCAACHN-UHFFFAOYSA-N
7359122;CYSP_TRYCR;7;6.976000000000001e-78;0.4;18.947;138.0702;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131801991;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;JODFYBIHEFCIFI-UHFFFAOYSA-N
131753659;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DQXQIWIQYYEGLG-UHFFFAOYSA-N
131801990;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;VLJNBDVONLLDHB-UHFFFAOYSA-N
89567;ENPP2;6;1.282e-56;0.8462;8.3272;99.8938;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;LAYXSTYJRSVXIH-UHFFFAOYSA-N
150964;TMPRSS6;7;8.888e-74;0.4247;4.87;130.7001;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
52924776;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;KXVQBSORIXQSRP-UHFFFAOYSA-N
4656408;CCKBR;6;3.491e-124;0.5246;125.8112;221.1946;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
53479796;LPAR3;6;1.609e-88;0.5;13.5221;157.1669;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;VZEYVZNRVARGGK-UHFFFAOYSA-N
100048;MME;6;8.033000000000001e-207;0.6538;177.0147;369.5563;MME;Neprilysin (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
515709;FCER2;6;1.634e-107;0.4655;13.18;191.2662;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
7020642;DPP9;6;7.125e-42;0.6739;14.1201;73.4222;DPP9;Dipeptidyl peptidase 9 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
3421919;C3AR1;6;1.3689999999999998e-47;0.5152;7.8558;83.6848;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
7010506;CAPNS1;6;4.856e-75;0.4483;5.1458;132.9667;CAPNS1;Calpain small subunit 1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
134906;YARS;6;4.738e-67;0.4364;3.8867;118.6234;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924717;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;QMQLZZVQOMZDCN-UHFFFAOYSA-N
10445608;C3AR1;6;7.085e-41;0.5333;6.734;71.6314;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
18218218;NAALAD2;6;2.4649999999999997e-68;0.5143;3.962;120.9282;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
53479570;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;QHFLHJLJIVRZEW-UHFFFAOYSA-N
4657542;MMP9;6;1.7419999999999998e-41;0.5676;59.9074;72.7251;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
53480012;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MTYZXHQAIRJTJM-UHFFFAOYSA-N
10458;BBOX1;6;1.619e-47;0.4;1.8905;83.5544;BBOX1;Gamma-butyrobetaine dioxygenase (pKi >= 6);C(CCCCCC(=O)O)CCCCCC(=O)O;DXNCZXXFRKPEPY-UHFFFAOYSA-N
515717;ANPEP;8;4.5899999999999995e-89;0.4286;12.054;158.145;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
151410;OPRM1;6;1.649e-81;0.5397;235.4562;144.5809;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
12530;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
14275411;FABP3;7;9.292999999999998e-53;0.4884;1.7369;92.9637;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCCCCC;JVRVKOOOXHGJKI-UHFFFAOYSA-N
131801919;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;MARDKHBEDGKFMD-UHFFFAOYSA-N
5312797;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCC(C(=O)O)O;GHPVDCPCKSNJDR-UHFFFAOYSA-N
52922268;LPAR3;6;1.709e-45;0.4839;6.9055;79.9215;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCC=CCC=CCC;BPBWECRGAITUAO-UHFFFAOYSA-N
53479908;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PIRVOZHXFFFFFG-UHFFFAOYSA-N
131755712;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;IAFYDEPWYHOLIH-UHFFFAOYSA-N
132282053;NOD1;9;1.224e-80;0.4167;5.7357;143.018;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCC=CCCC)O;LBBFOWQGVUEADU-UHFFFAOYSA-N
76041074;LPAR3;6;7.499e-122;0.7692;18.6479;217.0078;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;RPAOEHFOGLEBTJ-UHFFFAOYSA-N
13783081;ACE2;6;1.796e-93;0.4407;13.154;166.0582;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
19816755;TACR1;6;1.485e-43;0.4923;75.3729;76.4405;TACR1;Substance-P receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
435728;FCER2;6;7.063000000000001e-109;0.4364;13.3482;193.7154;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
5283496;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;FHQVHHIBKUMWTI-UHFFFAOYSA-N
7010506;BLA1_STEMA;6;1.8160000000000002e-84;0.4138;7.5897;149.8915;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
3634442;OPRM1;6;3.3089999999999997e-41;0.5132;120.0799;72.2249;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
102763;CCKAR;6;1.191e-150;0.5593;149.0526;268.7114;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
53479616;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;XJRBLUARQNXNQS-UHFFFAOYSA-N
12575964;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCC(C(=O)O)O;JGHSBPIZNUXPLA-UHFFFAOYSA-N
515709;TYR;6;1.897e-44;0.5357;2.3125;78.0449;TYR;Tyrosinase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
7010506;NAALAD2;6;2.8549999999999997e-44;0.4583;2.5515;77.726;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
131801883;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;RESRNMIXCOXYHQ-UHFFFAOYSA-N
9543870;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JDCKQBKHWBEMSZ-UHFFFAOYSA-N
7009598;HLA-A;6;4.073e-43;0.4386;6.6123;75.6536;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
131754580;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CDADMZPLSYSPIH-UHFFFAOYSA-N
131755728;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;PODGNDQRHPDVSY-UHFFFAOYSA-N
7016045;HLA-A;6;7.791e-54;0.4355;8.2787;94.8964;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)N)C(=O)O)N;XXDVDTMEVBYRPK-UHFFFAOYSA-N
53481872;LPAR1;6;8.786e-53;0.6909;9.8809;93.0074;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCCCCC=CCC=CCC=CCC;OKSGKZRUQJEAKX-UHFFFAOYSA-N
131759870;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PSHWARYKXDUDSM-UHFFFAOYSA-N
515709;OPRD1;6;7.18e-147;0.6809;347.8316;261.9247;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
7021456;CAPN2;6;1.235e-52;0.5472;15.2492;92.742;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
52924785;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;JCZXAXBRLLOCPM-UHFFFAOYSA-N
53480960;FABP3;7;2.642e-55;0.5429;1.822;97.5349;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(CO)CO;CXUXMSACCLYMBI-UHFFFAOYSA-N
329275;HLA-DRB1;6;2.23e-51;0.4118;5.0341;90.4858;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
134906;CAPN1;6;8.635e-75;0.541;43.2786;132.5179;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53479659;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;DZLWFPKMBZCBNP-UHFFFAOYSA-N
7010566;OPRM1;6;3.91e-83;0.5179;240.1081;147.4982;OPRM1;Mu-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
96814;RNPEP;6;2.092e-48;0.619;2.3802;85.1496;RNPEP;Aminopeptidase B (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
4466134;YARS;6;7.044e-113;0.587;6.5729;200.8988;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
25260623;FABP3;7;3.9320000000000005e-55;0.5526;1.8162;97.2249;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;LZSJCSQKHQTZID-UHFFFAOYSA-N
4466134;FCER2;6;6.962e-80;0.4127;9.7729;141.6624;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
131754546;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LBTCQHAIXPLSSD-UHFFFAOYSA-N
52924436;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JNMLRFRSKRFHKL-UHFFFAOYSA-N
131801858;LPAR1;6;1.579e-45;0.7209;8.5086;79.9831;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;YWYQODJQQTZXGP-UHFFFAOYSA-N
10468;PLA2G4B;6;2.175e-68;0.4595;5.9815;121.0259;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
7009598;CPA1;6;2.105e-97;0.5714;12.1169;173.1156;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
3800205;HLA-A;6;3.6960000000000004e-46;0.4259;7.0853;81.1153;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
53478133;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCCCCC;RTZSIOQKPJZTKI-UHFFFAOYSA-N
14409732;MC1R;6;7.298000000000001e-69;0.4225;34.9738;121.8772;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
168182;MC4R;6;1.3779999999999998e-60;0.4853;89.5026;107.0189;MC4R;Melanocortin receptor 4 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
515709;KLK3;7;1.3280000000000002e-69;0.4058;7.418;123.2055;KLK3;Prostate-specific antigen (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
7359122;ANPEP;8;2.9159999999999997e-127;0.4894;17.2594;226.721;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
3634442;ERAP2;6;1.243e-56;0.493;1.8664;99.9181;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
515709;NAALAD2;6;1.766e-43;0.5333;2.5051;76.3051;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
8163;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
53479479;LPAR3;6;3.753e-49;0.4677;7.468;86.4893;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC=CCCCCCCCCCCCCCC;YUEYBAGQVGBAPR-UHFFFAOYSA-N
7775;LPAR3;6;1.963e-51;0.5405;7.8189;90.5852;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC(=O)OCC(C)C;UXUPPWPIGVTVQI-UHFFFAOYSA-N
118276;FPR1;6;2.9939999999999997e-66;0.5;12.5289;117.1858;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CCSC)C(=O)O)N;NTISAKGPIGTIJJ-UHFFFAOYSA-N
5488196;MMP3;6;4.1569999999999996e-53;0.5306;62.2439;93.5909;MMP3;Stromelysin-1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
259327;Q9N6S8_PLAFA;8;3.645e-52;0.5;2.2476;91.8981;Q9N6S8_PLAFA;Falcipain 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
6993118;HLA-A;6;5.838e-79;0.5;12.1851;140.0044;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
19816756;MC3R;6;1.294e-73;0.4359;36.0916;130.4071;MC3R;Melanocortin receptor 3 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
131755004;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QREQPUUUIPJTAA-UHFFFAOYSA-N
6427003;FOLH1;7;8.319e-42;0.5946;9.6073;73.3015;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
53479812;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;IZEJYRQAFUAOSD-UHFFFAOYSA-N
100048;NPPA;7;2.3149999999999996e-41;0.4727;1.3559;72.5034;NPPA;Natriuretic peptides A (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
168182;SSTR2;7;3.047e-86;0.4648;20.878;153.0785;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131758806;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CGPMDMDZQFZLHH-UHFFFAOYSA-N
53479710;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MIPOZDXFSKBSGM-UHFFFAOYSA-N
92946;NPR;6;4.6450000000000005e-65;0.431;9.3571;115.0482;NPR;Thermolysin (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
131801755;FABP3;7;5.258e-54;0.5;1.7786;95.203;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;OSXMEYNKEVXBGM-UHFFFAOYSA-N
9856500;CAPNS1;6;1.784e-60;0.4;4.1374;106.8178;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
76807;ANPEP;6;2.87e-50;0.5366;17.5981;88.4938;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
5057430;ACE;6;8.23e-82;0.6047;81.2786;145.1226;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
435728;XIAP;6;4.629e-50;0.4762;20.4662;88.1211;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
515717;CAPNS1;6;1.0919999999999999e-66;0.431;4.5675;117.9723;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
52926034;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;QPLGPOYWQGNODB-UHFFFAOYSA-N
435728;TIMP3;6;2.4570000000000001e-85;0.4;7.4787;151.4512;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
193508;FPR1;6;1.0159999999999999e-89;0.5;17.0041;159.3206;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
131759891;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WWCDEFDAYUEHDA-UHFFFAOYSA-N
14767562;OPRD1;6;1.613e-105;0.5818;250.2832;187.6857;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
19816755;ECE1;6;1.6949999999999998e-83;0.5493;36.0941;148.1498;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
435728;NPR;6;3.808e-113;0.4828;16.3375;201.3783;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
52924681;FABP3;7;3.41e-50;0.6167;1.6511;88.3594;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;HDCWJEDGPFQUKG-UHFFFAOYSA-N
131764304;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;WWBWZANTQJGIBV-UHFFFAOYSA-N
131755391;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YRHHWDQMQNTGFU-UHFFFAOYSA-N
537297;LPAR3;6;9.02e-53;0.5385;8.0246;92.9869;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(CO)CO;SJUYTIGRIZBTCI-UHFFFAOYSA-N
152198;CAPNS1;6;2.367e-62;0.4426;4.2673;110.188;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
318292;MC5R;7;7.994e-86;0.4932;21.3475;152.3266;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
131760022;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;SEJBPZVTMDKZMT-UHFFFAOYSA-N
151410;CTSL;6;2.482e-62;0.6078;47.8834;110.1508;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
52924553;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;FMYXHSVUQFRMGW-UHFFFAOYSA-N
52924436;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JNMLRFRSKRFHKL-UHFFFAOYSA-N
273262;CAPN1;6;1.835e-119;0.5556;69.2038;212.7196;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131755723;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;RHVDDKIIECRCMU-UHFFFAOYSA-N
7009555;GRIA1;6;7.0489999999999995e-68;0.434;15.0125;120.1089;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
7015704;NAALAD2;6;4.166e-62;0.4722;3.5969;109.7472;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
53479558;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PHNTZMYSEVOGFP-UHFFFAOYSA-N
7021820;POLG_WNV;6;9.432e-80;0.4;6.9853;141.4257;POLG_WNV;Genome polyprotein (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
9700;P2RY2;6;5.812e-111;0.5862;27.0449;197.4581;P2RY2;P2Y purinoceptor 2 (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
5488196;NPR;6;2.721e-105;0.5952;15.1974;187.2779;NPR;Thermolysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
19816750;HLA-A;7;6.416e-70;0.4444;7.3098;123.773;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
13783081;MME;6;7.660999999999999e-158;0.6316;135.0843;281.6227;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
31292;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
52924778;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XNZHFYSLNIZKJP-UHFFFAOYSA-N
53480140;LPAR1;6;4.63e-44;0.541;8.2311;77.349;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;XDPWHDYPIVOSGA-UHFFFAOYSA-N
7010580;OPRD1;6;1.029e-80;0.5;191.7683;143.153;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
20835023;LPAR1;6;7.0050000000000004e-65;0.9286;12.1694;114.7279;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
323786;ACE;6;2.565e-62;0.6667;61.9176;110.1252;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7009598;MME;6;9.581000000000001e-222;0.6316;189.7904;396.3487;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
131755892;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JPOLYQGYZVQSPO-UHFFFAOYSA-N
7010580;PSMB8;7;3.495e-68;0.4138;6.8452;120.6559;PSMB8;Proteasome subunit beta type-8 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53480884;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DZPHTQGGRSWHLG-UHFFFAOYSA-N
111299;CTSL;6;1.0589999999999999e-52;0.4375;40.4741;92.8621;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
18218238;NMBR;6;1.0699999999999999e-55;0.4444;8.8463;98.2399;NMBR;Neuromedin-B receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
53479688;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DSZLDVIMYQKWGY-UHFFFAOYSA-N
118276;HLA-A;6;1.3720000000000002e-63;0.6154;9.7953;112.4083;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CCSC)C(=O)O)N;NTISAKGPIGTIJJ-UHFFFAOYSA-N
102763;GRPR;7;4.335e-80;0.4026;8.8674;142.0318;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
80108;HDAC8;8;3.113e-41;0.5135;3.0087;72.2726;HDAC8;Histone deacetylase 8 (pKi >= 8);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
9948926;TACR1;6;2.783e-43;0.5167;74.9044;75.9505;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
131753718;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CJNBEPRDDYRSPK-UHFFFAOYSA-N
131759301;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;NTANLNVWSGZVNG-UHFFFAOYSA-N
53480484;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGZSJHAMIMLPBP-UHFFFAOYSA-N
131801934;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;MGNMWMMQKHUXCT-UHFFFAOYSA-N
53478215;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ADQHTXPTSHXNKF-UHFFFAOYSA-N
131753490;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BVZUJVWCCYACND-UHFFFAOYSA-N
168182;KISS1R;8;4.182e-91;0.425;11.8356;161.8083;KISS1R;KiSS-1 receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131756490;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VNKAHKVFGRGTQD-UHFFFAOYSA-N
52924465;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QCCKXFCODQEYIW-UHFFFAOYSA-N
131753516;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNKDMZBYGADBFP-UHFFFAOYSA-N
4078684;MME;6;4.068e-153;0.7778;131.0392;273.1396;MME;Neprilysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
102763;MME;6;9.003e-85;0.6667;72.5303;150.4385;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
97415;CTSB;6;5.153e-60;0.561;35.3767;105.9906;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
53479811;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QIMXBAASHOXOCT-UHFFFAOYSA-N
19421321;ACE;6;4.6019999999999996e-66;0.5;65.6383;116.8508;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
151134;MC1R;6;3.609e-49;0.403;24.9332;86.5199;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
97045147;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AMXRERGJDVUTMF-UHFFFAOYSA-N
168182;PAPA1_CARPA;7;2.855e-43;0.4118;4.7577;75.9305;PAPA1_CARPA;Papain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
92021849;ADK;6;1.807e-63;0.5323;32.2239;112.1936;ADK;Adenosine kinase (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
7021456;TMPRSS6;8;4.104e-59;0.4267;2.5515;104.3727;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
53479159;LPAR3;6;3.753e-49;0.4677;7.468;86.4893;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC=CCCCCCCCCCCCCCCCC;SDWOXAMRJOFVSY-UHFFFAOYSA-N
435728;BLA1_STEMA;6;1.251e-92;0.4545;8.3291;164.5443;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
329275;CTSL;8;3.09e-44;0.4925;12.3597;77.6644;CTSL;Cathepsin L1 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
52925094;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVTRPEJBOGUHBJ-UHFFFAOYSA-N
10445608;PGA;8;3.818e-42;0.4107;5.3543;73.9087;PGA;Pepsin A (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
3421919;OPRD1;6;7.18e-147;0.6809;347.8316;261.9247;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
9543869;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XLFXOFMAQPNCDB-UHFFFAOYSA-N
7021820;CAPN2;6;2.2e-72;0.5918;21.0191;128.1982;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515709;LNPEP;6;6.564e-62;0.5;6.9604;109.3926;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
53480139;FABP3;7;7.184999999999999e-45;0.5147;1.4732;78.8017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;SNVHCYWMCGHCMU-UHFFFAOYSA-N
5284499;FABP3;7;2.964e-43;0.5556;1.4192;75.9015;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCO;ALSTYHKOOCGGFT-UHFFFAOYSA-N
92946;ANPEP;8;7.624e-101;0.5102;13.6593;179.2933;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
131755337;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MZFQLGNBXGADLH-UHFFFAOYSA-N
6427003;NOD1;9;4.402e-88;0.4773;6.2699;156.3824;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
3038501;CCKBR;6;2.301e-107;0.5278;108.7765;190.9991;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
7021828;HLA-A;6;1.0189999999999999e-82;0.56;12.7694;146.7517;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
53479738;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;MPCVLWFEQHTFHH-UHFFFAOYSA-N
7359122;CTSC;6;9.006e-64;0.5714;9.8237;112.7366;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131801798;LPAR3;6;2.703e-63;0.6522;9.6429;111.8798;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;UFBCJKWLEUICAE-UHFFFAOYSA-N
131766679;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;IAFKLCDFTGOUGB-UHFFFAOYSA-N
152198;MC5R;8;2.587e-65;0.5417;9.6197;115.5045;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
6993120;CAPNS1;6;6.151e-85;0.5192;5.8311;150.7355;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53479659;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;DZLWFPKMBZCBNP-UHFFFAOYSA-N
69421;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
9547243;CYP24A1;7;2.208e-56;0.5946;5.2911;99.4701;CYP24A1;1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (pKi >= 7);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
111299;CMA1;6;1.179e-42;0.5111;17.0206;74.8251;CMA1;Chymase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
52924814;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WALILJXJZOCRCD-UHFFFAOYSA-N
31292;CQSS;6;1.491e-86;0.5385;2.5399;153.6359;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
96814;OPRM1;6;2.763e-86;0.5;249.1281;153.155;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131754524;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOTJQCORLIFPLC-UHFFFAOYSA-N
53478300;FABP3;7;3.532e-54;0.5;1.7843;95.5133;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTSLGWIGCLOQRX-UHFFFAOYSA-N
52924528;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;KZMQZJZTKYKTJQ-UHFFFAOYSA-N
7020642;ACE2;6;5.221e-47;0.537;6.5727;82.6413;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
53480972;CQSS;6;5.057e-72;0.4375;2.1095;127.5491;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;SNMGFBFZTAYEBF-UHFFFAOYSA-N
131759577;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZJUJYFBFJFLODJ-UHFFFAOYSA-N
131766787;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;YTOCFNTUAXVUGF-UHFFFAOYSA-N
10445608;ECE1;6;5.535999999999999e-41;0.4286;17.6455;71.8238;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
7021456;GRIA1;6;6.409e-77;0.4;17.0273;136.341;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
53477895;SELP;6;1.182e-77;0.7286;6.086;137.659;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O;HLIJNIKSBCIDGO-UHFFFAOYSA-N
111299;ACE2;6;9.419e-121;0.5349;17.018;215.0348;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
61030;EST1_PIG;7;1.372e-65;0.4242;4.3241;115.999;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
3421919;ECE1;6;1.834e-94;0.5435;40.8526;167.8369;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4466134;CTSK;6;1.323e-43;0.4364;52.3283;76.5303;CTSK;Cathepsin K (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
92829;FPR1;6;5.733e-67;0.4167;12.6658;118.4747;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
150964;CTSL;6;2.8e-55;0.5;42.4573;97.4898;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
53480949;LPAR1;6;1.892e-49;0.75;9.2504;87.0232;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;WAYKKNOEMJFLDI-UHFFFAOYSA-N
131759262;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPLCXIXCJSJOOR-UHFFFAOYSA-N
131801901;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;FYYBTKGJGCSNCV-UHFFFAOYSA-N
7359122;RNPEP;6;7.056e-50;0.4894;2.4538;87.7924;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
52924408;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;GMXIUCLINHXQQD-UHFFFAOYSA-N
3038501;ERAP2;6;6.401e-60;0.5441;1.9763;105.8216;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;TYR;6;9.396e-42;0.5507;2.1698;73.2066;TYR;Tyrosinase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
131754362;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MODDNOQSVMCAIA-UHFFFAOYSA-N
7021820;ACE;6;1.224e-69;0.52;69.189;123.2692;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
52924593;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KSAJIJQUJUOZKJ-UHFFFAOYSA-N
52924167;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DAZYZDVAACSMFA-UHFFFAOYSA-N
53480964;LPAR3;6;2.448e-75;0.587;11.4949;133.5009;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)CO;PMJSUEZTCFTBMD-UHFFFAOYSA-N
318292;MMP2;6;3.797e-41;0.566;66.6765;72.1176;MMP2;72 kDa type IV collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
1563;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCC(C(=O)O)O;JYZJYKOZGGEXSX-UHFFFAOYSA-N
318292;MC1R;6;7.875000000000001e-122;0.5714;61.9778;216.9697;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
53477859;MAG;6;8.113e-82;0.5567;2.7082;145.1338;MAG;Myelin-associated glycoprotein (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2O)OC3C(C(OC(C3O)CO)OC4C(C(OC(C4O)OC(C(CO)O)C(C(C=O)O)O)CO)O)NC(=O)C)CO)O)O;QUOQJNYANJQSDA-UHFFFAOYSA-N
100048;LAP3;6;1.019e-76;0.5;8.7933;135.9793;LAP3;Cytosol aminopeptidase (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
151410;MME;6;7.066e-193;0.5581;165.0772;344.5219;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
14409732;GHSR;6;1.044e-63;0.4143;65.6432;112.6216;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
3421919;OPRM1;6;1.414e-147;0.6809;424.5886;263.1917;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
52925434;LPAR3;6;5.122e-95;0.6296;14.5212;168.8316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCC;GKXJCTQSLVKTAV-UHFFFAOYSA-N
53479624;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;FXSMMNUNFDTUMS-UHFFFAOYSA-N
7009567;GLO1;6;4.272e-50;0.4364;4.3653;88.1836;GLO1;Lactoylglutathione lyase (pKi >= 6);CSCCC(C(=O)O)NC(=O)CCC(C(=O)O)N;RQNSKRXMANOPQY-UHFFFAOYSA-N
4427709;NPR;8;2.3009999999999998e-82;0.6;4.7843;146.1162;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
151410;HLA-DRB1;6;4.259e-77;0.4754;7.5873;136.6597;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
9700;P2RY6;6;1.3690000000000002e-116;0.5862;19.1948;207.5622;P2RY6;P2Y purinoceptor 6 (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
329275;MC1R;6;1.0449999999999999e-118;0.5147;60.3857;211.3635;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
131759889;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;COWOCJLJJIQXGS-UHFFFAOYSA-N
7009553;HLA-A;6;1.529e-43;0.4167;6.6784;76.4177;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
9948926;ACE;6;6.728e-57;0.6939;56.5356;100.3968;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
3038501;GHSR;6;2.631e-76;0.5538;78.6157;135.24;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
96814;FCER2;6;3.401e-117;0.48;14.3739;208.6478;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010499;ENPEP;7;1.778e-91;0.4898;7.1792;162.4754;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
47579;ITGA4;6;2.759e-46;0.4314;14.009;81.3433;ITGA4;Integrin alpha-4 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
342468;GRIA1;6;2.7729999999999998e-67;0.4286;14.88;119.0412;GRIA1;Glutamate receptor 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
53479853;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;XOTZQQUUCAOSLB-UHFFFAOYSA-N
102763;ERAP2;6;1.769e-56;0.5152;1.8612;99.6429;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
131801988;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;RSFDYJRKLOLHJO-UHFFFAOYSA-N
131753339;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AWDHZZVHWUIZSY-UHFFFAOYSA-N
131754335;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NAFMESDUMVNTKX-UHFFFAOYSA-N
18218220;HLA-A;6;9.739999999999999e-67;0.5;10.2848;118.0615;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(C(C)O)C(=O)O)N;DRCKHKZYDLJYFQ-UHFFFAOYSA-N
132282053;LPAR3;6;1.642e-60;0.4;9.2148;106.8823;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCC=CCCC)O;LBBFOWQGVUEADU-UHFFFAOYSA-N
342468;TYR;6;3.616e-44;0.459;2.2976;77.5418;TYR;Tyrosinase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
53480867;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;URRCZPXKAKNTHV-UHFFFAOYSA-N
131766679;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;IAFKLCDFTGOUGB-UHFFFAOYSA-N
131753892;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VHWNCJQPNDUBCY-UHFFFAOYSA-N
96814;OPRD1;6;4.393e-86;0.549;204.4356;152.7934;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
52924216;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OONVIPGPMOPRTM-UHFFFAOYSA-N
435728;CTRB1;6;2.428e-49;0.4783;5.9134;86.8288;CTRB1;Chymotrypsinogen B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
97415;ECE1;6;2.456e-82;0.5116;35.5903;146.0655;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
53478458;FABP3;7;5.019e-52;0.4783;1.7124;91.6487;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCC;YDNAPGXYBAGJKV-UHFFFAOYSA-N
12530;NOD1;9;1.62e-69;0.4242;4.9375;123.0506;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
7009598;FPR1;6;2.8130000000000003e-99;0.5682;18.8266;176.4802;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
131801942;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)O;IGVSZJYOSQMZTC-UHFFFAOYSA-N
131753666;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KRVDGBILMBJWGW-UHFFFAOYSA-N
53478349;LPAR3;6;4.784e-47;0.5098;7.1443;82.7095;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RIRRWYKZEDZUDS-UHFFFAOYSA-N
444523;FURIN;6;1.232e-49;0.6829;9.0581;87.358;FURIN;Furin (pKi >= 6);CC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)O)N;IBIDRSSEHFLGSD-UHFFFAOYSA-N
131801964;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;QWBJFHUMPKVXOT-UHFFFAOYSA-N
46879024;LPAR3;6;1.1399999999999998e-52;0.6486;8.009;92.8043;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(CO)O;QSKPZDMBULYMDQ-UHFFFAOYSA-N
9561835;SLCO2A1;6;4.234e-62;0.4565;2.0491;109.7345;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCCCCC(CCCCCCCCC(=O)O)O;PAZZVPKITDJCPV-UHFFFAOYSA-N
152198;LAP3;6;1.801e-61;0.4364;7.031;108.6057;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
4305457;CAPN1;6;8.591e-42;0.4583;24.1288;73.2764;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
100048;MMP1;6;1.442e-48;0.4906;61.178;85.4401;MMP1;Interstitial collagenase (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
4427709;PSMB8;7;2.071e-43;0.4605;4.3337;76.181;PSMB8;Proteasome subunit beta type-8 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
8180;NOD1;9;1.62e-69;0.4242;4.9375;123.0506;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
7009598;ACE2;6;3.5019999999999997e-133;0.5714;18.7786;237.3502;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
5259590;NAALAD2;6;3.7309999999999998e-81;0.5526;4.7134;143.9441;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
131755004;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QREQPUUUIPJTAA-UHFFFAOYSA-N
263475;EDNRB;9;7.042e-58;0.4286;5.557;102.1565;EDNRB;Endothelin B receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
10468;FABP3;7;6.518e-57;0.7391;1.8757;100.4214;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
134906;FPR1;6;2.9819999999999996e-88;0.6066;16.7243;156.6861;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
52924614;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;AYXGHIQPMDYMJC-UHFFFAOYSA-N
6993120;PAPA1_CARPA;6;7.73e-97;0.4615;14.637;172.1012;PAPA1_CARPA;Papain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;LAP3;6;9.027999999999999e-67;0.4773;7.6436;118.1207;LAP3;Cytosol aminopeptidase (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7009598;CYSP_TRYCR;7;2.9e-79;0.451;19.2851;140.5499;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
12591;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
53478462;LPAR3;6;1.7899999999999999e-62;0.5385;9.5166;110.4055;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PXCOILRYJJUSSX-UHFFFAOYSA-N
14767562;OPRM1;6;1.021e-104;0.6154;301.8952;186.2469;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
131802002;LPAR3;6;4.137e-81;0.6889;12.3826;143.8636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;UFKFDATWXJRMOS-UHFFFAOYSA-N
131801910;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;JOJJIWNPSBTCRD-UHFFFAOYSA-N
53481872;FABP3;7;6.51e-50;0.5556;1.6418;87.8553;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCCCCC=CCC=CCC=CCC;OKSGKZRUQJEAKX-UHFFFAOYSA-N
53481049;CQSS;6;3.5559999999999996e-67;0.4211;1.9659;118.8471;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;FTSDYFFYZJTACJ-UHFFFAOYSA-N
131759242;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;OYGBKABOKBWAOA-UHFFFAOYSA-N
5282761;CES2;7;2.475e-48;0.4194;2.7896;85.0186;CES2;Cocaine esterase (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
131756490;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VNKAHKVFGRGTQD-UHFFFAOYSA-N
435949;HLA-A;6;9.161e-81;0.4902;12.4656;143.2437;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(C(C)C)C(=O)O)N;BCXBIONYYJCSDF-UHFFFAOYSA-N
323786;MMP8;9;6.213e-65;0.541;13.4315;114.8214;MMP8;Neutrophil collagenase (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7643;MME;6;1.1910000000000001e-58;0.439;50.1681;103.5421;MME;Neprilysin (pKi >= 6);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
6992643;BLA1_STEMA;6;1.428e-86;0.4151;7.7804;153.6695;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53479717;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;KRZKEZVISPYOPJ-UHFFFAOYSA-N
6993118;ANPEP;6;5.356e-45;0.5238;15.7386;79.0308;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
435949;ENPEP;7;8.058e-85;0.4565;6.6527;150.525;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(C(C)C)C(=O)O)N;BCXBIONYYJCSDF-UHFFFAOYSA-N
5488196;CTSL;6;6.744000000000001e-72;0.449;55.2435;127.3247;CTSL;Cathepsin L1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
52924653;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BUIZMIHPZOBMLF-UHFFFAOYSA-N
7359122;CPA1;6;2.5549999999999995e-88;0.4375;10.9795;156.8067;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4427709;CPA1;6;5.6399999999999995e-61;0.4528;7.5559;107.7156;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
7020642;MME;6;3.4690000000000003e-72;0.6596;61.7558;127.8431;MME;Neprilysin (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
131801864;LPAR3;6;4.274e-76;0.6739;11.6115;134.8617;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DSPKXVYJORTNRJ-UHFFFAOYSA-N
131755900;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GEPOGMMCAWOWOH-UHFFFAOYSA-N
19816755;PAPA1_CARPA;7;1.842e-52;0.4432;5.7835;92.4302;PAPA1_CARPA;Papain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
134906;FURIN;6;6.225e-45;0.4789;8.19;78.9135;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
6992643;CTSB;6;8.721999999999999e-80;0.5581;47.072;141.4867;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7010566;ECE1;6;2.367e-45;0.4203;19.5414;79.6673;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3038501;ECE1;6;5.617e-92;0.5893;39.7738;163.3737;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
8180;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
515709;ANPEP;8;1.753e-133;0.5306;18.1072;237.8895;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
5259590;CAPN1;6;3.5130000000000006e-46;0.4545;26.6755;81.1549;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9546726;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LYJWNHGFGVVCAO-UHFFFAOYSA-N
323786;TACR1;6;1.482e-51;0.5246;89.1094;90.8044;TACR1;Substance-P receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
13890535;HLA-DRB1;6;3.337e-64;0.5263;6.3073;113.5108;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131801858;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;YWYQODJQQTZXGP-UHFFFAOYSA-N
7359122;ACE2;6;4.32e-107;0.4375;15.083;190.5081;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;ACE2;6;3.499e-136;0.5682;19.2036;242.7367;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
134906;MME;6;8.412e-170;0.74;145.3225;303.0936;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
5488196;HLA-DRB1;6;7.321e-86;0.4107;8.4574;152.3952;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
131801935;LPAR3;6;4.274e-76;0.6739;11.6115;134.8617;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;JADWQWJGAYXZKD-UHFFFAOYSA-N
13783081;MC3R;6;6.931999999999999e-94;0.4872;46.0676;166.8003;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
4466134;KLK3;7;4.897e-86;0.4143;9.1859;152.7086;KLK3;Prostate-specific antigen (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
20057360;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;RIGGIBNQNREJCL-UHFFFAOYSA-N
47579;CAPN2;6;8.776000000000001e-69;0.55;19.967;121.7334;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
151410;NTSR2;6;8.068e-49;0.4125;9.1312;85.8926;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
454064;LASR;7;1.409e-65;0.425;3.0395;115.9781;LASR;Transcriptional activator protein LasR (pKi >= 7);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
131758755;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;ARRWAWFZJHRGLN-UHFFFAOYSA-N
131758783;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NKWRAFYNNIEZPH-UHFFFAOYSA-N
152198;ACE;6;1.292e-70;0.5;70.159;125.0226;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
21116917;CA4;6;4.930999999999999e-41;0.557;46.75;71.9139;CA4;Carbonic anhydrase 4 (pKi >= 6);CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)OS(=O)(=O)O)C)O)C;DKXXSIJHWWVNMO-UHFFFAOYSA-N
53479710;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MIPOZDXFSKBSGM-UHFFFAOYSA-N
5312554;OXER1;6;1.178e-45;0.6667;3.7671;80.2116;OXER1;Oxoeicosanoid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
10468;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
53479796;FABP3;7;5.9120000000000005e-46;0.5079;1.5094;80.7491;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;VZEYVZNRVARGGK-UHFFFAOYSA-N
19816755;CAPN2;6;4.744e-67;0.4521;19.4607;118.6223;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
263471;MC3R;6;9.646e-82;0.4211;40.0914;144.9988;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
131801983;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;DQSHOTZVAMTFFY-UHFFFAOYSA-N
342468;SORT1;6;1.235e-59;0.4048;4.0792;105.3091;SORT1;Sortilin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
150964;ACE;6;1.84e-76;0.5106;75.9657;135.5188;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151410;HLA-A;6;1.9919999999999999e-44;0.5143;6.816;78.0065;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131759435;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGFTVBFRGRHBJX-UHFFFAOYSA-N
3038501;KISS1R;8;5.167e-89;0.4198;11.5619;158.0528;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
7009650;ECE1;6;3.926e-85;0.5763;36.8037;151.0857;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
7009650;MC5R;8;1.019e-89;0.6528;13.2472;159.3182;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
53479612;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KYERVKWKQQBRQB-UHFFFAOYSA-N
151134;CTSB;6;1.372e-67;0.5217;39.8573;119.5895;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
435728;MMP9;6;2.9989999999999996e-41;0.4423;59.5687;72.3017;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
168182;ACE;6;1.6520000000000002e-72;0.75;72.0393;128.4214;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7010580;MMP3;6;7.593e-62;0.463;72.4641;109.2791;MMP3;Stromelysin-1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
168182;FPR1;6;2.121e-82;0.5806;15.6084;146.1799;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
53479630;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;HPHYBSPOEJMPAN-UHFFFAOYSA-N
131758733;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCC;DTWPBANPCJFNIA-UHFFFAOYSA-N
131755148;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QDDBVRCUCSETRT-UHFFFAOYSA-N
263471;MME;6;2.5989999999999997e-44;0.4912;37.8929;77.7993;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
44232492;CAPN2;6;2.095e-95;0.4074;27.7448;169.5285;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
53480914;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PQEYJXRJLFZSPT-UHFFFAOYSA-N
19816750;NAALAD2;6;1.036e-83;0.6905;4.8633;148.534;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
111299;RNPEP;6;8.473e-50;0.4792;2.4498;87.6498;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
7010566;GAG-PRO;6;2.237e-60;0.4143;5.1379;106.6414;GAG-PRO;Gag-Pro polyprotein (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
52926076;LPAR3;6;3.06e-90;0.5763;13.7867;160.2566;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCC=CCC;GRXQVLCZJYBDDD-UHFFFAOYSA-N
53480866;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;WCSDULLQTPYJFU-UHFFFAOYSA-N
131755705;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FBJIMBUHNICHHH-UHFFFAOYSA-N
4305457;NAALAD2;6;9.567e-61;0.4286;3.5172;107.3035;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
53479747;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;VFSMZSWKKPWQQW-UHFFFAOYSA-N
7020642;OPRD1;6;8.876e-81;0.6071;191.92;143.2684;OPRD1;Delta-type opioid receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
96814;NPFFR2;7;1.091e-79;0.4074;6.6184;141.3123;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
4657542;CTSB;6;2.643e-62;0.5;36.7314;110.102;CTSB;Cathepsin B (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
131801904;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;BWPPXWXSNNMLOW-UHFFFAOYSA-N
151003;F2;6;1.165e-49;0.55;98.3919;87.4015;F2;Prothrombin (pKi >= 6);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
131753836;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;POWNQYNUJQKIJN-UHFFFAOYSA-N
131758626;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DJBSAGJERMKCDN-UHFFFAOYSA-N
8180;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
168182;ERAP2;6;1.445e-59;0.5294;1.9645;105.1866;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
100048;ACE2;6;6.4379999999999995e-127;0.5102;17.8913;226.1035;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
11010621;TRHR;6;4.367e-71;0.5088;3.5132;125.8681;TRHR;Thyrotropin-releasing hormone receptor (pKi >= 6);C1CC(=O)NC1C(=O)NC(CCC(=O)N)C(=O)O;ILAITOFTZJRIFJ-UHFFFAOYSA-N
14275411;LPAR3;6;3.3659999999999995e-51;0.54;7.7829;90.1648;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCCCCC;JVRVKOOOXHGJKI-UHFFFAOYSA-N
152198;FPR1;6;8.467e-87;0.463;16.4472;154.0771;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
11579826;CPA1;6;3.4189999999999997e-81;0.4615;10.0872;144.0123;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
53479756;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PYFNLOPDTZXGTN-UHFFFAOYSA-N
9543840;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LQWVDOZRCDULIP-UHFFFAOYSA-N
100048;ANPEP;8;9.442e-129;0.6538;17.4624;229.3955;ANPEP;Aminopeptidase N (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
193508;CTSC;6;2.524e-59;0.5854;9.1322;104.7519;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
4427709;MMP2;6;5.858e-52;0.5088;84.0684;91.5282;MMP2;72 kDa type IV collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
96814;CYSP_TRYCR;7;3.4499999999999997e-90;0.4706;21.9595;160.163;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
53479718;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;GKXLKICEHUALBW-UHFFFAOYSA-N
97415;LAP3;6;7.612e-72;0.4681;8.23;127.2303;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
19816756;MC1R;6;1.502e-102;0.4783;52.1481;182.3552;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
53480717;LPAR3;6;1.5209999999999998e-47;0.5167;7.2208;83.6029;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C;ODWWPXNLOCQPJK-UHFFFAOYSA-N
759256;FPR1;6;5.729e-83;0.5532;15.7168;147.2004;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
21116917;SLC10A1;6;1.4859999999999998e-81;0.6026;3.2673;144.6621;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)OS(=O)(=O)O)C)O)C;DKXXSIJHWWVNMO-UHFFFAOYSA-N
329275;KISS1R;8;1.993e-97;0.4557;12.6625;173.1581;KISS1R;KiSS-1 receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151008;FABP3;7;8.525999999999999e-45;0.5667;1.4707;78.6683;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)NCC(=O)O;KVTFEOAKFFQCCX-UHFFFAOYSA-N
53480924;FABP3;7;6.897e-48;0.569;1.5741;84.2196;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;CZYOFWNORPEFDG-UHFFFAOYSA-N
131759294;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XYKBFKVMVVJQIJ-UHFFFAOYSA-N
352038;NPR;7;5.633e-47;0.4528;5.3555;82.582;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)NC(C(C)C)C(=O)O)N;MDSUKZSLOATHMH-UHFFFAOYSA-N
10445608;CAPN2;6;1.839e-120;0.4375;35.0654;214.5133;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
273262;GRIA1;6;1.9749999999999997e-68;0.4182;15.1356;121.1009;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
13890535;NPFFR1;7;1.015e-69;0.4;5.9422;123.4155;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
10445608;CTSB;6;1.5770000000000001e-87;0.4694;51.6519;155.3873;CTSB;Cathepsin B (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
131758865;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;WUUWBWLVYRBSQT-UHFFFAOYSA-N
53479631;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;UKRAYYYOKQQQKZ-UHFFFAOYSA-N
53479570;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;QHFLHJLJIVRZEW-UHFFFAOYSA-N
150964;FURIN;6;2.685e-68;0.6667;12.5019;120.8614;FURIN;Furin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
52926061;LPAR1;6;3.639e-44;0.5614;8.2509;77.5369;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(C(=O)O)N;MGXXGWZPTJJSOQ-UHFFFAOYSA-N
53480139;LPAR3;6;4.4e-89;0.5556;13.6087;158.1781;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;SNVHCYWMCGHCMU-UHFFFAOYSA-N
53479811;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QIMXBAASHOXOCT-UHFFFAOYSA-N
96814;PGA;6;1.632e-48;0.4;11.034;85.3434;PGA;Pepsin A (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
19816755;MC5R;7;5.021e-71;0.4198;17.646;125.7593;MC5R;Melanocortin receptor 5 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
131754362;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MODDNOQSVMCAIA-UHFFFAOYSA-N
131753464;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOVZBEYRPDKHAL-UHFFFAOYSA-N
14325553;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCABCCITBXMTKG-UHFFFAOYSA-N
13890535;NOD1;9;2.052e-110;0.5;7.8725;196.4745;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
52925065;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LYFMZJCIGLZMJF-UHFFFAOYSA-N
7010566;CTSB;6;2.009e-108;0.48;64.0117;192.9004;CTSB;Cathepsin B (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
97415;FPR1;6;2.4699999999999997e-90;0.5349;17.1212;160.4236;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
151410;RNPEP;8;4.404e-65;0.587;2.1488;115.0897;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53479897;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;SQWAGNNCWNPIQG-UHFFFAOYSA-N
131756087;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TZMQOSMAJITOAT-UHFFFAOYSA-N
131754934;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;POAVLZRSJOCQEL-UHFFFAOYSA-N
14282475;NTSR1;6;1.372e-124;0.4928;30.2139;221.923;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
8180;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
131765702;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;QLJCFMWAJRKWEQ-UHFFFAOYSA-N
100094;CCKAR;6;4.3800000000000005e-144;0.5352;142.5577;256.9241;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
63842847;OPRD1;9;1.917e-85;0.4615;65.28;151.6445;OPRD1;Delta-type opioid receptor (pKi >= 9);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
131801798;FABP3;7;5.258e-54;0.5;1.7786;95.203;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;UFBCJKWLEUICAE-UHFFFAOYSA-N
3634442;MC1R;6;5.529e-119;0.5294;60.5266;211.8596;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
53479719;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPPCXIJSFVQDL-UHFFFAOYSA-N
9546824;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WYDGEVICLIVPEG-UHFFFAOYSA-N
111299;GRIA1;6;4.097000000000001e-56;0.4068;12.391;98.9882;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
53480959;LPAR3;6;1.7259999999999998e-54;0.5909;8.2889;96.0718;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OC(CO)CO;UETKPVCPWANBPE-UHFFFAOYSA-N
6993120;FPR1;6;7.239000000000001e-109;0.6279;20.6552;193.6963;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
52924901;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HNFSZKRUPTYBOQ-UHFFFAOYSA-N
7359122;CTSK;6;4.3669999999999995e-41;0.4286;49.3145;72.0087;CTSK;Cathepsin K (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131763497;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FWLOAHZIIPEDQA-UHFFFAOYSA-N
9856500;ENPEP;6;3.483e-65;0.4314;7.8368;115.2726;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
53480897;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CFANDHZPOSNKNO-UHFFFAOYSA-N
6993120;BLA1_STEMA;6;2.64e-96;0.4808;8.662;171.1437;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53478341;FABP3;7;1.195e-53;0.4681;1.7667;94.563;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CQHRDRZMSJCJBX-UHFFFAOYSA-N
18218238;NTSR1;10;2.62e-41;0.4222;1.1997;72.4071;NTSR1;Neurotensin receptor type 1 (pKi >= 10);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
53480993;LPAR3;6;2.2830000000000003e-42;0.5625;6.4248;74.3098;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(CO)O;HDIQCISTZKHUDO-UHFFFAOYSA-N
9543878;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;BNNRAXXNNFEFAX-UHFFFAOYSA-N
52924815;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PQCDVFVOQBZXJA-UHFFFAOYSA-N
134906;MMP11;6;2.588e-135;0.5217;13.651;241.1766;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
9547010;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;CCIRMRKPMPEIFZ-UHFFFAOYSA-N
19816756;NPR;8;1.2550000000000001e-58;0.5714;3.393;103.5014;NPR;Thermolysin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
7010580;CYSP_TRYCR;7;1.7220000000000002e-85;0.4444;20.8093;151.7282;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131758820;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;HWXYJCBLRIWFEE-UHFFFAOYSA-N
131756136;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UJRVGGIOIJYNLP-UHFFFAOYSA-N
3634442;TACR1;6;1.181e-44;0.4795;77.2603;78.4141;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
9797038;NMBR;6;1.134e-47;0.5246;7.5582;83.8316;NMBR;Neuromedin-B receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
9546749;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;YDTWOEYVDRKKCR-UHFFFAOYSA-N
4657542;CAPN2;6;6.507e-74;0.5;21.4658;130.9432;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
92946;MME;6;4.677e-194;0.6512;166.0867;346.6389;MME;Neprilysin (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
273262;MMP3;6;2.3470000000000003e-46;0.4727;54.3473;81.4696;MMP3;Stromelysin-1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
221122;SHBG;9;3.3629999999999995e-53;0.6087;3.4982;93.7561;SHBG;Sex hormone-binding globulin (pKi >= 9);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
53479893;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;WMGNZOBBKTUGGQ-UHFFFAOYSA-N
52924578;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;NWJGEXWORFCRSI-UHFFFAOYSA-N
52924528;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;KZMQZJZTKYKTJQ-UHFFFAOYSA-N
7016103;NOD1;9;2.948e-92;0.4468;6.5694;163.8763;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7009567;NOD1;9;1.754e-126;0.5952;9.0256;225.3218;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CSCCC(C(=O)O)NC(=O)CCC(C(=O)O)N;RQNSKRXMANOPQY-UHFFFAOYSA-N
92021849;ADORA1;6;8.756e-174;0.629;445.4854;310.2436;ADORA1;Adenosine receptor A1 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
53480982;FABP3;7;1.61e-51;0.5;1.6955;90.7399;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)O;HPTOSMWVVSKAGZ-UHFFFAOYSA-N
263475;ERAP2;6;4.579e-56;0.4783;1.8474;98.9015;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
12530;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
9797038;LNPEP;6;2.258e-43;0.5211;4.8544;76.1135;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
435728;NTSR1;6;1.278e-106;0.4024;25.8391;189.6625;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
52924728;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCPNXDHEZUMTLB-UHFFFAOYSA-N
53479747;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;VFSMZSWKKPWQQW-UHFFFAOYSA-N
52924537;FABP3;7;3.41e-50;0.6167;1.6511;88.3594;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MWDRGYRNYDLFKA-UHFFFAOYSA-N
9546843;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;VOSQJLVNDRUECW-UHFFFAOYSA-N
7010580;REN;6;2.312e-81;0.4561;136.2367;144.3171;REN;Renin (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131761186;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YZEITGDSYFHHEK-UHFFFAOYSA-N
131753682;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XOUODEXYIDULFE-UHFFFAOYSA-N
7359122;CASP1;6;3.642e-46;0.4528;24.9983;81.1269;CASP1;Caspase-1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131760029;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OFXPDVFCVMOXOI-UHFFFAOYSA-N
53478597;PRKCA;7;8.422e-45;1.0;25.3277;78.6778;PRKCA;Protein kinase C alpha type (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;YUFFMVIZZQIBPN-UHFFFAOYSA-N
323786;MC4R;6;3.074e-63;0.5147;93.404;111.7795;MC4R;Melanocortin receptor 4 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
52924378;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;ODKCSLGCTVUPMX-UHFFFAOYSA-N
3081383;ADORA1;6;3.838e-50;0.4674;129.7037;88.2671;ADORA1;Adenosine receptor A1 (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
53479861;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;RHBZSPYYUTVJHJ-UHFFFAOYSA-N
323786;NPR;6;1.098e-118;0.6667;17.1417;211.3246;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
439853;CQSS;6;1.923e-101;0.7407;2.981;180.3672;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)C(CO)N;KBUNOSOGGAARKZ-UHFFFAOYSA-N
131801745;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;SFMJHWFZJBATQB-UHFFFAOYSA-N
96814;AMP1_PLAFQ;6;1.615e-64;0.619;8.2393;114.0765;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
9900561;NTSR1;6;2.003e-46;0.4658;11.1839;81.5931;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)O)N;HYXQKVOADYPQEA-UHFFFAOYSA-N
25200879;MC4R;6;7.832e-63;0.4667;92.8064;111.0502;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
151410;BLA1_STEMA;6;7.66e-95;0.4545;8.5296;168.5178;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
92021849;SLC29A1;6;2.836e-131;0.5556;42.2944;233.9238;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
53480968;LPAR3;6;2.448e-75;0.587;11.4949;133.5009;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)CO;PFISEVUKDJTNGO-UHFFFAOYSA-N
13890535;CTRB_BOVIN;6;1.3220000000000001e-55;0.4138;1.832;98.0748;CTRB_BOVIN;Chymotrypsinogen B (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
97415;NPFFR1;7;1.308e-70;0.4314;6.0188;125.0128;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
3038501;SSTR2;6;9.579999999999999e-48;0.4189;14.5118;83.9634;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
53480968;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)CO;PFISEVUKDJTNGO-UHFFFAOYSA-N
131761603;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CSHNWGMOFDDION-UHFFFAOYSA-N
131755369;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KJRMVHBWNRWOEF-UHFFFAOYSA-N
7020642;TMPRSS11D;6;3.976e-73;0.4328;8.9397;129.5319;TMPRSS11D;Transmembrane protease serine 11D (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
52922266;LPAR3;6;7.273e-67;0.5254;10.1919;118.2892;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)([O-])OCC[N+](C)(C)C;MVGBUJJTKGIFFM-UHFFFAOYSA-N
3421919;MC1R;6;2.827e-49;0.403;24.9873;86.7104;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
6993120;CTSB;6;5.797999999999999e-103;0.5814;60.7818;183.0974;CTSB;Cathepsin B (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131750529;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;VUYXIQLBLBPRDY-UHFFFAOYSA-N
131801772;FABP3;7;2.4999999999999997e-55;0.55;1.8228;97.578;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;XIZKIPQKOHUAHX-UHFFFAOYSA-N
5259590;HLA-A;6;1.003e-79;0.4386;12.3041;141.378;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
7010532;HLA-A;6;1.367e-66;0.5833;10.2619;117.7973;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(C(C)C)N;PNVLWFYAPWAQMU-UHFFFAOYSA-N
131766787;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;YTOCFNTUAXVUGF-UHFFFAOYSA-N
7359122;AMP1_PLAFQ;6;8.051e-60;0.4894;7.6336;105.6428;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
3038501;MC5R;8;1.4669999999999999e-80;0.4286;11.886;142.8769;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
24779107;LPAR3;6;3.419e-52;0.6327;7.9356;91.948;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC;XOEFPTAEGQLDQS-UHFFFAOYSA-N
131756136;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UJRVGGIOIJYNLP-UHFFFAOYSA-N
342468;CAPNS1;6;6.3790000000000004e-71;0.4483;4.8607;125.5727;CAPNS1;Calpain small subunit 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
52924125;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUEUPCHAIFZTKH-UHFFFAOYSA-N
6993120;ANPEP;6;1.0750000000000001e-143;0.6087;50.5578;256.2238;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53480858;FABP3;7;1.275e-47;0.5152;1.5652;83.7407;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QIJJGYHBXLEBJV-UHFFFAOYSA-N
134906;MMP1;6;3.39e-48;0.5806;60.7117;84.7734;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
10445608;ACE2;6;2.385e-100;0.4286;14.128;178.4041;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
19816750;ACE;6;2.042e-71;0.5091;70.9547;126.4609;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
5057430;FCER2;6;2.3720000000000001e-63;0.4138;7.7343;111.9815;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
5488196;RNPEP;6;6.108e-53;0.5111;2.6068;93.2909;RNPEP;Aminopeptidase B (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
53479863;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IZWPZNGYCMMGHU-UHFFFAOYSA-N
263475;MMP8;7;1.1409999999999999e-45;0.5172;30.0592;80.2364;MMP8;Neutrophil collagenase (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
131753516;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNKDMZBYGADBFP-UHFFFAOYSA-N
53479972;FABP3;7;1.76e-48;0.5077;1.5939;85.2846;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DHZUMZVZAZYQIW-UHFFFAOYSA-N
52924233;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;RPYIJSOTHVJLOR-UHFFFAOYSA-N
53480848;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OSDKOUUHCQCQEG-UHFFFAOYSA-N
53480249;FABP3;7;3.2589999999999997e-44;0.4928;1.4512;77.6227;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;SJLOPHYYGZLTGX-UHFFFAOYSA-N
515709;CYSP_TRYCR;7;7.569e-82;0.4528;19.9175;145.1879;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
131801777;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DRUQEDUMAQZVOU-UHFFFAOYSA-N
318292;MME;6;1.5220000000000001e-120;0.68;103.1539;214.6604;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
19816756;GRPR;6;1.461e-96;0.443;11.8296;171.6047;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
7010580;CAPN2;6;1.068e-154;0.5682;45.0677;275.9778;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
14169768;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC;UXWDTZNNQVHGSG-UHFFFAOYSA-N
318292;ACE2;6;6.266e-75;0.4286;10.5275;132.768;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
52925079;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;XVXISDREVDGQPX-UHFFFAOYSA-N
18218238;ECE1;6;9.717e-82;0.5517;35.3311;144.9931;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
53479647;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;ANRCNDSZUNAAEU-UHFFFAOYSA-N
9546838;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;XYHIPPZFNNOMQL-UHFFFAOYSA-N
131758978;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UHVCAEYDCRIXKY-UHFFFAOYSA-N
3038501;NOD1;9;1.1139999999999999e-92;0.4364;6.5998;164.6351;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
53480873;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QEDROTQEMCQUNE-UHFFFAOYSA-N
4656408;CCKAR;6;3.622e-135;0.4909;133.7361;240.9145;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
52926071;LPAR1;6;7.223e-48;0.6275;8.9512;84.1836;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCCCC;SYAYTZJXUCQTMJ-UHFFFAOYSA-N
151410;ANPEP;8;5.355e-129;0.5098;17.496;229.8377;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
446440;LPAR3;6;3.2459999999999996e-60;0.7234;9.1693;106.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCCCCCCCCC;BIABMEZBCHDPBV-UHFFFAOYSA-N
439853;NOD1;9;2.104e-91;0.4048;6.5082;162.3441;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCC(=O)C(CO)N;KBUNOSOGGAARKZ-UHFFFAOYSA-N
4225619;NPC1L1;6;7.81e-56;0.5595;4.0927;98.4852;NPC1L1;Niemann-Pick C1-like 1 protein (pKi >= 6);CCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C;LJGMGXXCKVFFIS-UHFFFAOYSA-N
52924728;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCPNXDHEZUMTLB-UHFFFAOYSA-N
131754572;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YJVSUEAKVIVQIZ-UHFFFAOYSA-N
7359122;ACE;6;6.109e-92;0.5227;91.3392;163.3082;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131801712;FABP3;7;6.335999999999999e-51;0.4651;1.6756;89.6716;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)O;DNGFLPFNXOMGJW-UHFFFAOYSA-N
329275;SSTR2;7;4.348e-84;0.4583;20.3535;149.2108;SSTR2;Somatostatin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151134;CCKBR;6;4.7540000000000006e-42;0.5179;42.6236;73.7378;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
151410;NTSR1;6;1.295e-87;0.4125;21.2119;155.5413;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
7021820;OPRM1;6;1.327e-95;0.5667;275.8045;169.8846;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
9900065;ENPEP;7;3.249e-70;0.4035;5.4976;124.3035;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CN=CN1)N;IDXZDKMBEXLFMB-UHFFFAOYSA-N
4466134;CYSP_TRYCR;7;3.208e-56;0.4483;13.6439;99.1789;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
19816756;GHSR;6;5.1810000000000005e-79;0.6102;81.4017;140.0975;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
70095;FABP3;7;5.073e-44;0.5217;1.4448;77.2777;FABP3;Fatty acid-binding protein, heart (pKi >= 7);C(CCCCCCCCC(=O)O)CCCCCCCC(=O)O;BNJOQKFENDDGSC-UHFFFAOYSA-N
13890535;FPR1;6;1.839e-91;0.5714;17.3364;162.449;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
9546841;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DBYSGBYABPVNGO-UHFFFAOYSA-N
52925128;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ZVVYJAAMWXATNY-UHFFFAOYSA-N
3421919;CAPN2;6;4.659e-137;0.7209;39.9141;244.3088;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
53479588;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQIMLWFRWGTTOZ-UHFFFAOYSA-N
435728;ACE2;6;3.447e-154;0.7143;21.7541;275.0641;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
4427709;TACR1;6;2.5920000000000002e-58;0.5417;100.7109;102.9358;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;OPRM1;6;7.936e-79;0.4545;227.7769;139.765;OPRM1;Mu-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
4656408;ECE1;6;7.278e-83;0.5455;35.8195;147.0138;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
3038501;TACR1;6;2.327e-44;0.493;76.7548;77.8855;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
131753238;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;ROBJWPSKKQDYDD-UHFFFAOYSA-N
318292;EDNRA;6;1.6199999999999999e-55;0.5312;82.7397;97.9161;EDNRA;Endothelin-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
131761056;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HAGMTXDICLFDOC-UHFFFAOYSA-N
134906;MC3R;6;9.514e-106;0.5342;51.9055;188.0972;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
9546755;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;LICSIKXBSOVGBP-UHFFFAOYSA-N
759256;CAPN1;6;1.361e-107;0.5385;62.3151;191.4087;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
53479855;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;URRUJVMBYGYWNL-UHFFFAOYSA-N
92946;NTSR1;6;3.198e-120;0.4203;29.1505;214.0816;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
7009553;NTSR1;6;1.1680000000000001e-58;0.5294;14.1624;103.557;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
13783081;CAPNS1;6;1.9889999999999998e-60;0.4091;4.1341;106.733;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
131753561;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VBYDXPQVGUJUTN-UHFFFAOYSA-N
7009623;NAALAD2;6;2.978e-78;0.5625;4.5433;138.7339;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
131750649;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QELMLHKKGIZABI-UHFFFAOYSA-N
131755699;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JPBYHVQUOOKCGQ-UHFFFAOYSA-N
131759399;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDWAIWYOHVLVMF-UHFFFAOYSA-N
9546826;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UITCASPZWUAJBW-UHFFFAOYSA-N
52924549;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;UBTNBSZLGQJLPI-UHFFFAOYSA-N
70095;BBOX1;6;1.619e-47;0.4;1.8905;83.5544;BBOX1;Gamma-butyrobetaine dioxygenase (pKi >= 6);C(CCCCCCCCC(=O)O)CCCCCCCC(=O)O;BNJOQKFENDDGSC-UHFFFAOYSA-N
7009598;NPFFR1;7;1.753e-82;0.4103;7.0408;146.3282;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
7009650;MC3R;6;4.745e-86;0.6528;42.2116;152.7332;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
9797038;ECE1;6;3.31e-108;0.6545;46.8165;192.5111;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
47579;OPRM1;6;1.219e-47;0.4182;138.4984;83.7757;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;MMP1;6;2.075e-60;0.4808;76.0481;106.6998;MMP1;Interstitial collagenase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
151008;NOD1;9;6.516e-87;0.4595;6.1859;154.2813;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCC(=O)NCC(=O)O;KVTFEOAKFFQCCX-UHFFFAOYSA-N
7021456;MC5R;7;1.616e-51;0.4247;12.7663;90.7367;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
52924232;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;DWDUPRRUGYDGQF-UHFFFAOYSA-N
193508;CPA1;6;1.622e-96;0.525;12.0059;171.5234;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52925452;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;LZBAIACFBSMXFQ-UHFFFAOYSA-N
4466134;OPRD1;6;2.71e-120;0.6981;285.1365;214.2107;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
111299;NOD1;9;1.604e-106;0.5;7.5931;189.4853;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
20057359;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;DOIOUJPHIXRQFM-UHFFFAOYSA-N
7009598;OPRD1;6;3.416e-85;0.5088;202.3341;151.1941;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
56938633;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AYBNKZOBZIRMHJ-UHFFFAOYSA-N
53479605;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VNAHWIQCBOQKAJ-UHFFFAOYSA-N
53479650;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZTSRQLQWGSDQGP-UHFFFAOYSA-N
189008;MME;6;5.167e-48;0.4528;41.0617;84.4448;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
13783081;OPRD1;6;2.539e-110;0.6615;261.6132;196.3084;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
8164;CES2C;6;5.207e-62;0.4516;2.0461;109.5732;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCCCOC(=O)C;YLYBTZIQSIBWLI-UHFFFAOYSA-N
9797038;KISS1R;8;2.722e-88;0.4096;11.4676;156.7572;KISS1R;KiSS-1 receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
8201;CES2;7;2.65e-53;0.4643;3.0809;93.942;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
7016103;KLK3;7;2.387e-97;0.45;10.403;173.0175;KLK3;Prostate-specific antigen (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
131753905;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WGTADRBQBBKAGF-UHFFFAOYSA-N
131755451;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NPRADIIHNTWIBW-UHFFFAOYSA-N
8048;LPAR3;6;2.1619999999999997e-53;0.5;8.12;94.1007;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
53479648;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;BIYXBOGKCFGRKR-UHFFFAOYSA-N
259327;ANPEP;6;2.232e-62;0.5476;21.8701;110.2337;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
9543842;LPAR3;6;4.784e-47;0.5098;7.1443;82.7095;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QEOYMVJQPHELJB-UHFFFAOYSA-N
52922268;FABP3;7;1.8899999999999997e-48;0.6032;1.5929;85.229;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCC=CCC=CCC;BPBWECRGAITUAO-UHFFFAOYSA-N
3038501;MC3R;6;7.576e-83;0.4545;40.6352;146.9825;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
131753311;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYFACDKCDVPZSE-UHFFFAOYSA-N
53479881;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;MVASPAIFCLTHSN-UHFFFAOYSA-N
171204;DPP7;7;1.426e-48;0.5111;9.3772;85.4487;DPP7;Dipeptidyl peptidase 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
5057430;MME;6;1.315e-172;0.6047;147.7246;308.1311;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
131755553;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OAJGGPOBXCODBI-UHFFFAOYSA-N
9797038;ACE2;7;2.404e-96;0.5357;11.9845;171.2166;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
131753215;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCC;DOEBPNOTMREOMP-UHFFFAOYSA-N
131755712;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;IAFYDEPWYHOLIH-UHFFFAOYSA-N
515709;FPR1;6;7.583e-97;0.5319;18.3631;172.1162;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
4120027;FIMH;6;5.98e-90;0.4651;11.5188;159.7342;FIMH;FimH (pKi >= 6);C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)O)O)CO)O)O)O)O)O)O)O;OWEGMIWEEQEYGQ-UHFFFAOYSA-N
22556;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
100048;CTSL;6;6.365e-76;0.4828;58.3404;134.551;CTSL;Cathepsin L1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
151410;KLK3;7;4.11e-112;0.4844;11.9914;199.5236;KLK3;Prostate-specific antigen (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131758978;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UHVCAEYDCRIXKY-UHFFFAOYSA-N
273262;MME;6;1.4380000000000002e-184;0.6458;157.9643;329.6052;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
9543870;FABP3;7;9.842e-55;0.4783;1.8029;96.5095;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JDCKQBKHWBEMSZ-UHFFFAOYSA-N
151134;RNPEP;6;1.758e-49;0.5;2.434;87.0808;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
520710;CQSS;6;2.67e-78;0.5172;2.2955;138.819;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
53479947;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;WQHSMYBPCGOJLV-UHFFFAOYSA-N
3421919;RNPEP;6;2.606e-50;0.5;2.4754;88.569;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;CAPN2;6;3.69e-72;0.5098;20.9534;127.795;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
4656408;MC3R;6;1.916e-78;0.4085;38.4684;139.0779;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
329275;MMP7;8;2.071e-50;0.5231;6.1385;88.7484;MMP7;Matrilysin (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
150964;ACE2;6;3.378e-107;0.4717;15.0981;190.6999;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
131750649;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QELMLHKKGIZABI-UHFFFAOYSA-N
53478437;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCHJOJAVIATUSR-UHFFFAOYSA-N
100094;MC3R;6;7.831999999999999e-88;0.4805;43.0887;155.9332;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
14282475;YARS;6;4.514e-115;0.5745;6.7014;204.8364;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
5312797;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCC(C(=O)O)O;GHPVDCPCKSNJDR-UHFFFAOYSA-N
131761056;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HAGMTXDICLFDOC-UHFFFAOYSA-N
52926061;FABP3;7;4.666e-52;0.5556;1.7135;91.7055;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(C(=O)O)N;MGXXGWZPTJJSOQ-UHFFFAOYSA-N
7010580;NPR;6;2.238e-105;0.4737;15.2097;187.4304;NPR;Thermolysin (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
89566;LPAR1;6;2.4769999999999998e-60;1.0;11.309;106.5617;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;YNDYKPRNFWPPFU-UHFFFAOYSA-N
318292;ACE;6;5.638e-63;0.7234;62.5711;111.3066;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;CYSP_TRYCR;7;1.019e-79;0.431;19.3964;141.3658;CYSP_TRYCR;Cruzipain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
263475;SSTR3;6;6.054999999999999e-41;0.4375;12.6689;71.7538;SSTR3;Somatostatin receptor type 3 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
53480976;LPAR3;6;2.217e-82;0.6977;12.578;146.1452;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(CO)O;KVYUBFKSKZWZSV-UHFFFAOYSA-N
92829;ACE2;6;1.1409999999999999e-97;0.5366;13.7484;173.5928;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
13890535;QRFPR;6;4.486e-47;0.4262;5.7271;82.7597;QRFPR;Pyroglutamylated RFamide peptide receptor (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131755362;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZKXYDJCNAJPJQ-UHFFFAOYSA-N
12591;NOD1;9;1.62e-69;0.4242;4.9375;123.0506;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
643820;GGPS1;6;6.968e-54;0.4839;5.6174;94.9835;GGPS1;Geranylgeranyl pyrophosphate synthase (pKi >= 6);CC(=CCCC(=CCO)C)C;GLZPCOQZEFWAFX-UHFFFAOYSA-N
15448;CQSS;6;1.2349999999999999e-68;0.4615;2.0092;121.4668;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCC(C)O;XMUJIPOFTAHSOK-UHFFFAOYSA-N
150964;C3AR1;6;1.758e-60;0.5091;10.0098;106.8293;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151410;ACE2;6;7.429e-117;0.5106;16.4661;208.0386;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
52925230;LPAR1;6;1.043e-45;0.6154;8.5427;80.3066;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCC(C(=O)O)N;QBNCFMDNNPQYIL-UHFFFAOYSA-N
76807;HLA-A;6;1.74e-75;0.5098;11.6449;133.7669;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
12366;CES2;7;3.9539999999999995e-51;0.4483;2.9535;90.0394;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
4427709;MC1R;6;1.836e-147;0.619;75.0459;262.9881;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
92946;MMP1;6;9.82e-45;0.4231;56.3644;78.5581;MMP1;Interstitial collagenase (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6351946;MC4R;6;2.4189999999999998e-51;0.443;75.9018;90.4226;MC4R;Melanocortin receptor 4 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
545258;CES2;7;5.265e-54;0.4667;3.1221;95.2019;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
19816750;OPRD1;6;1.358e-112;0.55;266.9724;200.3869;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
12051354;S1PR4;8;2.147e-43;0.4667;3.7733;76.153;S1PR4;Sphingosine 1-phosphate receptor 4 (pKi >= 8);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
53478415;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCCCCC;RQWLSMTYYCMIJQ-UHFFFAOYSA-N
92946;CYSP_TRYCR;7;1.8509999999999998e-54;0.4;13.2127;96.0169;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
9900561;NPR1;6;6.185e-50;0.4225;1.8195;87.8952;NPR1;Atrial natriuretic peptide receptor 1 (pKi >= 6);CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)O)N;HYXQKVOADYPQEA-UHFFFAOYSA-N
12599;GPR17;6;4.197e-61;0.5873;3.1939;107.9461;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
13890535;PTPN2;6;7.471000000000001e-42;0.4478;11.4781;73.3853;PTPN2;Tyrosine-protein phosphatase non-receptor type 2 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
3081383;P2RX4;6;2.249e-57;0.4946;2.2892;101.251;P2RX4;P2X purinoceptor 4 (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
4657542;BLA1_STEMA;6;2.532e-86;0.4375;7.7578;153.2231;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
131801859;LPAR3;6;1.843e-70;0.6667;10.745;124.7455;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;CDTXMUFCBIHNCK-UHFFFAOYSA-N
131754192;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OGNCECWXMXWFGY-UHFFFAOYSA-N
131753518;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ITNUXAAETYEROX-UHFFFAOYSA-N
5488196;MME;6;2.736e-213;1.0;182.5516;381.168;MME;Neprilysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
19816755;HLA-A;6;1.9759999999999997e-53;0.4225;8.2159;94.1708;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
131801928;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;KYTZSBQBUCWGRJ-UHFFFAOYSA-N
131755004;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QREQPUUUIPJTAA-UHFFFAOYSA-N
25200879;EDNRB;7;4.752e-44;0.4915;22.85;77.3287;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
13879965;ENPEP;7;6.199e-93;0.5349;7.2944;165.0921;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)N;BCVIOZZGJNOEQS-UHFFFAOYSA-N
263475;CCKAR;6;3.945e-138;0.5424;136.6671;246.2338;CCKAR;Cholecystokinin receptor type A (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
6993120;LAP3;6;2.813e-90;0.5909;10.3606;160.3222;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
97415;RNPEP;6;4.882e-41;0.4667;2.0122;71.9218;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
472;HAO1;6;1.6299999999999998e-74;0.4324;3.225;132.0226;HAO1;Protein Hao1 (pKi >= 6);C1=CC=C(C(=C1)C(=O)CC(=O)C(=O)O)N;CAOVWYZQMPNAFJ-UHFFFAOYSA-N
53480924;LPAR3;6;2.219e-101;0.6226;15.4998;180.2556;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;CZYOFWNORPEFDG-UHFFFAOYSA-N
7010580;CAPNS1;6;1.715e-83;0.5094;5.731;148.1408;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
131759473;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MONMKVNVVBWTKM-UHFFFAOYSA-N
6992643;RNPEP;6;1.0389999999999999e-53;0.5333;2.6452;94.6718;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
31292;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
17525;LPAR3;6;3.782e-51;0.4333;7.7751;90.0739;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
131801915;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;QPKXQZITTOAAKY-UHFFFAOYSA-N
53479700;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;RQRUBEBOUYHPDW-UHFFFAOYSA-N
53480853;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;HUHQLMQCUTXEIJ-UHFFFAOYSA-N
6992643;TPH1;6;3.332e-89;0.4151;11.5869;158.3949;TPH1;Tryptophan 5-hydroxylase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480985;FABP3;7;2.368e-50;0.5;1.6564;88.6436;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(CO)O;NXOGCYSVLAIYAP-UHFFFAOYSA-N
24778864;LPAR3;6;3.419e-52;0.6327;7.9356;91.948;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C;XCPRRNDRDMFPPP-UHFFFAOYSA-N
13890535;KLK3;6;2.417e-44;0.4531;5.4734;77.8559;KLK3;Prostate-specific antigen (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
53481050;NOD1;9;1.213e-101;0.4878;7.243;180.7265;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;HCDLRJUFVJOBJP-UHFFFAOYSA-N
435728;CAPN2;6;2.735e-173;0.5778;50.4993;309.3557;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
19816756;PAPA1_CARPA;7;6.016e-52;0.4286;5.7261;91.5074;PAPA1_CARPA;Papain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
131764304;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;WWBWZANTQJGIBV-UHFFFAOYSA-N
6321361;FIMH;7;2.0279999999999998e-41;0.4821;2.4963;72.6068;FIMH;FimH (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;POQRWMRXUOPCLD-UHFFFAOYSA-N
131753543;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UOGFRTWKEGEEJU-UHFFFAOYSA-N
7021820;KLK3;7;2.79e-83;0.4853;8.8895;147.7615;KLK3;Prostate-specific antigen (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
65254;FOLH1;7;7.488e-43;0.5789;9.8505;75.1789;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
53477693;SLC10A1;6;1.251e-63;0.443;2.5422;112.4801;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(=O)CC4C3(CCC(C4)O)C)C;DXOCDBGWDZAYRQ-UHFFFAOYSA-N
19816755;GRPR;6;1.616e-86;0.4048;10.591;153.5731;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
53479812;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;IZEJYRQAFUAOSD-UHFFFAOYSA-N
19816756;CCKBR;6;4.458000000000001e-109;0.5224;110.5113;194.0742;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
6351946;FPR1;6;4.3739999999999997e-82;0.434;15.5485;145.6154;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
53480903;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CJTMZOOUZQGAPV-UHFFFAOYSA-N
7010506;ECE1;6;1.1440000000000001e-58;0.4516;25.3197;103.5737;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
19816756;MMP11;6;7.977e-116;0.44;11.6752;206.1877;MMP11;Stromelysin-3 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
150964;MMP3;6;2.1859999999999998e-44;0.5079;52.044;77.934;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
96814;ACE;6;9.627000000000002e-156;0.6486;154.7075;277.8539;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7009553;NPR1;6;1.229e-48;0.4225;1.7715;85.5647;NPR1;Atrial natriuretic peptide receptor 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
53479784;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CWPKVJPBYGQUHE-UHFFFAOYSA-N
329275;GHSR;6;7.151e-82;0.6897;84.3466;145.2322;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
52925094;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVTRPEJBOGUHBJ-UHFFFAOYSA-N
131753490;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BVZUJVWCCYACND-UHFFFAOYSA-N
53480962;FABP3;7;6.935e-50;0.5526;1.6408;87.8059;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCC(=O)OC(CO)CO;WNCUAIVHPMNYAK-UHFFFAOYSA-N
52924548;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;APTOFTJOCNPNQP-UHFFFAOYSA-N
7010580;HLA-A;6;9.148e-84;0.4737;12.9321;148.6308;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6993120;MMP1;6;8.223e-65;0.5102;81.5759;114.6028;MMP1;Interstitial collagenase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131750324;CDC25A;6;5.265e-58;0.4545;2.6844;102.3833;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C;DKPMWHFRUGMUKF-UHFFFAOYSA-N
53479861;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;RHBZSPYYUTVJHJ-UHFFFAOYSA-N
515709;MMP3;6;1.5500000000000002e-43;0.4906;51.0492;76.407;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
53479640;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OPJHRPGFKUCTOK-UHFFFAOYSA-N
12294;LPAR3;6;6.984000000000001e-48;0.4595;7.2728;84.2098;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC(=O)OCCCC;RPRPDTXKGSIXMD-UHFFFAOYSA-N
151410;CAPN1;6;7.308e-118;0.5909;68.2751;209.8467;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
52925214;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FGWZGYGIIUCSFO-UHFFFAOYSA-N
9546835;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;VDNXNFMAFDYQSI-UHFFFAOYSA-N
5057430;CAPN1;6;4.8329999999999995e-60;0.5476;34.7198;106.0407;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
131755723;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;RHVDDKIIECRCMU-UHFFFAOYSA-N
52921641;SELP;6;1.182e-77;0.7286;6.086;137.659;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O;QYWVASPEUXEHSY-UHFFFAOYSA-N
13817313;RIR1_HHV11;6;5.1079999999999994e-90;0.4;5.9527;159.8571;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
3085216;MAG;6;6.123e-85;0.5579;2.8126;150.7392;MAG;Myelin-associated glycoprotein (pKi >= 6);CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC4C(OC(C(C4O)O)O)CO)CO)O)NC(=O)C)OC5C(C(C(C(O5)CO)O)OC6(CC(C(C(O6)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O;FCIROHDMPFOSFG-UHFFFAOYSA-N
131801983;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;DQSHOTZVAMTFFY-UHFFFAOYSA-N
7009650;ERAP2;6;3.2849999999999997e-54;0.48;1.7854;95.5698;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
134906;KISS1R;8;5.496e-95;0.443;12.3433;168.7766;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
759256;MME;6;2.901e-182;0.5405;155.9913;325.4675;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
6992304;ACE2;6;1.9729999999999998e-60;0.4;8.4739;106.739;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;ECE1;6;1.81e-53;0.5952;23.0634;94.239;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
131759889;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;COWOCJLJJIQXGS-UHFFFAOYSA-N
454064;CES2;7;4.1700000000000003e-51;0.4483;2.9522;89.9979;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
150964;BLA1_STEMA;6;1.796e-90;0.4237;8.1337;160.6719;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7359122;LAP3;6;4.149e-92;0.4894;10.5722;163.6099;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
53479856;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;CUUQTWOJYKCYRS-UHFFFAOYSA-N
6992304;ANPEP;8;4.8870000000000005e-121;0.6216;16.4112;215.5464;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
323786;MMP11;6;3.443e-116;0.4932;11.7122;206.8429;MMP11;Stromelysin-3 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
323786;NMBR;6;2.51e-70;0.5167;11.1944;124.5048;NMBR;Neuromedin-B receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
53479852;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;AHVVIUYIKIQVDO-UHFFFAOYSA-N
53479570;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;QHFLHJLJIVRZEW-UHFFFAOYSA-N
329275;MMP3;6;6.513999999999999e-41;0.5667;47.9808;71.6969;MMP3;Stromelysin-1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
332962;FPR1;6;7.965e-70;0.4444;13.2106;123.6043;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
53480874;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VQMPZNPOSKPGTN-UHFFFAOYSA-N
53481900;LPAR1;6;8.786e-53;0.6909;9.8809;93.0074;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(COP(=O)(O)O)O;YGJPTGGFWWXCQF-UHFFFAOYSA-N
9561835;CQSS;6;4.2049999999999997e-82;0.5161;2.4081;145.6461;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCC(CCCCCCCCC(=O)O)O;PAZZVPKITDJCPV-UHFFFAOYSA-N
4466134;CAPN1;6;6.519e-129;0.5882;74.6877;229.6843;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
131753561;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VBYDXPQVGUJUTN-UHFFFAOYSA-N
323786;CAPNS1;6;8.035e-71;0.4286;4.8537;125.3928;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
52924563;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXLWNJDUZUKLO-UHFFFAOYSA-N
12591;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
7009567;BHMT;6;1.1590000000000001e-63;0.4286;1.8619;112.5402;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)CCC(C(=O)O)N;RQNSKRXMANOPQY-UHFFFAOYSA-N
193508;MMP1;6;2.423e-43;0.4898;54.6162;76.0587;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
7010506;CTSC;6;1.5730000000000001e-46;0.5106;7.1429;81.7813;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
9700;TK2;6;4.312e-75;0.5077;4.5623;133.0594;TK2;Thymidine kinase 2, mitochondrial (Predicted) (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
318292;KISS1R;8;8.682e-87;0.4051;11.2709;154.0575;KISS1R;KiSS-1 receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
19816755;NMBR;6;2.624e-54;0.4762;8.6233;95.7451;NMBR;Neuromedin-B receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
168182;MMP9;7;1.7879999999999999e-44;0.5789;53.3955;78.0909;MMP9;Matrix metalloproteinase-9 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
13890535;ECE1;6;2.875e-76;0.4681;32.9569;135.1707;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
134906;MMP9;6;7.841999999999999e-51;0.5357;73.3299;89.5054;MMP9;Matrix metalloproteinase-9 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
515709;NPR;6;1.78e-92;0.4655;13.337;164.2696;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
47579;NPR;8;6.507e-63;0.4318;3.6442;111.1947;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131759281;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WVBFGMOFOIEXMP-UHFFFAOYSA-N
515717;YARS;6;1.752e-99;0.5208;5.7877;176.8494;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
273262;CTSB;6;1.773e-77;0.5833;45.7067;137.3431;CTSB;Cathepsin B (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
3038501;MC4R;6;1.552e-59;0.4714;87.9554;105.1308;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
97415;ACE2;6;3.924e-127;0.6053;17.9218;226.4894;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
3421919;TYR;6;1.897e-44;0.5357;2.3125;78.0449;TYR;Tyrosinase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
134906;CPA1;6;1.9209999999999998e-60;0.4259;7.4892;106.7602;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
131758821;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YMPDPPQASWDPRK-UHFFFAOYSA-N
9948926;MC4R;6;1.272e-61;0.5303;91.025;108.8765;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
6992643;CAPNS1;6;7.14e-77;0.4444;5.2727;136.2568;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
47579;CTSB;6;1.9460000000000002e-63;0.55;37.4015;112.1361;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
193508;OPRM1;6;1.954e-99;0.5636;286.7742;176.764;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52924814;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WALILJXJZOCRCD-UHFFFAOYSA-N
6993120;CYSP_TRYCR;7;2.87e-86;0.4528;20.9998;153.1253;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
263475;ANPEP;8;5.428999999999999e-51;0.4;6.8655;89.7921;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
111299;MMP3;6;1.653e-42;0.4364;49.8468;74.5614;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
8164;CES2;7;1.767e-52;0.4516;3.0326;92.4627;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCOC(=O)C;YLYBTZIQSIBWLI-UHFFFAOYSA-N
96814;REN;6;1.2809999999999999e-67;0.4286;113.3158;119.643;REN;Renin (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
435728;C3AR1;6;2.532e-42;0.4;6.9758;74.229;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
131766787;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;YTOCFNTUAXVUGF-UHFFFAOYSA-N
7021820;NTSR1;6;3.793e-138;0.4935;33.5148;246.2644;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
19816755;NPR;8;4.784e-75;0.5167;4.3554;132.9784;NPR;Thermolysin (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
53479612;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KYERVKWKQQBRQB-UHFFFAOYSA-N
13890535;MMP1;6;3.266e-43;0.463;54.4533;75.8258;MMP1;Interstitial collagenase (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
52924563;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXLWNJDUZUKLO-UHFFFAOYSA-N
329275;MMP8;9;1.356e-64;0.5667;13.3609;114.2129;MMP8;Neutrophil collagenase (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7015683;NOD1;9;1.173e-107;0.5122;7.6746;191.5248;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
7789;FABP3;7;8.525999999999999e-45;0.5667;1.4707;78.6683;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC(CCCCCCCCCCC(=O)O)O;ULQISTXYYBZJSJ-UHFFFAOYSA-N
131759434;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FVASQEUWMANRGF-UHFFFAOYSA-N
7015704;FOLH1;9;7.840000000000001e-70;0.4444;5.4674;123.6166;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
45934043;LPAR3;6;4.647999999999999e-47;0.6222;7.1462;82.732;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;NSOPGAYUGBZWHL-UHFFFAOYSA-N
53479755;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;RUOGJLKOZLGYHK-UHFFFAOYSA-N
131801744;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;SYTLTRZEHNVTSX-UHFFFAOYSA-N
7010580;FPR1;6;1.707e-105;0.6136;20.0121;187.6413;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
323786;MMP7;8;3.186e-50;0.5;6.1154;88.4124;MMP7;Matrilysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
273262;RNPEP;6;3.281e-44;0.5417;2.1707;77.6175;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131754163;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PZPSHGGBTBOCBZ-UHFFFAOYSA-N
13879965;ACE2;7;7.531000000000001e-46;0.4324;5.662;80.5604;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)N;BCVIOZZGJNOEQS-UHFFFAOYSA-N
151410;NPR;6;3.9150000000000002e-87;0.45;12.5615;154.6785;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53478416;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;KVDLGXAZPYNPJG-UHFFFAOYSA-N
96814;CTSK;6;1.1390000000000001e-42;0.4583;51.2096;74.8519;CTSK;Cathepsin K (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
4466134;CAPNS1;6;4.6269999999999994e-88;0.5091;6.0473;156.3435;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
9543840;FABP3;7;2.521e-55;0.5116;1.8227;97.5715;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LQWVDOZRCDULIP-UHFFFAOYSA-N
19816755;GHSR;6;9.985e-79;0.5806;81.1083;139.5859;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
53480990;LPAR3;6;2.217e-82;0.6977;12.578;146.1452;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)O;ZXNAIPHYBVMMPY-UHFFFAOYSA-N
131754985;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HZWGBWWUMHOOAG-UHFFFAOYSA-N
4466134;SORT1;6;1.559e-60;0.4268;4.1414;106.923;SORT1;Sortilin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53479739;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;SSVPEUWHHFKSEB-UHFFFAOYSA-N
111299;OPRM1;6;4.622e-74;0.4655;214.1352;131.2099;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
515717;NPFFR2;6;1.0039999999999999e-53;0.4407;8.4408;94.699;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
53480964;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)CO;PMJSUEZTCFTBMD-UHFFFAOYSA-N
131753339;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AWDHZZVHWUIZSY-UHFFFAOYSA-N
6993118;CAPN1;6;1.929e-68;0.5789;39.594;121.1193;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
545258;CES1;8;2.387e-53;0.4667;5.8826;94.0235;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
515717;CYSP_TRYCR;7;7.964999999999999e-51;0.4;12.3232;89.4933;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
435728;CTSL;6;7.886999999999999e-81;0.4615;62.1158;143.3605;CTSL;Cathepsin L1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
19421321;RNPEP;8;5.224e-43;0.4211;1.411;75.4596;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
19421321;TMPRSS6;8;2.095e-59;0.4507;2.5642;104.897;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
97415;CAPN1;6;1.771e-101;0.5897;58.7667;180.4314;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
5488196;YARS;6;3.572e-95;0.5581;5.5351;169.1125;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
9546843;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;VOSQJLVNDRUECW-UHFFFAOYSA-N
131753718;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CJNBEPRDDYRSPK-UHFFFAOYSA-N
53478008;FABP3;7;4.9e-53;0.4815;1.7462;93.4627;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCCCC;DICYCLUXEYFAQX-UHFFFAOYSA-N
131802041;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;WGCCNBRJWHJBEZ-UHFFFAOYSA-N
53480650;NOD1;9;8.44e-98;0.4651;6.9672;173.828;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCC(=O)NC(CO)C(C(CCCCCCCCCCCCCC)O)O;IVBULNXGVIHEKN-UHFFFAOYSA-N
8048;CQSS;6;7.424e-77;0.5;2.2527;136.2264;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
151134;MMP1;6;2.7299999999999998e-46;0.4615;58.3182;81.3515;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
164853;SLC10A1;6;6.362999999999999e-66;0.4487;2.635;116.5981;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;SMEROWZSTRWXGI-UHFFFAOYSA-N
193508;CYSP_TRYCR;7;2.449e-87;0.4231;21.2615;155.0443;CYSP_TRYCR;Cruzipain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52927171;FABP3;7;2.379e-50;0.5833;1.6564;88.64;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;MVHBCRUZHMRQHX-UHFFFAOYSA-N
53479907;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FISVEBQJGBZOPW-UHFFFAOYSA-N
7010566;NPR;6;3.59e-96;0.5172;13.8734;170.9039;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
8048;EST1_PIG;7;7.052e-67;0.4483;4.4101;118.3133;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
5488196;HLA-A;6;4.625e-70;0.4058;10.8015;124.0281;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
168182;NMBR;6;1.314e-50;0.5254;8.0295;89.1029;NMBR;Neuromedin-B receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131802002;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;UFKFDATWXJRMOS-UHFFFAOYSA-N
7009623;ENPEP;7;4.666e-86;0.449;6.7506;152.7463;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
3038501;NPR;8;2.252e-47;0.5893;2.7334;83.2968;NPR;Thermolysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
14282475;OPRM1;6;5.749e-96;0.5714;276.8444;170.5367;OPRM1;Mu-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
435718;NPR;6;7.586e-64;0.4909;9.181;112.8705;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
4466134;CTSB;6;1.089e-77;0.5918;45.8319;137.7229;CTSB;Cathepsin B (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
134906;LAP3;6;1.47e-55;0.4545;6.3476;97.9918;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
131801942;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)O;IGVSZJYOSQMZTC-UHFFFAOYSA-N
23274411;HLA-A;6;1.5419999999999998e-53;0.4909;8.2326;94.3643;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCSC)N;BJFJQOMZCSHBMY-UHFFFAOYSA-N
53478177;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MLKOWSFMVFMITR-UHFFFAOYSA-N
131755191;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QJRAIXUZRUZYSD-UHFFFAOYSA-N
52925150;LPAR3;6;4.283e-69;0.7143;10.5349;122.2927;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;FGHPDPYCRTXYNZ-UHFFFAOYSA-N
14282475;OPRD1;6;3.664e-95;0.5833;225.8526;169.0928;OPRD1;Delta-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
53480966;FABP3;7;7.509e-54;0.5385;1.7734;94.9252;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)CO;CRSKSGIHJXUIHD-UHFFFAOYSA-N
6993120;NPR;6;1.2340000000000002e-109;0.4821;15.8279;195.0759;NPR;Thermolysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131760625;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SXSRTUPMLATBNN-UHFFFAOYSA-N
131753464;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOVZBEYRPDKHAL-UHFFFAOYSA-N
53479863;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IZWPZNGYCMMGHU-UHFFFAOYSA-N
131755168;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BUBKDTQRUWZQHX-UHFFFAOYSA-N
7010506;YARS;6;6.982e-85;0.48;4.9319;150.6368;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
323786;C3AR1;6;2.172e-44;0.6143;7.3211;77.9392;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7359122;YARS;6;1.969e-91;0.5333;5.3158;162.3956;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
4225619;CYP17A1;6;1.8610000000000002e-46;0.4714;20.7591;81.6504;CYP17A1;Steroid 17-alpha-hydroxylase/17,20 lyase (pKi >= 6);CCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C;LJGMGXXCKVFFIS-UHFFFAOYSA-N
96814;MMP3;6;1.745e-71;0.5319;83.7373;126.5834;MMP3;Stromelysin-1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
4427709;C5AR1;6;1.73e-44;0.4091;12.8148;78.1167;C5AR1;C5a anaphylatoxin chemotactic receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
19816750;FOLH1;6;8.251e-79;0.6154;24.8781;139.7347;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
76807;CAPN1;6;3.656e-94;0.5366;54.5216;167.299;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
3800205;C3AR1;6;5.2510000000000005e-42;0.463;6.9228;73.6603;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
759256;ACE2;6;7.124e-97;0.4878;13.6358;172.1649;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
12599;P2RX4;6;7.211e-65;0.6102;2.5923;114.7052;P2RX4;P2X purinoceptor 4 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
168182;HLA-DRB1;6;6.100999999999999e-47;0.4337;4.5937;82.5198;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009555;CAPN1;6;8.985e-70;0.7895;40.3669;123.5104;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
131801712;LPAR3;6;5.143e-52;0.617;7.9084;91.6297;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)O;DNGFLPFNXOMGJW-UHFFFAOYSA-N
7021456;MC3R;6;6.027e-52;0.4865;25.4281;91.5059;MC3R;Melanocortin receptor 3 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
131753892;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VHWNCJQPNDUBCY-UHFFFAOYSA-N
53479594;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;LAFTYABRLNPQHQ-UHFFFAOYSA-N
342468;MME;6;1.796e-174;0.7273;149.321;311.4789;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
92829;GRIA1;6;3.16e-75;0.4898;16.65;133.3018;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
131802009;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;IVASVZFPDOWZBQ-UHFFFAOYSA-N
273262;ACE;6;4.713e-83;0.6458;82.5123;147.3525;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
3634442;GHSR;6;5.961e-77;0.5902;79.2796;136.3975;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
10468;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
435728;ECE1;6;9.253e-104;0.5;44.887;184.5283;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
19816755;NTSR1;6;6.348e-48;0.4607;11.5489;84.2842;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
102763;GHSR;6;1.154e-82;0.5085;85.1622;146.6542;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
131801990;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;VLJNBDVONLLDHB-UHFFFAOYSA-N
52924553;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;FMYXHSVUQFRMGW-UHFFFAOYSA-N
53479611;LPAR1;6;3.382e-45;0.5818;8.446;79.3892;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DPRXQVIZBLENFV-UHFFFAOYSA-N
52924776;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;KXVQBSORIXQSRP-UHFFFAOYSA-N
9700;POLA1;6;2.837e-64;0.6667;2.3504;113.6373;POLA1;DNA polymerase alpha catalytic subunit (pKi >= 6);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
134906;CTSB;6;1.705e-52;0.4776;30.9287;92.4904;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53481816;LPAR1;6;6.215e-54;0.717;10.0984;95.0726;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NTQLGVPKRSFHIQ-UHFFFAOYSA-N
6993118;LAP3;6;2.1839999999999998e-45;0.6667;5.1719;79.7301;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
52925059;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NRDJGXANLABPHN-UHFFFAOYSA-N
131759870;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PSHWARYKXDUDSM-UHFFFAOYSA-N
131753695;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QQZZZCIYMICCKG-UHFFFAOYSA-N
131754985;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HZWGBWWUMHOOAG-UHFFFAOYSA-N
53479729;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;USEKWJQLASGHIH-UHFFFAOYSA-N
263475;KISS1R;8;6.294e-86;0.4074;11.1583;152.5129;KISS1R;KiSS-1 receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3421919;LNPEP;6;6.564e-62;0.5;6.9604;109.3926;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
3421919;NPR;6;1.78e-92;0.4655;13.337;164.2696;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
53479625;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VHHMKXOBDPAFKC-UHFFFAOYSA-N
19816755;MME;6;8.843000000000001e-69;0.5167;58.8396;121.7275;MME;Neprilysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
3421919;TMPRSS6;8;7.841e-45;0.4167;1.9269;78.7336;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
151134;NAALAD2;6;2.828e-88;0.675;5.1308;156.7273;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
52925456;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;QFGBUBRLCJWGHL-UHFFFAOYSA-N
131758783;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NKWRAFYNNIEZPH-UHFFFAOYSA-N
131766702;FABP3;7;7.509e-54;0.5385;1.7734;94.9252;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)O;GOLRHKZVCRTBFW-UHFFFAOYSA-N
53481449;SLCO2A1;6;2.9140000000000003e-58;0.4262;1.9208;102.8445;SLCO2A1;Solute carrier organic anion transporter family member 2A1 (pKi >= 6);CCCCCC=CCC(CCC=CC=CC(CCCC(=O)O)O)O;NKUPFHTVILUPKF-UHFFFAOYSA-N
150964;MME;6;8.099000000000001e-166;0.5106;141.9123;295.9418;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
515709;C3AR1;6;1.3689999999999998e-47;0.5152;7.8558;83.6848;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
53480991;FABP3;7;4.2039999999999997e-54;0.5366;1.7818;95.3774;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)O;UCYPOAPUDLUXQX-UHFFFAOYSA-N
12599;DNMT3B;6;8.566e-56;0.4306;2.5807;98.4131;DNMT3B;DNA (cytosine-5)-methyltransferase 3B (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
131801999;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;WZWSISJCYNBNPX-UHFFFAOYSA-N
7009555;YARS;6;3.505e-93;0.4792;5.4184;165.5368;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
7789;NOD1;9;3.106e-95;0.4595;6.7831;169.2214;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCC(CCCCCCCCCCC(=O)O)O;ULQISTXYYBZJSJ-UHFFFAOYSA-N
131754967;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;DHISSBAEVLDFEV-UHFFFAOYSA-N
102763;EDNRB;9;1.18e-62;0.5077;6.0209;110.7304;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
11622;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
515709;CTSL;6;3.999e-74;0.5294;56.9569;131.3228;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
259327;ACE2;7;3.25e-57;0.4043;7.085;100.9642;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
7021456;ERAP2;6;8.998e-52;0.4203;1.7039;91.1935;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
6993120;MMP3;6;1.586e-65;0.4717;76.7685;115.8862;MMP3;Stromelysin-1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
6993120;FCER2;6;1.537e-115;0.4615;14.1698;205.6762;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
53480978;FABP3;7;1.8259999999999998e-51;0.5122;1.6936;90.6417;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)O;XQBHBEXBUZDCRY-UHFFFAOYSA-N
9547068;LPAR3;6;4.283e-69;0.7143;10.5349;122.2927;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;BBYWOYAFBUOUFP-UHFFFAOYSA-N
323786;MMP3;6;1.27e-44;0.541;52.32;78.3577;MMP3;Stromelysin-1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
11579826;NAALAD2;6;3.4219999999999997e-103;0.6757;6.0051;183.5086;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
53479640;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OPJHRPGFKUCTOK-UHFFFAOYSA-N
69421;FABP3;7;5.498e-47;0.4815;1.5439;82.601;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
44232492;KLK3;7;1.168e-75;0.4333;8.0695;134.0778;KLK3;Prostate-specific antigen (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
47579;TIMP3;6;5.265e-82;0.4468;7.1844;145.4709;TIMP3;Metalloproteinase inhibitor 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
131754309;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IMVXYPBBFJIVGK-UHFFFAOYSA-N
151410;TMPRSS6;8;8.495e-55;0.4085;2.3627;96.6243;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4414300;HLA-A;6;1.109e-62;0.431;9.6542;110.779;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC(=O)N)C(=O)O)N;HZYHBDVRCBDJJV-UHFFFAOYSA-N
19816755;CTSL;8;4.9589999999999995e-45;0.5938;12.584;79.0908;CTSL;Cathepsin L1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
7010499;NTSR2;7;1.023e-51;0.4103;8.0359;91.0937;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
53479600;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;SMHQICHVYVREKX-UHFFFAOYSA-N
4427709;MMP8;7;2.173e-62;0.5;41.1039;110.2546;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
5057430;CAPNS1;6;1.21e-68;0.4444;4.7029;121.4832;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;CAPN2;6;2.505e-85;0.4717;24.8006;151.4361;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
6992643;NAALAD2;6;5.142999999999999e-47;0.4884;2.7124;82.653;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
53480896;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;CCSPRYPUMQZSKU-UHFFFAOYSA-N
25260623;LPAR3;6;1.1319999999999999e-73;0.7143;11.2389;130.5117;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;LZSJCSQKHQTZID-UHFFFAOYSA-N
20057359;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;DOIOUJPHIXRQFM-UHFFFAOYSA-N
57315376;HLA-A;6;1.5750000000000001e-65;0.4559;10.0969;115.8913;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)N)N;XITLYYAIPBBHPX-UHFFFAOYSA-N
53480902;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;BOIHDLQLPRODPV-UHFFFAOYSA-N
5312378;FABP3;7;1.5240000000000001e-71;0.9167;2.3648;126.6888;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
5488196;LAP3;6;2.012e-93;0.5111;10.7242;165.9696;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
76807;MME;6;1.3250000000000002e-42;0.5128;36.4311;74.7338;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
131758776;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGUXHCYCFLVGES-UHFFFAOYSA-N
131763497;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FWLOAHZIIPEDQA-UHFFFAOYSA-N
52929772;LPAR1;6;3.7889999999999997e-54;0.6444;10.1391;95.4584;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)O)O;LBGSRVIXIVDRQM-UHFFFAOYSA-N
11646044;LPAR3;6;1.1460000000000001e-48;0.5652;7.3935;85.6192;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)CO;BXAXVVVVPFELOK-UHFFFAOYSA-N
52924583;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;FRVWPWGGHGGKMD-UHFFFAOYSA-N
131758776;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGUXHCYCFLVGES-UHFFFAOYSA-N
53479676;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;JLYDNXJQTBLQKZ-UHFFFAOYSA-N
52924594;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JIEASZUPMDFVLW-UHFFFAOYSA-N
131758626;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DJBSAGJERMKCDN-UHFFFAOYSA-N
9948926;MME;6;2.09e-112;0.6538;96.1875;200.0508;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
537294;CQSS;6;5.057e-72;0.4375;2.1095;127.5491;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;KECCPKLXQUOWMI-UHFFFAOYSA-N
22880141;LPAR3;6;3.419e-52;0.6327;7.9356;91.948;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC;YKIOPDIXYAUOFN-UHFFFAOYSA-N
9547000;LPAR3;6;2.4939999999999997e-67;0.7391;10.2634;119.1238;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCCN;FXNACVVCWBVCGD-UHFFFAOYSA-N
53480969;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(CO)CO;DVYDCUGIJCYIQN-UHFFFAOYSA-N
5057430;CPA1;6;9.932e-53;0.5909;6.5234;92.9118;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
52925452;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;LZBAIACFBSMXFQ-UHFFFAOYSA-N
8201;LPAR3;6;1.198e-48;0.4324;7.3905;85.5845;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
7010566;RNPEP;6;1.3379999999999998e-41;0.46;2.0402;72.9307;RNPEP;Aminopeptidase B (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
53479947;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;WQHSMYBPCGOJLV-UHFFFAOYSA-N
101227803;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZDZVWVCNWRMGLA-UHFFFAOYSA-N
9546838;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;XYHIPPZFNNOMQL-UHFFFAOYSA-N
131755362;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZKXYDJCNAJPJQ-UHFFFAOYSA-N
13817313;HLA-A;6;4.642e-96;0.5769;14.8437;170.7035;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
22556;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
100094;FPR1;6;4.276e-62;0.5152;11.7367;109.7268;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
10445608;NPR;6;1.051e-89;0.4286;12.9347;159.2941;NPR;Thermolysin (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
9797038;HLA-DRB1;7;1.942e-46;0.4353;3.3951;81.6172;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
131801899;LPAR3;6;3.449e-87;0.7045;13.3174;154.7773;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;RJUNCJKUOOBPGW-UHFFFAOYSA-N
70095;KDM2A;6;9.509e-48;0.4074;1.8998;83.9692;KDM2A;Lysine-specific demethylase 2A (pKi >= 6);C(CCCCCCCCC(=O)O)CCCCCCCC(=O)O;BNJOQKFENDDGSC-UHFFFAOYSA-N
18631369;LPAR3;6;3.419e-52;0.6327;7.9356;91.948;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC;VNVBJTOZNQTTCV-UHFFFAOYSA-N
53479755;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;RUOGJLKOZLGYHK-UHFFFAOYSA-N
3421919;NAALAD2;6;1.766e-43;0.5333;2.5051;76.3051;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131760023;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;OYVIPANDVFEMEV-UHFFFAOYSA-N
131801999;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;WZWSISJCYNBNPX-UHFFFAOYSA-N
332962;ANPEP;6;3.851e-44;0.5238;15.4363;77.4926;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
96814;MMP7;7;7.274e-43;0.46;8.7674;75.2015;MMP7;Matrilysin (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
52925127;LPAR1;6;2.992e-43;0.4915;8.0778;75.8943;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;LJVXDBWIBQQKFU-UHFFFAOYSA-N
12366;CQSS;6;7.424e-77;0.5;2.2527;136.2264;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
263475;MC4R;6;8.256e-57;0.5152;83.945;100.2372;MC4R;Melanocortin receptor 4 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
13890535;CAPNS1;6;5.255e-87;0.4107;5.9743;154.449;CAPNS1;Calpain small subunit 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
52924624;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BYVQCOREHGDXRD-UHFFFAOYSA-N
53480925;FABP3;7;6.897e-48;0.569;1.5741;84.2196;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NOVZJYYJYIFXJC-UHFFFAOYSA-N
53481885;LPAR1;6;1.331e-54;0.7308;10.225;96.274;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(COP(=O)(O)O)O;OYWQLEFQIHHFDV-UHFFFAOYSA-N
11958364;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;YMYQEDCYNANIPI-UHFFFAOYSA-N
52925087;LPAR3;6;2.8529999999999998e-89;0.5593;13.6376;158.5158;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HLSDKIUXCZPFLL-UHFFFAOYSA-N
4427709;FPR1;6;1.728e-92;0.6066;17.5322;164.2929;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53478598;LPAR3;6;2.184e-76;0.5957;11.6563;135.3851;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SOWAPPIVBQCDGN-UHFFFAOYSA-N
342468;CYSP_TRYCR;7;2.0529999999999998e-54;0.4167;13.2017;95.9362;CYSP_TRYCR;Cruzipain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
7021820;OPRD1;6;1.096e-93;0.5;222.3708;166.443;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
131758653;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DAAWWDSQUNUMHY-UHFFFAOYSA-N
342468;CTSL;6;7.773e-42;0.4286;32.1138;73.3545;CTSL;Cathepsin L1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
107475;HLA-A;6;1.396e-49;0.449;7.6174;87.2604;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(C(C)C)C(=O)O)N;KRNYOVHEKOBTEF-UHFFFAOYSA-N
4427709;CCKAR;6;5.614e-154;0.55;152.3435;274.6838;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
9547071;LPAR3;6;2.079e-106;0.75;16.2731;189.2832;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;PYVRVRFVLRNJLY-UHFFFAOYSA-N
97415;ACE;6;9.542e-105;0.6667;104.0583;186.2996;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
6992563;F2R;6;2.353e-45;0.5614;27.364;79.672;F2R;Proteinase-activated receptor 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
7009650;GHSR;6;1.582e-72;0.7231;74.7245;128.4554;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
14767562;CAPN2;6;5.8440000000000005e-46;0.451;13.299;80.7581;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
52924174;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZHZTYDTVUSPVLX-UHFFFAOYSA-N
10445608;ANPEP;8;4.187e-123;0.5106;16.6929;219.2575;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
5312378;OXER1;6;1.759e-43;0.5833;3.5849;76.3083;OXER1;Oxoeicosanoid receptor 1 (pKi >= 6);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
52927171;LPAR1;6;1.19e-47;0.6071;8.9101;83.7941;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;MVHBCRUZHMRQHX-UHFFFAOYSA-N
7021456;MC1R;6;1.003e-82;0.4865;42.0409;146.7633;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
164853;CA4;6;4.819e-42;0.6308;47.8981;73.7273;CA4;Carbonic anhydrase 4 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;SMEROWZSTRWXGI-UHFFFAOYSA-N
92946;CAPN1;6;3.412e-81;0.6098;46.9947;144.0138;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
19816756;ECE1;6;9.651000000000001e-85;0.5893;36.6342;150.3844;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
111299;PIN1;6;2.568e-44;0.4032;5.7962;77.8084;PIN1;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
100048;OPRM1;6;3.516e-84;0.5862;243.1027;149.3762;OPRM1;Mu-type opioid receptor (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
131759577;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZJUJYFBFJFLODJ-UHFFFAOYSA-N
14169768;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC;UXWDTZNNQVHGSG-UHFFFAOYSA-N
53479611;FABP3;7;4.2749999999999997e-51;0.6271;1.6813;89.9785;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DPRXQVIZBLENFV-UHFFFAOYSA-N
13890535;NAALAD2;6;3.271e-48;0.5476;2.7825;84.8013;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
101227803;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZDZVWVCNWRMGLA-UHFFFAOYSA-N
131753524;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMAGTKGPGZLWKS-UHFFFAOYSA-N
52924548;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;APTOFTJOCNPNQP-UHFFFAOYSA-N
3634442;ECE1;6;1.107e-87;0.5714;37.9101;155.6632;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
97415;CPA1;6;2.701e-106;0.5676;13.2302;189.0791;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
10257;HTR1B;6;2.476e-79;1.0;77.9218;140.6733;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 6);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
131753860;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QPPIYNYVDUYVQL-UHFFFAOYSA-N
3800205;FURIN;6;5.6e-45;0.7317;8.1985;78.996;FURIN;Furin (pKi >= 6);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
111299;NPR;6;2.619e-80;0.4237;11.5707;142.4248;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
131755173;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UOSXDBUYARIRPO-UHFFFAOYSA-N
6993120;NPFFR1;7;5.495000000000001e-84;0.4;7.1703;149.0282;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131759434;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FVASQEUWMANRGF-UHFFFAOYSA-N
7009598;MMP1;6;1.896e-46;0.5208;58.5171;81.6358;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
45479454;LPAR3;6;2.195e-63;0.5918;9.6568;112.0419;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCC(CO)O;ZYKIFISVQNGKFE-UHFFFAOYSA-N
7076347;GHRL;6;1.2490000000000001e-58;0.4219;7.0411;103.5052;GHRL;Appetite-regulating hormone (pKi >= 6);CC(C)CC1C(=O)NC(C(=O)N1)CC2=CC=CC=C2;QPDMOMIYLJMOQJ-UHFFFAOYSA-N
259327;CAPN2;6;2.173e-144;0.44;42.0559;257.4705;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
134906;ANPEP;8;5.475e-99;0.4545;13.4063;175.9608;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
9948926;ERAP2;6;2.75e-60;0.5373;1.9885;106.4803;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
263475;EDNRA;6;6.995e-52;0.4844;77.3464;91.3898;EDNRA;Endothelin-1 receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
131753463;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;FICVIOYVXOEZEN-UHFFFAOYSA-N
7643;NAAA;6;2.329e-43;0.4146;6.0558;76.0893;NAAA;N-acylethanolamine-hydrolyzing acid amidase (pKi >= 6);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
435728;OPRD1;6;7.553000000000001e-78;0.4545;185.0082;138.0082;OPRD1;Delta-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
131755530;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KKBIJNWSACWOQA-UHFFFAOYSA-N
263471;EDNRB;9;1.478e-55;0.4;5.3315;97.988;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
131754079;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;VMJJCASFGIUXQS-UHFFFAOYSA-N
52924167;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DAZYZDVAACSMFA-UHFFFAOYSA-N
7010566;ACE;6;9.82e-83;0.5319;82.1956;146.7802;ACE;Angiotensin-converting enzyme (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
435728;PSMB5;7;9.113e-59;0.4074;13.1462;103.7508;PSMB5;Proteasome subunit beta type-5 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
7009598;AMP1_PLAFQ;6;4.4039999999999996e-51;0.5333;6.5068;89.9553;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151003;NTSR1;8;1.844e-59;0.4304;9.2529;104.9964;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
12741;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
5057430;OPRM1;6;1.7560000000000001e-121;0.6216;349.8877;216.3444;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
7009555;OPRM1;6;2.8120000000000002e-96;0.5192;277.7338;171.0945;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
53479566;FABP3;7;3.448e-42;0.6727;1.3836;73.9881;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;CUUIBVDVVFLYGA-UHFFFAOYSA-N
131754580;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CDADMZPLSYSPIH-UHFFFAOYSA-N
7010566;CTSK;6;5.915e-45;0.4727;53.9434;78.9534;CTSK;Cathepsin K (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
53479893;LPAR3;6;1.556e-97;0.5254;14.9084;173.3511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;WMGNZOBBKTUGGQ-UHFFFAOYSA-N
53479988;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;UJDHYDGXZXDWNT-UHFFFAOYSA-N
4466134;MMP3;6;4.224e-45;0.5577;52.8791;79.2159;MMP3;Stromelysin-1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
53479623;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MKMUWJJSVUOCQC-UHFFFAOYSA-N
99647664;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SDNYRTVJOFMYIW-UHFFFAOYSA-N
5057430;CTSL;6;1.644e-41;0.4706;31.8634;72.7703;CTSL;Cathepsin L1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
97415;OPRM1;6;1.136e-54;0.4286;158.6254;96.3979;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
52924213;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UDBXKKKIEXMSEA-UHFFFAOYSA-N
273262;YARS;6;6.102e-101;0.5208;5.8732;179.4669;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131755698;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HTFZBWPHGZEFJU-UHFFFAOYSA-N
150964;NPFFR2;7;1.472e-92;0.5;7.6967;164.4175;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
131758799;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RYWWBXHDEGSCOG-UHFFFAOYSA-N
131754431;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HVMWRSISSYXDSD-UHFFFAOYSA-N
63842847;OPRM1;6;6.253e-86;0.6271;248.1125;152.5181;OPRM1;Mu-type opioid receptor (pKi >= 6);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
7015683;GRIK3;6;2.062e-48;0.5;4.3237;85.1608;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
13783081;MMP2;6;4.428e-45;0.493;73.0036;79.1791;MMP2;72 kDa type IV collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
52925058;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;MFRYWKSWYSTLOB-UHFFFAOYSA-N
102763;ECE1;6;3.5830000000000004e-98;0.64;42.4621;174.4961;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
96814;CTSC;6;5.9010000000000006e-46;0.4565;7.0537;80.7505;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
25200879;ECE1;6;5.165e-72;0.4912;31.1108;127.5327;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
45934043;FABP3;7;1.2469999999999999e-52;0.5789;1.7326;92.7343;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;NSOPGAYUGBZWHL-UHFFFAOYSA-N
131753695;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QQZZZCIYMICCKG-UHFFFAOYSA-N
323786;ACE2;6;6.634000000000001e-78;0.4138;10.9489;138.1094;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
53479731;LPAR1;6;1.9649999999999998e-47;0.5926;8.8689;83.4031;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;HCQUFOLAJNWIDV-UHFFFAOYSA-N
9543989;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SKGWNZXOCSYJQL-UHFFFAOYSA-N
332962;NPR;6;1.478e-91;0.4423;13.2036;162.6194;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
151410;ACE;6;6.237e-114;0.5581;113.1805;202.789;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
134906;EDNRB;9;2.0610000000000002e-72;0.5455;6.9688;128.2489;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
100048;RNPEP;6;2.6930000000000002e-55;0.5;2.7244;97.5199;RNPEP;Aminopeptidase B (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
3421919;CTSL;6;3.999e-74;0.5294;56.9569;131.3228;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
53479625;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VHHMKXOBDPAFKC-UHFFFAOYSA-N
5317319;GGPS1;6;4.677e-49;0.4857;5.108;86.3177;GGPS1;Geranylgeranyl pyrophosphate synthase (pKi >= 6);CC(=CCCC(=CCCC(=C)C=C)C)C;JSNRRGGBADWTMC-UHFFFAOYSA-N
47579;FOLH1;6;5.418e-45;0.5405;14.1462;79.0218;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
96814;CAPN2;6;2.1090000000000002e-159;0.6098;46.4421;284.4237;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7021820;ACE2;6;1.766e-97;0.5098;13.7216;173.2523;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
3421919;BLA1_STEMA;6;5.63e-96;0.4727;8.6322;170.5531;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131763537;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZGXRJWDPYLJJFG-UHFFFAOYSA-N
6992643;PAPA1_CARPA;7;6.034e-73;0.4074;8.0701;129.2068;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
96814;MMP8;6;3.5229999999999995e-45;0.4894;35.8027;79.3573;MMP8;Neutrophil collagenase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
42607457;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;XVYPOHCSLJZFED-UHFFFAOYSA-N
53480868;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VXAQICWVKHYAOM-UHFFFAOYSA-N
151134;OPRM1;6;9.962e-103;0.5192;296.2002;182.6754;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131801988;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;RSFDYJRKLOLHJO-UHFFFAOYSA-N
131759301;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;NTANLNVWSGZVNG-UHFFFAOYSA-N
3421919;CPA1;6;9.627999999999999e-93;0.5682;11.5334;164.7487;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
3634442;MC4R;6;1.084e-61;0.5294;91.1271;109.0011;MC4R;Melanocortin receptor 4 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
53479804;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JUYYWEDATPYDSS-UHFFFAOYSA-N
52925086;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;HXUHHWPZGOIBGO-UHFFFAOYSA-N
20057360;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;RIGGIBNQNREJCL-UHFFFAOYSA-N
18218238;CCKAR;6;4.646000000000001e-128;0.4706;126.7044;228.1531;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7010499;NTSR1;6;8.491999999999999e-67;0.4103;16.1439;118.1684;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
7009623;FOLH1;9;9.786e-82;0.5405;6.4088;144.9876;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
4078684;RNPEP;6;5.542e-45;0.434;2.2092;79.0041;RNPEP;Aminopeptidase B (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
273262;CAPNS1;6;1.005e-87;0.537;6.024;155.7389;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
263475;TACR1;6;4.3250000000000005e-46;0.5254;79.7264;80.9929;TACR1;Substance-P receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
53478415;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCCCCC;RQWLSMTYYCMIJQ-UHFFFAOYSA-N
6992643;LAP3;6;2.3889999999999998e-88;0.5333;10.1376;156.8589;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
221122;CDC25A;6;1.371e-74;0.6786;3.4621;132.1572;CDC25A;M-phase inducer phosphatase 1 (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
10459;FABP3;7;5.073e-44;0.5217;1.4448;77.2777;FABP3;Fatty acid-binding protein, heart (pKi >= 7);C(CCCCCCCC(=O)O)CCCCCCC(=O)O;QQHJDPROMQRDLA-UHFFFAOYSA-N
14409732;NTSR1;10;7.097999999999999e-44;0.4396;1.2757;77.0159;NTSR1;Neurotensin receptor type 1 (pKi >= 10);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
53481049;NOD1;9;1.213e-101;0.4878;7.243;180.7265;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;FTSDYFFYZJTACJ-UHFFFAOYSA-N
152416;HDAC11;7;1.992e-42;0.4035;6.5759;74.4162;HDAC11;Histone deacetylase 11 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C1CCC(=O)N1;DTSWLLBBGHRXQH-UHFFFAOYSA-N
6438186;FABP3;7;2.642e-55;0.5429;1.822;97.5349;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)CO;TZDOBCZHGBGJLS-UHFFFAOYSA-N
9546835;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;VDNXNFMAFDYQSI-UHFFFAOYSA-N
5057430;OPRD1;6;8.776e-120;0.617;283.9328;213.2946;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9546757;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;MWRBNPKJOOWZPW-UHFFFAOYSA-N
131801711;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;YEUGSVVCGREBDT-UHFFFAOYSA-N
7020642;ACE;6;2.696e-167;0.62;166.1817;298.5949;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
52926008;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;DWNFLQISNVMTDP-UHFFFAOYSA-N
53479595;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;FCPBFHHIKXPHHN-UHFFFAOYSA-N
19816756;EDNRB;9;1.008e-56;0.4167;5.4448;100.0819;EDNRB;Endothelin B receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
515717;NAALAD2;6;1.006e-71;0.6905;4.1606;127.0126;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
7021820;YARS;6;6.767e-97;0.5;5.6361;172.205;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
53479772;FABP3;7;5.9120000000000005e-46;0.5079;1.5094;80.7491;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;GOKCOIYNLBLTCL-UHFFFAOYSA-N
134906;OPRM1;6;9.295e-89;0.6667;256.2079;157.5949;OPRM1;Mu-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53477837;LPAR3;6;5.843e-42;0.549;6.362;73.577;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C;IPOLTUVFXFHAHI-UHFFFAOYSA-N
53480932;FABP3;7;1.144e-49;0.541;1.6336;87.4156;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NHBRVTKHMMOYTG-UHFFFAOYSA-N
131801711;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;YEUGSVVCGREBDT-UHFFFAOYSA-N
6993120;CAPN2;6;1.018e-150;0.5814;43.9051;268.8339;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
189008;CAPN1;6;4.804e-65;0.4444;37.623;115.0219;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
56960317;LPAR3;6;7.499e-122;0.7692;18.6479;217.0078;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;LPQBQFLKBCPNAV-UHFFFAOYSA-N
96814;MME;6;6.8720000000000005e-264;0.6486;225.8694;472.0111;MME;Neprilysin (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
8163;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
4078684;NTSR1;7;1.307e-85;0.4203;16.0904;151.943;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
111299;MME;6;8.455e-195;0.5435;166.7227;347.9726;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
61030;LPAR3;6;3.782e-51;0.4333;7.7751;90.0739;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
131802010;LPAR3;6;2.7089999999999997e-90;0.7209;13.7949;160.3515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;ODIFDYMVTZMQLS-UHFFFAOYSA-N
100048;KLK3;7;4.856e-95;0.4531;10.1546;168.8731;KLK3;Prostate-specific antigen (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
52924652;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WLTBPSUTBXIPBI-UHFFFAOYSA-N
8163;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
6351946;ITGA4;6;2.8410000000000004e-69;0.4667;21.0313;122.6127;ITGA4;Integrin alpha-4 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
131802042;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;GRJUVGUIQWBDLN-UHFFFAOYSA-N
151134;ANPEP;8;5.0360000000000004e-129;0.5;17.4996;229.8855;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
6321361;SELP;6;2.755e-83;0.7812;6.5314;147.7712;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O;POQRWMRXUOPCLD-UHFFFAOYSA-N
7359122;OPRD1;6;1.337e-96;0.5455;229.2441;171.6739;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
53479575;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LKUKJIYAXQFZTD-UHFFFAOYSA-N
92946;CPA1;6;1.1709999999999998e-53;0.6512;6.6397;94.5789;CPA1;Carboxypeptidase A1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
10957631;LPAR3;6;1.1399999999999998e-52;0.6486;8.009;92.8043;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(CO)O;DCBSHORRWZKAKO-UHFFFAOYSA-N
131754941;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CABYGZXBJNUBCV-UHFFFAOYSA-N
9948926;MC1R;6;7.306000000000001e-122;0.5303;61.9944;217.0282;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
168182;EDNRA;6;1.077e-60;0.5538;90.421;107.211;EDNRA;Endothelin-1 receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131801778;FABP3;7;6.335999999999999e-51;0.4651;1.6756;89.6716;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)O;RRALAGZOUWRTFP-UHFFFAOYSA-N
342468;HLA-A;7;2.3359999999999999e-97;0.4744;10.2057;173.0342;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
6351946;ACE2;6;3.451e-110;0.4717;15.5217;196.0691;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
53479829;LPAR1;6;8.126e-42;0.5;7.8065;73.3198;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;ZRQPYJXAEPDRDM-UHFFFAOYSA-N
435728;CTRB_BOVIN;6;1.453e-64;0.4;2.1315;114.1588;CTRB_BOVIN;Chymotrypsinogen B (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
10445608;CAPN1;6;2.703e-115;0.5227;66.7848;205.2363;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
329275;MC3R;6;1.6170000000000002e-85;0.4595;41.9496;151.7774;MC3R;Melanocortin receptor 3 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
4466134;Q9N6S8_PLAFA;8;1.2909999999999999e-45;0.4151;1.9612;80.1402;Q9N6S8_PLAFA;Falcipain 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
13890535;NPFFR2;6;2.2189999999999997e-53;0.4;8.3861;94.0802;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
131755369;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KJRMVHBWNRWOEF-UHFFFAOYSA-N
9546747;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;HBZNVZIRJWODIB-UHFFFAOYSA-N
53477969;FABP3;7;2.752e-49;0.4333;1.6208;86.7312;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FRUADKDVYOLUEU-UHFFFAOYSA-N
134906;PAPA1_CARPA;7;1.748e-63;0.4118;7.0139;112.2197;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
53480902;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;BOIHDLQLPRODPV-UHFFFAOYSA-N
100048;CPA1;6;9.592000000000001e-72;0.5102;8.9043;127.05;CPA1;Carboxypeptidase A1 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
53480972;LPAR3;6;9.02e-53;0.5385;8.0246;92.9869;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)CO;SNMGFBFZTAYEBF-UHFFFAOYSA-N
131801916;LPAR1;6;3.626e-43;0.7045;8.062;75.7442;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;GHJOXQFLZDFHBM-UHFFFAOYSA-N
131760503;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADOAWMSGAVKGKY-UHFFFAOYSA-N
131754775;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BWUZGPYYZXQIFD-UHFFFAOYSA-N
131755773;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;HFPMGYAXBUYRKI-UHFFFAOYSA-N
53480866;LPAR1;6;1.835e-42;0.5179;7.9288;74.4802;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;WCSDULLQTPYJFU-UHFFFAOYSA-N
3421919;PAPA1_CARPA;7;5.967e-80;0.4364;8.852;141.7827;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
52922827;FABP3;7;1.8899999999999997e-48;0.6032;1.5929;85.229;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)([O-])OCC[N+](C)(C)C;VMDDNEGQBQWKEU-UHFFFAOYSA-N
5283496;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;FHQVHHIBKUMWTI-UHFFFAOYSA-N
435728;CYSP_TRYCR;7;2.895e-80;0.4821;19.5301;142.3467;CYSP_TRYCR;Cruzipain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
6351946;CAPN1;6;2.5000000000000003e-65;0.449;37.7877;115.5312;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
52924436;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JNMLRFRSKRFHKL-UHFFFAOYSA-N
9797038;MC1R;6;4.123e-116;0.4648;59.0621;206.7024;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
6992643;CPA1;6;1.017e-103;0.5135;12.9077;184.4545;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
10029397;LPAR3;6;7.92e-69;0.75;10.4938;121.8134;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)O;HFJVKBVEKQHVTO-UHFFFAOYSA-N
131759435;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGFTVBFRGRHBJX-UHFFFAOYSA-N
96814;GRIA1;6;2.525e-53;0.4;11.7693;93.9798;GRIA1;Glutamate receptor 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131753413;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;FSNNOULJUSMJGI-UHFFFAOYSA-N
53480857;FABP3;7;1.8069999999999999e-44;0.4923;1.4598;78.0827;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HHQFKPJXVYWLLJ-UHFFFAOYSA-N
168058;FURIN;6;1.095e-65;0.6596;12.0201;116.1747;FURIN;Furin (pKi >= 6);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
53480018;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;LYQNHUUXGYHXPH-UHFFFAOYSA-N
7009650;MC1R;6;5.108000000000001e-131;0.6528;66.662;233.465;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
52926071;FABP3;7;6.683e-51;0.614;1.6748;89.6301;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCCCC;SYAYTZJXUCQTMJ-UHFFFAOYSA-N
53480845;LPAR3;6;1.111e-95;0.5893;14.6233;170.0231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;IMGJLLXZPUDFFN-UHFFFAOYSA-N
19816755;ERAP2;6;1.2749999999999999e-53;0.4675;1.7657;94.5127;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
18218238;MC4R;6;1.6660000000000003e-58;0.4348;86.4389;103.2804;MC4R;Melanocortin receptor 4 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
14767562;HLA-DRB1;6;6.31e-71;0.411;6.9747;125.5812;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
131759242;LPAR1;6;4.061e-42;0.5294;7.8635;73.8606;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;OYGBKABOKBWAOA-UHFFFAOYSA-N
53479566;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;CUUIBVDVVFLYGA-UHFFFAOYSA-N
52924152;LPAR3;6;5.045e-105;0.6415;16.0601;186.7965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;BSVQKPRGDPWRBO-UHFFFAOYSA-N
53480017;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;HNZTVXMGKFBWNB-UHFFFAOYSA-N
7010580;C3AR1;6;1.8369999999999999e-59;0.4603;9.8395;104.9996;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
193508;YARS;6;3.723e-91;0.5455;5.2996;161.899;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
52924774;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XJLGATDALCZXFX-UHFFFAOYSA-N
53479720;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DVFTWBPPIMYUEN-UHFFFAOYSA-N
53478133;LPAR3;6;6.297e-70;0.56;10.6629;123.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCCCCC;RTZSIOQKPJZTKI-UHFFFAOYSA-N
6992643;CTSC;6;3.705e-59;0.5854;9.1063;104.4525;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
52925701;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;RGLIERIRKNERBJ-UHFFFAOYSA-N
53478598;PRKCA;7;8.422e-45;1.0;25.3277;78.6778;PRKCA;Protein kinase C alpha type (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SOWAPPIVBQCDGN-UHFFFAOYSA-N
3421919;MMP1;6;2.037e-45;0.4902;57.2221;79.7844;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
53479569;LPAR1;6;1.1110000000000002e-46;0.6275;8.7267;82.0528;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;IPBXKYJWPCRPLD-UHFFFAOYSA-N
9856500;CAPN2;6;4.153e-105;0.4074;30.5796;186.9483;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
131755900;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GEPOGMMCAWOWOH-UHFFFAOYSA-N
52924564;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VPDGQGZVNVFJGD-UHFFFAOYSA-N
131753767;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UUHNNGQNNNMIKK-UHFFFAOYSA-N
52924216;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OONVIPGPMOPRTM-UHFFFAOYSA-N
13817313;ACE2;7;2.895e-70;0.4043;8.719;124.3934;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
131760510;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MGEAAPQRAKZVAR-UHFFFAOYSA-N
259327;CAPNS1;6;1.7060000000000002e-72;0.451;4.9696;128.3962;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
53479772;LPAR3;6;1.609e-88;0.5;13.5221;157.1669;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;GOKCOIYNLBLTCL-UHFFFAOYSA-N
11736661;ACE;6;1.6809999999999998e-67;0.6667;67.0658;119.4314;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CCC(=O)N)N)C(=O)O;NJMYZEJORPYOTO-UHFFFAOYSA-N
53478008;PRKCA;7;8.422e-45;1.0;25.3277;78.6778;PRKCA;Protein kinase C alpha type (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCCCC;DICYCLUXEYFAQX-UHFFFAOYSA-N
52924778;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XNZHFYSLNIZKJP-UHFFFAOYSA-N
131754979;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;VYWMIHTWENZSSH-UHFFFAOYSA-N
9856500;CAPN1;6;2.024e-83;0.5111;48.287;148.0117;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
53480975;FABP3;7;1.275e-48;0.4615;1.5986;85.5357;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(CO)O;ARCRKLOZHGPFFJ-UHFFFAOYSA-N
150964;LAP3;6;1.2719999999999998e-66;0.4444;7.6263;117.8531;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
52924223;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QHNWICFFSBJICC-UHFFFAOYSA-N
101227804;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FSTOZAMDIJDRCH-UHFFFAOYSA-N
52924594;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JIEASZUPMDFVLW-UHFFFAOYSA-N
4466134;NPR;6;2.222e-116;0.4746;16.8069;207.1842;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
52924614;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;AYXGHIQPMDYMJC-UHFFFAOYSA-N
53479716;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;UAPYZCDNFGJZSC-UHFFFAOYSA-N
96814;XIAP;6;2.222e-48;0.5849;19.7741;85.1025;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
19816755;CAPN1;6;3.628e-44;0.4853;25.5067;77.5392;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
7009555;OPRD1;6;6.147e-95;0.5192;225.3224;168.6893;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
131760631;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NRVWPUNQTJDNID-UHFFFAOYSA-N
47579;AMP1_PLAFQ;6;1.3359999999999998e-66;0.4545;8.5079;117.8152;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
6993120;AMP1_PLAFQ;6;7.300000000000001e-60;0.5909;7.6391;105.7191;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131754085;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;STLRCTZSDOQPTC-UHFFFAOYSA-N
4657542;CAPN1;6;1.1240000000000002e-109;0.5676;63.5239;195.1484;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5283853;SLC10A1;6;1.5570000000000002e-46;0.4286;1.8507;81.7896;SLC10A1;Sodium/bile acid cotransporter (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C;DKPMWHFRUGMUKF-UHFFFAOYSA-N
53479972;LPAR3;6;3.06e-87;0.5;13.3254;154.8707;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DHZUMZVZAZYQIW-UHFFFAOYSA-N
14409732;ACE;6;3.591e-92;0.6212;91.5683;163.7224;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
7010506;LAP3;6;3.951e-79;0.5;9.0721;140.3088;LAP3;Cytosol aminopeptidase (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
273262;HLA-A;6;2.9680000000000004e-104;0.45;16.1177;185.4148;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
454064;EST1_PIG;7;7.388999999999999e-67;0.4483;4.4087;118.2768;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
131753543;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UOGFRTWKEGEEJU-UHFFFAOYSA-N
13932172;PLA2G4B;6;1.048e-61;0.5714;5.391;109.0278;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
131753905;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WGTADRBQBBKAGF-UHFFFAOYSA-N
6992643;MMP1;6;1.065e-44;0.4898;56.3202;78.4948;MMP1;Interstitial collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
131759262;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPLCXIXCJSJOOR-UHFFFAOYSA-N
19816750;YARS;6;4.594e-113;0.587;6.5838;201.232;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
7009598;CTSL;6;3.1719999999999997e-68;0.4792;52.4179;120.7315;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
342468;FPR1;6;4.608e-89;0.4706;16.8789;158.1421;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
131754934;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;POAVLZRSJOCQEL-UHFFFAOYSA-N
52924786;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;BRZHNCZGBULDIZ-UHFFFAOYSA-N
69421;LPAR3;6;1.0399999999999999e-45;0.4;6.9386;80.3085;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
131753305;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RVRHSALQSYBGAG-UHFFFAOYSA-N
102763;MMP8;9;8.048000000000001e-46;0.4833;9.4459;80.5086;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
7009598;YARS;6;8.634000000000001e-71;0.4783;4.1059;125.3367;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
3634442;C3AR1;6;4.804e-48;0.5405;7.9318;84.5015;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
96814;C3AR1;6;2.052e-54;0.4333;8.996;95.9369;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
53479670;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;PTTOPPWTEHEDTA-UHFFFAOYSA-N
111299;C3AR1;6;1.871e-55;0.4219;9.1698;97.804;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
193508;CTSL;6;1.358e-66;0.449;51.1627;117.8026;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
111299;ANPEP;8;1.219e-129;0.5;17.5836;230.9918;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
131760510;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MGEAAPQRAKZVAR-UHFFFAOYSA-N
515709;CPA1;6;9.627999999999999e-93;0.5682;11.5334;164.7487;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
131802010;FABP3;7;1.298e-56;0.5641;1.8657;99.8842;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;ODIFDYMVTZMQLS-UHFFFAOYSA-N
7010580;MME;6;4.165e-239;0.6;204.6535;427.5186;MME;Neprilysin (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
47579;CAPNS1;6;7.347e-74;0.4314;5.0641;130.8486;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
10458;FABP3;7;5.073e-44;0.5217;1.4448;77.2777;FABP3;Fatty acid-binding protein, heart (pKi >= 7);C(CCCCCC(=O)O)CCCCCC(=O)O;DXNCZXXFRKPEPY-UHFFFAOYSA-N
273262;OPRM1;6;7.922e-111;0.6071;319.3871;197.2165;OPRM1;Mu-type opioid receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7010580;PGA;6;2.2889999999999998e-51;0.4262;11.6897;90.4655;PGA;Pepsin A (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53480975;LPAR3;6;2.946e-60;0.6591;9.1758;106.4267;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OCC(CO)O;ARCRKLOZHGPFFJ-UHFFFAOYSA-N
52925127;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;LJVXDBWIBQQKFU-UHFFFAOYSA-N
318292;CCKAR;6;1.4300000000000002e-144;0.5758;143.0387;257.7971;CCKAR;Cholecystokinin receptor type A (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
17525;CQSS;6;3.475e-65;0.4062;1.907;115.2744;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
323786;EDNRB;9;2.511e-65;0.4714;6.2805;115.5277;EDNRB;Endothelin B receptor (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
131801745;LPAR1;6;3.74e-46;0.7381;8.6269;81.1061;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;SFMJHWFZJBATQB-UHFFFAOYSA-N
131758645;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;FSTDLLFKLQLNCY-UHFFFAOYSA-N
150964;CAPN2;6;2.842e-116;0.551;33.8415;206.9924;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
92946;LAP3;6;1.4499999999999998e-54;0.4894;6.2327;96.2074;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
24779556;LPAR3;6;1.976e-56;0.6939;8.5874;99.5567;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O)OC(=O)CCCCCCCCCCCCCCC;IBUKXRINTKQBRQ-UHFFFAOYSA-N
53478597;FABP3;7;4.9e-53;0.4815;1.7462;93.4627;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;YUFFMVIZZQIBPN-UHFFFAOYSA-N
53479660;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ANVMSBIGOHYJFD-UHFFFAOYSA-N
70694;LPAR3;6;1.3539999999999999e-53;0.4474;8.1513;94.4657;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
152198;BLA1_STEMA;6;1.0710000000000001e-85;0.4098;7.7011;152.0988;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
10445608;CTSC;6;8.197e-68;0.5952;10.4519;119.9913;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
92829;PAPA1_CARPA;6;1.8349999999999999e-41;0.4038;6.2156;72.6848;PAPA1_CARPA;Papain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
131801883;LPAR1;6;1.479e-41;0.6889;7.7573;72.8527;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;RESRNMIXCOXYHQ-UHFFFAOYSA-N
7010580;PAPA1_CARPA;7;1.299e-86;0.4286;9.5956;153.7431;PAPA1_CARPA;Papain (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
52925140;LPAR1;6;1.561e-48;0.7059;9.077;85.3779;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;QJHRNPQXCMXOOH-UHFFFAOYSA-N
9797038;ERAP2;6;6.0769999999999995e-59;0.5286;1.9436;104.0667;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
7020642;DPP7;8;2.94e-74;0.4407;10.3012;131.5626;DPP7;Dipeptidyl peptidase 2 (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
96814;ANPEP;6;2.691e-150;0.6364;52.8868;268.0758;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131755167;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NJWLXJXDVKOEOP-UHFFFAOYSA-N
53477997;FABP3;7;3.438e-52;0.4783;1.7179;91.9436;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QSZQNXRKRGRBGH-UHFFFAOYSA-N
6992341;NOD1;9;1.6140000000000001e-71;0.4043;5.0812;126.6443;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CCCCN)N;YQAIUOWPSUOINN-UHFFFAOYSA-N
9797038;HLA-A;6;1.351e-53;0.4028;8.2416;94.4673;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
5366147;CQSS;6;1.0970000000000001e-72;0.4444;2.1292;128.7406;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCC(=CC)C;LKWKOLGLWOJMQP-UHFFFAOYSA-N
5282761;OXER1;6;1.759e-43;0.5833;3.5849;76.3083;OXER1;Oxoeicosanoid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
131754749;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DCEIEGPNDFHINJ-UHFFFAOYSA-N
10634;CYP17A1;6;1.087e-86;0.75;38.8573;153.8824;CYP17A1;Steroid 17-alpha-hydroxylase/17,20 lyase (pKi >= 6);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
323786;MC5R;7;6.11e-86;0.4487;21.3767;152.5361;MC5R;Melanocortin receptor 5 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7359122;ECE1;6;6.461e-59;0.4375;25.4273;104.019;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
131753717;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZMOOAMBHOJSHY-UHFFFAOYSA-N
18218238;TACR1;6;5.864e-41;0.6769;70.9149;71.7789;TACR1;Substance-P receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
18218222;HLA-A;6;1.989e-89;0.45;13.8125;158.797;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(C(C)O)C(=O)O)N;LRKCBIUDWAXNEG-UHFFFAOYSA-N
12366;EST1_PIG;7;7.052e-67;0.4483;4.4101;118.3133;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
52924174;FABP3;7;6.659e-53;0.6491;1.7417;93.2235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZHZTYDTVUSPVLX-UHFFFAOYSA-N
6992304;PAPA1_CARPA;6;6.637e-49;0.4318;7.3473;86.0448;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
131758865;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;WUUWBWLVYRBSQT-UHFFFAOYSA-N
12530;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
151134;ECE1;6;2.638e-65;0.449;28.1998;115.4893;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
53479906;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;OJCHOVMLEHFBOD-UHFFFAOYSA-N
4656408;MME;6;2.047e-63;0.5962;54.2472;112.0966;MME;Neprilysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
9546749;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;YDTWOEYVDRKKCR-UHFFFAOYSA-N
17863274;FPR1;8;3.148e-41;0.4035;1.4972;72.2638;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CCC(C)C(C(=O)NC(CCSC)C(=O)O)N;TUYOFUHICRWDGA-UHFFFAOYSA-N
7010566;CTSC;6;1.149e-51;0.5333;7.9415;91.0027;CTSC;Dipeptidyl peptidase 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
52924554;LPAR3;6;1.471e-106;0.6538;16.2962;189.5529;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;BUCLJVJCFFPNPB-UHFFFAOYSA-N
6438186;LPAR3;6;6.34e-73;0.6279;11.1238;129.1682;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)CO;TZDOBCZHGBGJLS-UHFFFAOYSA-N
53479862;LPAR1;6;4.746e-45;0.5714;8.4182;79.1251;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;YHKHZYNNNXVJRS-UHFFFAOYSA-N
7010506;CYSP_TRYCR;7;1.792e-82;0.4407;20.0707;146.3113;CYSP_TRYCR;Cruzipain (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
92829;ACE;6;3.192e-64;0.6047;63.8097;113.5454;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
52924787;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;QISXRGLAZUIPCG-UHFFFAOYSA-N
53480992;FABP3;7;4.2039999999999997e-54;0.5366;1.7818;95.3774;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(CO)O;UDZUDFKFJCAENZ-UHFFFAOYSA-N
10029397;ENPP2;6;8.773e-42;0.6522;6.1221;73.26;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)O;HFJVKBVEKQHVTO-UHFFFAOYSA-N
171204;NTSR1;6;1.012e-71;0.4211;17.3426;127.0084;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
7010566;LAP3;6;1.351e-77;0.46;8.8948;137.5549;LAP3;Cytosol aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
131801706;LPAR3;6;3.449e-87;0.7045;13.3174;154.7773;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;TUHWKCBRUXQIHQ-UHFFFAOYSA-N
24778627;FABP3;7;1.635e-50;0.629;1.6618;88.9325;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SZQBOFQJPDNGHN-UHFFFAOYSA-N
52925701;FABP3;7;1.441e-52;0.5833;1.7305;92.6215;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;RGLIERIRKNERBJ-UHFFFAOYSA-N
52924238;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;XUUQFFVLEYTYES-UHFFFAOYSA-N
111299;SLC1A1;6;5.5190000000000005e-65;0.475;4.6123;114.9138;SLC1A1;Excitatory amino acid transporter 3 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
151134;FPR1;6;8.034999999999999e-88;0.4694;16.6422;155.9132;FPR1;fMet-Leu-Phe receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
131754192;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OGNCECWXMXWFGY-UHFFFAOYSA-N
52924721;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;ZNMZYHOEYPCVMP-UHFFFAOYSA-N
131759908;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PIYNNEKPAVFCLZ-UHFFFAOYSA-N
19816750;ACE2;6;2.201e-89;0.4706;12.5749;158.718;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151003;TRY1_BOVIN;8;6.233e-64;0.4267;13.13;113.0235;TRY1_BOVIN;Cationic trypsin (pKi >= 8);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
102763;NMBR;6;2.821e-44;0.5088;7.0132;77.7353;NMBR;Neuromedin-B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
131755479;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MBOXBOYLRVJTGJ-UHFFFAOYSA-N
53479756;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PYFNLOPDTZXGTN-UHFFFAOYSA-N
9797038;NPR;8;6.695e-80;0.6545;4.6399;141.6929;NPR;Thermolysin (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
3421919;CAPN1;6;9.55e-123;0.619;71.1094;218.6147;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
111299;CAPNS1;6;2.083e-70;0.4286;4.8251;124.6502;CAPNS1;Calpain small subunit 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
14409732;MC3R;6;4.334e-61;0.4225;29.9278;107.921;MC3R;Melanocortin receptor 3 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
5488196;AMP1_PLAFQ;6;6.934999999999999e-66;0.5111;8.4156;116.5311;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
168182;MC1R;6;3.034e-118;0.4853;60.1496;210.5321;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
131755191;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QJRAIXUZRUZYSD-UHFFFAOYSA-N
7009598;ECE1;6;1.087e-89;0.5455;38.7814;159.2681;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
9797038;ACE;6;5.241e-69;0.7059;68.5617;122.1353;ACE;Angiotensin-converting enzyme (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
47579;OPRD1;6;4.203e-44;0.4182;105.4025;77.4244;OPRD1;Delta-type opioid receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
89566;ENPP2;6;1.282e-56;0.8462;8.3272;99.8938;ENPP2;Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;YNDYKPRNFWPPFU-UHFFFAOYSA-N
273262;CYSP_TRYCR;7;1.454e-61;0.4483;14.952;108.7724;CYSP_TRYCR;Cruzipain (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
9546726;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LYJWNHGFGVVCAO-UHFFFAOYSA-N
9797038;GRPR;8;1.382e-84;0.4217;6.8329;150.1045;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
13783081;ECE1;6;6.28e-125;0.6364;54.0728;222.5322;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
6993039;HLA-A;6;5.251e-45;0.5;6.9061;79.0462;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(CCSC)C(=O)O)N;YSGSDAIMSCVPHG-UHFFFAOYSA-N
131753464;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOVZBEYRPDKHAL-UHFFFAOYSA-N
53478054;LPAR3;6;1.7899999999999999e-62;0.5385;9.5166;110.4055;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LTTZSZYLXABAOL-UHFFFAOYSA-N
131753682;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XOUODEXYIDULFE-UHFFFAOYSA-N
3081383;GPR17;7;4.096e-64;0.4257;1.8752;113.3509;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 7);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
20057357;SELP;6;2.146e-82;0.7692;6.4609;146.1705;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)O;WBOZIXHPUPAOIA-UHFFFAOYSA-N
151410;LAP3;6;5.123e-80;0.48;9.1746;141.9016;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
53480140;LPAR3;6;4.4e-89;0.5556;13.6087;158.1781;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;XDPWHDYPIVOSGA-UHFFFAOYSA-N
18218182;CAPN1;6;1.731e-65;0.4889;37.8803;115.8178;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
25200879;MPO;7;9.029e-44;0.434;4.4607;76.8283;MPO;Myeloperoxidase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
3634442;CCKBR;6;4.704e-112;0.6061;113.5262;199.4184;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
131754666;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;PBXBPMVNZAGNPS-UHFFFAOYSA-N
131761617;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;YSTMVIOAKCDXEL-UHFFFAOYSA-N
131753741;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MFFDRCAJUNCFIE-UHFFFAOYSA-N
131753806;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUCYHIOFVUWJDD-UHFFFAOYSA-N
193508;PAPA1_CARPA;7;6.034e-73;0.4074;8.0701;129.2068;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
74328989;FIMH;6;6.653999999999999e-94;0.4444;12.0286;166.8321;FIMH;FimH (pKi >= 6);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
5312554;PLA2G4B;6;1.048e-61;0.5714;5.391;109.0278;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
323786;CCKBR;6;8.554e-110;0.5606;111.2374;195.3614;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
111299;CAPN1;6;1.1169999999999999e-89;0.5952;51.9188;159.2469;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
94235;CA4;6;8.386e-45;0.527;51.0346;78.6812;CA4;Carbonic anhydrase 4 (pKi >= 6);CC(CCC(=O)O)C1CCC2C1(C(=O)CC3C2C(CC4C3(CCC(C4)O)C)O)C;MIHNUBCEFJLAGN-UHFFFAOYSA-N
329275;CCKBR;6;5.679e-111;0.5362;112.4305;197.4762;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
92946;ACE2;6;4.343e-117;0.6512;16.4991;208.4572;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
96814;CAPN1;6;5.0520000000000005e-160;0.7778;92.7424;285.538;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
9948926;EDNRB;9;1.424e-67;0.5075;6.4987;119.5606;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
131760624;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;QBTDCDJQWFFVGF-UHFFFAOYSA-N
92946;HLA-A;6;1.767e-77;0.4821;11.9548;137.3457;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
53479784;LPAR1;6;4.4860000000000005e-46;0.5254;8.612;80.9643;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CWPKVJPBYGQUHE-UHFFFAOYSA-N
18218182;FPR1;6;3.306e-66;0.4565;12.5207;117.1087;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
131750653;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFUGNQFGFOCTMS-UHFFFAOYSA-N
131755131;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RXJPMHUSUSIBKN-UHFFFAOYSA-N
263475;MME;6;2.494e-80;0.6;68.7271;142.4628;MME;Neprilysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
318292;TACR1;6;4.906e-47;0.5345;81.3492;82.6898;TACR1;Substance-P receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
47579;MMP3;6;4.899e-44;0.4444;51.6343;77.3051;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
3421919;YARS;6;1.012e-115;0.6905;6.7395;206.0021;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131759891;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WWCDEFDAYUEHDA-UHFFFAOYSA-N
66066;SHBG;9;3.3629999999999995e-53;0.6087;3.4982;93.7561;SHBG;Sex hormone-binding globulin (pKi >= 9);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
131754572;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YJVSUEAKVIVQIZ-UHFFFAOYSA-N
7010506;C3AR1;6;5.369999999999999e-69;0.5;11.4325;122.1164;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
92946;CTSL;6;1.244e-44;0.4423;34.2648;78.3736;CTSL;Cathepsin L1 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
52925130;LPAR1;6;1.561e-48;0.7059;9.077;85.3779;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;DBHKHNGBVGWQJE-UHFFFAOYSA-N
318292;GRPR;6;7.333000000000001e-84;0.4051;10.2634;148.8032;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
53479914;FABP3;7;4.2749999999999997e-51;0.6271;1.6813;89.9785;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;NCWMYSRFLUIVBC-UHFFFAOYSA-N
53478164;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QSEJQXZIIUGBTF-UHFFFAOYSA-N
96814;PAPA1_CARPA;6;3.391e-96;0.4773;14.5394;170.9484;PAPA1_CARPA;Papain (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
131753860;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QPPIYNYVDUYVQL-UHFFFAOYSA-N
9546742;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;JQKOHRZNEOQNJE-UHFFFAOYSA-N
329275;EDNRA;6;5.297e-70;0.5938;104.2311;123.9223;EDNRA;Endothelin-1 receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
263475;NPR;8;2.835e-70;0.5636;4.0756;124.4096;NPR;Thermolysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
53479726;LPAR3;6;1.356e-100;0.5536;15.3789;178.8442;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;RZGFDECXQULSLM-UHFFFAOYSA-N
150964;PAPA1_CARPA;7;1.355e-77;0.4384;8.589;137.5525;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
18986;HTR1D;6;6.967e-70;0.641;70.2632;123.7087;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
52924370;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DPTUTWFSXXDMEO-UHFFFAOYSA-N
53479554;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RETPVUGMYRRYPF-UHFFFAOYSA-N
6992563;FURIN;6;4.692e-42;0.7317;7.6591;73.748;FURIN;Furin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
9856500;NAALAD2;6;6.302e-72;0.5128;4.1725;127.3776;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
52924878;FABP3;7;5.5349999999999996e-52;0.6379;1.711;91.5724;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CIXWKDHTFXYVTC-UHFFFAOYSA-N
131750486;LPAR1;6;4.63e-44;0.541;8.2311;77.349;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;IQIUZAVCJONSBD-UHFFFAOYSA-N
5282761;FABP3;7;8.263e-78;1.0;2.5743;137.9383;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
193508;BLA1_STEMA;6;2.382e-86;0.4151;7.7602;153.2706;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
4305457;FPR1;6;9.247e-52;0.4082;9.766;91.1722;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
131755020;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SHZPWJWHCSZOEX-UHFFFAOYSA-N
100094;MMP11;6;1.129e-123;0.473;12.471;220.2793;MMP11;Stromelysin-3 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
131750646;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NVBSJAZGISYRIW-UHFFFAOYSA-N
168182;CCKBR;6;7.339e-113;0.5;114.3433;200.8668;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
329275;ACE;6;1.532e-68;0.7347;68.099;121.2988;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
7009598;CAPN1;6;2.9330000000000003e-124;0.6667;71.9873;221.3305;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;FPR1;6;1.65e-92;0.623;17.536;164.3288;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
131802041;FABP3;7;3.0870000000000003e-57;0.5366;1.8866;101.0042;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;WGCCNBRJWHJBEZ-UHFFFAOYSA-N
515709;ECE1;6;1.834e-94;0.5435;40.8526;167.8369;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
52924774;LPAR1;6;5.594e-48;0.6038;8.9722;84.3828;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XJLGATDALCZXFX-UHFFFAOYSA-N
52925701;LPAR1;6;4.647999999999999e-47;0.5926;8.7982;82.7319;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;RGLIERIRKNERBJ-UHFFFAOYSA-N
4657542;ACE;6;1.1970000000000002e-128;0.5714;127.7972;229.2103;ACE;Angiotensin-converting enzyme (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
273262;SORT1;6;3.821e-58;0.4096;3.976;102.6333;SORT1;Sortilin (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
131753682;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XOUODEXYIDULFE-UHFFFAOYSA-N
19421321;MME;6;6.035000000000001e-124;0.5;106.0662;220.7679;MME;Neprilysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
5312378;PLA2G4B;6;7.041e-47;0.5294;4.0811;82.4081;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
131758602;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QGSFHGSYPKDCBO-UHFFFAOYSA-N
3038501;MMP8;9;5.2809999999999996e-45;0.4688;9.2755;79.0417;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
131753717;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZMOOAMBHOJSHY-UHFFFAOYSA-N
323786;GRPR;6;7.941999999999999e-110;0.4375;13.4653;195.4192;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
52924549;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;UBTNBSZLGQJLPI-UHFFFAOYSA-N
131754431;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HVMWRSISSYXDSD-UHFFFAOYSA-N
52922883;LPAR3;6;1.952e-58;0.5082;8.8957;103.1567;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)([O-])OCC[N+](C)(C)C;LFNLJXLPGIASGV-UHFFFAOYSA-N
9546835;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;VDNXNFMAFDYQSI-UHFFFAOYSA-N
5282942;FABP3;7;4.203e-56;0.697;1.8487;98.9683;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC(CC=CCCCCCCCC(=O)O)O;WBHHMMIMDMUBKC-UHFFFAOYSA-N
7010580;AMP1_PLAFQ;6;2.2360000000000003e-55;0.6136;7.0606;97.6652;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
53479575;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LKUKJIYAXQFZTD-UHFFFAOYSA-N
221122;NPC1L1;6;1.794e-43;0.4853;3.175;76.2929;NPC1L1;Niemann-Pick C1-like 1 protein (pKi >= 6);CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C;QYIXCDOBOSTCEI-UHFFFAOYSA-N
11010621;HDAC11;7;3.008e-50;0.4667;7.8051;88.4571;HDAC11;Histone deacetylase 11 (pKi >= 7);C1CC(=O)NC1C(=O)NC(CCC(=O)N)C(=O)O;ILAITOFTZJRIFJ-UHFFFAOYSA-N
53480982;LPAR3;6;2.217e-82;0.6977;12.578;146.1452;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)O;HPTOSMWVVSKAGZ-UHFFFAOYSA-N
53480847;LPAR3;6;9.267e-76;0.5323;11.5598;134.2582;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YITZQGLIICATLN-UHFFFAOYSA-N
53479914;LPAR3;6;3.147e-100;0.5965;15.3227;178.1878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;NCWMYSRFLUIVBC-UHFFFAOYSA-N
7010580;CAPN1;6;3.415e-144;0.8108;83.5557;257.1183;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
12599;P2RY2;7;5.0660000000000006e-55;0.7222;7.3158;97.0273;P2RY2;P2Y purinoceptor 2 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
7010566;YARS;6;1.433e-90;0.5;5.2653;160.848;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
53479861;LPAR3;6;4.603999999999999e-103;0.6182;15.7586;183.2772;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;RHBZSPYYUTVJHJ-UHFFFAOYSA-N
151410;MMP3;6;6.699e-54;0.5;63.1711;95.0142;MMP3;Stromelysin-1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
131755752;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SAZSVOQHSUNCSC-UHFFFAOYSA-N
131755728;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;PODGNDQRHPDVSY-UHFFFAOYSA-N
131801999;FABP3;7;5.83e-58;0.5789;1.9108;102.3038;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;WZWSISJCYNBNPX-UHFFFAOYSA-N
25200879;GRIA1;7;2.511e-49;0.5231;7.2434;86.8028;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
131754525;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QZSQJRGOJCTPHI-UHFFFAOYSA-N
52924324;LPAR3;6;2.4939999999999997e-67;0.7391;10.2634;119.1238;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC;CBJZKZNOFISZSC-UHFFFAOYSA-N
6993120;ACE2;6;1.492e-141;0.6047;19.9642;252.3777;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
131758937;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PHSOZYZQNQNQAK-UHFFFAOYSA-N
53479862;FABP3;7;2.602e-52;0.6167;1.7219;92.1609;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;YHKHZYNNNXVJRS-UHFFFAOYSA-N
7010566;OPRD1;6;3.106e-86;0.5156;204.7908;153.0637;OPRD1;Delta-type opioid receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;YARS;6;7.447e-66;0.4231;3.8166;116.4754;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
131759434;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FVASQEUWMANRGF-UHFFFAOYSA-N
6992643;ACE2;6;2.3320000000000003e-123;0.5;17.3872;219.714;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
263471;ECE1;6;4.749e-70;0.5185;30.2587;124.0075;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
6992643;MME;6;3.04e-221;0.6579;189.3611;395.4484;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
14409732;OPRM1;6;5.478000000000001e-56;0.5915;162.3945;98.7617;OPRM1;Mu-type opioid receptor (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
7800;LPAR3;6;2.1619999999999997e-53;0.5;8.12;94.1007;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
273262;NTSR1;6;1.316e-135;0.5;32.8963;241.7036;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
137938;CQSS;6;5.057e-72;0.4375;2.1095;127.5491;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(CO)CO;TVIMZSOUQXNWHO-UHFFFAOYSA-N
4427709;CAPN2;6;7.948e-90;0.5;26.1149;159.5124;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
53478121;LPAR3;6;3.33e-60;0.5283;9.1676;106.3311;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;OGEVDGPPHTZMPM-UHFFFAOYSA-N
6992304;NPR;6;5.486e-44;0.4375;6.2982;77.2167;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
131753659;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DQXQIWIQYYEGLG-UHFFFAOYSA-N
131753666;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KRVDGBILMBJWGW-UHFFFAOYSA-N
7800;CES2;7;3.9539999999999995e-51;0.4483;2.9535;90.0394;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
131754335;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NAFMESDUMVNTKX-UHFFFAOYSA-N
329275;ERAP2;6;1.647e-62;0.5522;2.0628;110.4706;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
53479728;LPAR1;6;2.3819999999999998e-45;0.5536;8.4748;79.6627;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;OHBRNOPVIZLBBE-UHFFFAOYSA-N
131758799;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RYWWBXHDEGSCOG-UHFFFAOYSA-N
329275;CAPNS1;6;2.3739999999999997e-67;0.4286;4.6134;119.1622;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9543841;FABP3;7;3.532e-54;0.5;1.7843;95.5133;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NSVJKGBXOPSAKL-UHFFFAOYSA-N
14282475;CAPN1;6;4.31e-58;0.4138;33.588;102.5393;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7010506;ACE;6;1.3369999999999999e-105;0.6957;104.906;187.8319;ACE;Angiotensin-converting enzyme (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
150964;NPR;6;1.214e-76;0.4219;11.0385;135.8427;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
131801898;LPAR3;6;5.836e-92;0.7381;14.0512;163.3438;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;IKSWSKJAXUGKHC-UHFFFAOYSA-N
131759294;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XYKBFKVMVVJQIJ-UHFFFAOYSA-N
9546836;LPAR1;6;2.249e-47;0.64;8.8579;83.298;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XMJSNHMFTISTET-UHFFFAOYSA-N
193508;ACE;6;2.794e-111;0.619;110.5474;198.0293;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
131755773;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;HFPMGYAXBUYRKI-UHFFFAOYSA-N
52922827;LPAR3;6;1.709e-45;0.4839;6.9055;79.9215;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)([O-])OCC[N+](C)(C)C;VMDDNEGQBQWKEU-UHFFFAOYSA-N
7009555;ACE2;6;6.333e-111;0.6222;15.626;197.3911;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
19816755;EDNRA;6;4.501e-54;0.5758;80.5977;95.3242;EDNRA;Endothelin-1 receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
52925456;LPAR3;6;4.4800000000000003e-97;0.6071;14.8377;172.5265;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;QFGBUBRLCJWGHL-UHFFFAOYSA-N
53480994;FABP3;7;3.402e-49;0.5366;1.6178;86.5658;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(CO)O;IDSLCYURGAOTOA-UHFFFAOYSA-N
435728;HLA-A;6;1.57e-80;0.5424;12.4293;142.8238;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
11579826;LTA4H;6;2.857e-43;0.4314;23.7318;75.9302;LTA4H;Leukotriene A-4 hydrolase (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
9546800;LPAR3;6;1.697e-101;0.6071;15.5177;180.4649;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DRIVXEVMDWCWLI-UHFFFAOYSA-N
13890535;CTSL;6;1.858e-61;0.4783;47.2108;108.5815;CTSL;Cathepsin L1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
189008;CAPNS1;6;2.07e-59;0.4032;4.0637;104.9065;CAPNS1;Calpain small subunit 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
131801778;LPAR3;6;5.143e-52;0.617;7.9084;91.6297;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)O;RRALAGZOUWRTFP-UHFFFAOYSA-N
7021820;TMPRSS6;8;1.7510000000000001e-56;0.411;2.4364;99.6512;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
134906;ECE1;6;3.894e-129;0.7551;55.8987;230.0861;ECE1;Endothelin-converting enzyme 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
263475;MC1R;6;8.487e-112;0.5152;56.8629;198.9582;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
13783081;CTSL;7;3.0669999999999995e-53;0.5;24.7448;93.8281;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
53479631;FABP3;7;2.3009999999999998e-51;0.6852;1.6903;90.4615;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;UKRAYYYOKQQQKZ-UHFFFAOYSA-N
25200879;CCKBR;6;2.007e-115;0.4848;116.9393;205.4684;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
3421919;ACE2;6;3.499e-136;0.5682;19.2036;242.7367;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
131755759;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;XBEBXEQYPIBWCY-UHFFFAOYSA-N
515709;AMP1_PLAFQ;6;8.51e-47;0.5;5.9541;82.2604;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
759256;AMP1_PLAFQ;6;1.19e-50;0.4222;6.4512;89.1803;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
131753319;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JYQXYTFYWDKLPT-UHFFFAOYSA-N
100094;CCKBR;6;3.414e-106;0.5588;107.5901;188.8962;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
53480884;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DZPHTQGGRSWHLG-UHFFFAOYSA-N
13783081;EDNRB;9;1.775e-66;0.5143;6.3923;117.5935;EDNRB;Endothelin B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
25200879;ERAP2;6;1.61e-49;0.4306;1.6286;87.1492;ERAP2;Endoplasmic reticulum aminopeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
53480992;LPAR3;6;1.377e-75;0.6522;11.5333;133.9492;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(CO)O;UDZUDFKFJCAENZ-UHFFFAOYSA-N
5488196;OPRD1;6;4.387e-108;0.5957;256.3352;192.2915;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
97415;MME;6;1.065e-208;0.6053;178.6221;372.9272;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
111299;CPA1;6;1.504e-75;0.5;9.3806;133.8805;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
131755705;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FBJIMBUHNICHHH-UHFFFAOYSA-N
9797038;MC3R;6;2.4959999999999999e-82;0.4474;40.3804;146.0529;MC3R;Melanocortin receptor 3 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
61030;CES2;7;2.662e-50;0.4242;2.905;88.5526;CES2;Cocaine esterase (pKi >= 7);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
13890535;OPRD1;6;7.245e-47;0.4426;111.9217;82.3859;OPRD1;Delta-type opioid receptor (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
53480927;LPAR1;6;1.487e-41;0.4737;7.7569;72.8487;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COP(=O)(O)OCCN;QYXNIRQICOBIAE-UHFFFAOYSA-N
3634442;MC5R;8;6.967e-83;0.4805;12.2313;147.0478;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
131755892;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JPOLYQGYZVQSPO-UHFFFAOYSA-N
193508;RNPEP;6;6.226999999999999e-51;0.5333;2.5064;89.6852;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
18218238;MC1R;6;1.237e-103;0.4348;52.7009;184.3019;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
515709;NTSR1;6;4.7330000000000006e-102;0.4156;24.7268;181.4603;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
19816755;ACE2;8;2.75e-58;0.4098;6.3177;102.8895;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
5057430;CAPN2;6;1.674e-68;0.6512;19.8851;121.2298;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
92946;OPRD1;6;4.754e-103;0.54;244.4577;183.2522;OPRD1;Delta-type opioid receptor (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
131801859;FABP3;7;1.8259999999999998e-51;0.5122;1.6936;90.6417;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;CDTXMUFCBIHNCK-UHFFFAOYSA-N
6993120;MMP8;6;6.972e-41;0.4898;32.3918;71.644;MMP8;Neutrophil collagenase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
9543989;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SKGWNZXOCSYJQL-UHFFFAOYSA-N
131754979;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;VYWMIHTWENZSSH-UHFFFAOYSA-N
47579;NPPA;7;6.646e-41;0.4583;1.3406;71.6812;NPPA;Natriuretic peptides A (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
53479688;LPAR3;6;4.163e-94;0.5862;14.3813;167.1978;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DSZLDVIMYQKWGY-UHFFFAOYSA-N
53479908;FABP3;7;8.024e-49;0.5323;1.6053;85.8969;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PIRVOZHXFFFFFG-UHFFFAOYSA-N
53480914;FABP3;7;6.186e-48;0.5397;1.5756;84.3044;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PQEYJXRJLFZSPT-UHFFFAOYSA-N
5488196;ACE2;6;5.4250000000000005e-117;0.4565;16.4854;208.2837;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
6992563;NTSR1;6;4.4419999999999994e-88;0.5606;21.325;156.3754;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
131754309;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IMVXYPBBFJIVGK-UHFFFAOYSA-N
11646044;FABP3;7;3.9320000000000005e-55;0.5526;1.8162;97.2249;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)CO;BXAXVVVVPFELOK-UHFFFAOYSA-N
63842847;ACE;6;2.0069999999999998e-44;0.4915;44.1458;78.0007;ACE;Angiotensin-converting enzyme (pKi >= 6);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
6993120;ACE;7;7.46e-116;0.6154;92.5113;206.24;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ACE;7;1.0649999999999999e-113;0.5714;90.7896;202.3718;ACE;Angiotensin-converting enzyme (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;ACE;7;7.9650000000000005e-56;0.52;44.5441;98.4698;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;ACE;7;5.636e-55;0.5417;43.8651;96.9442;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
100094;ACE;7;2.951e-50;0.6538;40.0943;88.4721;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
6992304;ACE;7;2.494e-61;0.4419;48.9425;108.352;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;ACE;7;3.29e-49;0.5455;39.2574;86.592;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;ACE;7;1.567e-46;0.5294;37.1176;81.7843;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;ACE;7;5.038e-96;0.6757;76.6661;170.6398;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ACE;7;2.0840000000000003e-108;0.6;86.5612;192.8716;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;ACE;7;1.998e-98;0.4783;78.5851;174.9514;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;ACE;7;2.959e-89;0.6053;71.2572;158.4875;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ACE;7;1.732e-101;0.6316;81.0319;180.4488;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;ACE;7;2.492e-58;0.7347;46.5455;102.9665;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;ACE;7;6.446e-97;0.5581;77.3796;172.2428;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ACE;7;8.722e-62;0.6047;49.3071;109.171;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;ACE;7;4.102e-58;0.7059;46.3725;102.5778;ACE;Angiotensin-converting enzyme (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ACE;7;2.421e-64;0.7115;51.35;113.761;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;ACE;7;4.814e-55;0.6122;43.9198;97.0672;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;ACE;7;3.1519999999999998e-68;0.7115;54.4547;120.7364;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ACE;7;2.345e-107;0.6389;85.7213;190.9846;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
171204;ACE;7;1.977e-67;0.65;53.8176;119.305;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
11579826;ACE;7;6.068e-94;0.4444;75.0033;166.9041;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;ACE;7;7.788e-118;0.6122;94.0945;209.7971;ACE;Angiotensin-converting enzyme (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ACE;7;5.8690000000000005e-84;0.5532;67.0242;148.9769;ACE;Angiotensin-converting enzyme (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ACE;7;1.702e-62;0.75;49.874;110.4448;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;ACE;7;1.137e-62;0.6458;50.0141;110.7596;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;ACE;7;4.6039999999999994e-66;0.6042;52.7251;116.8503;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ACE;7;1.967e-67;0.6316;53.8193;119.3088;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7020642;ACE;7;7.479e-156;0.62;124.4733;278.0508;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
323786;ACE;7;3.2809999999999996e-53;0.6667;42.4547;93.7755;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;ACE;7;1.889e-68;0.6222;54.6324;121.1356;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ACE;7;2.4630000000000002e-85;0.5349;68.1246;151.4493;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;ACE;7;2.6310000000000003e-108;0.55;86.4804;192.6902;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ACE;7;1.445e-78;0.5227;62.7162;139.2979;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;ACE;7;2.438e-50;0.4833;40.1606;88.6211;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;ACE;7;6.621e-41;0.4821;32.6222;71.6842;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;ACE;7;2.0549999999999998e-94;0.6744;75.379;167.7482;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ACE;7;2.0549999999999998e-94;0.6744;75.379;167.7482;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
11736661;ACE;7;1.6800000000000002e-56;0.6667;45.0843;99.6835;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CCC(=O)N)N)C(=O)O;NJMYZEJORPYOTO-UHFFFAOYSA-N
152198;ACE;7;2.991e-57;0.5;45.6832;101.029;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;ACE;7;4.784e-135;0.6486;107.8479;240.6975;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
152322;ACE;7;2.291e-50;0.5417;40.1821;88.6696;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CN=CN2)N)C(=O)O;LNCFUHAPNTYMJB-UHFFFAOYSA-N
342468;ACE;7;4.2e-64;0.6531;51.1588;113.3314;ACE;Angiotensin-converting enzyme (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;ACE;7;1.049e-50;0.5238;40.4533;89.2787;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;ACE;7;7.503e-66;0.4773;52.5556;116.4696;ACE;Angiotensin-converting enzyme (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ACE;7;1.234e-62;0.5106;49.9857;110.6957;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151003;ACE;7;1.199e-50;0.6279;40.4068;89.1743;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
19816750;ACE;7;3.806e-55;0.4915;44.0013;97.2503;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;ACE;7;1.006e-76;0.5405;61.2438;135.9897;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
9948926;ACE;7;2.205e-48;0.6939;38.5973;85.1089;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
151134;ACE;7;4.314e-136;0.5926;108.6828;242.5734;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;ACE;7;8.366e-54;0.7234;42.9289;94.8409;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;ACE;7;6.988999999999999e-66;0.5185;52.5802;116.5249;ACE;Angiotensin-converting enzyme (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3634442;ACE;7;1.693e-48;0.5926;38.689;85.3148;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
193508;ACE;7;1.343e-93;0.55;74.7276;166.2845;ACE;Angiotensin-converting enzyme (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
14409732;ACE;7;5.943e-81;0.6212;64.6226;143.5812;ACE;Angiotensin-converting enzyme (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100048;ACE;7;2.1089999999999998e-94;0.625;75.37;167.7279;ACE;Angiotensin-converting enzyme (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ACE;7;2.343e-84;0.6957;67.3429;149.6929;ACE;Angiotensin-converting enzyme (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
171204;ACE;9;3.229e-52;0.5357;8.0272;91.9924;ACE;Angiotensin-converting enzyme (pKi >= 9);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
7020642;ACE;9;1.157e-90;0.6078;14.0046;161.0147;ACE;Angiotensin-converting enzyme (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;ACE;9;3.6319999999999997e-41;0.4179;6.3091;72.1523;ACE;Angiotensin-converting enzyme (pKi >= 9);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
96814;ACE;9;2.3319999999999997e-41;0.4423;6.339;72.4978;ACE;Angiotensin-converting enzyme (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
151134;ACE;9;4.5749999999999994e-41;0.4375;6.2935;71.9724;ACE;Angiotensin-converting enzyme (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
6993120;ACE2;7;3.71e-137;0.6047;17.0943;244.4864;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ACE2;7;1.5970000000000002e-122;0.525;15.2621;218.2137;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;ACE2;7;1.77e-97;0.5098;12.1263;173.2507;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;ACE2;7;2.628e-100;0.5306;12.4804;178.3283;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;ACE2;7;5.938e-55;0.4;6.8018;96.9035;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;ACE2;7;1.421e-96;0.5333;12.013;171.6266;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;ACE2;7;3.67e-77;0.46;9.5825;136.7756;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;ACE2;7;3.057e-110;0.4565;13.7243;196.1637;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ACE2;7;1.9459999999999997e-136;0.5909;17.0042;243.1942;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;ACE2;7;5.248e-104;0.4717;12.9437;184.9704;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;ACE2;7;1.1580000000000002e-122;0.5366;15.2795;218.4643;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ACE2;7;1.59e-127;0.5714;15.8883;227.194;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;ACE2;7;1.4500000000000001e-77;0.4483;9.633;137.4997;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;ACE2;7;1.207e-112;0.5106;14.0252;200.4787;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ACE2;7;3.0400000000000003e-109;0.5909;13.5994;194.3727;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;ACE2;7;1.5739999999999998e-94;0.4259;11.7571;167.9561;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;ACE2;7;5.484e-101;0.5306;12.5656;179.5502;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;ACE2;7;2.807e-98;0.4528;12.2264;174.6863;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ACE2;7;5.285e-134;0.575;16.6995;238.8244;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;ACE2;7;9.013e-83;0.4043;10.2849;146.847;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;ACE2;7;1.532e-152;0.7143;19.0205;272.1058;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ACE2;7;2.794e-124;0.5532;15.4821;221.3684;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ACE2;7;5.756e-78;0.4561;9.6833;138.2201;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;ACE2;7;1.359e-111;0.5957;13.8936;198.591;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;ACE2;7;1.118e-109;0.6222;13.6538;195.1528;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ACE2;7;5.6e-93;0.4407;11.5629;165.1713;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7020642;ACE2;7;1.758e-44;0.537;5.4907;78.1041;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
323786;ACE2;7;3.811e-73;0.4138;9.0797;129.5651;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;ACE2;7;4.963e-116;0.6512;14.4492;206.5578;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ACE2;7;4.56e-117;0.5111;14.579;208.4192;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;ACE2;7;8.112999999999999e-118;0.5;14.6729;209.7652;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ACE2;7;1.739e-101;0.4375;12.6281;180.4459;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;ACE2;7;1.3960000000000001e-78;0.4615;9.7603;139.3249;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;ACE2;7;1.883e-82;0.4727;10.2448;146.2725;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;ACE2;7;1.537e-130;0.5682;16.2658;232.606;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ACE2;7;1.537e-130;0.5682;16.2658;232.606;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;ACE2;7;3.627e-104;0.4615;12.9637;185.2585;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;ACE2;7;1.52e-144;0.6341;18.0193;257.7493;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
4078684;ACE2;7;4.221e-87;0.4792;10.827;154.6198;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;ACE2;7;1.5e-94;0.4286;11.7597;167.9939;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ACE2;7;4.678e-103;0.4706;12.8247;183.2648;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;ACE2;7;6.385e-87;0.4706;10.8045;154.2971;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;ACE2;7;3.325e-93;0.4878;11.5912;165.5779;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
19816755;ACE2;7;2.77e-56;0.4098;6.9685;99.2934;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;ACE2;7;3.9379999999999994e-68;0.4138;8.4518;120.563;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
151134;ACE2;7;9.505999999999999e-112;0.4681;13.913;198.8697;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;ACE2;7;1.497e-73;0.4286;9.1305;130.2938;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;ACE2;7;2.5079999999999998e-113;0.5319;14.1107;201.704;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;ACE2;7;1.859e-115;0.5;14.3774;205.5283;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;ACE2;7;1.458e-119;0.5102;14.8914;212.8986;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ACE2;7;6.735e-108;0.451;13.4309;191.9572;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
7408625;ACE2;6;3.237e-64;0.4203;9.0101;113.5344;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)O)N;BNQVUHQWZGTIBX-UHFFFAOYSA-N
14304554;ACE2;6;4.698e-63;0.413;8.8455;111.4487;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
13817313;ACE2;6;3.396e-64;0.4043;9.0071;113.497;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
9797038;ACE2;6;9.954e-94;0.5357;13.1903;166.5182;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
14282475;ACE2;6;2.523e-91;0.551;12.8498;162.2024;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
189008;ACE2;6;5.284e-49;0.4493;6.8553;86.2226;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
259327;ACE2;6;4.5929999999999995e-53;0.4043;7.4305;93.5131;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;ACE2;6;4.940000000000001e-122;0.7273;17.1994;217.3334;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
19816755;ACE2;6;8.388e-50;0.4098;6.9685;87.6576;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
6993120;ACE2;9;9.030999999999999e-41;0.4231;1.4802;71.4421;ACE2;Angiotensin-converting enzyme 2 (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7010580;ACE2;9;5.093e-48;0.4151;1.7486;84.456;ACE2;Angiotensin-converting enzyme 2 (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
47579;ACE2;9;2.019e-47;0.4167;1.7265;83.3822;ACE2;Angiotensin-converting enzyme 2 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;ACE2;9;1.2939999999999999e-45;0.5098;1.6596;80.1381;ACE2;Angiotensin-converting enzyme 2 (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
96814;ACE2;9;5.822e-50;0.44;1.8205;87.9423;ACE2;Angiotensin-converting enzyme 2 (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
6993120;ACE2;8;1.074e-131;0.6047;14.3642;234.6807;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ACE2;8;7.583999999999999e-118;0.525;12.8462;209.8178;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;ACE2;8;1.756e-90;0.5098;9.8467;160.6896;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;ACE2;8;5.848e-93;0.5306;10.1183;165.1375;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
92829;ACE2;8;5.8859999999999996e-89;0.5333;9.6795;157.9512;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14304554;ACE2;8;6.141e-65;0.413;7.0468;114.8304;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
14767562;ACE2;8;1.165e-73;0.46;8.0028;130.4892;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;ACE2;8;3.2359999999999996e-103;0.4565;11.2426;183.5522;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;ACE2;8;2.024e-64;0.4043;6.99;113.9006;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7010580;ACE2;8;2.301e-131;0.5909;14.328;234.0867;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;ACE2;8;5.2740000000000003e-104;0.4717;11.3289;184.9666;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;ACE2;8;4.574e-117;0.5116;12.7607;208.4168;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ACE2;8;5.339000000000001e-121;0.5455;13.1918;215.4774;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;ACE2;8;1.343e-75;0.4483;8.2152;133.9686;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;ACE2;8;2.542e-106;0.4898;11.5829;189.1264;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ACE2;8;3.05e-101;0.5909;11.0262;180.0076;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;ACE2;8;4.3749999999999996e-88;0.5357;9.584;156.3873;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ACE2;8;1.2059999999999998e-93;0.4107;10.1934;166.3688;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;ACE2;8;3.186e-95;0.5306;10.3664;169.2017;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;ACE2;8;4.102e-92;0.4364;10.0255;163.6186;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ACE2;8;1.7390000000000002e-128;0.575;14.0125;228.9192;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;ACE2;8;1.401e-81;0.4043;8.8709;144.708;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;ACE2;8;3.909e-142;0.7143;15.5085;253.4221;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ACE2;8;7.823e-120;0.5532;13.064;213.3843;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ACE2;8;5.006e-76;0.4561;8.2622;134.7383;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;ACE2;8;7.805e-105;0.5957;11.4199;186.4563;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;ACE2;8;4.92e-102;0.6222;11.113;181.4301;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ACE2;8;2.921e-86;0.4407;9.384;153.1114;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;ACE2;8;3.567e-83;0.551;9.0457;147.5699;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;ACE2;8;3.764e-45;0.537;4.8778;79.3058;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
323786;ACE2;8;1.453e-71;0.4138;7.7731;126.7263;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;ACE2;8;2.217e-108;0.6512;11.8086;192.8235;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ACE2;8;1.26e-112;0.5111;12.274;200.4454;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;ACE2;8;5.552e-113;0.4783;12.313;201.0844;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ACE2;8;3.43e-100;0.4375;10.911;178.1208;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;ACE2;8;1.1839999999999999e-73;0.4615;8.002;130.4762;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;ACE2;8;5.433e-77;0.4727;8.368;136.4699;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;ACE2;8;1.96e-124;0.5532;13.5683;221.6447;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ACE2;8;1.96e-124;0.5532;13.5683;221.6447;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;ACE2;8;1.0690000000000001e-98;0.4444;10.7472;175.439;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;ACE2;8;4.347e-139;0.6341;15.1746;247.9535;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;ACE2;8;1.495e-54;0.4043;5.9083;96.1836;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;ACE2;8;6.422e-113;0.7273;12.3061;200.9708;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;ACE2;8;2.4840000000000004e-78;0.4792;8.5148;138.8752;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;ACE2;8;4.381e-95;0.4286;10.3512;168.9533;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ACE2;8;1.114e-96;0.4528;10.526;171.8164;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;ACE2;8;2.598e-80;0.4706;8.7319;142.4309;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;ACE2;8;8.607e-89;0.4651;9.6614;157.6549;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
9948926;ACE2;8;8.341000000000001e-65;0.4138;7.0322;114.5917;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
151134;ACE2;8;2.987e-107;0.449;11.6848;190.7959;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;ACE2;8;1.548e-70;0.4286;7.6604;124.8816;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;ACE2;8;5.177e-104;0.5319;11.3298;184.9811;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;ACE2;8;4.77e-110;0.4783;11.9914;195.8168;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;ACE2;8;4.8069999999999996e-114;0.5102;12.4295;202.9921;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ACE2;8;2.2439999999999997e-103;0.451;11.26;183.8376;ACE2;Angiotensin-converting enzyme 2 (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;ACE;8;7.507e-93;0.5778;45.2083;164.9428;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ACE;8;4.645e-89;0.5;43.3567;158.1358;ACE;Angiotensin-converting enzyme (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;ACE;8;3.131e-71;0.5952;34.6499;126.1276;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ACE;8;6.647999999999999e-88;0.5652;42.7923;156.061;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;ACE;8;5.075e-81;0.4151;39.431;143.7042;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;ACE;8;3.1220000000000004e-69;0.5;33.6738;122.5394;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ACE;8;6.079e-77;0.5333;37.4393;136.3822;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;ACE;8;5.125e-76;0.4808;36.9872;134.72;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ACE;8;1.1539999999999999e-41;0.6047;20.2108;73.0463;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;ACE;8;3.376e-42;0.7115;20.4715;74.0047;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;ACE;8;3.609e-44;0.7115;21.4341;77.5434;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ACE;8;5.079e-81;0.5238;39.4309;143.7037;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
171204;ACE;8;6.953e-59;0.5357;28.6203;103.9617;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
435728;ACE;8;1.8889999999999998e-93;0.6122;45.501;166.0187;ACE;Angiotensin-converting enzyme (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ACE;8;1.148e-62;0.5532;30.4675;110.7523;ACE;Angiotensin-converting enzyme (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;ACE;8;2.5159999999999996e-41;0.6458;20.0455;72.4386;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;ACE;8;3.9259999999999996e-44;0.5957;21.4162;77.4776;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ACE;8;1.169e-43;0.6316;21.1848;76.6271;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7020642;ACE;8;7.590999999999999e-136;0.62;66.2054;242.1328;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;ACE;8;3.221e-42;0.4694;20.4814;74.0412;ACE;Angiotensin-converting enzyme (pKi >= 8);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
92946;ACE;8;5.682000000000001e-46;0.6222;22.3145;80.7801;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ACE;8;3.3929999999999996e-66;0.4694;32.191;117.0884;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;ACE;8;1.019e-80;0.4681;39.2832;143.1608;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ACE;8;3.07e-55;0.4902;26.8403;97.4178;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;ACE;8;4.4220000000000004e-72;0.6744;35.065;127.6538;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ACE;8;4.4220000000000004e-72;0.6744;35.065;127.6538;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
11736661;ACE;8;2.209e-50;0.5116;24.4683;88.6981;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CCC(=O)N)N)C(=O)O;NJMYZEJORPYOTO-UHFFFAOYSA-N
96814;ACE;8;9.327999999999999e-107;0.6047;51.9993;189.9079;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
152322;ACE;8;1.432e-45;0.4231;22.1185;80.0594;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CN=CN2)N)C(=O)O;LNCFUHAPNTYMJB-UHFFFAOYSA-N
342468;ACE;8;2.893e-45;0.6531;21.9693;79.511;ACE;Angiotensin-converting enzyme (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;ACE;8;1.051e-48;0.4286;23.6491;85.6864;ACE;Angiotensin-converting enzyme (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ACE;8;5.489e-46;0.4464;22.3218;80.8069;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151003;ACE;8;2.081e-44;0.46;21.5508;77.9724;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
759256;ACE;8;1.446e-65;0.4545;31.8835;115.9579;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;ACE;8;2.037e-105;0.4423;51.3453;187.5035;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;ACE;8;9.51e-51;0.5185;24.6471;89.355;ACE;Angiotensin-converting enzyme (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;ACE;8;5.560000000000001e-72;0.4783;35.0164;127.4752;ACE;Angiotensin-converting enzyme (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
14409732;ACE;8;7.186999999999999e-66;0.6212;32.0319;116.5032;ACE;Angiotensin-converting enzyme (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100048;ACE;8;1.07e-73;0.4902;35.8543;130.5552;ACE;Angiotensin-converting enzyme (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ACE;8;2.674e-67;0.434;32.7299;119.0695;ACE;Angiotensin-converting enzyme (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
92021849;ADK;7;1.5220000000000001e-46;0.4394;19.4473;81.8069;ADK;Adenosine kinase (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;ADORA1;7;3.9209999999999998e-59;0.5469;98.2504;104.4084;ADORA1;Adenosine receptor A1 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
135398728;ADORA1;7;3.485e-72;0.4516;119.8183;127.8394;ADORA1;Adenosine receptor A1 (pKi >= 7);C1=NC2=C(N1C3C4C(C(O3)CO)OP(=O)(O4)O)N=C(NC2=O)N;UASRYODFRYWBRC-UHFFFAOYSA-N
92021849;ADORA1;7;6.24e-158;0.629;261.5203;281.7826;ADORA1;Adenosine receptor A1 (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;ADORA1;8;1.366e-50;0.4918;42.7239;89.0724;ADORA1;Adenosine receptor A1 (pKi >= 8);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
135398728;ADORA1;8;5.784e-58;0.4516;48.9574;102.31;ADORA1;Adenosine receptor A1 (pKi >= 8);C1=NC2=C(N1C3C4C(C(O3)CO)OP(=O)(O4)O)N=C(NC2=O)N;UASRYODFRYWBRC-UHFFFAOYSA-N
92021849;ADORA1;8;1.2109999999999999e-130;0.629;110.4009;232.7919;ADORA1;Adenosine receptor A1 (pKi >= 8);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;ADORA1;9;2.425e-81;0.6;26.4394;144.2802;ADORA1;Adenosine receptor A1 (pKi >= 9);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;ADORA2A;7;1.945e-52;0.5493;83.4872;92.3878;ADORA2A;Adenosine receptor A2a (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;ADORA3;8;8.730999999999999e-66;0.48;10.2469;116.3514;ADORA3;Adenosine receptor A3 (pKi >= 8);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;ADORA3;7;3.85e-122;0.5538;33.4307;217.5276;ADORA3;Adenosine receptor A3 (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;AHCY;7;3.671e-80;0.4828;9.5018;142.1615;AHCY;Adenosylhomocysteinase (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
12599;AHCY;8;1.083e-60;0.4464;3.1721;107.2072;AHCY;Adenosylhomocysteinase (pKi >= 8);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
263471;AKT1;6;1.8679999999999998e-45;0.5;43.8909;79.8521;AKT1;RAC-alpha serine/threonine-protein kinase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
6993120;ANPEP;7;2.088e-130;0.6087;30.9261;232.3673;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ANPEP;7;3.46e-97;0.4762;23.0182;172.7279;ANPEP;Aminopeptidase N (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;ANPEP;7;4.5250000000000004e-72;0.5;17.0392;127.6358;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;ANPEP;7;4.736e-84;0.5185;19.8911;149.1441;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;ANPEP;7;9.806e-99;0.6216;23.3866;175.5064;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;ANPEP;7;8.676e-71;0.4902;16.7338;125.3329;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;ANPEP;7;2.894e-73;0.4035;17.3234;129.7796;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;ANPEP;7;3.9400000000000004e-117;0.6;27.7658;208.5332;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ANPEP;7;1.825e-129;0.6136;30.7019;230.6768;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;ANPEP;7;5.517e-104;0.5;24.6363;184.9314;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ANPEP;7;5.685e-119;0.5652;28.204;211.8379;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;ANPEP;7;1.0239999999999999e-60;0.4727;14.3362;107.2504;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;ANPEP;7;1.625e-111;0.5098;26.429;198.4518;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ANPEP;7;1.395e-86;0.5714;20.4936;153.688;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;ANPEP;7;9.939e-61;0.4068;14.3393;107.2738;ANPEP;Aminopeptidase N (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ANPEP;7;3.0179999999999997e-81;0.4545;19.2235;144.1096;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;ANPEP;7;7.141e-87;0.6087;20.5628;154.2099;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;ANPEP;7;2.052e-84;0.4561;19.9775;149.7962;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ANPEP;7;4.6659999999999997e-97;0.4889;22.9873;172.4948;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;ANPEP;7;1.7570000000000002e-124;0.58;29.5156;221.73;ANPEP;Aminopeptidase N (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ANPEP;7;7.782999999999999e-81;0.4615;19.1256;143.3708;ANPEP;Aminopeptidase N (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ANPEP;7;9.357e-60;0.4286;14.1074;105.5255;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;ANPEP;7;3.1969999999999997e-90;0.5417;21.36;160.2223;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;ANPEP;7;4.1649999999999996e-88;0.5385;20.8565;156.4255;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ANPEP;7;9.316999999999999e-67;0.4839;15.7742;118.0961;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;ANPEP;7;1.2259999999999999e-68;0.4;16.222;121.4728;ANPEP;Aminopeptidase N (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
323786;ANPEP;7;2.752e-60;0.5283;14.234;106.4797;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;ANPEP;7;5.407e-95;0.56;22.4959;168.7893;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ANPEP;7;2.768e-109;0.5;25.8979;194.4459;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
189008;ANPEP;7;1.256e-45;0.4717;10.7443;80.1617;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
6992643;ANPEP;7;1.7479999999999999e-112;0.5333;26.6595;200.19;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ANPEP;7;9.987999999999999e-114;0.4894;26.9554;202.4219;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;ANPEP;7;4.7310000000000004e-64;0.4561;15.1301;113.2385;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;ANPEP;7;2.604e-57;0.4667;13.5255;101.1368;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;ANPEP;7;9.102e-120;0.6327;28.3933;213.2662;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ANPEP;7;9.102e-120;0.6327;28.3933;213.2662;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;ANPEP;7;1.7250000000000002e-102;0.4909;24.2804;182.2474;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;ANPEP;7;1.392e-134;0.6364;31.9202;239.865;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;ANPEP;7;1.331e-43;0.5476;10.2622;76.5255;ANPEP;Aminopeptidase N (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;ANPEP;7;1.59e-82;0.5091;19.5278;146.4042;ANPEP;Aminopeptidase N (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;ANPEP;7;2.14e-78;0.4902;18.5449;138.9917;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;ANPEP;7;2.364e-107;0.5273;25.4381;190.9782;ANPEP;Aminopeptidase N (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ANPEP;7;3.473e-92;0.4737;21.8275;163.7485;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;ANPEP;7;8.102e-79;0.4643;18.6453;139.7489;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;ANPEP;7;9.22e-83;0.4255;19.5841;146.8294;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;ANPEP;7;1.6810000000000002e-108;0.5;25.7114;193.0393;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;ANPEP;7;1.2189999999999999e-45;0.4;10.7474;80.1846;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;ANPEP;7;6.379e-108;0.46;25.5735;191.9996;ANPEP;Aminopeptidase N (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;ANPEP;7;7.059e-111;0.5333;26.2772;197.3065;ANPEP;Aminopeptidase N (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;ANPEP;7;6.4e-110;0.6538;26.0492;195.5876;ANPEP;Aminopeptidase N (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ANPEP;7;2.623e-103;0.5926;24.4751;183.7158;ANPEP;Aminopeptidase N (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
76807;ANPEP;8;3.2340000000000004e-42;0.5366;5.6697;74.0381;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;ANPEP;8;6.722000000000001e-143;0.6087;19.3904;254.7949;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
329275;ANPEP;8;3.6469999999999997e-66;0.4727;8.9332;117.0322;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
4466134;ANPEP;8;6.831e-86;0.6087;11.6216;152.4491;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;ANPEP;8;8.192e-134;0.58;18.1522;238.4828;ANPEP;Aminopeptidase N (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;ANPEP;8;5.312e-90;0.5417;12.1816;159.8265;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
323786;ANPEP;8;4.8240000000000005e-65;0.5283;8.7804;115.0186;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
96814;ANPEP;8;9.892999999999999e-149;0.6364;20.1852;265.2654;ANPEP;Aminopeptidase N (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;ANPEP;8;4.864e-52;0.5476;7.0083;91.6731;ANPEP;Aminopeptidase N (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
7010566;ANPEP;8;1.409e-117;0.46;15.9397;209.335;ANPEP;Aminopeptidase N (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
4657542;ANPEP;6;4.55e-99;0.5;34.8141;176.1051;ANPEP;Aminopeptidase N (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;ANPEP;6;5.716e-62;0.5;21.726;109.5004;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;ANPEP;6;6.999e-76;0.5185;26.634;134.477;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
7408625;ANPEP;6;4.699999999999999e-43;0.5342;15.053;75.542;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)O)N;BNQVUHQWZGTIBX-UHFFFAOYSA-N
6992304;ANPEP;6;1.4660000000000002e-102;0.6216;36.046;182.3744;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;ANPEP;6;2.116e-59;0.4902;20.8199;104.8894;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;ANPEP;6;9.467e-68;0.4035;23.7654;119.879;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;ANPEP;6;5.722e-130;0.6;45.7154;231.5812;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ANPEP;6;9.693e-141;0.6136;49.5153;250.9188;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;ANPEP;6;4.706e-54;0.4314;18.9335;95.2895;ANPEP;Aminopeptidase N (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;ANPEP;6;2.402e-102;0.561;35.9703;181.9892;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ANPEP;6;1.248e-117;0.5652;41.3625;209.4295;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;ANPEP;6;6.073e-109;0.5098;38.2977;193.8332;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ANPEP;6;1.8600000000000002e-77;0.5714;27.1898;137.3054;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;ANPEP;6;4.174e-56;0.4068;19.6574;98.9736;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ANPEP;6;3.199e-77;0.4545;27.1068;136.8829;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;ANPEP;6;1.124e-79;0.4561;27.9726;141.289;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ANPEP;6;9.326e-101;0.5897;35.4097;179.1362;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;ANPEP;6;2.22e-62;0.4444;21.8709;110.238;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
13890535;ANPEP;6;2.954e-85;0.5111;29.9413;151.3075;ANPEP;Aminopeptidase N (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ANPEP;6;1.6209999999999999e-60;0.4286;21.2135;106.8925;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009555;ANPEP;6;6.175000000000001e-85;0.5385;29.8283;150.7326;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;ANPEP;6;8.863999999999999e-59;0.4839;20.6004;103.7724;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;ANPEP;6;5.719e-65;0.4;22.7843;114.886;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
92946;ANPEP;6;6.697e-90;0.56;31.5798;159.6459;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ANPEP;6;5.123e-109;0.5;38.3238;193.9657;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
189008;ANPEP;6;3.8429999999999997e-44;0.4717;15.4366;77.4942;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
6992643;ANPEP;6;9.773e-112;0.5333;39.2832;198.8482;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ANPEP;6;1.011e-122;0.4894;43.1586;218.5699;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;ANPEP;6;2.609e-56;0.4921;19.7294;99.34;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;ANPEP;6;1.91e-48;0.4667;16.9549;85.2207;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;ANPEP;6;1.0759999999999999e-114;0.6327;40.3269;204.1594;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ANPEP;6;1.0759999999999999e-114;0.6327;40.3269;204.1594;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;ANPEP;6;1.177e-92;0.4935;32.5517;164.5919;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
342468;ANPEP;6;1.283e-77;0.5091;27.2468;137.5954;ANPEP;Aminopeptidase N (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;ANPEP;6;1.092e-74;0.4902;26.2131;132.335;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;ANPEP;6;2.1939999999999997e-114;0.5273;40.2177;203.6036;ANPEP;Aminopeptidase N (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ANPEP;6;3.306e-89;0.4921;31.3352;158.401;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;ANPEP;6;7.107999999999999e-73;0.4643;25.5733;129.079;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;ANPEP;6;6.935e-83;0.4762;29.1049;147.0514;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;ANPEP;6;1.2e-109;0.5;38.5461;195.0973;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;ANPEP;6;4.484e-109;0.5333;38.3442;194.0698;ANPEP;Aminopeptidase N (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;ANPEP;6;1.7160000000000002e-109;0.6538;38.4914;194.8185;ANPEP;Aminopeptidase N (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ANPEP;6;3.9630000000000006e-102;0.5926;35.8936;181.5988;ANPEP;Aminopeptidase N (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;ANPEP;9;3.216e-65;0.5909;2.6065;115.3348;ANPEP;Aminopeptidase N (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ANPEP;9;3.5719999999999996e-53;0.4762;2.1193;93.7091;ANPEP;Aminopeptidase N (pKi >= 9);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
6992304;ANPEP;9;1.619e-69;0.6216;2.7804;123.0513;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;ANPEP;9;2.113e-65;0.5111;2.6139;115.6625;ANPEP;Aminopeptidase N (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;ANPEP;9;2.843e-65;0.6136;2.6087;115.4311;ANPEP;Aminopeptidase N (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;ANPEP;9;7.949999999999999e-60;0.4667;2.3884;105.6526;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ANPEP;9;7.521000000000001e-65;0.5333;2.5916;114.6725;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;ANPEP;9;7.504e-63;0.48;2.5107;111.0835;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
47579;ANPEP;9;9.472e-51;0.4545;2.0212;89.3582;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;ANPEP;9;1.246e-54;0.5532;2.1782;96.3258;ANPEP;Aminopeptidase N (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
111299;ANPEP;9;9.207e-61;0.4792;2.4262;107.3335;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;ANPEP;9;1.33e-65;0.5333;2.622;116.0233;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;ANPEP;9;1.042e-62;0.4894;2.505;110.8277;ANPEP;Aminopeptidase N (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;ANPEP;9;4.51e-62;0.5;2.4792;109.6852;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;ANPEP;9;4.51e-62;0.5;2.4792;109.6852;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;ANPEP;9;1.6330000000000003e-55;0.4364;2.2139;97.91;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;ANPEP;9;4.5329999999999994e-68;0.619;2.7218;120.4532;ANPEP;Aminopeptidase N (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
10445608;ANPEP;9;3.183e-62;0.5106;2.4853;109.9569;ANPEP;Aminopeptidase N (pKi >= 9);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;ANPEP;9;1.186e-50;0.4444;2.0173;89.183;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;ANPEP;9;5.964e-50;0.4222;1.9889;87.9235;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;ANPEP;9;5.955e-65;0.5;2.5957;114.8545;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;ANPEP;9;2.508e-52;0.46;2.085;92.1896;ANPEP;Aminopeptidase N (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;ANPEP;9;7.521000000000001e-65;0.5333;2.5916;114.6725;ANPEP;Aminopeptidase N (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;ANPEP;9;2.45e-61;0.5;2.4495;108.3657;ANPEP;Aminopeptidase N (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;ANPEP;9;2.45e-61;0.5;2.4495;108.3657;ANPEP;Aminopeptidase N (pKi >= 9);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;BLA1_STEMA;7;1.027e-54;0.4444;1.5968;96.4763;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;BLA1_STEMA;7;1.136e-48;0.4;1.4178;85.6257;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7010580;BLA1_STEMA;7;1.655e-55;0.463;1.6203;97.8999;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;BLA1_STEMA;7;2.0409999999999998e-53;0.4231;1.5584;94.1457;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;BLA1_STEMA;7;1.14e-55;0.4528;1.6251;98.1901;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;BLA1_STEMA;7;2.871e-54;0.4386;1.5836;95.6749;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
47579;BLA1_STEMA;7;1.1509999999999998e-53;0.44;1.5657;94.5923;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;BLA1_STEMA;7;4.849e-52;0.4211;1.5176;91.6756;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
111299;BLA1_STEMA;7;6.864999999999999e-53;0.4107;1.5428;93.1997;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;BLA1_STEMA;7;9.232999999999999e-51;0.4;1.4797;89.3781;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
515709;BLA1_STEMA;7;1.7119999999999998e-54;0.4286;1.5902;96.0781;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;BLA1_STEMA;7;1.7119999999999998e-54;0.4286;1.5902;96.0781;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;BLA1_STEMA;7;1.654e-49;0.4032;1.4426;87.1281;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;BLA1_STEMA;7;1.169e-56;0.4615;1.6544;99.966;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;BLA1_STEMA;7;2.143e-52;0.4098;1.5281;92.3121;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;BLA1_STEMA;7;2.4239999999999997e-51;0.4035;1.4969;90.4209;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;BLA1_STEMA;7;9.232999999999999e-51;0.4;1.4797;89.3781;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;BLA1_STEMA;7;2.1249999999999996e-53;0.431;1.5578;94.114;BLA1_STEMA;Metallo-beta-lactamase L1 (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
11579826;C3AR1;8;1.76e-62;0.42;2.4958;110.4191;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 8);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
111299;C3AR1;8;2.084e-44;0.4151;1.7647;77.9714;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
150964;C3AR1;8;2.0089999999999998e-53;0.5091;2.1294;94.1578;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7010580;C3AR1;7;1.5829999999999998e-47;0.4603;4.0318;83.5716;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
19421321;C3AR1;7;2.4649999999999997e-41;0.4118;3.4988;72.4545;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
150964;C3AR1;7;9.193e-48;0.5091;4.0522;83.9955;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;C3AR1;7;1.2509999999999999e-68;0.4762;5.8483;121.4569;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010506;C3AR1;7;2.023e-50;0.4769;4.2809;88.7666;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
11579826;C3AR1;6;9.369e-71;0.42;11.7262;125.273;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
25200879;C3AR1;6;4.8460000000000003e-57;0.4304;9.4349;100.6527;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
6781;CACNA1C;7;9.46e-45;0.425;13.9643;78.5872;CACNA1C;Voltage-dependent L-type calcium channel subunit alpha-1C (pKi >= 7);CCOC(=O)C1=CC=CC=C1C(=O)OCC;FLKPEMZONWLCSK-UHFFFAOYSA-N
76807;CAPN1;8;3.3449999999999996e-41;0.5366;5.3831;72.2166;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;CAPN1;8;3.462e-74;0.4894;9.7582;131.4352;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CAPN1;8;9.267e-64;0.4091;8.3751;112.7143;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;CAPN1;8;1.553e-63;0.4468;8.3454;112.3117;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CAPN1;8;1.488e-74;0.4792;9.8069;132.0936;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CAPN1;8;8.439e-63;0.4043;8.2479;110.992;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CAPN1;8;5.193999999999999e-66;0.4681;8.6738;116.7564;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;CAPN1;8;1.572e-42;0.4844;5.5592;74.6005;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;CAPN1;8;9.633e-66;0.451;8.6382;116.2748;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CAPN1;8;9.713e-55;0.5745;7.1787;96.5199;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
47579;CAPN1;8;1.401e-69;0.4314;9.1471;123.1639;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CAPN1;8;9.306e-76;0.4898;9.9666;134.2549;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;CAPN1;8;1.3559999999999999e-52;0.5263;6.8941;92.6689;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;CAPN1;8;1.0879999999999999e-45;0.4407;5.9784;80.2733;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
323786;CAPN1;8;1.321e-46;0.5;6.0998;81.9176;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;CAPN1;8;2.724e-51;0.4561;6.7213;90.3297;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6992643;CAPN1;8;7.569e-67;0.4681;8.7847;118.2581;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CAPN1;8;2.078e-67;0.5;8.8592;119.266;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CAPN1;8;1.258e-66;0.4912;8.7554;117.8617;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CAPN1;8;1.258e-66;0.4912;8.7554;117.8617;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CAPN1;8;1.7990000000000001e-78;0.5111;10.3265;139.127;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;CAPN1;8;2.901e-45;0.5854;5.9219;79.5087;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;CAPN1;8;5.1630000000000004e-46;0.4426;6.0213;80.8547;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;CAPN1;8;1.061e-60;0.434;7.9694;107.2231;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CAPN1;8;2.235e-56;0.4182;7.3959;99.4608;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;CAPN1;8;8.153e-58;0.44;7.5867;102.0423;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CAPN1;8;9.808999999999999e-60;0.4444;7.8413;105.4887;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CAPN1;8;3.4439999999999997e-68;0.4681;8.9627;120.6674;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CAPN1;8;7.835e-64;0.4706;8.3848;112.8452;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CAPN1;8;1.558e-58;0.4423;7.682;103.3327;CAPN1;Calpain-1 catalytic subunit (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
44232492;CAPN1;7;4.186e-56;0.5;20.5819;98.9715;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
76807;CAPN1;7;1.639e-65;0.5366;24.0559;115.8602;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;CAPN1;7;5.218e-107;1.0;39.3806;190.3609;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CAPN1;7;2.939e-91;0.5676;33.564;162.0834;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021828;CAPN1;7;4.653e-53;0.4773;19.4571;93.5031;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
515717;CAPN1;7;1.093e-45;0.4894;16.7351;80.2701;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;CAPN1;7;1.7660000000000002e-57;0.4419;21.0896;101.4396;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
9856500;CAPN1;7;2.238e-60;0.5111;22.1595;106.6408;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
14767562;CAPN1;7;1.251e-42;0.4468;15.6055;74.7786;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;CAPN1;7;1.629e-104;0.561;38.4594;185.8824;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;CAPN1;7;2.514e-58;0.4889;21.4023;102.9597;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7010580;CAPN1;7;2.045e-105;0.8108;38.7923;187.5007;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;CAPN1;7;4.6039999999999996e-51;0.449;18.7201;89.9206;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;CAPN1;7;2.982e-86;0.5897;31.7152;153.0955;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CAPN1;7;9.997e-95;0.6667;34.8448;168.3101;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;CAPN1;7;1.793e-61;0.5781;22.5644;108.6092;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;CAPN1;7;8.755e-87;0.5909;31.9117;154.051;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;CAPN1;7;1.082e-48;0.5476;17.8446;85.664;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;CAPN1;7;1.798e-57;0.541;21.0867;101.4255;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;CAPN1;7;1.327e-90;0.5745;33.3222;160.908;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
18218182;CAPN1;7;5.582999999999999e-53;0.4889;19.4278;93.3609;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
4427709;CAPN1;7;8.068e-60;0.52;21.9538;105.6411;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;CAPN1;7;9.556e-92;0.5789;33.7441;162.9593;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CAPN1;7;2.0479999999999999e-112;0.7692;41.3771;200.0666;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;CAPN1;7;1.577e-111;0.5349;41.0496;198.4749;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
6992563;CAPN1;7;8.098e-43;0.56;15.6752;75.1178;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;CAPN1;7;6.047e-84;0.5556;30.8632;148.9535;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;CAPN1;7;4.5909999999999995e-60;0.7895;22.0443;106.0807;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;CAPN1;7;8.309999999999999e-45;0.4857;16.4097;78.6883;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;CAPN1;7;4.246e-43;0.4068;15.7788;75.6212;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
323786;CAPN1;7;6.117000000000001e-69;0.5781;25.3219;122.0148;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;CAPN1;7;5.3660000000000006e-65;0.6098;23.8657;114.9357;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;CAPN1;7;7.478e-74;0.5952;27.1362;130.8348;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
189008;CAPN1;7;1.279e-45;0.4444;16.7097;80.1471;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
6992643;CAPN1;7;3.252e-92;0.5854;33.917;163.7998;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
332962;CAPN1;7;7.398e-62;0.5116;22.7063;109.2994;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7359122;CAPN1;7;6.61e-105;0.5714;38.6041;186.5858;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CAPN1;7;2.549e-93;0.619;34.3253;165.7849;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CAPN1;7;2.549e-93;0.619;34.3253;165.7849;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;CAPN1;7;2.395e-56;0.5306;20.6715;99.4069;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;CAPN1;7;5.607e-121;0.7778;44.5392;215.4393;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;CAPN1;7;5.188e-76;0.5854;27.9334;134.7105;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;CAPN1;7;3.084e-65;0.6136;23.9545;115.3675;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;CAPN1;7;4.228e-42;0.4348;15.4101;73.8292;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;CAPN1;7;6.485e-93;0.5227;34.1756;165.0569;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CAPN1;7;1.13e-76;0.5417;28.1778;135.8988;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
6993118;CAPN1;7;2.396e-56;0.5789;20.6713;99.4063;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
4128305;CAPN1;7;2.005e-46;0.4565;17.007;81.5922;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC(=O)N)C(=O)O)N;MLTRLIITQPXHBJ-UHFFFAOYSA-N
7016103;CAPN1;7;2.817e-57;0.4894;21.0147;101.0755;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
759256;CAPN1;7;6.461e-104;0.5385;38.2384;184.8083;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;CAPN1;7;2.161e-86;0.5455;31.7668;153.3466;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CAPN1;7;2.7e-96;0.5;35.424;171.1259;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CAPN1;7;1.927e-96;0.5854;35.4781;171.3892;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CAPN1;7;1.982e-91;0.6136;33.6271;162.3905;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CAPN1;7;4.728e-83;0.5435;30.5333;147.3501;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
44232492;CAPN2;7;3.821e-82;0.4074;13.0911;145.7208;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
76807;CAPN2;7;3.951e-97;0.4;15.4963;172.6245;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;CAPN2;7;7.3840000000000004e-124;0.4815;19.7863;220.6105;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CAPN2;7;1.0219999999999999e-61;0.4318;9.8125;109.0474;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;CAPN2;7;4.0450000000000004e-63;0.4576;10.0376;111.5653;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;CAPN2;7;1.436e-50;0.4483;8.0233;89.0335;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
9856500;CAPN2;7;6.137e-87;0.4074;13.8606;154.328;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
5488196;CAPN2;7;5.776e-118;0.4314;18.8404;210.0302;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;CAPN2;7;5.554e-102;0.44;16.2751;181.3356;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7010580;CAPN2;7;1.912e-124;0.4727;19.8805;221.6642;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CAPN2;7;5.91e-59;0.4615;9.3692;104.0884;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CAPN2;7;1.581e-111;0.4906;17.8072;198.4732;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;CAPN2;7;3.988e-100;0.4857;15.9772;178.0032;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;CAPN2;7;1.413e-116;0.5;18.6176;207.537;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;CAPN2;7;2.674e-56;0.463;8.943;99.3209;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;CAPN2;7;1.892e-84;0.4722;13.4612;149.8597;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CAPN2;7;1.344e-70;0.4507;11.2379;124.9918;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;CAPN2;7;7.47e-128;0.5;20.4275;227.7828;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;CAPN2;7;3.096e-74;0.4507;11.8218;131.5224;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;CAPN2;7;4.18e-58;0.451;9.2328;102.5632;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CAPN2;7;7.809999999999999e-140;0.5094;22.3505;249.2919;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;CAPN2;7;1.1869999999999999e-80;0.5094;12.8516;143.0417;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;CAPN2;7;3.134e-41;0.4306;6.5243;72.2674;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;CAPN2;7;2.708e-122;0.5;19.5352;217.8019;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;CAPN2;7;1.3160000000000002e-71;0.4386;11.3999;126.8035;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;CAPN2;7;1.606e-51;0.4267;8.176;90.7417;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CAPN2;7;1.239e-110;0.5072;17.6637;196.8677;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;CAPN2;7;1.625e-84;0.4545;13.4717;149.978;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6992643;CAPN2;7;9.534e-109;0.4364;17.361;193.4815;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CAPN2;7;9.930999999999999e-107;0.4151;17.0371;189.8591;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
7021456;CAPN2;7;2.1420000000000002e-46;0.4286;7.3534;81.5406;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;CAPN2;7;7.367000000000001e-115;0.5185;18.342;204.4545;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CAPN2;7;7.367000000000001e-115;0.5185;18.342;204.4545;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;CAPN2;7;5.637e-53;0.4127;8.4095;93.3535;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;CAPN2;7;2.0070000000000001e-131;0.5;21.0006;234.1933;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;CAPN2;7;9.967000000000001e-115;0.44;18.3209;204.2188;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;CAPN2;7;2.0480000000000001e-109;0.4655;17.4682;194.6805;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;CAPN2;7;6.816e-102;0.4074;16.2609;181.1759;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CAPN2;7;7.682000000000001e-102;0.4667;16.2525;181.0827;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;CAPN2;7;1.101e-46;0.4444;7.3998;82.0595;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
19816755;CAPN2;7;7.966e-62;0.4521;9.8299;109.2417;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
151134;CAPN2;7;3.322e-98;0.4138;15.6689;174.555;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CAPN2;7;3.0159999999999996e-125;0.4286;20.0093;223.104;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CAPN2;7;5.045e-110;0.4364;17.5659;195.7732;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CAPN2;7;1.545e-119;0.4912;19.0929;212.8537;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CAPN2;7;6.884e-101;0.4167;16.0997;179.3729;CAPN2;Calpain-2 catalytic subunit (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;CAPN2;8;7.101e-66;0.4706;2.1753;116.5126;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CAPN2;8;4.024e-63;0.4255;2.0833;111.5694;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;CAPN2;8;5.178e-63;0.4314;2.0796;111.3729;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CAPN2;8;4.58e-64;0.4615;2.1149;113.2638;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;CAPN2;8;2.145e-61;0.451;2.0256;108.4692;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CAPN2;8;1.026e-59;0.4364;1.9694;105.4538;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
435728;CAPN2;8;5.271e-66;0.4717;2.1797;116.7449;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
92946;CAPN2;8;1.322e-48;0.4151;1.5981;85.5079;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6992643;CAPN2;8;1.466e-60;0.4231;1.9977;106.9706;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CAPN2;8;1.366e-61;0.4151;2.0321;108.821;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CAPN2;8;2.795e-62;0.4528;2.0552;110.0582;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CAPN2;8;2.795e-62;0.4528;2.0552;110.0582;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CAPN2;8;1.695e-67;0.4898;2.2296;119.4247;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;CAPN2;8;1.579e-48;0.4035;1.5955;85.3692;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;CAPN2;8;1.4469999999999998e-60;0.4074;1.9979;106.9809;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CAPN2;8;6.257e-48;0.4068;1.5755;84.2955;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;CAPN2;8;2.97e-49;0.4;1.6197;86.6717;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CAPN2;8;1.546e-62;0.4182;2.0638;110.52;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CAPN2;8;6.511e-64;0.4231;2.1097;112.9896;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CAPN2;8;3.096e-63;0.4545;2.0871;111.7737;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CAPN2;8;2.817e-59;0.4035;1.9548;104.6661;CAPN2;Calpain-2 catalytic subunit (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;CAPNS1;7;3.697e-61;0.4364;2.4423;108.0449;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
5488196;CAPNS1;7;3.974e-64;0.4035;2.5623;113.3744;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CAPNS1;7;3.951e-60;0.4286;2.4006;106.1977;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;CAPNS1;7;4.7370000000000005e-58;0.4182;2.3166;102.4657;CAPNS1;Calpain small subunit 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CAPNS1;7;8.242e-57;0.4098;2.2664;100.2385;CAPNS1;Calpain small subunit 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CAPNS1;7;1.468e-63;0.4561;2.5394;112.3559;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;CAPNS1;7;1.083e-61;0.4483;2.4638;109.0021;CAPNS1;Calpain small subunit 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;CAPNS1;7;4.873e-63;0.4561;2.5183;111.4202;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
92946;CAPNS1;7;7.403000000000001e-55;0.4107;2.1874;96.7316;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
515709;CAPNS1;7;4.2210000000000006e-58;0.4211;2.3186;102.5556;CAPNS1;Calpain small subunit 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CAPNS1;7;4.2210000000000006e-58;0.4211;2.3186;102.5556;CAPNS1;Calpain small subunit 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CAPNS1;7;1.252e-71;0.4808;2.8658;126.8424;CAPNS1;Calpain small subunit 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010566;CAPNS1;7;5.302e-71;0.4;2.8404;125.717;CAPNS1;Calpain small subunit 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;CAPNS1;7;1.2270000000000001e-58;0.4237;2.3403;103.5186;CAPNS1;Calpain small subunit 1 (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
759256;CAPN2;6;2.419e-48;0.4762;13.9952;85.0364;CAPN2;Calpain-2 catalytic subunit (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
6992643;CASP1;7;2.282e-41;0.52;17.771;72.5146;CASP1;Caspase-1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CASP1;7;3.0309999999999997e-41;0.4528;17.7176;72.2934;CASP1;Caspase-1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
100094;CCKAR;8;3.836e-92;0.4865;35.6703;163.6709;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;CCKAR;8;3.6469999999999997e-88;0.4615;34.1244;156.5292;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;CCKAR;8;2.8509999999999995e-88;0.4416;34.1659;156.721;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CCKAR;8;1.1959999999999999e-94;0.5333;36.6443;168.1705;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;CCKAR;8;3.4670000000000003e-84;0.4487;32.5784;149.3874;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;CCKAR;8;6.562999999999999e-93;0.5429;35.9683;165.0476;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;CCKAR;8;1.2119999999999999e-88;0.44;34.3103;157.3879;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;CCKAR;8;4.879000000000001e-78;0.4458;30.189;138.349;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;CCKAR;8;4.311e-86;0.4324;33.3189;152.8081;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;CCKAR;8;5.837e-87;0.5658;33.6564;154.3671;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CCKAR;8;3.111e-84;0.5;32.5967;149.4717;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;CCKAR;8;1.27e-76;0.4051;29.639;135.8079;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;CCKAR;8;1.4180000000000002e-79;0.4247;30.7862;141.1077;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;CCKAR;8;1.738e-81;0.48;31.529;144.5396;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;CCKAR;8;2.289e-79;0.45;30.7054;140.7346;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;CCKAR;8;7.725999999999999e-92;0.4933;35.5521;163.1251;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;CCKAR;8;5.154e-88;0.5068;34.066;156.2594;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;CCKAR;8;4.8689999999999997e-91;0.5132;35.2414;161.6898;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;CCKAR;8;1.556e-79;0.4487;30.7705;141.0355;CCKAR;Cholecystokinin receptor type A (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;CCKAR;8;1.059e-80;0.4605;31.2241;143.1306;CCKAR;Cholecystokinin receptor type A (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;CCKAR;7;1.646e-129;0.4865;85.1255;230.7574;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;CCKAR;7;1.621e-127;0.4868;83.8137;227.1789;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;CCKAR;7;3.29e-127;0.4615;83.6114;226.6269;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CCKAR;7;3.3189999999999997e-137;0.5333;90.1901;244.5731;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;CCKAR;7;1.384e-121;0.4487;79.9101;216.5302;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;CCKAR;7;6.809e-135;0.5429;88.6685;240.4222;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;CCKAR;7;1.1099999999999999e-126;0.4605;83.2638;225.6787;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;CCKAR;7;1.626e-108;0.4458;71.3084;193.0655;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;CCKAR;7;1.204e-126;0.5;83.2404;225.615;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;CCKAR;7;3.4290000000000003e-124;0.5658;81.6252;221.2086;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CCKAR;7;1.981e-122;0.5;80.4657;218.0458;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;CCKAR;7;1.162e-115;0.45;76.0112;205.8943;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;CCKAR;7;3.795e-114;0.4909;75.0149;203.1763;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;CCKAR;7;3.8029999999999997e-119;0.48;78.3049;212.1512;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;CCKAR;7;1.357e-113;0.45;74.6507;202.1829;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;CCKAR;7;3.405e-129;0.4933;84.9178;230.1907;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;CCKAR;7;1.164e-126;0.5068;83.2501;225.6414;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;CCKAR;7;3.206e-130;0.5132;85.5931;232.0329;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;CCKAR;7;6.422999999999999e-114;0.4487;74.8645;202.7661;CCKAR;Cholecystokinin receptor type A (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;CCKAR;7;6.471e-114;0.4605;74.8623;202.7602;CCKAR;Cholecystokinin receptor type A (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;CCKBR;8;9.12e-83;0.5588;41.4477;146.8379;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;CCKBR;8;1.807e-81;0.5147;40.7961;144.5093;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;CCKBR;8;1.0150000000000001e-84;0.4932;42.4291;150.3447;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CCKBR;8;3.636e-86;0.6061;43.1556;152.9407;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;CCKBR;8;2.741e-80;0.5278;40.2028;142.3892;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;CCKBR;8;1.162e-84;0.6452;42.3997;150.2397;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;CCKBR;8;1.103e-82;0.4857;41.4062;146.6893;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;CCKBR;8;6.294e-82;0.4304;41.0262;145.3317;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7009650;CCKBR;8;1.1480000000000001e-64;0.5139;32.3541;114.3426;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;CCKBR;8;8.258e-92;0.5;45.9911;163.0731;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;CCKBR;8;8.218000000000001e-78;0.5821;38.9584;137.9425;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CCKBR;8;3.5309999999999998e-81;0.5606;40.65;143.9871;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;CCKBR;8;1.186e-80;0.44;40.3855;143.0422;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;CCKBR;8;1.117e-88;0.4533;44.418;157.4519;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;CCKBR;8;5.517e-82;0.5385;41.055;145.4344;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;CCKBR;8;8.944e-81;0.5217;40.4472;143.2624;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;CCKBR;8;2.996e-82;0.5616;41.1882;145.9105;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;CCKBR;8;2.919e-82;0.5714;41.1939;145.9308;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;CCKBR;8;3.541e-85;0.6061;42.659;151.1661;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;CCKBR;8;5.597000000000001e-55;0.481;27.4867;96.9497;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;CCKBR;8;3.8829999999999995e-80;0.5224;40.1268;142.1178;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;CCKBR;8;3.201e-80;0.5077;40.1689;142.2682;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;CCKBR;9;2.7639999999999996e-47;0.5;11.7699;83.1373;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;CCKBR;9;2.256e-47;0.5065;11.792;83.2954;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;CCKBR;9;2.08e-48;0.4568;12.0524;85.1543;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CCKBR;9;1.71e-52;0.527;13.0796;92.4881;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;CCKBR;9;7.949000000000001e-46;0.4684;11.403;80.5182;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;CCKBR;9;2.518e-52;0.5132;13.0373;92.1866;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;CCKBR;9;7.029e-48;0.4557;11.9194;84.2048;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;CCKBR;9;7.454e-49;0.4416;12.1644;85.9543;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;CCKBR;9;3.0550000000000002e-46;0.5063;11.5075;81.2639;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CCKBR;9;1.1e-46;0.4684;11.619;82.0601;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;CCKBR;9;1.478e-43;0.4;10.8324;76.4441;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;CCKBR;9;1.124e-47;0.4533;11.8681;83.8384;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;CCKBR;9;3.848e-46;0.4605;11.4822;81.0838;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;CCKBR;9;1.9e-45;0.45;11.3078;79.8387;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;CCKBR;9;3.446e-49;0.5616;12.2487;86.5558;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;CCKBR;9;1.331e-47;0.4933;11.8496;83.7068;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;CCKBR;9;4.334e-48;0.4935;11.9722;84.5818;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;CCKBR;9;4.315e-45;0.4375;11.2183;79.1994;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;CCKBR;9;6.6240000000000006e-46;0.4416;11.4229;80.6604;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;CCKBR;7;5.296999999999999e-91;0.5588;71.0333;161.6241;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;CCKBR;7;1.4759999999999999e-94;0.5362;73.8109;168.0062;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;CCKBR;7;6.518e-101;0.5;78.7763;179.4155;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;CCKBR;7;7.358e-95;0.6154;74.0471;168.5491;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;CCKBR;7;7.678e-92;0.5278;71.6886;163.1299;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;CCKBR;7;9.971e-95;0.6452;73.944;168.3121;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;CCKBR;7;1.1889999999999999e-94;0.5;73.8843;168.1749;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;CCKBR;7;3.341e-97;0.4304;75.8777;172.7552;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7009650;CCKBR;7;5.5119999999999995e-67;0.5139;52.2675;118.5054;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;CCKBR;7;6.937000000000001e-109;0.5;85.0059;193.7294;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;CCKBR;7;3.459e-81;0.5821;63.3644;144.0031;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CCKBR;7;5.046e-94;0.5606;73.3938;167.0479;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;CCKBR;7;7.498e-98;0.44;76.3847;173.9203;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;CCKBR;7;5.796e-106;0.4533;82.7229;188.4836;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;CCKBR;7;8.211e-98;0.5385;76.3539;173.8495;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;CCKBR;7;2.435e-96;0.5217;75.2037;171.2065;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;CCKBR;7;9.456e-91;0.5758;70.8366;161.1722;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;CCKBR;7;3.967e-93;0.5938;72.694;165.44;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;CCKBR;7;9.01e-96;0.6061;74.7597;170.1864;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;CCKBR;7;1.589e-71;0.481;55.815;126.6566;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;CCKBR;7;7.67e-93;0.5224;72.4703;164.926;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;CCKBR;7;1.773e-91;0.5077;71.4046;162.4772;CCKBR;Gastrin/cholecystokinin type B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
69421;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
12591;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
8163;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
12530;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
80108;CES1;7;1.1579999999999999e-73;0.4;11.6077;130.4941;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
11622;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
7643;CES1;7;4.1e-70;0.4054;11.044;124.1221;CES1;Liver carboxylesterase 1 (pKi >= 7);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
31292;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
8180;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
10468;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
22556;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
12741;CES1;7;3.571e-43;0.52;6.7649;75.7562;CES1;Liver carboxylesterase 1 (pKi >= 7);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
80108;CES1;8;2.3359999999999998e-51;0.4;5.6604;90.4495;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
7643;CES1;8;5.263e-44;0.4054;4.8397;77.2491;CES1;Liver carboxylesterase 1 (pKi >= 8);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
69421;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
12591;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
8163;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
12530;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
11622;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
31292;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
8180;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
10468;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
22556;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
12741;CES2;6;6.937e-43;0.52;3.6323;75.2384;CES2;Cocaine esterase (pKi >= 6);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
4657542;CPA1;7;5.32e-66;0.4848;3.0593;116.7378;CPA1;Carboxypeptidase A1 (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;CPA1;7;8.634e-60;0.4103;2.7681;105.5882;CPA1;Carboxypeptidase A1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
97415;CPA1;7;1.293e-61;0.4324;2.8537;108.8637;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CPA1;7;7.248e-58;0.4;2.6779;102.1341;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
47579;CPA1;7;3.1570000000000003e-71;0.4571;3.3045;126.1212;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;CPA1;7;5.406e-52;0.439;2.4025;91.5907;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
6992643;CPA1;7;2.29e-66;0.4186;3.0765;117.395;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CPA1;7;5.2059999999999996e-52;0.4107;2.4032;91.6201;CPA1;Carboxypeptidase A1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;CPA1;7;4.011e-67;0.4103;3.112;118.7532;CPA1;Carboxypeptidase A1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
759256;CPA1;7;4.498e-56;0.4571;2.5938;98.9154;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
193508;CPA1;7;6.109e-59;0.4;2.7282;104.0627;CPA1;Carboxypeptidase A1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
7020642;CTRA_BOVIN;6;7.313e-43;0.4058;7.3401;75.1973;CTRA_BOVIN;Chymotrypsinogen A (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;CTRA_BOVIN;7;7.285e-43;0.4;4.3669;75.2003;CTRA_BOVIN;Chymotrypsinogen A (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7010580;CTSB;8;1.958e-45;0.4151;7.3481;79.8152;CTSB;Cathepsin B (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
4466134;CTSB;8;4.381e-48;0.4444;7.7823;84.5735;CTSB;Cathepsin B (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;CTSB;8;2.631e-48;0.4118;7.8186;84.9711;CTSB;Cathepsin B (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;CTSB;8;9.748e-41;0.4182;6.5787;71.3825;CTSB;Cathepsin B (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7359122;CTSB;8;4.476e-47;0.4231;7.617;82.7613;CTSB;Cathepsin B (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;CTSB;8;1.1409999999999999e-51;0.4118;8.3694;91.0082;CTSB;Cathepsin B (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010566;CTSB;8;4.0819999999999994e-51;0.4545;8.2787;90.0144;CTSB;Cathepsin B (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;CTSB;8;1.247e-42;0.4035;6.8888;74.781;CTSB;Cathepsin B (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
4466134;CTSB;9;3.192e-53;0.4286;3.7682;93.7968;CTSB;Cathepsin B (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;CTSB;9;5.652e-68;0.4118;4.8268;120.2812;CTSB;Cathepsin B (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;CTSB;9;2.834e-51;0.4068;3.6284;90.2989;CTSB;Cathepsin B (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
515709;CTSB;9;2.5450000000000002e-42;0.4727;2.9858;74.225;CTSB;Cathepsin B (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CTSB;9;2.5450000000000002e-42;0.4727;2.9858;74.225;CTSB;Cathepsin B (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CTSB;9;4.596e-60;0.4038;4.2592;106.0798;CTSB;Cathepsin B (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;CTSB;9;1.7729999999999998e-45;0.4;3.2124;79.8926;CTSB;Cathepsin B (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
7010566;CTSB;9;3.4259999999999995e-66;0.4545;4.6989;117.0807;CTSB;Cathepsin B (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;CTSB;9;1.252e-49;0.4035;3.5103;87.3456;CTSB;Cathepsin B (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
6993120;CTSB;7;2.403e-90;0.5814;29.7972;160.4451;CTSB;Cathepsin B (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CTSB;7;2.325e-58;0.5;19.2005;103.0205;CTSB;Cathepsin B (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;CTSB;7;2.285e-76;0.6429;25.1663;135.3497;CTSB;Cathepsin B (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CTSB;7;1.7200000000000001e-87;0.5682;28.8514;155.3199;CTSB;Cathepsin B (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CTSB;7;5.206e-58;0.561;19.0845;102.392;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CTSB;7;8.532e-71;0.6341;23.3203;125.346;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CTSB;7;5.802e-68;0.6;22.3819;120.2608;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CTSB;7;1.298e-56;0.5918;18.6218;99.8847;CTSB;Cathepsin B (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;CTSB;7;4.328e-43;0.5;14.1417;75.6063;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;CTSB;7;1.207e-60;0.55;19.9574;107.1225;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CTSB;7;1.373e-90;0.5778;29.8778;160.8817;CTSB;Cathepsin B (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;CTSB;7;1.074e-62;0.4783;20.6368;110.8043;CTSB;Cathepsin B (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;CTSB;7;1.051e-56;0.5833;18.6521;100.049;CTSB;Cathepsin B (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
323786;CTSB;7;3.12e-44;0.5072;14.5201;77.6569;CTSB;Cathepsin B (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;CTSB;7;1.716e-44;0.6;14.6061;78.123;CTSB;Cathepsin B (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;CTSB;7;4.425e-47;0.5;15.4637;82.7703;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;CTSB;7;6.027e-68;0.5581;22.3764;120.2311;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CTSB;7;1.887e-83;0.5;27.5129;148.0663;CTSB;Cathepsin B (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CTSB;7;9.759e-79;0.7209;25.9513;139.6038;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CTSB;7;9.759e-79;0.7209;25.9513;139.6038;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CTSB;7;6.071999999999999e-93;0.6098;30.6577;165.1082;CTSB;Cathepsin B (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;CTSB;7;1.83e-49;0.5714;16.2533;87.0493;CTSB;Cathepsin B (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;CTSB;7;9.061000000000001e-70;0.4694;22.9803;123.5038;CTSB;Cathepsin B (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CTSB;7;7.825e-57;0.551;18.6946;100.279;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;CTSB;7;4.9590000000000006e-55;0.5217;18.0976;97.0441;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CTSB;7;8.585999999999999e-88;0.48;28.9514;155.8615;CTSB;Cathepsin B (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CTSB;7;8.331000000000001e-72;0.5581;23.655;127.1599;CTSB;Cathepsin B (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CTSB;7;1.9990000000000002e-78;0.587;25.8481;139.0447;CTSB;Cathepsin B (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CTSB;7;2.0330000000000002e-63;0.4898;20.8763;112.1018;CTSB;Cathepsin B (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6992304;CTSC;7;3.4629999999999997e-41;0.42;4.4433;72.1895;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;CTSC;7;1.4250000000000002e-57;0.46;6.2394;101.607;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
6992643;CTSC;7;2.837e-48;0.451;5.2201;84.9123;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CTSC;7;2.917e-53;0.4423;5.7668;93.8671;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CTSC;7;1.282e-44;0.4423;4.8195;78.3503;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CTSC;7;1.282e-44;0.4423;4.8195;78.3503;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
10445608;CTSC;7;3.006e-56;0.4615;6.0943;99.2297;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
151134;CTSC;7;8.12e-44;0.4259;4.7316;76.911;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;CTSC;7;1.646e-48;0.451;5.246;85.3369;CTSC;Dipeptidyl peptidase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
5488196;CTSC;8;3.5770000000000005e-42;0.46;3.4753;73.9596;CTSC;Dipeptidyl peptidase 1 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
10445608;CTSC;8;1.3109999999999998e-44;0.4615;3.6794;78.3327;CTSC;Dipeptidyl peptidase 1 (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
14282475;CTSB;6;2.9699999999999997e-46;0.4528;27.2371;81.286;CTSB;Cathepsin B (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
759256;CTSB;6;1.0010000000000001e-42;0.4762;25.1504;74.9527;CTSB;Cathepsin B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
435728;CTSK;7;1.528e-42;0.4464;41.0501;74.6225;CTSK;Cathepsin K (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
7010566;CTSK;7;1.6669999999999997e-41;0.4727;40.0492;72.7597;CTSK;Cathepsin K (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
6993120;CTSL;7;1.158e-66;0.46;31.0183;117.9266;CTSL;Cathepsin L1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CTSL;7;4.499e-52;0.4419;24.1997;91.7339;CTSL;Cathepsin L1 (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
5488196;CTSL;7;1.933e-63;0.449;29.5122;112.141;CTSL;Cathepsin L1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CTSL;7;2.349e-67;0.451;31.3421;119.1703;CTSL;Cathepsin L1 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CTSL;7;1.836e-55;0.4167;25.7837;97.8186;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CTSL;7;1.626e-60;0.4792;28.1452;106.8902;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;CTSL;7;3.8639999999999995e-41;0.4925;19.0895;72.1042;CTSL;Cathepsin L1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;CTSL;7;8.47e-58;0.4615;26.8755;102.0126;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CTSL;7;8.517e-50;0.4426;23.1354;87.6457;CTSL;Cathepsin L1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;CTSL;7;3.98e-60;0.5636;27.9635;106.1921;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;CTSL;7;4.136e-58;0.4464;27.021;102.5715;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CTSL;7;1.123e-74;0.4615;34.7635;132.3132;CTSL;Cathepsin L1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;CTSL;7;5.1459999999999997e-51;0.4423;23.705;89.8339;CTSL;Cathepsin L1 (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;CTSL;7;3.052e-50;0.4333;23.3437;88.4457;CTSL;Cathepsin L1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
323786;CTSL;7;9.376e-46;0.5152;21.2464;80.3895;CTSL;Cathepsin L1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
6992643;CTSL;7;1.56e-59;0.449;27.6862;105.1269;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CTSL;7;4.681e-57;0.4314;26.5285;100.6796;CTSL;Cathepsin L1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CTSL;7;1.625e-65;0.5294;30.4822;115.8671;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CTSL;7;1.625e-65;0.5294;30.4822;115.8671;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CTSL;7;2.942e-74;0.4792;34.568;131.5621;CTSL;Cathepsin L1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
10445608;CTSL;7;2.371e-54;0.4231;25.2645;95.8242;CTSL;Cathepsin L1 (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;CTSL;7;5.081e-50;0.4906;23.2402;88.0484;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;CTSL;7;4.0080000000000002e-56;0.4231;26.0926;99.0053;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CTSL;7;4.087e-70;0.4545;32.6318;124.1245;CTSL;Cathepsin L1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CTSL;7;5.939e-62;0.449;28.817;109.4706;CTSL;Cathepsin L1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CTSL;7;5.278e-69;0.4828;32.1125;122.1299;CTSL;Cathepsin L1 (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CTSL;7;7.11e-60;0.4576;27.8457;105.7397;CTSL;Cathepsin L1 (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;CTSL;9;1.946e-41;0.4118;5.339;72.6389;CTSL;Cathepsin L1 (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
435728;CTSL;9;5.854e-48;0.4151;6.192;84.3474;CTSL;Cathepsin L1 (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
96814;CTSL;9;8.937e-43;0.4286;5.514;75.0409;CTSL;Cathepsin L1 (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010566;CTSL;9;1.803e-49;0.4262;6.3897;87.061;CTSL;Cathepsin L1 (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;CTSL;9;1.0359999999999999e-44;0.4259;5.7672;78.5167;CTSL;Cathepsin L1 (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
6993120;CTSL;8;5.935e-50;0.46;13.9733;87.9274;CTSL;Cathepsin L1 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
5488196;CTSL;8;1.269e-46;0.449;13.0334;81.9489;CTSL;Cathepsin L1 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CTSL;8;1.929e-49;0.451;13.8288;87.0083;CTSL;Cathepsin L1 (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CTSL;8;2.2139999999999999e-41;0.4167;11.5538;72.5384;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CTSL;8;5.948e-47;0.449;13.1263;82.5397;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CTSL;8;2.049e-46;0.434;12.9746;81.5753;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
134906;CTSL;8;1.006e-50;0.5;14.1909;89.3115;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;CTSL;8;4.125e-55;0.5231;15.4293;97.1876;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;CTSL;8;5.065e-41;0.4043;11.4524;71.893;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CTSL;8;1.9720000000000002e-63;0.4615;17.7779;112.1257;CTSL;Cathepsin L1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13783081;CTSL;8;5.896999999999999e-51;0.4714;14.2564;89.7276;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
6992643;CTSL;8;2.155e-44;0.42;12.4039;77.9453;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CTSL;8;5.179e-46;0.4314;12.861;80.8523;CTSL;Cathepsin L1 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CTSL;8;6.471999999999999e-51;0.5294;14.245;89.6551;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CTSL;8;6.471999999999999e-51;0.5294;14.245;89.6551;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CTSL;8;1.465e-54;0.4792;15.2739;96.1996;CTSL;Cathepsin L1 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
10445608;CTSL;8;3.3389999999999997e-45;0.4231;12.6325;79.3993;CTSL;Cathepsin L1 (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
151134;CTSL;8;3.997e-42;0.4211;11.7637;73.873;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CTSL;8;1.1039999999999999e-66;0.4545;18.6958;117.964;CTSL;Cathepsin L1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CTSL;8;1.4690000000000001e-46;0.42;13.0154;81.8347;CTSL;Cathepsin L1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CTSL;8;9.453e-57;0.4828;15.8921;100.1317;CTSL;Cathepsin L1 (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CTSL;8;5.0589999999999995e-45;0.4576;12.5816;79.0752;CTSL;Cathepsin L1 (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
134906;CTSL;6;7.002e-54;0.5636;41.3816;94.9797;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
13783081;CTSL;6;1.284e-52;0.5217;40.4094;92.7113;CTSL;Cathepsin L1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;CTSL;6;5.151e-44;0.5156;33.7901;77.2659;CTSL;Cathepsin L1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
10634;CYP17A1;7;8.059e-56;0.75;15.0692;98.4607;CYP17A1;Steroid 17-alpha-hydroxylase/17,20 lyase (pKi >= 7);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
10634;CYP17A1;8;1.149e-48;0.75;4.7649;85.6172;CYP17A1;Steroid 17-alpha-hydroxylase/17,20 lyase (pKi >= 8);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
5280666;CYP1A1;7;2.586e-70;1.0;11.0758;124.4814;CYP1A1;Cytochrome P450 1A1 (pKi >= 7);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
5280666;CYP1B1;6;1.3960000000000002e-72;1.0;14.3887;128.5529;CYP1B1;Cytochrome P450 1B1 (pKi >= 6);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
5280666;CYP1B1;8;6.166e-72;0.7273;6.2949;127.3946;CYP1B1;Cytochrome P450 1B1 (pKi >= 8);COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O;SCZVLDHREVKTSH-UHFFFAOYSA-N
9547243;CYP24A1;6;2.616e-50;0.6438;5.9349;88.5659;CYP24A1;1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (pKi >= 6);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
9547243;CYP24A1;8;1.6949999999999998e-41;0.5584;1.3605;72.7466;CYP24A1;1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (pKi >= 8);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
6993120;CYSP_TRYCR;6;1.302e-77;0.4528;25.6676;137.5839;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;CYSP_TRYCR;6;5.302e-64;0.5143;21.143;113.1497;CYSP_TRYCR;Cruzipain (pKi >= 6);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
515717;CYSP_TRYCR;6;4.4890000000000003e-42;0.4;13.8533;73.7824;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
5488196;CYSP_TRYCR;6;7.399e-69;0.4151;22.7571;121.8665;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CYSP_TRYCR;6;4.748e-76;0.4444;25.1483;134.7796;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;CYSP_TRYCR;6;5.923e-61;0.425;20.1297;107.6775;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;CYSP_TRYCR;6;1.506e-70;0.451;23.3194;124.903;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CYSP_TRYCR;6;1.011e-65;0.4364;21.7148;116.2372;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CYSP_TRYCR;6;3.6469999999999995e-47;0.4483;15.5455;82.9211;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
47579;CYSP_TRYCR;6;1.235e-62;0.4474;20.6885;110.6949;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;CYSP_TRYCR;6;3.147e-71;0.4821;23.5454;126.1235;CYSP_TRYCR;Cruzipain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;CYSP_TRYCR;6;1.295e-60;0.4186;20.0168;107.0674;CYSP_TRYCR;Cruzipain (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;CYSP_TRYCR;6;3.6949999999999995e-51;0.4483;16.8734;90.0922;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
92946;CYSP_TRYCR;6;1.4230000000000002e-46;0.4;15.3489;81.8595;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6992643;CYSP_TRYCR;6;1.0700000000000001e-70;0.4231;23.3688;125.1696;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CYSP_TRYCR;6;4.074e-70;0.4;23.1758;124.1271;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CYSP_TRYCR;6;1.837e-75;0.4528;24.953;133.7248;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CYSP_TRYCR;6;1.837e-75;0.4528;24.953;133.7248;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CYSP_TRYCR;6;6.751e-81;0.4706;26.7597;143.4817;CYSP_TRYCR;Cruzipain (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;CYSP_TRYCR;6;9.145e-45;0.4167;14.7479;78.6137;CYSP_TRYCR;Cruzipain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
150964;CYSP_TRYCR;6;1.519e-58;0.4262;19.3288;103.3523;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;CYSP_TRYCR;6;7.985e-46;0.4103;15.0999;80.5147;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;CYSP_TRYCR;6;3.807e-73;0.4259;24.1829;129.5658;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CYSP_TRYCR;6;2.0140000000000002e-71;0.431;23.6099;126.4718;CYSP_TRYCR;Cruzipain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CYSP_TRYCR;6;4.211e-81;0.4231;26.8278;143.8497;CYSP_TRYCR;Cruzipain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CYSP_TRYCR;6;5.363e-78;0.4912;25.7956;138.2752;CYSP_TRYCR;Cruzipain (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CYSP_TRYCR;6;5.8250000000000005e-74;0.4407;24.4539;131.0296;CYSP_TRYCR;Cruzipain (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;CYSP_TRYCR;8;2.172e-78;0.4528;10.3156;138.9798;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
515717;CYSP_TRYCR;8;4.3149999999999995e-47;0.4;6.1643;82.7899;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
5488196;CYSP_TRYCR;8;3.779e-74;0.4151;9.7532;131.3668;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;CYSP_TRYCR;8;1.972e-79;0.4444;10.4539;140.8508;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;CYSP_TRYCR;8;5.747e-72;0.4423;9.4638;127.4494;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;CYSP_TRYCR;8;3.6280000000000004e-64;0.431;8.4291;113.4456;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;CYSP_TRYCR;8;1.2560000000000001e-55;0.4483;7.2965;98.1145;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;CYSP_TRYCR;8;1.9960000000000002e-72;0.4821;9.5247;128.2739;CYSP_TRYCR;Cruzipain (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;CYSP_TRYCR;8;1.7750000000000001e-56;0.4483;7.4092;99.6404;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
92946;CYSP_TRYCR;8;4.1429999999999996e-47;0.4;6.1666;82.8217;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
6992643;CYSP_TRYCR;8;1.868e-69;0.4182;9.1306;122.9399;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;CYSP_TRYCR;8;2.5869999999999998e-75;0.4;9.9076;133.4576;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;CYSP_TRYCR;8;8.58e-71;0.4464;9.308;125.3416;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;CYSP_TRYCR;8;8.58e-71;0.4464;9.308;125.3416;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;CYSP_TRYCR;8;7.716e-81;0.4706;10.6405;143.3776;CYSP_TRYCR;Cruzipain (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;CYSP_TRYCR;8;5.638999999999999e-47;0.4167;6.1489;82.5813;CYSP_TRYCR;Cruzipain (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
150964;CYSP_TRYCR;8;4.533e-55;0.4262;7.2226;97.114;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;CYSP_TRYCR;8;1.0389999999999999e-66;0.4211;8.7664;118.0108;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;CYSP_TRYCR;8;1.0980000000000001e-76;0.431;10.0897;135.9213;CYSP_TRYCR;Cruzipain (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;CYSP_TRYCR;8;1.976e-76;0.4182;10.0558;135.4631;CYSP_TRYCR;Cruzipain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;CYSP_TRYCR;8;3.104e-76;0.4727;10.0298;135.111;CYSP_TRYCR;Cruzipain (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;CYSP_TRYCR;8;1.5390000000000001e-71;0.4237;9.407;126.6815;CYSP_TRYCR;Cruzipain (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
3081383;DOT1L;7;9.388000000000001e-85;0.4167;5.6017;150.4059;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 7);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
92021849;DOT1L;7;4.193e-96;0.4382;6.3584;170.7828;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;DOT1L;9;3.182e-62;0.4382;1.8193;109.9573;DOT1L;Histone-lysine N-methyltransferase, H3 lysine-79 specific (pKi >= 9);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
7020642;DPP4;7;8.384e-53;0.6889;83.3954;93.0439;DPP4;Dipeptidyl peptidase 4 (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;DPP7;7;2.441e-68;0.4407;13.236;120.9357;DPP7;Dipeptidyl peptidase 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;DPP7;6;2.6110000000000003e-63;0.4844;23.5171;111.9067;DPP7;Dipeptidyl peptidase 2 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
171204;DPP7;8;4.577e-44;0.5111;6.0783;77.358;DPP7;Dipeptidyl peptidase 2 (pKi >= 8);C1CC(N(C1)C(=O)C(CCCCN)N)C(=O)O;AIXUQKMMBQJZCU-UHFFFAOYSA-N
11736661;DPP7;8;3.736e-43;0.4565;5.9508;75.721;DPP7;Dipeptidyl peptidase 2 (pKi >= 8);C1CC(N(C1)C(=O)C(CCC(=O)N)N)C(=O)O;NJMYZEJORPYOTO-UHFFFAOYSA-N
6993120;ECE1;8;3.515e-46;0.4375;4.898;81.1544;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
100094;ECE1;8;3.702e-45;0.6071;4.788;79.3187;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7010580;ECE1;8;3.058e-45;0.4286;4.7969;79.4678;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
329275;ECE1;8;1.578e-55;0.7308;5.9037;97.9366;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;ECE1;8;3.256e-50;0.6545;5.3319;88.3955;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ECE1;8;3.467e-56;0.6296;5.9745;99.1185;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;ECE1;8;7.301e-43;0.5893;4.5411;75.1986;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;ECE1;8;9.587e-55;0.6;5.8194;96.53;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;ECE1;8;1.877e-46;0.4118;4.9273;81.6436;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
168182;ECE1;8;9.378e-55;0.7255;5.8204;96.5472;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;ECE1;8;1.7299999999999997e-42;0.5574;4.5008;74.5257;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;ECE1;8;1.1139999999999999e-44;0.6154;4.7365;78.46;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;ECE1;8;1.9620000000000003e-46;0.5593;4.9253;81.6092;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;ECE1;8;9.047e-50;0.6667;5.2842;87.5986;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
4656408;ECE1;8;6.184e-41;0.5185;4.3337;71.7374;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;ECE1;8;6.374e-43;0.5636;4.5474;75.3045;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
96814;ECE1;8;1.689e-49;0.4565;5.255;87.1119;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
19816755;ECE1;8;3.722e-49;0.5167;5.2181;86.4957;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;ECE1;8;4.573e-47;0.6415;4.9933;82.7447;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;ECE1;8;2.198e-48;0.6667;5.1351;85.1111;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;ECE1;8;3.384e-42;0.4118;4.4694;74.0028;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3634442;ECE1;8;3.0220000000000004e-42;0.5517;4.4747;74.0911;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;ECE1;8;2.957e-42;0.5714;4.4758;74.1081;ECE1;Endothelin-converting enzyme 1 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
6993120;ECE1;7;6.383000000000001e-70;0.4545;19.5227;123.7769;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;ECE1;7;1.124e-48;0.4186;13.5522;85.634;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
100094;ECE1;7;2.06e-64;0.6071;17.9746;113.887;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
7010580;ECE1;7;8.949e-69;0.4364;19.2004;121.7182;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;ECE1;7;1.491e-50;0.4231;14.0798;89.0046;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;ECE1;7;1.069e-56;0.4528;15.8064;100.0354;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;ECE1;7;3.382e-79;0.7308;22.1293;140.43;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;ECE1;7;2.271e-53;0.4138;14.8714;94.0621;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;ECE1;7;2.752e-55;0.4058;15.41;97.503;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;ECE1;7;1.302e-73;0.6545;20.5598;130.4026;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;ECE1;7;7.454e-95;0.6545;26.5292;168.5389;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;ECE1;7;3.1070000000000002e-46;0.4286;12.8661;81.2506;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
3038501;ECE1;7;5.205e-67;0.5893;18.7045;118.5501;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;ECE1;7;2.529e-95;0.625;26.6611;169.3816;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;ECE1;7;1.982e-77;0.44;21.6325;137.2561;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;ECE1;7;5.058e-71;0.4828;19.8321;125.7536;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;ECE1;7;1.676e-51;0.4483;14.3465;90.7084;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;ECE1;7;9.449e-77;0.7255;21.4419;136.0383;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;ECE1;7;7.235e-55;0.5333;15.2921;96.7495;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
273262;ECE1;7;5.469e-64;0.4333;17.8554;113.1255;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009650;ECE1;7;2.057e-58;0.5574;16.2886;103.116;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
7009555;ECE1;7;2.55e-55;0.4138;15.4194;97.5625;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
102763;ECE1;7;2.143e-70;0.6154;19.6559;124.6281;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;ECE1;7;4.635e-91;0.6102;25.4631;161.7281;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;ECE1;7;5.734e-76;0.6667;21.2219;134.6325;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;ECE1;7;3.902e-57;0.4035;15.9295;100.8216;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;ECE1;7;3.8379999999999996e-45;0.4;12.5593;79.2905;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
25200879;ECE1;7;1.685e-49;0.4754;13.7839;87.1139;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;ECE1;7;2.803e-59;0.5455;16.5319;104.67;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
6992643;ECE1;7;6.609e-49;0.4167;13.617;86.0481;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
515709;ECE1;7;8.491e-67;0.4545;18.6448;118.1685;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
263475;ECE1;7;2.115e-55;0.5636;15.4422;97.7085;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3421919;ECE1;7;8.491e-67;0.4545;18.6448;118.1685;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;ECE1;7;3.069e-80;0.4615;22.4222;142.3012;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;ECE1;7;2.966e-47;0.4426;13.1528;83.0822;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
19816755;ECE1;7;1.2980000000000002e-58;0.5167;16.3449;103.4753;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;ECE1;7;5.899e-71;0.6415;19.8133;125.6337;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;ECE1;7;1.6760000000000002e-78;0.6667;21.934;139.1822;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;ECE1;7;1.629e-62;0.5517;17.4412;110.4792;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
193508;ECE1;7;1.4270000000000002e-46;0.4167;12.9611;81.8574;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
19816756;ECE1;7;3.811e-59;0.5714;16.4944;104.4307;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100048;ECE1;7;8.122e-54;0.5;14.997;94.864;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
263471;ECE1;7;2.82e-48;0.4737;13.4399;84.9168;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
7010506;ECE1;7;1.9149999999999999e-41;0.4516;11.5201;72.6515;ECE1;Endothelin-converting enzyme 1 (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
329275;EDNRA;7;8.351e-49;0.5938;58.1356;85.8657;EDNRA;Endothelin-1 receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;EDNRA;7;1.442e-44;0.625;53.1005;78.2583;EDNRA;Endothelin-1 receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
168182;EDNRA;7;1.1870000000000001e-42;0.5538;50.8246;74.8197;EDNRA;Endothelin-1 receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
323786;EDNRA;7;1.035e-49;0.5692;59.213;87.4935;EDNRA;Endothelin-1 receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
100094;EDNRB;7;2.571e-56;0.5493;29.2503;99.3516;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;EDNRB;7;6.5110000000000004e-62;0.5938;32.1703;109.3989;EDNRB;Endothelin B receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;EDNRB;7;4.902e-62;0.625;32.2346;109.6203;EDNRB;Endothelin B receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;EDNRB;7;6.437e-55;0.6032;28.5206;96.8406;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;EDNRB;7;6.673e-44;0.5517;22.7731;77.064;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;EDNRB;7;7.415999999999999e-53;0.5781;27.445;93.1396;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;EDNRB;7;1.9000000000000002e-58;0.5614;30.3623;103.1778;EDNRB;Endothelin B receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;EDNRB;7;2.1759999999999997e-51;0.6316;26.6793;90.5049;EDNRB;Endothelin B receptor (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
13783081;EDNRB;7;2.221e-42;0.5541;21.9789;74.3312;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;EDNRB;7;2.0109999999999998e-60;0.5692;31.3929;106.7242;EDNRB;Endothelin B receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;EDNRB;7;1.796e-43;0.4746;22.5488;76.2923;EDNRB;Endothelin B receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;EDNRB;7;2.5329999999999997e-47;0.5758;24.5578;83.2053;EDNRB;Endothelin B receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;EDNRB;7;2.921e-55;0.5714;28.6996;97.4567;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;EDNRB;7;1.5930000000000001e-57;0.5926;29.8805;101.5201;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;EDNRB;7;2.229e-55;0.5278;28.7609;97.6674;EDNRB;Endothelin B receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;EDNRB;7;2.464e-41;0.4935;21.4335;72.4548;EDNRB;Endothelin B receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100094;EDNRB;8;5.206e-55;0.4857;14.2862;97.0061;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;EDNRB;8;8.916999999999999e-60;0.5147;15.5346;105.5631;EDNRB;Endothelin B receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;EDNRB;8;2.6930000000000002e-58;0.519;15.1469;102.9059;EDNRB;Endothelin B receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;EDNRB;8;5.24e-50;0.5455;12.9758;88.0244;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;EDNRB;8;9.015e-49;0.5224;12.6521;85.8061;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;EDNRB;8;1.972e-56;0.5224;14.6585;99.5583;EDNRB;Endothelin B receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;EDNRB;8;3.701e-52;0.4722;13.5392;91.8862;EDNRB;Endothelin B receptor (pKi >= 8);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
323786;EDNRB;8;1.4380000000000001e-58;0.4714;15.2183;103.3952;EDNRB;Endothelin B receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;EDNRB;8;4.603e-43;0.4028;11.157;75.5583;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
9948926;EDNRB;8;2.064e-51;0.5075;13.3437;90.546;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;EDNRB;8;7.444000000000001e-57;0.5231;14.7694;100.318;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;EDNRB;8;6.285e-56;0.4444;14.5267;98.6545;EDNRB;Endothelin B receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
100094;EDNRB;6;3.391e-49;0.5571;40.7978;86.5684;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;EDNRB;6;3.447e-54;0.5938;44.9437;95.5323;EDNRB;Endothelin B receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;EDNRB;6;4.02e-55;0.625;45.7186;97.2076;EDNRB;Endothelin B receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;EDNRB;6;1.387e-48;0.6032;40.2898;85.4699;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;EDNRB;6;1.4260000000000001e-46;0.5781;38.6191;81.8578;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;EDNRB;6;2.777e-51;0.5614;42.5306;90.3148;EDNRB;Endothelin B receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;EDNRB;6;3.0569999999999997e-44;0.6316;36.6835;77.6728;EDNRB;Endothelin B receptor (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
323786;EDNRB;6;1.212e-52;0.5692;43.6599;92.7566;EDNRB;Endothelin B receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
19816755;EDNRB;6;5.245e-44;0.5758;36.4888;77.2518;EDNRB;Endothelin B receptor (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;EDNRB;6;5.176e-49;0.5714;40.6453;86.2387;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;EDNRB;6;9.063e-50;0.5926;41.2737;87.5972;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;EDNRB;6;9.941e-48;0.5352;39.5796;83.9346;EDNRB;Endothelin B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14304554;ENPEP;6;3.196e-97;0.5435;11.7263;172.79;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
18218220;ENPEP;6;1.955e-77;0.4468;9.3241;137.2668;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(C(C)O)C(=O)O)N;DRCKHKZYDLJYFQ-UHFFFAOYSA-N
435949;ENPEP;6;3.432e-81;0.4565;9.7801;144.0094;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(C(C)C)C(=O)O)N;BCXBIONYYJCSDF-UHFFFAOYSA-N
13817313;ENPEP;6;8.062e-72;0.4118;8.6424;127.1855;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7009623;ENPEP;6;4.564e-84;0.449;10.1292;149.1729;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
7010532;ENPEP;6;9.923999999999999e-88;0.5227;10.5739;155.7486;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(C(C)C)N;PNVLWFYAPWAQMU-UHFFFAOYSA-N
9900065;ENPEP;6;1.744e-62;0.4035;7.5091;110.4259;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CN=CN1)N;IDXZDKMBEXLFMB-UHFFFAOYSA-N
57315376;ENPEP;6;5.288e-84;0.5;10.1215;149.0581;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)N)N;XITLYYAIPBBHPX-UHFFFAOYSA-N
13879965;ENPEP;6;1.078e-88;0.5349;10.6909;157.4792;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)N;BCVIOZZGJNOEQS-UHFFFAOYSA-N
17863274;ENPEP;6;1.1979999999999999e-68;0.4074;8.2573;121.491;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CCSC)C(=O)O)N;TUYOFUHICRWDGA-UHFFFAOYSA-N
7010499;ENPEP;6;5.338e-85;0.4898;10.2424;150.8462;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
56991460;ENPEP;6;1.5670000000000001e-84;0.4894;10.1856;150.0064;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC(=O)N)N;MQLZLIYPFDIDMZ-UHFFFAOYSA-N
7009553;ENPEP;6;2.767e-80;0.4808;9.67;142.3818;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
14282475;ENPEP;6;8.793e-87;0.4259;10.4589;154.0476;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
435718;ENPEP;6;4.585e-84;0.5;10.129;149.1694;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
6992643;ENPEP;6;6.875e-64;0.4545;7.6796;112.9472;ENPEP;Glutamyl aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
96814;ENPEP;6;3.639e-62;0.4;7.4703;109.8526;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;ENPEP;6;4.156e-77;0.4737;9.2844;136.6787;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4414300;ENPEP;6;4.2510000000000005e-78;0.46;9.4046;138.4565;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)NC(CC(=O)N)C(=O)O)N;HZYHBDVRCBDJJV-UHFFFAOYSA-N
57281443;ENPEP;6;4.166e-83;0.5111;10.0127;147.4488;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(C(C)O)N;LUMXICQAOKVQOB-UHFFFAOYSA-N
7010566;ENPEP;6;3.6929999999999996e-81;0.4423;9.7762;143.9521;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
18218218;ENPEP;7;3.668e-95;0.5417;7.4706;169.0918;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
5259590;ENPEP;7;3.703e-69;0.4314;5.4141;122.4062;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9856500;ENPEP;7;5.416e-62;0.4314;4.8474;109.5426;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
6992567;ENPEP;7;7.743e-68;0.42;5.3096;120.0357;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SITLTJHOQZFJGG-UHFFFAOYSA-N
9813855;ENPEP;7;5.1740000000000004e-98;0.5417;7.6961;174.2095;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SNFUTDLOCQQRQD-UHFFFAOYSA-N
18218218;ENPEP;8;8.545e-59;0.5417;2.3466;103.801;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
5259590;ENPEP;8;3.4440000000000005e-42;0.4314;1.675;73.989;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
14304554;ENPEP;8;1.1880000000000001e-56;0.5435;2.26;99.9533;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;WKXVAXOSIPTXEC-UHFFFAOYSA-N
435949;ENPEP;8;2.7259999999999998e-53;0.4;2.124;93.9198;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(C(C)C)C(=O)O)N;BCXBIONYYJCSDF-UHFFFAOYSA-N
7009623;ENPEP;8;1.029e-50;0.449;2.0198;89.2933;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
7010532;ENPEP;8;4.554e-58;0.4286;2.3173;102.4964;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(C(C)C)N;PNVLWFYAPWAQMU-UHFFFAOYSA-N
57315376;ENPEP;8;2.577e-56;0.4423;2.2464;99.3498;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)N)N;XITLYYAIPBBHPX-UHFFFAOYSA-N
13879965;ENPEP;8;4.9730000000000006e-58;0.4375;2.3157;102.4278;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(C(C)CC)C(=O)O)N;BCVIOZZGJNOEQS-UHFFFAOYSA-N
7010499;ENPEP;8;1.4250000000000002e-57;0.434;2.2972;101.6071;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
56991460;ENPEP;8;6.046e-56;0.4314;2.2314;98.6848;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC(=O)N)N;MQLZLIYPFDIDMZ-UHFFFAOYSA-N
435718;ENPEP;8;5.641000000000001e-55;0.4118;2.1921;96.9435;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
6992643;ENPEP;8;1.3709999999999999e-45;0.4545;1.8125;80.093;ENPEP;Glutamyl aminopeptidase (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
96814;ENPEP;8;9.915e-49;0.4;1.9395;85.7319;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;ENPEP;8;2.513e-57;0.4737;2.2872;101.1646;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
9813855;ENPEP;8;8.745e-61;0.5417;2.4271;107.3736;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)O)N;SNFUTDLOCQQRQD-UHFFFAOYSA-N
4414300;ENPEP;8;1.751e-42;0.46;1.6869;74.5167;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)NC(CC(=O)N)C(=O)O)N;HZYHBDVRCBDJJV-UHFFFAOYSA-N
57281443;ENPEP;8;5.891e-56;0.42;2.2318;98.705;ENPEP;Glutamyl aminopeptidase (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(C(C)O)N;LUMXICQAOKVQOB-UHFFFAOYSA-N
7020642;ELANE;6;3.478e-47;0.4355;46.0372;82.9581;ELANE;Neutrophil elastase (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;ELANE;7;1.027e-54;0.4355;42.7211;96.4763;ELANE;Neutrophil elastase (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
70694;EST1_PIG;6;2.9840000000000003e-63;0.4242;4.9469;111.8026;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
8201;EST1_PIG;6;6.362e-67;0.4643;5.2373;118.3935;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
8164;EST1_PIG;6;2.596e-66;0.4516;5.189;117.2971;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCOC(=O)C;YLYBTZIQSIBWLI-UHFFFAOYSA-N
17525;EST1_PIG;6;2.9840000000000003e-63;0.4242;4.9469;111.8026;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCOC(=O)CCC;XAPCMTMQBXLDBB-UHFFFAOYSA-N
8048;EST1_PIG;6;1.437e-64;0.4483;5.0511;114.1674;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
7800;EST1_PIG;6;1.437e-64;0.4483;5.0511;114.1674;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
454064;EST1_PIG;6;1.495e-64;0.4483;5.0498;114.1367;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
5282761;EST1_PIG;6;3.988e-61;0.4194;4.7788;107.9858;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
12366;EST1_PIG;6;1.437e-64;0.4483;5.0511;114.1674;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
61030;EST1_PIG;6;2.9840000000000003e-63;0.4242;4.9469;111.8026;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCCOC(=O)CCC;PWLNAUNEAKQYLH-UHFFFAOYSA-N
69421;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
12591;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
8163;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
12530;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
11622;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
545258;EST1_PIG;7;8.823000000000001e-71;0.4667;4.6702;125.3199;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
31292;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
8180;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
10468;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
22556;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
520710;EST1_PIG;7;2.418e-63;0.4194;4.1744;111.9667;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
12741;EST1_PIG;7;5.498e-79;0.52;5.2172;140.0512;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
69421;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCC(=O)N;HSEMFIZWXHQJAE-UHFFFAOYSA-N
12591;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
8201;EST1_PIG;8;1.9070000000000003e-58;0.4643;2.3325;103.175;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCCCC(=O)OC;HPEUJPJOZXNMSJ-UHFFFAOYSA-N
8163;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCC(=O)C;KYWIYKKSMDLRDC-UHFFFAOYSA-N
12530;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
11622;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCC(=O)C;CYIFVRUOHKNECG-UHFFFAOYSA-N
545258;EST1_PIG;8;5.282e-60;0.4667;2.3955;105.9713;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCC(=O)OC(C)(C)C;WLUUTGIJNRNHRF-UHFFFAOYSA-N
31292;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCCCC(=O)N;LYRFLYHAGKPMFH-UHFFFAOYSA-N
8180;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
8048;EST1_PIG;8;8.868000000000001e-57;0.4483;2.2651;100.1814;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCC(=O)OCC;RGXWDWUGBIJHDO-UHFFFAOYSA-N
7800;EST1_PIG;8;8.868000000000001e-57;0.4483;2.2651;100.1814;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCC(=O)OCC;MMXKVMNBHPAILY-UHFFFAOYSA-N
10468;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
22556;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCC(=O)C;LSKONYYRONEBKA-UHFFFAOYSA-N
520710;EST1_PIG;8;1.0159999999999999e-53;0.4194;2.1414;94.6893;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCC(=O)OC(C)C;RMQUEHVMCJEEOS-UHFFFAOYSA-N
12741;EST1_PIG;8;2.745e-71;0.52;2.852;126.2303;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCC(=O)C;ZAJNGDIORYACQU-UHFFFAOYSA-N
454064;EST1_PIG;8;8.868000000000001e-57;0.4483;2.2651;100.1814;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
5282761;EST1_PIG;8;1.0159999999999999e-53;0.4194;2.1414;94.6893;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
12366;EST1_PIG;8;8.868000000000001e-57;0.4483;2.2651;100.1814;EST1_PIG;Liver carboxylesterase (pKi >= 8);CCCCCCCCCCCCCCCC(=O)OCC;XIRNKXNNONJFQO-UHFFFAOYSA-N
7020642;F2;10;5.4499999999999994e-61;0.4478;12.2535;107.7423;F2;Prothrombin (pKi >= 10);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;F2;8;1.411e-86;0.6296;82.13;153.6789;F2;Prothrombin (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
14409732;F2;8;4.111e-56;0.4627;53.2307;98.9855;F2;Prothrombin (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
7020642;F2;9;3.713e-71;0.4857;36.9283;125.9948;F2;Prothrombin (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
151003;F2;7;5.3689999999999995e-45;0.55;63.7701;79.0289;F2;Prothrombin (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7020642;F2;6;4.135e-84;0.6538;166.0488;149.25;F2;Prothrombin (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
14409732;F2;6;1.9849999999999997e-53;0.4769;105.7929;94.1671;F2;Prothrombin (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
80108;FAAH;8;1.0270000000000001e-106;0.5238;71.1603;189.8327;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 8);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
80108;FAAH;9;1.3519999999999999e-73;0.4419;18.5795;130.3729;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 9);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
7643;FAAH;9;6.648e-64;0.4419;16.1169;112.9733;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 9);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
5312554;FABP3;6;1.323e-60;1.0;4.4469;107.0508;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
13932172;FABP3;6;1.323e-60;1.0;4.4469;107.0508;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
12591;FABP3;6;7.603e-50;0.7391;3.6481;87.7342;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
12530;FABP3;6;7.603e-50;0.7391;3.6481;87.7342;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
5312378;FABP3;6;2.969e-57;0.9167;4.1981;101.0346;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
8180;FABP3;6;7.603e-50;0.7391;3.6481;87.7342;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
5282942;FABP3;6;2.201e-44;0.697;3.2426;77.929;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCC(CC=CCCCCCCCC(=O)O)O;WBHHMMIMDMUBKC-UHFFFAOYSA-N
10468;FABP3;6;7.603e-50;0.7391;3.6481;87.7342;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
6435901;FABP3;6;6.225e-44;0.7333;3.2091;77.1182;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
5282761;FABP3;6;2.551e-62;1.0;4.5743;110.1296;FABP3;Fatty acid-binding protein, heart (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
7643;FAAH;7;1.149e-80;0.4783;86.3773;143.0671;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 7);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
80108;FAAH;6;1.086e-113;0.5238;147.9212;202.3568;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 6);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
7643;FAAH;6;1.043e-77;0.4783;101.175;137.7565;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 6);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
6993120;FCER2;7;1.234e-94;0.4286;8.0869;168.146;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7010580;FCER2;7;9.831e-98;0.4211;8.3536;173.7091;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
4466134;FCER2;7;1.103e-70;0.4127;6.0252;125.1461;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
435728;FCER2;7;1.589e-88;0.4068;7.561;157.177;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;FCER2;7;1.126e-74;0.4355;6.3687;132.3112;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
515709;FCER2;7;1.254e-84;0.4032;7.2255;150.1802;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;FCER2;7;1.254e-84;0.4032;7.2255;150.1802;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;FCER2;7;1.631e-94;0.4444;8.0765;167.9284;FCER2;Low affinity immunoglobulin epsilon Fc receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7643;FFAR1;7;1.152e-46;0.4286;18.1447;82.0242;FFAR1;Free fatty acid receptor 1 (pKi >= 7);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
161234;FIMH;7;1.5960000000000001e-74;0.4314;4.5274;132.0391;FIMH;FimH (pKi >= 7);C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)O;PUEDDPCUCPRQNY-UHFFFAOYSA-O
4120027;FIMH;7;4.917e-78;0.4651;4.7429;138.3429;FIMH;FimH (pKi >= 7);C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)O)O)CO)O)O)O)O)O)O)O;OWEGMIWEEQEYGQ-UHFFFAOYSA-N
7427;FIMH;7;9.948000000000001e-102;0.5455;6.1966;180.8812;FIMH;FimH (pKi >= 7);C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O;HDTRYLNUVZCQOY-UHFFFAOYSA-N
7020642;FKBP1A;7;7.916999999999999e-54;0.4068;16.633;94.8839;FKBP1A;Peptidyl-prolyl cis-trans isomerase FKBP1A (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
18218218;FOLH1;7;1.084e-65;0.5143;15.1624;116.1824;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
5259590;FOLH1;7;1.936e-64;0.6389;14.8712;113.9353;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9856500;FOLH1;7;1.522e-42;0.6389;9.7788;74.626;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
7009623;FOLH1;7;1.1040000000000001e-72;0.5625;16.7886;128.736;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
11579826;FOLH1;7;1.859e-121;0.5455;28.1323;216.2999;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
7015704;FOLH1;7;8.634000000000001e-63;0.6944;14.4876;110.9742;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
19816750;FOLH1;7;7.297e-77;0.45;17.7607;136.2398;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;FOLH1;7;1.9079999999999998e-89;0.4906;20.6872;158.8297;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
3634442;FOLH1;7;5.133000000000001e-57;0.459;13.1447;100.6077;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
5259590;FOLH1;9;4.576e-67;0.6389;5.2486;118.6505;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9856500;FOLH1;9;9.539999999999999e-45;0.6389;3.4835;78.5806;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
11579826;FOLH1;9;2.654e-93;0.5102;7.3236;165.7535;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
19816750;FOLH1;9;7.703000000000001e-70;0.4;5.468;123.6304;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;FOLH1;9;5.562e-74;0.4906;5.7955;131.0656;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
18218218;FOLH1;6;1.0819999999999999e-66;0.6111;21.0325;117.9792;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
7009623;FOLH1;6;1.0220000000000001e-71;0.6667;22.6272;127.0008;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
65254;FOLH1;6;8.065e-43;0.5789;13.4566;75.121;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
6427003;FOLH1;6;2.497e-41;0.5946;12.9835;72.4447;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
7015704;FOLH1;6;1.683e-61;0.7576;19.3849;108.6584;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
3634442;FOLH1;6;7.244e-60;0.5106;18.8664;105.7251;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
18218218;FOLH1;8;6.716e-67;0.5143;9.6242;118.3513;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
5259590;FOLH1;8;3.17e-66;0.6389;9.5263;117.1414;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
7009623;FOLH1;8;8.951e-75;0.5625;10.7674;132.4899;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
11579826;FOLH1;8;7.595e-111;0.5455;16.0036;197.2494;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
7015704;FOLH1;8;4.034e-64;0.4722;9.2208;113.3629;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
19816750;FOLH1;8;2.371e-71;0.45;10.2705;126.3445;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;FOLH1;8;4.507e-82;0.4906;11.8268;145.5922;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
6993120;FPR1;8;7.131e-68;0.4906;2.4837;120.1;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;FPR1;8;1.089e-50;0.42;1.8475;89.2496;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
118276;FPR1;8;5.666e-49;0.4906;1.7839;86.1682;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C)CC(C(=O)NC(CCSC)C(=O)O)N;NTISAKGPIGTIJJ-UHFFFAOYSA-N
7010580;FPR1;8;8.522999999999999e-67;0.4815;2.4438;118.1655;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;FPR1;8;1.983e-50;0.4151;1.8378;88.7822;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;FPR1;8;4.089e-62;0.4444;2.2705;109.7617;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;FPR1;8;3.623e-61;0.4561;2.2354;108.0607;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;FPR1;8;1.9700000000000002e-64;0.431;2.3563;113.9218;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
47579;FPR1;8;8.803999999999999e-53;0.4314;1.9249;93.0058;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;FPR1;8;2.5809999999999997e-66;0.4643;2.426;117.3017;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;FPR1;8;1.3179999999999999e-51;0.463;1.8814;90.8959;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;FPR1;8;1.228e-65;0.4561;2.4009;116.0856;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
92946;FPR1;8;1.113e-58;0.4107;2.1433;103.5947;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;FPR1;8;7.833e-52;0.4286;1.8898;91.3016;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
515709;FPR1;8;5.186e-62;0.4211;2.2667;109.5763;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;FPR1;8;5.186e-62;0.4211;2.2667;109.5763;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;FPR1;8;3.8700000000000005e-70;0.5098;2.5676;124.1671;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;FPR1;8;6.014e-50;0.4262;1.82;87.917;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;FPR1;8;1.15e-50;0.5532;1.8466;89.2068;FPR1;fMet-Leu-Phe receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
100048;FPR1;8;2.752e-78;0.6154;2.8692;138.7954;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;FPR1;8;1.365e-68;0.5849;2.5103;121.3888;FPR1;fMet-Leu-Phe receptor (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
44232492;FPR1;7;9.975000000000001e-55;0.4375;5.8176;96.4991;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
4305457;FPR1;7;1.483e-48;0.4082;5.1535;85.4182;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
76807;FPR1;7;1.432e-66;0.4651;7.0917;117.761;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;FPR1;7;1.293e-92;0.6279;9.8937;164.5188;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;FPR1;7;1.587e-76;0.5122;8.1627;135.6338;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;FPR1;7;1.728e-59;0.434;6.3298;105.0471;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
7021828;FPR1;7;5.34e-56;0.4444;5.9543;98.7817;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
515717;FPR1;7;7.467000000000001e-63;0.4231;6.6918;111.0874;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
92829;FPR1;7;7.893999999999999e-60;0.4167;6.3664;105.6581;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
9856500;FPR1;7;1.415e-57;0.4167;6.124;101.6124;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
5488196;FPR1;7;2.9620000000000003e-71;0.4783;7.5957;126.171;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;FPR1;7;6.279e-64;0.4255;6.8074;113.0179;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
118276;FPR1;7;3.5509999999999997e-53;0.4906;5.6506;93.7137;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CCSC)C(=O)O)N;NTISAKGPIGTIJJ-UHFFFAOYSA-N
7010580;FPR1;7;5.051e-91;0.6136;9.7224;161.6611;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;FPR1;7;3.218e-71;0.4151;7.5918;126.1062;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;FPR1;7;4.257e-77;0.5349;8.2242;136.66;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;FPR1;7;7.622e-85;0.5682;9.0577;150.5684;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;FPR1;7;8.903e-76;0.4727;8.0822;134.2895;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;FPR1;7;1.029e-80;0.5417;8.6133;143.1533;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;FPR1;7;1.576e-73;0.4681;7.8403;130.2535;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;FPR1;7;3.181e-65;0.4068;6.9468;115.3435;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;FPR1;7;1.447e-71;0.4545;7.6291;126.7297;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;FPR1;7;6.855e-86;0.5417;9.1702;152.4464;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
18218182;FPR1;7;5.566e-55;0.4565;5.8448;96.9539;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
4427709;FPR1;7;3.5559999999999997e-75;0.4815;8.0175;133.2097;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;FPR1;7;3.065e-80;0.5238;8.5623;142.3021;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;FPR1;7;1.061e-90;0.587;9.6877;161.0824;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;FPR1;7;4.883e-77;0.4894;8.2178;136.553;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;FPR1;7;5.823e-66;0.4286;7.0261;116.6673;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;FPR1;7;9.978999999999999e-89;0.5745;9.4754;157.5396;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;FPR1;7;9.966e-77;0.5;8.1845;135.9968;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;FPR1;7;3.729e-68;0.4237;7.2621;120.6054;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;FPR1;7;4.579e-77;0.4727;8.2208;136.6031;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;FPR1;7;9.7e-80;0.5217;8.5085;141.4038;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;FPR1;7;4.475e-76;0.5106;8.1143;134.8257;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
189008;FPR1;7;1.183e-60;0.4182;6.4551;107.1378;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
6992643;FPR1;7;3.73e-77;0.5;8.2304;136.7631;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
332962;FPR1;7;1.375e-56;0.4444;6.0177;99.8397;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7359122;FPR1;7;4.398e-71;0.4583;7.5772;125.8627;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
7021456;FPR1;7;2.747e-50;0.4035;5.3399;88.5279;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;FPR1;7;1.97e-83;0.5319;8.9057;148.0327;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;FPR1;7;1.97e-83;0.5319;8.9057;148.0327;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;FPR1;7;1.9960000000000002e-72;0.463;7.7217;128.274;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;FPR1;7;1.703e-96;0.6585;10.3111;171.4853;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;FPR1;7;3.357e-76;0.5116;8.1277;135.0499;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;FPR1;7;1.318e-75;0.4706;8.0638;133.9835;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;FPR1;7;5.335e-68;0.449;7.2454;120.3261;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;FPR1;7;1.292e-72;0.5;7.742;128.6132;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
6993118;FPR1;7;1.272e-59;0.4545;6.3441;105.2859;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
4128305;FPR1;7;2.5789999999999997e-45;0.4255;4.8049;79.6005;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC(=O)N)C(=O)O)N;MLTRLIITQPXHBJ-UHFFFAOYSA-N
7016103;FPR1;7;1.8609999999999998e-54;0.4286;5.7884;96.0128;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
759256;FPR1;7;1.0750000000000001e-71;0.5532;7.643;126.9614;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;FPR1;7;2.4059999999999997e-75;0.4694;8.0357;133.5143;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;FPR1;7;1.573e-60;0.4;6.4418;106.9159;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;FPR1;7;1.605e-68;0.4314;7.3015;121.2628;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;FPR1;7;2.481e-77;0.5;8.2494;137.081;FPR1;fMet-Leu-Phe receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;FPR1;7;8.004e-91;0.6154;9.7009;161.3022;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;FPR1;7;2.303e-82;0.5926;8.7908;146.1155;FPR1;fMet-Leu-Phe receptor (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
151410;FURIN;8;3.189e-62;0.4167;6.1107;109.9554;FURIN;Furin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
47579;FURIN;8;1.5829999999999998e-53;0.4286;5.2475;94.3438;FURIN;Furin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
25200879;FURIN;8;1.5079999999999998e-51;0.4648;5.051;90.7909;FURIN;Furin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;FURIN;8;1.432e-44;0.4348;4.3583;78.2639;FURIN;Furin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
168058;FURIN;8;1.508e-53;0.6596;5.2496;94.3817;FURIN;Furin (pKi >= 8);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
6992341;FURIN;8;1.845e-41;0.5;4.0496;72.6803;FURIN;Furin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CCCCN)N;YQAIUOWPSUOINN-UHFFFAOYSA-N
151410;FURIN;7;7.276000000000001e-69;0.4167;9.5468;121.8795;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
134906;FURIN;7;1.051e-44;0.4789;6.1677;78.5049;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;FURIN;7;8.107999999999999e-45;0.4583;6.1835;78.7075;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;FURIN;7;3.841e-63;0.4286;8.7465;111.6058;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;FURIN;7;9.128999999999999e-66;0.4;9.1135;116.3167;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
25200879;FURIN;7;6.344e-61;0.4648;8.4362;107.6239;FURIN;Furin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
151134;FURIN;7;1.423e-42;0.4068;5.8696;74.6784;FURIN;Furin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
168058;FURIN;7;2.887e-52;0.6596;7.2253;92.0799;FURIN;Furin (pKi >= 7);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
4656408;FURIN;6;2.2239999999999996e-47;0.4348;8.6416;83.3068;FURIN;Furin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
100094;GHSR;7;1.2339999999999998e-47;0.5714;40.4308;83.7662;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;GHSR;7;9.481e-57;0.6897;48.1751;100.1293;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;GHSR;7;8.795e-57;0.5645;48.2028;100.1879;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;GHSR;7;1.0519999999999999e-60;0.6441;51.5356;107.2298;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;GHSR;7;3.61e-52;0.5079;44.283;91.9056;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;GHSR;7;1.0019999999999999e-60;0.6441;51.5534;107.2674;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;GHSR;7;3.135e-56;0.5932;47.7338;99.197;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;GHSR;7;1.2149999999999999e-51;0.6308;43.835;90.9591;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7009650;GHSR;7;1.635e-48;0.7231;41.1764;85.3417;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;GHSR;7;2.8330000000000002e-58;0.5;49.4705;102.8664;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;GHSR;7;3.4709999999999996e-52;0.5781;44.2975;91.9362;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;GHSR;7;4.685e-56;0.661;47.5855;98.8836;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;GHSR;7;2.935e-55;0.4308;46.9085;97.453;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;GHSR;7;6.968e-52;0.4444;44.0403;91.3928;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;GHSR;7;4.842e-57;0.5574;48.4231;100.6533;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;GHSR;7;7.811000000000001e-55;0.5152;46.5472;96.6898;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;GHSR;7;2.784e-52;0.6842;44.3789;92.1082;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;GHSR;7;7.279e-56;0.5932;47.4229;98.54;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;GHSR;7;1.507e-52;0.5469;44.6054;92.5868;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;GHSR;7;2.5899999999999997e-54;0.5397;46.1049;95.7551;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;GHSR;7;1.084e-45;0.5;38.779;80.2762;GHSR;Growth hormone secretagogue receptor type 1 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
111299;GLO1;7;1.459e-46;0.4561;2.6858;81.84;GLO1;Lactoylglutathione lyase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
3081383;GPR17;6;3.6410000000000004e-57;0.4257;2.9854;100.8755;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
92021849;GPR17;6;1.138e-46;0.4474;2.43;82.0338;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;GPR17;7;8.266e-54;0.4714;1.57;94.8503;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
7021820;GRIA1;7;1.462e-79;0.4737;11.7375;141.084;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
92829;GRIA1;7;5.441e-65;0.4898;9.5717;114.9249;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
5057430;GRIA1;7;1.5140000000000001e-58;0.4231;8.6138;103.3551;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
13890535;GRIA1;7;1.6999999999999998e-49;0.4545;7.2686;87.1069;GRIA1;Glutamate receptor 1 (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;GRIA1;7;3.833e-57;0.4107;8.4052;100.8355;GRIA1;Glutamate receptor 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;GRIA1;7;1.147e-58;0.4259;8.6317;103.5713;GRIA1;Glutamate receptor 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
92946;GRIA1;7;9.691999999999999e-61;0.4423;8.9399;107.2934;GRIA1;Glutamate receptor 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
515709;GRIA1;7;8.902e-58;0.4;8.4995;101.9738;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;GRIA1;7;8.902e-58;0.4;8.4995;101.9738;GRIA1;Glutamate receptor 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;GRIA1;7;2.433e-58;0.4286;8.5832;102.9852;GRIA1;Glutamate receptor 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;GRIA1;7;8.202000000000001e-58;0.4151;8.5047;102.0376;GRIA1;Glutamate receptor 1 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
25200879;GRIA1;6;1.6159999999999998e-45;0.5231;10.0298;79.9649;GRIA1;Glutamate receptor 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
100094;GRPR;6;3.3700000000000006e-79;0.4239;9.6885;140.4328;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
9797038;GRPR;6;2.814e-82;0.4217;10.0681;145.9593;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;GRPR;6;2.899e-80;0.4082;9.8199;142.3455;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;GRPR;6;9.944999999999999e-81;0.4024;9.8772;143.1797;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
102763;GRPR;6;5.938000000000001e-78;0.4026;9.5348;138.1958;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
9948926;GRPR;6;4.674e-78;0.4051;9.5477;138.3825;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
3634442;GRPR;6;2.099e-76;0.4;9.3439;135.416;GRPR;Gastrin-releasing peptide receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
100094;GRPR;7;1.299e-80;0.4239;8.9259;142.9714;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;GRPR;7;6.231e-95;0.4487;10.5242;168.6787;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;GRPR;7;1.3589999999999999e-81;0.4217;9.0353;144.7315;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
3038501;GRPR;7;3.472e-80;0.4024;8.8782;142.2049;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
168182;GRPR;7;8.366e-87;0.4359;9.6169;154.0865;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;GRPR;7;8.308e-82;0.5316;9.0592;145.1153;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
323786;GRPR;7;2.835e-103;0.4375;11.4553;183.6552;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;GRPR;7;2.905e-91;0.4359;10.1147;162.0925;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;GRPR;7;9.695e-84;0.4048;9.2749;148.5855;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;GRPR;7;1.708e-79;0.4051;8.801;140.9626;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;GRPR;7;2.382e-83;0.4051;9.2313;147.8846;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
19816756;GRPR;7;4.912e-92;0.443;10.2009;163.4782;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;GRPR;7;2.3039999999999997e-93;0.4103;10.3492;165.8639;GRPR;Gastrin-releasing peptide receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
329275;GRPR;8;2.5809999999999998e-93;0.4487;7.5439;165.7752;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
134906;GRPR;8;2.8059999999999997e-81;0.4;6.5635;144.1661;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
168182;GRPR;8;6.061e-87;0.4359;7.025;154.3377;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;GRPR;8;8.555e-82;0.4023;6.6055;145.0924;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;GRPR;8;5.403e-80;0.4026;6.4589;141.8601;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
323786;GRPR;8;5.016e-91;0.4304;7.3575;161.6665;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;GRPR;8;3.281e-86;0.4103;6.9652;153.021;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;GRPR;8;4.627e-81;0.4048;6.5458;143.7763;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
19816756;GRPR;8;1.424e-86;0.4359;6.9948;153.6715;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;GRPR;8;9.275e-80;0.4026;6.4398;141.4387;GRPR;Gastrin-releasing peptide receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
11010621;HDAC11;6;1.877e-47;0.4667;10.1264;83.439;HDAC11;Histone deacetylase 11 (pKi >= 6);C1CC(=O)NC1C(=O)NC(CCC(=O)N)C(=O)O;ILAITOFTZJRIFJ-UHFFFAOYSA-N
14282475;HLA-A;6;1.4180000000000001e-99;0.4531;15.3902;177.0142;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
515709;HLA-A;6;1.0980000000000001e-55;0.4167;8.5665;98.2194;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;HLA-A;6;1.0980000000000001e-55;0.4167;8.5665;98.2194;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;HLA-A;6;7.641e-95;0.4744;14.6545;168.5196;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;HLA-A;6;3.386e-69;0.4286;10.6671;122.4759;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
19816750;HLA-A;6;4.698e-62;0.4444;9.5567;109.6534;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
193508;HLA-A;6;1.651e-62;0.4138;9.6273;110.4689;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;HLA-A;6;2.495e-48;0.4194;7.4227;85.0123;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;HLA-A;6;5.629e-55;0.4407;8.4561;96.9452;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
18218222;HLA-A;8;4.156e-43;0.4426;1.7121;75.638;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)CC(C(=O)NC(C(C)O)C(=O)O)N;LRKCBIUDWAXNEG-UHFFFAOYSA-N
14767562;HLA-A;8;7.731999999999999e-66;0.443;2.6315;116.4462;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
4466134;HLA-A;8;9.334e-68;0.443;2.7091;119.89;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
323786;HLA-A;8;1.4239999999999999e-47;0.4111;1.8927;83.6541;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7359122;HLA-A;8;1.0069999999999999e-53;0.4177;2.1415;94.6963;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;HLA-A;8;1.293e-44;0.4074;1.7731;78.3437;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;HLA-A;8;1.293e-44;0.4074;1.7731;78.3437;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
259327;HLA-A;8;1.49e-41;0.4194;1.6492;72.8469;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
4078684;HLA-A;8;2.8679999999999997e-47;0.4286;1.8804;83.1085;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;HLA-A;8;8.300999999999999e-54;0.4125;2.1449;94.847;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
44232492;HLA-A;7;9.219999999999999e-48;0.4;4.9714;83.9932;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
76807;HLA-A;7;1.237e-43;0.4074;4.5357;76.5826;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;HLA-A;7;4.96e-51;0.5439;5.3164;89.8625;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;HLA-A;7;4.2959999999999995e-66;0.44;6.906;116.9044;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
7021828;HLA-A;7;2.084e-44;0.45;4.6174;77.9716;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)O)N;BQBCIBCLXBKYHW-UHFFFAOYSA-N
18218222;HLA-A;7;7.851e-68;0.4426;7.0895;120.0249;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(C(C)O)C(=O)O)N;LRKCBIUDWAXNEG-UHFFFAOYSA-N
14767562;HLA-A;7;1.857e-106;0.4605;11.166;189.3711;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
435949;HLA-A;7;5.758e-50;0.431;5.204;87.951;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(C(C)C)C(=O)O)N;BCXBIONYYJCSDF-UHFFFAOYSA-N
5488196;HLA-A;7;2.348e-61;0.4058;6.406;108.3987;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;HLA-A;7;1.652e-61;0.4407;6.4222;108.6729;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
118276;HLA-A;7;9.906e-43;0.5686;4.4404;74.9607;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(CCSC)C(=O)O)N;NTISAKGPIGTIJJ-UHFFFAOYSA-N
7010580;HLA-A;7;5.027e-62;0.4737;6.4767;109.6006;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;HLA-A;7;1.553e-42;0.4386;4.4198;74.6103;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
352038;HLA-A;7;2.161e-70;0.45;7.3597;124.6212;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(C(C)C)C(=O)O)N;MDSUKZSLOATHMH-UHFFFAOYSA-N
7010532;HLA-A;7;7.263e-41;0.5091;4.2435;71.612;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C(C)C)N;PNVLWFYAPWAQMU-UHFFFAOYSA-N
9797038;HLA-A;7;1.5839999999999998e-41;0.4028;4.3133;72.7994;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
4466134;HLA-A;7;7.038e-112;0.4746;11.7382;199.1041;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
57315376;HLA-A;7;6.042e-41;0.4559;4.252;71.7555;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCC(=O)N)N;XITLYYAIPBBHPX-UHFFFAOYSA-N
18218182;HLA-A;7;3.654e-45;0.4746;4.6972;79.329;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
17863274;HLA-A;7;2.294e-42;0.4727;4.4019;74.306;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(CCSC)C(=O)O)N;TUYOFUHICRWDGA-UHFFFAOYSA-N
435728;HLA-A;7;1.4429999999999999e-68;0.5424;7.1671;121.3457;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;HLA-A;7;7.124e-102;0.45;10.6822;181.1415;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;HLA-A;7;1.166e-85;0.4516;8.9711;152.0325;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
323786;HLA-A;7;9.177e-62;0.4242;6.4491;109.1313;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
435718;HLA-A;7;2.548e-56;0.5;5.8746;99.3587;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
92946;HLA-A;7;1.965e-73;0.4821;7.6807;130.0816;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
189008;HLA-A;7;2.834e-78;0.4267;8.1916;138.7726;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CN=CN1)N;MMFKFJORZBJVNF-UHFFFAOYSA-N
7359122;HLA-A;7;5.7570000000000005e-96;0.4821;10.0588;170.5357;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;HLA-A;7;4.06e-44;0.5882;4.5868;77.4515;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;HLA-A;7;1.408e-77;0.4444;8.1181;137.5227;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
10445608;HLA-A;7;3.815e-95;0.4493;9.9721;169.0612;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
57281443;HLA-A;7;5.211e-46;0.4286;4.7864;80.8475;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C(C)O)N;LUMXICQAOKVQOB-UHFFFAOYSA-N
6993118;HLA-A;7;8.553000000000001e-42;0.4576;4.3416;73.2798;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
7016103;HLA-A;7;1.4220000000000001e-46;0.5385;4.846;81.8603;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
19816755;HLA-A;7;2.3860000000000003e-46;0.4225;4.8222;81.4567;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
7010566;HLA-A;7;2.52e-89;0.5424;9.3579;158.6127;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
6993120;HLA-DRB1;7;8.897999999999999e-80;0.4407;5.8704;141.4712;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
14767562;HLA-DRB1;7;4.1439999999999996e-60;0.411;4.4101;106.1605;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;HLA-DRB1;7;2.2709999999999998e-67;0.4;4.9492;119.1967;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;HLA-DRB1;7;4.191e-71;0.4333;5.2265;125.9003;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
329275;HLA-DRB1;7;2.351e-48;0.4118;3.5375;85.0586;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;HLA-DRB1;7;2.951e-61;0.4754;4.4953;108.2207;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
435728;HLA-DRB1;7;2.096e-79;0.4194;5.8428;140.8029;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
168182;HLA-DRB1;7;6.827e-43;0.4337;3.1319;75.2509;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
111299;HLA-DRB1;7;2.473e-46;0.4032;3.3873;81.4285;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
7359122;HLA-DRB1;7;1.001e-87;0.4333;6.4605;155.7415;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;HLA-DRB1;7;1.4620000000000002e-78;0.431;5.7801;139.2884;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;HLA-DRB1;7;2.9419999999999997e-68;0.5077;5.0151;120.7902;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816756;HLA-DRB1;7;2.376e-49;0.4691;3.6114;86.8458;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
9797038;HLA-DRB1;6;1.055e-43;0.4353;4.2722;76.7065;HLA-DRB1;HLA class II histocompatibility antigen, DRB1-1 beta chain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
18986;HTR1B;6;1.074e-46;0.641;45.8724;82.0789;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 6);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;HTR1B;8;1.6269999999999997e-41;0.641;18.4134;72.7786;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 8);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
10257;HTR1B;8;1.966e-43;0.6667;19.2704;76.2217;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 8);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
10257;HTR1B;7;1.126e-77;0.6667;56.5506;137.6971;HTR1B;5-hydroxytryptamine receptor 1B (pKi >= 7);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
18986;HTR1D;7;1.661e-69;0.641;61.0871;123.0313;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 7);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;HTR1D;8;1.0209999999999999e-53;0.641;37.1019;94.6856;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 8);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
10257;HTR1D;8;7.016e-95;0.6667;65.6088;168.5862;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 8);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
10257;HTR1D;6;4.175e-113;0.7368;113.7016;201.3066;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 6);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
18986;HTR1D;9;6.81e-44;0.459;18.4212;77.0482;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 9);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
10257;HTR1D;9;2.3339999999999998e-68;0.6667;28.7661;120.9707;HTR1D;5-hydroxytryptamine receptor 1D (pKi >= 9);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
6351946;ITGA4;7;3.086e-44;0.4667;10.5921;77.6654;ITGA4;Integrin alpha-4 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
12599;ITPR1;6;2.49e-43;0.5373;3.2687;76.0373;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
329275;KISS1R;6;2.05e-72;0.4557;14.6753;128.2533;KISS1R;KiSS-1 receptor (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;KISS1R;6;9.621e-66;0.4096;13.3133;116.2758;KISS1R;KiSS-1 receptor (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;KISS1R;6;1.011e-70;0.443;14.3296;125.2137;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;KISS1R;6;5.698e-66;0.4198;13.3597;116.6842;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;KISS1R;6;4.2740000000000003e-72;0.443;14.6101;127.6804;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;KISS1R;6;7.512999999999999e-68;0.425;13.7435;120.0592;KISS1R;KiSS-1 receptor (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;KISS1R;6;2.462e-64;0.4103;13.0258;113.7478;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;KISS1R;6;1.2929999999999999e-67;0.4524;13.6954;119.6358;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;KISS1R;6;1.0150000000000001e-71;0.4557;14.5335;127.0063;KISS1R;KiSS-1 receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;KISS1R;6;5.533e-64;0.4074;12.954;113.1165;KISS1R;KiSS-1 receptor (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
318292;KISS1R;6;1.235e-64;0.4051;13.087;114.2856;KISS1R;KiSS-1 receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
329275;KISS1R;9;2.7729999999999997e-81;0.4557;2.9802;144.1754;KISS1R;KiSS-1 receptor (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;KISS1R;9;2.1079999999999998e-73;0.4096;2.6884;130.0268;KISS1R;KiSS-1 receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;KISS1R;9;1.646e-79;0.443;2.9145;140.9914;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;KISS1R;9;7.44e-74;0.4198;2.7051;130.8387;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;KISS1R;9;4.682e-79;0.443;2.8977;140.1764;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;KISS1R;9;6.086e-76;0.425;2.7824;134.586;KISS1R;KiSS-1 receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;KISS1R;9;1.4640000000000001e-71;0.4103;2.6202;126.7202;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;KISS1R;9;5.1809999999999996e-73;0.4048;2.6739;129.3256;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;KISS1R;9;2.0029999999999998e-80;0.4557;2.9484;142.6337;KISS1R;KiSS-1 receptor (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;KISS1R;9;3.969e-71;0.4;2.6042;125.9428;KISS1R;KiSS-1 receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
318292;KISS1R;9;2.2530000000000001e-72;0.4051;2.6503;128.1796;KISS1R;KiSS-1 receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
329275;KISS1R;7;7.716999999999999e-73;0.4557;13.452;129.0149;KISS1R;KiSS-1 receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;KISS1R;7;4.388e-66;0.4096;12.195;116.8878;KISS1R;KiSS-1 receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;KISS1R;7;4.38e-71;0.443;13.1256;125.8658;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;KISS1R;7;1.9429999999999998e-66;0.4198;12.2608;117.5228;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;KISS1R;7;5.3930000000000005e-71;0.443;13.1088;125.7037;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;KISS1R;7;3.428e-68;0.425;12.5872;120.671;KISS1R;KiSS-1 receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;KISS1R;7;8.257e-65;0.4103;11.9578;114.5996;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;KISS1R;7;1.3069999999999998e-66;0.4524;12.2929;117.8324;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;KISS1R;7;3.0520000000000003e-72;0.4557;13.3409;127.9429;KISS1R;KiSS-1 receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;KISS1R;7;2.582e-64;0.4074;11.8657;113.7107;KISS1R;KiSS-1 receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
318292;KISS1R;7;5.8170000000000004e-65;0.4051;11.9862;114.8727;KISS1R;KiSS-1 receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
44232492;KLK3;6;4.457e-65;0.4333;8.0695;115.0803;KLK3;Prostate-specific antigen (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
7021820;KLK3;6;8.454e-80;0.4853;9.9128;141.511;KLK3;Prostate-specific antigen (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
151410;KLK3;6;7.379000000000001e-106;0.4844;13.1755;188.2953;KLK3;Prostate-specific antigen (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
4466134;KLK3;6;2.3430000000000002e-76;0.4143;9.4817;135.3302;KLK3;Prostate-specific antigen (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
273262;KLK3;6;2.2810000000000002e-74;0.4348;9.2328;131.7605;KLK3;Prostate-specific antigen (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
515709;KLK3;6;1.291e-62;0.4058;7.7612;110.6604;KLK3;Prostate-specific antigen (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;KLK3;6;1.291e-62;0.4058;7.7612;110.6604;KLK3;Prostate-specific antigen (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
7016103;KLK3;6;2.237e-86;0.45;10.7363;153.3195;KLK3;Prostate-specific antigen (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
193508;KLK3;6;5.049e-96;0.4182;11.9441;170.6379;KLK3;Prostate-specific antigen (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;KLK3;6;4.716000000000001e-87;0.4531;10.821;154.5334;KLK3;Prostate-specific antigen (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;KLK3;6;3.99e-76;0.4531;9.4528;134.9151;KLK3;Prostate-specific antigen (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
44232492;KLK3;8;7.144e-66;0.4333;2.8471;116.5078;KLK3;Prostate-specific antigen (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
151410;KLK3;8;3.5600000000000005e-79;0.4375;3.4288;140.39;KLK3;Prostate-specific antigen (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
7016103;KLK3;8;1.2470000000000002e-78;0.4426;3.405;139.4127;KLK3;Prostate-specific antigen (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
100048;KLK3;8;3.138e-69;0.4531;2.9939;122.5352;KLK3;Prostate-specific antigen (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;KLK3;8;1.41e-59;0.4531;2.5717;105.2058;KLK3;Prostate-specific antigen (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
76807;LAP3;7;1.213e-42;0.5366;2.6841;74.803;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;LAP3;7;3.027e-69;0.5909;4.3877;122.5634;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;LAP3;7;2.881e-53;0.4762;3.3644;93.8768;LAP3;Cytosol aminopeptidase (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
6992304;LAP3;7;3.611e-61;0.4043;3.8704;108.0632;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;LAP3;7;4.7550000000000006e-65;0.5111;4.1189;115.0299;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;LAP3;7;1.591e-69;0.6136;4.4055;123.0647;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;LAP3;7;2.9100000000000003e-57;0.4667;3.6203;101.0503;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;LAP3;7;2.647e-68;0.5333;4.3273;120.8727;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;LAP3;7;1.3749999999999999e-66;0.48;4.2175;117.7929;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
47579;LAP3;7;1.8190000000000003e-46;0.4545;2.9289;81.668;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;LAP3;7;8.844e-61;0.5532;3.8455;107.3648;LAP3;Cytosol aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
111299;LAP3;7;1.368e-60;0.4792;3.8334;107.0245;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;LAP3;7;1.488e-69;0.5333;4.4074;123.1173;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
332962;LAP3;7;3.575e-41;0.5238;2.59;72.1647;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7359122;LAP3;7;1.166e-67;0.4894;4.2861;119.7165;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;LAP3;7;2.857e-62;0.5;3.941;110.0413;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;LAP3;7;2.857e-62;0.5;3.941;110.0413;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;LAP3;7;4.8869999999999997e-51;0.4364;3.2217;89.8742;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;LAP3;7;1.231e-71;0.619;4.5407;126.8555;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;LAP3;7;1.4279999999999999e-41;0.5476;2.6155;72.8804;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
10445608;LAP3;7;1.7869999999999998e-66;0.5106;4.2102;117.5884;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;LAP3;7;8.514e-53;0.4444;3.3343;93.032;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
6993118;LAP3;7;4.294e-41;0.5238;2.5849;72.0218;LAP3;Cytosol aminopeptidase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C(C)C)N;XCTHZFGSVQBHBW-UHFFFAOYSA-N
759256;LAP3;7;5.816e-46;0.4222;2.8966;80.7618;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;LAP3;7;5.159e-68;0.5;4.3088;120.3523;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;LAP3;7;5.847e-59;0.46;3.729;104.0968;LAP3;Cytosol aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;LAP3;7;6.427e-68;0.5333;4.3027;120.1809;LAP3;Cytosol aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;LAP3;7;6.893999999999999e-61;0.5;3.8525;107.559;LAP3;Cytosol aminopeptidase (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;LAP3;7;6.893999999999999e-61;0.5;3.8525;107.559;LAP3;Cytosol aminopeptidase (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
454064;LASR;6;1.28e-59;0.425;3.7712;105.2812;LASR;Transcriptional activator protein LasR (pKi >= 6);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
454064;LASR;8;8.516e-53;0.425;1.54;93.0318;LASR;Transcriptional activator protein LasR (pKi >= 8);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
515709;LNPEP;7;1.272e-48;0.5;3.5573;85.5375;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;LNPEP;7;1.272e-48;0.5;3.5573;85.5375;LNPEP;Leucyl-cystinyl aminopeptidase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
20835023;LPAR1;7;1.5320000000000002e-42;0.9286;5.4054;74.6207;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
52925058;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;MFRYWKSWYSTLOB-UHFFFAOYSA-N
52925059;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NRDJGXANLABPHN-UHFFFAOYSA-N
131765707;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;RIDIILYYYNCBPC-UHFFFAOYSA-N
9546843;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;VOSQJLVNDRUECW-UHFFFAOYSA-N
9546841;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DBYSGBYABPVNGO-UHFFFAOYSA-N
131758799;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RYWWBXHDEGSCOG-UHFFFAOYSA-N
131801877;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;JWCNGONSUJKGDO-UHFFFAOYSA-N
5312554;LPAR3;7;3.019e-49;0.413;3.4829;86.659;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)O;HVGRZDASOHMCSK-UHFFFAOYSA-N
13932172;LPAR3;7;3.019e-49;0.413;3.4829;86.659;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCC(=O)O;WPJGPAAPSBVXNU-UHFFFAOYSA-N
131763181;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JKLVWHFEADJCSE-UHFFFAOYSA-N
52924901;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HNFSZKRUPTYBOQ-UHFFFAOYSA-N
9546836;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XMJSNHMFTISTET-UHFFFAOYSA-N
131753413;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;FSNNOULJUSMJGI-UHFFFAOYSA-N
9546835;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;VDNXNFMAFDYQSI-UHFFFAOYSA-N
52924125;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUEUPCHAIFZTKH-UHFFFAOYSA-N
131754962;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;YLDIXESVFMDKJA-UHFFFAOYSA-N
131753892;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VHWNCJQPNDUBCY-UHFFFAOYSA-N
131754192;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OGNCECWXMXWFGY-UHFFFAOYSA-N
52924370;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DPTUTWFSXXDMEO-UHFFFAOYSA-N
53478080;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NKDHOYXNDMODDX-UHFFFAOYSA-N
9543869;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XLFXOFMAQPNCDB-UHFFFAOYSA-N
131764015;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RJJPSRSFWRKXGV-UHFFFAOYSA-N
52926008;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;DWNFLQISNVMTDP-UHFFFAOYSA-N
131755530;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KKBIJNWSACWOQA-UHFFFAOYSA-N
52924878;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CIXWKDHTFXYVTC-UHFFFAOYSA-N
131753305;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RVRHSALQSYBGAG-UHFFFAOYSA-N
131758777;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QGLNBMRMNJAFOO-UHFFFAOYSA-N
53479914;LPAR3;7;3.086e-74;0.5818;5.2763;131.5249;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;NCWMYSRFLUIVBC-UHFFFAOYSA-N
131759263;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MDXVSMKNQLMYQZ-UHFFFAOYSA-N
131759262;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPLCXIXCJSJOOR-UHFFFAOYSA-N
131759577;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZJUJYFBFJFLODJ-UHFFFAOYSA-N
52924578;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;NWJGEXWORFCRSI-UHFFFAOYSA-N
131754666;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;PBXBPMVNZAGNPS-UHFFFAOYSA-N
53479710;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MIPOZDXFSKBSGM-UHFFFAOYSA-N
53479717;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;KRZKEZVISPYOPJ-UHFFFAOYSA-N
131764304;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;WWBWZANTQJGIBV-UHFFFAOYSA-N
53479719;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPPCXIJSFVQDL-UHFFFAOYSA-N
131753659;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DQXQIWIQYYEGLG-UHFFFAOYSA-N
52924583;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;FRVWPWGGHGGKMD-UHFFFAOYSA-N
53480966;LPAR3;7;1.5419999999999998e-51;0.5532;3.6473;90.7733;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)CO;CRSKSGIHJXUIHD-UHFFFAOYSA-N
131761186;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YZEITGDSYFHHEK-UHFFFAOYSA-N
53480963;LPAR3;7;1.5149999999999998e-60;0.6279;4.2938;106.9454;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)CO;YRAZXZXQMMJRRV-UHFFFAOYSA-N
53480960;LPAR3;7;1.5149999999999998e-60;0.6279;4.2938;106.9454;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(CO)CO;CXUXMSACCLYMBI-UHFFFAOYSA-N
131802009;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;IVASVZFPDOWZBQ-UHFFFAOYSA-N
131801755;LPAR3;7;3.682e-48;0.6522;3.4049;84.709;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;OSXMEYNKEVXBGM-UHFFFAOYSA-N
53480968;LPAR3;7;1.541e-57;0.587;4.0779;101.5458;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)CO;PFISEVUKDJTNGO-UHFFFAOYSA-N
52924408;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;GMXIUCLINHXQQD-UHFFFAOYSA-N
131756087;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TZMQOSMAJITOAT-UHFFFAOYSA-N
53479862;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;YHKHZYNNNXVJRS-UHFFFAOYSA-N
53479863;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IZWPZNGYCMMGHU-UHFFFAOYSA-N
53479861;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;RHBZSPYYUTVJHJ-UHFFFAOYSA-N
131758800;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UAXBSAJQKYIKRG-UHFFFAOYSA-N
131763207;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HXJRHBUXUMSJKX-UHFFFAOYSA-N
131758806;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CGPMDMDZQFZLHH-UHFFFAOYSA-N
53478106;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BYLXXZYUDXCZFN-UHFFFAOYSA-N
131755728;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;PODGNDQRHPDVSY-UHFFFAOYSA-N
53479624;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;FXSMMNUNFDTUMS-UHFFFAOYSA-N
53479625;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VHHMKXOBDPAFKC-UHFFFAOYSA-N
101227803;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZDZVWVCNWRMGLA-UHFFFAOYSA-N
101227804;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FSTOZAMDIJDRCH-UHFFFAOYSA-N
53479784;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CWPKVJPBYGQUHE-UHFFFAOYSA-N
9546742;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;JQKOHRZNEOQNJE-UHFFFAOYSA-N
9546747;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;HBZNVZIRJWODIB-UHFFFAOYSA-N
53478281;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXZEPDSGFSCPJ-UHFFFAOYSA-N
9546800;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DRIVXEVMDWCWLI-UHFFFAOYSA-N
12051354;LPAR3;7;3.994e-71;0.6944;5.0529;125.9379;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
53478321;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UCEIHNHHMYDTNZ-UHFFFAOYSA-N
131801935;LPAR3;7;5.725e-54;0.6739;3.8217;95.1367;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;JADWQWJGAYXZKD-UHFFFAOYSA-N
131801934;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;MGNMWMMQKHUXCT-UHFFFAOYSA-N
131760625;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SXSRTUPMLATBNN-UHFFFAOYSA-N
131760624;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;QBTDCDJQWFFVGF-UHFFFAOYSA-N
131753518;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ITNUXAAETYEROX-UHFFFAOYSA-N
131753516;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNKDMZBYGADBFP-UHFFFAOYSA-N
131761617;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;YSTMVIOAKCDXEL-UHFFFAOYSA-N
131766787;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;YTOCFNTUAXVUGF-UHFFFAOYSA-N
53480884;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DZPHTQGGRSWHLG-UHFFFAOYSA-N
52924465;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QCCKXFCODQEYIW-UHFFFAOYSA-N
131753287;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DBIJZZLMYBLAQP-UHFFFAOYSA-N
52925128;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ZVVYJAAMWXATNY-UHFFFAOYSA-N
131754309;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IMVXYPBBFJIVGK-UHFFFAOYSA-N
131763497;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FWLOAHZIIPEDQA-UHFFFAOYSA-N
52925127;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;LJVXDBWIBQQKFU-UHFFFAOYSA-N
53480140;LPAR3;7;1.3890000000000002e-72;0.541;5.1576;128.5564;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;XDPWHDYPIVOSGA-UHFFFAOYSA-N
9546838;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;XYHIPPZFNNOMQL-UHFFFAOYSA-N
53478437;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCHJOJAVIATUSR-UHFFFAOYSA-N
131754525;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QZSQJRGOJCTPHI-UHFFFAOYSA-N
131754524;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOTJQCORLIFPLC-UHFFFAOYSA-N
131759908;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PIYNNEKPAVFCLZ-UHFFFAOYSA-N
53478438;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWHGFSHXNNIITD-UHFFFAOYSA-N
131753346;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LIMGVWSRPUIYTD-UHFFFAOYSA-N
131753464;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOVZBEYRPDKHAL-UHFFFAOYSA-N
131753463;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;FICVIOYVXOEZEN-UHFFFAOYSA-N
131760520;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WZQHACRHKQJTGS-UHFFFAOYSA-N
131759889;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;COWOCJLJJIQXGS-UHFFFAOYSA-N
131755479;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MBOXBOYLRVJTGJ-UHFFFAOYSA-N
131753860;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QPPIYNYVDUYVQL-UHFFFAOYSA-N
53481885;LPAR3;7;9.128e-89;0.7308;6.3189;157.6091;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(COP(=O)(O)O)O;OYWQLEFQIHHFDV-UHFFFAOYSA-N
24779494;LPAR3;7;2.344e-60;0.5614;4.2802;106.6049;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)([O-])OCC[N+](C)(C)C;SULIDBRAXVDKBU-UHFFFAOYSA-N
131753905;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WGTADRBQBBKAGF-UHFFFAOYSA-N
53479755;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;RUOGJLKOZLGYHK-UHFFFAOYSA-N
53479756;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PYFNLOPDTZXGTN-UHFFFAOYSA-N
52924652;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WLTBPSUTBXIPBI-UHFFFAOYSA-N
131755321;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVLMVUOWVUUAHL-UHFFFAOYSA-N
53480139;LPAR3;7;1.3890000000000002e-72;0.541;5.1576;128.5564;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;SNVHCYWMCGHCMU-UHFFFAOYSA-N
53481816;LPAR3;7;2.469e-87;0.717;6.2161;155.0378;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NTQLGVPKRSFHIQ-UHFFFAOYSA-N
131801898;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;IKSWSKJAXUGKHC-UHFFFAOYSA-N
131801899;LPAR3;7;1.207e-65;0.7045;4.6597;116.0989;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;RJUNCJKUOOBPGW-UHFFFAOYSA-N
131750486;LPAR3;7;1.3890000000000002e-72;0.541;5.1576;128.5564;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)O)O;IQIUZAVCJONSBD-UHFFFAOYSA-N
53479829;LPAR3;7;2.239e-67;0.5;4.7839;119.2077;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;ZRQPYJXAEPDRDM-UHFFFAOYSA-N
52922266;LPAR3;7;7.317e-53;0.5254;3.7423;93.1501;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)([O-])OCC[N+](C)(C)C;MVGBUJJTKGIFFM-UHFFFAOYSA-N
53479588;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQIMLWFRWGTTOZ-UHFFFAOYSA-N
52924528;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;KZMQZJZTKYKTJQ-UHFFFAOYSA-N
53479947;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;WQHSMYBPCGOJLV-UHFFFAOYSA-N
131754580;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CDADMZPLSYSPIH-UHFFFAOYSA-N
52929772;LPAR3;7;1.848e-86;0.6444;6.1534;153.4687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)O)O;LBGSRVIXIVDRQM-UHFFFAOYSA-N
131753767;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UUHNNGQNNNMIKK-UHFFFAOYSA-N
131754079;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;VMJJCASFGIUXQS-UHFFFAOYSA-N
131801777;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DRUQEDUMAQZVOU-UHFFFAOYSA-N
53479897;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;SQWAGNNCWNPIQG-UHFFFAOYSA-N
53479893;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;WMGNZOBBKTUGGQ-UHFFFAOYSA-N
131755391;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YRHHWDQMQNTGFU-UHFFFAOYSA-N
53480857;LPAR3;7;1.034e-59;0.5082;4.2339;105.448;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HHQFKPJXVYWLLJ-UHFFFAOYSA-N
53479856;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;CUUQTWOJYKCYRS-UHFFFAOYSA-N
53480853;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;HUHQLMQCUTXEIJ-UHFFFAOYSA-N
131753695;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QQZZZCIYMICCKG-UHFFFAOYSA-N
53480914;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PQEYJXRJLFZSPT-UHFFFAOYSA-N
131801772;LPAR3;7;1.207e-65;0.7045;4.6597;116.0989;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;XIZKIPQKOHUAHX-UHFFFAOYSA-N
53480858;LPAR3;7;4.136e-54;0.5323;3.8319;95.3901;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QIJJGYHBXLEBJV-UHFFFAOYSA-N
131755191;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QJRAIXUZRUZYSD-UHFFFAOYSA-N
42607457;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;XVYPOHCSLJZFED-UHFFFAOYSA-N
131753498;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JPNVFKJWXNFOKV-UHFFFAOYSA-N
131753492;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMPQNKRQIPPNFC-UHFFFAOYSA-N
131753490;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BVZUJVWCCYACND-UHFFFAOYSA-N
131758625;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QZRITKSXWHDXFB-UHFFFAOYSA-N
131758626;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DJBSAGJERMKCDN-UHFFFAOYSA-N
131755759;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;XBEBXEQYPIBWCY-UHFFFAOYSA-N
131758937;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PHSOZYZQNQNQAK-UHFFFAOYSA-N
131755752;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SAZSVOQHSUNCSC-UHFFFAOYSA-N
53479570;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;QHFLHJLJIVRZEW-UHFFFAOYSA-N
131801745;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;SFMJHWFZJBATQB-UHFFFAOYSA-N
53479670;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;PTTOPPWTEHEDTA-UHFFFAOYSA-N
131802042;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;GRJUVGUIQWBDLN-UHFFFAOYSA-N
53479676;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;JLYDNXJQTBLQKZ-UHFFFAOYSA-N
131802041;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;WGCCNBRJWHJBEZ-UHFFFAOYSA-N
53480967;LPAR3;7;1.541e-57;0.587;4.0779;101.5458;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(CO)CO;FHCHFKIVIFQBSC-UHFFFAOYSA-N
24778627;LPAR3;7;4.908e-45;0.5082;3.1807;79.0988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SZQBOFQJPDNGHN-UHFFFAOYSA-N
131801964;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;QWBJFHUMPKVXOT-UHFFFAOYSA-N
56960317;LPAR3;7;3.03e-85;0.7692;6.0662;151.2877;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;LPQBQFLKBCPNAV-UHFFFAOYSA-N
131758653;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DAAWWDSQUNUMHY-UHFFFAOYSA-N
131753543;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UOGFRTWKEGEEJU-UHFFFAOYSA-N
131759301;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;NTANLNVWSGZVNG-UHFFFAOYSA-N
131755369;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KJRMVHBWNRWOEF-UHFFFAOYSA-N
131755362;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZKXYDJCNAJPJQ-UHFFFAOYSA-N
131759098;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DSZMYGQJZQQSEL-UHFFFAOYSA-N
131750529;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;VUYXIQLBLBPRDY-UHFFFAOYSA-N
131759870;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PSHWARYKXDUDSM-UHFFFAOYSA-N
131754967;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;DHISSBAEVLDFEV-UHFFFAOYSA-N
131801991;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;JODFYBIHEFCIFI-UHFFFAOYSA-N
131801990;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;VLJNBDVONLLDHB-UHFFFAOYSA-N
131753339;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AWDHZZVHWUIZSY-UHFFFAOYSA-N
131801999;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;WZWSISJCYNBNPX-UHFFFAOYSA-N
53479908;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PIRVOZHXFFFFFG-UHFFFAOYSA-N
53479907;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FISVEBQJGBZOPW-UHFFFAOYSA-N
53479906;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;OJCHOVMLEHFBOD-UHFFFAOYSA-N
131760510;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MGEAAPQRAKZVAR-UHFFFAOYSA-N
131758887;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCC;GEDOOJBTRRNYEP-UHFFFAOYSA-N
52924564;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VPDGQGZVNVFJGD-UHFFFAOYSA-N
52924563;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHXLWNJDUZUKLO-UHFFFAOYSA-N
131753836;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;POWNQYNUJQKIJN-UHFFFAOYSA-N
52924644;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;FKCXXHSNNJJOHT-UHFFFAOYSA-N
131801798;LPAR3;7;3.682e-48;0.6522;3.4049;84.709;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;UFBCJKWLEUICAE-UHFFFAOYSA-N
53479700;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;RQRUBEBOUYHPDW-UHFFFAOYSA-N
131755016;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RBJMAKBTUZSIDN-UHFFFAOYSA-N
52926061;LPAR3;7;8.298e-69;0.5614;4.8866;121.777;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(C(=O)O)N;MGXXGWZPTJJSOQ-UHFFFAOYSA-N
53478149;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;QBTJRRWTWAXKSO-UHFFFAOYSA-N
53479569;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;IPBXKYJWPCRPLD-UHFFFAOYSA-N
53478491;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RMUBRZSHPSLPPN-UHFFFAOYSA-N
52922765;LPAR3;7;7.317e-53;0.5254;3.7423;93.1501;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCC;NPXTVNLLGVNVDJ-UHFFFAOYSA-N
131758733;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCC;DTWPBANPCJFNIA-UHFFFAOYSA-N
131801744;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;SYTLTRZEHNVTSX-UHFFFAOYSA-N
52923736;LPAR3;7;5.024e-50;0.5424;3.5388;88.0572;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCC;YMBXMIQDISYIFB-UHFFFAOYSA-N
131758978;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UHVCAEYDCRIXKY-UHFFFAOYSA-N
131758865;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;WUUWBWLVYRBSQT-UHFFFAOYSA-N
131755712;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;IAFYDEPWYHOLIH-UHFFFAOYSA-N
53479972;LPAR3;7;2.239e-67;0.5;4.7839;119.2077;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DHZUMZVZAZYQIW-UHFFFAOYSA-N
131766702;LPAR3;7;9.499e-62;0.6977;4.3801;109.1045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)O;GOLRHKZVCRTBFW-UHFFFAOYSA-N
131754546;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LBTCQHAIXPLSSD-UHFFFAOYSA-N
131759281;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WVBFGMOFOIEXMP-UHFFFAOYSA-N
131761056;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HAGMTXDICLFDOC-UHFFFAOYSA-N
131755915;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBYJHYPJVAOSBP-UHFFFAOYSA-N
53479631;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;UKRAYYYOKQQQKZ-UHFFFAOYSA-N
53479630;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;HPHYBSPOEJMPAN-UHFFFAOYSA-N
131750653;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFUGNQFGFOCTMS-UHFFFAOYSA-N
131754999;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YQQLYNBUCCDBQS-UHFFFAOYSA-N
131754934;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;POAVLZRSJOCQEL-UHFFFAOYSA-N
9547071;LPAR3;7;6.101e-81;0.75;5.7574;143.5607;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;PYVRVRFVLRNJLY-UHFFFAOYSA-N
131801928;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;KYTZSBQBUCWGRJ-UHFFFAOYSA-N
131760631;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NRVWPUNQTJDNID-UHFFFAOYSA-N
53478233;LPAR3;7;9.791e-43;0.549;3.0156;74.9698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(CO)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SPGHLBKMJHHORH-UHFFFAOYSA-N
131758755;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;ARRWAWFZJHRGLN-UHFFFAOYSA-N
131759456;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FXVLQYFZVVLQJO-UHFFFAOYSA-N
52925094;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVTRPEJBOGUHBJ-UHFFFAOYSA-N
131761603;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CSHNWGMOFDDION-UHFFFAOYSA-N
131755148;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QDDBVRCUCSETRT-UHFFFAOYSA-N
53480959;LPAR3;7;2.179e-50;0.5909;3.5648;88.7084;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(CO)CO;UETKPVCPWANBPE-UHFFFAOYSA-N
53480897;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CFANDHZPOSNKNO-UHFFFAOYSA-N
53480895;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;OBAAWAYLQLYWNN-UHFFFAOYSA-N
20835023;LPAR3;7;1.31e-102;0.9286;7.3124;182.4618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O;ZQTAMPRZFOOEEP-UHFFFAOYSA-N
131753292;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PDOWBMFLISSQRT-UHFFFAOYSA-N
131754085;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;STLRCTZSDOQPTC-UHFFFAOYSA-N
131763523;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;JULFTYLLKSHNRK-UHFFFAOYSA-N
52925130;LPAR3;7;8.159000000000001e-78;0.7059;5.533;137.9481;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;DBHKHNGBVGWQJE-UHFFFAOYSA-N
131754362;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MODDNOQSVMCAIA-UHFFFAOYSA-N
131755004;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QREQPUUUIPJTAA-UHFFFAOYSA-N
131754431;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HVMWRSISSYXDSD-UHFFFAOYSA-N
53478341;LPAR3;7;1.228e-45;0.5185;3.2239;80.1794;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CQHRDRZMSJCJBX-UHFFFAOYSA-N
131801858;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;YWYQODJQQTZXGP-UHFFFAOYSA-N
52924167;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;DAZYZDVAACSMFA-UHFFFAOYSA-N
131801859;LPAR3;7;1.663e-55;0.6667;3.932;97.8959;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;CDTXMUFCBIHNCK-UHFFFAOYSA-N
14325553;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCABCCITBXMTKG-UHFFFAOYSA-N
52924213;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UDBXKKKIEXMSEA-UHFFFAOYSA-N
52924216;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OONVIPGPMOPRTM-UHFFFAOYSA-N
131759473;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MONMKVNVVBWTKM-UHFFFAOYSA-N
9543841;LPAR3;7;9.791e-43;0.549;3.0156;74.9698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NSVJKGBXOPSAKL-UHFFFAOYSA-N
131760029;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OFXPDVFCVMOXOI-UHFFFAOYSA-N
9543847;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CPEWURNZWJEDDC-UHFFFAOYSA-N
53479747;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;VFSMZSWKKPWQQW-UHFFFAOYSA-N
131760023;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;OYVIPANDVFEMEV-UHFFFAOYSA-N
131753561;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VBYDXPQVGUJUTN-UHFFFAOYSA-N
53479716;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;UAPYZCDNFGJZSC-UHFFFAOYSA-N
131754163;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PZPSHGGBTBOCBZ-UHFFFAOYSA-N
53479718;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;GKXLKICEHUALBW-UHFFFAOYSA-N
53480990;LPAR3;7;1.425e-62;0.6977;4.4392;110.5838;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)O;ZXNAIPHYBVMMPY-UHFFFAOYSA-N
131755698;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HTFZBWPHGZEFJU-UHFFFAOYSA-N
131755699;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JPBYHVQUOOKCGQ-UHFFFAOYSA-N
53480484;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGZSJHAMIMLPBP-UHFFFAOYSA-N
131759242;LPAR3;7;1.2699999999999999e-60;0.5294;4.2992;107.0826;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;OYGBKABOKBWAOA-UHFFFAOYSA-N
131753718;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CJNBEPRDDYRSPK-UHFFFAOYSA-N
131753717;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZMOOAMBHOJSHY-UHFFFAOYSA-N
53479939;LPAR3;7;2.768e-61;0.4754;4.3467;108.2704;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PCKXGFCVDCVIHH-UHFFFAOYSA-N
131753806;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUCYHIOFVUWJDD-UHFFFAOYSA-N
131755894;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QXJSFSDQSFDVAT-UHFFFAOYSA-N
131755892;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JPOLYQGYZVQSPO-UHFFFAOYSA-N
25260623;LPAR3;7;8.66e-46;0.7143;3.2347;80.4514;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;LZSJCSQKHQTZID-UHFFFAOYSA-N
52925065;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LYFMZJCIGLZMJF-UHFFFAOYSA-N
52924785;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;JCZXAXBRLLOCPM-UHFFFAOYSA-N
52924614;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;AYXGHIQPMDYMJC-UHFFFAOYSA-N
53479726;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;RZGFDECXQULSLM-UHFFFAOYSA-N
131758647;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LMDMXKYAEKPMRJ-UHFFFAOYSA-N
53480902;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;BOIHDLQLPRODPV-UHFFFAOYSA-N
5312378;LPAR3;7;7.196000000000001e-43;0.4286;3.0252;75.2099;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCC(=O)O;IJBFSOLHRKELLR-UHFFFAOYSA-N
131766679;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;IAFKLCDFTGOUGB-UHFFFAOYSA-N
53478121;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;OGEVDGPPHTZMPM-UHFFFAOYSA-N
131758820;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;HWXYJCBLRIWFEE-UHFFFAOYSA-N
131758821;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YMPDPPQASWDPRK-UHFFFAOYSA-N
53479566;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;CUUIBVDVVFLYGA-UHFFFAOYSA-N
53480992;LPAR3;7;7.852e-48;0.6522;3.3813;84.1185;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(CO)O;UDZUDFKFJCAENZ-UHFFFAOYSA-N
53479648;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;BIYXBOGKCFGRKR-UHFFFAOYSA-N
53480991;LPAR3;7;7.852e-48;0.6522;3.3813;84.1185;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)O;UCYPOAPUDLUXQX-UHFFFAOYSA-N
53479647;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;ANRCNDSZUNAAEU-UHFFFAOYSA-N
53479640;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OPJHRPGFKUCTOK-UHFFFAOYSA-N
9546726;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LYJWNHGFGVVCAO-UHFFFAOYSA-N
131802002;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;UFKFDATWXJRMOS-UHFFFAOYSA-N
52924174;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZHZTYDTVUSPVLX-UHFFFAOYSA-N
52925079;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;XVXISDREVDGQPX-UHFFFAOYSA-N
131756490;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VNKAHKVFGRGTQD-UHFFFAOYSA-N
131756497;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;CHGVHAOSWOJCHZ-UHFFFAOYSA-N
53480964;LPAR3;7;1.541e-57;0.587;4.0779;101.5458;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)CO;PMJSUEZTCFTBMD-UHFFFAOYSA-N
131801919;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;MARDKHBEDGKFMD-UHFFFAOYSA-N
131754572;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YJVSUEAKVIVQIZ-UHFFFAOYSA-N
53478462;LPAR3;7;5.529999999999999e-42;0.5385;2.9617;73.6199;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PXCOILRYJJUSSX-UHFFFAOYSA-N
131801915;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;QPKXQZITTOAAKY-UHFFFAOYSA-N
131801916;LPAR3;7;1.207e-65;0.7045;4.6597;116.0989;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;GHJOXQFLZDFHBM-UHFFFAOYSA-N
53478300;LPAR3;7;9.791e-43;0.549;3.0156;74.9698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(CO)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTSLGWIGCLOQRX-UHFFFAOYSA-N
131801910;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCCC)O;JOJJIWNPSBTCRD-UHFFFAOYSA-N
131754775;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BWUZGPYYZXQIFD-UHFFFAOYSA-N
131755131;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RXJPMHUSUSIBKN-UHFFFAOYSA-N
131755130;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;RHYGXFNQVVYIJD-UHFFFAOYSA-N
53480868;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VXAQICWVKHYAOM-UHFFFAOYSA-N
131758645;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;FSTDLLFKLQLNCY-UHFFFAOYSA-N
52925456;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;QFGBUBRLCJWGHL-UHFFFAOYSA-N
53480866;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;WCSDULLQTPYJFU-UHFFFAOYSA-N
53480867;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;URRCZPXKAKNTHV-UHFFFAOYSA-N
52925452;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;LZBAIACFBSMXFQ-UHFFFAOYSA-N
53480896;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;CCSPRYPUMQZSKU-UHFFFAOYSA-N
131754985;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HZWGBWWUMHOOAG-UHFFFAOYSA-N
131754603;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KFJPYNZNXSQRNB-UHFFFAOYSA-N
53480969;LPAR3;7;1.541e-57;0.587;4.0779;101.5458;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(CO)CO;DVYDCUGIJCYIQN-UHFFFAOYSA-N
131754335;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NAFMESDUMVNTKX-UHFFFAOYSA-N
53480247;LPAR3;7;1.775e-71;0.541;5.0782;126.57;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;GSQABQVBVQXYJH-UHFFFAOYSA-N
131763089;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LPABDPJNNDGDTQ-UHFFFAOYSA-N
53478415;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCCCCC;RQWLSMTYYCMIJQ-UHFFFAOYSA-N
53478416;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCC=CCC;KVDLGXAZPYNPJG-UHFFFAOYSA-N
131801706;LPAR3;7;1.207e-65;0.7045;4.6597;116.0989;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)O;TUHWKCBRUXQIHQ-UHFFFAOYSA-N
53480249;LPAR3;7;1.775e-71;0.541;5.0782;126.57;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;SJLOPHYYGZLTGX-UHFFFAOYSA-N
52924815;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;PQCDVFVOQBZXJA-UHFFFAOYSA-N
52924814;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;WALILJXJZOCRCD-UHFFFAOYSA-N
52924776;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;KXVQBSORIXQSRP-UHFFFAOYSA-N
131801983;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)O;DQSHOTZVAMTFFY-UHFFFAOYSA-N
52924774;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XJLGATDALCZXFX-UHFFFAOYSA-N
131755773;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;HFPMGYAXBUYRKI-UHFFFAOYSA-N
52924778;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;XNZHFYSLNIZKJP-UHFFFAOYSA-N
131801988;LPAR3;7;3.4210000000000003e-72;0.7381;5.1295;127.8538;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)O;RSFDYJRKLOLHJO-UHFFFAOYSA-N
131756654;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SGNGDCVKDGTDQC-UHFFFAOYSA-N
131802016;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;ZLEJYIVDPRFANO-UHFFFAOYSA-N
52924553;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;FMYXHSVUQFRMGW-UHFFFAOYSA-N
52924223;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QHNWICFFSBJICC-UHFFFAOYSA-N
131755553;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OAJGGPOBXCODBI-UHFFFAOYSA-N
131753929;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HCFBZCCMOSAJDD-UHFFFAOYSA-N
52925701;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(C(=O)O)N;RGLIERIRKNERBJ-UHFFFAOYSA-N
131753319;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JYQXYTFYWDKLPT-UHFFFAOYSA-N
53480017;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;HNZTVXMGKFBWNB-UHFFFAOYSA-N
53479575;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;LKUKJIYAXQFZTD-UHFFFAOYSA-N
53480018;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;LYQNHUUXGYHXPH-UHFFFAOYSA-N
53479738;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;MPCVLWFEQHTFHH-UHFFFAOYSA-N
53479739;LPAR3;7;1.528e-72;0.5254;5.1547;128.4824;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;SSVPEUWHHFKSEB-UHFFFAOYSA-N
52927171;LPAR3;7;2.018e-76;0.6071;5.433;135.4466;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;MVHBCRUZHMRQHX-UHFFFAOYSA-N
52926071;LPAR3;7;6.881e-77;0.6275;5.4666;136.2856;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCCCC;SYAYTZJXUCQTMJ-UHFFFAOYSA-N
53480848;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OSDKOUUHCQCQEG-UHFFFAOYSA-N
52927174;LPAR3;7;2.4370000000000002e-79;0.6415;5.6424;140.6855;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCC;NOFOTAHTYLXZNV-UHFFFAOYSA-N
53478487;LPAR3;7;3.195e-41;0.5;2.907;72.2524;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XJELJGCMEUSYKS-UHFFFAOYSA-N
53479988;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;UJDHYDGXZXDWNT-UHFFFAOYSA-N
131754979;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;VYWMIHTWENZSSH-UHFFFAOYSA-N
53479804;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JUYYWEDATPYDSS-UHFFFAOYSA-N
131753311;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYFACDKCDVPZSE-UHFFFAOYSA-N
131753587;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VHTASOICTBAXTL-UHFFFAOYSA-N
131755705;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FBJIMBUHNICHHH-UHFFFAOYSA-N
131753666;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KRVDGBILMBJWGW-UHFFFAOYSA-N
131753660;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GZLQQXVVOPFZRE-UHFFFAOYSA-N
131755723;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;RHVDDKIIECRCMU-UHFFFAOYSA-N
53478164;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QSEJQXZIIUGBTF-UHFFFAOYSA-N
131753215;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCC;DOEBPNOTMREOMP-UHFFFAOYSA-N
131759294;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XYKBFKVMVVJQIJ-UHFFFAOYSA-N
131753741;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MFFDRCAJUNCFIE-UHFFFAOYSA-N
52925230;LPAR3;7;4.063e-72;0.6154;5.1242;127.7197;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCC(C(=O)O)N;QBNCFMDNNPQYIL-UHFFFAOYSA-N
53479600;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;SMHQICHVYVREKX-UHFFFAOYSA-N
53479605;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VNAHWIQCBOQKAJ-UHFFFAOYSA-N
131755900;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GEPOGMMCAWOWOH-UHFFFAOYSA-N
131750649;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QELMLHKKGIZABI-UHFFFAOYSA-N
131750646;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NVBSJAZGISYRIW-UHFFFAOYSA-N
53480932;LPAR3;7;1.45e-73;0.5893;5.228;130.3183;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NHBRVTKHMMOYTG-UHFFFAOYSA-N
53480248;LPAR3;7;1.775e-71;0.541;5.0782;126.57;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O;VFLPHYZOQHTWTQ-UHFFFAOYSA-N
131755173;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UOSXDBUYARIRPO-UHFFFAOYSA-N
89567;LPAR3;7;1.041e-90;0.8462;6.4584;161.0976;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;LAYXSTYJRSVXIH-UHFFFAOYSA-N
89566;LPAR3;7;1.041e-90;0.8462;6.4584;161.0976;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)O;YNDYKPRNFWPPFU-UHFFFAOYSA-N
52925087;LPAR3;7;1.107e-70;0.5593;5.0212;125.1431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HLSDKIUXCZPFLL-UHFFFAOYSA-N
52925086;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;HXUHHWPZGOIBGO-UHFFFAOYSA-N
131758602;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;QGSFHGSYPKDCBO-UHFFFAOYSA-N
53480949;LPAR3;7;6.101e-81;0.75;5.7574;143.5607;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;WAYKKNOEMJFLDI-UHFFFAOYSA-N
53478393;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXPLJLDIGVRTRM-UHFFFAOYSA-N
52924537;LPAR3;7;1.132e-56;0.5714;4.0158;99.9914;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MWDRGYRNYDLFKA-UHFFFAOYSA-N
131765702;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;QLJCFMWAJRKWEQ-UHFFFAOYSA-N
131763537;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZGXRJWDPYLJJFG-UHFFFAOYSA-N
53479623;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MKMUWJJSVUOCQC-UHFFFAOYSA-N
131758783;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NKWRAFYNNIEZPH-UHFFFAOYSA-N
53479594;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;LAFTYABRLNPQHQ-UHFFFAOYSA-N
53478597;LPAR3;7;1.951e-61;0.5957;4.3576;108.5431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;YUFFMVIZZQIBPN-UHFFFAOYSA-N
53479595;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;FCPBFHHIKXPHHN-UHFFFAOYSA-N
53478458;LPAR3;7;1.3139999999999999e-41;0.5283;2.9347;72.9448;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCCCC;YDNAPGXYBAGJKV-UHFFFAOYSA-N
131801864;LPAR3;7;5.725e-54;0.6739;3.8217;95.1367;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;DSPKXVYJORTNRJ-UHFFFAOYSA-N
53478598;LPAR3;7;1.951e-61;0.5957;4.3576;108.5431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SOWAPPIVBQCDGN-UHFFFAOYSA-N
131801942;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)O;IGVSZJYOSQMZTC-UHFFFAOYSA-N
131801943;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)O;PPTFPPBZILRDOI-UHFFFAOYSA-N
131759399;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDWAIWYOHVLVMF-UHFFFAOYSA-N
9546825;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;CLPMAPXZURYSNH-UHFFFAOYSA-N
9546824;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WYDGEVICLIVPEG-UHFFFAOYSA-N
9546826;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UITCASPZWUAJBW-UHFFFAOYSA-N
52924594;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JIEASZUPMDFVLW-UHFFFAOYSA-N
53479616;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;XJRBLUARQNXNQS-UHFFFAOYSA-N
131755451;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NPRADIIHNTWIBW-UHFFFAOYSA-N
6438186;LPAR3;7;1.5149999999999998e-60;0.6279;4.2938;106.9454;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)CO;TZDOBCZHGBGJLS-UHFFFAOYSA-N
53479772;LPAR3;7;1.221e-62;0.5;4.444;110.7039;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COP(=O)(O)OCCN;GOKCOIYNLBLTCL-UHFFFAOYSA-N
56938582;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SESIDPZYQNXGDB-UHFFFAOYSA-N
9543878;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCC=CCC=CCC;BNNRAXXNNFEFAX-UHFFFAOYSA-N
53480059;LPAR3;7;9.71e-69;0.5517;4.8817;121.6546;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCC)COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O;BZUNGYVNIWPISD-UHFFFAOYSA-N
52924152;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COP(=O)(O)OCCN;BSVQKPRGDPWRBO-UHFFFAOYSA-N
9543870;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JDCKQBKHWBEMSZ-UHFFFAOYSA-N
52926034;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCCCCC;QPLGPOYWQGNODB-UHFFFAOYSA-N
131754941;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CABYGZXBJNUBCV-UHFFFAOYSA-N
52924728;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCPNXDHEZUMTLB-UHFFFAOYSA-N
52924681;LPAR3;7;1.132e-56;0.5714;4.0158;99.9914;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;HDCWJEDGPFQUKG-UHFFFAOYSA-N
9546749;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCCCCC;YDTWOEYVDRKKCR-UHFFFAOYSA-N
52924721;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;ZNMZYHOEYPCVMP-UHFFFAOYSA-N
53479609;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZBKSDVGXOOCETO-UHFFFAOYSA-N
45934043;LPAR3;7;1.612e-43;0.6222;3.0718;76.3761;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O;NSOPGAYUGBZWHL-UHFFFAOYSA-N
131760503;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADOAWMSGAVKGKY-UHFFFAOYSA-N
52924554;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;BUCLJVJCFFPNPB-UHFFFAOYSA-N
52924653;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BUIZMIHPZOBMLF-UHFFFAOYSA-N
53481900;LPAR3;7;1.597e-86;0.6909;6.158;153.5823;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCC(COP(=O)(O)O)O;YGJPTGGFWWXCQF-UHFFFAOYSA-N
53480975;LPAR3;7;7.261999999999999e-45;0.6591;3.1685;78.7934;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(CO)O;ARCRKLOZHGPFFJ-UHFFFAOYSA-N
53480976;LPAR3;7;1.425e-62;0.6977;4.4392;110.5838;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(CO)O;KVYUBFKSKZWZSV-UHFFFAOYSA-N
53478054;LPAR3;7;5.529999999999999e-42;0.5385;2.9617;73.6199;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LTTZSZYLXABAOL-UHFFFAOYSA-N
9543752;LPAR3;7;1.228e-45;0.5185;3.2239;80.1794;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MUYDIVLBRBWUDW-UHFFFAOYSA-N
53479853;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;XOTZQQUUCAOSLB-UHFFFAOYSA-N
53479852;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;AHVVIUYIKIQVDO-UHFFFAOYSA-N
53478008;LPAR3;7;1.951e-61;0.5957;4.3576;108.5431;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCCCC;DICYCLUXEYFAQX-UHFFFAOYSA-N
53479855;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;URRUJVMBYGYWNL-UHFFFAOYSA-N
53479558;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PHNTZMYSEVOGFP-UHFFFAOYSA-N
131755736;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;GGCGDJPSQJXGBG-UHFFFAOYSA-N
53480983;LPAR3;7;7.852e-48;0.6522;3.3813;84.1185;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)O;QRBGFYBOCBYOSN-UHFFFAOYSA-N
53480982;LPAR3;7;1.425e-62;0.6977;4.4392;110.5838;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)O;HPTOSMWVVSKAGZ-UHFFFAOYSA-N
53479554;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RETPVUGMYRRYPF-UHFFFAOYSA-N
53480986;LPAR3;7;7.852e-48;0.6522;3.3813;84.1185;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(CO)O;LERKRWCYZNDWFH-UHFFFAOYSA-N
53479650;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;ZTSRQLQWGSDQGP-UHFFFAOYSA-N
52925214;LPAR3;7;3.823e-74;0.5926;5.2696;131.3578;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FGWZGYGIIUCSFO-UHFFFAOYSA-N
53479659;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;DZLWFPKMBZCBNP-UHFFFAOYSA-N
53479658;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;UJKZLJHORBRGNZ-UHFFFAOYSA-N
53479796;LPAR3;7;1.221e-62;0.5;4.444;110.7039;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;VZEYVZNRVARGGK-UHFFFAOYSA-N
52924162;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;ADCNXGARWPJRBV-UHFFFAOYSA-N
52924353;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIWMKSHLSCQARO-UHFFFAOYSA-N
9546757;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;MWRBNPKJOOWZPW-UHFFFAOYSA-N
9546755;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;LICSIKXBSOVGBP-UHFFFAOYSA-N
53480012;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MTYZXHQAIRJTJM-UHFFFAOYSA-N
56938633;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AYBNKZOBZIRMHJ-UHFFFAOYSA-N
52924548;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;APTOFTJOCNPNQP-UHFFFAOYSA-N
131801904;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;BWPPXWXSNNMLOW-UHFFFAOYSA-N
52924894;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;DXXUYBAISOHOLM-UHFFFAOYSA-N
131801901;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)O;FYYBTKGJGCSNCV-UHFFFAOYSA-N
9543840;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LQWVDOZRCDULIP-UHFFFAOYSA-N
53478252;LPAR3;7;9.791e-43;0.549;3.0156;74.9698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VSVITRIWEUGRGY-UHFFFAOYSA-N
131758776;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGUXHCYCFLVGES-UHFFFAOYSA-N
53479731;LPAR3;7;2.224e-75;0.5926;5.3582;133.5757;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;HCQUFOLAJNWIDV-UHFFFAOYSA-N
131754749;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DCEIEGPNDFHINJ-UHFFFAOYSA-N
131753524;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMAGTKGPGZLWKS-UHFFFAOYSA-N
53480874;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;VQMPZNPOSKPGTN-UHFFFAOYSA-N
131753682;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XOUODEXYIDULFE-UHFFFAOYSA-N
53480873;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC=CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;QEDROTQEMCQUNE-UHFFFAOYSA-N
131802010;LPAR3;7;8.018e-71;0.7209;5.0312;125.3944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)O;ODIFDYMVTZMQLS-UHFFFAOYSA-N
52924717;LPAR3;7;1.4280000000000002e-78;0.6275;5.5873;139.3069;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCC;QMQLZZVQOMZDCN-UHFFFAOYSA-N
131758666;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RFMPQNSSBPXIIY-UHFFFAOYSA-N
5283496;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC;FHQVHHIBKUMWTI-UHFFFAOYSA-N
131755026;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QRLNWUKVSNTXQG-UHFFFAOYSA-N
131755020;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SHZPWJWHCSZOEX-UHFFFAOYSA-N
53481872;LPAR3;7;1.597e-86;0.6909;6.158;153.5823;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCCCCC=CCC=CCC=CCC;OKSGKZRUQJEAKX-UHFFFAOYSA-N
9547010;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCCCC;CCIRMRKPMPEIFZ-UHFFFAOYSA-N
53479649;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;MTYMMKBRSNPIPR-UHFFFAOYSA-N
131801711;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)O;YEUGSVVCGREBDT-UHFFFAOYSA-N
52925140;LPAR3;7;8.159000000000001e-78;0.7059;5.533;137.9481;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)O;QJHRNPQXCMXOOH-UHFFFAOYSA-N
131760022;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;SEJBPZVTMDKZMT-UHFFFAOYSA-N
131756136;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UJRVGGIOIJYNLP-UHFFFAOYSA-N
52926076;LPAR3;7;8.298e-69;0.5614;4.8866;121.777;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCC=CCC=CCC;GRXQVLCZJYBDDD-UHFFFAOYSA-N
52924238;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;XUUQFFVLEYTYES-UHFFFAOYSA-N
52924549;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCC;UBTNBSZLGQJLPI-UHFFFAOYSA-N
6435901;LPAR3;7;2.845e-54;0.4444;3.8435;95.682;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)N;SFIHQZFZMWZOJV-UHFFFAOYSA-N
52924624;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;BYVQCOREHGDXRD-UHFFFAOYSA-N
52924233;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;RPYIJSOTHVJLOR-UHFFFAOYSA-N
52924232;LPAR3;7;1.6950000000000002e-79;0.64;5.6538;140.9687;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COP(=O)(O)OCCN;DWDUPRRUGYDGQF-UHFFFAOYSA-N
53479729;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;USEKWJQLASGHIH-UHFFFAOYSA-N
53479728;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCCCC=CCCCCCC;OHBRNOPVIZLBBE-UHFFFAOYSA-N
9543989;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SKGWNZXOCSYJQL-UHFFFAOYSA-N
53479660;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ANVMSBIGOHYJFD-UHFFFAOYSA-N
52924623;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COP(=O)(O)OCCN;CVPHRRKVQKYWSZ-UHFFFAOYSA-N
53479720;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DVFTWBPPIMYUEN-UHFFFAOYSA-N
53479688;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;DSZLDVIMYQKWGY-UHFFFAOYSA-N
131755233;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WQVLEJVLEGNDEG-UHFFFAOYSA-N
52924787;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCC=CCC=CCC;QISXRGLAZUIPCG-UHFFFAOYSA-N
52924786;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCC=CCC=CCC=CCCCCC;BRZHNCZGBULDIZ-UHFFFAOYSA-N
53479727;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;XEWZHCLDUCWNLB-UHFFFAOYSA-N
53480903;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC=CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;CJTMZOOUZQGAPV-UHFFFAOYSA-N
131755337;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MZFQLGNBXGADLH-UHFFFAOYSA-N
131755167;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NJWLXJXDVKOEOP-UHFFFAOYSA-N
131801884;LPAR3;7;5.725e-54;0.6739;3.8217;95.1367;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)O;XJJBSSJHWZLHHT-UHFFFAOYSA-N
131801883;LPAR3;7;6.1849999999999995e-59;0.6889;4.1781;104.053;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)O;RESRNMIXCOXYHQ-UHFFFAOYSA-N
131759891;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WWCDEFDAYUEHDA-UHFFFAOYSA-N
52922883;LPAR3;7;4.908e-45;0.5082;3.1807;79.0988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COP(=O)([O-])OCC[N+](C)(C)C;LFNLJXLPGIASGV-UHFFFAOYSA-N
52924378;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COP(=O)(O)OCCN;ODKCSLGCTVUPMX-UHFFFAOYSA-N
52924593;LPAR3;7;1.4710000000000002e-76;0.6038;5.4429;135.6931;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KSAJIJQUJUOZKJ-UHFFFAOYSA-N
53479812;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;IZEJYRQAFUAOSD-UHFFFAOYSA-N
53479811;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COP(=O)(O)OCCN;QIMXBAASHOXOCT-UHFFFAOYSA-N
52924436;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COP(=O)(O)OCCN;JNMLRFRSKRFHKL-UHFFFAOYSA-N
53481871;LPAR3;7;9.128e-89;0.7308;6.3189;157.6091;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(COP(=O)(O)O)O)OC(=O)CCCCC=CCC=CCC=CCCCCC;UZDPEBGNSKBQGX-UHFFFAOYSA-N
131758920;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHMSYFQZXWGGAR-UHFFFAOYSA-N
76041074;LPAR3;7;3.03e-85;0.7692;6.0662;151.2877;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)O;RPAOEHFOGLEBTJ-UHFFFAOYSA-N
53480847;LPAR3;7;4.136e-54;0.5323;3.8319;95.3901;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YITZQGLIICATLN-UHFFFAOYSA-N
53479617;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC=CCCCCCCC=CCCCCCCCC;ZTGVBXDPMCYOEV-UHFFFAOYSA-N
53479611;LPAR3;7;3.086e-74;0.5818;5.2763;131.5249;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DPRXQVIZBLENFV-UHFFFAOYSA-N
53479612;LPAR3;7;5.079e-75;0.5714;5.3325;132.9318;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KYERVKWKQQBRQB-UHFFFAOYSA-N
53477996;LPAR3;7;1.3139999999999999e-41;0.5283;2.9347;72.9448;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(CO)COC(=O)CCCCCCCC=CCCCC;VJQIPMXNHWLHEJ-UHFFFAOYSA-N
53477997;LPAR3;7;3.195e-41;0.5;2.907;72.2524;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QSZQNXRKRGRBGH-UHFFFAOYSA-N
53479881;LPAR3;7;3.642e-75;0.5536;5.3429;133.1911;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COP(=O)(O)OCCN;MVASPAIFCLTHSN-UHFFFAOYSA-N
53480845;LPAR3;7;2.832e-69;0.5893;4.9201;122.6153;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCC=CCCCCCC;IMGJLLXZPUDFFN-UHFFFAOYSA-N
52925434;LPAR3;7;4.063e-72;0.6154;5.1242;127.7197;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)OC(=O)CCCCCCCC=CCCCC;GKXJCTQSLVKTAV-UHFFFAOYSA-N
53478177;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MLKOWSFMVFMITR-UHFFFAOYSA-N
53480927;LPAR3;7;9.908999999999999e-67;0.5714;4.7376;118.0481;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(CO)COP(=O)(O)OCCN;QYXNIRQICOBIAE-UHFFFAOYSA-N
53480925;LPAR3;7;2.825e-76;0.6226;5.4226;135.1845;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;NOVZJYYJYIFXJC-UHFFFAOYSA-N
53480924;LPAR3;7;2.825e-76;0.6226;5.4226;135.1845;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCCN;CZYOFWNORPEFDG-UHFFFAOYSA-N
131755168;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BUBKDTQRUWZQHX-UHFFFAOYSA-N
52925126;LPAR3;7;5.161e-61;0.5333;4.3273;107.7848;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC=COCC(COP(=O)(O)OCCN)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UUYSKERSKRMYME-UHFFFAOYSA-N
53478215;LPAR3;7;2.272e-50;0.5283;3.5635;88.6759;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ADQHTXPTSHXNKF-UHFFFAOYSA-N
5282761;LPAR3;7;3.236e-52;0.4419;3.696;91.9909;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)O;UWHZIFQPPBDJPM-UHFFFAOYSA-N
131759434;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FVASQEUWMANRGF-UHFFFAOYSA-N
131759435;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MGFTVBFRGRHBJX-UHFFFAOYSA-N
53478133;LPAR3;7;1.623e-43;0.56;3.0716;76.3711;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCC=CCC=CCC=CCCCCC;RTZSIOQKPJZTKI-UHFFFAOYSA-N
131754010;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XDVVZXAIBRKPCM-UHFFFAOYSA-N
100094;MC1R;10;7.336e-58;0.4353;2.3089;102.1246;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 10);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
134906;MC1R;10;4.3910000000000004e-58;0.4286;2.3179;102.5248;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC1R;10;4.131e-48;0.4286;1.9145;84.6191;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 10);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC1R;10;2.815e-57;0.4217;2.2853;101.0762;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
3634442;MC1R;10;2.028e-56;0.4353;2.2506;99.5364;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 10);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
100094;MC1R;8;1.737e-99;0.4568;18.5633;176.8559;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MC1R;8;1.8579999999999998e-91;0.4304;17.0568;162.4407;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC1R;8;8.176999999999999e-89;0.4198;16.5608;157.6949;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC1R;8;1.378e-104;0.4605;19.5203;186.0129;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC1R;8;5.878e-93;0.4286;17.3382;165.1336;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC1R;8;6.913e-106;0.4605;19.7641;188.3462;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC1R;8;1.4629999999999999e-89;0.4359;16.701;159.0364;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;MC1R;8;5.135e-101;0.525;18.8502;179.6014;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC1R;8;8.195e-89;0.4267;16.5607;157.6932;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC1R;8;8.438e-97;0.4198;18.0593;172.0329;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC1R;8;3.791e-91;0.4125;16.9987;161.885;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC1R;8;3.529e-87;0.4103;16.2541;154.7594;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;MC1R;8;8.347e-80;0.4;14.8705;141.5209;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
7021456;MC1R;8;4.132e-71;0.4865;13.2392;125.9114;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
152198;MC1R;8;4.9869999999999996e-67;0.5;12.4734;118.5834;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
150964;MC1R;8;2.264e-98;0.4595;18.3541;174.8541;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9948926;MC1R;8;3.868e-93;0.4286;17.3723;165.4598;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC1R;8;1.04e-91;0.4211;17.1041;162.893;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MC1R;8;1.8030000000000002e-96;0.4568;17.9974;171.4409;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC1R;8;2.8270000000000003e-57;0.4225;10.6434;101.0728;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100094;MC1R;9;4.358e-75;0.4353;6.74;133.0511;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
134906;MC1R;9;2.267e-76;0.4321;6.8563;135.3559;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC1R;9;1.928e-70;0.4286;6.3192;124.7105;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC1R;9;3.645e-79;0.4321;7.1094;140.3717;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
7009650;MC1R;9;6.824e-74;0.5185;6.6318;130.9061;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC1R;9;1.708e-66;0.4;5.9616;117.6237;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
152198;MC1R;9;4.0639999999999997e-41;0.4198;3.6629;72.0647;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
150964;MC1R;9;1.434e-86;0.4024;7.7802;153.666;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9948926;MC1R;9;4.888e-68;0.4024;6.1014;120.3944;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
3634442;MC1R;9;1.157e-72;0.4353;6.5205;128.6994;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
100094;MC1R;7;2.945e-101;0.4805;30.1933;180.0349;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MC1R;7;1.069e-93;0.4487;27.9295;166.4628;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC1R;7;2.074e-91;0.4198;27.2443;162.3551;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC1R;7;6.82e-114;0.5342;33.9771;202.7193;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC1R;7;6.657999999999999e-94;0.443;27.991;166.8317;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC1R;7;5.0320000000000004e-117;0.5342;34.9151;208.3423;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC1R;7;1.2479999999999998e-93;0.4359;27.9093;166.3419;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;MC1R;7;1.8990000000000002e-108;0.6528;32.3466;192.9443;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC1R;7;1.38e-90;0.4267;26.9978;160.8777;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC1R;7;3.345e-107;0.4872;31.9736;190.7077;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC1R;7;2.129e-93;0.4487;27.8398;165.9252;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC1R;7;3.391e-90;0.4103;26.8809;160.1764;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;MC1R;7;2.2719999999999998e-80;0.4;23.9383;142.5355;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
7021456;MC1R;7;6.748e-79;0.4865;23.4973;139.8915;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
263475;MC1R;7;8.419999999999999e-89;0.4286;26.4631;157.672;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
152198;MC1R;7;2.516e-74;0.5417;22.1283;131.6841;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
150964;MC1R;7;7.584e-102;0.4865;30.3698;181.0927;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816755;MC1R;7;7.948999999999999e-83;0.4198;24.6738;146.945;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MC1R;7;1.184e-96;0.48;28.8145;171.769;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC1R;7;1.196e-95;0.4932;28.5137;169.9656;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MC1R;7;2.774e-97;0.4805;29.0033;172.9004;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC1R;7;3.4e-51;0.4225;15.2014;90.1571;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;MC1R;7;1.136e-83;0.4359;24.9269;148.4621;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;MC1R;7;7.034e-92;0.4211;27.3849;163.1982;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;MC3R;7;1.5799999999999998e-67;0.4568;17.2144;119.4798;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MC3R;7;8.277e-65;0.4286;16.5163;114.5977;MC3R;Melanocortin receptor 3 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC3R;7;6.259e-61;0.4177;15.5206;107.6344;MC3R;Melanocortin receptor 3 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC3R;7;1.5290000000000001e-84;0.493;21.5824;150.0255;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC3R;7;4.98e-60;0.4459;15.2893;106.0174;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC3R;7;2.1299999999999998e-82;0.493;21.032;146.1766;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC3R;7;2.798e-62;0.4342;15.8671;110.0576;MC3R;Melanocortin receptor 3 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;MC3R;7;6.034e-73;0.5455;18.6053;129.2067;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC3R;7;1.519e-62;0.4571;15.9352;110.534;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC3R;7;9.38e-72;0.4667;18.2994;127.0674;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC3R;7;4.06e-75;0.4103;19.163;133.1063;MC3R;Melanocortin receptor 3 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC3R;7;5.147000000000001e-78;0.4384;19.9067;138.3073;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;MC3R;7;1.572e-61;0.4085;15.6746;108.7118;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
7021456;MC3R;7;4.218e-42;0.4865;10.6868;73.8311;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
263475;MC3R;7;2.013e-62;0.4054;15.9038;110.3142;MC3R;Melanocortin receptor 3 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
150964;MC3R;7;1.3820000000000002e-63;0.4595;16.2024;112.4025;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
9948926;MC3R;7;7.078e-68;0.4384;17.3039;120.1057;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC3R;7;6.431000000000001e-70;0.4507;17.8281;123.7711;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MC3R;7;6.148e-69;0.4568;17.5764;122.0108;MC3R;Melanocortin receptor 3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC3R;7;2.806e-50;0.4225;12.7861;88.5115;MC3R;Melanocortin receptor 3 (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100094;MC3R;8;3.145e-42;0.4353;4.3874;74.06;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
134906;MC3R;8;1.203e-46;0.4444;4.8536;81.9907;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC3R;8;6.217999999999999e-41;0.4217;4.2506;71.7331;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC3R;8;6.141e-49;0.4268;5.0955;86.1053;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
102763;MC3R;8;1.313e-42;0.4125;4.4274;74.7408;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC3R;8;6.159999999999999e-48;0.407;4.9898;84.3076;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
7021456;MC3R;8;3.55e-42;0.4198;4.3819;73.9655;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
150964;MC3R;8;3.7649999999999995e-51;0.4487;5.329;90.0775;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
3634442;MC3R;8;3.5709999999999995e-41;0.4353;4.2761;72.1655;MC3R;Melanocortin receptor 3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
13890535;MC1R;6;1.753e-48;0.411;24.5832;85.2874;MC1R;Melanocyte-stimulating hormone receptor (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
134906;MC4R;8;9.057e-46;0.5455;28.5406;80.4165;MC4R;Melanocortin receptor 4 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;MC4R;8;1.642e-45;0.5224;28.3789;79.9528;MC4R;Melanocortin receptor 4 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
7009650;MC4R;8;3.0429999999999996e-41;0.5455;25.7066;72.2902;MC4R;Melanocortin receptor 4 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
13783081;MC4R;8;5.148999999999999e-41;0.5417;25.5636;71.8802;MC4R;Melanocortin receptor 4 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC4R;8;8.224999999999999e-41;0.4507;25.4363;71.5151;MC4R;Melanocortin receptor 4 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
100094;MC5R;6;6.459e-73;0.5294;34.1519;129.1536;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MC5R;6;1.035e-71;0.5147;33.5854;126.991;MC5R;Melanocortin receptor 5 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC5R;6;1.206e-71;0.4648;33.5541;126.8714;MC5R;Melanocortin receptor 5 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC5R;6;1.202e-92;0.6452;43.4302;164.5757;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC5R;6;1.925e-69;0.4714;32.5181;122.9163;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC5R;6;3.871e-92;0.619;43.1914;163.664;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC5R;6;6.031e-73;0.4853;34.1659;129.2071;MC5R;Melanocortin receptor 5 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;MC5R;6;5.355e-75;0.4118;35.1307;132.8905;MC5R;Melanocortin receptor 5 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7009650;MC5R;6;6.115e-70;0.6528;32.7523;123.8104;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC5R;6;9.251000000000001e-71;0.4478;33.138;125.2829;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC5R;6;7.2e-78;0.5588;36.481;138.0455;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC5R;6;1.733e-76;0.5147;35.8314;135.5653;MC5R;Melanocortin receptor 5 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC5R;6;1.7479999999999998e-80;0.4085;37.7106;142.7399;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
7021456;MC5R;6;5.541e-50;0.4286;23.3673;87.9808;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
263475;MC5R;6;5.292e-70;0.5152;32.7818;123.9231;MC5R;Melanocortin receptor 5 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
152198;MC5R;6;2.587e-44;0.5417;20.7013;77.8027;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
150964;MC5R;6;5.267e-63;0.5077;29.491;111.3596;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816755;MC5R;6;7.958e-61;0.4583;28.4662;107.4471;MC5R;Melanocortin receptor 5 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MC5R;6;8.430000000000001e-73;0.5303;34.0975;128.946;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC5R;6;5.787e-75;0.5714;35.1149;132.8299;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MC5R;6;3.2160000000000003e-71;0.5294;33.3538;126.1067;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC5R;6;1.858e-45;0.4458;21.2391;79.8562;MC5R;Melanocortin receptor 5 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;MC5R;6;7.236e-61;0.4783;28.4856;107.5212;MC5R;Melanocortin receptor 5 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;MC5R;6;1.511e-73;0.4848;34.4486;130.2863;MC5R;Melanocortin receptor 5 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
3038501;MC5R;7;2.7949999999999998e-80;0.4286;19.9608;142.3741;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
7009650;MC5R;7;8.845e-87;0.6528;21.5867;154.043;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
152198;MC5R;7;3.885e-57;0.5417;14.1719;100.8249;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
3634442;MC5R;7;8.599999999999999e-83;0.4805;20.5891;146.8836;MC5R;Melanocortin receptor 5 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC5R;7;1.987e-49;0.4225;12.2436;86.9851;MC5R;Melanocortin receptor 5 (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;MC5R;7;5.0999999999999996e-70;0.4359;17.3941;123.9519;MC5R;Melanocortin receptor 5 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100094;MC4R;7;1.1710000000000001e-57;0.5294;65.0726;101.7601;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
6351946;MC4R;7;1.6650000000000002e-46;0.443;52.5051;81.7369;MC4R;Melanocortin receptor 4 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
329275;MC4R;7;1.0520000000000001e-57;0.5147;65.1249;101.8435;MC4R;Melanocortin receptor 4 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC4R;7;5.762e-55;0.4648;62.0391;96.927;MC4R;Melanocortin receptor 4 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC4R;7;8.530999999999999e-68;0.6452;76.4957;119.9601;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC4R;7;7.496e-55;0.4714;61.9103;96.7219;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC4R;7;2.53e-68;0.619;77.0905;120.9078;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC4R;7;1.4840000000000001e-55;0.4853;62.703;97.9849;MC4R;Melanocortin receptor 4 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;MC4R;7;1.902e-54;0.4146;61.4547;95.996;MC4R;Melanocortin receptor 4 (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
7009650;MC4R;7;7.026e-59;0.6528;66.4493;103.9536;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MC4R;7;6.858e-56;0.4571;63.0806;98.5865;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MC4R;7;1.1279999999999999e-60;0.5588;68.4713;107.1751;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC4R;7;3.2610000000000004e-57;0.5147;64.5712;100.9614;MC4R;Melanocortin receptor 4 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC4R;7;3.95e-56;0.4384;63.3506;99.0167;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
4656408;MC4R;7;4.602e-45;0.4085;50.8808;79.149;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
263475;MC4R;7;3.421e-52;0.5152;58.9137;91.9474;MC4R;Melanocortin receptor 4 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
150964;MC4R;7;1.1560000000000001e-55;0.5;62.8253;98.1797;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816755;MC4R;7;1.209e-47;0.4583;53.7888;83.7822;MC4R;Melanocortin receptor 4 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MC4R;7;3.597e-56;0.5303;63.3964;99.0896;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC4R;7;6.591e-57;0.5714;64.2269;100.4128;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MC4R;7;4.428e-56;0.5294;63.2947;98.9276;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;MC4R;7;1.52e-47;0.4783;53.6765;83.6032;MC4R;Melanocortin receptor 4 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;MC4R;7;7.255999999999999e-53;0.4848;59.6726;93.1566;MC4R;Melanocortin receptor 4 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
100094;MC5R;9;3.2140000000000004e-64;0.4568;4.0658;113.5399;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
134906;MC5R;9;3.236e-65;0.45;4.1296;115.33;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MC5R;9;3.414e-63;0.4286;4.0001;111.6976;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MC5R;9;1.992e-64;0.4321;4.0791;113.913;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
25200879;MC5R;9;2.1029999999999998e-67;0.4024;4.2697;119.2565;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
9948926;MC5R;9;5.7230000000000005e-55;0.4024;3.4734;96.9322;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
3634442;MC5R;9;9.952000000000001e-65;0.4568;4.0984;114.4541;MC5R;Melanocortin receptor 5 (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
14409732;MC5R;9;2.236e-53;0.4225;3.3715;94.0745;MC5R;Melanocortin receptor 5 (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100094;MC5R;8;1.255e-84;0.4805;12.4906;150.1793;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MC5R;8;6.2710000000000005e-74;0.4487;10.9003;130.972;MC5R;Melanocortin receptor 5 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MC5R;8;2.494e-77;0.4024;11.4058;137.0769;MC5R;Melanocortin receptor 5 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MC5R;8;1.718e-92;0.5342;13.6595;164.2973;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;MC5R;8;5.973e-93;0.5342;13.7277;165.1211;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MC5R;8;1.9760000000000002e-78;0.4177;11.5694;139.0538;MC5R;Melanocortin receptor 5 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
13783081;MC5R;8;2.636e-81;0.4872;11.9968;144.2149;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MC5R;8;2.402e-79;0.4487;11.7055;140.6967;MC5R;Melanocortin receptor 5 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
25200879;MC5R;8;2.634e-90;0.4024;13.3346;160.3736;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CCC(=O)N)C(=O)O;DVJIJAYHBZALOJ-UHFFFAOYSA-N
7021456;MC5R;8;1.083e-46;0.4177;6.8517;82.0722;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
263475;MC5R;8;2.017e-79;0.4286;11.7168;140.8329;MC5R;Melanocortin receptor 5 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
150964;MC5R;8;5.769e-57;0.4865;8.3788;100.5166;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816755;MC5R;8;8.643000000000001e-69;0.4198;10.1364;121.7453;MC5R;Melanocortin receptor 5 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MC5R;8;1.574e-79;0.48;11.7328;141.0266;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MC5R;8;8.949e-83;0.4932;12.2151;146.8526;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
263471;MC5R;8;1.432e-80;0.4211;11.8875;142.8955;MC5R;Melanocortin receptor 5 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
6993120;MME;9;5.648e-83;0.5435;11.0744;147.2115;MME;Neprilysin (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;MME;9;2.445e-74;0.4878;9.9131;131.7063;MME;Neprilysin (pKi >= 9);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
515717;MME;9;8.769e-49;0.46;6.477;85.8277;MME;Neprilysin (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;MME;9;2.514e-66;0.6216;8.8358;117.3223;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;MME;9;8.286000000000001e-72;0.641;9.573;127.1642;MME;Neprilysin (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;MME;9;2.5300000000000002e-85;0.5319;11.3903;151.4281;MME;Neprilysin (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;MME;9;3.775e-74;0.4773;9.8878;131.3678;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;MME;9;7.414000000000001e-72;0.5111;9.5794;127.2509;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;MME;9;4.847e-43;0.7308;5.7048;75.518;MME;Neprilysin (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;MME;9;1.4169999999999998e-60;0.46;8.0625;106.9973;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;MME;9;4.918999999999999e-53;0.4783;7.0486;93.4596;MME;Neprilysin (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;MME;9;8.687e-49;0.6296;6.4775;85.8349;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;MME;9;4.316e-56;0.5;7.4596;98.9476;MME;Neprilysin (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;MME;9;1.044e-48;0.6;6.4668;85.6916;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;MME;9;8.373999999999999e-80;0.5;10.648;141.5184;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;MME;9;4.273e-49;0.4118;6.5189;86.3881;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;MME;9;2.532e-81;0.5652;10.8524;144.2464;MME;Neprilysin (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;MME;9;1.4770000000000002e-65;0.5;8.7324;115.9415;MME;Neprilysin (pKi >= 9);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;MME;9;1.02e-44;0.7255;5.9303;78.5287;MME;Neprilysin (pKi >= 9);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;MME;9;2.057e-58;0.5625;7.7718;103.116;MME;Neprilysin (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;MME;9;7.997e-56;0.4898;7.4236;98.4668;MME;Neprilysin (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;MME;9;2.6219999999999997e-44;0.5593;5.8751;77.7922;MME;Neprilysin (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MME;9;2.9209999999999997e-41;0.6667;5.4654;72.3222;MME;Neprilysin (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;MME;9;1.5200000000000002e-57;0.5106;7.655;101.5568;MME;Neprilysin (pKi >= 9);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;MME;9;7.698000000000001e-64;0.4583;8.5015;112.8589;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;MME;9;2.4100000000000003e-75;0.4468;10.0485;133.513;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;MME;9;1.135e-65;0.4773;8.7478;116.1467;MME;Neprilysin (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;MME;9;4.007e-77;0.5106;10.2877;136.7073;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;MME;9;4.007e-77;0.5106;10.2877;136.7073;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;MME;9;2.324e-54;0.4182;7.2268;95.8396;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;MME;9;7.712999999999999e-88;0.5682;11.7286;155.9451;MME;Neprilysin (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;MME;9;1.609e-51;0.5102;6.8449;90.7403;MME;Neprilysin (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;MME;9;2.474e-50;0.5;6.6853;88.6096;MME;Neprilysin (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;MME;9;4.58e-64;0.4667;8.5319;113.2639;MME;Neprilysin (pKi >= 9);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;MME;9;2.466e-54;0.4259;7.2234;95.7933;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;MME;9;2.341e-42;0.4038;5.6128;74.2902;MME;Neprilysin (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;MME;9;4.359e-61;0.4318;8.1314;107.9165;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;MME;9;1.547e-75;0.4528;10.0744;133.8587;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;MME;9;1.255e-62;0.4468;8.3385;110.6825;MME;Neprilysin (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;MME;9;1.7669999999999997e-67;0.4468;8.9909;119.3924;MME;Neprilysin (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;MME;9;6.249e-64;0.48;8.5137;113.0216;MME;Neprilysin (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;MME;9;1.45e-61;0.4231;8.1956;108.7745;MME;Neprilysin (pKi >= 9);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;MME;8;1.954e-173;0.5778;80.9204;309.6177;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;MME;8;4.083e-157;0.5128;73.293;280.318;MME;Neprilysin (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;MME;8;2.9049999999999997e-80;0.52;37.3747;142.3438;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;MME;8;7.394e-113;0.5417;52.6082;200.861;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
100094;MME;8;1.013e-77;0.6071;36.1865;137.7794;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
6992304;MME;8;1.374e-125;0.6216;58.5582;223.7168;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;MME;8;3.805e-102;0.5455;47.6021;181.6305;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;MME;8;1.707e-95;0.5294;44.4931;169.6881;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;MME;8;7.891e-157;0.6757;73.1592;279.8043;MME;Neprilysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;MME;8;2.47e-173;0.5652;80.8729;309.4351;MME;Neprilysin (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;MME;8;1.761e-115;0.4717;53.8342;205.5702;MME;Neprilysin (pKi >= 8);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;MME;8;2.162e-149;0.561;69.6831;266.4513;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;MME;8;1.0700000000000001e-157;0.5714;73.5648;281.3622;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;MME;8;1.1659999999999999e-103;0.7308;48.3095;184.348;MME;Neprilysin (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;MME;8;7.754e-132;0.5106;61.4786;234.935;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;MME;8;5.531e-123;0.6047;57.3408;219.0405;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;MME;8;1.588e-95;0.6545;44.5079;169.7446;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MME;8;3.1080000000000005e-123;0.6296;57.4579;219.49;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;MME;8;7.322999999999999e-119;0.6122;55.4144;211.6404;MME;Neprilysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
3038501;MME;8;1.294e-55;0.5893;25.8548;98.0917;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MME;8;1.391e-129;0.6;60.4252;230.8884;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;MME;8;6.811e-171;0.5897;79.7322;305.0534;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;MME;8;1.649e-107;0.4545;50.1086;191.259;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;MME;8;1.268e-171;0.6304;80.0735;306.3644;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;MME;8;7.54e-143;0.5532;66.6253;254.7053;MME;Neprilysin (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
7643;MME;8;1.8530000000000002e-46;0.439;21.5755;81.6537;MME;Neprilysin (pKi >= 8);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
168182;MME;8;9.436e-108;0.7255;50.2219;191.6943;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;MME;8;3.195e-130;0.6458;60.7238;232.0357;MME;Neprilysin (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009650;MME;8;1.227e-52;0.5574;24.4634;92.7472;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
7009555;MME;8;8.052000000000001e-131;0.5957;61.0036;233.1103;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
102763;MME;8;1.1689999999999999e-61;0.6154;28.6795;108.9423;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MME;8;6.361e-113;0.5593;52.6388;200.9783;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;MME;8;1.992e-80;0.5769;37.4513;142.6379;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;MME;8;5.67e-46;0.6078;21.3485;80.7816;MME;Neprilysin (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
323786;MME;8;1.1299999999999999e-95;0.6667;44.5768;170.0096;MME;Neprilysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;MME;8;5.185e-141;0.6222;65.7666;251.4067;MME;Neprilysin (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;MME;8;2.586e-135;0.5;63.1036;241.1772;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
4656408;MME;8;1.403e-50;0.5455;23.5014;89.0518;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
6992643;MME;8;5.083e-156;0.65;72.7811;278.3518;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;MME;8;8.115e-143;0.5333;66.6104;254.648;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;MME;8;1.033e-81;0.4706;38.052;144.9456;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;MME;8;5.397e-67;0.4815;31.1733;118.5219;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;MME;8;3.8860000000000003e-166;0.6744;77.5093;296.5144;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
263475;MME;8;2.218e-70;0.5636;32.7559;124.6012;MME;Neprilysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3421919;MME;8;3.8860000000000003e-166;0.6744;77.5093;296.5144;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;MME;8;9.057000000000001e-121;0.4615;56.306;215.0654;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;MME;8;1.668e-188;0.6047;87.963;336.6707;MME;Neprilysin (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;MME;8;7.739000000000001e-46;0.4773;21.2854;80.5391;MME;Neprilysin (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;MME;8;1.6919999999999998e-125;0.6531;58.516;223.5546;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;MME;8;4.341e-117;0.5238;54.5858;208.4575;MME;Neprilysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;MME;8;2.4730000000000004e-131;0.6667;61.2431;234.0306;MME;Neprilysin (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;MME;8;2.392e-115;0.4717;53.7721;205.3317;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;MME;8;9.879e-104;0.48;48.3431;184.4772;MME;Neprilysin (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;MME;8;3.7559999999999996e-125;0.4878;58.3542;222.933;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
19816755;MME;8;3.4959999999999996e-54;0.5167;25.1856;95.5213;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MME;8;4.025e-80;0.6415;37.3086;142.0898;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
151134;MME;8;2.919e-155;0.5333;72.4263;276.989;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;MME;8;2.68e-87;0.6667;40.6627;154.9739;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;MME;8;1.502e-125;0.5185;58.5402;223.6477;MME;Neprilysin (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3634442;MME;8;1.8690000000000002e-69;0.5517;32.3232;122.9393;MME;Neprilysin (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
193508;MME;8;8.627e-145;0.65;67.5327;258.191;MME;Neprilysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
19816756;MME;8;9.656e-60;0.5862;27.7836;105.501;MME;Neprilysin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100048;MME;8;5.391e-145;0.625;67.6281;258.5575;MME;Neprilysin (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;MME;8;1.5989999999999999e-134;0.6957;62.7338;239.7567;MME;Neprilysin (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;MME;7;1.0809999999999999e-215;0.6154;146.1884;385.4829;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;MME;7;4.565e-201;0.5714;136.2686;359.225;MME;Neprilysin (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7021820;MME;7;1.563e-106;0.52;72.1514;189.5054;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;MME;7;8.74e-144;0.5417;97.4176;256.3855;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
100094;MME;7;9.373e-99;0.6182;66.8761;175.5417;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
6992304;MME;7;1.455e-156;0.6216;106.0846;279.3273;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;MME;7;1.238e-126;0.6047;85.7849;225.5936;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;MME;7;5.269e-113;0.5294;76.5412;201.1252;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;MME;7;1.697e-191;0.6757;129.7777;342.0433;MME;Neprilysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;MME;7;6.304e-213;0.6;144.3125;380.5172;MME;Neprilysin (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
6351946;MME;7;7.287e-150;0.4783;101.5406;267.2991;MME;Neprilysin (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
97415;MME;7;1.604e-185;0.6053;125.7248;331.3153;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;MME;7;2.3949999999999996e-196;0.6316;133.0675;350.7514;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;MME;7;1.025e-125;0.7308;85.1624;223.9457;MME;Neprilysin (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;MME;7;3.384e-167;0.5581;113.2966;298.4176;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;MME;7;3.704e-155;0.6047;105.1311;276.8033;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;MME;7;1.186e-113;0.6545;76.9805;202.2882;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MME;7;1.013e-152;0.74;103.4783;272.4284;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;MME;7;3.25e-148;0.6122;100.422;264.3382;MME;Neprilysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
3038501;MME;7;4.342e-71;0.5893;48.112;125.8727;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MME;7;5.606e-159;0.7115;107.722;283.6615;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;MME;7;4.576e-211;0.6389;143.0503;377.1763;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
11579826;MME;7;1.06e-140;0.4773;95.3259;250.8487;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
435728;MME;7;2.2540000000000002e-212;0.7143;143.9372;379.5238;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;MME;7;1.947e-182;0.5556;123.6331;325.7785;MME;Neprilysin (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
7643;MME;7;1.132e-55;0.439;37.6561;98.1955;MME;Neprilysin (pKi >= 7);COC(=O)CCC1=CC=CC=C1;RPUSRLKKXPQSGP-UHFFFAOYSA-N
168182;MME;7;3.2219999999999997e-127;0.7255;86.1814;226.6431;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
18218238;MME;7;5.348e-44;0.5424;29.7381;77.2366;MME;Neprilysin (pKi >= 7);C1CC(NC1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O;UEKYKRQIAQHOOZ-UHFFFAOYSA-N
273262;MME;7;1.082e-164;0.6458;111.5977;293.9205;MME;Neprilysin (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009650;MME;7;1.575e-62;0.5667;42.3066;110.5056;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
7009555;MME;7;2.2160000000000003e-162;0.6222;110.0301;289.771;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
102763;MME;7;9.748e-77;0.6275;51.9433;136.014;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MME;7;2.491e-141;0.6316;95.7526;251.9783;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;MME;7;4.281e-99;0.5769;67.1069;176.1526;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;MME;7;3.112e-62;0.62;42.106;109.9745;MME;Neprilysin (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
323786;MME;7;7.442000000000001e-116;0.6667;78.4742;206.2419;MME;Neprilysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;MME;7;1.645e-174;0.6512;118.2568;311.5473;MME;Neprilysin (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;MME;7;4.134e-170;0.5435;115.2724;303.6474;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
4656408;MME;7;2.7699999999999997e-60;0.5455;40.7838;106.4748;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(=O)NC(CC(=O)O)C(=O)O;VAFNMNRKDDAKRM-UHFFFAOYSA-N
6992643;MME;7;4.542e-194;0.65;131.5225;346.6618;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;MME;7;2.235e-175;0.5417;118.8448;313.1036;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;MME;7;1.018e-108;0.4717;73.6341;193.4302;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;MME;7;3.6929999999999996e-88;0.4821;59.6898;156.5193;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;MME;7;1.336e-200;0.6744;135.9523;358.3876;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
263475;MME;7;1.726e-76;0.5636;51.7749;135.5684;MME;Neprilysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3421919;MME;7;1.336e-200;0.6744;135.9523;358.3876;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;MME;7;2.867e-151;0.5;102.4936;269.8219;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;MME;7;1.772e-235;0.6486;159.6076;421.0037;MME;Neprilysin (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;MME;7;1.378e-56;0.5;38.2765;99.8379;MME;Neprilysin (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;MME;7;1.5500000000000001e-156;0.7273;106.0659;279.2777;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;MME;7;3.167e-140;0.5238;95.0036;249.9957;MME;Neprilysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;MME;7;2.692e-161;0.6667;109.2946;287.8241;MME;Neprilysin (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;MME;7;4.79e-144;0.5106;97.5947;256.8544;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;MME;7;1.7990000000000002e-132;0.4912;89.7442;236.074;MME;Neprilysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
759256;MME;7;6.728000000000001e-160;0.5405;108.3465;285.3146;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
19816755;MME;7;3.2899999999999997e-62;0.5167;42.0896;109.9311;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MME;7;7.795e-100;0.6538;67.6087;177.4807;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
151134;MME;7;8.251000000000001e-199;0.5333;134.7378;355.1729;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
318292;MME;7;8.845e-107;0.68;72.3191;189.9494;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;MME;7;2.952e-158;0.5577;107.2327;282.3662;MME;Neprilysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3634442;MME;7;4.418e-90;0.5614;60.9935;159.9702;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
193508;MME;7;2.066e-183;0.65;124.2938;327.5274;MME;Neprilysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
14409732;MME;7;5.583e-43;0.6212;29.0472;75.4077;MME;Neprilysin (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
19816756;MME;7;2.228e-68;0.5862;46.2739;121.007;MME;Neprilysin (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100048;MME;7;4.7819999999999996e-181;0.625;122.6902;323.2825;MME;Neprilysin (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
263471;MME;7;3.3249999999999995e-41;0.4912;27.8434;72.2211;MME;Neprilysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
7010506;MME;7;4.9089999999999994e-169;0.6957;114.5435;301.7182;MME;Neprilysin (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
100094;MMP11;7;2.85e-113;0.473;9.9467;201.6044;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MMP11;7;1.527e-108;0.5139;9.5289;193.1144;MMP11;Stromelysin-3 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MMP11;7;1.5439999999999999e-105;0.4667;9.2634;187.7196;MMP11;Stromelysin-3 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MMP11;7;1.332e-123;0.507;10.8593;220.1503;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MMP11;7;2.463e-104;0.4211;9.1572;185.5603;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MMP11;7;7.731e-120;0.4861;10.5268;213.3935;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP11;7;8.574e-106;0.4658;9.286;188.1783;MMP11;Stromelysin-3 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;MMP11;7;1.623e-88;0.4118;7.7596;157.1603;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MMP11;7;5.093e-106;0.411;9.306;188.5845;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MMP11;7;1.104e-113;0.4625;9.9831;202.3436;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MMP11;7;1.267e-105;0.4932;9.271;187.8737;MMP11;Stromelysin-3 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;MMP11;7;1.105e-106;0.4384;9.3646;189.7759;MMP11;Stromelysin-3 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;MMP11;7;3.211e-99;0.4286;8.7053;176.3769;MMP11;Stromelysin-3 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;MMP11;7;3.83e-107;0.4521;9.4053;190.6019;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MMP11;7;2.498e-113;0.4648;9.9517;201.7072;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MMP11;7;6.817e-111;0.4533;9.7365;197.3337;MMP11;Stromelysin-3 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;MMP11;7;1.727e-106;0.44;9.3475;189.4275;MMP11;Stromelysin-3 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
329275;MMP1;8;1.816e-48;0.625;18.902;85.2601;MMP1;Interstitial collagenase (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
4427709;MMP1;8;5.93e-42;0.5;16.3429;73.5654;MMP1;Interstitial collagenase (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
323786;MMP1;8;1.4800000000000002e-47;0.5965;18.544;83.6241;MMP1;Interstitial collagenase (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
100094;MMP11;8;4.365e-89;0.473;5.1783;158.1843;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MMP11;8;5.575e-82;0.44;4.7618;145.4262;MMP11;Stromelysin-3 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MMP11;8;7.102e-80;0.4286;4.6384;141.6469;MMP11;Stromelysin-3 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MMP11;8;2.899e-97;0.507;5.6577;172.866;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MMP11;8;3.439e-84;0.4026;4.8913;149.3935;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MMP11;8;2.655e-95;0.4861;5.5427;169.3439;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP11;8;2.362e-80;0.4267;4.6664;142.5053;MMP11;Stromelysin-3 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009650;MMP11;8;1.164e-60;0.4074;3.5122;107.1504;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC3=CN=CN3)N;FBTYOQIYBULKEH-UHFFFAOYSA-N
102763;MMP11;8;2.168e-85;0.411;4.9617;151.5488;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MMP11;8;2.8339999999999997e-90;0.4605;5.2479;160.3164;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MMP11;8;1.8700000000000003e-80;0.4211;4.6724;142.6876;MMP11;Stromelysin-3 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;MMP11;8;9.598e-86;0.4048;4.9824;152.184;MMP11;Stromelysin-3 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9948926;MMP11;8;8.908e-82;0.4521;4.7499;145.0609;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MMP11;8;1.196e-88;0.4648;5.1527;157.3986;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MMP11;8;1.0989999999999999e-88;0.4533;5.1548;157.4644;MMP11;Stromelysin-3 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;MMP11;8;3.069e-85;0.4079;4.9528;151.2777;MMP11;Stromelysin-3 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
6993120;MMP1;7;4.17e-56;0.4706;45.7591;98.9745;MMP1;Interstitial collagenase (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;MMP1;7;1.1889999999999999e-44;0.4348;36.4049;78.4091;MMP1;Interstitial collagenase (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
7010580;MMP1;7;6.226e-52;0.4615;42.3505;91.4806;MMP1;Interstitial collagenase (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
329275;MMP1;7;4.7390000000000005e-55;0.625;44.8972;97.0794;MMP1;Interstitial collagenase (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
134906;MMP1;7;3.0239999999999996e-45;0.5385;36.8904;79.4766;MMP1;Interstitial collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;MMP1;7;1.188e-44;0.4478;36.405;78.4094;MMP1;Interstitial collagenase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;MMP1;7;2.812e-51;0.5152;41.8158;90.3049;MMP1;Interstitial collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;MMP1;7;5.010000000000001e-43;0.4255;35.0781;75.4922;MMP1;Interstitial collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;MMP1;7;8.823e-50;0.4717;40.5937;87.6182;MMP1;Interstitial collagenase (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;MMP1;7;3.83e-46;0.4478;37.6232;81.0876;MMP1;Interstitial collagenase (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
323786;MMP1;7;1.5970000000000001e-56;0.5965;46.0994;99.7226;MMP1;Interstitial collagenase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
7359122;MMP1;7;6.14e-41;0.4;33.3728;71.7429;MMP1;Interstitial collagenase (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;MMP1;7;5.541e-60;0.5319;48.9247;105.934;MMP1;Interstitial collagenase (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
100048;MMP1;7;6.759e-43;0.4286;34.9719;75.2587;MMP1;Interstitial collagenase (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
329275;MMP2;8;3.6509999999999994e-41;0.5667;36.6295;72.1482;MMP2;72 kDa type IV collagenase (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
323786;MMP2;8;6.104000000000001e-42;0.541;37.3213;73.5429;MMP2;72 kDa type IV collagenase (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
329275;MMP2;7;3.282e-51;0.625;66.751;90.1846;MMP2;72 kDa type IV collagenase (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
134906;MMP2;7;1.319e-47;0.5357;62.0688;83.7141;MMP2;72 kDa type IV collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;MMP2;7;5.507e-49;0.5088;63.8606;86.1903;MMP2;72 kDa type IV collagenase (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP2;7;2.633e-43;0.5789;56.4822;75.9938;MMP2;72 kDa type IV collagenase (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
13783081;MMP2;7;2.3e-43;0.493;56.5585;76.0993;MMP2;72 kDa type IV collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MMP2;7;2.798e-51;0.5965;66.8409;90.3088;MMP2;72 kDa type IV collagenase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
329275;MMP7;7;6.530999999999999e-47;0.5667;9.6054;82.4667;MMP7;Matrilysin (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
323786;MMP7;7;1.1230000000000001e-46;0.541;9.5567;82.044;MMP7;Matrilysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
6993120;MMP3;7;3.558e-43;0.4717;38.1471;75.7591;MMP3;Stromelysin-1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
96814;MMP3;7;1.031e-45;0.5319;40.3911;80.3154;MMP3;Stromelysin-1 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
100094;MMP8;6;1.538e-45;0.5333;36.0886;80.0037;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MMP8;6;5.9079999999999995e-59;0.625;46.7394;104.0887;MMP8;Neutrophil collagenase (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MMP8;6;4.509e-48;0.55;38.0995;84.551;MMP8;Neutrophil collagenase (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MMP8;6;1.242e-56;0.5254;44.8955;99.919;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MMP8;6;1.6859999999999998e-41;0.5082;32.8812;72.7508;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MMP8;6;8.086e-60;0.5;47.4252;105.6394;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP8;6;5.498999999999999e-51;0.5789;40.4128;89.7821;MMP8;Neutrophil collagenase (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;MMP8;6;1.8080000000000002e-42;0.5263;33.651;74.4914;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MMP8;6;1.5809999999999998e-53;0.493;42.4305;94.3448;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MMP8;6;2.078e-59;0.5965;47.0997;104.9034;MMP8;Neutrophil collagenase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;MMP8;6;1.438e-43;0.5172;34.5239;76.4654;MMP8;Neutrophil collagenase (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9948926;MMP8;6;3.3449999999999996e-47;0.5893;37.4085;82.9884;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MMP8;6;2.1829999999999998e-47;0.5536;37.5556;83.321;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MMP8;6;1.061e-44;0.5082;35.4227;78.4979;MMP8;Neutrophil collagenase (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;MMP8;6;1.1469999999999999e-41;0.5;33.0141;73.0512;MMP8;Neutrophil collagenase (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
134906;MMP8;9;2.027e-54;0.5;11.2391;95.9461;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;MMP8;9;1.8249999999999998e-51;0.4789;10.623;90.6422;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
13783081;MMP8;9;7.97e-48;0.493;9.8639;84.1069;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
263475;MMP8;9;3.085e-44;0.4921;9.1157;77.6657;MMP8;Neutrophil collagenase (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3634442;MMP8;9;1.768e-46;0.4627;9.5832;81.6902;MMP8;Neutrophil collagenase (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;MMP8;9;4.001e-41;0.4762;8.4665;72.077;MMP8;Neutrophil collagenase (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100094;MMP8;8;9.286e-45;0.4861;21.2113;78.6017;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MMP8;8;1.1670000000000001e-55;0.5667;26.4105;98.1717;MMP8;Neutrophil collagenase (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MMP8;8;2.169e-46;0.5231;21.9895;81.531;MMP8;Neutrophil collagenase (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;MMP8;8;1.6809999999999997e-53;0.5156;25.381;94.2967;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;MMP8;8;5.291999999999999e-41;0.4697;19.4199;71.8589;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;MMP8;8;1.714e-55;0.4923;26.331;97.8725;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
168182;MMP8;8;6.124e-50;0.5246;23.6823;87.9029;MMP8;Neutrophil collagenase (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;MMP8;8;9.927000000000001e-42;0.4839;19.7665;73.1637;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
13783081;MMP8;8;1.683e-48;0.493;22.996;85.3193;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;MMP8;8;2.673e-56;0.541;26.7159;99.3213;MMP8;Neutrophil collagenase (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;MMP8;8;9.270999999999998e-41;0.4921;19.3037;71.4217;MMP8;Neutrophil collagenase (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9948926;MMP8;8;2.7199999999999997e-46;0.5082;21.9426;81.3544;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MMP8;8;2.412e-45;0.5;21.4905;79.6528;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;MMP8;8;2.263e-43;0.4627;20.5497;76.1117;MMP8;Neutrophil collagenase (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
100094;MMP8;7;6.376e-48;0.5333;31.5473;84.2808;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;MMP8;7;1.936e-62;0.625;41.137;110.3447;MMP8;Neutrophil collagenase (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;MMP8;7;4.394e-51;0.55;33.6358;89.957;MMP8;Neutrophil collagenase (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
3038501;MMP8;7;7.666e-44;0.5082;28.8522;76.9558;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
168182;MMP8;7;4.993e-54;0.5789;35.5808;95.2434;MMP8;Neutrophil collagenase (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;MMP8;7;8.711e-45;0.5263;29.4761;78.6515;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
323786;MMP8;7;3.1510000000000004e-63;0.5965;41.6578;111.7602;MMP8;Neutrophil collagenase (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
96814;MMP8;7;2.968e-42;0.4894;27.8033;74.105;MMP8;Neutrophil collagenase (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
9948926;MMP8;7;4.072e-50;0.5893;32.9971;88.2211;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;MMP8;7;2.554e-50;0.5536;33.1308;88.5847;MMP8;Neutrophil collagenase (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
329275;MMP9;8;5.519e-41;0.5667;33.3505;71.8261;MMP9;Matrix metalloproteinase-9 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
323786;MMP9;8;9.290000000000001e-43;0.541;34.7964;75.0107;MMP9;Matrix metalloproteinase-9 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
18986;MPO;7;6.5339999999999996e-80;0.4043;8.2002;141.7118;MPO;Myeloperoxidase (pKi >= 7);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
10257;MPO;7;1.362e-94;0.6842;9.7192;168.0691;MPO;Myeloperoxidase (pKi >= 7);CN(C)CCC1=CNC2=C1C=C(C=C2)O;VTTONGPRPXSUTJ-UHFFFAOYSA-N
6993120;MMP9;7;7.791e-43;0.4898;51.4329;75.1479;MMP9;Matrix metalloproteinase-9 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
134906;MMP9;7;3.739e-50;0.5254;60.1955;88.2877;MMP9;Matrix metalloproteinase-9 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;MMP9;7;3.991e-54;0.5;64.9506;95.4181;MMP9;Matrix metalloproteinase-9 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
13783081;MMP9;7;7.055e-46;0.493;55.0763;80.6112;MMP9;Matrix metalloproteinase-9 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
96814;MMP9;7;4.294e-48;0.4894;57.729;84.589;MMP9;Matrix metalloproteinase-9 (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
329275;MMP9;6;1.6369999999999998e-51;0.625;74.3071;90.727;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
168182;MMP9;6;4.595e-43;0.5789;62.1747;75.5596;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
323786;MMP9;6;1.467e-53;0.5965;77.2474;94.403;MMP9;Matrix metalloproteinase-9 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
18986;MTNR1A;10;5.533999999999999e-44;0.6512;6.1442;77.21;MTNR1A;Melatonin receptor type 1A (pKi >= 10);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1A;8;1.0780000000000001e-72;0.6512;31.6243;128.7545;MTNR1A;Melatonin receptor type 1A (pKi >= 8);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1A;9;1.863e-41;0.6512;9.9743;72.6727;MTNR1A;Melatonin receptor type 1A (pKi >= 9);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1A;7;2.083e-99;0.6512;59.4435;176.7144;MTNR1A;Melatonin receptor type 1A (pKi >= 7);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1B;9;1.997e-65;0.6512;20.3999;115.7063;MTNR1B;Melatonin receptor type 1B (pKi >= 9);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1B;8;6.175e-83;0.6512;38.6238;147.1419;MTNR1B;Melatonin receptor type 1B (pKi >= 8);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18986;MTNR1B;7;3.2959999999999997e-91;0.6512;55.844;161.9939;MTNR1B;Melatonin receptor type 1B (pKi >= 7);COC1=CC2=C(C=C1)NC=C2CC(=O)O;COCNDHOPIHDTHK-UHFFFAOYSA-N
18218218;NAALAD2;8;4.869000000000001e-63;0.5143;2.3047;111.4208;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
7016045;NAALAD2;8;1.69e-45;0.4167;1.6553;79.9301;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);CC(C)C(C(=O)NC(CCC(=O)N)C(=O)O)N;XXDVDTMEVBYRPK-UHFFFAOYSA-N
515717;NAALAD2;8;1.142e-60;0.6905;2.2169;107.1652;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
5259590;NAALAD2;8;8.980000000000001e-73;0.5294;2.6651;128.8967;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9856500;NAALAD2;8;3.114e-63;0.4444;2.3119;111.7693;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
7010588;NAALAD2;8;2.0740000000000003e-56;0.4545;2.0593;99.5189;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C(CC(=O)N)C(C(=O)NC(CCC(=O)N)C(=O)O)N;LOJYQMFIIJVETK-UHFFFAOYSA-N
7009623;NAALAD2;8;1.558e-75;0.5625;2.7673;133.8532;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
11579826;NAALAD2;8;4.428e-86;0.575;3.1578;152.7871;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC=C(C=C1)CC(=O)NC(CCC(=O)O)C(=O)O;PTSRBZOZSRJCKX-UHFFFAOYSA-N
19421321;NAALAD2;8;3.8249999999999996e-54;0.5652;1.9754;95.4511;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7015704;NAALAD2;8;2.5480000000000003e-58;0.4722;2.13;102.9492;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
19816750;NAALAD2;8;3.475e-75;0.6905;2.7544;133.2276;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;NAALAD2;8;1.1880000000000001e-71;0.5333;2.6236;126.8829;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
3634442;NAALAD2;8;2.015e-59;0.4182;2.1708;104.9276;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
329275;NMBR;7;2.1499999999999998e-46;0.4795;4.2423;81.5376;NMBR;Neuromedin-B receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
323786;NMBR;7;1.844e-68;0.44;6.2899;121.1547;NMBR;Neuromedin-B receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;NMBR;7;5.3140000000000004e-58;0.4189;5.3193;102.376;NMBR;Neuromedin-B receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;NMBR;7;1.6740000000000002e-46;0.4103;4.2524;81.733;NMBR;Neuromedin-B receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
19816756;NMBR;7;4.846e-54;0.4079;4.9519;95.2667;NMBR;Neuromedin-B receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
263471;NMBR;6;9.378e-68;0.4828;10.7815;119.8864;NMBR;Neuromedin-B receptor (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NCC(=O)O)N;UYKREHOKELZSPB-UHFFFAOYSA-N
18218218;NOD1;6;4.1630000000000004e-71;0.4167;7.4352;125.9054;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;KTGFOCFYOZQVRJ-UHFFFAOYSA-N
44232492;NOD1;6;1.768e-57;0.4038;5.9969;101.4389;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
70694;NOD1;6;5.306999999999999e-53;0.5238;5.5244;93.4005;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCOC(=O)CCCC;YERFHJZYNMRVLO-UHFFFAOYSA-N
4305457;NOD1;6;3.977e-69;0.4167;7.2262;122.3505;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)O)N;JYOAXOMPIXKMKK-UHFFFAOYSA-N
53480650;NOD1;6;8.714e-73;0.4651;7.6124;128.9202;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NC(CO)C(C(CCCCCCCCCCCCCC)O)O;IVBULNXGVIHEKN-UHFFFAOYSA-N
7016045;NOD1;6;2.872e-65;0.4043;6.819;115.423;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)N)C(=O)O)N;XXDVDTMEVBYRPK-UHFFFAOYSA-N
12591;NOD1;6;1.928e-47;0.4242;4.9375;83.4179;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
5259590;NOD1;6;9.48e-70;0.4255;7.2919;123.4685;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;NFNVDJGXRFEYTK-UHFFFAOYSA-N
9856500;NOD1;6;4.236e-58;0.4118;6.0624;102.5528;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
5312797;NOD1;6;6.820000000000001e-58;0.4167;6.0406;102.1815;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCC(C(=O)O)O;GHPVDCPCKSNJDR-UHFFFAOYSA-N
9561835;NOD1;6;1.11e-70;0.4595;7.3902;125.1411;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCC(CCCCCCCCC(=O)O)O;PAZZVPKITDJCPV-UHFFFAOYSA-N
7009567;NOD1;6;3.4649999999999996e-92;0.5952;9.6599;163.7503;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CSCCC(C(=O)O)NC(=O)CCC(C(=O)O)N;RQNSKRXMANOPQY-UHFFFAOYSA-N
7010588;NOD1;6;9.906e-65;0.4167;6.7622;114.4576;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C(CC(=O)N)C(C(=O)NC(CCC(=O)N)C(=O)O)N;LOJYQMFIIJVETK-UHFFFAOYSA-N
53481049;NOD1;6;8.12e-76;0.4878;7.9323;134.3612;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;FTSDYFFYZJTACJ-UHFFFAOYSA-N
7009623;NOD1;6;7.84e-66;0.413;6.8785;116.4354;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)C(C(=O)NC(CCC(=O)O)C(=O)O)N;UPJONISHZRADBH-UHFFFAOYSA-N
439853;NOD1;6;2.528e-62;0.4048;6.5082;110.1365;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)C(CO)N;KBUNOSOGGAARKZ-UHFFFAOYSA-N
12530;NOD1;6;1.928e-47;0.4242;4.9375;83.4179;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
3038501;NOD1;6;1.018e-68;0.4364;7.1831;121.6174;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
12575964;NOD1;6;6.820000000000001e-58;0.4167;6.0406;102.1815;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCC(C(=O)O)O;JGHSBPIZNUXPLA-UHFFFAOYSA-N
7789;NOD1;6;1.11e-70;0.4595;7.3902;125.1411;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCC(CCCCCCCCCCC(=O)O)O;ULQISTXYYBZJSJ-UHFFFAOYSA-N
7010499;NOD1;6;6.507e-54;0.4082;5.6206;95.0369;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
132282053;NOD1;6;3.083e-61;0.4167;6.3936;108.1865;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)NC(CO)C(C=CCCCCCCCCC=CCCC)O;LBBFOWQGVUEADU-UHFFFAOYSA-N
13890535;NOD1;6;3.369e-82;0.5;8.6058;145.8191;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
65254;NOD1;6;1.546e-101;0.65;10.6467;180.5372;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;LNLLNTMHVMIMOG-UHFFFAOYSA-N
151008;NOD1;6;5.056e-65;0.4595;6.793;114.9821;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)NCC(=O)O;KVTFEOAKFFQCCX-UHFFFAOYSA-N
111299;NOD1;6;2.042e-75;0.5;7.89;133.642;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
8180;NOD1;6;1.928e-47;0.4242;4.9375;83.4179;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
7017195;NOD1;6;1.451e-65;0.4423;6.8503;115.9555;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C1=C(NC=N1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;PXVCMZCJAUJLJP-UHFFFAOYSA-N
10468;NOD1;6;1.928e-47;0.4242;4.9375;83.4179;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
6427003;NOD1;6;4.579e-60;0.4773;6.2699;106.0827;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CC(=O)O)N;OAMLVOVXNKILLQ-UHFFFAOYSA-N
1563;NOD1;6;6.820000000000001e-58;0.4167;6.0406;102.1815;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCC(C(=O)O)O;JYZJYKOZGGEXSX-UHFFFAOYSA-N
439887;NOD1;6;6.820000000000001e-58;0.4167;6.0406;102.1815;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCC(C(=O)O)O;KIHBGTRZFAVZRV-UHFFFAOYSA-N
7015704;NOD1;6;6.104999999999999e-66;0.4889;6.8899;116.6304;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);C(CCN)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;BBBXWRGITSUJPB-UHFFFAOYSA-N
7016103;NOD1;6;6.645e-63;0.4468;6.5694;111.1784;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7015683;NOD1;6;2.2419999999999998e-73;0.5122;7.6746;129.9787;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CCC(C(=O)O)N;AQAKHZVPOOGUCK-UHFFFAOYSA-N
53481050;NOD1;6;8.12e-76;0.4878;7.9323;134.3612;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(CO)C(CCCCCCCCCCCCCCC)O;HCDLRJUFVJOBJP-UHFFFAOYSA-N
168058;NOD1;6;1.5659999999999999e-66;0.5349;6.9523;117.6913;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)C(C(=O)NC(CCCCN)C(=O)O)N;JKHXYJKMNSSFFL-UHFFFAOYSA-N
454064;NOD1;6;1.8929999999999999e-47;0.4167;4.9384;83.4324;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CCCCCCCCCCCC(=O)CC(=O)O;XLKOZYOVXNPWGT-UHFFFAOYSA-N
6992341;NOD1;6;8.396e-49;0.4043;5.0812;85.8615;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CCCCN)N;YQAIUOWPSUOINN-UHFFFAOYSA-N
6993120;NPFFR1;6;2.276e-70;0.4;10.6117;124.5812;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
97415;NPFFR1;6;1.012e-58;0.4314;8.8403;103.6694;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;NPFFR1;6;4.196e-66;0.4103;9.9629;116.9228;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;NPFFR1;6;7.268e-70;0.4211;10.535;123.6757;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
134906;NPFFR1;6;9.704e-47;0.4217;7.0181;82.158;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;NPFFR1;6;1.203e-60;0.4217;9.133;107.1251;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;NPFFR1;6;2.105e-59;0.5106;8.944;104.8934;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
13890535;NPFFR1;6;5.014e-57;0.4;8.5825;100.6261;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
111299;NPFFR1;6;3.7410000000000004e-63;0.4182;9.5143;111.6263;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
96814;NPFFR1;6;4.386e-73;0.4151;11.0246;129.4554;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;NPFFR1;6;8.97e-70;0.4167;10.5211;123.5116;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7009598;NPFFR1;8;6.13e-70;0.4103;3.0249;123.8085;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;NPFFR1;8;7.574e-70;0.4138;3.0209;123.6436;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
96814;NPFFR1;8;3.304e-75;0.4074;3.2553;133.2669;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;NPFFR1;8;1.903e-70;0.4098;3.0471;124.7204;NPFFR1;Neuropeptide FF receptor 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7009598;NPFFR2;8;1.6439999999999999e-60;0.4103;2.2111;106.8812;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;NPFFR2;8;3.5659999999999996e-60;0.4138;2.1986;106.2778;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
19421321;NPFFR2;8;2.811e-62;0.4;2.2765;110.0539;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NPFFR2;8;2.288e-57;0.4286;2.0947;101.2376;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
96814;NPFFR2;8;5.65e-66;0.4074;2.4134;116.6908;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;NPFFR2;8;3.157e-68;0.5;2.4968;120.7353;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
515709;NPPA;6;8.795e-47;0.4717;2.2991;82.2347;NPPA;Natriuretic peptides A (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NPPA;6;8.795e-47;0.4717;2.2991;82.2347;NPPA;Natriuretic peptides A (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
7010580;NPPA;7;5.113e-52;0.5098;1.7121;91.6343;NPPA;Natriuretic peptides A (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
515717;NPR;6;1.8389999999999998e-44;0.4032;6.3671;78.0689;NPR;Thermolysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
100094;NPR;6;1.5840000000000001e-55;0.6071;7.9733;97.9337;NPR;Thermolysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
5057430;NPR;6;2.8839999999999995e-51;0.4138;7.3548;90.2852;NPR;Thermolysin (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
352038;NPR;6;1.249e-45;0.4528;6.5366;80.166;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(C(C)C)C(=O)O)N;MDSUKZSLOATHMH-UHFFFAOYSA-N
9797038;NPR;6;5.543e-76;0.6545;10.9428;134.6589;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;NPR;6;2.425e-82;0.6316;11.8659;146.0754;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;NPR;6;2.211e-81;0.6034;11.7265;144.352;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;NPR;6;9.992e-63;0.4318;9.0185;110.8603;NPR;Thermolysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
168182;NPR;6;1.916e-76;0.7255;11.0097;135.4871;NPR;Thermolysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
7009555;NPR;6;1.382e-61;0.4167;8.8529;108.8122;NPR;Thermolysin (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;NPR;6;1.417e-62;0.5593;8.9965;110.5881;NPR;Thermolysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
263475;NPR;6;3.924e-58;0.5636;8.3516;102.6124;NPR;Thermolysin (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;NPR;6;1.134e-61;0.5167;8.8653;108.9662;NPR;Thermolysin (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;NPR;6;5.984e-65;0.6415;9.3411;114.8507;NPR;Thermolysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;NPR;6;1.137e-63;0.6667;9.1555;112.555;NPR;Thermolysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;NPR;6;5.193e-48;0.5517;6.8823;84.4408;NPR;Thermolysin (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;NPR;6;1.667e-48;0.5714;6.9539;85.3269;NPR;Thermolysin (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
44232492;NPR;8;7.626e-50;0.4107;2.8782;87.7319;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
76807;NPR;8;2.431e-63;0.46;3.6693;111.9624;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;NPR;8;1.5630000000000002e-78;0.4375;4.5597;139.2364;NPR;Thermolysin (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;NPR;8;3.2970000000000003e-56;0.4186;3.2512;99.1577;NPR;Thermolysin (pKi >= 8);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
9856500;NPR;8;1.122e-50;0.4182;2.927;89.2258;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
5488196;NPR;8;1.942e-75;0.5952;4.3783;133.6812;NPR;Thermolysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;NPR;8;1.408e-49;0.4107;2.8626;87.2539;NPR;Thermolysin (pKi >= 8);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7010580;NPR;8;4.722e-76;0.4286;4.4143;134.7839;NPR;Thermolysin (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;NPR;8;4.789e-57;0.413;3.3003;100.6618;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;NPR;8;1.0399999999999999e-68;0.4167;3.9839;121.6007;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;NPR;8;2.3189999999999998e-94;0.7308;5.4875;167.6542;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
4466134;NPR;8;2.181e-74;0.4737;4.3168;131.7957;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
18218182;NPR;8;8.349e-55;0.4259;3.169;96.6379;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
435728;NPR;8;1.577e-82;0.4407;4.7939;146.4107;NPR;Thermolysin (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;NPR;8;2.861e-52;0.4082;3.0204;92.0869;NPR;Thermolysin (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;NPR;8;1.657e-73;0.4483;4.2652;130.2144;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
323786;NPR;8;1.101e-92;0.6667;5.3892;164.6444;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
111299;NPR;8;1.4040000000000002e-58;0.4;3.3902;103.4136;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;NPR;8;4.9320000000000003e-64;0.4167;3.7099;113.2061;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
332962;NPR;8;1.667e-56;0.4423;3.2686;99.6893;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7359122;NPR;8;3.6219999999999995e-67;0.4821;3.8936;118.8327;NPR;Thermolysin (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;NPR;8;6.648000000000001e-85;0.4565;4.9332;150.675;NPR;Thermolysin (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;NPR;8;2.4329999999999998e-68;0.5;3.9623;120.9385;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
4078684;NPR;8;2.0459999999999997e-41;0.4681;2.3842;72.5998;NPR;Thermolysin (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;NPR;8;1.764e-59;0.4286;3.443;105.0313;NPR;Thermolysin (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
7016103;NPR;8;2.084e-49;0.4035;2.8526;86.9479;NPR;Thermolysin (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7010566;NPR;8;1.5199999999999999e-61;0.4118;3.564;108.738;NPR;Thermolysin (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;NPR;8;1.739e-62;0.4167;3.6192;110.4283;NPR;Thermolysin (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
6993120;NPFFR2;6;1.055e-74;0.4;11.773;132.3618;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
6351946;NPFFR2;6;4.026e-47;0.5556;7.392;82.8439;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O;IWIANZLCJVYEFX-UHFFFAOYSA-N
7009598;NPFFR2;6;1.887e-75;0.4545;11.8917;133.7036;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;NPFFR2;6;1.6500000000000001e-77;0.4912;12.2186;137.3989;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
111299;NPFFR2;6;4.919e-70;0.4386;11.0314;123.9801;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;NPFFR2;6;1.105e-70;0.4286;11.1344;125.1444;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
19421321;NPFFR2;6;5.64e-66;0.4576;10.3866;116.6921;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NPFFR2;6;2.8829999999999996e-73;0.5965;11.5448;129.7827;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NPFFR2;6;4.1149999999999997e-73;0.431;11.5202;129.5051;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NPFFR2;6;4.1149999999999997e-73;0.431;11.5202;129.5051;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;NPFFR2;6;1.778e-77;0.4151;12.2135;137.3407;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;NPFFR2;6;1.843e-86;0.7115;13.6405;153.4704;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;NPFFR2;6;1.045e-75;0.4561;11.9325;134.1645;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;NPFFR2;6;1.977e-71;0.4286;11.2531;126.4859;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;NPFFR2;6;9.804e-73;0.4576;11.4604;128.8283;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;NPFFR2;6;4.139e-69;0.4098;10.8845;122.3195;NPFFR2;Neuropeptide FF receptor 2 (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
44232492;NPR;7;1.1530000000000001e-84;0.4107;9.7118;150.2455;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)N)N;ARPVSMCNIDAQBO-UHFFFAOYSA-N
76807;NPR;7;1.738e-96;0.46;11.0782;171.4695;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N;LCPYQJIKPJDLLB-UHFFFAOYSA-N
6993120;NPR;7;3.598e-100;0.4821;11.5041;178.0834;NPR;Thermolysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;NPR;7;1.894e-66;0.4186;7.6064;117.5428;NPR;Thermolysin (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
100094;NPR;7;4.141e-63;0.6071;7.2203;111.5472;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
9856500;NPR;7;3.326e-83;0.4182;9.5431;147.6244;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
5488196;NPR;7;6.317e-95;0.5952;10.8979;168.668;NPR;Thermolysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
13817313;NPR;7;3.885e-79;0.4107;9.0729;140.3219;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
7010580;NPR;7;5.272e-98;0.4737;11.2537;174.1949;NPR;Thermolysin (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;NPR;7;8.837e-60;0.413;6.8355;105.5701;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;NPR;7;1.768e-89;0.4643;10.2683;158.8889;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
329275;NPR;7;1.5509999999999999e-114;0.7308;13.1645;203.8738;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
151410;NPR;7;1.922e-80;0.45;9.2238;142.6661;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;NPR;7;3.016e-50;0.4138;5.7336;88.4551;NPR;Thermolysin (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
9797038;NPR;7;4.451e-77;0.6545;8.8349;136.6253;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;NPR;7;1.562e-82;0.6316;9.4654;146.4183;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;NPR;7;2.628e-106;0.4746;12.2133;189.1002;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
3038501;NPR;7;6.981e-43;0.5893;4.8824;75.2336;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
18218182;NPR;7;3.06e-88;0.4259;10.1252;156.666;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)N)N;HXWUJJADFMXNKA-UHFFFAOYSA-N
4427709;NPR;7;3.9969999999999997e-81;0.6034;9.3027;143.8905;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;NPR;7;2.4040000000000002e-58;0.4318;6.6697;102.9945;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;NPR;7;9.473e-104;0.4828;11.9178;184.5099;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;NPR;7;7.589e-63;0.4082;7.1899;111.0748;NPR;Thermolysin (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
168182;NPR;7;1.5029999999999999e-80;0.7255;9.2362;142.8578;NPR;Thermolysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
273262;NPR;7;1.774e-105;0.5263;12.1175;187.6116;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NPR;7;6.962999999999999e-60;0.4167;6.8475;105.756;NPR;Thermolysin (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;NPR;7;5.432e-64;0.5593;7.3223;113.1308;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;NPR;7;1.7039999999999998e-47;0.4516;5.4156;83.5145;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
323786;NPR;7;8.012e-116;0.6667;13.3132;206.1844;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
435718;NPR;7;1.102e-61;0.4909;7.0556;108.9886;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC(C)C)N;AZLASBBHHSLQDB-UHFFFAOYSA-N
92946;NPR;7;1.2370000000000002e-63;0.431;7.281;112.4889;NPR;Thermolysin (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;NPR;7;1.4750000000000002e-72;0.4237;8.3124;128.5096;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;NPR;7;6.2799999999999995e-89;0.4386;10.2047;157.9007;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
332962;NPR;7;9.559e-91;0.4423;10.4147;161.1638;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7359122;NPR;7;6.625e-88;0.4821;10.0864;156.0637;NPR;Thermolysin (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;NPR;7;2.359e-86;0.4655;9.9071;153.2782;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
263475;NPR;7;5.422e-59;0.5636;6.7445;104.1557;NPR;Thermolysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
3421919;NPR;7;2.359e-86;0.4655;9.9071;153.2782;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;NPR;7;4.5289999999999996e-105;0.5;12.0704;186.8807;NPR;Thermolysin (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
259327;NPR;7;5.065e-105;0.5;12.0648;186.7935;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
342468;NPR;7;1.21e-65;0.4194;7.5133;116.0968;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;NPR;7;8.814999999999999e-53;0.4681;6.0266;93.0048;NPR;Thermolysin (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;NPR;7;3.645e-83;0.4286;9.5385;147.553;NPR;Thermolysin (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;NPR;7;1.2659999999999999e-73;0.4219;8.4357;130.4243;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7016103;NPR;7;3.033e-76;0.4035;8.7386;135.1291;NPR;Thermolysin (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
19816755;NPR;7;4.297e-66;0.5167;7.5652;116.9043;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
9948926;NPR;7;2.718e-67;0.6415;7.7038;119.0567;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;NPR;7;1.99e-65;0.6667;7.4883;115.7091;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
7010566;NPR;7;2.314e-87;0.5172;10.0236;155.0885;NPR;Thermolysin (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3634442;NPR;7;3.8029999999999997e-54;0.5517;6.1843;95.4556;NPR;Thermolysin (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
193508;NPR;7;2.4690000000000002e-85;0.4167;9.7892;151.4474;NPR;Thermolysin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
19816756;NPR;7;1.043e-54;0.5714;6.2493;96.4643;NPR;Thermolysin (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
100048;NPR;7;1.771e-88;0.4667;10.1526;157.0922;NPR;Thermolysin (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
323786;NTSR1;10;9.874e-56;0.4713;1.6269;98.3023;NTSR1;Neurotensin receptor type 1 (pKi >= 10);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
19816755;NTSR1;10;9.166e-48;0.4607;1.3909;83.9978;NTSR1;Neurotensin receptor type 1 (pKi >= 10);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
7021820;NTSR1;8;2.494e-118;0.4935;18.5048;210.6849;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NTSR1;8;1.5440000000000001e-99;0.4306;15.5515;176.9479;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;NTSR1;8;2.9779999999999996e-88;0.4028;13.7779;156.6871;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
9900561;NTSR1;8;2.378e-41;0.4648;6.4067;72.4824;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)O)N;HYXQKVOADYPQEA-UHFFFAOYSA-N
151410;NTSR1;8;5.247e-59;0.4125;9.1815;104.1812;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;NTSR1;8;8.068e-99;0.4203;15.4386;175.6585;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;NTSR1;8;9.366e-134;0.5147;20.929;238.3784;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
7010499;NTSR1;8;1.98e-41;0.4103;6.4192;72.6253;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
435728;NTSR1;8;4.1069999999999995e-93;0.4024;14.5417;165.4131;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
6992563;NTSR1;8;8.182999999999999e-81;0.5606;12.6087;143.3318;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;NTSR1;8;8.847e-120;0.4928;18.7327;213.2883;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NTSR1;8;1.7239999999999997e-103;0.4028;16.1726;184.0433;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
7009553;NTSR1;8;3.09e-50;0.5294;7.8032;88.4362;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
14282475;NTSR1;8;5.109e-108;0.4857;16.8842;192.1726;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
323786;NTSR1;8;4.401e-44;0.4767;6.8361;77.3885;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;NTSR1;8;6.022000000000001e-106;0.4143;16.5587;188.4538;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
19421321;NTSR1;8;1.0140000000000001e-102;0.4054;16.0516;182.6617;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NTSR1;8;1.0819999999999999e-119;0.6269;18.7189;213.1312;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NTSR1;8;6.644e-91;0.4156;14.1946;161.4474;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NTSR1;8;6.644e-91;0.4156;14.1946;161.4474;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;NTSR1;8;7.453e-120;0.4648;18.7444;213.422;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;NTSR1;8;2.654e-84;0.4143;13.1571;149.5956;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
150964;NTSR1;8;6.39e-59;0.5333;9.1681;104.0276;NTSR1;Neurotensin receptor type 1 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7016103;NTSR1;8;5.255e-76;0.4342;11.8532;134.7005;NTSR1;Neurotensin receptor type 1 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7021820;NTSR1;7;4.797000000000001e-128;0.4935;24.1173;228.1281;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NTSR1;7;7.994e-106;0.4366;19.9139;188.233;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;NTSR1;7;1.001e-95;0.4085;18.0039;170.1044;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
9900561;NTSR1;7;2.531e-43;0.4648;8.0915;76.0246;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)O)N;HYXQKVOADYPQEA-UHFFFAOYSA-N
151410;NTSR1;7;1.2520000000000001e-74;0.4125;14.0132;132.2282;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;NTSR1;7;1.815e-106;0.4265;20.0357;189.3889;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;NTSR1;7;1.962e-144;0.5224;27.2173;257.5503;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
7010499;NTSR1;7;6.193e-53;0.4103;9.9096;93.2801;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
435728;NTSR1;7;2.498e-98;0.4024;18.4962;174.7772;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
6992563;NTSR1;7;6.764e-86;0.5606;16.1445;152.4569;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;NTSR1;7;3.1930000000000005e-128;0.5;24.1508;228.4456;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NTSR1;7;1.13e-110;0.4085;20.8313;196.9398;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
7009553;NTSR1;7;3.72e-53;0.5294;9.9515;93.6775;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)N;QYLJIYOGHRGUIH-UHFFFAOYSA-N
14282475;NTSR1;7;3.1609999999999997e-114;0.4928;21.5034;203.319;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
323786;NTSR1;7;1.883e-62;0.5;11.7098;110.3663;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;NTSR1;7;3.746e-113;0.4203;21.3003;201.3911;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
7021456;NTSR1;7;2.108e-126;0.6269;23.8066;225.1787;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NTSR1;7;4.265e-98;0.4156;18.4523;174.3602;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NTSR1;7;4.265e-98;0.4156;18.4523;174.3602;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;NTSR1;7;8.217000000000001e-128;0.4714;24.0731;227.7085;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
150964;NTSR1;7;5.198e-64;0.5333;12.0047;113.1651;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151003;NTSR1;7;1.181e-56;0.45;10.6132;99.9578;NTSR1;Neurotensin receptor type 1 (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7016103;NTSR1;7;2.026e-91;0.4342;17.1893;162.3734;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7010566;NTSR1;7;4.7600000000000003e-88;0.4028;16.5517;156.3215;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
3800205;NTSR1;7;1.112e-44;0.4928;8.3482;78.461;NTSR1;Neurotensin receptor type 1 (pKi >= 7);CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N;SENJXOPIZNYLHU-UHFFFAOYSA-N
9797038;NTSR1;6;9.121000000000001e-42;0.4773;10.0498;73.2297;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
19421321;NTSR1;6;2.5750000000000003e-109;0.411;26.4953;194.502;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
4078684;NTSR1;6;2.787e-82;0.4203;19.9136;145.9669;NTSR1;Neurotensin receptor type 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
151003;NTSR1;6;7.015e-56;0.4595;13.486;98.5688;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
14409732;NTSR1;6;1.6800000000000002e-43;0.5;10.4722;76.3443;NTSR1;Neurotensin receptor type 1 (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
7021820;NTSR1;9;1.229e-93;0.4583;9.8129;166.3537;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NTSR1;9;2.726e-82;0.4306;8.6155;145.9842;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;NTSR1;9;9.164999999999999e-80;0.4028;8.3489;141.448;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5057430;NTSR1;9;9.789e-83;0.4203;8.6624;146.7827;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;NTSR1;9;3.651e-107;0.5147;11.2406;190.6392;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
6992563;NTSR1;9;5.608e-75;0.5606;7.8437;132.8545;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;NTSR1;9;4.06e-97;0.4928;10.1803;172.6032;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NTSR1;9;1.1089999999999999e-83;0.4028;8.7623;148.4804;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
14282475;NTSR1;9;2.944e-97;0.4857;10.1951;172.8539;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
92946;NTSR1;9;6.46e-86;0.4143;8.9981;152.4927;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
19421321;NTSR1;9;2.258e-84;0.4054;8.8352;149.7217;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NTSR1;9;3.341e-97;0.6269;10.1893;172.7554;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NTSR1;9;5.508e-80;0.4028;8.3722;141.8451;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NTSR1;9;5.508e-80;0.4028;8.3722;141.8451;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;NTSR1;9;1.39e-98;0.4648;10.335;175.2344;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;NTSR1;9;5.564999999999999e-75;0.4143;7.844;132.8604;NTSR1;Neurotensin receptor type 1 (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
150964;NTSR1;9;1.207e-42;0.5286;4.4313;74.8069;NTSR1;Neurotensin receptor type 1 (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7021820;NTSR2;7;1.998e-90;0.4935;14.1194;160.5888;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NTSR2;7;4.717e-80;0.4366;12.4892;141.9659;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;NTSR2;7;1.203e-69;0.4085;10.8536;123.2825;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
151410;NTSR2;7;4.7770000000000006e-46;0.4125;7.1449;80.9153;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;NTSR2;7;1.28e-75;0.4265;11.7924;134.0061;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;NTSR2;7;4.966000000000001e-109;0.5224;17.0433;193.99;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
6992563;NTSR2;7;3.457e-76;0.4933;11.8817;135.0269;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;NTSR2;7;4.767e-95;0.5;14.8459;168.8875;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NTSR2;7;5.909e-74;0.4085;11.5308;131.0184;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
14282475;NTSR2;7;4.2739999999999996e-89;0.4928;13.9104;158.2008;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
92946;NTSR2;7;1.3900000000000001e-77;0.4203;12.1011;137.5326;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
19421321;NTSR2;7;3.244e-81;0.411;12.6719;144.0532;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NTSR2;7;1.638e-88;0.5526;13.8187;157.1533;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NTSR2;7;1.408e-69;0.4085;10.8429;123.1602;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NTSR2;7;1.408e-69;0.4085;10.8429;123.1602;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;NTSR2;7;1.756e-93;0.4714;14.5997;166.0754;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;NTSR2;7;1.395e-66;0.4203;10.3721;117.7813;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
151003;NTSR2;7;1.1149999999999999e-45;0.425;7.087;80.2544;NTSR2;Neurotensin receptor type 2 (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7010566;NTSR2;7;7.766e-69;0.4028;10.7264;121.8287;NTSR2;Neurotensin receptor type 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
151410;NTSR2;8;6.605e-41;0.4125;3.9084;71.6861;NTSR2;Neurotensin receptor type 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
7010499;NTSR2;8;1.587e-44;0.4103;4.26;78.1839;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
7016103;NTSR2;8;1.7199999999999998e-68;0.4342;6.5879;121.2088;NTSR2;Neurotensin receptor type 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7021820;NTSR2;6;5.703e-86;0.4935;16.1585;152.5899;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;NTSR2;6;7.427e-76;0.4366;14.2453;134.4307;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;NTSR2;6;1.63e-66;0.4085;12.4783;117.6602;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5057430;NTSR2;6;7.139e-72;0.4265;13.4919;127.2803;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;NTSR2;6;9.476000000000001e-102;0.5224;19.1433;180.919;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
7010499;NTSR2;6;1.4259999999999998e-51;0.4103;9.6519;90.8347;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CCCCN)N;FMIIKPHLJKUXGE-UHFFFAOYSA-N
6992563;NTSR2;6;5.417000000000001e-72;0.4933;13.5146;127.4956;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;WYBVBIHNJWOLCJ-UHFFFAOYSA-N
273262;NTSR2;6;1.348e-89;0.5;16.8445;159.1003;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;NTSR2;6;3.53e-70;0.4085;13.1714;124.2388;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
14282475;NTSR2;6;4.206e-84;0.4928;15.8052;149.2367;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
92946;NTSR2;6;2.128e-73;0.4203;13.7805;130.0195;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
19421321;NTSR2;6;1.029e-76;0.411;14.4076;135.9716;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;NTSR2;6;2.241e-83;0.5526;15.6678;147.9321;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;NTSR2;6;1.5289999999999998e-66;0.4085;12.4835;117.7098;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;NTSR2;6;1.5289999999999998e-66;0.4085;12.4835;117.7098;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;NTSR2;6;6.551e-88;0.4714;16.5255;156.0725;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;NTSR2;6;9.206e-64;0.4203;11.9577;112.7195;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
151003;NTSR2;6;5.208999999999999e-41;0.425;7.6539;71.8713;NTSR2;Neurotensin receptor type 2 (pKi >= 6);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7016103;NTSR2;6;2.709e-70;0.4342;13.1932;124.4452;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CCCCN)N;ATIPDCIQTUXABX-UHFFFAOYSA-N
7010566;NTSR2;6;4.8130000000000004e-64;0.4028;12.011;113.2252;NTSR2;Neurotensin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
7021820;NTSR2;9;2.6859999999999998e-67;0.4;2.6906;119.0659;NTSR2;Neurotensin receptor type 2 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
7021456;NTSR2;9;3.2760000000000003e-69;0.4396;2.768;122.5018;NTSR2;Neurotensin receptor type 2 (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
7021820;OPRD1;10;4.5159999999999994e-41;0.4;9.2671;71.9825;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRD1;10;7.077999999999999e-45;0.5;10.1362;78.8134;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;OPRD1;10;6.203e-43;0.5246;9.6925;75.3256;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRD1;10;2.1419999999999998e-51;0.459;11.6254;90.5171;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
5057430;OPRD1;10;9.931e-50;0.4839;11.2448;87.526;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;OPRD1;10;1.717e-52;0.5902;11.8758;92.4852;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
273262;OPRD1;10;3.661e-48;0.5156;10.8869;84.7135;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRD1;10;1.5820000000000002e-42;0.4394;9.5996;74.5955;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRD1;10;2.9279999999999997e-45;0.4459;10.2238;79.5016;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRD1;10;9.868e-42;0.5469;9.418;73.1684;OPRD1;Delta-type opioid receptor (pKi >= 10);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRD1;10;4.598e-49;0.4237;11.0927;86.331;OPRD1;Delta-type opioid receptor (pKi >= 10);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRD1;10;1.015e-66;0.4262;15.1259;118.0291;OPRD1;Delta-type opioid receptor (pKi >= 10);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
6992643;OPRD1;10;4.804e-45;0.4754;10.1747;79.1156;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
19421321;OPRD1;10;3.331e-49;0.4697;11.1247;86.5823;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
515709;OPRD1;10;1.699e-59;0.5323;13.4758;105.0604;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRD1;10;1.699e-59;0.5323;13.4758;105.0604;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4078684;OPRD1;10;2.146e-45;0.4918;10.2546;79.7439;OPRD1;Delta-type opioid receptor (pKi >= 10);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
19816750;OPRD1;10;2.075e-56;0.5484;12.7707;99.5186;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRD1;10;8.336e-53;0.5161;11.9475;93.0484;OPRD1;Delta-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010506;OPRD1;10;1.865e-44;0.4091;10.0401;78.0581;OPRD1;Delta-type opioid receptor (pKi >= 10);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;OPRD1;8;2.096e-73;0.4737;101.329;130.0312;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRD1;8;2.696e-85;0.4697;117.6972;151.3787;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRD1;8;2.428e-86;0.5;119.1362;153.2555;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRD1;8;1.585e-74;0.5;102.8724;132.0442;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;OPRD1;8;1.0060000000000001e-49;0.4643;68.7304;87.5158;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;OPRD1;8;1.558e-91;0.5714;126.2842;162.578;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRD1;8;3.053e-96;0.5714;132.765;171.0303;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRD1;8;3.102e-72;0.4754;99.7181;127.9303;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;OPRD1;8;2.246e-44;0.4286;61.3674;77.9131;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;OPRD1;8;5.321e-77;0.5088;106.2782;136.486;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRD1;8;3.896e-77;0.5;106.4647;136.7292;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRD1;8;1.268e-106;0.5849;147.056;189.6687;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRD1;8;3.344e-69;0.5333;95.5434;122.4857;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRD1;8;3.174e-107;0.6981;147.8838;190.7484;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRD1;8;1.571e-68;0.5132;94.6186;121.2795;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;OPRD1;8;1.035e-70;0.45;97.621;125.1952;OPRD1;Delta-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;OPRD1;8;2.2700000000000003e-43;0.4;59.9846;76.1095;OPRD1;Delta-type opioid receptor (pKi >= 8);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;OPRD1;8;4.316e-100;0.6071;138.0642;177.9416;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRD1;8;3.014e-84;0.5088;116.2539;149.4964;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRD1;8;6.136999999999999e-94;0.5658;129.5945;166.8953;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRD1;8;2.3750000000000002e-85;0.5833;117.773;151.4776;OPRD1;Delta-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRD1;8;6.055e-69;0.5161;95.1885;122.0227;OPRD1;Delta-type opioid receptor (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRD1;8;4.803e-83;0.5205;114.5988;147.3378;OPRD1;Delta-type opioid receptor (pKi >= 8);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
323786;OPRD1;8;2.382e-43;0.5;59.9558;76.072;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;OPRD1;8;1.269e-91;0.5273;126.407;162.7381;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRD1;8;1.1220000000000001e-69;0.4655;96.1964;123.3372;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRD1;8;2.493e-93;0.5517;128.7564;165.8022;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRD1;8;2.1920000000000002e-85;0.5263;117.8209;151.5401;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRD1;8;1.107e-102;0.5714;141.6311;182.5934;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRD1;8;2.438e-77;0.5821;106.7449;137.0947;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRD1;8;3.699e-128;0.6415;176.7002;228.3309;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRD1;8;3.699e-128;0.6415;176.7002;228.3309;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRD1;8;2.408e-70;0.4286;97.1164;124.5371;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRD1;8;4.847e-78;0.549;107.7106;138.3541;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRD1;8;4.684e-77;0.4833;106.3544;136.5854;OPRD1;Delta-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRD1;8;5.109e-96;0.6122;132.4572;170.6289;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRD1;8;1.339e-81;0.6071;112.6095;144.7433;OPRD1;Delta-type opioid receptor (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRD1;8;1.976e-70;0.5538;97.2344;124.691;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRD1;8;4.192e-102;0.5484;140.8348;181.555;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRD1;8;6.980000000000001e-97;0.5161;133.6472;172.1808;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRD1;8;5.057e-78;0.5156;107.6852;138.3211;OPRD1;Delta-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRD1;8;1.1430000000000001e-87;0.5636;120.9634;155.6386;OPRD1;Delta-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;OPRD1;8;4.249e-79;0.5862;109.1658;140.2521;OPRD1;Delta-type opioid receptor (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRD1;8;6.762999999999999e-90;0.6727;124.0301;159.6382;OPRD1;Delta-type opioid receptor (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;OPRD1;9;1.086e-55;0.4737;42.5216;98.2283;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRD1;9;9.349e-66;0.4603;50.2204;116.2981;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRD1;9;5.73e-66;0.5;50.3831;116.6798;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRD1;9;2.9930000000000004e-57;0.5;43.7146;101.0283;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
14767562;OPRD1;9;3.429e-67;0.5424;51.3185;118.8755;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRD1;9;3.714e-76;0.5714;58.1762;134.9711;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRD1;9;1.697e-54;0.4655;41.6083;96.0846;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;OPRD1;9;3.499e-57;0.4655;43.6627;100.9065;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRD1;9;4.1409999999999996e-61;0.4286;46.6664;107.9564;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRD1;9;1.154e-79;0.5741;60.8593;141.2686;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRD1;9;3.5959999999999995e-53;0.5333;40.594;93.704;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRD1;9;3.3420000000000005e-78;0.6981;59.7411;138.6441;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRD1;9;9.312e-52;0.5132;39.513;91.1668;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;OPRD1;9;3.381e-55;0.45;42.1443;97.3425;OPRD1;Delta-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;OPRD1;9;7.713e-75;0.6071;57.1685;132.6059;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRD1;9;1.9e-65;0.5088;49.9848;115.7452;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRD1;9;3.4870000000000004e-71;0.5658;54.3726;126.0437;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRD1;9;9.444000000000001e-63;0.5469;47.9223;110.9042;OPRD1;Delta-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRD1;9;4.725e-69;0.5077;52.7419;122.2162;OPRD1;Delta-type opioid receptor (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
92946;OPRD1;9;1.2909999999999999e-68;0.5273;52.4079;121.4322;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRD1;9;6.5069999999999995e-53;0.4655;40.397;93.2415;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRD1;9;1.4040000000000001e-71;0.4915;54.6748;126.7531;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRD1;9;4.9690000000000004e-64;0.5085;48.9006;113.2002;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRD1;9;1.3120000000000002e-78;0.5469;60.0517;139.373;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRD1;9;7.663e-57;0.5147;43.4023;100.2953;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRD1;9;1.258e-99;0.6296;76.1286;177.1073;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRD1;9;1.258e-99;0.6296;76.1286;177.1073;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRD1;9;7.834e-53;0.4179;40.3354;93.0969;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRD1;9;1.1620000000000001e-58;0.549;44.7939;103.5616;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRD1;9;2.663e-58;0.4833;44.5184;102.9148;OPRD1;Delta-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRD1;9;2.816e-71;0.6122;54.4436;126.2103;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRD1;9;4.4649999999999996e-60;0.5763;45.8765;106.1024;OPRD1;Delta-type opioid receptor (pKi >= 9);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRD1;9;1.516e-52;0.5538;40.1159;92.5818;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRD1;9;2.128e-80;0.5484;61.4209;142.5867;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRD1;9;4.159e-77;0.5161;58.9035;136.6782;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRD1;9;1.7219999999999998e-60;0.5156;46.1929;106.8452;OPRD1;Delta-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRD1;9;1.155e-64;0.4918;49.3852;114.3378;OPRD1;Delta-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;OPRD1;9;4.074e-60;0.5862;45.9069;106.1739;OPRD1;Delta-type opioid receptor (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRD1;9;6.41e-68;0.6727;51.8756;120.183;OPRD1;Delta-type opioid receptor (pKi >= 9);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;OPRD1;7;4.036e-77;0.4737;150.1674;136.7017;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRD1;7;6.423999999999999e-89;0.5;173.0131;157.883;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRD1;7;6.861e-91;0.5246;176.8306;161.4223;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRD1;7;2.415e-81;0.5455;158.3447;144.2832;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;OPRD1;7;1.1119999999999998e-53;0.4643;104.7778;94.619;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;OPRD1;7;7.743e-99;0.5818;192.2201;175.6906;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRD1;7;3.016e-103;0.5714;200.7586;183.607;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRD1;7;5.284e-77;0.4754;149.9407;136.4915;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;OPRD1;7;2.101e-48;0.4286;94.5607;85.1463;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;OPRD1;7;1.014e-80;0.5088;157.1384;143.1648;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRD1;7;3.2390000000000003e-79;0.5397;154.2251;140.4638;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRD1;7;6.599e-113;0.5849;219.4641;200.9497;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRD1;7;1.861e-76;0.6667;148.8819;135.5098;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRD1;7;2.696e-113;0.6981;220.217;201.6477;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRD1;7;4.226e-75;0.6364;146.2559;133.0751;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;OPRD1;7;4.484e-41;0.4182;80.3686;71.9881;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;OPRD1;7;2.984e-74;0.45;144.6122;131.5512;OPRD1;Delta-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;OPRD1;7;3.949e-46;0.4426;90.1574;81.0638;OPRD1;Delta-type opioid receptor (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;OPRD1;7;7.57e-105;0.6071;203.8575;186.4801;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRD1;7;2.181e-90;0.5088;175.858;160.5206;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRD1;7;2.1700000000000001e-103;0.6615;201.0355;183.8637;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRD1;7;2.3599999999999997e-89;0.5833;173.8553;158.6638;OPRD1;Delta-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRD1;7;1.625e-76;0.5862;148.9958;135.6154;OPRD1;Delta-type opioid receptor (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRD1;7;9.982e-83;0.5205;161.0241;146.7674;OPRD1;Delta-type opioid receptor (pKi >= 7);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
323786;OPRD1;7;1.36e-47;0.5441;92.9899;83.6899;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;OPRD1;7;1.342e-97;0.5273;189.8211;173.4664;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRD1;7;1.152e-72;0.4655;141.54;128.7028;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRD1;7;1.2950000000000001e-98;0.5714;191.7878;175.2898;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRD1;7;4.044e-92;0.5455;179.2115;163.6298;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRD1;7;2.191e-108;0.6271;210.7093;192.8328;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRD1;7;8.088e-81;0.5821;157.3283;143.3409;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRD1;7;7.621999999999999e-139;0.6415;269.6891;247.5156;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRD1;7;7.621999999999999e-139;0.6415;269.6891;247.5156;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRD1;7;2.022e-73;0.4658;143.0028;130.0591;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRD1;7;2.123e-82;0.549;160.3896;146.1791;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRD1;7;1.6e-82;0.4833;160.6275;146.3997;OPRD1;Delta-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRD1;7;1.463e-104;0.6122;203.3032;185.9662;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRD1;7;9.610999999999999e-88;0.6071;170.738;155.7736;OPRD1;Delta-type opioid receptor (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRD1;7;3.0300000000000005e-73;0.6032;142.6627;129.7437;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRD1;7;4.8039999999999996e-107;0.55;208.1126;190.4252;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRD1;7;4.237e-101;0.5167;196.5999;179.7513;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRD1;7;2.2089999999999998e-82;0.5156;160.356;146.148;OPRD1;Delta-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRD1;7;1.008e-93;0.5636;182.3163;166.5084;OPRD1;Delta-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;OPRD1;7;1.222e-81;0.5932;158.9174;144.8142;OPRD1;Delta-type opioid receptor (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRD1;7;3.4189999999999997e-94;0.6727;183.2255;167.3513;OPRD1;Delta-type opioid receptor (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
63842847;OPRD1;6;3.651e-85;0.6275;202.2661;151.1423;OPRD1;Delta-type opioid receptor (pKi >= 6);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
5057430;OPRM1;10;5.79e-44;0.45;12.1184;77.1747;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRM1;10;7.665e-42;0.5067;11.5274;73.3653;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRM1;10;6.529e-43;0.4918;11.8253;75.2857;OPRM1;Mu-type opioid receptor (pKi >= 10);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRM1;10;2.674e-41;0.4868;11.3763;72.3912;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
273262;OPRM1;10;9.333e-41;0.4219;11.2251;71.4165;OPRM1;Mu-type opioid receptor (pKi >= 10);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
13783081;OPRM1;10;5.0359999999999995e-51;0.5;14.0849;89.8508;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
19421321;OPRM1;10;1.9739999999999998e-47;0.4923;13.0841;83.3996;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
515709;OPRM1;10;3.439e-58;0.5;16.0806;102.7153;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRM1;10;3.439e-58;0.5;16.0806;102.7153;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
19816750;OPRM1;10;2.085e-43;0.4328;11.9634;76.1758;OPRM1;Mu-type opioid receptor (pKi >= 10);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
6993120;OPRM1;8;3.405e-59;0.4808;97.2799;104.5185;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRM1;8;4.3540000000000003e-69;0.5667;113.4528;122.2799;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRM1;8;9.676e-67;0.5;109.6164;118.0666;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRM1;8;8.802e-62;0.5714;101.5099;109.1639;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
14767562;OPRM1;8;2.368e-70;0.549;115.5198;124.55;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRM1;8;2.845e-82;0.5957;135.0065;145.9507;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRM1;8;1.807e-58;0.5;96.0948;103.2169;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;OPRM1;8;6.428e-66;0.4902;108.272;116.5902;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRM1;8;7.058e-65;0.5397;106.5709;114.722;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRM1;8;3.636e-85;0.617;139.7368;151.1456;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRM1;8;2.992e-66;0.6207;108.8149;117.1865;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRM1;8;1.6449999999999999e-83;0.6981;137.0303;148.1733;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRM1;8;1.129e-65;0.6;107.8722;116.1512;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;OPRM1;8;3.241e-56;0.4545;92.4107;99.1709;OPRM1;Mu-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;OPRM1;8;5.607e-77;0.6071;126.3511;136.4452;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRM1;8;5.664e-67;0.5192;109.9966;118.4842;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRM1;8;3.66e-86;0.6615;141.3668;152.9357;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRM1;8;3.357e-62;0.5185;102.1941;109.9153;OPRM1;Mu-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRM1;8;1.252e-69;0.6415;114.3379;123.252;OPRM1;Mu-type opioid receptor (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRM1;8;1.66e-66;0.4545;109.2331;117.6457;OPRM1;Mu-type opioid receptor (pKi >= 8);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
92946;OPRM1;8;9.827e-73;0.54;119.4139;128.8265;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRM1;8;3.1480000000000003e-56;0.4655;92.4315;99.1937;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRM1;8;1.734e-75;0.52;123.9148;133.7695;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRM1;8;4.565e-71;0.5098;116.6887;125.8337;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRM1;8;1.026e-82;0.5593;135.7307;146.746;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRM1;8;5.703e-64;0.65;105.0875;113.0929;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRM1;8;2.129e-110;0.6809;180.9854;196.4459;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRM1;8;2.129e-110;0.6809;180.9854;196.4459;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRM1;8;3.7090000000000006e-55;0.4333;90.6801;97.2704;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRM1;8;2.2270000000000002e-63;0.5;104.1204;112.0308;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRM1;8;7.735e-61;0.4909;99.9668;107.4693;OPRM1;Mu-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRM1;8;1.296e-78;0.6383;129.026;139.3828;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRM1;8;8.361e-66;0.5;108.0853;116.3852;OPRM1;Mu-type opioid receptor (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRM1;8;6.145e-59;0.6429;96.8608;104.0581;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRM1;8;8.119e-79;0.5283;129.3579;139.7473;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRM1;8;1.126e-78;0.4918;129.1257;139.4923;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRM1;8;9.476e-61;0.4815;99.8227;107.311;OPRM1;Mu-type opioid receptor (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRM1;8;2.012e-74;0.52;122.1747;131.8585;OPRM1;Mu-type opioid receptor (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
14409732;OPRM1;8;3.759e-43;0.5915;71.0536;75.7161;OPRM1;Mu-type opioid receptor (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100048;OPRM1;8;7.937000000000001e-63;0.5862;103.218;111.0398;OPRM1;Mu-type opioid receptor (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRM1;8;1.7650000000000002e-71;0.6727;117.3635;126.5747;OPRM1;Mu-type opioid receptor (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;OPRM1;9;1.4490000000000002e-46;0.4808;46.0866;81.8452;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRM1;9;6.044e-52;0.5667;51.4086;91.5038;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRM1;9;9.044e-49;0.5;48.2677;85.8036;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRM1;9;3.4119999999999997e-44;0.5714;43.7403;77.587;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
14767562;OPRM1;9;8.564e-48;0.549;47.3019;84.0508;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRM1;9;9.956e-65;0.5957;64.0544;114.4537;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRM1;9;4.921e-47;0.5;46.5507;82.6874;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;OPRM1;9;8.411999999999999e-52;0.4902;51.2666;91.246;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRM1;9;4.9559999999999996e-52;0.5397;51.4939;91.6585;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRM1;9;2.029e-61;0.617;60.7809;108.5128;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRM1;9;3.391e-47;0.5333;46.7106;82.9777;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRM1;9;8.244999999999999e-60;0.6981;59.1892;105.6242;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRM1;9;2.459e-48;0.5132;47.838;85.0238;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
435728;OPRM1;9;3.543e-44;0.4545;43.7241;77.5576;OPRM1;Mu-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
273262;OPRM1;9;3.47e-57;0.6071;56.5932;100.913;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRM1;9;5.387e-50;0.5192;49.4795;88.0028;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRM1;9;1.7710000000000002e-63;0.5658;62.8177;112.2093;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRM1;9;5.691e-41;0.5185;40.5528;71.8022;OPRM1;Mu-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRM1;9;7.254999999999999e-54;0.6415;53.3087;94.952;OPRM1;Mu-type opioid receptor (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRM1;9;5.403e-48;0.4394;47.4998;84.41;OPRM1;Mu-type opioid receptor (pKi >= 9);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
92946;OPRM1;9;2.3699999999999998e-52;0.54;51.8107;92.2336;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRM1;9;3.245e-44;0.45;43.7618;77.6261;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRM1;9;3.491e-56;0.52;55.6014;99.113;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRM1;9;9.774e-56;0.5098;55.1591;98.3103;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRM1;9;8.113e-61;0.5593;60.1854;107.4321;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRM1;9;9.439e-47;0.6333;46.2709;82.1796;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRM1;9;2.344e-83;0.6809;82.4823;147.8973;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRM1;9;2.344e-83;0.6809;82.4823;147.8973;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRM1;9;1.7490000000000002e-42;0.4333;42.049;74.5176;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRM1;9;4.621e-50;0.5;49.5454;88.1224;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRM1;9;1.5779999999999998e-44;0.4909;44.0716;78.1883;OPRM1;Mu-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRM1;9;5.418e-57;0.6383;56.4018;100.5656;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRM1;9;5.762e-51;0.5;50.4399;89.7457;OPRM1;Mu-type opioid receptor (pKi >= 9);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRM1;9;4.6509999999999995e-45;0.6032;44.5964;79.1407;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRM1;9;1.5940000000000002e-57;0.5283;56.9276;101.5197;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRM1;9;1.9649999999999999e-59;0.4906;58.816;104.9469;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRM1;9;9.929e-46;0.4815;45.2599;80.3448;OPRM1;Mu-type opioid receptor (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRM1;9;3.215e-56;0.52;55.6368;99.1772;OPRM1;Mu-type opioid receptor (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;OPRM1;9;2.557e-49;0.5238;48.8105;86.7885;OPRM1;Mu-type opioid receptor (pKi >= 9);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRM1;9;3.28e-55;0.5738;54.639;97.3663;OPRM1;Mu-type opioid receptor (pKi >= 9);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;OPRM1;7;4.1680000000000006e-72;0.4808;166.3856;127.6999;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7021820;OPRM1;7;1.07e-85;0.5667;197.5059;152.0989;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;OPRM1;7;1.44e-84;0.5;194.9214;150.0726;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
6992304;OPRM1;7;2.109e-77;0.5714;178.5126;137.2078;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
92829;OPRM1;7;1.106e-56;0.4643;131.0667;100.0092;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)CN)O;XBGGUPMXALFZOT-UHFFFAOYSA-N
14767562;OPRM1;7;4.893e-92;0.6154;212.0238;163.4813;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;OPRM1;7;1.422e-97;0.5957;224.7019;173.4212;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;OPRM1;7;1.7410000000000002e-72;0.5;167.2536;128.3805;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
97415;OPRM1;7;5.1319999999999996e-51;0.4286;118.0912;89.8361;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
7009598;OPRM1;7;3.763e-80;0.4902;184.8064;142.1422;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;OPRM1;7;1.013e-75;0.5397;174.6617;134.1885;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;OPRM1;7;1.997e-108;0.617;249.5532;192.9052;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;OPRM1;7;2.731e-80;0.6667;185.1252;142.3922;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4466134;OPRM1;7;8.931e-107;0.6981;245.7736;189.9419;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
4427709;OPRM1;7;4.369e-79;0.6364;182.3678;140.2304;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
47579;OPRM1;7;3.062e-45;0.4182;104.8654;79.4667;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;OPRM1;7;1.617e-70;0.4545;162.7472;124.8474;OPRM1;Mu-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;OPRM1;7;1.094e-42;0.4426;99.0191;74.8831;OPRM1;Mu-type opioid receptor (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
273262;OPRM1;7;1.04e-97;0.6071;225.013;173.6651;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;OPRM1;7;1.721e-84;0.5192;194.7441;149.9336;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
13783081;OPRM1;7;1.383e-105;0.6615;243.0484;187.8053;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
14282475;OPRM1;7;9.292e-84;0.5536;193.0669;148.6186;OPRM1;Mu-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
7020642;OPRM1;7;2.853e-84;0.6415;194.2409;149.5391;OPRM1;Mu-type opioid receptor (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
63842847;OPRM1;7;8.052e-80;0.6271;184.0498;141.549;OPRM1;Mu-type opioid receptor (pKi >= 7);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
323786;OPRM1;7;2.5609999999999996e-47;0.5588;109.6229;83.1967;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
92946;OPRM1;7;1.0909999999999999e-91;0.54;211.2267;162.8563;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
111299;OPRM1;7;1.115e-68;0.4655;158.5372;121.5466;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;OPRM1;7;2.9689999999999998e-92;0.58;212.5204;163.8706;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;OPRM1;7;2.168e-85;0.5769;196.8039;151.5486;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;OPRM1;7;2.401e-103;0.6271;237.9205;183.7849;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;OPRM1;7;5.361e-81;0.65;186.7441;143.6615;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;OPRM1;7;2.209e-134;0.6809;308.9897;239.5047;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;OPRM1;7;2.209e-134;0.6809;308.9897;239.5047;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
152198;OPRM1;7;2.3899999999999997e-67;0.4355;155.4893;119.157;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CN=CN2)N;XMAUFHMAAVTODF-UHFFFAOYSA-N
96814;OPRM1;7;9.484e-78;0.5;179.3072;137.8307;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
342468;OPRM1;7;5.527e-80;0.4909;184.424;141.8424;OPRM1;Mu-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;OPRM1;7;1.506e-100;0.6383;231.5145;178.7625;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;OPRM1;7;7.721e-81;0.6071;186.3814;143.3771;OPRM1;Mu-type opioid receptor (pKi >= 7);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;OPRM1;7;1.416e-71;0.6429;165.1691;126.7462;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
19816750;OPRM1;7;9.551e-100;0.5323;229.6776;177.3223;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;OPRM1;7;4.482e-94;0.5192;216.6906;167.1402;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;OPRM1;7;5.016e-75;0.5179;173.071;132.9414;OPRM1;Mu-type opioid receptor (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;OPRM1;7;2.778e-91;0.5424;210.2968;162.1273;OPRM1;Mu-type opioid receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
14409732;OPRM1;7;1.581e-52;0.5915;121.552;92.5494;OPRM1;Mu-type opioid receptor (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CNC3=CC=CC=C32)N)C(=O)O;DXYQIGZZWYBXSD-UHFFFAOYSA-N
100048;OPRM1;7;3.775e-76;0.5862;175.6436;134.9584;OPRM1;Mu-type opioid receptor (pKi >= 7);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;OPRM1;7;9.253e-87;0.6727;199.9406;154.0078;OPRM1;Mu-type opioid receptor (pKi >= 7);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
12599;OXGR1;7;1.442e-128;0.4615;12.1471;229.0651;OXGR1;2-oxoglutarate receptor 1 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
92021849;OXGR1;7;4.452e-126;0.4444;11.9106;224.5957;OXGR1;2-oxoglutarate receptor 1 (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;P2RX1;6;8.804000000000001e-70;0.6102;4.0468;123.5262;P2RX1;P2X purinoceptor 1 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
3081383;P2RX1;6;5.648e-60;0.4946;3.472;105.9192;P2RX1;P2X purinoceptor 1 (pKi >= 6);CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)O)O;SYKWLIJQEHRDNH-UHFFFAOYSA-N
92021849;P2RX1;6;2.2339999999999998e-44;0.4189;2.5578;77.9173;P2RX1;P2X purinoceptor 1 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
12599;P2RY1;8;1.169e-43;0.6393;9.6764;76.627;P2RY1;P2Y purinoceptor 1 (pKi >= 8);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
12599;P2RY1;7;2.66e-53;0.6393;19.1392;93.9391;P2RY1;P2Y purinoceptor 1 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
12599;P2RY2;6;9.841e-50;0.7222;12.0559;87.533;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
9700;P2RY6;7;9.582e-84;0.4603;6.5677;148.5946;P2RY6;P2Y purinoceptor 6 (pKi >= 7);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
435728;PAPA1_CARPA;8;8.058e-76;0.4118;4.607;134.3672;PAPA1_CARPA;Papain (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
7359122;PAPA1_CARPA;8;9.829e-80;0.4286;4.8471;141.3936;PAPA1_CARPA;Papain (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;PAPA1_CARPA;8;1.448e-54;0.4;3.3029;96.2084;PAPA1_CARPA;Papain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;PAPA1_CARPA;8;1.448e-54;0.4;3.3029;96.2084;PAPA1_CARPA;Papain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
96814;PAPA1_CARPA;8;5.62e-66;0.4038;4.003;116.695;PAPA1_CARPA;Papain (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
150964;PAPA1_CARPA;8;1.064e-57;0.4384;3.4952;101.835;PAPA1_CARPA;Papain (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7010566;PAPA1_CARPA;8;1.665e-83;0.4328;5.0785;148.1637;PAPA1_CARPA;Papain (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
100048;PAPA1_CARPA;8;2.092e-64;0.4035;3.9067;113.8748;PAPA1_CARPA;Papain (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
435728;PAPA1_CARPA;9;1.982e-61;0.4118;2.4532;108.5309;PAPA1_CARPA;Papain (pKi >= 9);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
150964;PAPA1_CARPA;9;3.724e-47;0.4384;1.8758;82.9047;PAPA1_CARPA;Papain (pKi >= 9);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7010566;PAPA1_CARPA;9;1.11e-72;0.4328;2.9083;128.7316;PAPA1_CARPA;Papain (pKi >= 9);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
14767562;PAPA1_CARPA;6;8.166e-68;0.4364;10.2231;119.9942;PAPA1_CARPA;Papain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;PAPA1_CARPA;6;7.771e-80;0.4444;12.0513;141.5767;PAPA1_CARPA;Papain (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7010580;PAPA1_CARPA;6;8.932e-85;0.4468;12.8025;150.4447;PAPA1_CARPA;Papain (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7009598;PAPA1_CARPA;6;1.331e-77;0.449;11.7116;137.5663;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
151410;PAPA1_CARPA;6;4.198e-69;0.434;10.4191;122.3083;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
5057430;PAPA1_CARPA;6;5.0660000000000006e-55;0.4231;8.2776;97.0274;PAPA1_CARPA;Papain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
134906;PAPA1_CARPA;6;3.0999999999999997e-53;0.4118;8.0059;93.8197;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
273262;PAPA1_CARPA;6;1.9679999999999998e-73;0.4107;11.0775;130.0803;PAPA1_CARPA;Papain (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;PAPA1_CARPA;6;5.864e-60;0.4259;9.0284;105.8898;PAPA1_CARPA;Papain (pKi >= 6);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
323786;PAPA1_CARPA;6;1.894e-41;0.4405;6.2135;72.6599;PAPA1_CARPA;Papain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
6992643;PAPA1_CARPA;6;9.905e-70;0.4348;10.5145;123.4344;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;PAPA1_CARPA;6;4.815e-104;0.5098;15.7328;185.0375;PAPA1_CARPA;Papain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
7021456;PAPA1_CARPA;6;4.997e-43;0.4328;6.4536;75.4942;PAPA1_CARPA;Papain (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;PAPA1_CARPA;6;9.604e-80;0.451;12.0374;141.4116;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;PAPA1_CARPA;6;9.604e-80;0.451;12.0374;141.4116;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;PAPA1_CARPA;6;6.877e-74;0.4286;11.1469;130.9001;PAPA1_CARPA;Papain (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
10445608;PAPA1_CARPA;6;6.25e-78;0.4444;11.7616;138.1559;PAPA1_CARPA;Papain (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;PAPA1_CARPA;6;1.01e-69;0.5161;10.5132;123.419;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
759256;PAPA1_CARPA;6;1.273e-46;0.4186;7.0001;81.9462;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC=O;NSTPXGARCQOSAU-UHFFFAOYSA-N
151134;PAPA1_CARPA;6;2.542e-59;0.4082;8.9315;104.7464;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7010566;PAPA1_CARPA;6;5.977999999999999e-90;0.4545;13.5894;159.7345;PAPA1_CARPA;Papain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
193508;PAPA1_CARPA;6;9.905e-70;0.4348;10.5145;123.4344;PAPA1_CARPA;Papain (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;PAPA1_CARPA;6;1.05e-84;0.4528;12.7919;150.319;PAPA1_CARPA;Papain (pKi >= 6);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;PAPA1_CARPA;6;6.472000000000001e-70;0.4118;10.5426;123.7661;PAPA1_CARPA;Papain (pKi >= 6);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
6993120;PAPA1_CARPA;7;6.573e-95;0.4615;10.5216;168.6371;PAPA1_CARPA;Papain (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
4657542;PAPA1_CARPA;7;1.4330000000000001e-65;0.4524;7.2468;115.9653;PAPA1_CARPA;Papain (pKi >= 7);CNC(CC1=CC=CC=C1)C(=O)O;SCIFESDRCALIIM-UHFFFAOYSA-N
97415;PAPA1_CARPA;7;4.2830000000000004e-63;0.413;6.9705;111.5208;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN;JBCLFWXMTIKCCB-UHFFFAOYSA-N
329275;PAPA1_CARPA;7;3.029e-47;0.4405;5.2013;83.0658;PAPA1_CARPA;Papain (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;PAPA1_CARPA;7;1.35e-44;0.427;4.9056;78.3099;PAPA1_CARPA;Papain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
47579;PAPA1_CARPA;7;6.6889999999999995e-68;0.4318;7.507;120.1498;PAPA1_CARPA;Papain (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
435728;PAPA1_CARPA;7;1.1340000000000001e-99;0.4464;11.0533;177.1887;PAPA1_CARPA;Papain (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
13890535;PAPA1_CARPA;7;3.655e-67;0.4545;7.4246;118.8257;PAPA1_CARPA;Papain (pKi >= 7);CCCCC(=O)NC(CC1=CC=CC=C1)C(=O)O;YXQLJEQFZUMUPB-UHFFFAOYSA-N
323786;PAPA1_CARPA;7;1.182e-53;0.4405;5.9166;94.5714;PAPA1_CARPA;Papain (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
96814;PAPA1_CARPA;7;1.156e-92;0.4565;10.271;164.6062;PAPA1_CARPA;Papain (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
6993120;PGA;7;2.359e-43;0.4098;7.4253;76.0793;PGA;Pepsin A (pKi >= 7);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7010580;PGA;7;9.611e-48;0.4262;8.1872;83.9609;PGA;Pepsin A (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7359122;PGA;7;1.254e-43;0.4444;7.473;76.5723;PGA;Pepsin A (pKi >= 7);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
96814;PGA;7;4.451e-46;0.4;7.8981;80.9705;PGA;Pepsin A (pKi >= 7);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7359122;PGA;6;1.035e-47;0.4444;10.8497;83.9034;PGA;Pepsin A (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
10445608;PGA;6;6.08e-42;0.4107;9.5238;73.5459;PGA;Pepsin A (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
6993120;PGA;8;1.125e-42;0.4098;5.4227;74.8616;PGA;Pepsin A (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;GJNDXQBALKCYSZ-UHFFFAOYSA-N
7010580;PGA;8;1.4e-45;0.4262;5.7973;80.077;PGA;Pepsin A (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
96814;PGA;8;9.651e-44;0.4;5.5602;76.7763;PGA;Pepsin A (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7359122;PGA;9;1.0149999999999999e-45;0.4444;2.7602;80.3278;PGA;Pepsin A (pKi >= 9);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
47579;PIN1;7;2.8209999999999996e-47;0.4074;2.9808;83.1214;PIN1;Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CC2=CC=CC=C2;LIIPHJDKZNTNII-UHFFFAOYSA-N
12591;PLA2G4B;7;9.925000000000001e-46;0.4595;2.7608;80.3452;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCCCCCCCCCCCC(=O)O;ISYWECDDZWTKFF-UHFFFAOYSA-N
12530;PLA2G4B;7;9.925000000000001e-46;0.4595;2.7608;80.3452;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCCCCCC(=O)O;SZHOJFHSIKHZHA-UHFFFAOYSA-N
80108;PLA2G4B;7;6.21e-75;0.4;4.5526;132.775;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCC(=O)C1=CC=CC=C1;PFUPABFCHVRLLY-UHFFFAOYSA-N
8180;PLA2G4B;7;9.925000000000001e-46;0.4595;2.7608;80.3452;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCCCC(=O)O;ZDPHROOEEOARMN-UHFFFAOYSA-N
10468;PLA2G4B;7;9.925000000000001e-46;0.4595;2.7608;80.3452;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O;MWMPEAHGUXCSMY-UHFFFAOYSA-N
11551966;PLA2G4B;7;4.654e-92;0.4667;5.6033;163.5203;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1;RAMRROOXFMYSNA-UHFFFAOYSA-N
151410;POLG_WNV;6;3.9379999999999995e-93;0.4643;8.1673;165.4459;POLG_WNV;Genome polyprotein (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
150964;POLG_WNV;6;5.871e-52;0.5357;4.5298;91.5265;POLG_WNV;Genome polyprotein (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7020642;PREP;6;1.9240000000000002e-116;0.5179;49.0982;207.2968;PREP;Prolyl endopeptidase (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;PREP;8;7.725000000000001e-121;0.5179;27.6555;215.1893;PREP;Prolyl endopeptidase (pKi >= 8);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
7020642;PREP;9;6.861e-74;0.4364;7.1123;130.9019;PREP;Prolyl endopeptidase (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
53478597;PRKCA;6;1.4730000000000002e-42;1.0;33.4046;74.6514;PRKCA;Protein kinase C alpha type (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(CO)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;YUFFMVIZZQIBPN-UHFFFAOYSA-N
53478598;PRKCA;6;1.4730000000000002e-42;1.0;33.4046;74.6514;PRKCA;Protein kinase C alpha type (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SOWAPPIVBQCDGN-UHFFFAOYSA-N
53478008;PRKCA;6;1.4730000000000002e-42;1.0;33.4046;74.6514;PRKCA;Protein kinase C alpha type (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCC=CCCCCCCCC;DICYCLUXEYFAQX-UHFFFAOYSA-N
7010580;PSMB5;6;4.04e-54;0.451;15.1495;95.4084;PSMB5;Proteasome subunit beta type-5 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
435728;PSMB5;6;1.364e-58;0.4265;16.4117;103.4361;PSMB5;Proteasome subunit beta type-5 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
96814;PSMB5;6;2.156e-50;0.449;14.0974;88.7168;PSMB5;Proteasome subunit beta type-5 (pKi >= 6);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010566;PSMB5;6;1.94e-50;0.4058;14.1104;88.7993;PSMB5;Proteasome subunit beta type-5 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;JWBLQDDHSDGEGR-UHFFFAOYSA-N
7010580;PSMB5;8;8.264e-52;0.451;7.2527;91.2599;PSMB5;Proteasome subunit beta type-5 (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
96814;PSMB5;8;1.303e-46;0.449;6.5165;81.9281;PSMB5;Proteasome subunit beta type-5 (pKi >= 8);CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;OMNVYXHOSHNURL-UHFFFAOYSA-N
7010580;PSMB5;9;1.579e-46;0.431;2.8097;81.7786;PSMB5;Proteasome subunit beta type-5 (pKi >= 9);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
7010580;PSMB8;6;3.331e-66;0.4138;7.8341;117.1027;PSMB8;Proteasome subunit beta type-8 (pKi >= 6);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
134906;PSMB8;6;1.338e-43;0.48;5.1334;76.5214;PSMB8;Proteasome subunit beta type-8 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
7010580;PSMB8;8;1.506e-63;0.4138;4.1881;112.3359;PSMB8;Proteasome subunit beta type-8 (pKi >= 8);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
92021849;Q4VQ11_PIG;6;4.2809999999999995e-53;0.5538;3.8894;93.568;Q4VQ11_PIG;Adenosine receptor A1 (pKi >= 6);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
4466134;Q9N6S8_PLAFA;7;3.5350000000000006e-42;0.4151;2.5428;73.9689;Q9N6S8_PLAFA;Falcipain 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
259327;Q9N6S8_PLAFA;7;4.932e-48;0.5;2.9021;84.481;Q9N6S8_PLAFA;Falcipain 2 (pKi >= 7);CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)N;DNDWZFHLZVYOGF-UHFFFAOYSA-N
7010580;REN;7;4.133e-67;0.4058;95.964;118.7298;REN;Renin (pKi >= 7);CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N)O;IQHUITKNHOKGFC-UHFFFAOYSA-N
435728;REN;7;1.175e-51;0.5;73.9404;90.9856;REN;Renin (pKi >= 7);CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;WMDZARSFSMZOQO-UHFFFAOYSA-N
9856500;RIR1_HHV11;7;3.369e-71;0.4068;2.8484;126.0706;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;YBAFDPFAUTYYRW-UHFFFAOYSA-N
13817313;RIR1_HHV11;7;1.039e-69;0.4;2.7882;123.3969;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 7);CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N;JWBXCSQZLLIOCI-UHFFFAOYSA-N
332962;RIR1_HHV11;7;5.223e-73;0.4151;2.9216;129.3193;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZVDPYSVOZFINEE-UHFFFAOYSA-N
7021820;RNPEP;6;6.102e-53;0.4706;2.6068;93.2916;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;RNPEP;6;2.5720000000000002e-42;0.4035;2.076;74.2169;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
151410;RNPEP;6;1.0709999999999999e-60;0.587;2.9942;107.2156;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
19421321;RNPEP;6;1.657e-42;0.4211;2.0856;74.5595;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
19816750;RNPEP;6;2.5720000000000002e-42;0.4035;2.076;74.2169;RNPEP;Aminopeptidase B (pKi >= 6);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
6992304;RNPEP;8;4.5499999999999995e-45;0.4;1.4798;79.158;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N;GLUBLISJVJFHQS-UHFFFAOYSA-N
5488196;RNPEP;8;3.257e-49;0.4894;1.6184;86.5999;RNPEP;Aminopeptidase B (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
7009598;RNPEP;8;9.876e-48;0.5106;1.5689;83.9396;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CO)N;PPQRSMGDOHLTBE-UHFFFAOYSA-N
5057430;RNPEP;8;4.562e-44;0.42;1.4464;77.3605;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
111299;RNPEP;8;2.753e-47;0.46;1.554;83.1403;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;XHHOHZPNYFQJKL-UHFFFAOYSA-N
6992643;RNPEP;8;5.714e-51;0.5106;1.6771;89.7522;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
7359122;RNPEP;8;6.581e-46;0.4694;1.5079;80.6655;RNPEP;Aminopeptidase B (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
515709;RNPEP;8;1.588e-48;0.48;1.5954;85.3644;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;RNPEP;8;1.588e-48;0.48;1.5954;85.3644;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
4078684;RNPEP;8;6.204999999999999e-44;0.434;1.4419;77.1207;RNPEP;Aminopeptidase B (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;RNPEP;8;4.6469999999999995e-45;0.46;1.4795;79.1415;RNPEP;Aminopeptidase B (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
150964;RNPEP;8;6.165e-48;0.4286;1.5757;84.3071;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151134;RNPEP;8;2.753e-47;0.48;1.554;83.1404;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
193508;RNPEP;8;9.876e-48;0.5106;1.5689;83.9396;RNPEP;Aminopeptidase B (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CO)C(=O)O)N;ROHDXJUFQVRDAV-UHFFFAOYSA-N
100048;RNPEP;8;1.2209999999999999e-45;0.4808;1.4989;80.1837;RNPEP;Aminopeptidase B (pKi >= 8);CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N;HGCNKOLVKRAVHD-UHFFFAOYSA-N
7010506;RNPEP;8;1.2209999999999999e-45;0.4808;1.4989;80.1837;RNPEP;Aminopeptidase B (pKi >= 8);CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;PYOHODCEOHCZBM-UHFFFAOYSA-N
12051354;S1PR2;6;1.038e-49;0.4667;9.2997;87.4918;S1PR2;Sphingosine 1-phosphate receptor 2 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
12051354;S1PR2;7;6.664999999999999e-47;0.4667;6.9632;82.4509;S1PR2;Sphingosine 1-phosphate receptor 2 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
12051354;S1PR3;7;8.000000000000001e-49;0.4667;12.2849;85.8992;S1PR3;Sphingosine 1-phosphate receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
12051354;S1PR3;9;6.793e-45;0.4667;1.7844;78.8455;S1PR3;Sphingosine 1-phosphate receptor 3 (pKi >= 9);CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O;HUUYDUFSUADEJQ-UHFFFAOYSA-N
10634;SHBG;8;2.092e-89;1.0;11.4486;158.7577;SHBG;Sex hormone-binding globulin (pKi >= 8);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
10634;SHBG;7;4.388e-96;1.0;14.5223;170.7474;SHBG;Sex hormone-binding globulin (pKi >= 7);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
10634;SHBG;6;3.613e-91;1.0;16.8629;161.9225;SHBG;Sex hormone-binding globulin (pKi >= 6);CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C;QADHLRWLCPCEKT-UHFFFAOYSA-N
12599;SLC29A1;7;6.604e-49;0.4247;10.4401;86.0488;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 7);C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O;KHWCHTKSEGGWEX-UHFFFAOYSA-N
92021849;SLC29A1;7;6.051e-119;0.4933;25.5506;211.7892;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 7);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;SLC29A1;8;9.774e-82;0.4324;9.213;144.9886;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 8);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
92021849;SLC29A1;9;5.1760000000000003e-48;0.4231;2.9008;84.4434;SLC29A1;Equilibrative nucleoside transporter 1 (pKi >= 9);CC(C(C(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(=O)N)O;GYCVHQYQICRFAX-UHFFFAOYSA-N
74328989;SLC5A1;7;1.353e-50;0.403;5.5752;89.0802;SLC5A1;Sodium/glucose cotransporter 1 (pKi >= 7);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
74328989;SLC5A2;8;7.36e-60;0.4355;19.7659;105.7128;SLC5A2;Sodium/glucose cotransporter 2 (pKi >= 8);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
74328989;SLC5A2;7;4.501e-77;0.4355;43.6638;136.6165;SLC5A2;Sodium/glucose cotransporter 2 (pKi >= 7);COC1=C(C=CC(=C1)CC(COC2C(C(C(C(O2)CO)O)O)O)C(CC3=CC(=C(C=C3)O)OC)COC4C(C(C(C(O4)CO)O)O)O)O;SBVBJPHMDABKJV-UHFFFAOYSA-N
100094;SSTR2;8;5.059e-49;0.4177;8.8693;86.2565;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;SSTR2;8;1e-70;0.4231;12.8409;125.2223;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;SSTR2;8;3.861e-69;0.4304;12.5506;122.3736;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
134906;SSTR2;8;2.217e-56;0.4103;10.2158;99.467;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
168182;SSTR2;8;9.528e-71;0.4286;12.8448;125.2599;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
102763;SSTR2;8;1.9179999999999998e-47;0.4225;8.5804;83.4223;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
323786;SSTR2;8;1.186e-71;0.4051;13.0104;126.8846;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;SSTR2;8;5.114e-72;0.411;13.0772;127.5404;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
9948926;SSTR2;8;1.157e-45;0.4156;8.2546;80.2259;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
318292;SSTR2;8;5.15e-50;0.4267;9.0509;88.0379;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;SSTR2;8;4.866e-55;0.4177;9.9703;97.0588;SSTR2;Somatostatin receptor type 2 (pKi >= 8);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;SSTR2;8;2.3030000000000002e-63;0.4;11.4937;112.0047;SSTR2;Somatostatin receptor type 2 (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
134906;SSTR2;7;3.472e-68;0.4444;16.4819;120.6612;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
3038501;SSTR2;7;9.371e-46;0.4189;11.0208;80.3899;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N;CATMPQFFVNKDEY-UHFFFAOYSA-N
4427709;SSTR2;7;3.64e-67;0.4247;16.2334;118.8289;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
102763;SSTR2;7;3.115e-61;0.4493;14.7891;108.1784;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN;AJHCSUXXECOXOY-UHFFFAOYSA-N
9948926;SSTR2;7;1.674e-55;0.4507;13.394;97.8906;SSTR2;Somatostatin receptor type 2 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CC(=O)O)N;ZARXTZFGQZBYFO-UHFFFAOYSA-N
100094;SSTR2;6;4.882999999999999e-53;0.4521;16.135;93.4654;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N;LLEUXCDZPQOJMY-UHFFFAOYSA-N
329275;SSTR2;6;8.607e-83;0.4583;25.2599;146.883;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
9797038;SSTR2;6;2.9709999999999996e-81;0.4658;24.7882;144.1216;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BVRPESWOSNFUCJ-UHFFFAOYSA-N
168182;SSTR2;6;1.666e-85;0.4648;26.0921;151.7542;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;LZDNBBYBDGBADK-UHFFFAOYSA-N
13783081;SSTR2;6;5.793e-50;0.4026;15.1922;87.9462;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;SSTR2;6;2.679e-82;0.4384;25.1087;145.9978;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
263475;SSTR2;6;9.675e-84;0.4167;25.5511;148.5871;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;OHGNSVACHBZKSS-UHFFFAOYSA-N
19816755;SSTR2;6;1.784e-75;0.4079;23.0161;133.7476;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;PITVQFJBUFDJDD-UHFFFAOYSA-N
318292;SSTR2;6;3.1739999999999997e-59;0.4638;18.0324;104.5732;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)N;NQIHMZLGCZNZBN-UHFFFAOYSA-N
3634442;SSTR2;6;7.759e-62;0.4324;18.8334;109.2621;SSTR2;Somatostatin receptor type 2 (pKi >= 6);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;PWIQCLSQVQBOQV-UHFFFAOYSA-N
19816756;SSTR2;6;3.808e-75;0.4054;22.9151;133.1563;SSTR2;Somatostatin receptor type 2 (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LWFWZRANSFAJDR-UHFFFAOYSA-N
329275;TACR1;7;4.0680000000000004e-42;0.5385;63.801;73.8592;TACR1;Substance-P receptor (pKi >= 7);CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N;BQVUABVGYYSDCJ-UHFFFAOYSA-N
134906;TACR1;7;6.847999999999999e-47;0.5424;70.9883;82.4298;TACR1;Substance-P receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)N;JMCOUWKXLXDERB-UHFFFAOYSA-N
4427709;TACR1;7;1.135e-46;0.5417;70.6577;82.0356;TACR1;Substance-P receptor (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N;IMMPMHKLUUZKAZ-UHFFFAOYSA-N
13783081;TACR1;7;4.981e-41;0.5385;62.1631;71.906;TACR1;Substance-P receptor (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
323786;TACR1;7;4.318e-43;0.4938;65.2676;75.6081;TACR1;Substance-P receptor (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N;LYMVXFSTACVOLP-UHFFFAOYSA-N
9700;TK;7;1.7549999999999999e-47;0.5;4.1344;83.4914;TK;Thymidine kinase (pKi >= 7);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
9700;TK1;7;3.501e-62;0.7021;2.0519;109.8828;TK1;Thymidine kinase, cytosolic (pKi >= 7);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
7020642;TMPRSS11D;7;5.039e-56;0.4328;5.0132;98.8268;TMPRSS11D;Transmembrane protease serine 11D (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
150964;TMPRSS6;6;1.004e-49;0.4247;4.87;87.5177;TMPRSS6;Transmembrane protease serine 6 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
150964;TMPRSS6;8;5.37e-64;0.4247;2.765;113.1397;TMPRSS6;Transmembrane protease serine 6 (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
7021820;TMPRSS6;7;1.8759999999999998e-53;0.4267;3.5151;94.2112;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
151410;TMPRSS6;7;1.705e-52;0.4085;3.4512;92.4906;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCCN)N;QCZYYEFXOBKCNQ-UHFFFAOYSA-N
13783081;TMPRSS6;7;2.172e-46;0.55;3.0442;81.5299;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)N;TYYLDKGBCJGJGW-UHFFFAOYSA-N
19421321;TMPRSS6;7;4.154e-59;0.4507;3.8921;104.3634;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;TMPRSS6;7;2.176e-53;0.4267;3.5108;94.0955;TMPRSS6;Transmembrane protease serine 6 (pKi >= 7);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
6992643;TPH1;7;2.709e-72;0.4151;5.9989;128.036;TPH1;Tryptophan 5-hydroxylase 1 (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)NC(CC(=O)O)C(=O)O)N;HWMGTNOVUDIKRE-UHFFFAOYSA-N
11010621;TRHR;8;8.172999999999999e-45;0.4603;1.3035;78.7012;TRHR;Thyrotropin-releasing hormone receptor (pKi >= 8);C1CC(=O)NC1C(=O)NC(CCC(=O)N)C(=O)O;ILAITOFTZJRIFJ-UHFFFAOYSA-N
7020642;TRY1_BOVIN;6;8.107e-90;0.4857;43.4721;159.4969;TRY1_BOVIN;Cationic trypsin (pKi >= 6);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
151003;TRY1_BOVIN;6;2.003e-48;0.5;23.3749;85.1837;TRY1_BOVIN;Cationic trypsin (pKi >= 6);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7020642;TRY1_BOVIN;7;1.3640000000000001e-104;0.4857;33.1825;186.0209;TRY1_BOVIN;Cationic trypsin (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
150964;TRY1_BOVIN;7;7.261e-44;0.4648;13.8398;76.9982;TRY1_BOVIN;Cationic trypsin (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N;PQBHGSGQZSOLIR-UHFFFAOYSA-N
151003;TRY1_BOVIN;7;5.6840000000000005e-58;0.5;18.333;102.3236;TRY1_BOVIN;Cationic trypsin (pKi >= 7);C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)O;LQJAALCCPOTJGB-UHFFFAOYSA-N
7020642;TRY1_BOVIN;9;5.347e-77;0.4265;6.2149;136.4823;TRY1_BOVIN;Cationic trypsin (pKi >= 9);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
9700;TYMP;7;8.537e-44;0.5091;1.8815;76.872;TYMP;Thymidine phosphorylase (pKi >= 7);CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O;GYOZYWVXFNDGLU-UHFFFAOYSA-N
9547243;VDR;10;1.62e-127;0.7077;12.8606;227.179;VDR;Vitamin D3 receptor (pKi >= 10);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
9547243;VDR;7;7.331000000000001e-223;0.7742;67.4155;398.3526;VDR;Vitamin D3 receptor (pKi >= 7);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
9547243;VDR;8;6.52e-205;0.7742;51.4071;366.1284;VDR;Vitamin D3 receptor (pKi >= 8);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
9547243;VDR;9;2.602e-174;0.7742;28.1725;311.1898;VDR;Vitamin D3 receptor (pKi >= 9);CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C;ZGLHBRQAEXKACO-UHFFFAOYSA-N
7021820;YARS;8;3.4189999999999996e-73;0.4407;2.6806;129.6497;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCCN)N)O;MYTOTTSMVMWVJN-UHFFFAOYSA-N
515717;YARS;8;1.976e-74;0.4561;2.7265;131.8727;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCC(=O)O)N)O;YSWHPLCDIMUKFE-UHFFFAOYSA-N
14767562;YARS;8;6.677999999999999e-88;0.5283;3.2252;156.0575;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;OYOQKMOWUDVWCR-UHFFFAOYSA-N
5488196;YARS;8;2.093e-70;0.4259;2.5774;124.6464;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;MIDZLCFIAINOQN-UHFFFAOYSA-N
5057430;YARS;8;8.633e-90;0.5294;3.2951;159.4479;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N)O;JAQGKXUEKGKTKX-UHFFFAOYSA-N
4466134;YARS;8;5.513e-85;0.5091;3.1172;150.821;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;AUEJLPRZGVVDNU-UHFFFAOYSA-N
273262;YARS;8;3.652e-76;0.4561;2.7906;134.9842;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;LHSGPCFBGJHPCY-UHFFFAOYSA-N
7009555;YARS;8;1.298e-70;0.4211;2.5851;125.0191;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;VEYJKJORLPYVLO-UHFFFAOYSA-N
14282475;YARS;8;2.131e-87;0.5;3.2065;155.1528;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CCC(C)C(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;QJKMCQRFHJRIPU-UHFFFAOYSA-N
63842847;YARS;8;2.277e-70;0.4333;2.5761;124.5805;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1C(CN(C1C(=O)O)C(=O)C(CC2=CC=C(C=C2)O)N)O;FTWOPDCJCRFTHX-UHFFFAOYSA-N
92946;YARS;8;2.1740000000000002e-72;0.4364;2.6509;128.2072;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;ALZVPLKYDKJKQU-UHFFFAOYSA-N
7359122;YARS;8;4.106e-68;0.4107;2.4926;120.5303;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N;IEHDJWSAXBGJIP-UHFFFAOYSA-N
19421321;YARS;8;9.57e-84;0.5273;3.0713;148.5957;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)N)C(=O)O)N)O;UBAQSAUDKMIEQZ-UHFFFAOYSA-N
7021456;YARS;8;5.653e-70;0.4127;2.5615;123.8716;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O;XTWSWDJMIKUJDQ-UHFFFAOYSA-N
515709;YARS;8;3.288e-85;0.5;3.1255;151.224;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N;FSXRLASFHBWESK-UHFFFAOYSA-N
3421919;YARS;8;3.288e-85;0.5;3.1255;151.224;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)N;CGWAPUBOXJWXMS-UHFFFAOYSA-N
342468;YARS;8;9.41e-71;0.4;2.5903;125.2696;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)N;MUFXDFWAJSPHIQ-UHFFFAOYSA-N
4078684;YARS;8;4.983999999999999e-91;0.549;3.341;161.6716;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N;NLKUJNGEGZDXGO-UHFFFAOYSA-N
10445608;YARS;8;5.0559999999999995e-67;0.4035;2.4522;118.5727;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);CC(C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)N)O;NYQBYASWHVRESG-UHFFFAOYSA-N
19816750;YARS;8;3.882e-85;0.537;3.1229;151.0944;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC(=CC=C1CC(C(=O)NC(CCC(=O)O)C(=O)O)N)O;PDSLRCZINIDLMU-UHFFFAOYSA-N
151134;YARS;8;4.276e-66;0.4211;2.4179;116.9081;YARS;Tyrosine--tRNA ligase, cytoplasmic (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)NC(CCC(=O)O)C(=O)O)N;JXWLMUIXUXLIJR-UHFFFAOYSA-N
7020642;XIAP;7;5.0090000000000006e-42;0.4754;10.2811;73.697;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 7);C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)O;WEQJQNWXCSUVMA-UHFFFAOYSA-N
131766105;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YNSZYTDNGONQCW-UHFFFAOYSA-N
131756319;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DJYNSHLHLLYWLD-UHFFFAOYSA-N
131753506;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RUZNGRCQLAJOGE-UHFFFAOYSA-N
131759581;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WXMOURHYAWKCON-UHFFFAOYSA-N
131759536;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UCAVRBQATPCINL-UHFFFAOYSA-N
131758544;FABP3;7;1.875e-51;0.475;1.6933;90.621;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;FUAWAXRBBSTPLW-UHFFFAOYSA-N
131761108;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AYGOZGMOLWTELQ-UHFFFAOYSA-N
131753341;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SENTUJWTPLLHAV-UHFFFAOYSA-N
131760086;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;APBGQGAQJLLFMC-UHFFFAOYSA-N
131750602;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KSUDLITWNAQVCF-UHFFFAOYSA-N
131755418;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;OMLTYAGNYCAYQB-UHFFFAOYSA-N
131753725;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NEUKLKKOFRWHDB-UHFFFAOYSA-N
131755965;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOJVDNJANFYSHZ-UHFFFAOYSA-N
131758822;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OPZBOXKFTDVAOR-UHFFFAOYSA-N
131759325;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HSSCOLBULXMJLZ-UHFFFAOYSA-N
131763500;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OLENDCDRWPUUBG-UHFFFAOYSA-N
131757216;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VCTGTMSVVLORIT-UHFFFAOYSA-N
131763914;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ANTOAERGFNUGHV-UHFFFAOYSA-N
131765937;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHUWPEXZDFNJHC-UHFFFAOYSA-N
131753857;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VDEFXUQSUBAFFB-UHFFFAOYSA-N
131759460;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BTLLBFZSJPKPDE-UHFFFAOYSA-N
131760185;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UKJDYVVYSNHIJH-UHFFFAOYSA-N
131762624;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;ZUDALJHGXKNMOO-UHFFFAOYSA-N
131753592;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HLUWGRVFRNCPHH-UHFFFAOYSA-N
131754955;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;DVRLSVCQXWGXCP-UHFFFAOYSA-N
131757183;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;ZRKRTZFYHUBTQQ-UHFFFAOYSA-N
131756324;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ASJHAVAPNBVXQH-UHFFFAOYSA-N
131753342;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJKXBTKTOXZQFL-UHFFFAOYSA-N
131753808;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCFQRCZDNUSJCL-UHFFFAOYSA-N
131759349;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PKWPXOXGYXWVKK-UHFFFAOYSA-N
131755806;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;GZBPQMRKEPSOQQ-UHFFFAOYSA-N
131750415;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;YONCDTJKIZDSKQ-UHFFFAOYSA-N
13183956;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RBLADLVPSYELCA-UHFFFAOYSA-N
56936651;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IUDLXSDWDIHVDD-UHFFFAOYSA-N
131759893;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NXOBVWVEMROHRA-UHFFFAOYSA-N
131753720;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RNHDCKNXDJJGEF-UHFFFAOYSA-N
131764967;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;BDCSDBVNZGJCKJ-UHFFFAOYSA-N
131756350;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XTHHRTVNJZAGND-UHFFFAOYSA-N
131758844;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DELOENOPQWJVLP-UHFFFAOYSA-N
131763304;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZECUZTZXUJIHD-UHFFFAOYSA-N
131756089;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AAXMCYUUKFLUMJ-UHFFFAOYSA-N
131755775;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;JKGVPFAPBARTLP-UHFFFAOYSA-N
131755769;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZKAJTUDTPFXDPB-UHFFFAOYSA-N
131753505;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SCJKAJUAZPTDRO-UHFFFAOYSA-N
131753369;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BLXQIUODGKBTGK-UHFFFAOYSA-N
131756687;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;IZLQMMZWIGPZNX-UHFFFAOYSA-N
131764744;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHESVRVAJGWCRH-UHFFFAOYSA-N
131760777;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SNSCEPRATRYHSL-UHFFFAOYSA-N
131755943;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XZEHHPQAMMWALZ-UHFFFAOYSA-N
131755377;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBAXOOZVZZDVJC-UHFFFAOYSA-N
131755163;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZXLEWFIONDQJM-UHFFFAOYSA-N
131763290;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MUYSBOYFSLCKQE-UHFFFAOYSA-N
131753307;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WDOQOSSKIJDAOB-UHFFFAOYSA-N
131753713;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKYCZRRSXYVTLB-UHFFFAOYSA-N
131755771;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AFMQYZXPYJFAPA-UHFFFAOYSA-N
131755951;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;AHASBULBODWAPU-UHFFFAOYSA-N
131759925;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;KGCKCEDJXPOMSE-UHFFFAOYSA-N
131753370;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SDBSYLMJMSWVJK-UHFFFAOYSA-N
131763619;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VSYKULSUHBBKQN-UHFFFAOYSA-N
131756459;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;MCIPPLJLYFTODM-UHFFFAOYSA-N
131761095;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYLDVVKRGAXESB-UHFFFAOYSA-N
131763206;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MKTVKWIGWXIEHG-UHFFFAOYSA-N
131759343;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XYIGSYIGMXHUQI-UHFFFAOYSA-N
131757210;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NNJOIWXHONILSA-UHFFFAOYSA-N
131759566;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PASRUCZTFLIYBM-UHFFFAOYSA-N
131753887;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AXWUDJVLHVBXKA-UHFFFAOYSA-N
131758544;LPAR1;6;4.629e-43;0.5625;8.0419;75.5538;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;FUAWAXRBBSTPLW-UHFFFAOYSA-N
131763709;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WYRQFRRXDSBWDH-UHFFFAOYSA-N
131758822;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OPZBOXKFTDVAOR-UHFFFAOYSA-N
131756558;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;WOYJJCSXKNHKCN-UHFFFAOYSA-N
131762141;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GFXBBKRPUJCXGD-UHFFFAOYSA-N
131760949;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GHRXIMZQVOZDCY-UHFFFAOYSA-N
131759536;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UCAVRBQATPCINL-UHFFFAOYSA-N
131760545;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MXFKCAQPYLTUMC-UHFFFAOYSA-N
131763525;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZRVFQAMIIKQWFU-UHFFFAOYSA-N
131757239;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;YTPRVRWPVFSOAL-UHFFFAOYSA-N
131755022;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FAWROKQWRPDLOA-UHFFFAOYSA-N
131755919;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZXPZKPTYTWDDTR-UHFFFAOYSA-N
15607293;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FGNXNKQAEKNDNA-UHFFFAOYSA-N
131759372;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AKRDICGFDXTDDB-UHFFFAOYSA-N
131755635;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VMKQCJKDAJJLNO-UHFFFAOYSA-N
131760079;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DTTIGIZBXFQWNL-UHFFFAOYSA-N
131753519;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CQKDVCRIDIZFBZ-UHFFFAOYSA-N
131757216;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VCTGTMSVVLORIT-UHFFFAOYSA-N
131759581;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WXMOURHYAWKCON-UHFFFAOYSA-N
131755524;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STSSOOUAZVGHGT-UHFFFAOYSA-N
131755830;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RXFCPNVEKZDTFB-UHFFFAOYSA-N
131759622;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HVCCNWVJBNTHRL-UHFFFAOYSA-N
131761066;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FNZXUUOILKQHJU-UHFFFAOYSA-N
131754093;LPAR3;6;1.9580000000000002e-58;0.4815;8.8955;103.1545;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;TZXMSONPXDUMEW-UHFFFAOYSA-N
131753349;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QVTBPCIHCQQWGM-UHFFFAOYSA-N
131758707;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;UDBFLEBTRNBEBZ-UHFFFAOYSA-N
131755589;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MTMROZADXJWIBV-UHFFFAOYSA-N
101706281;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;MKRZSXAKFYWUAW-UHFFFAOYSA-N
131763632;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HTODETRMAVZETG-UHFFFAOYSA-N
131760190;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WOPXUTZTLHAOFJ-UHFFFAOYSA-N
131755192;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLDZOBNZLQGSSG-UHFFFAOYSA-N
131755896;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AQMKAYODMONDGF-UHFFFAOYSA-N
131759928;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QURCKNKEXAUCID-UHFFFAOYSA-N
131753591;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;KTVQVVATLSBTAO-UHFFFAOYSA-N
131757381;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GJZLKYUSHJORNQ-UHFFFAOYSA-N
131755725;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PDFSKQVPIUDFLH-UHFFFAOYSA-N
131754027;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ADFSEZIUBMYLQX-UHFFFAOYSA-N
131765788;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DEOXWPGCLRDGFZ-UHFFFAOYSA-N
131753821;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFEXMJFDPVATAO-UHFFFAOYSA-N
131760648;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XFZASIKJCCDVQE-UHFFFAOYSA-N
131759076;FABP3;7;6.136e-55;0.5;1.8098;96.8779;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CYKDFWCGVFNUQI-UHFFFAOYSA-N
131759786;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SHWWTBXHUVHNGT-UHFFFAOYSA-N
131755677;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IXNKUAVBSAJEIR-UHFFFAOYSA-N
131760222;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DTSVNYMUJNAOOU-UHFFFAOYSA-N
9544341;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131755350;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OLDVVLPHLVANLD-UHFFFAOYSA-N
131755370;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PRBCKTCEVWJEPN-UHFFFAOYSA-N
131759314;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IJAGVFPXKMAQRV-UHFFFAOYSA-N
131753999;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RLKDRDNYMSMXGL-UHFFFAOYSA-N
131755777;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YCBZYOWJNQIJSW-UHFFFAOYSA-N
131753592;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HLUWGRVFRNCPHH-UHFFFAOYSA-N
131758983;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JBTOLUCASDBORC-UHFFFAOYSA-N
131761058;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RKPJGADXZNHPGE-UHFFFAOYSA-N
131755398;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;TWSBBIIUNDVTNF-UHFFFAOYSA-N
131763614;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GTLNJAOUKJAZIU-UHFFFAOYSA-N
56939631;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZTNCEOWHIGXJAM-UHFFFAOYSA-N
131755442;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XOJDXSDPICSSTA-UHFFFAOYSA-N
131759305;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRPHUHNPXZVJHC-UHFFFAOYSA-N
131755906;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SCRUPIUQFHRDIJ-UHFFFAOYSA-N
131756111;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JIYHMQDXQDVDIQ-UHFFFAOYSA-N
131755000;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;FLALCZKVXJDYDG-UHFFFAOYSA-N
131762189;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DXLAMQSKKMZWNP-UHFFFAOYSA-N
131756535;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;KAKUNEKXMAHXNF-UHFFFAOYSA-N
131759621;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HMGFDNAQAKGKOT-UHFFFAOYSA-N
131755715;LPAR3;6;1.9580000000000002e-58;0.4815;8.8955;103.1545;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PQQIAQSGMRDMKV-UHFFFAOYSA-N
131760059;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MIZFXTLHUPLNGP-UHFFFAOYSA-N
131755829;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;HMQDPLNLSJNOFZ-UHFFFAOYSA-N
131753506;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RUZNGRCQLAJOGE-UHFFFAOYSA-N
131763294;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HNCZROXFYKAXOH-UHFFFAOYSA-N
131759486;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JSYBHNVWTXAJTA-UHFFFAOYSA-N
131759371;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZTOPVHNXZUMKFI-UHFFFAOYSA-N
9544341;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131759337;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HZZKPTPGUSEZPI-UHFFFAOYSA-N
131753398;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LWNAPQADTXCNTE-UHFFFAOYSA-N
131756548;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JWVUDERNGFMBBB-UHFFFAOYSA-N
131764666;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;FOYFALOBIYPIPL-UHFFFAOYSA-N
131760184;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WQAWIGRUXVAAIX-UHFFFAOYSA-N
131753487;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XMQODCFBJXQBDV-UHFFFAOYSA-N
131754718;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IQSXRIYKFXKPPU-UHFFFAOYSA-N
131756112;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JLLNDMXBRCFCMO-UHFFFAOYSA-N
131766105;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YNSZYTDNGONQCW-UHFFFAOYSA-N
131763114;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIPISOXQGTUPKE-UHFFFAOYSA-N
131754939;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OHNOJBCXHSIKCO-UHFFFAOYSA-N
131753562;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RRKINLPZPZCTKA-UHFFFAOYSA-N
131763437;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BVJKPJCDKQJPAW-UHFFFAOYSA-N
131758664;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QMOZRBHWRVHQOJ-UHFFFAOYSA-N
131755542;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QUFRRPUAEDKDEW-UHFFFAOYSA-N
131754080;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;AIBSNIRRVBNNBP-UHFFFAOYSA-N
131761761;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BUUOSXNVBINTDM-UHFFFAOYSA-N
131759913;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DZYJOMOZYGTRHJ-UHFFFAOYSA-N
131760796;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YFWNVIUVILVVDR-UHFFFAOYSA-N
131754589;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTYKAHIYZXXTIN-UHFFFAOYSA-N
131753370;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SDBSYLMJMSWVJK-UHFFFAOYSA-N
131757360;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;WIJRMMMSSQJMCO-UHFFFAOYSA-N
131758065;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZMOMBZWRGVTTLX-UHFFFAOYSA-N
131753620;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZALJSAZYHMHSGO-UHFFFAOYSA-N
131754418;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QFFKKKUOMXZADH-UHFFFAOYSA-N
131755480;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PHUWKNUSDWRCGE-UHFFFAOYSA-N
131753362;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HOPNBDYQIPEPJT-UHFFFAOYSA-N
131761212;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;HLXCIVKTQOCSJO-UHFFFAOYSA-N
131759792;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VQLVXVCYSYIBGT-UHFFFAOYSA-N
131753698;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NQDCMWMLFSAQCX-UHFFFAOYSA-N
131753520;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSDZXQPLCUUMHQ-UHFFFAOYSA-N
131766058;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SQQWFCDATGFENQ-UHFFFAOYSA-N
131760031;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ISZIDYGJUZQXDR-UHFFFAOYSA-N
131758697;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LSLCAMBCQCOKNH-UHFFFAOYSA-N
131759607;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VBUYAWOUEDDBBW-UHFFFAOYSA-N
131753883;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VGXAVCFJDOECRR-UHFFFAOYSA-N
131755050;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XALHWTWEHSQIBY-UHFFFAOYSA-N
131755377;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBAXOOZVZZDVJC-UHFFFAOYSA-N
131756132;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OKJDYZDDQFURDR-UHFFFAOYSA-N
131756541;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VTPICOUFYQJTJI-UHFFFAOYSA-N
131759244;LPAR3;6;2.896e-74;0.5192;11.3299;131.5745;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UBYXSIWFCYZTHX-UHFFFAOYSA-N
9544227;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MSQBYCWSXAUJHK-UHFFFAOYSA-N
131757216;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VCTGTMSVVLORIT-UHFFFAOYSA-N
131750596;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ADLPFNWYXJKFQW-UHFFFAOYSA-N
131755261;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AODXXMPHCMURJU-UHFFFAOYSA-N
131761047;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JYMXJRDHIBKAPL-UHFFFAOYSA-N
131763206;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MKTVKWIGWXIEHG-UHFFFAOYSA-N
131755938;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DRXKVDMYIYMLIN-UHFFFAOYSA-N
131759318;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WACLWOAQCVZQHO-UHFFFAOYSA-N
131759479;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UKLOGABOYJJQSN-UHFFFAOYSA-N
131758872;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WMXYDRBAGJDSCG-UHFFFAOYSA-N
131759766;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SHCRBDGMFUJKHT-UHFFFAOYSA-N
131755951;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;AHASBULBODWAPU-UHFFFAOYSA-N
131759417;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LUNKFQMIUALALF-UHFFFAOYSA-N
131754417;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HJFZDYGJDQBLQJ-UHFFFAOYSA-N
131766110;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HEIAOQGWRROSQN-UHFFFAOYSA-N
131759437;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JRNCFIBTWGMRER-UHFFFAOYSA-N
131753755;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YVGVIKRPSGNSQN-UHFFFAOYSA-N
131758648;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;TYUOYBHEQWBQON-UHFFFAOYSA-N
131754248;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;IDANUBRXZAZNTQ-UHFFFAOYSA-N
131753391;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HPJWNEPHGPSMML-UHFFFAOYSA-N
131750596;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ADLPFNWYXJKFQW-UHFFFAOYSA-N
131755232;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;COSWJIZWAODXNP-UHFFFAOYSA-N
131753621;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QKSXLUQUGVRSFU-UHFFFAOYSA-N
131750355;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJBGBKUEIBXOEG-UHFFFAOYSA-N
131756472;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WNIDTLACSIPEOD-UHFFFAOYSA-N
14325549;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IQZHYABKFPLPHG-UHFFFAOYSA-N
131758916;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RQEKPMWGSCALDR-UHFFFAOYSA-N
131759925;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;KGCKCEDJXPOMSE-UHFFFAOYSA-N
131755268;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBCKVROCLDZVDL-UHFFFAOYSA-N
131760081;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IKJIWAALGJUTLA-UHFFFAOYSA-N
131753970;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OIAXGMPMFLBWEB-UHFFFAOYSA-N
131753725;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NEUKLKKOFRWHDB-UHFFFAOYSA-N
131763832;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;USAUVXGGZAHQNY-UHFFFAOYSA-N
131760537;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FNKCAFMYNGUZAU-UHFFFAOYSA-N
131759070;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CSTLHGPIWNGXFJ-UHFFFAOYSA-N
131755177;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WKSLEDJKCJNITP-UHFFFAOYSA-N
131758888;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZXYLDUDAXJJFMZ-UHFFFAOYSA-N
9544227;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MSQBYCWSXAUJHK-UHFFFAOYSA-N
131755371;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VEESJNIKHNLRCH-UHFFFAOYSA-N
131755684;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZUMTISSRAZIGC-UHFFFAOYSA-N
131763123;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RRQQICLGULVDHJ-UHFFFAOYSA-N
131759246;LPAR3;6;4.587999999999999e-81;0.5294;12.3757;143.7829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LWCKIESQXRPOHD-UHFFFAOYSA-N
131755163;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZXLEWFIONDQJM-UHFFFAOYSA-N
131750352;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YWKYRFUPKVVPAH-UHFFFAOYSA-N
131756669;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VNHABZLRSOJWDZ-UHFFFAOYSA-N
131757184;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;UKQZYMLCKHOSTG-UHFFFAOYSA-N
131759475;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BIPVSIKNOFBMKW-UHFFFAOYSA-N
131761078;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SOCNQOBFARPJBO-UHFFFAOYSA-N
131757853;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;JAMTWOKYIOCODD-UHFFFAOYSA-N
131757922;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KWWVXMLEUYDGGY-UHFFFAOYSA-N
131766095;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FRZIUSLXTUICSQ-UHFFFAOYSA-N
131755141;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBDNVPPIUIROLZ-UHFFFAOYSA-N
131765931;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;JTHKVFDOMHYCNA-UHFFFAOYSA-N
131765471;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LRLNNYOCFSSDOW-UHFFFAOYSA-N
131756137;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEOJWPZDTKLQJA-UHFFFAOYSA-N
131756652;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HWPRTUFRMUOZLY-UHFFFAOYSA-N
131760186;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GLMVCLWSBJJWTR-UHFFFAOYSA-N
131755001;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LRTMQTBQQUGLKW-UHFFFAOYSA-N
131755420;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WLVCRJNHNFZNFC-UHFFFAOYSA-N
131758703;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;YIPJUHYAYCZWRJ-UHFFFAOYSA-N
131755917;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IDMJDWJMYCKJQJ-UHFFFAOYSA-N
131755384;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGWSKVYZBMTHNX-UHFFFAOYSA-N
131753802;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HSISMYYRVVPXKG-UHFFFAOYSA-N
131755589;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MTMROZADXJWIBV-UHFFFAOYSA-N
131755162;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QKCZWZMHMPYOPG-UHFFFAOYSA-N
131753838;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VIYIIFOXWFOBDE-UHFFFAOYSA-N
131761187;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;APYYLLXHUQMDDS-UHFFFAOYSA-N
131758042;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JKLQMZASXAUKDG-UHFFFAOYSA-N
56938607;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OOXHPYMTHPKODA-UHFFFAOYSA-N
131755146;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KSMPHUBCCOCMRE-UHFFFAOYSA-N
131756499;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;OAWZXYQFSSUDQG-UHFFFAOYSA-N
131758648;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;TYUOYBHEQWBQON-UHFFFAOYSA-N
131761899;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KBDOPVRVUZKPQY-UHFFFAOYSA-N
131753958;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AQOIZNNITCNBQE-UHFFFAOYSA-N
131759304;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGEZSPSFVTXJTF-UHFFFAOYSA-N
131753592;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HLUWGRVFRNCPHH-UHFFFAOYSA-N
131757373;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UNKHDPXDHSBDOZ-UHFFFAOYSA-N
131758042;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JKLQMZASXAUKDG-UHFFFAOYSA-N
131755610;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QGFXXHQHYVJYSH-UHFFFAOYSA-N
131759082;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OGZXEGHARYHFNG-UHFFFAOYSA-N
131760933;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QKAXGKITAFZXPQ-UHFFFAOYSA-N
131755707;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QYHOZSHVNKWJLV-UHFFFAOYSA-N
131760649;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MVWHBFFHLYXZJQ-UHFFFAOYSA-N
131756547;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;LJYSOCUILOBCPA-UHFFFAOYSA-N
131765901;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;FDFREEAVFLANHV-UHFFFAOYSA-N
131757256;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LJWFWKJSUKWNCH-UHFFFAOYSA-N
131766314;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;YTFUBOUKMGWXHM-UHFFFAOYSA-N
131760506;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SHWUEDFQQXTCJE-UHFFFAOYSA-N
131755805;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DATRBAYWFQZJEM-UHFFFAOYSA-N
131760702;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MWZGBHBJOPROOU-UHFFFAOYSA-N
131765931;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;JTHKVFDOMHYCNA-UHFFFAOYSA-N
131750372;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PDEQUPGHMOMBFC-UHFFFAOYSA-N
131754583;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RTBRCTDGSUJPRS-UHFFFAOYSA-N
131760078;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CLCQSBVFBLSNEE-UHFFFAOYSA-N
131759660;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEMZZKBCGPBDKP-UHFFFAOYSA-N
131755797;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;UFGXGACWXCNPJD-UHFFFAOYSA-N
131763148;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XYFSTETYCVWOEN-UHFFFAOYSA-N
131765933;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;TZNCRMSXUPMKHT-UHFFFAOYSA-N
131756558;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;WOYJJCSXKNHKCN-UHFFFAOYSA-N
131757360;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;WIJRMMMSSQJMCO-UHFFFAOYSA-N
131761193;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;KEGWRTMECYJUBP-UHFFFAOYSA-N
131759640;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VKYKIUHFHBYWIQ-UHFFFAOYSA-N
131753753;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PBZUQKBKTBJPQG-UHFFFAOYSA-N
131759621;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HMGFDNAQAKGKOT-UHFFFAOYSA-N
131759442;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XTSQWTDQTZVALB-UHFFFAOYSA-N
131759579;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HJJGKDWWDQGJME-UHFFFAOYSA-N
131758664;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QMOZRBHWRVHQOJ-UHFFFAOYSA-N
131763635;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HLDNWFKUIPUXFI-UHFFFAOYSA-N
131757215;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;FXJPVPHYLZUPPO-UHFFFAOYSA-N
131759474;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PXIRAQVGRSCHAE-UHFFFAOYSA-N
131753931;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XDAZZLONPIHPNZ-UHFFFAOYSA-N
131755227;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DFOGLEBUXTZMDU-UHFFFAOYSA-N
131761758;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;WJLTVCYAAPDLHN-UHFFFAOYSA-N
131756692;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NFECCYXCUXSJJQ-UHFFFAOYSA-N
131754674;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AJCVSKDDEKJMGM-UHFFFAOYSA-N
131760081;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IKJIWAALGJUTLA-UHFFFAOYSA-N
131753854;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HYDJVFGMENBDEL-UHFFFAOYSA-N
131760505;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QTMSSVDGQFTUGW-UHFFFAOYSA-N
131754049;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZYWNYYJHZYDVCC-UHFFFAOYSA-N
131760024;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;PPGYTWCQPFGHHF-UHFFFAOYSA-N
131755006;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MZUGAQXXWDXZIR-UHFFFAOYSA-N
131755583;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEXKOFIGSYEMIC-UHFFFAOYSA-N
131756744;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ITRVDAWLKSPAKB-UHFFFAOYSA-N
131760540;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XWUIEUCNKIBJAB-UHFFFAOYSA-N
131750388;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XOCUQHRPEPNSJE-UHFFFAOYSA-N
131756216;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWBKQSARGDXJLH-UHFFFAOYSA-N
131756089;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AAXMCYUUKFLUMJ-UHFFFAOYSA-N
131760072;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;MWIGZNCBUJFLIL-UHFFFAOYSA-N
131761046;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JLKCEKRVLYHNTR-UHFFFAOYSA-N
131756466;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RPLBRIYXQKGFND-UHFFFAOYSA-N
131755978;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OCUVIQQPCBIFRP-UHFFFAOYSA-N
131759515;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DFMOOXJLNYMJDV-UHFFFAOYSA-N
131753790;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LXHLNESXEDBVQR-UHFFFAOYSA-N
101706281;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;MKRZSXAKFYWUAW-UHFFFAOYSA-N
10854964;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UBFOEWXGSAZLKS-UHFFFAOYSA-N
56938607;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OOXHPYMTHPKODA-UHFFFAOYSA-N
131758670;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FCJIOGHLJHBKRR-UHFFFAOYSA-N
131753908;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VMUGUHJRAOSIMU-UHFFFAOYSA-N
131756460;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;YEMQFZGWRFYGJM-UHFFFAOYSA-N
131753807;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KRNGXZWFBACZCQ-UHFFFAOYSA-N
131758089;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SEPILWBSQJWVGW-UHFFFAOYSA-N
131759197;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JQLUSEPGRGEFIO-UHFFFAOYSA-N
131759066;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PORHNNNMYDBBOL-UHFFFAOYSA-N
131753621;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QKSXLUQUGVRSFU-UHFFFAOYSA-N
131758039;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KWSTWEQIGGYEMX-UHFFFAOYSA-N
131755474;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OZTOROOYEIRFAB-UHFFFAOYSA-N
131761181;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;AVDYVPMWQRDZRZ-UHFFFAOYSA-N
131755792;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VJGBLJQPGREUIJ-UHFFFAOYSA-N
131759581;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WXMOURHYAWKCON-UHFFFAOYSA-N
131755791;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KQKXUUFGXDXTLP-UHFFFAOYSA-N
131756466;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RPLBRIYXQKGFND-UHFFFAOYSA-N
131757827;LPAR1;6;4.629e-43;0.5625;8.0419;75.5538;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;JEERBMFDIWSRBT-UHFFFAOYSA-N
131757899;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;IZQSAPJJVMUNHL-UHFFFAOYSA-N
131759336;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;JPGXGLQWIXJXMB-UHFFFAOYSA-N
131753808;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCFQRCZDNUSJCL-UHFFFAOYSA-N
131759624;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NRHVUGOGJJHYKY-UHFFFAOYSA-N
131759733;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SBMGSPMUZLTYRO-UHFFFAOYSA-N
131756645;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SSQAVJZOEYXKJM-UHFFFAOYSA-N
131759047;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QAKLYWYMXOZHCJ-UHFFFAOYSA-N
131759601;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWXBRFPKZQLDSI-UHFFFAOYSA-N
131763148;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XYFSTETYCVWOEN-UHFFFAOYSA-N
131763115;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPBJHRGEWAYSDO-UHFFFAOYSA-N
131759511;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKSVCFOMADIPHE-UHFFFAOYSA-N
131754080;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;AIBSNIRRVBNNBP-UHFFFAOYSA-N
14029830;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JSSROPRCXOAGCW-UHFFFAOYSA-N
131756298;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HIOAMCRVNLXZQC-UHFFFAOYSA-N
131761078;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SOCNQOBFARPJBO-UHFFFAOYSA-N
131755171;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBTULCCTZFQLPM-UHFFFAOYSA-N
131755912;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CVHMEZFGALFXMT-UHFFFAOYSA-N
131757382;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CQGCPQNAYLDVOH-UHFFFAOYSA-N
131759717;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KFAZITXLGUDPHA-UHFFFAOYSA-N
131761892;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JHBQRHHIBFVBER-UHFFFAOYSA-N
131764003;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JOUMXYIISHXANV-UHFFFAOYSA-N
131760369;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SJPXPPDFLZCAGK-UHFFFAOYSA-N
131754612;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYAXBKPUHHCJZ-UHFFFAOYSA-N
131753683;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBKTWXVFMTZJMM-UHFFFAOYSA-N
99649123;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YFFIQXNTTVSKJC-UHFFFAOYSA-N
131760525;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;AGEPNYPMOSCATG-UHFFFAOYSA-N
131753573;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QQWCQYWWJUBCHW-UHFFFAOYSA-N
131755070;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;DLHLOJATURJKGG-UHFFFAOYSA-N
131754751;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFTLYHXOQWFSCO-UHFFFAOYSA-N
131755197;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSESJUIKHHMUIV-UHFFFAOYSA-N
131757183;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;ZRKRTZFYHUBTQQ-UHFFFAOYSA-N
131753838;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VIYIIFOXWFOBDE-UHFFFAOYSA-N
131759514;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JTOXJDDZUMEKEU-UHFFFAOYSA-N
131753540;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MSCHPHKYTIAZQI-UHFFFAOYSA-N
131763747;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QSYBICSNXGWCJX-UHFFFAOYSA-N
131755930;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WVIOMIGIVJHZTN-UHFFFAOYSA-N
131755971;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;BRLGHZXETDWABO-UHFFFAOYSA-N
131755370;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PRBCKTCEVWJEPN-UHFFFAOYSA-N
131758823;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHQUEWMLMFUPTL-UHFFFAOYSA-N
131755427;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WPQGVSPULJCTQM-UHFFFAOYSA-N
131753887;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AXWUDJVLHVBXKA-UHFFFAOYSA-N
131759441;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GJUYNZPMUHMLSD-UHFFFAOYSA-N
131756131;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OSNTYLCOCUHBGM-UHFFFAOYSA-N
131756793;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SLVVTLNMFWVJDL-UHFFFAOYSA-N
131754149;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;CKJFKCABBRYLMR-UHFFFAOYSA-N
131759024;LPAR3;6;3.934e-67;0.5294;10.233;118.7683;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IXEARPXRHLLVNK-UHFFFAOYSA-N
131760393;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VFDSPTRIQXDNNU-UHFFFAOYSA-N
131753813;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLNIBJNSVRHQPM-UHFFFAOYSA-N
131753553;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKPSHAYASLXJTD-UHFFFAOYSA-N
131757372;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;OYMKHLWGIUBLIM-UHFFFAOYSA-N
131755977;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QGKVIRKDCRKDQI-UHFFFAOYSA-N
131755376;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SVXVJZXYYAEVSC-UHFFFAOYSA-N
131759352;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZPJFCNOYMFWVHX-UHFFFAOYSA-N
131755065;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KVLYQVRJXYJGRU-UHFFFAOYSA-N
131759460;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BTLLBFZSJPKPDE-UHFFFAOYSA-N
131755537;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PDTAQKYFJJGDCD-UHFFFAOYSA-N
131753603;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JSFLWCDRHPDCLD-UHFFFAOYSA-N
131757262;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIWODFZGWMDPCD-UHFFFAOYSA-N
131760626;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PREDIUAQXWFUMA-UHFFFAOYSA-N
131755091;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;YCRUOZPSQCDMCU-UHFFFAOYSA-N
131759305;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRPHUHNPXZVJHC-UHFFFAOYSA-N
131764384;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FPSHTYJHVSXLOR-UHFFFAOYSA-N
131759597;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XEVQMHZJFRSFOB-UHFFFAOYSA-N
131755724;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;CQDCLPYZVBWAGY-UHFFFAOYSA-N
131759315;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RKMYDQZHNDAFDU-UHFFFAOYSA-N
131759873;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPTNHTUUMDTEJR-UHFFFAOYSA-N
131761653;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;TYZDMXCEMORABR-UHFFFAOYSA-N
131760553;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UZBLVYUHSFGJIV-UHFFFAOYSA-N
131755562;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NGEHHICSKHOVLR-UHFFFAOYSA-N
131753719;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IONCGPWOGZERQG-UHFFFAOYSA-N
131753893;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PZGMSWKRVOYKSW-UHFFFAOYSA-N
131765751;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OEMFAWUKBJFEBP-UHFFFAOYSA-N
131753603;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JSFLWCDRHPDCLD-UHFFFAOYSA-N
131763551;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XYIQAWXUEATHMZ-UHFFFAOYSA-N
131759443;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORNQRRXFGCNXPC-UHFFFAOYSA-N
131760480;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OUUHBPIFIILUCA-UHFFFAOYSA-N
131764719;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FWBFYCRYECSRNA-UHFFFAOYSA-N
131753479;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NZEDZJHGVGEWRO-UHFFFAOYSA-N
131755971;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;BRLGHZXETDWABO-UHFFFAOYSA-N
131758668;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NUYRINJQOPQTKC-UHFFFAOYSA-N
131753691;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MAFFVOBYYPRXHD-UHFFFAOYSA-N
131755064;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MGLUNDCYIGYIEO-UHFFFAOYSA-N
131755232;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;COSWJIZWAODXNP-UHFFFAOYSA-N
131755797;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;UFGXGACWXCNPJD-UHFFFAOYSA-N
131753726;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PCGADUJICVENFJ-UHFFFAOYSA-N
131753975;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GQNNXOVIYAQPRC-UHFFFAOYSA-N
131759880;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LNXIGBSVBNTNGO-UHFFFAOYSA-N
131755805;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DATRBAYWFQZJEM-UHFFFAOYSA-N
131754007;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CTBYABNARYJUOG-UHFFFAOYSA-N
131755737;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;ZSFGHQACWUKLCX-UHFFFAOYSA-N
131754674;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AJCVSKDDEKJMGM-UHFFFAOYSA-N
131763927;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;FTPNNFMDJNYTOR-UHFFFAOYSA-N
131762158;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZMLPYXDICDGROD-UHFFFAOYSA-N
131755707;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QYHOZSHVNKWJLV-UHFFFAOYSA-N
131759461;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ONYOXARKNBCDOW-UHFFFAOYSA-N
131755782;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JVXNBCRQHASIJK-UHFFFAOYSA-N
131757190;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;CZOALYUQVVTJLR-UHFFFAOYSA-N
131766110;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HEIAOQGWRROSQN-UHFFFAOYSA-N
131759349;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PKWPXOXGYXWVKK-UHFFFAOYSA-N
131756494;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SYGFOSKNZKVBDP-UHFFFAOYSA-N
131756351;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PYBMXNRCLHIQRA-UHFFFAOYSA-N
131753831;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XIEUJHVLPZAHHA-UHFFFAOYSA-N
131753654;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AYBGGTUWOJKGTF-UHFFFAOYSA-N
131759664;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AHGKMUVICCTCFM-UHFFFAOYSA-N
131753790;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LXHLNESXEDBVQR-UHFFFAOYSA-N
131758981;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KIAYIOGNKVRZDY-UHFFFAOYSA-N
131760552;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OCXMVEFWZCJXTP-UHFFFAOYSA-N
131756487;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;IPYRBHTYCZWCET-UHFFFAOYSA-N
131766096;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZBFSNQAJGYUCEB-UHFFFAOYSA-N
131750406;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXIRNQZZDMHWHR-UHFFFAOYSA-N
131763536;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PZDNZVIDHUTVSG-UHFFFAOYSA-N
131757364;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VZQSJRZRVOMAEX-UHFFFAOYSA-N
131754089;FABP3;7;9.821999999999999e-53;0.5;1.7361;92.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DHPCZZMWIIRYJJ-UHFFFAOYSA-N
131753478;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JNAGPKIFCRPVFY-UHFFFAOYSA-N
56938694;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HZTVWEWLCFVURZ-UHFFFAOYSA-N
131753519;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CQKDVCRIDIZFBZ-UHFFFAOYSA-N
131758670;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FCJIOGHLJHBKRR-UHFFFAOYSA-N
131758829;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BCMHHAAVHIRHKO-UHFFFAOYSA-N
131754717;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IEYUWTSKPUBHDM-UHFFFAOYSA-N
131753541;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AYBAPOVPJJUOKS-UHFFFAOYSA-N
131763184;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SFCNWLSIOSCRMM-UHFFFAOYSA-N
131760679;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HOBVFWBPKZZJDS-UHFFFAOYSA-N
131756350;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XTHHRTVNJZAGND-UHFFFAOYSA-N
131758844;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DELOENOPQWJVLP-UHFFFAOYSA-N
131760422;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NWWIMNVSUNRCOZ-UHFFFAOYSA-N
131755924;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RQYFNWIONOQUSC-UHFFFAOYSA-N
131760225;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JSUSEOMHUNJYLL-UHFFFAOYSA-N
131760560;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XWWHTVUODKLIIT-UHFFFAOYSA-N
131759466;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDPGTJRMESRMBM-UHFFFAOYSA-N
131755700;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XTQUNVXMTVIEJG-UHFFFAOYSA-N
101758459;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LDVWBXGIAOXJKP-UHFFFAOYSA-N
131759016;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BOGNZWFVCFWTDN-UHFFFAOYSA-N
131753661;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUSQLYSSJGPWCI-UHFFFAOYSA-N
131759801;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JNHLCTFBNVEPGE-UHFFFAOYSA-N
131759732;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KHIGDHJAAJSAMT-UHFFFAOYSA-N
131755001;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LRTMQTBQQUGLKW-UHFFFAOYSA-N
131758019;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;JCOOWXXKIVGLLZ-UHFFFAOYSA-N
131755830;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RXFCPNVEKZDTFB-UHFFFAOYSA-N
131763090;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LDVDALBKRWDBPL-UHFFFAOYSA-N
131753981;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RKFWDJFGPBNCBJ-UHFFFAOYSA-N
131760065;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FZUGYVDDNAJZLF-UHFFFAOYSA-N
131760633;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YVYVTNJRAGMXOD-UHFFFAOYSA-N
131760225;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JSUSEOMHUNJYLL-UHFFFAOYSA-N
131754093;FABP3;7;1.3719999999999998e-51;0.4565;1.6978;90.8644;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;TZXMSONPXDUMEW-UHFFFAOYSA-N
131760525;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;AGEPNYPMOSCATG-UHFFFAOYSA-N
131760649;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MVWHBFFHLYXZJQ-UHFFFAOYSA-N
131755018;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KJQOITVLKVGNFB-UHFFFAOYSA-N
102242320;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OJWXCNKRIMWLSH-UHFFFAOYSA-N
131760085;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RKPVLJWMLADBIO-UHFFFAOYSA-N
131757247;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;ZSRZPVOHGXEPMJ-UHFFFAOYSA-N
131753742;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DCAWTWWNADPCKX-UHFFFAOYSA-N
131755782;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JVXNBCRQHASIJK-UHFFFAOYSA-N
131755234;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LTJDBKBPSJHJDU-UHFFFAOYSA-N
131756487;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;IPYRBHTYCZWCET-UHFFFAOYSA-N
131755349;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JJNQBKOWLBHGAW-UHFFFAOYSA-N
131759400;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;VLLWHKDCWQXIBL-UHFFFAOYSA-N
131755317;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PUMLPWHNOMWLFJ-UHFFFAOYSA-N
131753532;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JOYRTBZPFLTFIB-UHFFFAOYSA-N
131753314;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XEOFILXSSITART-UHFFFAOYSA-N
131755708;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XGUVLROHLQCRKO-UHFFFAOYSA-N
131759807;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KTXCVHLICBKPGH-UHFFFAOYSA-N
131754534;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MAWNXWUEDRYQEG-UHFFFAOYSA-N
131755913;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SWUDGTDLMRDUKM-UHFFFAOYSA-N
131753777;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZFYKFVATZUURMJ-UHFFFAOYSA-N
131760046;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XDWSGZHSFJBWFG-UHFFFAOYSA-N
131753957;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SPKQDEVVANGEJY-UHFFFAOYSA-N
131759874;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NMFGLZJGDVTWFX-UHFFFAOYSA-N
131760505;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QTMSSVDGQFTUGW-UHFFFAOYSA-N
131755561;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCIYSTQFXHSCKA-UHFFFAOYSA-N
131754488;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VSGBEUWASJCUJL-UHFFFAOYSA-N
131755811;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XVCFHZCPVLNAMA-UHFFFAOYSA-N
131755677;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IXNKUAVBSAJEIR-UHFFFAOYSA-N
131755610;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QGFXXHQHYVJYSH-UHFFFAOYSA-N
131753749;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;AWANUXSOQBARQI-UHFFFAOYSA-N
131759951;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DNMGYNOZYHVTMB-UHFFFAOYSA-N
131761736;FABP3;7;6.136e-55;0.5;1.8098;96.8779;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QZQJDOWDQQNPNJ-UHFFFAOYSA-N
131766215;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;KFSFKHFCDAWOLQ-UHFFFAOYSA-N
131750372;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PDEQUPGHMOMBFC-UHFFFAOYSA-N
131759868;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;OEZUXFLSEGCWIE-UHFFFAOYSA-N
131760041;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NUQXGTMHWLBOFD-UHFFFAOYSA-N
131757372;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;OYMKHLWGIUBLIM-UHFFFAOYSA-N
131756557;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NDDBFQIGGOFJRX-UHFFFAOYSA-N
131759462;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QXRVJZIWSZYNFE-UHFFFAOYSA-N
131755038;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CZMAJLBPYUFDNA-UHFFFAOYSA-N
131756664;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UHJOVPMFQXZMGP-UHFFFAOYSA-N
131760206;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VHJVYLPSJSQQCX-UHFFFAOYSA-N
131756158;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IDNFRJBDXYQKBM-UHFFFAOYSA-N
131758676;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKBVKNFLTKNLFF-UHFFFAOYSA-N
131763920;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YDUDDRNPXONNIT-UHFFFAOYSA-N
131761616;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSYRFXMMGSZPLP-UHFFFAOYSA-N
131760536;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;QEQZJVMDJZDGPY-UHFFFAOYSA-N
131756533;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZAQSWHTVZWGPPD-UHFFFAOYSA-N
131757898;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCC;QOPDMHCKZZFVHH-UHFFFAOYSA-N
131753306;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;BXFHKVOMHBKGBJ-UHFFFAOYSA-N
131755325;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PWAOXOJAJJJACV-UHFFFAOYSA-N
131761053;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SHYQNKZJLJXKPA-UHFFFAOYSA-N
131755220;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DACIDRBKCGJUFT-UHFFFAOYSA-N
9544167;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131761188;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;MIFIJCHVVASRCZ-UHFFFAOYSA-N
131759887;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FCEBICVTRXFYLZ-UHFFFAOYSA-N
131753306;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;BXFHKVOMHBKGBJ-UHFFFAOYSA-N
131755776;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;PJEBJEMINBSXRV-UHFFFAOYSA-N
131755701;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LLMPANOXXMGKRF-UHFFFAOYSA-N
131760047;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCTYSQSAXZXBBM-UHFFFAOYSA-N
131753668;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PZHUYFBIXNXBLU-UHFFFAOYSA-N
131754674;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AJCVSKDDEKJMGM-UHFFFAOYSA-N
131753335;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MPHCGZMQUSAMKJ-UHFFFAOYSA-N
131755930;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WVIOMIGIVJHZTN-UHFFFAOYSA-N
131760546;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZMONUYUAVAZYFU-UHFFFAOYSA-N
131760045;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YOEDLSRYINEBNN-UHFFFAOYSA-N
131762018;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZTULNDCILAYJFW-UHFFFAOYSA-N
131759872;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WXYYNUWVWHESOG-UHFFFAOYSA-N
131753376;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYZULKIDHZXLHX-UHFFFAOYSA-N
131756517;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;MGWARNQTGMPDFT-UHFFFAOYSA-N
131766067;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHWDZFUPBDUEAH-UHFFFAOYSA-N
131760184;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WQAWIGRUXVAAIX-UHFFFAOYSA-N
131759495;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BRUKBMVWXMWLGD-UHFFFAOYSA-N
131757858;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;IPMCDSYSCPXHTB-UHFFFAOYSA-N
131760206;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VHJVYLPSJSQQCX-UHFFFAOYSA-N
131754136;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;SSIXVUQNKRINJM-UHFFFAOYSA-N
131760540;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XWUIEUCNKIBJAB-UHFFFAOYSA-N
131758977;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YSZSTRFCTSGBDD-UHFFFAOYSA-N
131763482;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBRPETNWPCBFTJ-UHFFFAOYSA-N
131762155;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NUXBWTCPUJBEJP-UHFFFAOYSA-N
131755269;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XFLBIJMMCSCPBO-UHFFFAOYSA-N
131753627;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OPXVSFLGAKIILH-UHFFFAOYSA-N
131756345;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JISZBVIBYWPZGI-UHFFFAOYSA-N
131755023;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XUNZJZHRHUQSIJ-UHFFFAOYSA-N
131763664;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RIMOQAPPBXQQSU-UHFFFAOYSA-N
15607293;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FGNXNKQAEKNDNA-UHFFFAOYSA-N
131761038;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;TUHYVLFMYBFPEE-UHFFFAOYSA-N
131755091;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;YCRUOZPSQCDMCU-UHFFFAOYSA-N
131757851;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;UVYBPHXSHXEHQX-UHFFFAOYSA-N
131756718;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TWOFGMYMSNEEJX-UHFFFAOYSA-N
131755325;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PWAOXOJAJJJACV-UHFFFAOYSA-N
131756035;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YXNAYHGGFGKLHS-UHFFFAOYSA-N
131759027;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QCKZCPLWSOKIIF-UHFFFAOYSA-N
101146157;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131757185;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;MTMFSFJLPCNPOI-UHFFFAOYSA-N
131765518;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NNCRXYJYPJVORP-UHFFFAOYSA-N
131760080;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOURDTSYZKYHFB-UHFFFAOYSA-N
131750344;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XRKBRKZCVJSDIQ-UHFFFAOYSA-N
131753617;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OWDZAXOWKQAOKC-UHFFFAOYSA-N
131759436;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HVIQWNBZDUXPDM-UHFFFAOYSA-N
131756658;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;GWNUSEKGRALKED-UHFFFAOYSA-N
131755938;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DRXKVDMYIYMLIN-UHFFFAOYSA-N
131758756;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;BIBCTHOYLBOAJR-UHFFFAOYSA-N
131758778;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WUTNRLSFTGCBMN-UHFFFAOYSA-N
131761090;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LABRUJVSUYYTTA-UHFFFAOYSA-N
131760086;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;APBGQGAQJLLFMC-UHFFFAOYSA-N
9544475;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PLFFUZALKUXPFW-UHFFFAOYSA-N
131759867;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LNKHZBGNOPRSQH-UHFFFAOYSA-N
56938550;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VPROCYYUGRMDKB-UHFFFAOYSA-N
131755757;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ZMDXJSHVNGLQDM-UHFFFAOYSA-N
131753952;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KXZVZPPTASOQMG-UHFFFAOYSA-N
131754528;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUDWGAJJZFZCER-UHFFFAOYSA-N
131762035;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HEYPQMCFNJLJQQ-UHFFFAOYSA-N
131761058;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RKPJGADXZNHPGE-UHFFFAOYSA-N
131757853;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;JAMTWOKYIOCODD-UHFFFAOYSA-N
131759016;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BOGNZWFVCFWTDN-UHFFFAOYSA-N
131765282;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XIIXNUYLGYUCGJ-UHFFFAOYSA-N
131755345;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ATZQIXHEMLCJGM-UHFFFAOYSA-N
56938550;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VPROCYYUGRMDKB-UHFFFAOYSA-N
131759766;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SHCRBDGMFUJKHT-UHFFFAOYSA-N
131759943;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AIJGPUXXVZKCOC-UHFFFAOYSA-N
131755931;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LXPJIWPRELJYCD-UHFFFAOYSA-N
131753393;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;VCRFEZPIACRCNR-UHFFFAOYSA-N
131756912;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RIYWVWTTXYWHMA-UHFFFAOYSA-N
131753533;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YSLQGXDXYVVXSS-UHFFFAOYSA-N
131756465;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LLAVCIGKJBNPIR-UHFFFAOYSA-N
131754556;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZURRHBGBXGLPHI-UHFFFAOYSA-N
131760633;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YVYVTNJRAGMXOD-UHFFFAOYSA-N
131759028;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBLLHDWARKBXDR-UHFFFAOYSA-N
131753336;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZXXNIIBQUJJGT-UHFFFAOYSA-N
131763114;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIPISOXQGTUPKE-UHFFFAOYSA-N
131753661;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUSQLYSSJGPWCI-UHFFFAOYSA-N
131756699;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DSLDDCZRINWODJ-UHFFFAOYSA-N
131754088;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FVACYRCSAZRBJC-UHFFFAOYSA-N
131754474;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZSTISJVJCWGTAZ-UHFFFAOYSA-N
131759423;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YUBPSQNVVBRHKY-UHFFFAOYSA-N
131757209;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AIUFGXSNPIPWDK-UHFFFAOYSA-N
131755140;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AGLSUDWGYKMXMK-UHFFFAOYSA-N
131756663;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GRVZQIMVHTZJHB-UHFFFAOYSA-N
131760099;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MUVVSXKCOYPIJY-UHFFFAOYSA-N
131757899;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;IZQSAPJJVMUNHL-UHFFFAOYSA-N
131757262;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIWODFZGWMDPCD-UHFFFAOYSA-N
131753494;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XLTDBJCJNQRMTH-UHFFFAOYSA-N
131755770;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIAZWSJURHHRMR-UHFFFAOYSA-N
131755452;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JZDWMRHLZXGIMN-UHFFFAOYSA-N
131760666;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MSQGSTKKOSEGDB-UHFFFAOYSA-N
131759337;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HZZKPTPGUSEZPI-UHFFFAOYSA-N
131756485;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;BWOHNVUJJCXFQP-UHFFFAOYSA-N
131753724;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OPTZHODNQOBXMO-UHFFFAOYSA-N
131755447;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BHUGVTHDSSXVAN-UHFFFAOYSA-N
131750361;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;JFGIMQPGGNOOHN-UHFFFAOYSA-N
131754612;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYAXBKPUHHCJZ-UHFFFAOYSA-N
131764941;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PYDVXTYEQUTPLD-UHFFFAOYSA-N
131757852;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;OOHIULWPYUEZRR-UHFFFAOYSA-N
15664102;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JMHHDSQNLZCCLT-UHFFFAOYSA-N
131761204;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XAHFVLNVNUAPSO-UHFFFAOYSA-N
131763914;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ANTOAERGFNUGHV-UHFFFAOYSA-N
131759958;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KMXCXZGPKXMYER-UHFFFAOYSA-N
131756678;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BXZBVJMLHIMPCY-UHFFFAOYSA-N
131756035;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YXNAYHGGFGKLHS-UHFFFAOYSA-N
131761077;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VGOGEYSPDFHEJZ-UHFFFAOYSA-N
15664122;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SXDAWDWMVQAQOY-UHFFFAOYSA-N
131755895;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;HFLPEQAAOJSPGG-UHFFFAOYSA-N
131756243;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWNCWDLVLHBCRO-UHFFFAOYSA-N
131764710;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZYRKKZMTAMUMHI-UHFFFAOYSA-N
131754412;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKFBAJJRYUESID-UHFFFAOYSA-N
131756686;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RHCHGASZNFDFNT-UHFFFAOYSA-N
131765937;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHUWPEXZDFNJHC-UHFFFAOYSA-N
131750382;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131762141;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GFXBBKRPUJCXGD-UHFFFAOYSA-N
131755942;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TVLMJMFKNWRCGI-UHFFFAOYSA-N
131750388;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XOCUQHRPEPNSJE-UHFFFAOYSA-N
131760064;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WYYFGQDJMAHICF-UHFFFAOYSA-N
131763525;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZRVFQAMIIKQWFU-UHFFFAOYSA-N
131760673;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;LBRUZFUQXUCAIU-UHFFFAOYSA-N
131756534;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YPMNDOUIDVDQOW-UHFFFAOYSA-N
131760501;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFMFNZAUKDXUBS-UHFFFAOYSA-N
131761054;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LJLIFTYRIMZUNV-UHFFFAOYSA-N
131758020;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XHAVMTLJTOZKKY-UHFFFAOYSA-N
131755399;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXWHOVSUVNCPAU-UHFFFAOYSA-N
131761256;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FEQGTAIRRDJZLL-UHFFFAOYSA-N
131759511;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKSVCFOMADIPHE-UHFFFAOYSA-N
131755176;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QNLOBUFLPWUYFF-UHFFFAOYSA-N
131758866;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;FODKVBNCUCXQDG-UHFFFAOYSA-N
131755725;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PDFSKQVPIUDFLH-UHFFFAOYSA-N
131753377;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JADYBVKYENQSPF-UHFFFAOYSA-N
131760987;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UBNYYWZUYOQPFD-UHFFFAOYSA-N
131756595;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;WJSBURXJPCGRCH-UHFFFAOYSA-N
131750387;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131754634;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NCHFLBDZSDCXDQ-UHFFFAOYSA-N
131759308;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WRMBXJIECLAGIV-UHFFFAOYSA-N
131753449;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KWFQLWFYKULMGD-UHFFFAOYSA-N
131760560;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XWWHTVUODKLIIT-UHFFFAOYSA-N
131764744;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHESVRVAJGWCRH-UHFFFAOYSA-N
131755010;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JKYPCWURBUPJMX-UHFFFAOYSA-N
131756517;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;MGWARNQTGMPDFT-UHFFFAOYSA-N
131764718;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LCAJDMGZZMLHNH-UHFFFAOYSA-N
131764398;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QTTCWZLTKUELKJ-UHFFFAOYSA-N
131765278;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NKGXOVYKIFCXET-UHFFFAOYSA-N
131754033;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GJQHRPDIWSJRQK-UHFFFAOYSA-N
131755028;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IJMQCAKVFHJJTI-UHFFFAOYSA-N
131756325;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCXOXNIREQFVQW-UHFFFAOYSA-N
25240374;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131759872;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WXYYNUWVWHESOG-UHFFFAOYSA-N
131750601;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JKKJXOPBDBRBKU-UHFFFAOYSA-N
131755924;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RQYFNWIONOQUSC-UHFFFAOYSA-N
131755732;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;ZNJHBXLEVATVCP-UHFFFAOYSA-N
102524318;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CCKKDORBDQDVMQ-UHFFFAOYSA-N
131756486;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PYZPMTALAXHGCB-UHFFFAOYSA-N
131761103;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WQMRXKLRGJHYMP-UHFFFAOYSA-N
131759724;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZAIUAHMIZJWRPI-UHFFFAOYSA-N
131760204;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUWDYQPFUONYLK-UHFFFAOYSA-N
131759834;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PVBOVZWBGFRMPX-UHFFFAOYSA-N
131756674;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CWYJHSJCZIYZKB-UHFFFAOYSA-N
131755117;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;GWIFZHMAJCHBBF-UHFFFAOYSA-N
131765274;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;LWKWJKUKDKCQJT-UHFFFAOYSA-N
131759304;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGEZSPSFVTXJTF-UHFFFAOYSA-N
131758983;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JBTOLUCASDBORC-UHFFFAOYSA-N
131755162;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QKCZWZMHMPYOPG-UHFFFAOYSA-N
131760644;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SRKCJTCWCCPZMA-UHFFFAOYSA-N
131755562;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NGEHHICSKHOVLR-UHFFFAOYSA-N
131759796;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QMXKKHSUBLMCBY-UHFFFAOYSA-N
131760662;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VEOVLFBKKMGGBT-UHFFFAOYSA-N
131763664;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RIMOQAPPBXQQSU-UHFFFAOYSA-N
131755327;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UWIJLBUWLZZSBQ-UHFFFAOYSA-N
131760085;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RKPVLJWMLADBIO-UHFFFAOYSA-N
131764028;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IYSQDSJAZVXCDU-UHFFFAOYSA-N
131763632;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HTODETRMAVZETG-UHFFFAOYSA-N
131755063;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;VQWFQOJRISNWCH-UHFFFAOYSA-N
131759418;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HJRVVCOWJQUKTM-UHFFFAOYSA-N
131761054;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LJLIFTYRIMZUNV-UHFFFAOYSA-N
131760493;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLRXETBUGMIPJK-UHFFFAOYSA-N
131755196;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JQSCFVCYBPEHML-UHFFFAOYSA-N
131753807;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KRNGXZWFBACZCQ-UHFFFAOYSA-N
56938694;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HZTVWEWLCFVURZ-UHFFFAOYSA-N
131759933;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACPCBDGMDMCVRO-UHFFFAOYSA-N
131757255;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YKCVKNPTWXLRMR-UHFFFAOYSA-N
131760933;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QKAXGKITAFZXPQ-UHFFFAOYSA-N
131755241;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KUYUHOFPMWBZLG-UHFFFAOYSA-N
131760042;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ITWXUAWJAMUWRI-UHFFFAOYSA-N
131755038;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CZMAJLBPYUFDNA-UHFFFAOYSA-N
131755701;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LLMPANOXXMGKRF-UHFFFAOYSA-N
131754007;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CTBYABNARYJUOG-UHFFFAOYSA-N
101453996;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SFSFPCWGADNGHN-UHFFFAOYSA-N
131753546;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PEGBVZIRKWFBAT-UHFFFAOYSA-N
131759514;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JTOXJDDZUMEKEU-UHFFFAOYSA-N
131755609;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZDQSYJNEPMDFCF-UHFFFAOYSA-N
131762142;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CTGSVLMVNLDPLN-UHFFFAOYSA-N
131760383;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLBDBVTYZICFPC-UHFFFAOYSA-N
131756863;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KUWZMMMTHHIVEK-UHFFFAOYSA-N
131753279;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ABNSWGKFFQUIAR-UHFFFAOYSA-N
131758923;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POHNOIJAASRKQU-UHFFFAOYSA-N
131760065;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FZUGYVDDNAJZLF-UHFFFAOYSA-N
131755561;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCIYSTQFXHSCKA-UHFFFAOYSA-N
131755006;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MZUGAQXXWDXZIR-UHFFFAOYSA-N
131756744;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ITRVDAWLKSPAKB-UHFFFAOYSA-N
131760205;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UMPQTCRVUAVQQI-UHFFFAOYSA-N
131753628;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VWLZYYAQPNZEAL-UHFFFAOYSA-N
131755338;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SAKURFWWZUPUGR-UHFFFAOYSA-N
131765898;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LOPISFWKDHPVGZ-UHFFFAOYSA-N
131755377;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBAXOOZVZZDVJC-UHFFFAOYSA-N
131759100;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YEHPWJBHXFGRBU-UHFFFAOYSA-N
131755906;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SCRUPIUQFHRDIJ-UHFFFAOYSA-N
131759324;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLEMYYGTXQHVFE-UHFFFAOYSA-N
131760650;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CPINNDOHYCSUGR-UHFFFAOYSA-N
131759219;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTSPSCRQQWFSPQ-UHFFFAOYSA-N
131756393;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HQMVQKBESXYEOV-UHFFFAOYSA-N
131759950;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;BZAUSRZLPIJRHO-UHFFFAOYSA-N
131753877;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GPYCLFQJCGOBIU-UHFFFAOYSA-N
9544227;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MSQBYCWSXAUJHK-UHFFFAOYSA-N
131759827;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JFKSTJCBEDXQKN-UHFFFAOYSA-N
131756492;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HEZIFHPOCSMIRI-UHFFFAOYSA-N
131755912;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CVHMEZFGALFXMT-UHFFFAOYSA-N
131758880;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CSWKLJWLTNNDPE-UHFFFAOYSA-N
131753392;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;XOKFJRGPQQOMMF-UHFFFAOYSA-N
131755155;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;PBFPTUPUIISNJT-UHFFFAOYSA-N
131753562;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RRKINLPZPZCTKA-UHFFFAOYSA-N
131759060;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ATDIOVCHAKPQSA-UHFFFAOYSA-N
131761072;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FGRFOAKBUFMFQQ-UHFFFAOYSA-N
131755070;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;DLHLOJATURJKGG-UHFFFAOYSA-N
131760536;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;QEQZJVMDJZDGPY-UHFFFAOYSA-N
131755776;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;PJEBJEMINBSXRV-UHFFFAOYSA-N
131760643;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PFIMEBGCGUJFNB-UHFFFAOYSA-N
131756541;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VTPICOUFYQJTJI-UHFFFAOYSA-N
131750382;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131765757;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;QKBOUSRTZKBNLJ-UHFFFAOYSA-N
131760943;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QIWDVFCGYRFMCC-UHFFFAOYSA-N
131755326;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BAJHYMHNWFZWKC-UHFFFAOYSA-N
131753683;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBKTWXVFMTZJMM-UHFFFAOYSA-N
131753348;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GEYNVUPCUDZJMH-UHFFFAOYSA-N
131756093;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOOVNYMOCOZYCS-UHFFFAOYSA-N
131750547;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CXVKBFLPGNGMQW-UHFFFAOYSA-N
131753376;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYZULKIDHZXLHX-UHFFFAOYSA-N
131759592;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YSXJWNGVILWQDX-UHFFFAOYSA-N
131755731;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KMUBMOMDOAVSGD-UHFFFAOYSA-N
131755798;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;QDQDETHJEUGTEX-UHFFFAOYSA-N
131755365;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BMVWCBZVEZTSPY-UHFFFAOYSA-N
131755170;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZTNYZUSKQOHZBE-UHFFFAOYSA-N
131753553;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKPSHAYASLXJTD-UHFFFAOYSA-N
131765518;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NNCRXYJYPJVORP-UHFFFAOYSA-N
131756557;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NDDBFQIGGOFJRX-UHFFFAOYSA-N
131759448;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KDCKRLAPPIAVIP-UHFFFAOYSA-N
131755063;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;VQWFQOJRISNWCH-UHFFFAOYSA-N
131764003;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JOUMXYIISHXANV-UHFFFAOYSA-N
131763104;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YJZARZPHBIAWSP-UHFFFAOYSA-N
131754367;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PGPUQOBIJOUZAP-UHFFFAOYSA-N
131758663;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DIKFHEKYQJZAEV-UHFFFAOYSA-N
131753612;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HPPGYJJKGFAKGA-UHFFFAOYSA-N
131755201;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WZPQAQGIOSQQKF-UHFFFAOYSA-N
131763300;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YPLTVEAOWNDKFQ-UHFFFAOYSA-N
131753377;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JADYBVKYENQSPF-UHFFFAOYSA-N
131755781;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;PTRBUWWBGNLWCI-UHFFFAOYSA-N
131750368;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OCYFAHIHWCVZKS-UHFFFAOYSA-N
131757185;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;MTMFSFJLPCNPOI-UHFFFAOYSA-N
131765893;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WFGBZGXKOVKMDE-UHFFFAOYSA-N
9544531;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LLZPZRGVBKFBKR-UHFFFAOYSA-N
131753369;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BLXQIUODGKBTGK-UHFFFAOYSA-N
131759957;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MIAUUKZRJAXLRT-UHFFFAOYSA-N
131754055;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KZROWLZDIGBBIN-UHFFFAOYSA-N
131763226;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;POAFQIOHYATMRL-UHFFFAOYSA-N
131758982;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZQQGMCWVFPHUPJ-UHFFFAOYSA-N
15664121;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YJHQECFFCOYQLS-UHFFFAOYSA-N
131753575;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WKYUVRSDBBUBSZ-UHFFFAOYSA-N
131756088;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OKAAPUQYUHINCC-UHFFFAOYSA-N
131764212;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DUPNCGTUAKCMPW-UHFFFAOYSA-N
131753837;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LTKZJLJRCVCLBH-UHFFFAOYSA-N
131759060;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ATDIOVCHAKPQSA-UHFFFAOYSA-N
131761047;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JYMXJRDHIBKAPL-UHFFFAOYSA-N
131753363;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGVRIPFAUKNKTG-UHFFFAOYSA-N
131754094;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZAMYFQHKFGFWHM-UHFFFAOYSA-N
131756324;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ASJHAVAPNBVXQH-UHFFFAOYSA-N
131760501;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFMFNZAUKDXUBS-UHFFFAOYSA-N
131757828;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;CAPXDNNJSKSNHK-UHFFFAOYSA-N
131755856;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;UUZMFQOOGKVJDO-UHFFFAOYSA-N
131755806;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;GZBPQMRKEPSOQQ-UHFFFAOYSA-N
131757373;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UNKHDPXDHSBDOZ-UHFFFAOYSA-N
131761060;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SDKRXCCKVQOCAO-UHFFFAOYSA-N
131759448;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KDCKRLAPPIAVIP-UHFFFAOYSA-N
131755985;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NQKRWZVYDJMTOX-UHFFFAOYSA-N
131755724;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;CQDCLPYZVBWAGY-UHFFFAOYSA-N
131755426;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PJZXKSHPRSUFOM-UHFFFAOYSA-N
131756319;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DJYNSHLHLLYWLD-UHFFFAOYSA-N
131756494;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SYGFOSKNZKVBDP-UHFFFAOYSA-N
131765893;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WFGBZGXKOVKMDE-UHFFFAOYSA-N
11007443;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UDQCIYKUZOQISE-UHFFFAOYSA-N
131755051;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MEUNMCWGMQZVER-UHFFFAOYSA-N
131755856;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;UUZMFQOOGKVJDO-UHFFFAOYSA-N
131758785;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XUSMNDFFJSIIQR-UHFFFAOYSA-N
131766314;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;YTFUBOUKMGWXHM-UHFFFAOYSA-N
131753307;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WDOQOSSKIJDAOB-UHFFFAOYSA-N
131754221;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSUWZDOHFVTWQP-UHFFFAOYSA-N
131764486;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PMIXGVBCAUCGTR-UHFFFAOYSA-N
131755474;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OZTOROOYEIRFAB-UHFFFAOYSA-N
131757256;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LJWFWKJSUKWNCH-UHFFFAOYSA-N
131755219;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XAMNFTPGEKLFFB-UHFFFAOYSA-N
131760493;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLRXETBUGMIPJK-UHFFFAOYSA-N
131760120;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LMFJKPBELSZHCE-UHFFFAOYSA-N
56938589;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FYOAFNBAIZJVFT-UHFFFAOYSA-N
131754089;LPAR3;6;5.564000000000001e-78;0.5192;11.9014;138.2466;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DHPCZZMWIIRYJJ-UHFFFAOYSA-N
131754222;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IMBBOIUUCCVERC-UHFFFAOYSA-N
131759423;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YUBPSQNVVBRHKY-UHFFFAOYSA-N
131757257;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DNKJHSCCXVKXSU-UHFFFAOYSA-N
131753575;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WKYUVRSDBBUBSZ-UHFFFAOYSA-N
131761095;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYLDVVKRGAXESB-UHFFFAOYSA-N
131755392;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DAYIBGRSBOHJLY-UHFFFAOYSA-N
131760190;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WOPXUTZTLHAOFJ-UHFFFAOYSA-N
131761605;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;TVFKBKZPDYIUEQ-UHFFFAOYSA-N
131759486;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JSYBHNVWTXAJTA-UHFFFAOYSA-N
131753362;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HOPNBDYQIPEPJT-UHFFFAOYSA-N
131753837;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LTKZJLJRCVCLBH-UHFFFAOYSA-N
131761205;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OHIKEWGTVMTPFC-UHFFFAOYSA-N
131759495;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BRUKBMVWXMWLGD-UHFFFAOYSA-N
131753343;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RCZREYIMELSGSA-UHFFFAOYSA-N
131753315;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HJBSNTKEHJKZIB-UHFFFAOYSA-N
131760679;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HOBVFWBPKZZJDS-UHFFFAOYSA-N
131755288;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RJHUVVVYTCGXGM-UHFFFAOYSA-N
131760093;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YWOLEUFHHASIAX-UHFFFAOYSA-N
131760650;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CPINNDOHYCSUGR-UHFFFAOYSA-N
131756458;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;OLZRHDMTTQNXSI-UHFFFAOYSA-N
131756112;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JLLNDMXBRCFCMO-UHFFFAOYSA-N
131764710;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZYRKKZMTAMUMHI-UHFFFAOYSA-N
131758981;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KIAYIOGNKVRZDY-UHFFFAOYSA-N
131758019;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;JCOOWXXKIVGLLZ-UHFFFAOYSA-N
131755425;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DUALUCVNZADEIN-UHFFFAOYSA-N
131755896;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AQMKAYODMONDGF-UHFFFAOYSA-N
131759303;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MPJVJPDVMFMULD-UHFFFAOYSA-N
131753877;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GPYCLFQJCGOBIU-UHFFFAOYSA-N
11007443;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UDQCIYKUZOQISE-UHFFFAOYSA-N
131760060;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DVVVWSWPMOHCJM-UHFFFAOYSA-N
131756535;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;KAKUNEKXMAHXNF-UHFFFAOYSA-N
131755882;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SKXGGXXHUILISA-UHFFFAOYSA-N
131758642;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;CDJBHUGXUCDURI-UHFFFAOYSA-N
131750362;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XCJBYQXUCQJPCZ-UHFFFAOYSA-N
131757827;FABP3;7;1.875e-51;0.475;1.6933;90.621;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;JEERBMFDIWSRBT-UHFFFAOYSA-N
131762025;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AODBUYLODSYPEX-UHFFFAOYSA-N
131754605;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WTMANSPIMTYBGE-UHFFFAOYSA-N
131759703;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MORKMZKGDIIIBY-UHFFFAOYSA-N
131753795;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKKDPSPGKMHBNY-UHFFFAOYSA-N
131755590;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NGPGSHBLLYRGNQ-UHFFFAOYSA-N
131764395;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WZOAXQSXOUDVTF-UHFFFAOYSA-N
131759786;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SHWWTBXHUVHNGT-UHFFFAOYSA-N
131757365;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NQZWUGZPCSPJEX-UHFFFAOYSA-N
131758706;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;ZQMZDXCKJADKAC-UHFFFAOYSA-N
131764475;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LJQQNDOWXYVVGF-UHFFFAOYSA-N
131759623;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HKADKLQZXQXYER-UHFFFAOYSA-N
131762624;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;ZUDALJHGXKNMOO-UHFFFAOYSA-N
131765943;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;YYSSONAYWLGUQT-UHFFFAOYSA-N
131761034;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OWYOMQRSVDVHPO-UHFFFAOYSA-N
131755345;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ATZQIXHEMLCJGM-UHFFFAOYSA-N
131765788;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DEOXWPGCLRDGFZ-UHFFFAOYSA-N
131765460;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;OPUGTLQTYUOVLC-UHFFFAOYSA-N
131762150;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DOZPBKCIXFDCBR-UHFFFAOYSA-N
131763220;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YLZZIBPODWNHEY-UHFFFAOYSA-N
131756595;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;WJSBURXJPCGRCH-UHFFFAOYSA-N
131755709;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RUVUJZWBOUFWTN-UHFFFAOYSA-N
131753533;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YSLQGXDXYVVXSS-UHFFFAOYSA-N
131755289;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QZSWQEQRBHPEOS-UHFFFAOYSA-N
102524318;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CCKKDORBDQDVMQ-UHFFFAOYSA-N
131753493;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBBJXVATNOPWNT-UHFFFAOYSA-N
131765898;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LOPISFWKDHPVGZ-UHFFFAOYSA-N
131763747;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QSYBICSNXGWCJX-UHFFFAOYSA-N
131756767;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IQHVYGKMAJFIAG-UHFFFAOYSA-N
131759239;LPAR1;6;4.629e-43;0.5625;8.0419;75.5538;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XNHWYHFYYUALLY-UHFFFAOYSA-N
131758801;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GBTKABUIAQMAPV-UHFFFAOYSA-N
131763402;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JKQWGXQHSNHJJE-UHFFFAOYSA-N
131753814;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UOMPQWRFJUXCEB-UHFFFAOYSA-N
131763195;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBKMWLHIRAKLID-UHFFFAOYSA-N
10854964;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UBFOEWXGSAZLKS-UHFFFAOYSA-N
131763946;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WCWOBBHQCJULDM-UHFFFAOYSA-N
131759607;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VBUYAWOUEDDBBW-UHFFFAOYSA-N
131754669;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UJQAYELTSBRSML-UHFFFAOYSA-N
131755045;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QHMIFVZMPUXEAH-UHFFFAOYSA-N
131761059;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WUKREVVPLNPHSK-UHFFFAOYSA-N
131753814;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UOMPQWRFJUXCEB-UHFFFAOYSA-N
131753520;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSDZXQPLCUUMHQ-UHFFFAOYSA-N
131753612;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HPPGYJJKGFAKGA-UHFFFAOYSA-N
131759933;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACPCBDGMDMCVRO-UHFFFAOYSA-N
131758960;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YIKPYYUODQLYRB-UHFFFAOYSA-N
131755715;FABP3;7;1.3719999999999998e-51;0.4565;1.6978;90.8644;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PQQIAQSGMRDMKV-UHFFFAOYSA-N
131753720;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RNHDCKNXDJJGEF-UHFFFAOYSA-N
131760041;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NUQXGTMHWLBOFD-UHFFFAOYSA-N
131755632;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHBKQHGKLWWKQN-UHFFFAOYSA-N
131755702;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;SXBWOXCOXHTAAM-UHFFFAOYSA-N
131758685;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;VOLUUICWFQPQGG-UHFFFAOYSA-N
131753724;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OPTZHODNQOBXMO-UHFFFAOYSA-N
131755269;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XFLBIJMMCSCPBO-UHFFFAOYSA-N
131755029;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WGKBXGXZUVULLG-UHFFFAOYSA-N
131755220;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DACIDRBKCGJUFT-UHFFFAOYSA-N
131755579;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NPDNCNMIHPPXLG-UHFFFAOYSA-N
131757246;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;YFTFKGRPESIBQI-UHFFFAOYSA-N
131754055;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KZROWLZDIGBBIN-UHFFFAOYSA-N
131760045;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YOEDLSRYINEBNN-UHFFFAOYSA-N
131755702;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;SXBWOXCOXHTAAM-UHFFFAOYSA-N
131758867;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZITWCTCGAATZHT-UHFFFAOYSA-N
131755295;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CKPZBSPXVJHCRO-UHFFFAOYSA-N
131758843;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;QBKIULACTZPXJR-UHFFFAOYSA-N
131756511;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;ASJDYPQIFWQJPP-UHFFFAOYSA-N
131756656;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NFCQXICLNHGVGZ-UHFFFAOYSA-N
131756117;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FHKXPCWAEDEJKG-UHFFFAOYSA-N
131753611;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MBGJURGZJWMMPU-UHFFFAOYSA-N
100921659;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MVAGPZSVOSGBMR-UHFFFAOYSA-N
131755241;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KUYUHOFPMWBZLG-UHFFFAOYSA-N
131758923;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POHNOIJAASRKQU-UHFFFAOYSA-N
131755050;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XALHWTWEHSQIBY-UHFFFAOYSA-N
131755193;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;DSGUAGSLOJNCIC-UHFFFAOYSA-N
131757401;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LFLULLQVQPKAMK-UHFFFAOYSA-N
131759950;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;BZAUSRZLPIJRHO-UHFFFAOYSA-N
131755609;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZDQSYJNEPMDFCF-UHFFFAOYSA-N
131755907;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTNNVFMIFYLBOY-UHFFFAOYSA-N
131761060;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SDKRXCCKVQOCAO-UHFFFAOYSA-N
131763423;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEIVVIBOWKCKQZ-UHFFFAOYSA-N
131755480;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PHUWKNUSDWRCGE-UHFFFAOYSA-N
131754094;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZAMYFQHKFGFWHM-UHFFFAOYSA-N
131763646;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XBRGDJCOPAOHAK-UHFFFAOYSA-N
131753586;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LDSWEOUGZDGWFT-UHFFFAOYSA-N
131758642;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;CDJBHUGXUCDURI-UHFFFAOYSA-N
131760484;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PEJYXBAMEZPBAX-UHFFFAOYSA-N
131756342;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OSCPURITXSWNQF-UHFFFAOYSA-N
131754392;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SIDLIHCVDJIGBO-UHFFFAOYSA-N
131753611;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MBGJURGZJWMMPU-UHFFFAOYSA-N
131760565;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PUKJHNUKDAALMG-UHFFFAOYSA-N
131760389;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SCJRWDPPOJUNPY-UHFFFAOYSA-N
131755188;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFLOLSWWIHPMFV-UHFFFAOYSA-N
131755452;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JZDWMRHLZXGIMN-UHFFFAOYSA-N
131755829;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;HMQDPLNLSJNOFZ-UHFFFAOYSA-N
131759977;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;UORVMJWANGGOMW-UHFFFAOYSA-N
131765012;LPAR3;6;9.083e-74;0.54;11.2536;130.6831;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;FYQUINNRFMMPKJ-UHFFFAOYSA-N
131759325;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HSSCOLBULXMJLZ-UHFFFAOYSA-N
131765754;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YZUQGBAOTLBFFG-UHFFFAOYSA-N
131757858;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;IPMCDSYSCPXHTB-UHFFFAOYSA-N
131758756;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;BIBCTHOYLBOAJR-UHFFFAOYSA-N
131753545;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BLFWZVXARGMXGK-UHFFFAOYSA-N
131759100;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YEHPWJBHXFGRBU-UHFFFAOYSA-N
131759643;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTGPQOIWPOHYSI-UHFFFAOYSA-N
100921659;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MVAGPZSVOSGBMR-UHFFFAOYSA-N
131755197;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSESJUIKHHMUIV-UHFFFAOYSA-N
131758808;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;CNRGDEVLIJIREE-UHFFFAOYSA-N
131765460;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;OPUGTLQTYUOVLC-UHFFFAOYSA-N
131764014;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;QZUZXWSQFLLIBE-UHFFFAOYSA-N
131760064;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WYYFGQDJMAHICF-UHFFFAOYSA-N
131756793;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SLVVTLNMFWVJDL-UHFFFAOYSA-N
131759440;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CREVCBCOPOOZEP-UHFFFAOYSA-N
131763915;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMSZKZQYJMFYOM-UHFFFAOYSA-N
131753778;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JLBLEJPPNIHTIQ-UHFFFAOYSA-N
131755574;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZLDJFFNRXQCWDI-UHFFFAOYSA-N
131755757;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ZMDXJSHVNGLQDM-UHFFFAOYSA-N
15664122;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SXDAWDWMVQAQOY-UHFFFAOYSA-N
131763336;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LSBYOEWZVKAXQD-UHFFFAOYSA-N
131760626;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PREDIUAQXWFUMA-UHFFFAOYSA-N
131766100;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;VXMBUOMIVSCLTQ-UHFFFAOYSA-N
131756524;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;UJUOOWYFRZLMGP-UHFFFAOYSA-N
131757209;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AIUFGXSNPIPWDK-UHFFFAOYSA-N
131759493;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AUMXQCVFWSNALF-UHFFFAOYSA-N
131754481;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UPJQJJOQKCRAID-UHFFFAOYSA-N
131759879;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SSKQGMAHQBYKGA-UHFFFAOYSA-N
131760643;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PFIMEBGCGUJFNB-UHFFFAOYSA-N
131755201;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WZPQAQGIOSQQKF-UHFFFAOYSA-N
131755769;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZKAJTUDTPFXDPB-UHFFFAOYSA-N
131764967;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;BDCSDBVNZGJCKJ-UHFFFAOYSA-N
131759665;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FLBFFPPBNOZWBA-UHFFFAOYSA-N
131760673;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;LBRUZFUQXUCAIU-UHFFFAOYSA-N
131756722;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPLCSZBQAQAYRD-UHFFFAOYSA-N
131755781;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;PTRBUWWBGNLWCI-UHFFFAOYSA-N
131759925;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;KGCKCEDJXPOMSE-UHFFFAOYSA-N
131753334;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;WEUNTUVUAWDABH-UHFFFAOYSA-N
101146157;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131759457;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FJPOWCDSUMTJMY-UHFFFAOYSA-N
131755700;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XTQUNVXMTVIEJG-UHFFFAOYSA-N
131753970;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OIAXGMPMFLBWEB-UHFFFAOYSA-N
131756137;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEOJWPZDTKLQJA-UHFFFAOYSA-N
131755552;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AWKZRMLSPPFBRT-UHFFFAOYSA-N
131765220;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;BMHFNXTYTINNLE-UHFFFAOYSA-N
131750340;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;AOSKWYIWKDMXST-UHFFFAOYSA-N
131755018;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KJQOITVLKVGNFB-UHFFFAOYSA-N
131764729;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UJBVBTXTIWQXQY-UHFFFAOYSA-N
131758964;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;KTIVGYMIDNMKAU-UHFFFAOYSA-N
131755039;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JCVFZHFBLDWEFA-UHFFFAOYSA-N
9544830;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IOBBMTADSCMSQV-UHFFFAOYSA-N
131764666;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;FOYFALOBIYPIPL-UHFFFAOYSA-N
131753599;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GKCAFLCQQIADCE-UHFFFAOYSA-N
131756535;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;KAKUNEKXMAHXNF-UHFFFAOYSA-N
131761094;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MWGRLUDJZRTHTP-UHFFFAOYSA-N
131760949;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GHRXIMZQVOZDCY-UHFFFAOYSA-N
131755262;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LOEVQQYBQLFELJ-UHFFFAOYSA-N
131760552;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OCXMVEFWZCJXTP-UHFFFAOYSA-N
131759422;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YLSQMGKHEUFXMJ-UHFFFAOYSA-N
131753343;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RCZREYIMELSGSA-UHFFFAOYSA-N
131759602;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GARPFACGXFDLSO-UHFFFAOYSA-N
131754412;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKFBAJJRYUESID-UHFFFAOYSA-N
131754081;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OHGQZSIZFJHEIP-UHFFFAOYSA-N
131765754;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YZUQGBAOTLBFFG-UHFFFAOYSA-N
131755889;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RWXPDMYGJSOHGX-UHFFFAOYSA-N
131755044;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BHIUUNLDJFUIJS-UHFFFAOYSA-N
131753755;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YVGVIKRPSGNSQN-UHFFFAOYSA-N
131757382;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CQGCPQNAYLDVOH-UHFFFAOYSA-N
131755209;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWSYMQKEXATFKF-UHFFFAOYSA-N
131759319;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WXMJAPVKXZKBEF-UHFFFAOYSA-N
131761039;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SXXIVYLKZBTODG-UHFFFAOYSA-N
131756679;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OCSXULFZMSSXID-UHFFFAOYSA-N
131753493;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBBJXVATNOPWNT-UHFFFAOYSA-N
131754440;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QNFJULRDTQNJGZ-UHFFFAOYSA-N
131755420;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WLVCRJNHNFZNFC-UHFFFAOYSA-N
131757208;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;NZPQRJJPGATRLU-UHFFFAOYSA-N
131755365;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BMVWCBZVEZTSPY-UHFFFAOYSA-N
131756678;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BXZBVJMLHIMPCY-UHFFFAOYSA-N
131755176;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QNLOBUFLPWUYFF-UHFFFAOYSA-N
131755658;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VVTVYFURJIUZNX-UHFFFAOYSA-N
131759351;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;SAZDDXQYEIJVSC-UHFFFAOYSA-N
131755919;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZXPZKPTYTWDDTR-UHFFFAOYSA-N
131756493;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SQKYADYBUNVMCF-UHFFFAOYSA-N
131761741;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AEIYVURNZPSTRI-UHFFFAOYSA-N
131761127;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNDQJEPSXBZSNW-UHFFFAOYSA-N
131759443;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORNQRRXFGCNXPC-UHFFFAOYSA-N
131750369;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWMDNFFJJVRJMG-UHFFFAOYSA-N
131760041;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NUQXGTMHWLBOFD-UHFFFAOYSA-N
131755583;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEXKOFIGSYEMIC-UHFFFAOYSA-N
131753861;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GZIFFSTVTIRNHB-UHFFFAOYSA-N
131759475;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BIPVSIKNOFBMKW-UHFFFAOYSA-N
131760072;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;MWIGZNCBUJFLIL-UHFFFAOYSA-N
131759457;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FJPOWCDSUMTJMY-UHFFFAOYSA-N
131755246;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JDYQORQUIVEAPP-UHFFFAOYSA-N
131754717;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IEYUWTSKPUBHDM-UHFFFAOYSA-N
131759162;LPAR3;6;2.479e-62;0.5094;9.4949;110.1517;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PRBBZGQORJEBML-UHFFFAOYSA-N
131750415;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;YONCDTJKIZDSKQ-UHFFFAOYSA-N
131754197;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ALOIXMAWZZBRNQ-UHFFFAOYSA-N
131760422;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NWWIMNVSUNRCOZ-UHFFFAOYSA-N
131759475;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BIPVSIKNOFBMKW-UHFFFAOYSA-N
131761078;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SOCNQOBFARPJBO-UHFFFAOYSA-N
131763406;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OJYRZPXGOAVFNV-UHFFFAOYSA-N
131755918;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTAXARKBUGEENK-UHFFFAOYSA-N
131761193;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;KEGWRTMECYJUBP-UHFFFAOYSA-N
131753541;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AYBAPOVPJJUOKS-UHFFFAOYSA-N
56938682;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ODHWPZFGXIMZRL-UHFFFAOYSA-N
131765278;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NKGXOVYKIFCXET-UHFFFAOYSA-N
131755022;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FAWROKQWRPDLOA-UHFFFAOYSA-N
131759308;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WRMBXJIECLAGIV-UHFFFAOYSA-N
131756111;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JIYHMQDXQDVDIQ-UHFFFAOYSA-N
131754668;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCXAOTNONHNUHF-UHFFFAOYSA-N
131759250;LPAR3;6;3.694e-71;0.5;10.8523;125.9988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YKKMFXGDUMHZFK-UHFFFAOYSA-N
131759422;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YLSQMGKHEUFXMJ-UHFFFAOYSA-N
131756740;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;VRZHAFWZMYJZMD-UHFFFAOYSA-N
131755208;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QVDYDIZGXSWABG-UHFFFAOYSA-N
131758861;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNDJLJYFFTWUTN-UHFFFAOYSA-N
131758845;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JMNWHZCLZAOONT-UHFFFAOYSA-N
131760968;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VTKPPWHYRVIYMV-UHFFFAOYSA-N
131757381;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GJZLKYUSHJORNQ-UHFFFAOYSA-N
131750602;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KSUDLITWNAQVCF-UHFFFAOYSA-N
131755658;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VVTVYFURJIUZNX-UHFFFAOYSA-N
131763500;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OLENDCDRWPUUBG-UHFFFAOYSA-N
131755732;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;ZNJHBXLEVATVCP-UHFFFAOYSA-N
131761090;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LABRUJVSUYYTTA-UHFFFAOYSA-N
131754691;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVOKYELEYWPQHJ-UHFFFAOYSA-N
131756061;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SHPCUQLAGQRBSR-UHFFFAOYSA-N
131764395;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WZOAXQSXOUDVTF-UHFFFAOYSA-N
131758676;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKBVKNFLTKNLFF-UHFFFAOYSA-N
131759622;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HVCCNWVJBNTHRL-UHFFFAOYSA-N
131759580;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XUOLMCLGWGLYGT-UHFFFAOYSA-N
131758689;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AXFNIIJYCHZARY-UHFFFAOYSA-N
131750410;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QXMHHXQBBKDSSL-UHFFFAOYSA-N
131755151;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JULWPANCJCTRDN-UHFFFAOYSA-N
131756887;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SNGHDWHBYJYQOD-UHFFFAOYSA-N
131754548;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYEQRCSOCOOKBP-UHFFFAOYSA-N
131765456;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UQOIPWJWGPNKBQ-UHFFFAOYSA-N
131758089;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SEPILWBSQJWVGW-UHFFFAOYSA-N
131757405;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMVEGQXRXTDQX-UHFFFAOYSA-N
131763195;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBKMWLHIRAKLID-UHFFFAOYSA-N
131755775;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;JKGVPFAPBARTLP-UHFFFAOYSA-N
131755260;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YJWYQQFOJUDNJP-UHFFFAOYSA-N
131750387;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131756132;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OKJDYZDDQFURDR-UHFFFAOYSA-N
131763483;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PARQILSYFLMAIN-UHFFFAOYSA-N
131759418;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HJRVVCOWJQUKTM-UHFFFAOYSA-N
131753908;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VMUGUHJRAOSIMU-UHFFFAOYSA-N
131756493;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SQKYADYBUNVMCF-UHFFFAOYSA-N
131750344;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XRKBRKZCVJSDIQ-UHFFFAOYSA-N
131760796;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YFWNVIUVILVVDR-UHFFFAOYSA-N
131756887;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SNGHDWHBYJYQOD-UHFFFAOYSA-N
131755943;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XZEHHPQAMMWALZ-UHFFFAOYSA-N
131758801;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GBTKABUIAQMAPV-UHFFFAOYSA-N
131753391;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HPJWNEPHGPSMML-UHFFFAOYSA-N
131756698;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GYPCYQZGNPPXQY-UHFFFAOYSA-N
131756460;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;YEMQFZGWRFYGJM-UHFFFAOYSA-N
131753604;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XHMARDUNPRBYKM-UHFFFAOYSA-N
56938682;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ODHWPZFGXIMZRL-UHFFFAOYSA-N
131755261;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AODXXMPHCMURJU-UHFFFAOYSA-N
131759957;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MIAUUKZRJAXLRT-UHFFFAOYSA-N
131759494;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HRCLBQUOANENCJ-UHFFFAOYSA-N
131754718;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IQSXRIYKFXKPPU-UHFFFAOYSA-N
131761237;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LQFACPSTFHEEKK-UHFFFAOYSA-N
131755209;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWSYMQKEXATFKF-UHFFFAOYSA-N
131755404;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KHJFBIFHBBUBGL-UHFFFAOYSA-N
131762018;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZTULNDCILAYJFW-UHFFFAOYSA-N
131755907;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTNNVFMIFYLBOY-UHFFFAOYSA-N
131755636;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LEXKCMGVSOPGQN-UHFFFAOYSA-N
131759298;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPRQNLZEKMZHBT-UHFFFAOYSA-N
131758845;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JMNWHZCLZAOONT-UHFFFAOYSA-N
131755972;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;IXDYCTWELIBSSO-UHFFFAOYSA-N
131756299;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;APUGAHTVBGXVKV-UHFFFAOYSA-N
131753698;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NQDCMWMLFSAQCX-UHFFFAOYSA-N
131755917;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IDMJDWJMYCKJQJ-UHFFFAOYSA-N
131761059;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WUKREVVPLNPHSK-UHFFFAOYSA-N
131755322;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MTMTXYXQGBCYCD-UHFFFAOYSA-N
131755984;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GTGOXBMVMINSSB-UHFFFAOYSA-N
131754955;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;DVRLSVCQXWGXCP-UHFFFAOYSA-N
131754488;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VSGBEUWASJCUJL-UHFFFAOYSA-N
131756674;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CWYJHSJCZIYZKB-UHFFFAOYSA-N
131756298;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HIOAMCRVNLXZQC-UHFFFAOYSA-N
131761187;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;APYYLLXHUQMDDS-UHFFFAOYSA-N
131756318;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZSJMIBWBNKODT-UHFFFAOYSA-N
131755268;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBCKVROCLDZVDL-UHFFFAOYSA-N
131755792;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VJGBLJQPGREUIJ-UHFFFAOYSA-N
131755881;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;CLQGNDGHULBBGK-UHFFFAOYSA-N
131755065;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KVLYQVRJXYJGRU-UHFFFAOYSA-N
131761761;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BUUOSXNVBINTDM-UHFFFAOYSA-N
131756563;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FEWUEBYAXQMTPT-UHFFFAOYSA-N
131759892;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CLRWKONSSADDAS-UHFFFAOYSA-N
131763721;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VQRIKACZDQJACM-UHFFFAOYSA-N
131753569;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGUAEFVIYUUGBB-UHFFFAOYSA-N
131753742;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DCAWTWWNADPCKX-UHFFFAOYSA-N
131756533;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZAQSWHTVZWGPPD-UHFFFAOYSA-N
131753599;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GKCAFLCQQIADCE-UHFFFAOYSA-N
131753320;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IEIOCZLRHWBWAA-UHFFFAOYSA-N
131759191;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;URNTVXPNKOGORD-UHFFFAOYSA-N
131759436;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HVIQWNBZDUXPDM-UHFFFAOYSA-N
131757246;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;YFTFKGRPESIBQI-UHFFFAOYSA-N
131761072;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FGRFOAKBUFMFQQ-UHFFFAOYSA-N
131763402;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JKQWGXQHSNHJJE-UHFFFAOYSA-N
131756718;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TWOFGMYMSNEEJX-UHFFFAOYSA-N
131759929;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;GLBKLCZHEXMDML-UHFFFAOYSA-N
131754473;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BVUKOOZQIGAWRK-UHFFFAOYSA-N
131759893;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NXOBVWVEMROHRA-UHFFFAOYSA-N
131753620;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZALJSAZYHMHSGO-UHFFFAOYSA-N
131761039;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SXXIVYLKZBTODG-UHFFFAOYSA-N
131757364;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VZQSJRZRVOMAEX-UHFFFAOYSA-N
131765933;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;TZNCRMSXUPMKHT-UHFFFAOYSA-N
131753341;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SENTUJWTPLLHAV-UHFFFAOYSA-N
131757183;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;ZRKRTZFYHUBTQQ-UHFFFAOYSA-N
131753487;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XMQODCFBJXQBDV-UHFFFAOYSA-N
131754215;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FFJZQCAVRAQRGO-UHFFFAOYSA-N
131753363;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGVRIPFAUKNKTG-UHFFFAOYSA-N
131755193;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;DSGUAGSLOJNCIC-UHFFFAOYSA-N
131757401;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LFLULLQVQPKAMK-UHFFFAOYSA-N
131760185;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UKJDYVVYSNHIJH-UHFFFAOYSA-N
131758867;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZITWCTCGAATZHT-UHFFFAOYSA-N
131763721;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VQRIKACZDQJACM-UHFFFAOYSA-N
131755425;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DUALUCVNZADEIN-UHFFFAOYSA-N
131756473;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DWWVDERGXAMHFX-UHFFFAOYSA-N
131755881;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;CLQGNDGHULBBGK-UHFFFAOYSA-N
131755140;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AGLSUDWGYKMXMK-UHFFFAOYSA-N
131753772;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JSJXBHBZMVKITQ-UHFFFAOYSA-N
131753808;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCFQRCZDNUSJCL-UHFFFAOYSA-N
131757239;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;YTPRVRWPVFSOAL-UHFFFAOYSA-N
131756216;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWBKQSARGDXJLH-UHFFFAOYSA-N
131753336;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZXXNIIBQUJJGT-UHFFFAOYSA-N
131756651;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HLPJZXVCHWKDNK-UHFFFAOYSA-N
13183956;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RBLADLVPSYELCA-UHFFFAOYSA-N
131758866;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;FODKVBNCUCXQDG-UHFFFAOYSA-N
131764384;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FPSHTYJHVSXLOR-UHFFFAOYSA-N
131756540;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;XYQFDSGKFQESCN-UHFFFAOYSA-N
131753364;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;VAGKZVNTAZNDGU-UHFFFAOYSA-N
131753628;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VWLZYYAQPNZEAL-UHFFFAOYSA-N
131757079;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UMZQUOZZVLDATH-UHFFFAOYSA-N
131763619;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VSYKULSUHBBKQN-UHFFFAOYSA-N
56939612;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CDDMLDFHOOIDDR-UHFFFAOYSA-N
131758778;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WUTNRLSFTGCBMN-UHFFFAOYSA-N
131763490;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;ODALSWIZSGWUHZ-UHFFFAOYSA-N
131759929;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;GLBKLCZHEXMDML-UHFFFAOYSA-N
131753505;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SCJKAJUAZPTDRO-UHFFFAOYSA-N
131758707;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;UDBFLEBTRNBEBZ-UHFFFAOYSA-N
131753713;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKYCZRRSXYVTLB-UHFFFAOYSA-N
131765217;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IITVMCHTPSACLP-UHFFFAOYSA-N
131755090;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QSQLLDYMTXNRPS-UHFFFAOYSA-N
131756652;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HWPRTUFRMUOZLY-UHFFFAOYSA-N
131754939;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OHNOJBCXHSIKCO-UHFFFAOYSA-N
131759033;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FRHNALHHTGKIGG-UHFFFAOYSA-N
131759250;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YKKMFXGDUMHZFK-UHFFFAOYSA-N
131761182;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;JYSAOWHMYRNKSW-UHFFFAOYSA-N
131759246;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LWCKIESQXRPOHD-UHFFFAOYSA-N
131755064;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MGLUNDCYIGYIEO-UHFFFAOYSA-N
131757210;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NNJOIWXHONILSA-UHFFFAOYSA-N
131755895;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;HFLPEQAAOJSPGG-UHFFFAOYSA-N
131759939;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QFNUIDSUZKRNIE-UHFFFAOYSA-N
131760080;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOURDTSYZKYHFB-UHFFFAOYSA-N
131759943;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AIJGPUXXVZKCOC-UHFFFAOYSA-N
131759873;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPTNHTUUMDTEJR-UHFFFAOYSA-N
131766095;LPAR3;6;2.479e-62;0.5094;9.4949;110.1517;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FRZIUSLXTUICSQ-UHFFFAOYSA-N
131757378;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDPJRENIZGEJEP-UHFFFAOYSA-N
131762141;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GFXBBKRPUJCXGD-UHFFFAOYSA-N
131761237;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LQFACPSTFHEEKK-UHFFFAOYSA-N
131759082;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OGZXEGHARYHFNG-UHFFFAOYSA-N
131757239;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;YTPRVRWPVFSOAL-UHFFFAOYSA-N
131753545;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BLFWZVXARGMXGK-UHFFFAOYSA-N
131763819;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GHZUZGDZYLIXSI-UHFFFAOYSA-N
131759643;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTGPQOIWPOHYSI-UHFFFAOYSA-N
131759732;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KHIGDHJAAJSAMT-UHFFFAOYSA-N
131755361;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XSSYPDIVPNHTQU-UHFFFAOYSA-N
131760079;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DTTIGIZBXFQWNL-UHFFFAOYSA-N
131753552;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LBUUFNMBIYFPRT-UHFFFAOYSA-N
131760545;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MXFKCAQPYLTUMC-UHFFFAOYSA-N
131765901;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;FDFREEAVFLANHV-UHFFFAOYSA-N
131755384;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGWSKVYZBMTHNX-UHFFFAOYSA-N
131755830;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RXFCPNVEKZDTFB-UHFFFAOYSA-N
131755445;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SQITVZNQNGOSGD-UHFFFAOYSA-N
131758669;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;AUEYCFPJLUPBLD-UHFFFAOYSA-N
131759028;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBLLHDWARKBXDR-UHFFFAOYSA-N
131756164;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WZYMUGLYGUNQDO-UHFFFAOYSA-N
131753647;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SXPXBKWZYGAMMR-UHFFFAOYSA-N
131755447;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BHUGVTHDSSXVAN-UHFFFAOYSA-N
131750368;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OCYFAHIHWCVZKS-UHFFFAOYSA-N
131756158;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IDNFRJBDXYQKBM-UHFFFAOYSA-N
131760537;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FNKCAFMYNGUZAU-UHFFFAOYSA-N
131755175;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MLRYMYSXHCUZDL-UHFFFAOYSA-N
131755317;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PUMLPWHNOMWLFJ-UHFFFAOYSA-N
131755227;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DFOGLEBUXTZMDU-UHFFFAOYSA-N
131760552;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OCXMVEFWZCJXTP-UHFFFAOYSA-N
131754473;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BVUKOOZQIGAWRK-UHFFFAOYSA-N
131761077;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VGOGEYSPDFHEJZ-UHFFFAOYSA-N
131755725;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PDFSKQVPIUDFLH-UHFFFAOYSA-N
131760064;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WYYFGQDJMAHICF-UHFFFAOYSA-N
131760648;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XFZASIKJCCDVQE-UHFFFAOYSA-N
131758544;LPAR3;6;1.703e-93;0.5625;14.2872;166.0996;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;FUAWAXRBBSTPLW-UHFFFAOYSA-N
131754033;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GJQHRPDIWSJRQK-UHFFFAOYSA-N
131765939;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KCXCVMHVAMVXKN-UHFFFAOYSA-N
131755376;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SVXVJZXYYAEVSC-UHFFFAOYSA-N
131755965;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOJVDNJANFYSHZ-UHFFFAOYSA-N
131758822;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OPZBOXKFTDVAOR-UHFFFAOYSA-N
131759351;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;SAZDDXQYEIJVSC-UHFFFAOYSA-N
131756699;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DSLDDCZRINWODJ-UHFFFAOYSA-N
131755392;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DAYIBGRSBOHJLY-UHFFFAOYSA-N
131759796;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QMXKKHSUBLMCBY-UHFFFAOYSA-N
131760485;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OVZDGNXRQHXYRU-UHFFFAOYSA-N
131753999;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RLKDRDNYMSMXGL-UHFFFAOYSA-N
131755350;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OLDVVLPHLVANLD-UHFFFAOYSA-N
131756500;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;JBRTUJBXWSKTAY-UHFFFAOYSA-N
131750340;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;AOSKWYIWKDMXST-UHFFFAOYSA-N
131753279;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ABNSWGKFFQUIAR-UHFFFAOYSA-N
131756318;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZSJMIBWBNKODT-UHFFFAOYSA-N
131756657;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZXXXFPVLDMZBCA-UHFFFAOYSA-N
131757208;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;NZPQRJJPGATRLU-UHFFFAOYSA-N
131762159;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QHWWDKOXAJWHAQ-UHFFFAOYSA-N
131758939;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CTDMUXKSVFRWMX-UHFFFAOYSA-N
131750601;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JKKJXOPBDBRBKU-UHFFFAOYSA-N
131761058;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RKPJGADXZNHPGE-UHFFFAOYSA-N
131753857;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VDEFXUQSUBAFFB-UHFFFAOYSA-N
131755590;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NGPGSHBLLYRGNQ-UHFFFAOYSA-N
131755398;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;TWSBBIIUNDVTNF-UHFFFAOYSA-N
56936651;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IUDLXSDWDIHVDD-UHFFFAOYSA-N
131756008;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HGGUZVCKVZRCSS-UHFFFAOYSA-N
131758785;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XUSMNDFFJSIIQR-UHFFFAOYSA-N
131757184;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;UKQZYMLCKHOSTG-UHFFFAOYSA-N
131760065;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FZUGYVDDNAJZLF-UHFFFAOYSA-N
131759958;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KMXCXZGPKXMYER-UHFFFAOYSA-N
131763397;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ODXHCQRPIURWTJ-UHFFFAOYSA-N
131753506;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RUZNGRCQLAJOGE-UHFFFAOYSA-N
131755175;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MLRYMYSXHCUZDL-UHFFFAOYSA-N
131753398;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LWNAPQADTXCNTE-UHFFFAOYSA-N
131761736;LPAR3;6;3.435e-68;0.5625;10.3958;120.6694;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QZQJDOWDQQNPNJ-UHFFFAOYSA-N
131755445;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SQITVZNQNGOSGD-UHFFFAOYSA-N
131755220;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DACIDRBKCGJUFT-UHFFFAOYSA-N
131761741;LPAR3;6;4.9180000000000004e-64;0.551;9.7567;113.2083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AEIYVURNZPSTRI-UHFFFAOYSA-N
131755771;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AFMQYZXPYJFAPA-UHFFFAOYSA-N
131755240;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MLAOSVRSJAVRAU-UHFFFAOYSA-N
131764486;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PMIXGVBCAUCGTR-UHFFFAOYSA-N
131760485;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OVZDGNXRQHXYRU-UHFFFAOYSA-N
131756459;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;MCIPPLJLYFTODM-UHFFFAOYSA-N
131761095;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYLDVVKRGAXESB-UHFFFAOYSA-N
131760186;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GLMVCLWSBJJWTR-UHFFFAOYSA-N
131758909;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MNMVLKRCYQXAJF-UHFFFAOYSA-N
131753975;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GQNNXOVIYAQPRC-UHFFFAOYSA-N
131760190;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WOPXUTZTLHAOFJ-UHFFFAOYSA-N
131758685;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;VOLUUICWFQPQGG-UHFFFAOYSA-N
131756687;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;IZLQMMZWIGPZNX-UHFFFAOYSA-N
131759622;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HVCCNWVJBNTHRL-UHFFFAOYSA-N
131753341;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SENTUJWTPLLHAV-UHFFFAOYSA-N
131755635;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VMKQCJKDAJJLNO-UHFFFAOYSA-N
131754080;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;AIBSNIRRVBNNBP-UHFFFAOYSA-N
131765456;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UQOIPWJWGPNKBQ-UHFFFAOYSA-N
131754215;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FFJZQCAVRAQRGO-UHFFFAOYSA-N
131754589;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTYKAHIYZXXTIN-UHFFFAOYSA-N
131753370;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SDBSYLMJMSWVJK-UHFFFAOYSA-N
131756524;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;UJUOOWYFRZLMGP-UHFFFAOYSA-N
131756459;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;MCIPPLJLYFTODM-UHFFFAOYSA-N
131763649;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LBOVPAKRIPYJIX-UHFFFAOYSA-N
131753314;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XEOFILXSSITART-UHFFFAOYSA-N
131763927;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;FTPNNFMDJNYTOR-UHFFFAOYSA-N
131759372;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AKRDICGFDXTDDB-UHFFFAOYSA-N
131765274;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;LWKWJKUKDKCQJT-UHFFFAOYSA-N
131758977;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YSZSTRFCTSGBDD-UHFFFAOYSA-N
131759154;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GWAVHAUKODFLGT-UHFFFAOYSA-N
131759576;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NPWRXJYSKONMPV-UHFFFAOYSA-N
131757215;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;FXJPVPHYLZUPPO-UHFFFAOYSA-N
131753540;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MSCHPHKYTIAZQI-UHFFFAOYSA-N
131756132;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OKJDYZDDQFURDR-UHFFFAOYSA-N
131760648;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XFZASIKJCCDVQE-UHFFFAOYSA-N
131755427;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WPQGVSPULJCTQM-UHFFFAOYSA-N
131759319;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WXMJAPVKXZKBEF-UHFFFAOYSA-N
131754221;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSUWZDOHFVTWQP-UHFFFAOYSA-N
131755811;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XVCFHZCPVLNAMA-UHFFFAOYSA-N
131753591;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;KTVQVVATLSBTAO-UHFFFAOYSA-N
9544475;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PLFFUZALKUXPFW-UHFFFAOYSA-N
131757381;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GJZLKYUSHJORNQ-UHFFFAOYSA-N
131763115;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPBJHRGEWAYSDO-UHFFFAOYSA-N
131755938;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DRXKVDMYIYMLIN-UHFFFAOYSA-N
131760045;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YOEDLSRYINEBNN-UHFFFAOYSA-N
131754759;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZOBZWCYJZUYEQA-UHFFFAOYSA-N
131758872;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WMXYDRBAGJDSCG-UHFFFAOYSA-N
131753349;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QVTBPCIHCQQWGM-UHFFFAOYSA-N
131763123;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RRQQICLGULVDHJ-UHFFFAOYSA-N
131758880;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CSWKLJWLTNNDPE-UHFFFAOYSA-N
131753335;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MPHCGZMQUSAMKJ-UHFFFAOYSA-N
131760546;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZMONUYUAVAZYFU-UHFFFAOYSA-N
131761653;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;TYZDMXCEMORABR-UHFFFAOYSA-N
131753755;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YVGVIKRPSGNSQN-UHFFFAOYSA-N
131755404;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KHJFBIFHBBUBGL-UHFFFAOYSA-N
131753391;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HPJWNEPHGPSMML-UHFFFAOYSA-N
131755931;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LXPJIWPRELJYCD-UHFFFAOYSA-N
131766067;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHWDZFUPBDUEAH-UHFFFAOYSA-N
131750355;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJBGBKUEIBXOEG-UHFFFAOYSA-N
131754440;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QNFJULRDTQNJGZ-UHFFFAOYSA-N
131759027;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QCKZCPLWSOKIIF-UHFFFAOYSA-N
131753513;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GJHGQWDONIZQBR-UHFFFAOYSA-N
131756191;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UOLSYLSXKGOQQK-UHFFFAOYSA-N
131759219;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTSPSCRQQWFSPQ-UHFFFAOYSA-N
131753320;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IEIOCZLRHWBWAA-UHFFFAOYSA-N
131754669;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UJQAYELTSBRSML-UHFFFAOYSA-N
131755882;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SKXGGXXHUILISA-UHFFFAOYSA-N
131755000;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;FLALCZKVXJDYDG-UHFFFAOYSA-N
131759442;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XTSQWTDQTZVALB-UHFFFAOYSA-N
131760537;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FNKCAFMYNGUZAU-UHFFFAOYSA-N
131764719;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FWBFYCRYECSRNA-UHFFFAOYSA-N
131755007;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YGANYFGQLLNHPX-UHFFFAOYSA-N
131753959;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHMBATLVCVBMAU-UHFFFAOYSA-N
131753731;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PDJONFLBKPVTAF-UHFFFAOYSA-N
131755326;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BAJHYMHNWFZWKC-UHFFFAOYSA-N
131760059;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MIZFXTLHUPLNGP-UHFFFAOYSA-N
56939631;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZTNCEOWHIGXJAM-UHFFFAOYSA-N
131753982;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GBJTZFHEXHJBKU-UHFFFAOYSA-N
131763123;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RRQQICLGULVDHJ-UHFFFAOYSA-N
131755708;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XGUVLROHLQCRKO-UHFFFAOYSA-N
131761034;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OWYOMQRSVDVHPO-UHFFFAOYSA-N
131760353;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MRBGPFJGICLPKZ-UHFFFAOYSA-N
131755163;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZXLEWFIONDQJM-UHFFFAOYSA-N
131756669;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VNHABZLRSOJWDZ-UHFFFAOYSA-N
131754780;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LYNIUWOJUCUGNH-UHFFFAOYSA-N
131765012;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;FYQUINNRFMMPKJ-UHFFFAOYSA-N
131759337;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HZZKPTPGUSEZPI-UHFFFAOYSA-N
9544475;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PLFFUZALKUXPFW-UHFFFAOYSA-N
131753487;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XMQODCFBJXQBDV-UHFFFAOYSA-N
131753393;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;VCRFEZPIACRCNR-UHFFFAOYSA-N
131754221;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSUWZDOHFVTWQP-UHFFFAOYSA-N
131762253;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PPUMCDNARAYNQV-UHFFFAOYSA-N
131753398;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LWNAPQADTXCNTE-UHFFFAOYSA-N
131760565;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PUKJHNUKDAALMG-UHFFFAOYSA-N
131757922;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KWWVXMLEUYDGGY-UHFFFAOYSA-N
131755039;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JCVFZHFBLDWEFA-UHFFFAOYSA-N
131753513;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GJHGQWDONIZQBR-UHFFFAOYSA-N
131755556;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;PDFFYHNLAKMFAW-UHFFFAOYSA-N
56938640;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IHSDKTOLZNRUIJ-UHFFFAOYSA-N
131758039;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KWSTWEQIGGYEMX-UHFFFAOYSA-N
131756137;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEOJWPZDTKLQJA-UHFFFAOYSA-N
131756002;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GFGMXYASPNDDEJ-UHFFFAOYSA-N
131758664;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QMOZRBHWRVHQOJ-UHFFFAOYSA-N
131758668;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NUYRINJQOPQTKC-UHFFFAOYSA-N
131759745;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PTGPWEGIOWAQLD-UHFFFAOYSA-N
131754556;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZURRHBGBXGLPHI-UHFFFAOYSA-N
131759441;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GJUYNZPMUHMLSD-UHFFFAOYSA-N
131757360;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;WIJRMMMSSQJMCO-UHFFFAOYSA-N
131755563;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VWRXQZKIYNYMGG-UHFFFAOYSA-N
131758065;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZMOMBZWRGVTTLX-UHFFFAOYSA-N
131753620;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZALJSAZYHMHSGO-UHFFFAOYSA-N
131754418;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QFFKKKUOMXZADH-UHFFFAOYSA-N
131755182;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;BGXYIUSCTPZXJT-UHFFFAOYSA-N
131760024;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;PPGYTWCQPFGHHF-UHFFFAOYSA-N
131760930;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AAFPBUWBKCMUOC-UHFFFAOYSA-N
131753532;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JOYRTBZPFLTFIB-UHFFFAOYSA-N
131759774;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BUIOKWYGCCSIHR-UHFFFAOYSA-N
131755770;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIAZWSJURHHRMR-UHFFFAOYSA-N
131754433;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IHOAMWFZSKNMBJ-UHFFFAOYSA-N
131759934;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NBXZHICDXWJXHJ-UHFFFAOYSA-N
131754418;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QFFKKKUOMXZADH-UHFFFAOYSA-N
131755398;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;TWSBBIIUNDVTNF-UHFFFAOYSA-N
131759792;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VQLVXVCYSYIBGT-UHFFFAOYSA-N
131757222;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;LKMMURDMXJRDKU-UHFFFAOYSA-N
131759623;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HKADKLQZXQXYER-UHFFFAOYSA-N
131755950;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;QWODFTFSLHKZKF-UHFFFAOYSA-N
131756008;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HGGUZVCKVZRCSS-UHFFFAOYSA-N
131761182;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;JYSAOWHMYRNKSW-UHFFFAOYSA-N
131757210;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NNJOIWXHONILSA-UHFFFAOYSA-N
131753478;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JNAGPKIFCRPVFY-UHFFFAOYSA-N
131762253;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PPUMCDNARAYNQV-UHFFFAOYSA-N
131759602;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GARPFACGXFDLSO-UHFFFAOYSA-N
131764328;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CWLXAXNJGBVGCW-UHFFFAOYSA-N
131755192;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLDZOBNZLQGSSG-UHFFFAOYSA-N
131759318;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WACLWOAQCVZQHO-UHFFFAOYSA-N
131758909;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MNMVLKRCYQXAJF-UHFFFAOYSA-N
9544830;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IOBBMTADSCMSQV-UHFFFAOYSA-N
131755202;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WNGNQJVTTOEUDY-UHFFFAOYSA-N
131760186;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GLMVCLWSBJJWTR-UHFFFAOYSA-N
131763184;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SFCNWLSIOSCRMM-UHFFFAOYSA-N
131760353;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MRBGPFJGICLPKZ-UHFFFAOYSA-N
131754417;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HJFZDYGJDQBLQJ-UHFFFAOYSA-N
131753726;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PCGADUJICVENFJ-UHFFFAOYSA-N
131761205;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OHIKEWGTVMTPFC-UHFFFAOYSA-N
131755028;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IJMQCAKVFHJJTI-UHFFFAOYSA-N
131760953;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLXYAEOUXAFXKB-UHFFFAOYSA-N
131755289;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QZSWQEQRBHPEOS-UHFFFAOYSA-N
131753621;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QKSXLUQUGVRSFU-UHFFFAOYSA-N
131759579;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HJJGKDWWDQGJME-UHFFFAOYSA-N
131759474;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PXIRAQVGRSCHAE-UHFFFAOYSA-N
131755978;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OCUVIQQPCBIFRP-UHFFFAOYSA-N
131758827;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WYUKTVBUNYZEPG-UHFFFAOYSA-N
131759807;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KTXCVHLICBKPGH-UHFFFAOYSA-N
131753861;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GZIFFSTVTIRNHB-UHFFFAOYSA-N
131762189;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DXLAMQSKKMZWNP-UHFFFAOYSA-N
131754228;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HGQVGVFOEAHXRO-UHFFFAOYSA-N
131754228;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HGQVGVFOEAHXRO-UHFFFAOYSA-N
131759939;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QFNUIDSUZKRNIE-UHFFFAOYSA-N
131760666;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MSQGSTKKOSEGDB-UHFFFAOYSA-N
131756466;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RPLBRIYXQKGFND-UHFFFAOYSA-N
131759154;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GWAVHAUKODFLGT-UHFFFAOYSA-N
131758888;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZXYLDUDAXJJFMZ-UHFFFAOYSA-N
131759934;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NBXZHICDXWJXHJ-UHFFFAOYSA-N
131755371;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VEESJNIKHNLRCH-UHFFFAOYSA-N
131755473;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LCHZHNOSBDOUOB-UHFFFAOYSA-N
131759515;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DFMOOXJLNYMJDV-UHFFFAOYSA-N
131759246;LPAR1;6;4.061e-42;0.5294;7.8635;73.8606;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LWCKIESQXRPOHD-UHFFFAOYSA-N
10854964;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UBFOEWXGSAZLKS-UHFFFAOYSA-N
131750352;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YWKYRFUPKVVPAH-UHFFFAOYSA-N
131757209;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AIUFGXSNPIPWDK-UHFFFAOYSA-N
131755141;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBDNVPPIUIROLZ-UHFFFAOYSA-N
131757184;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;UKQZYMLCKHOSTG-UHFFFAOYSA-N
131755965;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOJVDNJANFYSHZ-UHFFFAOYSA-N
131760024;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;PPGYTWCQPFGHHF-UHFFFAOYSA-N
131755141;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBDNVPPIUIROLZ-UHFFFAOYSA-N
56936651;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IUDLXSDWDIHVDD-UHFFFAOYSA-N
131762283;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LQPSWGXHWSIHNS-UHFFFAOYSA-N
131759024;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IXEARPXRHLLVNK-UHFFFAOYSA-N
131754136;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;SSIXVUQNKRINJM-UHFFFAOYSA-N
131753802;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HSISMYYRVVPXKG-UHFFFAOYSA-N
131755162;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QKCZWZMHMPYOPG-UHFFFAOYSA-N
131763290;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MUYSBOYFSLCKQE-UHFFFAOYSA-N
131753958;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AQOIZNNITCNBQE-UHFFFAOYSA-N
131755006;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MZUGAQXXWDXZIR-UHFFFAOYSA-N
131755146;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KSMPHUBCCOCMRE-UHFFFAOYSA-N
131757827;LPAR3;6;1.703e-93;0.5625;14.2872;166.0996;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;JEERBMFDIWSRBT-UHFFFAOYSA-N
131759336;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;JPGXGLQWIXJXMB-UHFFFAOYSA-N
131759624;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NRHVUGOGJJHYKY-UHFFFAOYSA-N
131756645;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SSQAVJZOEYXKJM-UHFFFAOYSA-N
131761066;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FNZXUUOILKQHJU-UHFFFAOYSA-N
131759665;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FLBFFPPBNOZWBA-UHFFFAOYSA-N
131759372;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AKRDICGFDXTDDB-UHFFFAOYSA-N
131761038;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;TUHYVLFMYBFPEE-UHFFFAOYSA-N
131756500;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;JBRTUJBXWSKTAY-UHFFFAOYSA-N
131757405;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMVEGQXRXTDQX-UHFFFAOYSA-N
131764028;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IYSQDSJAZVXCDU-UHFFFAOYSA-N
131758042;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JKLQMZASXAUKDG-UHFFFAOYSA-N
131755537;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PDTAQKYFJJGDCD-UHFFFAOYSA-N
131766208;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;HLRCCNBXHAZKEY-UHFFFAOYSA-N
131755171;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBTULCCTZFQLPM-UHFFFAOYSA-N
131756664;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UHJOVPMFQXZMGP-UHFFFAOYSA-N
131764734;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTHJFQWGYLCNCP-UHFFFAOYSA-N
131754248;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;IDANUBRXZAZNTQ-UHFFFAOYSA-N
131760980;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATKWSHJQYSCESK-UHFFFAOYSA-N
131759318;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WACLWOAQCVZQHO-UHFFFAOYSA-N
131766215;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;KFSFKHFCDAWOLQ-UHFFFAOYSA-N
131760649;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MVWHBFFHLYXZJQ-UHFFFAOYSA-N
131750388;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XOCUQHRPEPNSJE-UHFFFAOYSA-N
131754612;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYAXBKPUHHCJZ-UHFFFAOYSA-N
131761639;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AMYBBMIDIXFAAQ-UHFFFAOYSA-N
131755327;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UWIJLBUWLZZSBQ-UHFFFAOYSA-N
131755070;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;DLHLOJATURJKGG-UHFFFAOYSA-N
131758843;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;QBKIULACTZPXJR-UHFFFAOYSA-N
131753766;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXPNAJYOBOKITK-UHFFFAOYSA-N
131760052;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;XLTVJSFXOMIXKW-UHFFFAOYSA-N
131754589;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTYKAHIYZXXTIN-UHFFFAOYSA-N
131756345;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JISZBVIBYWPZGI-UHFFFAOYSA-N
131761204;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XAHFVLNVNUAPSO-UHFFFAOYSA-N
131750372;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PDEQUPGHMOMBFC-UHFFFAOYSA-N
131754583;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RTBRCTDGSUJPRS-UHFFFAOYSA-N
131755150;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GLPSWGYMFAIAQL-UHFFFAOYSA-N
131763747;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QSYBICSNXGWCJX-UHFFFAOYSA-N
131760702;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MWZGBHBJOPROOU-UHFFFAOYSA-N
131755930;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WVIOMIGIVJHZTN-UHFFFAOYSA-N
131759245;LPAR1;6;4.061e-42;0.5294;7.8635;73.8606;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NWUHDVPEYQTVME-UHFFFAOYSA-N
131755418;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;OMLTYAGNYCAYQB-UHFFFAOYSA-N
131756558;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;WOYJJCSXKNHKCN-UHFFFAOYSA-N
131756473;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DWWVDERGXAMHFX-UHFFFAOYSA-N
131755370;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PRBCKTCEVWJEPN-UHFFFAOYSA-N
131761188;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;MIFIJCHVVASRCZ-UHFFFAOYSA-N
131760484;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PEJYXBAMEZPBAX-UHFFFAOYSA-N
131753753;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PBZUQKBKTBJPQG-UHFFFAOYSA-N
131759441;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GJUYNZPMUHMLSD-UHFFFAOYSA-N
131759480;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NAKJXCQFDQFGQP-UHFFFAOYSA-N
131757215;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;FXJPVPHYLZUPPO-UHFFFAOYSA-N
131759733;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SBMGSPMUZLTYRO-UHFFFAOYSA-N
131753813;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLNIBJNSVRHQPM-UHFFFAOYSA-N
131753617;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OWDZAXOWKQAOKC-UHFFFAOYSA-N
131760081;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IKJIWAALGJUTLA-UHFFFAOYSA-N
131760505;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QTMSSVDGQFTUGW-UHFFFAOYSA-N
131753603;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JSFLWCDRHPDCLD-UHFFFAOYSA-N
131761181;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;AVDYVPMWQRDZRZ-UHFFFAOYSA-N
131758916;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RQEKPMWGSCALDR-UHFFFAOYSA-N
131755234;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LTJDBKBPSJHJDU-UHFFFAOYSA-N
131759880;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LNXIGBSVBNTNGO-UHFFFAOYSA-N
131755978;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OCUVIQQPCBIFRP-UHFFFAOYSA-N
131758939;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CTDMUXKSVFRWMX-UHFFFAOYSA-N
131759315;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RKMYDQZHNDAFDU-UHFFFAOYSA-N
131760553;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UZBLVYUHSFGJIV-UHFFFAOYSA-N
131764725;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QETHLCLILQLBJN-UHFFFAOYSA-N
131753647;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SXPXBKWZYGAMMR-UHFFFAOYSA-N
131753591;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;KTVQVVATLSBTAO-UHFFFAOYSA-N
131755240;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MLAOSVRSJAVRAU-UHFFFAOYSA-N
131760541;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WICODSUDRZUJKB-UHFFFAOYSA-N
131758999;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNZNHYGZYKXHHL-UHFFFAOYSA-N
131753691;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MAFFVOBYYPRXHD-UHFFFAOYSA-N
131755064;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MGLUNDCYIGYIEO-UHFFFAOYSA-N
131755219;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XAMNFTPGEKLFFB-UHFFFAOYSA-N
131755805;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DATRBAYWFQZJEM-UHFFFAOYSA-N
15664121;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YJHQECFFCOYQLS-UHFFFAOYSA-N
131760540;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XWUIEUCNKIBJAB-UHFFFAOYSA-N
9544341;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131759417;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LUNKFQMIUALALF-UHFFFAOYSA-N
131755146;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KSMPHUBCCOCMRE-UHFFFAOYSA-N
131763525;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZRVFQAMIIKQWFU-UHFFFAOYSA-N
131759303;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MPJVJPDVMFMULD-UHFFFAOYSA-N
131755791;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KQKXUUFGXDXTLP-UHFFFAOYSA-N
131757190;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;CZOALYUQVVTJLR-UHFFFAOYSA-N
131753772;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JSJXBHBZMVKITQ-UHFFFAOYSA-N
131760185;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UKJDYVVYSNHIJH-UHFFFAOYSA-N
131753831;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XIEUJHVLPZAHHA-UHFFFAOYSA-N
131756563;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FEWUEBYAXQMTPT-UHFFFAOYSA-N
131753449;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KWFQLWFYKULMGD-UHFFFAOYSA-N
131760204;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUWDYQPFUONYLK-UHFFFAOYSA-N
131759461;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ONYOXARKNBCDOW-UHFFFAOYSA-N
131759848;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RXPNRICKBTZRQQ-UHFFFAOYSA-N
131754808;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KEFNWJKPJBZOJN-UHFFFAOYSA-N
131759601;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWXBRFPKZQLDSI-UHFFFAOYSA-N
131755714;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKASLILCGPZWOF-UHFFFAOYSA-N
131755984;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GTGOXBMVMINSSB-UHFFFAOYSA-N
131759750;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HYGBWSXRFZKWPT-UHFFFAOYSA-N
131754248;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;IDANUBRXZAZNTQ-UHFFFAOYSA-N
131750410;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QXMHHXQBBKDSSL-UHFFFAOYSA-N
131754751;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFTLYHXOQWFSCO-UHFFFAOYSA-N
56940294;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXWMIUIQFYBSNA-UHFFFAOYSA-N
131763397;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ODXHCQRPIURWTJ-UHFFFAOYSA-N
131755269;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XFLBIJMMCSCPBO-UHFFFAOYSA-N
131759466;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDPGTJRMESRMBM-UHFFFAOYSA-N
131753838;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VIYIIFOXWFOBDE-UHFFFAOYSA-N
131750352;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YWKYRFUPKVVPAH-UHFFFAOYSA-N
131766096;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZBFSNQAJGYUCEB-UHFFFAOYSA-N
99649123;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YFFIQXNTTVSKJC-UHFFFAOYSA-N
131759437;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JRNCFIBTWGMRER-UHFFFAOYSA-N
131756663;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GRVZQIMVHTZJHB-UHFFFAOYSA-N
131764014;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;QZUZXWSQFLLIBE-UHFFFAOYSA-N
131753725;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NEUKLKKOFRWHDB-UHFFFAOYSA-N
131758828;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;BGODCVGWEBYLGN-UHFFFAOYSA-N
131755807;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;PMGLNPPJDNWBFI-UHFFFAOYSA-N
131755574;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZLDJFFNRXQCWDI-UHFFFAOYSA-N
131756547;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;LJYSOCUILOBCPA-UHFFFAOYSA-N
131756093;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOOVNYMOCOZYCS-UHFFFAOYSA-N
131763635;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HLDNWFKUIPUXFI-UHFFFAOYSA-N
131759462;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QXRVJZIWSZYNFE-UHFFFAOYSA-N
131758698;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HIHQJJVDWLEWFD-UHFFFAOYSA-N
131760047;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCTYSQSAXZXBBM-UHFFFAOYSA-N
131755942;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TVLMJMFKNWRCGI-UHFFFAOYSA-N
131756793;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SLVVTLNMFWVJDL-UHFFFAOYSA-N
131753573;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QQWCQYWWJUBCHW-UHFFFAOYSA-N
131759493;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AUMXQCVFWSNALF-UHFFFAOYSA-N
131756669;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VNHABZLRSOJWDZ-UHFFFAOYSA-N
131761108;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AYGOZGMOLWTELQ-UHFFFAOYSA-N
9544262;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HLTSKBNGPCVUQB-UHFFFAOYSA-N
131761605;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;TVFKBKZPDYIUEQ-UHFFFAOYSA-N
131760393;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VFDSPTRIQXDNNU-UHFFFAOYSA-N
131759460;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BTLLBFZSJPKPDE-UHFFFAOYSA-N
131759336;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;JPGXGLQWIXJXMB-UHFFFAOYSA-N
131756089;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AAXMCYUUKFLUMJ-UHFFFAOYSA-N
131753343;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RCZREYIMELSGSA-UHFFFAOYSA-N
131755001;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LRTMQTBQQUGLKW-UHFFFAOYSA-N
131754481;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UPJQJJOQKCRAID-UHFFFAOYSA-N
131761046;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JLKCEKRVLYHNTR-UHFFFAOYSA-N
131753779;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VCJBIPBUZKHEIQ-UHFFFAOYSA-N
131755091;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;YCRUOZPSQCDMCU-UHFFFAOYSA-N
131759305;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRPHUHNPXZVJHC-UHFFFAOYSA-N
131755724;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;CQDCLPYZVBWAGY-UHFFFAOYSA-N
131760480;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OUUHBPIFIILUCA-UHFFFAOYSA-N
131755018;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KJQOITVLKVGNFB-UHFFFAOYSA-N
131760793;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NIYFCMHVCRSLEF-UHFFFAOYSA-N
131759873;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPTNHTUUMDTEJR-UHFFFAOYSA-N
131760085;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RKPVLJWMLADBIO-UHFFFAOYSA-N
131753719;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IONCGPWOGZERQG-UHFFFAOYSA-N
131759352;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZPJFCNOYMFWVHX-UHFFFAOYSA-N
131756487;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;IPYRBHTYCZWCET-UHFFFAOYSA-N
131755349;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JJNQBKOWLBHGAW-UHFFFAOYSA-N
131759400;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;VLLWHKDCWQXIBL-UHFFFAOYSA-N
131753532;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JOYRTBZPFLTFIB-UHFFFAOYSA-N
15664102;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JMHHDSQNLZCCLT-UHFFFAOYSA-N
131763294;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HNCZROXFYKAXOH-UHFFFAOYSA-N
131753479;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NZEDZJHGVGEWRO-UHFFFAOYSA-N
131755177;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WKSLEDJKCJNITP-UHFFFAOYSA-N
131759750;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HYGBWSXRFZKWPT-UHFFFAOYSA-N
131754367;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PGPUQOBIJOUZAP-UHFFFAOYSA-N
131758675;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QATNEARFLCYVEE-UHFFFAOYSA-N
131759344;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GQZRZDIDOJKGLP-UHFFFAOYSA-N
131758703;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;YIPJUHYAYCZWRJ-UHFFFAOYSA-N
131759924;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OUQVHWIIFCXSRJ-UHFFFAOYSA-N
131754136;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;SSIXVUQNKRINJM-UHFFFAOYSA-N
131755606;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PHOOIXVIRZQNMT-UHFFFAOYSA-N
131764641;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PVWLIUKXMYHSER-UHFFFAOYSA-N
131760046;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XDWSGZHSFJBWFG-UHFFFAOYSA-N
131758828;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;BGODCVGWEBYLGN-UHFFFAOYSA-N
131757851;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;UVYBPHXSHXEHQX-UHFFFAOYSA-N
131753726;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PCGADUJICVENFJ-UHFFFAOYSA-N
131759874;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NMFGLZJGDVTWFX-UHFFFAOYSA-N
131760080;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOURDTSYZKYHFB-UHFFFAOYSA-N
131759566;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PASRUCZTFLIYBM-UHFFFAOYSA-N
131761039;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SXXIVYLKZBTODG-UHFFFAOYSA-N
131753505;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SCJKAJUAZPTDRO-UHFFFAOYSA-N
131757222;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;LKMMURDMXJRDKU-UHFFFAOYSA-N
131756351;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PYBMXNRCLHIQRA-UHFFFAOYSA-N
131759924;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OUQVHWIIFCXSRJ-UHFFFAOYSA-N
131755777;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YCBZYOWJNQIJSW-UHFFFAOYSA-N
131755889;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RWXPDMYGJSOHGX-UHFFFAOYSA-N
131762158;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZMLPYXDICDGROD-UHFFFAOYSA-N
131759461;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ONYOXARKNBCDOW-UHFFFAOYSA-N
131755771;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AFMQYZXPYJFAPA-UHFFFAOYSA-N
131753547;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YJIQPDYUKSNQSN-UHFFFAOYSA-N
131756112;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JLLNDMXBRCFCMO-UHFFFAOYSA-N
131755170;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZTNYZUSKQOHZBE-UHFFFAOYSA-N
131756061;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SHPCUQLAGQRBSR-UHFFFAOYSA-N
131753654;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AYBGGTUWOJKGTF-UHFFFAOYSA-N
131756325;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCXOXNIREQFVQW-UHFFFAOYSA-N
131759462;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QXRVJZIWSZYNFE-UHFFFAOYSA-N
131763965;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YLJRMSSFHWLPIF-UHFFFAOYSA-N
131758690;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VJRAKLSHWUZUGJ-UHFFFAOYSA-N
131760953;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLXYAEOUXAFXKB-UHFFFAOYSA-N
131759245;LPAR3;6;4.587999999999999e-81;0.5294;12.3757;143.7829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NWUHDVPEYQTVME-UHFFFAOYSA-N
131762158;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZMLPYXDICDGROD-UHFFFAOYSA-N
131750361;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;JFGIMQPGGNOOHN-UHFFFAOYSA-N
131756533;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZAQSWHTVZWGPPD-UHFFFAOYSA-N
131756657;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZXXXFPVLDMZBCA-UHFFFAOYSA-N
131758675;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QATNEARFLCYVEE-UHFFFAOYSA-N
131753478;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JNAGPKIFCRPVFY-UHFFFAOYSA-N
131760078;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CLCQSBVFBLSNEE-UHFFFAOYSA-N
131753519;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CQKDVCRIDIZFBZ-UHFFFAOYSA-N
131760662;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VEOVLFBKKMGGBT-UHFFFAOYSA-N
101337649;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DZXZWZCELPDEAY-UHFFFAOYSA-N
131765757;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;QKBOUSRTZKBNLJ-UHFFFAOYSA-N
131764664;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZWLJFCNGDYASKC-UHFFFAOYSA-N
131759887;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FCEBICVTRXFYLZ-UHFFFAOYSA-N
131760793;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NIYFCMHVCRSLEF-UHFFFAOYSA-N
131762142;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CTGSVLMVNLDPLN-UHFFFAOYSA-N
131753306;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;BXFHKVOMHBKGBJ-UHFFFAOYSA-N
131753541;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AYBAPOVPJJUOKS-UHFFFAOYSA-N
131760047;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCTYSQSAXZXBBM-UHFFFAOYSA-N
131759344;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GQZRZDIDOJKGLP-UHFFFAOYSA-N
131753392;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;XOKFJRGPQQOMMF-UHFFFAOYSA-N
131753668;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PZHUYFBIXNXBLU-UHFFFAOYSA-N
131756692;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NFECCYXCUXSJJQ-UHFFFAOYSA-N
131759867;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LNKHZBGNOPRSQH-UHFFFAOYSA-N
101758459;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LDVWBXGIAOXJKP-UHFFFAOYSA-N
131754255;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;GNXLOCJIEADZDN-UHFFFAOYSA-N
131755045;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QHMIFVZMPUXEAH-UHFFFAOYSA-N
131756644;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XNLCSBIDDKARLA-UHFFFAOYSA-N
131753661;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUSQLYSSJGPWCI-UHFFFAOYSA-N
131760492;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PCTKCCIZPRJCIQ-UHFFFAOYSA-N
131763090;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LDVDALBKRWDBPL-UHFFFAOYSA-N
131753627;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OPXVSFLGAKIILH-UHFFFAOYSA-N
131757858;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;IPMCDSYSCPXHTB-UHFFFAOYSA-N
131755260;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YJWYQQFOJUDNJP-UHFFFAOYSA-N
131755023;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XUNZJZHRHUQSIJ-UHFFFAOYSA-N
131760525;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;AGEPNYPMOSCATG-UHFFFAOYSA-N
131759474;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PXIRAQVGRSCHAE-UHFFFAOYSA-N
131759734;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ITVZPSFYQXIRPA-UHFFFAOYSA-N
131763423;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEIVVIBOWKCKQZ-UHFFFAOYSA-N
131755918;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTAXARKBUGEENK-UHFFFAOYSA-N
131755317;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PUMLPWHNOMWLFJ-UHFFFAOYSA-N
56938624;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QEYIHHBEALJAPR-UHFFFAOYSA-N
131753314;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XEOFILXSSITART-UHFFFAOYSA-N
131755708;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XGUVLROHLQCRKO-UHFFFAOYSA-N
131760553;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UZBLVYUHSFGJIV-UHFFFAOYSA-N
131753494;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XLTDBJCJNQRMTH-UHFFFAOYSA-N
131757185;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;MTMFSFJLPCNPOI-UHFFFAOYSA-N
131753957;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SPKQDEVVANGEJY-UHFFFAOYSA-N
131750344;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XRKBRKZCVJSDIQ-UHFFFAOYSA-N
131758960;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YIKPYYUODQLYRB-UHFFFAOYSA-N
131754534;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MAWNXWUEDRYQEG-UHFFFAOYSA-N
131755913;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SWUDGTDLMRDUKM-UHFFFAOYSA-N
131758756;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;BIBCTHOYLBOAJR-UHFFFAOYSA-N
131761090;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LABRUJVSUYYTTA-UHFFFAOYSA-N
131755798;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;QDQDETHJEUGTEX-UHFFFAOYSA-N
131763226;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;POAFQIOHYATMRL-UHFFFAOYSA-N
131754528;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUDWGAJJZFZCER-UHFFFAOYSA-N
131754222;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IMBBOIUUCCVERC-UHFFFAOYSA-N
131759066;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PORHNNNMYDBBOL-UHFFFAOYSA-N
131755345;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ATZQIXHEMLCJGM-UHFFFAOYSA-N
131755295;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CKPZBSPXVJHCRO-UHFFFAOYSA-N
131755636;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LEXKCMGVSOPGQN-UHFFFAOYSA-N
56938550;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VPROCYYUGRMDKB-UHFFFAOYSA-N
131755811;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XVCFHZCPVLNAMA-UHFFFAOYSA-N
131764303;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ROGPEDYCAOGILA-UHFFFAOYSA-N
131753749;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;AWANUXSOQBARQI-UHFFFAOYSA-N
131755931;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LXPJIWPRELJYCD-UHFFFAOYSA-N
131755972;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;IXDYCTWELIBSSO-UHFFFAOYSA-N
131758861;LPAR3;6;4.9180000000000004e-64;0.551;9.7567;113.2083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNDJLJYFFTWUTN-UHFFFAOYSA-N
131753533;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YSLQGXDXYVVXSS-UHFFFAOYSA-N
131756465;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LLAVCIGKJBNPIR-UHFFFAOYSA-N
131755531;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QMOIIDCAFLCLKL-UHFFFAOYSA-N
131760383;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLBDBVTYZICFPC-UHFFFAOYSA-N
131754088;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FVACYRCSAZRBJC-UHFFFAOYSA-N
131754474;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZSTISJVJCWGTAZ-UHFFFAOYSA-N
25240374;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131756458;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;OLZRHDMTTQNXSI-UHFFFAOYSA-N
131760206;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VHJVYLPSJSQQCX-UHFFFAOYSA-N
131755007;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YGANYFGQLLNHPX-UHFFFAOYSA-N
131756164;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WZYMUGLYGUNQDO-UHFFFAOYSA-N
131760372;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RZDWVTRPHNHEBJ-UHFFFAOYSA-N
131753779;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VCJBIPBUZKHEIQ-UHFFFAOYSA-N
131763410;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CKOPDYBJSZTSFP-UHFFFAOYSA-N
131755140;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AGLSUDWGYKMXMK-UHFFFAOYSA-N
131757898;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCC;QOPDMHCKZZFVHH-UHFFFAOYSA-N
14029830;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JSSROPRCXOAGCW-UHFFFAOYSA-N
131754474;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZSTISJVJCWGTAZ-UHFFFAOYSA-N
131755326;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BAJHYMHNWFZWKC-UHFFFAOYSA-N
131759076;LPAR3;6;3.435e-68;0.5625;10.3958;120.6694;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CYKDFWCGVFNUQI-UHFFFAOYSA-N
131757899;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;IZQSAPJJVMUNHL-UHFFFAOYSA-N
131755792;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VJGBLJQPGREUIJ-UHFFFAOYSA-N
131761181;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;AVDYVPMWQRDZRZ-UHFFFAOYSA-N
131756541;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VTPICOUFYQJTJI-UHFFFAOYSA-N
131756191;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UOLSYLSXKGOQQK-UHFFFAOYSA-N
131755325;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PWAOXOJAJJJACV-UHFFFAOYSA-N
131756485;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;BWOHNVUJJCXFQP-UHFFFAOYSA-N
131759956;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJOJFBLODPQJLX-UHFFFAOYSA-N
131763915;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMSZKZQYJMFYOM-UHFFFAOYSA-N
131754759;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZOBZWCYJZUYEQA-UHFFFAOYSA-N
131760485;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OVZDGNXRQHXYRU-UHFFFAOYSA-N
131756518;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SEEXZSJWUOGTDD-UHFFFAOYSA-N
131755038;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CZMAJLBPYUFDNA-UHFFFAOYSA-N
131754149;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;CKJFKCABBRYLMR-UHFFFAOYSA-N
131759597;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XEVQMHZJFRSFOB-UHFFFAOYSA-N
131763104;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YJZARZPHBIAWSP-UHFFFAOYSA-N
131759580;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XUOLMCLGWGLYGT-UHFFFAOYSA-N
131760506;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SHWUEDFQQXTCJE-UHFFFAOYSA-N
131759442;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XTSQWTDQTZVALB-UHFFFAOYSA-N
131761204;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XAHFVLNVNUAPSO-UHFFFAOYSA-N
131760582;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GOMDFFGKASVPBQ-UHFFFAOYSA-N
131759660;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEMZZKBCGPBDKP-UHFFFAOYSA-N
131757190;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;CZOALYUQVVTJLR-UHFFFAOYSA-N
131755606;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PHOOIXVIRZQNMT-UHFFFAOYSA-N
131759872;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WXYYNUWVWHESOG-UHFFFAOYSA-N
131762166;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XPUHNGSIUVKMSD-UHFFFAOYSA-N
131756517;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;MGWARNQTGMPDFT-UHFFFAOYSA-N
131756035;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YXNAYHGGFGKLHS-UHFFFAOYSA-N
131759566;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PASRUCZTFLIYBM-UHFFFAOYSA-N
131757852;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;OOHIULWPYUEZRR-UHFFFAOYSA-N
131761077;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VGOGEYSPDFHEJZ-UHFFFAOYSA-N
131762155;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NUXBWTCPUJBEJP-UHFFFAOYSA-N
131764303;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ROGPEDYCAOGILA-UHFFFAOYSA-N
15664122;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SXDAWDWMVQAQOY-UHFFFAOYSA-N
131760548;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZKCCURQELYISMZ-UHFFFAOYSA-N
131753668;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PZHUYFBIXNXBLU-UHFFFAOYSA-N
131755714;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKASLILCGPZWOF-UHFFFAOYSA-N
131758690;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VJRAKLSHWUZUGJ-UHFFFAOYSA-N
131750382;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131753513;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GJHGQWDONIZQBR-UHFFFAOYSA-N
131763482;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBRPETNWPCBFTJ-UHFFFAOYSA-N
131753778;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JLBLEJPPNIHTIQ-UHFFFAOYSA-N
131763832;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;USAUVXGGZAHQNY-UHFFFAOYSA-N
131755117;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;GWIFZHMAJCHBBF-UHFFFAOYSA-N
15607293;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FGNXNKQAEKNDNA-UHFFFAOYSA-N
131757828;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;CAPXDNNJSKSNHK-UHFFFAOYSA-N
131753342;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJKXBTKTOXZQFL-UHFFFAOYSA-N
131758888;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZXYLDUDAXJJFMZ-UHFFFAOYSA-N
131755023;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XUNZJZHRHUQSIJ-UHFFFAOYSA-N
131759244;FABP3;7;9.821999999999999e-53;0.5;1.7361;92.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UBYXSIWFCYZTHX-UHFFFAOYSA-N
131759745;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PTGPWEGIOWAQLD-UHFFFAOYSA-N
131754011;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VTZCRGVLPMDWGI-UHFFFAOYSA-N
131758020;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XHAVMTLJTOZKKY-UHFFFAOYSA-N
131761103;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WQMRXKLRGJHYMP-UHFFFAOYSA-N
131753691;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MAFFVOBYYPRXHD-UHFFFAOYSA-N
131759319;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WXMJAPVKXZKBEF-UHFFFAOYSA-N
131758834;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;TYVUFKFTHSFXIT-UHFFFAOYSA-N
131754780;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LYNIUWOJUCUGNH-UHFFFAOYSA-N
131758866;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;FODKVBNCUCXQDG-UHFFFAOYSA-N
131765220;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;BMHFNXTYTINNLE-UHFFFAOYSA-N
131761256;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FEQGTAIRRDJZLL-UHFFFAOYSA-N
131758778;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WUTNRLSFTGCBMN-UHFFFAOYSA-N
131764739;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZSUORVUZOXBKRZ-UHFFFAOYSA-N
131760086;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;APBGQGAQJLLFMC-UHFFFAOYSA-N
131759867;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LNKHZBGNOPRSQH-UHFFFAOYSA-N
131753449;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KWFQLWFYKULMGD-UHFFFAOYSA-N
131755757;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ZMDXJSHVNGLQDM-UHFFFAOYSA-N
131757853;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;JAMTWOKYIOCODD-UHFFFAOYSA-N
131766070;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OODSECKBPNOQSL-UHFFFAOYSA-N
131757378;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDPJRENIZGEJEP-UHFFFAOYSA-N
131750369;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWMDNFFJJVRJMG-UHFFFAOYSA-N
131755262;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LOEVQQYBQLFELJ-UHFFFAOYSA-N
131753901;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OXALJAMNRIYLJO-UHFFFAOYSA-N
131754668;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCXAOTNONHNUHF-UHFFFAOYSA-N
131758856;LPAR3;6;3.435e-68;0.5625;10.3958;120.6694;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HASCFYSLDYFKJC-UHFFFAOYSA-N
131762025;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AODBUYLODSYPEX-UHFFFAOYSA-N
131755956;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NTZYNUIJRPZFCR-UHFFFAOYSA-N
131759601;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWXBRFPKZQLDSI-UHFFFAOYSA-N
131755182;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;BGXYIUSCTPZXJT-UHFFFAOYSA-N
131755399;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXWHOVSUVNCPAU-UHFFFAOYSA-N
131754556;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZURRHBGBXGLPHI-UHFFFAOYSA-N
131755183;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;NPZXCVFGWXHFFP-UHFFFAOYSA-N
131763114;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIPISOXQGTUPKE-UHFFFAOYSA-N
131758706;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;ZQMZDXCKJADKAC-UHFFFAOYSA-N
131756699;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DSLDDCZRINWODJ-UHFFFAOYSA-N
131759423;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YUBPSQNVVBRHKY-UHFFFAOYSA-N
131763646;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XBRGDJCOPAOHAK-UHFFFAOYSA-N
11146;LPAR3;6;1.028e-62;0.7714;9.5537;110.8385;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DCXXMTOCNZCJGO-UHFFFAOYSA-N
11146;CQSS;6;2.596e-69;0.4286;2.0292;122.683;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DCXXMTOCNZCJGO-UHFFFAOYSA-N
131760662;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VEOVLFBKKMGGBT-UHFFFAOYSA-N
131757262;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIWODFZGWMDPCD-UHFFFAOYSA-N
131753494;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XLTDBJCJNQRMTH-UHFFFAOYSA-N
131762149;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTVCIQXPZYXPQV-UHFFFAOYSA-N
131755452;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JZDWMRHLZXGIMN-UHFFFAOYSA-N
131760666;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MSQGSTKKOSEGDB-UHFFFAOYSA-N
131754534;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MAWNXWUEDRYQEG-UHFFFAOYSA-N
131758669;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;AUEYCFPJLUPBLD-UHFFFAOYSA-N
131759436;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HVIQWNBZDUXPDM-UHFFFAOYSA-N
131750369;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWMDNFFJJVRJMG-UHFFFAOYSA-N
131753724;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OPTZHODNQOBXMO-UHFFFAOYSA-N
131755985;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NQKRWZVYDJMTOX-UHFFFAOYSA-N
131755327;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UWIJLBUWLZZSBQ-UHFFFAOYSA-N
131763715;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PLKPFFMMSUBFDF-UHFFFAOYSA-N
131759418;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HJRVVCOWJQUKTM-UHFFFAOYSA-N
131759576;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NPWRXJYSKONMPV-UHFFFAOYSA-N
131757852;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;OOHIULWPYUEZRR-UHFFFAOYSA-N
131759664;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AHGKMUVICCTCFM-UHFFFAOYSA-N
131755882;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SKXGGXXHUILISA-UHFFFAOYSA-N
131762283;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LQPSWGXHWSIHNS-UHFFFAOYSA-N
15664102;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JMHHDSQNLZCCLT-UHFFFAOYSA-N
131753807;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KRNGXZWFBACZCQ-UHFFFAOYSA-N
56938694;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HZTVWEWLCFVURZ-UHFFFAOYSA-N
131756117;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FHKXPCWAEDEJKG-UHFFFAOYSA-N
131755473;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LCHZHNOSBDOUOB-UHFFFAOYSA-N
131753795;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKKDPSPGKMHBNY-UHFFFAOYSA-N
131755208;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QVDYDIZGXSWABG-UHFFFAOYSA-N
131759958;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KMXCXZGPKXMYER-UHFFFAOYSA-N
131763946;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WCWOBBHQCJULDM-UHFFFAOYSA-N
131760060;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DVVVWSWPMOHCJM-UHFFFAOYSA-N
131758726;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;IFAFZYRLCMKOIJ-UHFFFAOYSA-N
131760548;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZKCCURQELYISMZ-UHFFFAOYSA-N
131763719;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PVOYOWCTHMOOIC-UHFFFAOYSA-N
131753546;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PEGBVZIRKWFBAT-UHFFFAOYSA-N
131764641;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PVWLIUKXMYHSER-UHFFFAOYSA-N
131757223;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;WFAJQYLYYSZBCZ-UHFFFAOYSA-N
131754862;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CYCUFSFDDJJTHB-UHFFFAOYSA-N
131764212;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DUPNCGTUAKCMPW-UHFFFAOYSA-N
131755977;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QGKVIRKDCRKDQI-UHFFFAOYSA-N
131753279;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ABNSWGKFFQUIAR-UHFFFAOYSA-N
131755942;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TVLMJMFKNWRCGI-UHFFFAOYSA-N
131759624;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NRHVUGOGJJHYKY-UHFFFAOYSA-N
131756744;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ITRVDAWLKSPAKB-UHFFFAOYSA-N
131760205;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UMPQTCRVUAVQQI-UHFFFAOYSA-N
131754027;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ADFSEZIUBMYLQX-UHFFFAOYSA-N
131755338;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SAKURFWWZUPUGR-UHFFFAOYSA-N
131756534;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YPMNDOUIDVDQOW-UHFFFAOYSA-N
9544167;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131760352;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZOSLKYDCFWPCI-UHFFFAOYSA-N
131755956;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NTZYNUIJRPZFCR-UHFFFAOYSA-N
131755399;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXWHOVSUVNCPAU-UHFFFAOYSA-N
131759515;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DFMOOXJLNYMJDV-UHFFFAOYSA-N
131755906;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SCRUPIUQFHRDIJ-UHFFFAOYSA-N
131753981;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RKFWDJFGPBNCBJ-UHFFFAOYSA-N
131758966;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GGESIZJOLUZGHM-UHFFFAOYSA-N
131759874;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NMFGLZJGDVTWFX-UHFFFAOYSA-N
131760046;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XDWSGZHSFJBWFG-UHFFFAOYSA-N
131758994;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQSSPIJIQXOSMQ-UHFFFAOYSA-N
131756492;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HEZIFHPOCSMIRI-UHFFFAOYSA-N
131756518;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SEEXZSJWUOGTDD-UHFFFAOYSA-N
131763551;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XYIQAWXUEATHMZ-UHFFFAOYSA-N
131760480;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OUUHBPIFIILUCA-UHFFFAOYSA-N
131750387;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131763649;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LBOVPAKRIPYJIX-UHFFFAOYSA-N
131760987;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UBNYYWZUYOQPFD-UHFFFAOYSA-N
131759887;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FCEBICVTRXFYLZ-UHFFFAOYSA-N
131760184;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WQAWIGRUXVAAIX-UHFFFAOYSA-N
131753392;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;XOKFJRGPQQOMMF-UHFFFAOYSA-N
131756698;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GYPCYQZGNPPXQY-UHFFFAOYSA-N
131760643;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PFIMEBGCGUJFNB-UHFFFAOYSA-N
131763437;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BVJKPJCDKQJPAW-UHFFFAOYSA-N
131765713;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;MQJUYBMLAXVAFU-UHFFFAOYSA-N
131759579;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HJJGKDWWDQGJME-UHFFFAOYSA-N
131760548;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZKCCURQELYISMZ-UHFFFAOYSA-N
131757255;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YKCVKNPTWXLRMR-UHFFFAOYSA-N
131756548;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JWVUDERNGFMBBB-UHFFFAOYSA-N
131756326;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YIJBKAITYUJKQL-UHFFFAOYSA-N
131762736;LPAR3;6;7.827999999999999e-75;0.5745;11.4173;132.5944;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XPDLXJYQTJBVLY-UHFFFAOYSA-N
131753569;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGUAEFVIYUUGBB-UHFFFAOYSA-N
131758065;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZMOMBZWRGVTTLX-UHFFFAOYSA-N
131763090;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LDVDALBKRWDBPL-UHFFFAOYSA-N
131756164;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WZYMUGLYGUNQDO-UHFFFAOYSA-N
131755731;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KMUBMOMDOAVSGD-UHFFFAOYSA-N
131755000;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;FLALCZKVXJDYDG-UHFFFAOYSA-N
131753777;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZFYKFVATZUURMJ-UHFFFAOYSA-N
131755365;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BMVWCBZVEZTSPY-UHFFFAOYSA-N
131750621;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DWUCTGPOYZTRAA-UHFFFAOYSA-N
131760389;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SCJRWDPPOJUNPY-UHFFFAOYSA-N
131758663;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DIKFHEKYQJZAEV-UHFFFAOYSA-N
131756674;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CWYJHSJCZIYZKB-UHFFFAOYSA-N
131755117;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;GWIFZHMAJCHBBF-UHFFFAOYSA-N
131759304;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGEZSPSFVTXJTF-UHFFFAOYSA-N
131756557;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NDDBFQIGGOFJRX-UHFFFAOYSA-N
131756644;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XNLCSBIDDKARLA-UHFFFAOYSA-N
131764398;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QTTCWZLTKUELKJ-UHFFFAOYSA-N
131754256;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;USVBQBCNNHETJO-UHFFFAOYSA-N
131755017;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CICXNKCKBFXJSH-UHFFFAOYSA-N
131753364;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;VAGKZVNTAZNDGU-UHFFFAOYSA-N
131760980;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATKWSHJQYSCESK-UHFFFAOYSA-N
131759400;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;VLLWHKDCWQXIBL-UHFFFAOYSA-N
131755246;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JDYQORQUIVEAPP-UHFFFAOYSA-N
131753923;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADDMBQHEJRQEPO-UHFFFAOYSA-N
131755063;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;VQWFQOJRISNWCH-UHFFFAOYSA-N
131760655;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;ZEKFRROIYZYMJB-UHFFFAOYSA-N
131755226;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PZLANHYIZMKDPR-UHFFFAOYSA-N
131760369;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SJPXPPDFLZCAGK-UHFFFAOYSA-N
131761054;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LJLIFTYRIMZUNV-UHFFFAOYSA-N
131759197;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JQLUSEPGRGEFIO-UHFFFAOYSA-N
131755196;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JQSCFVCYBPEHML-UHFFFAOYSA-N
131754583;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RTBRCTDGSUJPRS-UHFFFAOYSA-N
131765713;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;MQJUYBMLAXVAFU-UHFFFAOYSA-N
9544531;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LLZPZRGVBKFBKR-UHFFFAOYSA-N
131757255;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YKCVKNPTWXLRMR-UHFFFAOYSA-N
131753369;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BLXQIUODGKBTGK-UHFFFAOYSA-N
131761102;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YTADVVFTTOMNKE-UHFFFAOYSA-N
131759957;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MIAUUKZRJAXLRT-UHFFFAOYSA-N
131765217;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IITVMCHTPSACLP-UHFFFAOYSA-N
131755701;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LLMPANOXXMGKRF-UHFFFAOYSA-N
9544262;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HLTSKBNGPCVUQB-UHFFFAOYSA-N
101453996;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SFSFPCWGADNGHN-UHFFFAOYSA-N
131756644;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XNLCSBIDDKARLA-UHFFFAOYSA-N
101758459;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LDVWBXGIAOXJKP-UHFFFAOYSA-N
131753334;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;WEUNTUVUAWDABH-UHFFFAOYSA-N
131760372;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RZDWVTRPHNHEBJ-UHFFFAOYSA-N
131758856;FABP3;7;6.136e-55;0.5;1.8098;96.8779;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HASCFYSLDYFKJC-UHFFFAOYSA-N
131763490;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;ODALSWIZSGWUHZ-UHFFFAOYSA-N
131753883;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VGXAVCFJDOECRR-UHFFFAOYSA-N
131755588;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UVTYOGUMIJDHCL-UHFFFAOYSA-N
131758649;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FAEIJJBFHNTKST-UHFFFAOYSA-N
131756686;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RHCHGASZNFDFNT-UHFFFAOYSA-N
131753628;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VWLZYYAQPNZEAL-UHFFFAOYSA-N
131760501;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFMFNZAUKDXUBS-UHFFFAOYSA-N
131759929;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;GLBKLCZHEXMDML-UHFFFAOYSA-N
131758823;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHQUEWMLMFUPTL-UHFFFAOYSA-N
131759315;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RKMYDQZHNDAFDU-UHFFFAOYSA-N
131763500;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OLENDCDRWPUUBG-UHFFFAOYSA-N
131762149;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTVCIQXPZYXPQV-UHFFFAOYSA-N
131755806;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;GZBPQMRKEPSOQQ-UHFFFAOYSA-N
131756326;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YIJBKAITYUJKQL-UHFFFAOYSA-N
56936880;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CIHIPEMTHZCHCJ-UHFFFAOYSA-N
131753923;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADDMBQHEJRQEPO-UHFFFAOYSA-N
131755426;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PJZXKSHPRSUFOM-UHFFFAOYSA-N
131755985;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NQKRWZVYDJMTOX-UHFFFAOYSA-N
131758873;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FFFBJYLAWNZQBW-UHFFFAOYSA-N
131753393;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;VCRFEZPIACRCNR-UHFFFAOYSA-N
131753348;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GEYNVUPCUDZJMH-UHFFFAOYSA-N
131759480;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NAKJXCQFDQFGQP-UHFFFAOYSA-N
131754256;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;USVBQBCNNHETJO-UHFFFAOYSA-N
131762260;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AXCNRVAYUVDITR-UHFFFAOYSA-N
131758020;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XHAVMTLJTOZKKY-UHFFFAOYSA-N
131760968;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VTKPPWHYRVIYMV-UHFFFAOYSA-N
131760930;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AAFPBUWBKCMUOC-UHFFFAOYSA-N
131765787;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KRCNTZDQJTVXHX-UHFFFAOYSA-N
131761065;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LSFAIOBGARHDLM-UHFFFAOYSA-N
131756494;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SYGFOSKNZKVBDP-UHFFFAOYSA-N
131759033;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FRHNALHHTGKIGG-UHFFFAOYSA-N
131763300;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YPLTVEAOWNDKFQ-UHFFFAOYSA-N
131758999;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNZNHYGZYKXHHL-UHFFFAOYSA-N
131761212;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;HLXCIVKTQOCSJO-UHFFFAOYSA-N
131761882;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HNCSGYNWTZTAKF-UHFFFAOYSA-N
131753307;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WDOQOSSKIJDAOB-UHFFFAOYSA-N
131755188;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFLOLSWWIHPMFV-UHFFFAOYSA-N
131760506;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SHWUEDFQQXTCJE-UHFFFAOYSA-N
131755371;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VEESJNIKHNLRCH-UHFFFAOYSA-N
131755474;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OZTOROOYEIRFAB-UHFFFAOYSA-N
131759352;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZPJFCNOYMFWVHX-UHFFFAOYSA-N
131757256;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LJWFWKJSUKWNCH-UHFFFAOYSA-N
131755219;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XAMNFTPGEKLFFB-UHFFFAOYSA-N
131759956;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJOJFBLODPQJLX-UHFFFAOYSA-N
131754862;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CYCUFSFDDJJTHB-UHFFFAOYSA-N
56938640;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IHSDKTOLZNRUIJ-UHFFFAOYSA-N
131755392;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DAYIBGRSBOHJLY-UHFFFAOYSA-N
131753952;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KXZVZPPTASOQMG-UHFFFAOYSA-N
131764379;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OACZMCYGLSBUJM-UHFFFAOYSA-N
131753683;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBKTWXVFMTZJMM-UHFFFAOYSA-N
131759479;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UKLOGABOYJJQSN-UHFFFAOYSA-N
131755151;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JULWPANCJCTRDN-UHFFFAOYSA-N
131753749;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;AWANUXSOQBARQI-UHFFFAOYSA-N
131756093;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOOVNYMOCOZYCS-UHFFFAOYSA-N
131753831;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XIEUJHVLPZAHHA-UHFFFAOYSA-N
131765282;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XIIXNUYLGYUCGJ-UHFFFAOYSA-N
131754011;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VTZCRGVLPMDWGI-UHFFFAOYSA-N
131753654;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AYBGGTUWOJKGTF-UHFFFAOYSA-N
131750547;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CXVKBFLPGNGMQW-UHFFFAOYSA-N
131755044;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BHIUUNLDJFUIJS-UHFFFAOYSA-N
131763482;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBRPETNWPCBFTJ-UHFFFAOYSA-N
131765229;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HDEGSNZKEZNQTG-UHFFFAOYSA-N
131755563;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VWRXQZKIYNYMGG-UHFFFAOYSA-N
131750355;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJBGBKUEIBXOEG-UHFFFAOYSA-N
14325549;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IQZHYABKFPLPHG-UHFFFAOYSA-N
131754691;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVOKYELEYWPQHJ-UHFFFAOYSA-N
131760650;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CPINNDOHYCSUGR-UHFFFAOYSA-N
131756458;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;OLZRHDMTTQNXSI-UHFFFAOYSA-N
131763536;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PZDNZVIDHUTVSG-UHFFFAOYSA-N
131758019;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;JCOOWXXKIVGLLZ-UHFFFAOYSA-N
131758994;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQSSPIJIQXOSMQ-UHFFFAOYSA-N
131762035;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HEYPQMCFNJLJQQ-UHFFFAOYSA-N
131759070;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CSTLHGPIWNGXFJ-UHFFFAOYSA-N
131758834;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;TYVUFKFTHSFXIT-UHFFFAOYSA-N
131756534;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YPMNDOUIDVDQOW-UHFFFAOYSA-N
131758642;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;CDJBHUGXUCDURI-UHFFFAOYSA-N
131759827;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JFKSTJCBEDXQKN-UHFFFAOYSA-N
131754605;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WTMANSPIMTYBGE-UHFFFAOYSA-N
131754367;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PGPUQOBIJOUZAP-UHFFFAOYSA-N
9544167;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131763304;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZECUZTZXUJIHD-UHFFFAOYSA-N
131758706;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;ZQMZDXCKJADKAC-UHFFFAOYSA-N
131761127;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNDQJEPSXBZSNW-UHFFFAOYSA-N
131759580;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XUOLMCLGWGLYGT-UHFFFAOYSA-N
131753731;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PDJONFLBKPVTAF-UHFFFAOYSA-N
131759977;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;UORVMJWANGGOMW-UHFFFAOYSA-N
131753604;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XHMARDUNPRBYKM-UHFFFAOYSA-N
131750406;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXIRNQZZDMHWHR-UHFFFAOYSA-N
131765943;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;YYSSONAYWLGUQT-UHFFFAOYSA-N
131759623;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HKADKLQZXQXYER-UHFFFAOYSA-N
131756088;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OKAAPUQYUHINCC-UHFFFAOYSA-N
131758689;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AXFNIIJYCHZARY-UHFFFAOYSA-N
131765471;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LRLNNYOCFSSDOW-UHFFFAOYSA-N
131762736;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XPDLXJYQTJBVLY-UHFFFAOYSA-N
131759801;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JNHLCTFBNVEPGE-UHFFFAOYSA-N
131758827;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WYUKTVBUNYZEPG-UHFFFAOYSA-N
131759928;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QURCKNKEXAUCID-UHFFFAOYSA-N
131760222;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DTSVNYMUJNAOOU-UHFFFAOYSA-N
131756595;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;WJSBURXJPCGRCH-UHFFFAOYSA-N
131756767;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IQHVYGKMAJFIAG-UHFFFAOYSA-N
131755289;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QZSWQEQRBHPEOS-UHFFFAOYSA-N
131753493;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBBJXVATNOPWNT-UHFFFAOYSA-N
131761038;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;TUHYVLFMYBFPEE-UHFFFAOYSA-N
131766070;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OODSECKBPNOQSL-UHFFFAOYSA-N
131756740;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;VRZHAFWZMYJZMD-UHFFFAOYSA-N
131755176;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QNLOBUFLPWUYFF-UHFFFAOYSA-N
131764746;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMLLSDUMFIKCFD-UHFFFAOYSA-N
131755950;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;QWODFTFSLHKZKF-UHFFFAOYSA-N
131757828;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;CAPXDNNJSKSNHK-UHFFFAOYSA-N
131763195;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBKMWLHIRAKLID-UHFFFAOYSA-N
131763715;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PLKPFFMMSUBFDF-UHFFFAOYSA-N
131755029;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WGKBXGXZUVULLG-UHFFFAOYSA-N
131754669;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UJQAYELTSBRSML-UHFFFAOYSA-N
131755045;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QHMIFVZMPUXEAH-UHFFFAOYSA-N
131761059;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WUKREVVPLNPHSK-UHFFFAOYSA-N
131757898;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCC;QOPDMHCKZZFVHH-UHFFFAOYSA-N
131753854;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HYDJVFGMENBDEL-UHFFFAOYSA-N
131755226;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PZLANHYIZMKDPR-UHFFFAOYSA-N
131755524;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STSSOOUAZVGHGT-UHFFFAOYSA-N
131755442;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XOJDXSDPICSSTA-UHFFFAOYSA-N
131755856;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;UUZMFQOOGKVJDO-UHFFFAOYSA-N
131754417;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HJFZDYGJDQBLQJ-UHFFFAOYSA-N
131758685;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;VOLUUICWFQPQGG-UHFFFAOYSA-N
56938589;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FYOAFNBAIZJVFT-UHFFFAOYSA-N
131755579;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NPDNCNMIHPPXLG-UHFFFAOYSA-N
131754197;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ALOIXMAWZZBRNQ-UHFFFAOYSA-N
131762252;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AMRBACSYMREFMZ-UHFFFAOYSA-N
131762166;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XPUHNGSIUVKMSD-UHFFFAOYSA-N
131753821;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFEXMJFDPVATAO-UHFFFAOYSA-N
131763965;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YLJRMSSFHWLPIF-UHFFFAOYSA-N
131759913;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DZYJOMOZYGTRHJ-UHFFFAOYSA-N
131755196;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JQSCFVCYBPEHML-UHFFFAOYSA-N
131760052;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;XLTVJSFXOMIXKW-UHFFFAOYSA-N
131759371;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZTOPVHNXZUMKFI-UHFFFAOYSA-N
131754605;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WTMANSPIMTYBGE-UHFFFAOYSA-N
131760205;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UMPQTCRVUAVQQI-UHFFFAOYSA-N
131758964;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;KTIVGYMIDNMKAU-UHFFFAOYSA-N
131766058;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SQQWFCDATGFENQ-UHFFFAOYSA-N
131765746;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YEIYHQZOMAQZID-UHFFFAOYSA-N
131758726;FABP3;7;2.263e-51;0.5091;1.6905;90.4742;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;IFAFZYRLCMKOIJ-UHFFFAOYSA-N
131759324;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLEMYYGTXQHVFE-UHFFFAOYSA-N
102242320;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OJWXCNKRIMWLSH-UHFFFAOYSA-N
131756656;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NFCQXICLNHGVGZ-UHFFFAOYSA-N
131757257;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DNKJHSCCXVKXSU-UHFFFAOYSA-N
131756117;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FHKXPCWAEDEJKG-UHFFFAOYSA-N
131753837;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LTKZJLJRCVCLBH-UHFFFAOYSA-N
131764664;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZWLJFCNGDYASKC-UHFFFAOYSA-N
131761205;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OHIKEWGTVMTPFC-UHFFFAOYSA-N
131755376;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SVXVJZXYYAEVSC-UHFFFAOYSA-N
131761053;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SHYQNKZJLJXKPA-UHFFFAOYSA-N
131759239;FABP3;7;1.875e-51;0.475;1.6933;90.621;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XNHWYHFYYUALLY-UHFFFAOYSA-N
131755193;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;DSGUAGSLOJNCIC-UHFFFAOYSA-N
131755542;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QUFRRPUAEDKDEW-UHFFFAOYSA-N
131754081;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OHGQZSIZFJHEIP-UHFFFAOYSA-N
131756651;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HLPJZXVCHWKDNK-UHFFFAOYSA-N
131760099;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MUVVSXKCOYPIJY-UHFFFAOYSA-N
131753315;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HJBSNTKEHJKZIB-UHFFFAOYSA-N
131763920;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YDUDDRNPXONNIT-UHFFFAOYSA-N
131761616;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSYRFXMMGSZPLP-UHFFFAOYSA-N
131764746;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMLLSDUMFIKCFD-UHFFFAOYSA-N
131754144;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ODOZWZDIECCVSB-UHFFFAOYSA-N
131756492;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HEZIFHPOCSMIRI-UHFFFAOYSA-N
9544531;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LLZPZRGVBKFBKR-UHFFFAOYSA-N
131755480;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PHUWKNUSDWRCGE-UHFFFAOYSA-N
11007443;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UDQCIYKUZOQISE-UHFFFAOYSA-N
131760060;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DVVVWSWPMOHCJM-UHFFFAOYSA-N
131755700;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XTQUNVXMTVIEJG-UHFFFAOYSA-N
131760644;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SRKCJTCWCCPZMA-UHFFFAOYSA-N
131758966;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GGESIZJOLUZGHM-UHFFFAOYSA-N
131750362;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XCJBYQXUCQJPCZ-UHFFFAOYSA-N
131760093;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YWOLEUFHHASIAX-UHFFFAOYSA-N
131755829;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;HMQDPLNLSJNOFZ-UHFFFAOYSA-N
131755090;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QSQLLDYMTXNRPS-UHFFFAOYSA-N
131760059;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MIZFXTLHUPLNGP-UHFFFAOYSA-N
131765939;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KCXCVMHVAMVXKN-UHFFFAOYSA-N
131754037;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YGLHPJUQMNWNAS-UHFFFAOYSA-N
131755913;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SWUDGTDLMRDUKM-UHFFFAOYSA-N
131761882;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HNCSGYNWTZTAKF-UHFFFAOYSA-N
131761034;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OWYOMQRSVDVHPO-UHFFFAOYSA-N
131753545;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BLFWZVXARGMXGK-UHFFFAOYSA-N
131758808;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;CNRGDEVLIJIREE-UHFFFAOYSA-N
131755197;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSESJUIKHHMUIV-UHFFFAOYSA-N
131756540;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;XYQFDSGKFQESCN-UHFFFAOYSA-N
131764645;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HVCHCPBXTHVCNG-UHFFFAOYSA-N
131754255;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;GNXLOCJIEADZDN-UHFFFAOYSA-N
131755626;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZLPGNDHRJUFQTK-UHFFFAOYSA-N
131759298;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPRQNLZEKMZHBT-UHFFFAOYSA-N
131759440;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CREVCBCOPOOZEP-UHFFFAOYSA-N
131763915;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMSZKZQYJMFYOM-UHFFFAOYSA-N
131763709;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WYRQFRRXDSBWDH-UHFFFAOYSA-N
131755709;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RUVUJZWBOUFWTN-UHFFFAOYSA-N
131756099;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CFIAQJQGPHURGU-UHFFFAOYSA-N
131760626;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PREDIUAQXWFUMA-UHFFFAOYSA-N
131759239;LPAR3;6;1.703e-93;0.5625;14.2872;166.0996;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XNHWYHFYYUALLY-UHFFFAOYSA-N
131756645;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SSQAVJZOEYXKJM-UHFFFAOYSA-N
131759892;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CLRWKONSSADDAS-UHFFFAOYSA-N
131759314;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IJAGVFPXKMAQRV-UHFFFAOYSA-N
131759879;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SSKQGMAHQBYKGA-UHFFFAOYSA-N
131753814;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UOMPQWRFJUXCEB-UHFFFAOYSA-N
131754088;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FVACYRCSAZRBJC-UHFFFAOYSA-N
131755769;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZKAJTUDTPFXDPB-UHFFFAOYSA-N
131754392;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SIDLIHCVDJIGBO-UHFFFAOYSA-N
131761892;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JHBQRHHIBFVBER-UHFFFAOYSA-N
131761094;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MWGRLUDJZRTHTP-UHFFFAOYSA-N
131755155;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;PBFPTUPUIISNJT-UHFFFAOYSA-N
131755017;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CICXNKCKBFXJSH-UHFFFAOYSA-N
131753520;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSDZXQPLCUUMHQ-UHFFFAOYSA-N
131755791;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KQKXUUFGXDXTLP-UHFFFAOYSA-N
131761639;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AMYBBMIDIXFAAQ-UHFFFAOYSA-N
131762142;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CTGSVLMVNLDPLN-UHFFFAOYSA-N
131753753;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PBZUQKBKTBJPQG-UHFFFAOYSA-N
101146157;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131755556;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;PDFFYHNLAKMFAW-UHFFFAOYSA-N
131755150;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GLPSWGYMFAIAQL-UHFFFAOYSA-N
131755702;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;SXBWOXCOXHTAAM-UHFFFAOYSA-N
131755171;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBTULCCTZFQLPM-UHFFFAOYSA-N
131754808;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KEFNWJKPJBZOJN-UHFFFAOYSA-N
131755807;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;PMGLNPPJDNWBFI-UHFFFAOYSA-N
131755632;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHBKQHGKLWWKQN-UHFFFAOYSA-N
131754634;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NCHFLBDZSDCXDQ-UHFFFAOYSA-N
131754528;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUDWGAJJZFZCER-UHFFFAOYSA-N
131755039;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JCVFZHFBLDWEFA-UHFFFAOYSA-N
131755295;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CKPZBSPXVJHCRO-UHFFFAOYSA-N
131764125;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PARVDVGUFPHHJQ-UHFFFAOYSA-N
131763819;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GHZUZGDZYLIXSI-UHFFFAOYSA-N
131765751;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OEMFAWUKBJFEBP-UHFFFAOYSA-N
131754037;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YGLHPJUQMNWNAS-UHFFFAOYSA-N
131758649;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FAEIJJBFHNTKST-UHFFFAOYSA-N
131750621;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DWUCTGPOYZTRAA-UHFFFAOYSA-N
131764718;LPAR3;6;3.934e-67;0.5294;10.233;118.7683;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LCAJDMGZZMLHNH-UHFFFAOYSA-N
131756511;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;ASJDYPQIFWQJPP-UHFFFAOYSA-N
131764645;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HVCHCPBXTHVCNG-UHFFFAOYSA-N
131760943;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QIWDVFCGYRFMCC-UHFFFAOYSA-N
131757922;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KWWVXMLEUYDGGY-UHFFFAOYSA-N
131756658;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;GWNUSEKGRALKED-UHFFFAOYSA-N
131754081;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OHGQZSIZFJHEIP-UHFFFAOYSA-N
131755889;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RWXPDMYGJSOHGX-UHFFFAOYSA-N
131754433;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IHOAMWFZSKNMBJ-UHFFFAOYSA-N
101453996;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SFSFPCWGADNGHN-UHFFFAOYSA-N
131756679;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OCSXULFZMSSXID-UHFFFAOYSA-N
131756485;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;BWOHNVUJJCXFQP-UHFFFAOYSA-N
131759703;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MORKMZKGDIIIBY-UHFFFAOYSA-N
131756002;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GFGMXYASPNDDEJ-UHFFFAOYSA-N
131762260;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AXCNRVAYUVDITR-UHFFFAOYSA-N
131753802;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HSISMYYRVVPXKG-UHFFFAOYSA-N
131755707;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QYHOZSHVNKWJLV-UHFFFAOYSA-N
131756678;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BXZBVJMLHIMPCY-UHFFFAOYSA-N
131763104;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YJZARZPHBIAWSP-UHFFFAOYSA-N
131756190;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;STRGYEHUWWQWTA-UHFFFAOYSA-N
131759351;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;SAZDDXQYEIJVSC-UHFFFAOYSA-N
131756722;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPLCSZBQAQAYRD-UHFFFAOYSA-N
131759834;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PVBOVZWBGFRMPX-UHFFFAOYSA-N
131759440;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CREVCBCOPOOZEP-UHFFFAOYSA-N
131750362;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XCJBYQXUCQJPCZ-UHFFFAOYSA-N
131760484;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PEJYXBAMEZPBAX-UHFFFAOYSA-N
131755709;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RUVUJZWBOUFWTN-UHFFFAOYSA-N
131755588;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UVTYOGUMIJDHCL-UHFFFAOYSA-N
131760352;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZOSLKYDCFWPCI-UHFFFAOYSA-N
131756099;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CFIAQJQGPHURGU-UHFFFAOYSA-N
131754392;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SIDLIHCVDJIGBO-UHFFFAOYSA-N
131755188;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFLOLSWWIHPMFV-UHFFFAOYSA-N
131759443;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORNQRRXFGCNXPC-UHFFFAOYSA-N
131757365;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NQZWUGZPCSPJEX-UHFFFAOYSA-N
131763483;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PARQILSYFLMAIN-UHFFFAOYSA-N
131759607;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VBUYAWOUEDDBBW-UHFFFAOYSA-N
131759343;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XYIGSYIGMXHUQI-UHFFFAOYSA-N
131756342;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OSCPURITXSWNQF-UHFFFAOYSA-N
131755361;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XSSYPDIVPNHTQU-UHFFFAOYSA-N
131759479;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UKLOGABOYJJQSN-UHFFFAOYSA-N
131756131;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OSNTYLCOCUHBGM-UHFFFAOYSA-N
99649123;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YFFIQXNTTVSKJC-UHFFFAOYSA-N
56938682;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ODHWPZFGXIMZRL-UHFFFAOYSA-N
131760777;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SNSCEPRATRYHSL-UHFFFAOYSA-N
131755022;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FAWROKQWRPDLOA-UHFFFAOYSA-N
131762252;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AMRBACSYMREFMZ-UHFFFAOYSA-N
131765229;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HDEGSNZKEZNQTG-UHFFFAOYSA-N
131754668;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCXAOTNONHNUHF-UHFFFAOYSA-N
131756243;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWNCWDLVLHBCRO-UHFFFAOYSA-N
131753604;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XHMARDUNPRBYKM-UHFFFAOYSA-N
131758697;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LSLCAMBCQCOKNH-UHFFFAOYSA-N
131763336;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LSBYOEWZVKAXQD-UHFFFAOYSA-N
131758873;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FFFBJYLAWNZQBW-UHFFFAOYSA-N
131756912;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RIYWVWTTXYWHMA-UHFFFAOYSA-N
131759717;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KFAZITXLGUDPHA-UHFFFAOYSA-N
131759928;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QURCKNKEXAUCID-UHFFFAOYSA-N
131755208;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QVDYDIZGXSWABG-UHFFFAOYSA-N
131755183;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;NPZXCVFGWXHFFP-UHFFFAOYSA-N
131758829;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BCMHHAAVHIRHKO-UHFFFAOYSA-N
131765787;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KRCNTZDQJTVXHX-UHFFFAOYSA-N
131755925;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;LHXURPBLCDMSQT-UHFFFAOYSA-N
131758982;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZQQGMCWVFPHUPJ-UHFFFAOYSA-N
131755350;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OLDVVLPHLVANLD-UHFFFAOYSA-N
131762150;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DOZPBKCIXFDCBR-UHFFFAOYSA-N
131753586;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LDSWEOUGZDGWFT-UHFFFAOYSA-N
131766100;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;VXMBUOMIVSCLTQ-UHFFFAOYSA-N
131756061;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SHPCUQLAGQRBSR-UHFFFAOYSA-N
131761899;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KBDOPVRVUZKPQY-UHFFFAOYSA-N
131756190;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;STRGYEHUWWQWTA-UHFFFAOYSA-N
131759480;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NAKJXCQFDQFGQP-UHFFFAOYSA-N
131756722;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPLCSZBQAQAYRD-UHFFFAOYSA-N
131754548;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYEQRCSOCOOKBP-UHFFFAOYSA-N
131753334;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;WEUNTUVUAWDABH-UHFFFAOYSA-N
131764379;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OACZMCYGLSBUJM-UHFFFAOYSA-N
131753479;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NZEDZJHGVGEWRO-UHFFFAOYSA-N
131758089;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SEPILWBSQJWVGW-UHFFFAOYSA-N
131756937;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZTJPQTLPMOYUAV-UHFFFAOYSA-N
131762159;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QHWWDKOXAJWHAQ-UHFFFAOYSA-N
131756088;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OKAAPUQYUHINCC-UHFFFAOYSA-N
131753982;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GBJTZFHEXHJBKU-UHFFFAOYSA-N
131750340;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;AOSKWYIWKDMXST-UHFFFAOYSA-N
131766208;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;HLRCCNBXHAZKEY-UHFFFAOYSA-N
131763115;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPBJHRGEWAYSDO-UHFFFAOYSA-N
131755943;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XZEHHPQAMMWALZ-UHFFFAOYSA-N
131757079;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UMZQUOZZVLDATH-UHFFFAOYSA-N
131755349;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JJNQBKOWLBHGAW-UHFFFAOYSA-N
131761094;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MWGRLUDJZRTHTP-UHFFFAOYSA-N
131755262;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LOEVQQYBQLFELJ-UHFFFAOYSA-N
131756460;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;YEMQFZGWRFYGJM-UHFFFAOYSA-N
131763927;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;FTPNNFMDJNYTOR-UHFFFAOYSA-N
131753901;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OXALJAMNRIYLJO-UHFFFAOYSA-N
131753931;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XDAZZLONPIHPNZ-UHFFFAOYSA-N
131759602;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GARPFACGXFDLSO-UHFFFAOYSA-N
131755288;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RJHUVVVYTCGXGM-UHFFFAOYSA-N
131755777;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YCBZYOWJNQIJSW-UHFFFAOYSA-N
131757223;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;WFAJQYLYYSZBCZ-UHFFFAOYSA-N
131755209;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWSYMQKEXATFKF-UHFFFAOYSA-N
131753547;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YJIQPDYUKSNQSN-UHFFFAOYSA-N
131760492;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PCTKCCIZPRJCIQ-UHFFFAOYSA-N
131755044;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BHIUUNLDJFUIJS-UHFFFAOYSA-N
131757382;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CQGCPQNAYLDVOH-UHFFFAOYSA-N
131755917;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IDMJDWJMYCKJQJ-UHFFFAOYSA-N
131754691;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVOKYELEYWPQHJ-UHFFFAOYSA-N
131759245;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NWUHDVPEYQTVME-UHFFFAOYSA-N
56939612;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CDDMLDFHOOIDDR-UHFFFAOYSA-N
131759592;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YSXJWNGVILWQDX-UHFFFAOYSA-N
131754955;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;DVRLSVCQXWGXCP-UHFFFAOYSA-N
131754049;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZYWNYYJHZYDVCC-UHFFFAOYSA-N
131756304;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NYFNHSSPUMHKRM-UHFFFAOYSA-N
131756679;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OCSXULFZMSSXID-UHFFFAOYSA-N
131754488;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VSGBEUWASJCUJL-UHFFFAOYSA-N
131757208;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;NZPQRJJPGATRLU-UHFFFAOYSA-N
131759640;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VKYKIUHFHBYWIQ-UHFFFAOYSA-N
131757247;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;ZSRZPVOHGXEPMJ-UHFFFAOYSA-N
131760120;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LMFJKPBELSZHCE-UHFFFAOYSA-N
131755268;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBCKVROCLDZVDL-UHFFFAOYSA-N
131763719;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PVOYOWCTHMOOIC-UHFFFAOYSA-N
131755502;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KOKPTHNRUIPNHU-UHFFFAOYSA-N
131759665;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FLBFFPPBNOZWBA-UHFFFAOYSA-N
131756563;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FEWUEBYAXQMTPT-UHFFFAOYSA-N
131764125;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PARVDVGUFPHHJQ-UHFFFAOYSA-N
131753766;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXPNAJYOBOKITK-UHFFFAOYSA-N
131756486;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PYZPMTALAXHGCB-UHFFFAOYSA-N
131753742;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DCAWTWWNADPCKX-UHFFFAOYSA-N
131753599;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GKCAFLCQQIADCE-UHFFFAOYSA-N
131761065;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LSFAIOBGARHDLM-UHFFFAOYSA-N
131750415;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;YONCDTJKIZDSKQ-UHFFFAOYSA-N
131754197;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ALOIXMAWZZBRNQ-UHFFFAOYSA-N
131755010;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JKYPCWURBUPJMX-UHFFFAOYSA-N
131755918;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTAXARKBUGEENK-UHFFFAOYSA-N
101337649;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DZXZWZCELPDEAY-UHFFFAOYSA-N
131756863;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KUWZMMMTHHIVEK-UHFFFAOYSA-N
131756111;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JIYHMQDXQDVDIQ-UHFFFAOYSA-N
131759191;LPAR3;6;4.9180000000000004e-64;0.551;9.7567;113.2083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;URNTVXPNKOGORD-UHFFFAOYSA-N
131756937;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZTJPQTLPMOYUAV-UHFFFAOYSA-N
131753546;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PEGBVZIRKWFBAT-UHFFFAOYSA-N
131759422;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YLSQMGKHEUFXMJ-UHFFFAOYSA-N
131764734;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTHJFQWGYLCNCP-UHFFFAOYSA-N
131764475;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LJQQNDOWXYVVGF-UHFFFAOYSA-N
56938624;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QEYIHHBEALJAPR-UHFFFAOYSA-N
131763220;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YLZZIBPODWNHEY-UHFFFAOYSA-N
131753362;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HOPNBDYQIPEPJT-UHFFFAOYSA-N
131765746;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YEIYHQZOMAQZID-UHFFFAOYSA-N
131759047;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QAKLYWYMXOZHCJ-UHFFFAOYSA-N
131753363;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGVRIPFAUKNKTG-UHFFFAOYSA-N
131759724;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZAIUAHMIZJWRPI-UHFFFAOYSA-N
131759951;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DNMGYNOZYHVTMB-UHFFFAOYSA-N
131762159;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QHWWDKOXAJWHAQ-UHFFFAOYSA-N
131750547;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CXVKBFLPGNGMQW-UHFFFAOYSA-N
131755502;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KOKPTHNRUIPNHU-UHFFFAOYSA-N
131759734;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ITVZPSFYQXIRPA-UHFFFAOYSA-N
131760582;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GOMDFFGKASVPBQ-UHFFFAOYSA-N
131756304;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NYFNHSSPUMHKRM-UHFFFAOYSA-N
131753627;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OPXVSFLGAKIILH-UHFFFAOYSA-N
131763410;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CKOPDYBJSZTSFP-UHFFFAOYSA-N
131758867;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZITWCTCGAATZHT-UHFFFAOYSA-N
131763721;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VQRIKACZDQJACM-UHFFFAOYSA-N
131756499;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;OAWZXYQFSSUDQG-UHFFFAOYSA-N
131750410;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QXMHHXQBBKDSSL-UHFFFAOYSA-N
131755151;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JULWPANCJCTRDN-UHFFFAOYSA-N
131753959;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHMBATLVCVBMAU-UHFFFAOYSA-N
14029830;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JSSROPRCXOAGCW-UHFFFAOYSA-N
131755881;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;CLQGNDGHULBBGK-UHFFFAOYSA-N
131757405;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMVEGQXRXTDQX-UHFFFAOYSA-N
131754144;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ODOZWZDIECCVSB-UHFFFAOYSA-N
131753336;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZXXNIIBQUJJGT-UHFFFAOYSA-N
131759848;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RXPNRICKBTZRQQ-UHFFFAOYSA-N
131755775;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;JKGVPFAPBARTLP-UHFFFAOYSA-N
131764941;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PYDVXTYEQUTPLD-UHFFFAOYSA-N
25240374;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131764739;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZSUORVUZOXBKRZ-UHFFFAOYSA-N
131756393;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HQMVQKBESXYEOV-UHFFFAOYSA-N
131764729;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UJBVBTXTIWQXQY-UHFFFAOYSA-N
131763483;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PARQILSYFLMAIN-UHFFFAOYSA-N
131756540;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;XYQFDSGKFQESCN-UHFFFAOYSA-N
131753364;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;VAGKZVNTAZNDGU-UHFFFAOYSA-N
131760031;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ISZIDYGJUZQXDR-UHFFFAOYSA-N
131759913;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DZYJOMOZYGTRHJ-UHFFFAOYSA-N
131755338;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SAKURFWWZUPUGR-UHFFFAOYSA-N
131759868;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;OEZUXFLSEGCWIE-UHFFFAOYSA-N
131753893;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PZGMSWKRVOYKSW-UHFFFAOYSA-N
131760655;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;ZEKFRROIYZYMJB-UHFFFAOYSA-N
56939612;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CDDMLDFHOOIDDR-UHFFFAOYSA-N
131758801;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GBTKABUIAQMAPV-UHFFFAOYSA-N
131764328;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CWLXAXNJGBVGCW-UHFFFAOYSA-N
131756698;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GYPCYQZGNPPXQY-UHFFFAOYSA-N
56940294;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXWMIUIQFYBSNA-UHFFFAOYSA-N
131754548;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYEQRCSOCOOKBP-UHFFFAOYSA-N
131759893;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NXOBVWVEMROHRA-UHFFFAOYSA-N
131755552;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AWKZRMLSPPFBRT-UHFFFAOYSA-N
131758707;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;UDBFLEBTRNBEBZ-UHFFFAOYSA-N
131756472;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WNIDTLACSIPEOD-UHFFFAOYSA-N
131755261;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AODXXMPHCMURJU-UHFFFAOYSA-N
131755051;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MEUNMCWGMQZVER-UHFFFAOYSA-N
131753713;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKYCZRRSXYVTLB-UHFFFAOYSA-N
131760042;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ITWXUAWJAMUWRI-UHFFFAOYSA-N
131756299;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;APUGAHTVBGXVKV-UHFFFAOYSA-N
131757851;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;UVYBPHXSHXEHQX-UHFFFAOYSA-N
131755090;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QSQLLDYMTXNRPS-UHFFFAOYSA-N
131756652;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HWPRTUFRMUOZLY-UHFFFAOYSA-N
131754939;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OHNOJBCXHSIKCO-UHFFFAOYSA-N
131755404;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KHJFBIFHBBUBGL-UHFFFAOYSA-N
13183956;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RBLADLVPSYELCA-UHFFFAOYSA-N
131755907;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTNNVFMIFYLBOY-UHFFFAOYSA-N
131759298;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPRQNLZEKMZHBT-UHFFFAOYSA-N
131757257;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DNKJHSCCXVKXSU-UHFFFAOYSA-N
131755531;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QMOIIDCAFLCLKL-UHFFFAOYSA-N
131759939;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QFNUIDSUZKRNIE-UHFFFAOYSA-N
131755150;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GLPSWGYMFAIAQL-UHFFFAOYSA-N
131760079;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DTTIGIZBXFQWNL-UHFFFAOYSA-N
131753813;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLNIBJNSVRHQPM-UHFFFAOYSA-N
131759943;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AIJGPUXXVZKCOC-UHFFFAOYSA-N
131759868;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;OEZUXFLSEGCWIE-UHFFFAOYSA-N
131753698;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NQDCMWMLFSAQCX-UHFFFAOYSA-N
131755984;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GTGOXBMVMINSSB-UHFFFAOYSA-N
131755731;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KMUBMOMDOAVSGD-UHFFFAOYSA-N
131756465;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LLAVCIGKJBNPIR-UHFFFAOYSA-N
131759494;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HRCLBQUOANENCJ-UHFFFAOYSA-N
131755626;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZLPGNDHRJUFQTK-UHFFFAOYSA-N
131764725;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QETHLCLILQLBJN-UHFFFAOYSA-N
131755925;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;LHXURPBLCDMSQT-UHFFFAOYSA-N
131761102;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YTADVVFTTOMNKE-UHFFFAOYSA-N
131761758;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;WJLTVCYAAPDLHN-UHFFFAOYSA-N
56936880;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CIHIPEMTHZCHCJ-UHFFFAOYSA-N
131755322;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MTMTXYXQGBCYCD-UHFFFAOYSA-N
131750368;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OCYFAHIHWCVZKS-UHFFFAOYSA-N
131755065;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KVLYQVRJXYJGRU-UHFFFAOYSA-N
131755684;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZUMTISSRAZIGC-UHFFFAOYSA-N
131759892;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CLRWKONSSADDAS-UHFFFAOYSA-N
131755807;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;PMGLNPPJDNWBFI-UHFFFAOYSA-N
131760541;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WICODSUDRZUJKB-UHFFFAOYSA-N
131763914;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ANTOAERGFNUGHV-UHFFFAOYSA-N
131753552;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LBUUFNMBIYFPRT-UHFFFAOYSA-N
131763406;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OJYRZPXGOAVFNV-UHFFFAOYSA-N
131763614;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GTLNJAOUKJAZIU-UHFFFAOYSA-N
131755447;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BHUGVTHDSSXVAN-UHFFFAOYSA-N
131755202;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WNGNQJVTTOEUDY-UHFFFAOYSA-N
131755737;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;ZSFGHQACWUKLCX-UHFFFAOYSA-N
131759162;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PRBBZGQORJEBML-UHFFFAOYSA-N
131758698;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HIHQJJVDWLEWFD-UHFFFAOYSA-N
131753719;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IONCGPWOGZERQG-UHFFFAOYSA-N
131755175;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MLRYMYSXHCUZDL-UHFFFAOYSA-N
131759774;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BUIOKWYGCCSIHR-UHFFFAOYSA-N
131754473;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BVUKOOZQIGAWRK-UHFFFAOYSA-N
131756674;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CWYJHSJCZIYZKB-UHFFFAOYSA-N
131758020;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XHAVMTLJTOZKKY-UHFFFAOYSA-N
131760383;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLBDBVTYZICFPC-UHFFFAOYSA-N
131754256;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;USVBQBCNNHETJO-UHFFFAOYSA-N
131756679;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OCSXULFZMSSXID-UHFFFAOYSA-N
131756678;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BXZBVJMLHIMPCY-UHFFFAOYSA-N
131764125;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PARVDVGUFPHHJQ-UHFFFAOYSA-N
131758873;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FFFBJYLAWNZQBW-UHFFFAOYSA-N
131754556;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZURRHBGBXGLPHI-UHFFFAOYSA-N
131750355;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJBGBKUEIBXOEG-UHFFFAOYSA-N
131753391;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HPJWNEPHGPSMML-UHFFFAOYSA-N
131757079;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UMZQUOZZVLDATH-UHFFFAOYSA-N
131753393;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;VCRFEZPIACRCNR-UHFFFAOYSA-N
131753392;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;XOKFJRGPQQOMMF-UHFFFAOYSA-N
131754412;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKFBAJJRYUESID-UHFFFAOYSA-N
131759643;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTGPQOIWPOHYSI-UHFFFAOYSA-N
131753398;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LWNAPQADTXCNTE-UHFFFAOYSA-N
131756533;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZAQSWHTVZWGPPD-UHFFFAOYSA-N
131760662;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VEOVLFBKKMGGBT-UHFFFAOYSA-N
131755117;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;GWIFZHMAJCHBBF-UHFFFAOYSA-N
131754418;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QFFKKKUOMXZADH-UHFFFAOYSA-N
131758707;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;UDBFLEBTRNBEBZ-UHFFFAOYSA-N
131758706;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;ZQMZDXCKJADKAC-UHFFFAOYSA-N
131758703;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;YIPJUHYAYCZWRJ-UHFFFAOYSA-N
131766110;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HEIAOQGWRROSQN-UHFFFAOYSA-N
131753553;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JKPSHAYASLXJTD-UHFFFAOYSA-N
131753552;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LBUUFNMBIYFPRT-UHFFFAOYSA-N
131753959;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHMBATLVCVBMAU-UHFFFAOYSA-N
131753958;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AQOIZNNITCNBQE-UHFFFAOYSA-N
131759315;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RKMYDQZHNDAFDU-UHFFFAOYSA-N
131759314;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IJAGVFPXKMAQRV-UHFFFAOYSA-N
131753952;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KXZVZPPTASOQMG-UHFFFAOYSA-N
131759319;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WXMJAPVKXZKBEF-UHFFFAOYSA-N
131759318;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WACLWOAQCVZQHO-UHFFFAOYSA-N
131753957;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SPKQDEVVANGEJY-UHFFFAOYSA-N
131760643;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PFIMEBGCGUJFNB-UHFFFAOYSA-N
9544227;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MSQBYCWSXAUJHK-UHFFFAOYSA-N
56936651;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IUDLXSDWDIHVDD-UHFFFAOYSA-N
131764395;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WZOAXQSXOUDVTF-UHFFFAOYSA-N
131760205;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UMPQTCRVUAVQQI-UHFFFAOYSA-N
131755377;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBAXOOZVZZDVJC-UHFFFAOYSA-N
131755376;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SVXVJZXYYAEVSC-UHFFFAOYSA-N
131755371;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VEESJNIKHNLRCH-UHFFFAOYSA-N
131755370;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PRBCKTCEVWJEPN-UHFFFAOYSA-N
131756937;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZTJPQTLPMOYUAV-UHFFFAOYSA-N
131760204;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUWDYQPFUONYLK-UHFFFAOYSA-N
131755070;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;DLHLOJATURJKGG-UHFFFAOYSA-N
131753334;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;WEUNTUVUAWDABH-UHFFFAOYSA-N
131757922;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KWWVXMLEUYDGGY-UHFFFAOYSA-N
131759868;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;OEZUXFLSEGCWIE-UHFFFAOYSA-N
131757255;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YKCVKNPTWXLRMR-UHFFFAOYSA-N
131757256;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LJWFWKJSUKWNCH-UHFFFAOYSA-N
131757257;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DNKJHSCCXVKXSU-UHFFFAOYSA-N
56938694;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HZTVWEWLCFVURZ-UHFFFAOYSA-N
131753719;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IONCGPWOGZERQG-UHFFFAOYSA-N
131754481;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UPJQJJOQKCRAID-UHFFFAOYSA-N
131763114;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIPISOXQGTUPKE-UHFFFAOYSA-N
131763115;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPBJHRGEWAYSDO-UHFFFAOYSA-N
131754955;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;DVRLSVCQXWGXCP-UHFFFAOYSA-N
131754488;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VSGBEUWASJCUJL-UHFFFAOYSA-N
101453996;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SFSFPCWGADNGHN-UHFFFAOYSA-N
131763500;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OLENDCDRWPUUBG-UHFFFAOYSA-N
131753306;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;BXFHKVOMHBKGBJ-UHFFFAOYSA-N
131753307;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WDOQOSSKIJDAOB-UHFFFAOYSA-N
131754669;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UJQAYELTSBRSML-UHFFFAOYSA-N
131753749;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;AWANUXSOQBARQI-UHFFFAOYSA-N
131756524;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;UJUOOWYFRZLMGP-UHFFFAOYSA-N
131760560;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XWWHTVUODKLIIT-UHFFFAOYSA-N
131755777;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YCBZYOWJNQIJSW-UHFFFAOYSA-N
131759246;LPAR3;7;1.2699999999999999e-60;0.5294;4.2992;107.0826;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LWCKIESQXRPOHD-UHFFFAOYSA-N
131760565;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PUKJHNUKDAALMG-UHFFFAOYSA-N
131753731;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PDJONFLBKPVTAF-UHFFFAOYSA-N
131755609;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZDQSYJNEPMDFCF-UHFFFAOYSA-N
131753821;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFEXMJFDPVATAO-UHFFFAOYSA-N
131759576;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NPWRXJYSKONMPV-UHFFFAOYSA-N
131755201;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WZPQAQGIOSQQKF-UHFFFAOYSA-N
101337649;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DZXZWZCELPDEAY-UHFFFAOYSA-N
131755971;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;BRLGHZXETDWABO-UHFFFAOYSA-N
131755202;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;WNGNQJVTTOEUDY-UHFFFAOYSA-N
131755977;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QGKVIRKDCRKDQI-UHFFFAOYSA-N
131760099;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MUVVSXKCOYPIJY-UHFFFAOYSA-N
131765274;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;LWKWJKUKDKCQJT-UHFFFAOYSA-N
131755209;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWSYMQKEXATFKF-UHFFFAOYSA-N
131757853;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;JAMTWOKYIOCODD-UHFFFAOYSA-N
131755978;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OCUVIQQPCBIFRP-UHFFFAOYSA-N
131760093;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YWOLEUFHHASIAX-UHFFFAOYSA-N
131765471;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LRLNNYOCFSSDOW-UHFFFAOYSA-N
131753713;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKYCZRRSXYVTLB-UHFFFAOYSA-N
131764710;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZYRKKZMTAMUMHI-UHFFFAOYSA-N
131755906;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SCRUPIUQFHRDIJ-UHFFFAOYSA-N
131757223;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;WFAJQYLYYSZBCZ-UHFFFAOYSA-N
131757222;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;LKMMURDMXJRDKU-UHFFFAOYSA-N
131759579;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HJJGKDWWDQGJME-UHFFFAOYSA-N
131764719;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FWBFYCRYECSRNA-UHFFFAOYSA-N
131764718;LPAR3;7;1.856e-51;0.5294;3.6415;90.6289;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LCAJDMGZZMLHNH-UHFFFAOYSA-N
131754417;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;HJFZDYGJDQBLQJ-UHFFFAOYSA-N
131755856;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;UUZMFQOOGKVJDO-UHFFFAOYSA-N
131755737;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;ZSFGHQACWUKLCX-UHFFFAOYSA-N
131756486;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PYZPMTALAXHGCB-UHFFFAOYSA-N
131756912;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RIYWVWTTXYWHMA-UHFFFAOYSA-N
131762150;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DOZPBKCIXFDCBR-UHFFFAOYSA-N
131759047;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QAKLYWYMXOZHCJ-UHFFFAOYSA-N
131756132;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OKJDYZDDQFURDR-UHFFFAOYSA-N
131759162;LPAR3;7;1.0359999999999999e-51;0.5094;3.6597;91.0836;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PRBBZGQORJEBML-UHFFFAOYSA-N
131763184;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;SFCNWLSIOSCRMM-UHFFFAOYSA-N
131756088;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OKAAPUQYUHINCC-UHFFFAOYSA-N
131756089;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AAXMCYUUKFLUMJ-UHFFFAOYSA-N
131758960;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YIKPYYUODQLYRB-UHFFFAOYSA-N
131758966;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GGESIZJOLUZGHM-UHFFFAOYSA-N
131758964;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;KTIVGYMIDNMKAU-UHFFFAOYSA-N
131758801;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GBTKABUIAQMAPV-UHFFFAOYSA-N
131755724;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;CQDCLPYZVBWAGY-UHFFFAOYSA-N
131753604;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XHMARDUNPRBYKM-UHFFFAOYSA-N
131753603;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JSFLWCDRHPDCLD-UHFFFAOYSA-N
131766058;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SQQWFCDATGFENQ-UHFFFAOYSA-N
131756318;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZSJMIBWBNKODT-UHFFFAOYSA-N
131761102;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YTADVVFTTOMNKE-UHFFFAOYSA-N
131758808;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;CNRGDEVLIJIREE-UHFFFAOYSA-N
131761060;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SDKRXCCKVQOCAO-UHFFFAOYSA-N
131754634;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NCHFLBDZSDCXDQ-UHFFFAOYSA-N
131761066;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FNZXUUOILKQHJU-UHFFFAOYSA-N
131765751;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OEMFAWUKBJFEBP-UHFFFAOYSA-N
131760953;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XLXYAEOUXAFXKB-UHFFFAOYSA-N
131755480;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PHUWKNUSDWRCGE-UHFFFAOYSA-N
131764379;LPAR3;7;2.387e-44;0.5745;3.1314;77.8656;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;OACZMCYGLSBUJM-UHFFFAOYSA-N
131755404;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KHJFBIFHBBUBGL-UHFFFAOYSA-N
131762159;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QHWWDKOXAJWHAQ-UHFFFAOYSA-N
131760666;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MSQGSTKKOSEGDB-UHFFFAOYSA-N
131760389;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SCJRWDPPOJUNPY-UHFFFAOYSA-N
131753349;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QVTBPCIHCQQWGM-UHFFFAOYSA-N
131755295;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CKPZBSPXVJHCRO-UHFFFAOYSA-N
131756534;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;YPMNDOUIDVDQOW-UHFFFAOYSA-N
131756535;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;KAKUNEKXMAHXNF-UHFFFAOYSA-N
131754221;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSUWZDOHFVTWQP-UHFFFAOYSA-N
131754222;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IMBBOIUUCCVERC-UHFFFAOYSA-N
131760525;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;AGEPNYPMOSCATG-UHFFFAOYSA-N
131754228;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HGQVGVFOEAHXRO-UHFFFAOYSA-N
131758698;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HIHQJJVDWLEWFD-UHFFFAOYSA-N
14325549;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IQZHYABKFPLPHG-UHFFFAOYSA-N
131754759;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZOBZWCYJZUYEQA-UHFFFAOYSA-N
131760186;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GLMVCLWSBJJWTR-UHFFFAOYSA-N
131756686;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RHCHGASZNFDFNT-UHFFFAOYSA-N
131760184;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WQAWIGRUXVAAIX-UHFFFAOYSA-N
131760185;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UKJDYVVYSNHIJH-UHFFFAOYSA-N
131754751;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFTLYHXOQWFSCO-UHFFFAOYSA-N
131756687;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;IZLQMMZWIGPZNX-UHFFFAOYSA-N
131760626;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PREDIUAQXWFUMA-UHFFFAOYSA-N
131755155;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;PBFPTUPUIISNJT-UHFFFAOYSA-N
131758669;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;AUEYCFPJLUPBLD-UHFFFAOYSA-N
131755658;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VVTVYFURJIUZNX-UHFFFAOYSA-N
131755151;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JULWPANCJCTRDN-UHFFFAOYSA-N
131755150;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GLPSWGYMFAIAQL-UHFFFAOYSA-N
131755709;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RUVUJZWBOUFWTN-UHFFFAOYSA-N
131759448;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KDCKRLAPPIAVIP-UHFFFAOYSA-N
131753513;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GJHGQWDONIZQBR-UHFFFAOYSA-N
131753887;LPAR3;7;4.33e-51;0.5294;3.6152;89.9685;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AXWUDJVLHVBXKA-UHFFFAOYSA-N
131758663;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DIKFHEKYQJZAEV-UHFFFAOYSA-N
131758664;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QMOZRBHWRVHQOJ-UHFFFAOYSA-N
131759442;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XTSQWTDQTZVALB-UHFFFAOYSA-N
131756035;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YXNAYHGGFGKLHS-UHFFFAOYSA-N
131759440;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CREVCBCOPOOZEP-UHFFFAOYSA-N
131753691;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MAFFVOBYYPRXHD-UHFFFAOYSA-N
131753698;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NQDCMWMLFSAQCX-UHFFFAOYSA-N
131753861;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GZIFFSTVTIRNHB-UHFFFAOYSA-N
131754093;LPAR3;7;3.4470000000000003e-46;0.4815;3.2634;81.1698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;TZXMSONPXDUMEW-UHFFFAOYSA-N
131756744;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ITRVDAWLKSPAKB-UHFFFAOYSA-N
131756740;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;VRZHAFWZMYJZMD-UHFFFAOYSA-N
131754094;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZAMYFQHKFGFWHM-UHFFFAOYSA-N
131763490;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;ODALSWIZSGWUHZ-UHFFFAOYSA-N
131761204;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XAHFVLNVNUAPSO-UHFFFAOYSA-N
131761205;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;OHIKEWGTVMTPFC-UHFFFAOYSA-N
131753999;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RLKDRDNYMSMXGL-UHFFFAOYSA-N
131754255;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;GNXLOCJIEADZDN-UHFFFAOYSA-N
131755038;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CZMAJLBPYUFDNA-UHFFFAOYSA-N
131755039;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;JCVFZHFBLDWEFA-UHFFFAOYSA-N
56938640;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;IHSDKTOLZNRUIJ-UHFFFAOYSA-N
15664102;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JMHHDSQNLZCCLT-UHFFFAOYSA-N
131764666;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;FOYFALOBIYPIPL-UHFFFAOYSA-N
131750410;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QXMHHXQBBKDSSL-UHFFFAOYSA-N
131750415;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;YONCDTJKIZDSKQ-UHFFFAOYSA-N
131760059;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MIZFXTLHUPLNGP-UHFFFAOYSA-N
131754528;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WUDWGAJJZFZCER-UHFFFAOYSA-N
131755226;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PZLANHYIZMKDPR-UHFFFAOYSA-N
131762155;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NUXBWTCPUJBEJP-UHFFFAOYSA-N
131753342;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJKXBTKTOXZQFL-UHFFFAOYSA-N
131753343;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RCZREYIMELSGSA-UHFFFAOYSA-N
131753341;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SENTUJWTPLLHAV-UHFFFAOYSA-N
131758065;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZMOMBZWRGVTTLX-UHFFFAOYSA-N
131753348;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GEYNVUPCUDZJMH-UHFFFAOYSA-N
102524318;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CCKKDORBDQDVMQ-UHFFFAOYSA-N
131759349;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PKWPXOXGYXWVKK-UHFFFAOYSA-N
131753778;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JLBLEJPPNIHTIQ-UHFFFAOYSA-N
131753893;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PZGMSWKRVOYKSW-UHFFFAOYSA-N
131759887;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FCEBICVTRXFYLZ-UHFFFAOYSA-N
131755474;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OZTOROOYEIRFAB-UHFFFAOYSA-N
131759343;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XYIGSYIGMXHUQI-UHFFFAOYSA-N
131759344;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GQZRZDIDOJKGLP-UHFFFAOYSA-N
131755473;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LCHZHNOSBDOUOB-UHFFFAOYSA-N
131763721;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VQRIKACZDQJACM-UHFFFAOYSA-N
131759880;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LNXIGBSVBNTNGO-UHFFFAOYSA-N
131760353;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MRBGPFJGICLPKZ-UHFFFAOYSA-N
131760352;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YZOSLKYDCFWPCI-UHFFFAOYSA-N
131755574;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZLDJFFNRXQCWDI-UHFFFAOYSA-N
131759033;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FRHNALHHTGKIGG-UHFFFAOYSA-N
131753908;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VMUGUHJRAOSIMU-UHFFFAOYSA-N
131760052;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;XLTVJSFXOMIXKW-UHFFFAOYSA-N
131755246;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JDYQORQUIVEAPP-UHFFFAOYSA-N
131755241;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KUYUHOFPMWBZLG-UHFFFAOYSA-N
131755240;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MLAOSVRSJAVRAU-UHFFFAOYSA-N
131755579;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NPDNCNMIHPPXLG-UHFFFAOYSA-N
131763946;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WCWOBBHQCJULDM-UHFFFAOYSA-N
131755322;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MTMTXYXQGBCYCD-UHFFFAOYSA-N
131754007;LPAR3;7;6.793e-50;0.5192;3.5294;87.822;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CTBYABNARYJUOG-UHFFFAOYSA-N
131755326;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BAJHYMHNWFZWKC-UHFFFAOYSA-N
131755327;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UWIJLBUWLZZSBQ-UHFFFAOYSA-N
131755325;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PWAOXOJAJJJACV-UHFFFAOYSA-N
131764028;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IYSQDSJAZVXCDU-UHFFFAOYSA-N
131765943;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;YYSSONAYWLGUQT-UHFFFAOYSA-N
131759834;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PVBOVZWBGFRMPX-UHFFFAOYSA-N
131757262;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIWODFZGWMDPCD-UHFFFAOYSA-N
131763123;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RRQQICLGULVDHJ-UHFFFAOYSA-N
9544262;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HLTSKBNGPCVUQB-UHFFFAOYSA-N
131760793;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NIYFCMHVCRSLEF-UHFFFAOYSA-N
131755769;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;ZKAJTUDTPFXDPB-UHFFFAOYSA-N
131763614;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GTLNJAOUKJAZIU-UHFFFAOYSA-N
131760796;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YFWNVIUVILVVDR-UHFFFAOYSA-N
131759580;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XUOLMCLGWGLYGT-UHFFFAOYSA-N
131755684;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZUMTISSRAZIGC-UHFFFAOYSA-N
131750344;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XRKBRKZCVJSDIQ-UHFFFAOYSA-N
131750340;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;AOSKWYIWKDMXST-UHFFFAOYSA-N
131764014;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;QZUZXWSQFLLIBE-UHFFFAOYSA-N
131759536;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UCAVRBQATPCINL-UHFFFAOYSA-N
131760553;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UZBLVYUHSFGJIV-UHFFFAOYSA-N
131760552;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OCXMVEFWZCJXTP-UHFFFAOYSA-N
131753647;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SXPXBKWZYGAMMR-UHFFFAOYSA-N
131758844;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DELOENOPQWJVLP-UHFFFAOYSA-N
131758845;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JMNWHZCLZAOONT-UHFFFAOYSA-N
131753725;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NEUKLKKOFRWHDB-UHFFFAOYSA-N
131755170;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZTNYZUSKQOHZBE-UHFFFAOYSA-N
131753766;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXPNAJYOBOKITK-UHFFFAOYSA-N
131754674;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AJCVSKDDEKJMGM-UHFFFAOYSA-N
131755882;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SKXGGXXHUILISA-UHFFFAOYSA-N
131755881;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;CLQGNDGHULBBGK-UHFFFAOYSA-N
131756216;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWBKQSARGDXJLH-UHFFFAOYSA-N
131755183;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;NPZXCVFGWXHFFP-UHFFFAOYSA-N
131765220;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;BMHFNXTYTINNLE-UHFFFAOYSA-N
131755889;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RWXPDMYGJSOHGX-UHFFFAOYSA-N
131755677;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IXNKUAVBSAJEIR-UHFFFAOYSA-N
131755924;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RQYFNWIONOQUSC-UHFFFAOYSA-N
131755925;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;LHXURPBLCDMSQT-UHFFFAOYSA-N
11007443;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UDQCIYKUZOQISE-UHFFFAOYSA-N
131762158;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZMLPYXDICDGROD-UHFFFAOYSA-N
9544167;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131755399;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXWHOVSUVNCPAU-UHFFFAOYSA-N
131755398;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;TWSBBIIUNDVTNF-UHFFFAOYSA-N
131765893;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WFGBZGXKOVKMDE-UHFFFAOYSA-N
131755392;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DAYIBGRSBOHJLY-UHFFFAOYSA-N
131759792;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VQLVXVCYSYIBGT-UHFFFAOYSA-N
131760484;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PEJYXBAMEZPBAX-UHFFFAOYSA-N
131755775;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;JKGVPFAPBARTLP-UHFFFAOYSA-N
131755193;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;DSGUAGSLOJNCIC-UHFFFAOYSA-N
131754717;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IEYUWTSKPUBHDM-UHFFFAOYSA-N
131756158;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IDNFRJBDXYQKBM-UHFFFAOYSA-N
131755197;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSESJUIKHHMUIV-UHFFFAOYSA-N
131755196;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JQSCFVCYBPEHML-UHFFFAOYSA-N
131753494;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XLTDBJCJNQRMTH-UHFFFAOYSA-N
131759400;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;VLLWHKDCWQXIBL-UHFFFAOYSA-N
131754718;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IQSXRIYKFXKPPU-UHFFFAOYSA-N
131753493;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBBJXVATNOPWNT-UHFFFAOYSA-N
131760702;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MWZGBHBJOPROOU-UHFFFAOYSA-N
131756485;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;BWOHNVUJJCXFQP-UHFFFAOYSA-N
131756887;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SNGHDWHBYJYQOD-UHFFFAOYSA-N
131763336;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LSBYOEWZVKAXQD-UHFFFAOYSA-N
131764398;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QTTCWZLTKUELKJ-UHFFFAOYSA-N
131755610;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QGFXXHQHYVJYSH-UHFFFAOYSA-N
131755757;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ZMDXJSHVNGLQDM-UHFFFAOYSA-N
131758939;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CTDMUXKSVFRWMX-UHFFFAOYSA-N
131758834;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;TYVUFKFTHSFXIT-UHFFFAOYSA-N
131753795;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKKDPSPGKMHBNY-UHFFFAOYSA-N
131753742;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DCAWTWWNADPCKX-UHFFFAOYSA-N
131753790;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LXHLNESXEDBVQR-UHFFFAOYSA-N
131755811;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XVCFHZCPVLNAMA-UHFFFAOYSA-N
131754780;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LYNIUWOJUCUGNH-UHFFFAOYSA-N
131753621;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QKSXLUQUGVRSFU-UHFFFAOYSA-N
131756664;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UHJOVPMFQXZMGP-UHFFFAOYSA-N
99649123;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YFFIQXNTTVSKJC-UHFFFAOYSA-N
131756663;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;GRVZQIMVHTZJHB-UHFFFAOYSA-N
131753620;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZALJSAZYHMHSGO-UHFFFAOYSA-N
131754215;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FFJZQCAVRAQRGO-UHFFFAOYSA-N
25240374;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
131756541;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VTPICOUFYQJTJI-UHFFFAOYSA-N
131756540;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;XYQFDSGKFQESCN-UHFFFAOYSA-N
131761736;LPAR3;7;1.515e-43;0.5625;3.0738;76.4248;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QZQJDOWDQQNPNJ-UHFFFAOYSA-N
131753661;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUSQLYSSJGPWCI-UHFFFAOYSA-N
131763195;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBKMWLHIRAKLID-UHFFFAOYSA-N
131760673;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;LBRUZFUQXUCAIU-UHFFFAOYSA-N
131766067;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHWDZFUPBDUEAH-UHFFFAOYSA-N
131759717;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KFAZITXLGUDPHA-UHFFFAOYSA-N
131760679;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HOBVFWBPKZZJDS-UHFFFAOYSA-N
131763423;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEIVVIBOWKCKQZ-UHFFFAOYSA-N
131766105;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YNSZYTDNGONQCW-UHFFFAOYSA-N
131760777;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SNSCEPRATRYHSL-UHFFFAOYSA-N
131753540;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;MSCHPHKYTIAZQI-UHFFFAOYSA-N
131753541;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AYBAPOVPJJUOKS-UHFFFAOYSA-N
131753545;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BLFWZVXARGMXGK-UHFFFAOYSA-N
131753546;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PEGBVZIRKWFBAT-UHFFFAOYSA-N
131753547;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YJIQPDYUKSNQSN-UHFFFAOYSA-N
131759867;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LNKHZBGNOPRSQH-UHFFFAOYSA-N
131755028;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IJMQCAKVFHJJTI-UHFFFAOYSA-N
131759304;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LGEZSPSFVTXJTF-UHFFFAOYSA-N
131759305;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRPHUHNPXZVJHC-UHFFFAOYSA-N
131755531;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QMOIIDCAFLCLKL-UHFFFAOYSA-N
131755537;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PDTAQKYFJJGDCD-UHFFFAOYSA-N
131759303;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MPJVJPDVMFMULD-UHFFFAOYSA-N
131759308;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WRMBXJIECLAGIV-UHFFFAOYSA-N
131755732;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;ZNJHBXLEVATVCP-UHFFFAOYSA-N
131764384;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FPSHTYJHVSXLOR-UHFFFAOYSA-N
131758089;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SEPILWBSQJWVGW-UHFFFAOYSA-N
131755365;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BMVWCBZVEZTSPY-UHFFFAOYSA-N
131753612;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HPPGYJJKGFAKGA-UHFFFAOYSA-N
131755361;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XSSYPDIVPNHTQU-UHFFFAOYSA-N
131755045;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QHMIFVZMPUXEAH-UHFFFAOYSA-N
131755044;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BHIUUNLDJFUIJS-UHFFFAOYSA-N
131759943;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AIJGPUXXVZKCOC-UHFFFAOYSA-N
56938682;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ODHWPZFGXIMZRL-UHFFFAOYSA-N
131759874;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NMFGLZJGDVTWFX-UHFFFAOYSA-N
131759872;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WXYYNUWVWHESOG-UHFFFAOYSA-N
131759873;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FPTNHTUUMDTEJR-UHFFFAOYSA-N
131759977;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;UORVMJWANGGOMW-UHFFFAOYSA-N
131762189;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;DXLAMQSKKMZWNP-UHFFFAOYSA-N
131753336;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZXXNIIBQUJJGT-UHFFFAOYSA-N
131753335;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MPHCGZMQUSAMKJ-UHFFFAOYSA-N
9544341;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131756563;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FEWUEBYAXQMTPT-UHFFFAOYSA-N
131759245;LPAR3;7;1.2699999999999999e-60;0.5294;4.2992;107.0826;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NWUHDVPEYQTVME-UHFFFAOYSA-N
131758888;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZXYLDUDAXJJFMZ-UHFFFAOYSA-N
131761188;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;MIFIJCHVVASRCZ-UHFFFAOYSA-N
131758880;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CSWKLJWLTNNDPE-UHFFFAOYSA-N
131761187;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;APYYLLXHUQMDDS-UHFFFAOYSA-N
131760930;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AAFPBUWBKCMUOC-UHFFFAOYSA-N
131761181;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;AVDYVPMWQRDZRZ-UHFFFAOYSA-N
131761182;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;JYSAOWHMYRNKSW-UHFFFAOYSA-N
131753724;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OPTZHODNQOBXMO-UHFFFAOYSA-N
131753831;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XIEUJHVLPZAHHA-UHFFFAOYSA-N
131753726;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PCGADUJICVENFJ-UHFFFAOYSA-N
131759372;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AKRDICGFDXTDDB-UHFFFAOYSA-N
131753720;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RNHDCKNXDJJGEF-UHFFFAOYSA-N
131753837;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LTKZJLJRCVCLBH-UHFFFAOYSA-N
131753838;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VIYIIFOXWFOBDE-UHFFFAOYSA-N
131753755;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YVGVIKRPSGNSQN-UHFFFAOYSA-N
131754136;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;SSIXVUQNKRINJM-UHFFFAOYSA-N
131755965;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOJVDNJANFYSHZ-UHFFFAOYSA-N
131754037;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YGLHPJUQMNWNAS-UHFFFAOYSA-N
131760065;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FZUGYVDDNAJZLF-UHFFFAOYSA-N
131760064;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WYYFGQDJMAHICF-UHFFFAOYSA-N
131754033;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GJQHRPDIWSJRQK-UHFFFAOYSA-N
131764664;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZWLJFCNGDYASKC-UHFFFAOYSA-N
131758982;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZQQGMCWVFPHUPJ-UHFFFAOYSA-N
131755219;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XAMNFTPGEKLFFB-UHFFFAOYSA-N
131750621;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DWUCTGPOYZTRAA-UHFFFAOYSA-N
131754589;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTYKAHIYZXXTIN-UHFFFAOYSA-N
131765460;LPAR3;7;4.33e-51;0.5294;3.6152;89.9685;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;OPUGTLQTYUOVLC-UHFFFAOYSA-N
131757239;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;YTPRVRWPVFSOAL-UHFFFAOYSA-N
131755010;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JKYPCWURBUPJMX-UHFFFAOYSA-N
131754583;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;RTBRCTDGSUJPRS-UHFFFAOYSA-N
131760060;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DVVVWSWPMOHCJM-UHFFFAOYSA-N
131766314;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;YTFUBOUKMGWXHM-UHFFFAOYSA-N
131763832;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;USAUVXGGZAHQNY-UHFFFAOYSA-N
131756243;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWNCWDLVLHBCRO-UHFFFAOYSA-N
131765754;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YZUQGBAOTLBFFG-UHFFFAOYSA-N
131764967;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;BDCSDBVNZGJCKJ-UHFFFAOYSA-N
131765282;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XIIXNUYLGYUCGJ-UHFFFAOYSA-N
15664122;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SXDAWDWMVQAQOY-UHFFFAOYSA-N
131755829;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;HMQDPLNLSJNOFZ-UHFFFAOYSA-N
131755984;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GTGOXBMVMINSSB-UHFFFAOYSA-N
131755985;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NQKRWZVYDJMTOX-UHFFFAOYSA-N
131753592;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HLUWGRVFRNCPHH-UHFFFAOYSA-N
131753591;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;KTVQVVATLSBTAO-UHFFFAOYSA-N
131760422;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NWWIMNVSUNRCOZ-UHFFFAOYSA-N
131759607;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VBUYAWOUEDDBBW-UHFFFAOYSA-N
131753611;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MBGJURGZJWMMPU-UHFFFAOYSA-N
131753599;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GKCAFLCQQIADCE-UHFFFAOYSA-N
131758977;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YSZSTRFCTSGBDD-UHFFFAOYSA-N
131755715;LPAR3;7;3.4470000000000003e-46;0.4815;3.2634;81.1698;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PQQIAQSGMRDMKV-UHFFFAOYSA-N
131753617;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;OWDZAXOWKQAOKC-UHFFFAOYSA-N
131754149;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;CKJFKCABBRYLMR-UHFFFAOYSA-N
131753753;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PBZUQKBKTBJPQG-UHFFFAOYSA-N
131760582;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GOMDFFGKASVPBQ-UHFFFAOYSA-N
131756326;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YIJBKAITYUJKQL-UHFFFAOYSA-N
131761059;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;WUKREVVPLNPHSK-UHFFFAOYSA-N
131756324;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ASJHAVAPNBVXQH-UHFFFAOYSA-N
131758668;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NUYRINJQOPQTKC-UHFFFAOYSA-N
131761054;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LJLIFTYRIMZUNV-UHFFFAOYSA-N
131761053;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SHYQNKZJLJXKPA-UHFFFAOYSA-N
131754144;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;ODOZWZDIECCVSB-UHFFFAOYSA-N
131755913;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SWUDGTDLMRDUKM-UHFFFAOYSA-N
131755912;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CVHMEZFGALFXMT-UHFFFAOYSA-N
131755917;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IDMJDWJMYCKJQJ-UHFFFAOYSA-N
131755919;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZXPZKPTYTWDDTR-UHFFFAOYSA-N
131755918;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTAXARKBUGEENK-UHFFFAOYSA-N
131758843;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;QBKIULACTZPXJR-UHFFFAOYSA-N
131760081;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IKJIWAALGJUTLA-UHFFFAOYSA-N
131763397;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ODXHCQRPIURWTJ-UHFFFAOYSA-N
131758685;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;VOLUUICWFQPQGG-UHFFFAOYSA-N
131765217;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IITVMCHTPSACLP-UHFFFAOYSA-N
131759925;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;KGCKCEDJXPOMSE-UHFFFAOYSA-N
131760225;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JSUSEOMHUNJYLL-UHFFFAOYSA-N
131758689;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AXFNIIJYCHZARY-UHFFFAOYSA-N
131759028;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBLLHDWARKBXDR-UHFFFAOYSA-N
131754440;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QNFJULRDTQNJGZ-UHFFFAOYSA-N
10854964;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UBFOEWXGSAZLKS-UHFFFAOYSA-N
131759750;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HYGBWSXRFZKWPT-UHFFFAOYSA-N
131759024;LPAR3;7;1.856e-51;0.5294;3.6415;90.6289;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IXEARPXRHLLVNK-UHFFFAOYSA-N
131759027;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QCKZCPLWSOKIIF-UHFFFAOYSA-N
131760222;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DTSVNYMUJNAOOU-UHFFFAOYSA-N
131755146;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KSMPHUBCCOCMRE-UHFFFAOYSA-N
131756299;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;APUGAHTVBGXVKV-UHFFFAOYSA-N
131758756;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCCCCCC;BIBCTHOYLBOAJR-UHFFFAOYSA-N
131755140;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AGLSUDWGYKMXMK-UHFFFAOYSA-N
131755141;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YBDNVPPIUIROLZ-UHFFFAOYSA-N
131763304;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VZECUZTZXUJIHD-UHFFFAOYSA-N
131753506;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RUZNGRCQLAJOGE-UHFFFAOYSA-N
131759592;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YSXJWNGVILWQDX-UHFFFAOYSA-N
131763300;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YPLTVEAOWNDKFQ-UHFFFAOYSA-N
131759597;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XEVQMHZJFRSFOB-UHFFFAOYSA-N
131761605;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;TVFKBKZPDYIUEQ-UHFFFAOYSA-N
131761127;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNDQJEPSXBZSNW-UHFFFAOYSA-N
131759371;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZTOPVHNXZUMKFI-UHFFFAOYSA-N
131760650;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CPINNDOHYCSUGR-UHFFFAOYSA-N
131756298;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HIOAMCRVNLXZQC-UHFFFAOYSA-N
131763525;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZRVFQAMIIKQWFU-UHFFFAOYSA-N
131750547;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CXVKBFLPGNGMQW-UHFFFAOYSA-N
131761237;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LQFACPSTFHEEKK-UHFFFAOYSA-N
131754081;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OHGQZSIZFJHEIP-UHFFFAOYSA-N
131757898;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCC;QOPDMHCKZZFVHH-UHFFFAOYSA-N
131757899;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCC;IZQSAPJJVMUNHL-UHFFFAOYSA-N
131763482;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GBRPETNWPCBFTJ-UHFFFAOYSA-N
131763483;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PARQILSYFLMAIN-UHFFFAOYSA-N
131754367;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PGPUQOBIJOUZAP-UHFFFAOYSA-N
131754088;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FVACYRCSAZRBJC-UHFFFAOYSA-N
131754089;LPAR3;7;2.9199999999999998e-55;0.5192;3.9145;97.4569;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DHPCZZMWIIRYJJ-UHFFFAOYSA-N
131759734;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ITVZPSFYQXIRPA-UHFFFAOYSA-N
131755001;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LRTMQTBQQUGLKW-UHFFFAOYSA-N
131755000;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;FLALCZKVXJDYDG-UHFFFAOYSA-N
131755007;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;YGANYFGQLLNHPX-UHFFFAOYSA-N
131755006;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MZUGAQXXWDXZIR-UHFFFAOYSA-N
131754248;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;IDANUBRXZAZNTQ-UHFFFAOYSA-N
131753363;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGVRIPFAUKNKTG-UHFFFAOYSA-N
131754534;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MAWNXWUEDRYQEG-UHFFFAOYSA-N
131755781;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;PTRBUWWBGNLWCI-UHFFFAOYSA-N
131759933;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACPCBDGMDMCVRO-UHFFFAOYSA-N
131760648;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XFZASIKJCCDVQE-UHFFFAOYSA-N
131750406;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXIRNQZZDMHWHR-UHFFFAOYSA-N
9544475;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PLFFUZALKUXPFW-UHFFFAOYSA-N
131761741;LPAR3;7;4.607e-52;0.551;3.685;91.7155;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AEIYVURNZPSTRI-UHFFFAOYSA-N
131759934;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NBXZHICDXWJXHJ-UHFFFAOYSA-N
131765898;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LOPISFWKDHPVGZ-UHFFFAOYSA-N
131762141;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;GFXBBKRPUJCXGD-UHFFFAOYSA-N
131762142;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CTGSVLMVNLDPLN-UHFFFAOYSA-N
131753370;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;SDBSYLMJMSWVJK-UHFFFAOYSA-N
131753377;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JADYBVKYENQSPF-UHFFFAOYSA-N
131753376;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYZULKIDHZXLHX-UHFFFAOYSA-N
131759621;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HMGFDNAQAKGKOT-UHFFFAOYSA-N
131756111;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JIYHMQDXQDVDIQ-UHFFFAOYSA-N
131756112;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JLLNDMXBRCFCMO-UHFFFAOYSA-N
131754473;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BVUKOOZQIGAWRK-UHFFFAOYSA-N
131756117;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FHKXPCWAEDEJKG-UHFFFAOYSA-N
131753478;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JNAGPKIFCRPVFY-UHFFFAOYSA-N
131753479;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NZEDZJHGVGEWRO-UHFFFAOYSA-N
131753573;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QQWCQYWWJUBCHW-UHFFFAOYSA-N
131756500;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;JBRTUJBXWSKTAY-UHFFFAOYSA-N
131753575;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WKYUVRSDBBUBSZ-UHFFFAOYSA-N
131754668;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCXAOTNONHNUHF-UHFFFAOYSA-N
131765901;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;FDFREEAVFLANHV-UHFFFAOYSA-N
131759892;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;CLRWKONSSADDAS-UHFFFAOYSA-N
131759893;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;NXOBVWVEMROHRA-UHFFFAOYSA-N
131755447;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BHUGVTHDSSXVAN-UHFFFAOYSA-N
131755445;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SQITVZNQNGOSGD-UHFFFAOYSA-N
131755972;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;IXDYCTWELIBSSO-UHFFFAOYSA-N
131755561;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCIYSTQFXHSCKA-UHFFFAOYSA-N
131755562;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NGEHHICSKHOVLR-UHFFFAOYSA-N
131755563;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VWRXQZKIYNYMGG-UHFFFAOYSA-N
131763635;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HLDNWFKUIPUXFI-UHFFFAOYSA-N
131759239;LPAR3;7;1.8649999999999998e-67;0.5625;4.7896;119.3503;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XNHWYHFYYUALLY-UHFFFAOYSA-N
131753975;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GQNNXOVIYAQPRC-UHFFFAOYSA-N
131753562;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RRKINLPZPZCTKA-UHFFFAOYSA-N
15607293;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FGNXNKQAEKNDNA-UHFFFAOYSA-N
131753970;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OIAXGMPMFLBWEB-UHFFFAOYSA-N
131760024;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;PPGYTWCQPFGHHF-UHFFFAOYSA-N
131757827;LPAR3;7;1.8649999999999998e-67;0.5625;4.7896;119.3503;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;JEERBMFDIWSRBT-UHFFFAOYSA-N
131764744;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHESVRVAJGWCRH-UHFFFAOYSA-N
131764746;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ZMLLSDUMFIKCFD-UHFFFAOYSA-N
131756517;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;MGWARNQTGMPDFT-UHFFFAOYSA-N
131762283;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LQPSWGXHWSIHNS-UHFFFAOYSA-N
131765939;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KCXCVMHVAMVXKN-UHFFFAOYSA-N
131755090;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;QSQLLDYMTXNRPS-UHFFFAOYSA-N
131755091;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;YCRUOZPSQCDMCU-UHFFFAOYSA-N
131756511;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC;ASJDYPQIFWQJPP-UHFFFAOYSA-N
131755502;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KOKPTHNRUIPNHU-UHFFFAOYSA-N
131757852;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;OOHIULWPYUEZRR-UHFFFAOYSA-N
131763649;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LBOVPAKRIPYJIX-UHFFFAOYSA-N
131759801;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JNHLCTFBNVEPGE-UHFFFAOYSA-N
131754049;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZYWNYYJHZYDVCC-UHFFFAOYSA-N
131753981;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RKFWDJFGPBNCBJ-UHFFFAOYSA-N
131753982;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GBJTZFHEXHJBKU-UHFFFAOYSA-N
131756698;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GYPCYQZGNPPXQY-UHFFFAOYSA-N
131757373;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;UNKHDPXDHSBDOZ-UHFFFAOYSA-N
131757372;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;OYMKHLWGIUBLIM-UHFFFAOYSA-N
131762149;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTVCIQXPZYXPQV-UHFFFAOYSA-N
131750352;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YWKYRFUPKVVPAH-UHFFFAOYSA-N
131759480;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NAKJXCQFDQFGQP-UHFFFAOYSA-N
131759486;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JSYBHNVWTXAJTA-UHFFFAOYSA-N
131757401;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LFLULLQVQPKAMK-UHFFFAOYSA-N
131754808;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KEFNWJKPJBZOJN-UHFFFAOYSA-N
131757405;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMVEGQXRXTDQX-UHFFFAOYSA-N
131753883;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VGXAVCFJDOECRR-UHFFFAOYSA-N
131753654;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AYBGGTUWOJKGTF-UHFFFAOYSA-N
131753808;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JCFQRCZDNUSJCL-UHFFFAOYSA-N
131760540;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XWUIEUCNKIBJAB-UHFFFAOYSA-N
131760541;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WICODSUDRZUJKB-UHFFFAOYSA-N
131760546;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZMONUYUAVAZYFU-UHFFFAOYSA-N
131759244;LPAR3;7;1.1710000000000002e-55;0.5192;3.943;98.1695;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UBYXSIWFCYZTHX-UHFFFAOYSA-N
131760545;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MXFKCAQPYLTUMC-UHFFFAOYSA-N
131760548;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZKCCURQELYISMZ-UHFFFAOYSA-N
131764303;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ROGPEDYCAOGILA-UHFFFAOYSA-N
131755232;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;COSWJIZWAODXNP-UHFFFAOYSA-N
131753807;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KRNGXZWFBACZCQ-UHFFFAOYSA-N
131755895;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;HFLPEQAAOJSPGG-UHFFFAOYSA-N
131755896;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AQMKAYODMONDGF-UHFFFAOYSA-N
131755590;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NGPGSHBLLYRGNQ-UHFFFAOYSA-N
131758981;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KIAYIOGNKVRZDY-UHFFFAOYSA-N
131755956;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NTZYNUIJRPZFCR-UHFFFAOYSA-N
131755951;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;AHASBULBODWAPU-UHFFFAOYSA-N
131755950;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;QWODFTFSLHKZKF-UHFFFAOYSA-N
131753877;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GPYCLFQJCGOBIU-UHFFFAOYSA-N
131763090;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;LDVDALBKRWDBPL-UHFFFAOYSA-N
131755384;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGWSKVYZBMTHNX-UHFFFAOYSA-N
131764734;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BTHJFQWGYLCNCP-UHFFFAOYSA-N
131764739;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZSUORVUZOXBKRZ-UHFFFAOYSA-N
131760633;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;YVYVTNJRAGMXOD-UHFFFAOYSA-N
131764328;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CWLXAXNJGBVGCW-UHFFFAOYSA-N
131758909;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MNMVLKRCYQXAJF-UHFFFAOYSA-N
131759733;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SBMGSPMUZLTYRO-UHFFFAOYSA-N
13183956;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RBLADLVPSYELCA-UHFFFAOYSA-N
102242320;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OJWXCNKRIMWLSH-UHFFFAOYSA-N
131754392;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SIDLIHCVDJIGBO-UHFFFAOYSA-N
131755182;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;BGXYIUSCTPZXJT-UHFFFAOYSA-N
131759796;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QMXKKHSUBLMCBY-UHFFFAOYSA-N
131759066;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PORHNNNMYDBBOL-UHFFFAOYSA-N
131759418;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HJRVVCOWJQUKTM-UHFFFAOYSA-N
131759060;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ATDIOVCHAKPQSA-UHFFFAOYSA-N
131755188;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFLOLSWWIHPMFV-UHFFFAOYSA-N
131759417;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LUNKFQMIUALALF-UHFFFAOYSA-N
131755626;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZLPGNDHRJUFQTK-UHFFFAOYSA-N
131756473;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DWWVDERGXAMHFX-UHFFFAOYSA-N
131756472;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;WNIDTLACSIPEOD-UHFFFAOYSA-N
131758828;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;BGODCVGWEBYLGN-UHFFFAOYSA-N
131758829;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BCMHHAAVHIRHKO-UHFFFAOYSA-N
131753627;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OPXVSFLGAKIILH-UHFFFAOYSA-N
131758822;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OPZBOXKFTDVAOR-UHFFFAOYSA-N
131753628;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VWLZYYAQPNZEAL-UHFFFAOYSA-N
131754612;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYAXBKPUHHCJZ-UHFFFAOYSA-N
131758827;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WYUKTVBUNYZEPG-UHFFFAOYSA-N
131763220;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YLZZIBPODWNHEY-UHFFFAOYSA-N
131760968;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VTKPPWHYRVIYMV-UHFFFAOYSA-N
131755192;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLDZOBNZLQGSSG-UHFFFAOYSA-N
131760933;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QKAXGKITAFZXPQ-UHFFFAOYSA-N
131753505;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SCJKAJUAZPTDRO-UHFFFAOYSA-N
131756499;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;OAWZXYQFSSUDQG-UHFFFAOYSA-N
56939631;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZTNCEOWHIGXJAM-UHFFFAOYSA-N
131759016;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BOGNZWFVCFWTDN-UHFFFAOYSA-N
131756557;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NDDBFQIGGOFJRX-UHFFFAOYSA-N
131756558;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;WOYJJCSXKNHKCN-UHFFFAOYSA-N
131756493;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SQKYADYBUNVMCF-UHFFFAOYSA-N
131756492;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HEZIFHPOCSMIRI-UHFFFAOYSA-N
56939612;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CDDMLDFHOOIDDR-UHFFFAOYSA-N
131756494;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SYGFOSKNZKVBDP-UHFFFAOYSA-N
101146157;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JFKGKULDMWLHEK-UHFFFAOYSA-N
56938607;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OOXHPYMTHPKODA-UHFFFAOYSA-N
131754474;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZSTISJVJCWGTAZ-UHFFFAOYSA-N
131759660;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEMZZKBCGPBDKP-UHFFFAOYSA-N
131757382;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;CQGCPQNAYLDVOH-UHFFFAOYSA-N
131759665;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FLBFFPPBNOZWBA-UHFFFAOYSA-N
131759664;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AHGKMUVICCTCFM-UHFFFAOYSA-N
131759703;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MORKMZKGDIIIBY-UHFFFAOYSA-N
131766070;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OODSECKBPNOQSL-UHFFFAOYSA-N
131759461;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ONYOXARKNBCDOW-UHFFFAOYSA-N
131759460;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BTLLBFZSJPKPDE-UHFFFAOYSA-N
131759462;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QXRVJZIWSZYNFE-UHFFFAOYSA-N
9544531;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LLZPZRGVBKFBKR-UHFFFAOYSA-N
131759154;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GWAVHAUKODFLGT-UHFFFAOYSA-N
131758642;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;CDJBHUGXUCDURI-UHFFFAOYSA-N
131753533;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YSLQGXDXYVVXSS-UHFFFAOYSA-N
131753532;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JOYRTBZPFLTFIB-UHFFFAOYSA-N
131758648;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;TYUOYBHEQWBQON-UHFFFAOYSA-N
131763290;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MUYSBOYFSLCKQE-UHFFFAOYSA-N
131763294;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HNCZROXFYKAXOH-UHFFFAOYSA-N
131755524;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STSSOOUAZVGHGT-UHFFFAOYSA-N
131757216;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VCTGTMSVVLORIT-UHFFFAOYSA-N
131766215;LPAR3;7;6.793e-50;0.5192;3.5294;87.822;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;KFSFKHFCDAWOLQ-UHFFFAOYSA-N
131766096;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZBFSNQAJGYUCEB-UHFFFAOYSA-N
131757381;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;GJZLKYUSHJORNQ-UHFFFAOYSA-N
131756722;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPLCSZBQAQAYRD-UHFFFAOYSA-N
131766095;LPAR3;7;1.0359999999999999e-51;0.5094;3.6597;91.0836;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;FRZIUSLXTUICSQ-UHFFFAOYSA-N
131756595;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;WJSBURXJPCGRCH-UHFFFAOYSA-N
131755350;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OLDVVLPHLVANLD-UHFFFAOYSA-N
131755050;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XALHWTWEHSQIBY-UHFFFAOYSA-N
131755051;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MEUNMCWGMQZVER-UHFFFAOYSA-N
131756191;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UOLSYLSXKGOQQK-UHFFFAOYSA-N
131761653;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;TYZDMXCEMORABR-UHFFFAOYSA-N
131761090;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LABRUJVSUYYTTA-UHFFFAOYSA-N
131756548;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JWVUDERNGFMBBB-UHFFFAOYSA-N
131759848;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RXPNRICKBTZRQQ-UHFFFAOYSA-N
131763632;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HTODETRMAVZETG-UHFFFAOYSA-N
131753449;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KWFQLWFYKULMGD-UHFFFAOYSA-N
131756793;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SLVVTLNMFWVJDL-UHFFFAOYSA-N
131756658;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;GWNUSEKGRALKED-UHFFFAOYSA-N
131756652;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HWPRTUFRMUOZLY-UHFFFAOYSA-N
131756651;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;HLPJZXVCHWKDNK-UHFFFAOYSA-N
131756657;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ZXXXFPVLDMZBCA-UHFFFAOYSA-N
131756656;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NFCQXICLNHGVGZ-UHFFFAOYSA-N
131755418;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;OMLTYAGNYCAYQB-UHFFFAOYSA-N
131755792;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VJGBLJQPGREUIJ-UHFFFAOYSA-N
131759566;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PASRUCZTFLIYBM-UHFFFAOYSA-N
131755797;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;UFGXGACWXCNPJD-UHFFFAOYSA-N
131760506;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SHWUEDFQQXTCJE-UHFFFAOYSA-N
131755798;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;QDQDETHJEUGTEX-UHFFFAOYSA-N
131761193;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;KEGWRTMECYJUBP-UHFFFAOYSA-N
131760501;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFMFNZAUKDXUBS-UHFFFAOYSA-N
131755552;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AWKZRMLSPPFBRT-UHFFFAOYSA-N
131754197;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ALOIXMAWZZBRNQ-UHFFFAOYSA-N
131755556;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;PDFFYHNLAKMFAW-UHFFFAOYSA-N
131754080;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;AIBSNIRRVBNNBP-UHFFFAOYSA-N
131755022;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FAWROKQWRPDLOA-UHFFFAOYSA-N
131760372;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RZDWVTRPHNHEBJ-UHFFFAOYSA-N
131760072;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;MWIGZNCBUJFLIL-UHFFFAOYSA-N
131754027;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ADFSEZIUBMYLQX-UHFFFAOYSA-N
131750387;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;KJVYOEKCDNOOAP-UHFFFAOYSA-N
131765518;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NNCRXYJYPJVORP-UHFFFAOYSA-N
131755220;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DACIDRBKCGJUFT-UHFFFAOYSA-N
131760078;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CLCQSBVFBLSNEE-UHFFFAOYSA-N
131750388;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;XOCUQHRPEPNSJE-UHFFFAOYSA-N
131762252;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;AMRBACSYMREFMZ-UHFFFAOYSA-N
131762253;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PPUMCDNARAYNQV-UHFFFAOYSA-N
131765456;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UQOIPWJWGPNKBQ-UHFFFAOYSA-N
131761899;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KBDOPVRVUZKPQY-UHFFFAOYSA-N
131755776;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;PJEBJEMINBSXRV-UHFFFAOYSA-N
131757209;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;AIUFGXSNPIPWDK-UHFFFAOYSA-N
131757208;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;NZPQRJJPGATRLU-UHFFFAOYSA-N
131761892;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JHBQRHHIBFVBER-UHFFFAOYSA-N
131759640;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VKYKIUHFHBYWIQ-UHFFFAOYSA-N
131750369;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWMDNFFJJVRJMG-UHFFFAOYSA-N
131750368;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OCYFAHIHWCVZKS-UHFFFAOYSA-N
131755830;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RXFCPNVEKZDTFB-UHFFFAOYSA-N
131750362;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XCJBYQXUCQJPCZ-UHFFFAOYSA-N
131763206;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MKTVKWIGWXIEHG-UHFFFAOYSA-N
131759511;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKSVCFOMADIPHE-UHFFFAOYSA-N
131753586;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LDSWEOUGZDGWFT-UHFFFAOYSA-N
131756325;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCXOXNIREQFVQW-UHFFFAOYSA-N
131755708;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XGUVLROHLQCRKO-UHFFFAOYSA-N
131759514;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JTOXJDDZUMEKEU-UHFFFAOYSA-N
131759100;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YEHPWJBHXFGRBU-UHFFFAOYSA-N
131755707;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QYHOZSHVNKWJLV-UHFFFAOYSA-N
131755700;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;XTQUNVXMTVIEJG-UHFFFAOYSA-N
131755701;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LLMPANOXXMGKRF-UHFFFAOYSA-N
131755702;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;SXBWOXCOXHTAAM-UHFFFAOYSA-N
131758866;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCC;FODKVBNCUCXQDG-UHFFFAOYSA-N
131758867;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZITWCTCGAATZHT-UHFFFAOYSA-N
14029830;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JSSROPRCXOAGCW-UHFFFAOYSA-N
131761103;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WQMRXKLRGJHYMP-UHFFFAOYSA-N
131761046;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JLKCEKRVLYHNTR-UHFFFAOYSA-N
131760206;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VHJVYLPSJSQQCX-UHFFFAOYSA-N
131753315;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HJBSNTKEHJKZIB-UHFFFAOYSA-N
131756319;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DJYNSHLHLLYWLD-UHFFFAOYSA-N
131759298;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PPRQNLZEKMZHBT-UHFFFAOYSA-N
9544830;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IOBBMTADSCMSQV-UHFFFAOYSA-N
131764212;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DUPNCGTUAKCMPW-UHFFFAOYSA-N
131755907;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UTNNVFMIFYLBOY-UHFFFAOYSA-N
131759197;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JQLUSEPGRGEFIO-UHFFFAOYSA-N
131759191;LPAR3;7;4.607e-52;0.551;3.685;91.7155;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;URNTVXPNKOGORD-UHFFFAOYSA-N
131765757;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;QKBOUSRTZKBNLJ-UHFFFAOYSA-N
131759807;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KTXCVHLICBKPGH-UHFFFAOYSA-N
131763226;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;POAFQIOHYATMRL-UHFFFAOYSA-N
131763914;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ANTOAERGFNUGHV-UHFFFAOYSA-N
131763915;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMSZKZQYJMFYOM-UHFFFAOYSA-N
131761108;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AYGOZGMOLWTELQ-UHFFFAOYSA-N
131758649;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FAEIJJBFHNTKST-UHFFFAOYSA-N
131756190;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;STRGYEHUWWQWTA-UHFFFAOYSA-N
131759745;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PTGPWEGIOWAQLD-UHFFFAOYSA-N
131755171;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBTULCCTZFQLPM-UHFFFAOYSA-N
131761065;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LSFAIOBGARHDLM-UHFFFAOYSA-N
131755177;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WKSLEDJKCJNITP-UHFFFAOYSA-N
131755176;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QNLOBUFLPWUYFF-UHFFFAOYSA-N
131755175;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MLRYMYSXHCUZDL-UHFFFAOYSA-N
131753320;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IEIOCZLRHWBWAA-UHFFFAOYSA-N
131759423;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YUBPSQNVVBRHKY-UHFFFAOYSA-N
131759422;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YLSQMGKHEUFXMJ-UHFFFAOYSA-N
131755771;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;AFMQYZXPYJFAPA-UHFFFAOYSA-N
131755770;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MIAZWSJURHHRMR-UHFFFAOYSA-N
131760485;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OVZDGNXRQHXYRU-UHFFFAOYSA-N
131759581;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WXMOURHYAWKCON-UHFFFAOYSA-N
131758916;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RQEKPMWGSCALDR-UHFFFAOYSA-N
131763437;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BVJKPJCDKQJPAW-UHFFFAOYSA-N
131760480;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OUUHBPIFIILUCA-UHFFFAOYSA-N
131756547;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;LJYSOCUILOBCPA-UHFFFAOYSA-N
131756342;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OSCPURITXSWNQF-UHFFFAOYSA-N
131756345;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JISZBVIBYWPZGI-UHFFFAOYSA-N
131755714;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKASLILCGPZWOF-UHFFFAOYSA-N
131763536;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PZDNZVIDHUTVSG-UHFFFAOYSA-N
131760120;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LMFJKPBELSZHCE-UHFFFAOYSA-N
131758872;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WMXYDRBAGJDSCG-UHFFFAOYSA-N
131758861;LPAR3;7;4.607e-52;0.551;3.685;91.7155;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNDJLJYFFTWUTN-UHFFFAOYSA-N
131757858;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;IPMCDSYSCPXHTB-UHFFFAOYSA-N
131758039;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KWSTWEQIGGYEMX-UHFFFAOYSA-N
101706281;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;MKRZSXAKFYWUAW-UHFFFAOYSA-N
131758785;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XUSMNDFFJSIIQR-UHFFFAOYSA-N
131754433;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IHOAMWFZSKNMBJ-UHFFFAOYSA-N
131761758;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;WJLTVCYAAPDLHN-UHFFFAOYSA-N
131755017;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;CICXNKCKBFXJSH-UHFFFAOYSA-N
15664121;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YJHQECFFCOYQLS-UHFFFAOYSA-N
131754548;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYEQRCSOCOOKBP-UHFFFAOYSA-N
56940294;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BXWMIUIQFYBSNA-UHFFFAOYSA-N
131756669;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VNHABZLRSOJWDZ-UHFFFAOYSA-N
131755018;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KJQOITVLKVGNFB-UHFFFAOYSA-N
131759924;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OUQVHWIIFCXSRJ-UHFFFAOYSA-N
131762035;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HEYPQMCFNJLJQQ-UHFFFAOYSA-N
131758019;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCC;JCOOWXXKIVGLLZ-UHFFFAOYSA-N
131762736;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XPDLXJYQTJBVLY-UHFFFAOYSA-N
131753369;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;BLXQIUODGKBTGK-UHFFFAOYSA-N
131761639;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AMYBBMIDIXFAAQ-UHFFFAOYSA-N
131753364;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;VAGKZVNTAZNDGU-UHFFFAOYSA-N
131759082;LPAR3;7;2.387e-44;0.5745;3.1314;77.8656;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OGZXEGHARYHFNG-UHFFFAOYSA-N
131759732;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KHIGDHJAAJSAMT-UHFFFAOYSA-N
131759928;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QURCKNKEXAUCID-UHFFFAOYSA-N
131759929;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;GLBKLCZHEXMDML-UHFFFAOYSA-N
131753362;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HOPNBDYQIPEPJT-UHFFFAOYSA-N
131760655;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;ZEKFRROIYZYMJB-UHFFFAOYSA-N
131763402;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JKQWGXQHSNHJJE-UHFFFAOYSA-N
131756164;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WZYMUGLYGUNQDO-UHFFFAOYSA-N
100921659;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MVAGPZSVOSGBMR-UHFFFAOYSA-N
131753569;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGUAEFVIYUUGBB-UHFFFAOYSA-N
131756518;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;SEEXZSJWUOGTDD-UHFFFAOYSA-N
131756692;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NFECCYXCUXSJJQ-UHFFFAOYSA-N
131758042;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JKLQMZASXAUKDG-UHFFFAOYSA-N
131757184;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;UKQZYMLCKHOSTG-UHFFFAOYSA-N
131757185;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;MTMFSFJLPCNPOI-UHFFFAOYSA-N
131754939;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OHNOJBCXHSIKCO-UHFFFAOYSA-N
131759939;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QFNUIDSUZKRNIE-UHFFFAOYSA-N
131756699;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DSLDDCZRINWODJ-UHFFFAOYSA-N
131757183;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;ZRKRTZFYHUBTQQ-UHFFFAOYSA-N
131750596;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ADLPFNWYXJKFQW-UHFFFAOYSA-N
131763709;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WYRQFRRXDSBWDH-UHFFFAOYSA-N
131763747;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QSYBICSNXGWCJX-UHFFFAOYSA-N
131761047;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JYMXJRDHIBKAPL-UHFFFAOYSA-N
131761058;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RKPJGADXZNHPGE-UHFFFAOYSA-N
131755452;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JZDWMRHLZXGIMN-UHFFFAOYSA-N
131761094;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MWGRLUDJZRTHTP-UHFFFAOYSA-N
131759623;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HKADKLQZXQXYER-UHFFFAOYSA-N
131759324;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLEMYYGTXQHVFE-UHFFFAOYSA-N
131759325;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HSSCOLBULXMJLZ-UHFFFAOYSA-N
131755791;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KQKXUUFGXDXTLP-UHFFFAOYSA-N
131759622;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HVCCNWVJBNTHRL-UHFFFAOYSA-N
131755262;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LOEVQQYBQLFELJ-UHFFFAOYSA-N
131755261;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AODXXMPHCMURJU-UHFFFAOYSA-N
131755260;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YJWYQQFOJUDNJP-UHFFFAOYSA-N
131761256;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FEQGTAIRRDJZLL-UHFFFAOYSA-N
56938589;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FYOAFNBAIZJVFT-UHFFFAOYSA-N
131755269;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XFLBIJMMCSCPBO-UHFFFAOYSA-N
131755268;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBCKVROCLDZVDL-UHFFFAOYSA-N
131762624;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;ZUDALJHGXKNMOO-UHFFFAOYSA-N
131758690;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VJRAKLSHWUZUGJ-UHFFFAOYSA-N
131755063;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;VQWFQOJRISNWCH-UHFFFAOYSA-N
131760649;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MVWHBFFHLYXZJQ-UHFFFAOYSA-N
131755065;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KVLYQVRJXYJGRU-UHFFFAOYSA-N
131755064;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MGLUNDCYIGYIEO-UHFFFAOYSA-N
131763410;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CKOPDYBJSZTSFP-UHFFFAOYSA-N
131757247;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;ZSRZPVOHGXEPMJ-UHFFFAOYSA-N
131757246;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC;YFTFKGRPESIBQI-UHFFFAOYSA-N
131759951;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DNMGYNOZYHVTMB-UHFFFAOYSA-N
131759950;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;BZAUSRZLPIJRHO-UHFFFAOYSA-N
131757364;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VZQSJRZRVOMAEX-UHFFFAOYSA-N
131757365;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NQZWUGZPCSPJEX-UHFFFAOYSA-N
131759957;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;MIAUUKZRJAXLRT-UHFFFAOYSA-N
131759956;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJOJFBLODPQJLX-UHFFFAOYSA-N
131759958;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KMXCXZGPKXMYER-UHFFFAOYSA-N
131763104;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YJZARZPHBIAWSP-UHFFFAOYSA-N
131756767;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IQHVYGKMAJFIAG-UHFFFAOYSA-N
131753314;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XEOFILXSSITART-UHFFFAOYSA-N
131759494;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;HRCLBQUOANENCJ-UHFFFAOYSA-N
131759495;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BRUKBMVWXMWLGD-UHFFFAOYSA-N
131760505;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QTMSSVDGQFTUGW-UHFFFAOYSA-N
131759724;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZAIUAHMIZJWRPI-UHFFFAOYSA-N
131759493;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AUMXQCVFWSNALF-UHFFFAOYSA-N
131758726;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;IFAFZYRLCMKOIJ-UHFFFAOYSA-N
56938624;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QEYIHHBEALJAPR-UHFFFAOYSA-N
131754691;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TVOKYELEYWPQHJ-UHFFFAOYSA-N
131755420;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WLVCRJNHNFZNFC-UHFFFAOYSA-N
131759250;LPAR3;7;6.920000000000001e-56;0.5;3.9594;98.5795;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YKKMFXGDUMHZFK-UHFFFAOYSA-N
131755425;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DUALUCVNZADEIN-UHFFFAOYSA-N
131765278;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;NKGXOVYKIFCXET-UHFFFAOYSA-N
131755427;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WPQGVSPULJCTQM-UHFFFAOYSA-N
131755426;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PJZXKSHPRSUFOM-UHFFFAOYSA-N
131753813;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLNIBJNSVRHQPM-UHFFFAOYSA-N
131758697;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;LSLCAMBCQCOKNH-UHFFFAOYSA-N
131753814;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UOMPQWRFJUXCEB-UHFFFAOYSA-N
131757190;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;CZOALYUQVVTJLR-UHFFFAOYSA-N
131755583;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OEXKOFIGSYEMIC-UHFFFAOYSA-N
131764645;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HVCHCPBXTHVCNG-UHFFFAOYSA-N
131754055;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KZROWLZDIGBBIN-UHFFFAOYSA-N
131760080;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JOURDTSYZKYHFB-UHFFFAOYSA-N
131764641;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PVWLIUKXMYHSER-UHFFFAOYSA-N
131755943;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XZEHHPQAMMWALZ-UHFFFAOYSA-N
131755588;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UVTYOGUMIJDHCL-UHFFFAOYSA-N
131755589;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MTMROZADXJWIBV-UHFFFAOYSA-N
131766100;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;VXMBUOMIVSCLTQ-UHFFFAOYSA-N
131750602;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KSUDLITWNAQVCF-UHFFFAOYSA-N
131762260;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;AXCNRVAYUVDITR-UHFFFAOYSA-N
131750601;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JKKJXOPBDBRBKU-UHFFFAOYSA-N
131764729;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UJBVBTXTIWQXQY-UHFFFAOYSA-N
131764486;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PMIXGVBCAUCGTR-UHFFFAOYSA-N
131763819;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GHZUZGDZYLIXSI-UHFFFAOYSA-N
131762018;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZTULNDCILAYJFW-UHFFFAOYSA-N
131755442;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XOJDXSDPICSSTA-UHFFFAOYSA-N
131755942;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TVLMJMFKNWRCGI-UHFFFAOYSA-N
131764941;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PYDVXTYEQUTPLD-UHFFFAOYSA-N
131759786;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SHWWTBXHUVHNGT-UHFFFAOYSA-N
131760086;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;APBGQGAQJLLFMC-UHFFFAOYSA-N
131759076;LPAR3;7;1.515e-43;0.5625;3.0738;76.4248;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CYKDFWCGVFNUQI-UHFFFAOYSA-N
131764003;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;JOUMXYIISHXANV-UHFFFAOYSA-N
131756099;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CFIAQJQGPHURGU-UHFFFAOYSA-N
131760085;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RKPVLJWMLADBIO-UHFFFAOYSA-N
131759070;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CSTLHGPIWNGXFJ-UHFFFAOYSA-N
131753923;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADDMBQHEJRQEPO-UHFFFAOYSA-N
131760031;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;ISZIDYGJUZQXDR-UHFFFAOYSA-N
131755635;LPAR3;7;6.793e-50;0.5192;3.5294;87.822;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VMKQCJKDAJJLNO-UHFFFAOYSA-N
131755636;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LEXKCMGVSOPGQN-UHFFFAOYSA-N
131755632;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHBKQHGKLWWKQN-UHFFFAOYSA-N
131756465;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LLAVCIGKJBNPIR-UHFFFAOYSA-N
131756466;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;RPLBRIYXQKGFND-UHFFFAOYSA-N
131755731;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KMUBMOMDOAVSGD-UHFFFAOYSA-N
131756061;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SHPCUQLAGQRBSR-UHFFFAOYSA-N
131756304;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NYFNHSSPUMHKRM-UHFFFAOYSA-N
131761072;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FGRFOAKBUFMFQQ-UHFFFAOYSA-N
131765746;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YEIYHQZOMAQZID-UHFFFAOYSA-N
131761077;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VGOGEYSPDFHEJZ-UHFFFAOYSA-N
131754605;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WTMANSPIMTYBGE-UHFFFAOYSA-N
131755289;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QZSWQEQRBHPEOS-UHFFFAOYSA-N
131755288;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RJHUVVVYTCGXGM-UHFFFAOYSA-N
131759457;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;FJPOWCDSUMTJMY-UHFFFAOYSA-N
131760393;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VFDSPTRIQXDNNU-UHFFFAOYSA-N
131759337;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HZZKPTPGUSEZPI-UHFFFAOYSA-N
131755227;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DFOGLEBUXTZMDU-UHFFFAOYSA-N
131759336;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;JPGXGLQWIXJXMB-UHFFFAOYSA-N
131750382;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UTGDZOIOODXGAH-UHFFFAOYSA-N
131762025;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AODBUYLODSYPEX-UHFFFAOYSA-N
131764725;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QETHLCLILQLBJN-UHFFFAOYSA-N
131755208;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QVDYDIZGXSWABG-UHFFFAOYSA-N
131756487;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;IPYRBHTYCZWCET-UHFFFAOYSA-N
131758544;LPAR3;7;1.8649999999999998e-67;0.5625;4.7896;119.3503;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OCCCCCCCCCCCCCCCCCC;FUAWAXRBBSTPLW-UHFFFAOYSA-N
131763920;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YDUDDRNPXONNIT-UHFFFAOYSA-N
131757851;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCC;UVYBPHXSHXEHQX-UHFFFAOYSA-N
131763927;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;FTPNNFMDJNYTOR-UHFFFAOYSA-N
131759774;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BUIOKWYGCCSIHR-UHFFFAOYSA-N
131759479;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UKLOGABOYJJQSN-UHFFFAOYSA-N
131758778;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WUTNRLSFTGCBMN-UHFFFAOYSA-N
131759466;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDPGTJRMESRMBM-UHFFFAOYSA-N
131759474;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PXIRAQVGRSCHAE-UHFFFAOYSA-N
131759475;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BIPVSIKNOFBMKW-UHFFFAOYSA-N
131758676;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LKBVKNFLTKNLFF-UHFFFAOYSA-N
131758675;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QATNEARFLCYVEE-UHFFFAOYSA-N
131757828;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;CAPXDNNJSKSNHK-UHFFFAOYSA-N
131756002;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GFGMXYASPNDDEJ-UHFFFAOYSA-N
131753520;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;XSDZXQPLCUUMHQ-UHFFFAOYSA-N
131758670;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FCJIOGHLJHBKRR-UHFFFAOYSA-N
131753683;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBKTWXVFMTZJMM-UHFFFAOYSA-N
131756008;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HGGUZVCKVZRCSS-UHFFFAOYSA-N
131763664;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RIMOQAPPBXQQSU-UHFFFAOYSA-N
131760079;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DTTIGIZBXFQWNL-UHFFFAOYSA-N
131759443;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORNQRRXFGCNXPC-UHFFFAOYSA-N
131756718;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;TWOFGMYMSNEEJX-UHFFFAOYSA-N
131761212;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;HLXCIVKTQOCSJO-UHFFFAOYSA-N
131753802;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HSISMYYRVVPXKG-UHFFFAOYSA-N
131755345;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ATZQIXHEMLCJGM-UHFFFAOYSA-N
131755029;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WGKBXGXZUVULLG-UHFFFAOYSA-N
131759441;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GJUYNZPMUHMLSD-UHFFFAOYSA-N
131757360;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;WIJRMMMSSQJMCO-UHFFFAOYSA-N
131761616;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSYRFXMMGSZPLP-UHFFFAOYSA-N
131755349;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JJNQBKOWLBHGAW-UHFFFAOYSA-N
131755023;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XUNZJZHRHUQSIJ-UHFFFAOYSA-N
131756393;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HQMVQKBESXYEOV-UHFFFAOYSA-N
131761761;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;BUUOSXNVBINTDM-UHFFFAOYSA-N
131763148;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XYFSTETYCVWOEN-UHFFFAOYSA-N
131759601;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWXBRFPKZQLDSI-UHFFFAOYSA-N
131759602;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GARPFACGXFDLSO-UHFFFAOYSA-N
131759624;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NRHVUGOGJJHYKY-UHFFFAOYSA-N
131759913;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DZYJOMOZYGTRHJ-UHFFFAOYSA-N
131764475;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LJQQNDOWXYVVGF-UHFFFAOYSA-N
131754862;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CYCUFSFDDJJTHB-UHFFFAOYSA-N
131762166;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XPUHNGSIUVKMSD-UHFFFAOYSA-N
131756644;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XNLCSBIDDKARLA-UHFFFAOYSA-N
131756645;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SSQAVJZOEYXKJM-UHFFFAOYSA-N
131756131;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;OSNTYLCOCUHBGM-UHFFFAOYSA-N
131756137;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEOJWPZDTKLQJA-UHFFFAOYSA-N
131755317;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PUMLPWHNOMWLFJ-UHFFFAOYSA-N
131763719;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PVOYOWCTHMOOIC-UHFFFAOYSA-N
131760537;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FNKCAFMYNGUZAU-UHFFFAOYSA-N
131760536;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;QEQZJVMDJZDGPY-UHFFFAOYSA-N
131755782;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;JVXNBCRQHASIJK-UHFFFAOYSA-N
131759219;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTSPSCRQQWFSPQ-UHFFFAOYSA-N
131753519;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CQKDVCRIDIZFBZ-UHFFFAOYSA-N
131763715;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PLKPFFMMSUBFDF-UHFFFAOYSA-N
131755542;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;QUFRRPUAEDKDEW-UHFFFAOYSA-N
131753857;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VDEFXUQSUBAFFB-UHFFFAOYSA-N
131753854;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HYDJVFGMENBDEL-UHFFFAOYSA-N
131755606;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PHOOIXVIRZQNMT-UHFFFAOYSA-N
131759352;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ZPJFCNOYMFWVHX-UHFFFAOYSA-N
131759351;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;SAZDDXQYEIJVSC-UHFFFAOYSA-N
131760369;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SJPXPPDFLZCAGK-UHFFFAOYSA-N
131765931;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;JTHKVFDOMHYCNA-UHFFFAOYSA-N
131754011;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VTZCRGVLPMDWGI-UHFFFAOYSA-N
131765933;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;TZNCRMSXUPMKHT-UHFFFAOYSA-N
131755234;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LTJDBKBPSJHJDU-UHFFFAOYSA-N
131765937;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHUWPEXZDFNJHC-UHFFFAOYSA-N
131760047;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;VCTYSQSAXZXBBM-UHFFFAOYSA-N
131760046;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XDWSGZHSFJBWFG-UHFFFAOYSA-N
131760045;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YOEDLSRYINEBNN-UHFFFAOYSA-N
131760042;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ITWXUAWJAMUWRI-UHFFFAOYSA-N
131760041;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NUQXGTMHWLBOFD-UHFFFAOYSA-N
56938550;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCC;VPROCYYUGRMDKB-UHFFFAOYSA-N
131755338;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;SAKURFWWZUPUGR-UHFFFAOYSA-N
131761095;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYLDVVKRGAXESB-UHFFFAOYSA-N
101758459;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LDVWBXGIAOXJKP-UHFFFAOYSA-N
131757210;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;NNJOIWXHONILSA-UHFFFAOYSA-N
131757215;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;FXJPVPHYLZUPPO-UHFFFAOYSA-N
131759827;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JFKSTJCBEDXQKN-UHFFFAOYSA-N
131763619;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VSYKULSUHBBKQN-UHFFFAOYSA-N
131761882;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HNCSGYNWTZTAKF-UHFFFAOYSA-N
131760943;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QIWDVFCGYRFMCC-UHFFFAOYSA-N
131766208;LPAR3;7;6.793e-50;0.5192;3.5294;87.822;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;HLRCCNBXHAZKEY-UHFFFAOYSA-N
131763551;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XYIQAWXUEATHMZ-UHFFFAOYSA-N
131750372;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PDEQUPGHMOMBFC-UHFFFAOYSA-N
131758923;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POHNOIJAASRKQU-UHFFFAOYSA-N
131756863;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KUWZMMMTHHIVEK-UHFFFAOYSA-N
131765012;LPAR3;7;2.648e-56;0.54;3.9893;99.3284;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;FYQUINNRFMMPKJ-UHFFFAOYSA-N
131758994;LPAR3;7;2.387e-44;0.5745;3.1314;77.8656;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQSSPIJIQXOSMQ-UHFFFAOYSA-N
131758999;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNZNHYGZYKXHHL-UHFFFAOYSA-N
131758856;LPAR3;7;1.515e-43;0.5625;3.0738;76.4248;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HASCFYSLDYFKJC-UHFFFAOYSA-N
131765787;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KRCNTZDQJTVXHX-UHFFFAOYSA-N
131761034;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OWYOMQRSVDVHPO-UHFFFAOYSA-N
131753772;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JSJXBHBZMVKITQ-UHFFFAOYSA-N
131755725;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PDFSKQVPIUDFLH-UHFFFAOYSA-N
131760644;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SRKCJTCWCCPZMA-UHFFFAOYSA-N
131761039;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SXXIVYLKZBTODG-UHFFFAOYSA-N
131761038;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;TUHYVLFMYBFPEE-UHFFFAOYSA-N
131753779;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VCJBIPBUZKHEIQ-UHFFFAOYSA-N
131765788;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DEOXWPGCLRDGFZ-UHFFFAOYSA-N
56936880;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CIHIPEMTHZCHCJ-UHFFFAOYSA-N
131760949;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GHRXIMZQVOZDCY-UHFFFAOYSA-N
131756351;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PYBMXNRCLHIQRA-UHFFFAOYSA-N
131756093;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOOVNYMOCOZYCS-UHFFFAOYSA-N
131755931;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LXPJIWPRELJYCD-UHFFFAOYSA-N
131755930;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WVIOMIGIVJHZTN-UHFFFAOYSA-N
131760190;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WOPXUTZTLHAOFJ-UHFFFAOYSA-N
131765229;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC;HDEGSNZKEZNQTG-UHFFFAOYSA-N
131755938;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DRXKVDMYIYMLIN-UHFFFAOYSA-N
131753777;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZFYKFVATZUURMJ-UHFFFAOYSA-N
131761078;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SOCNQOBFARPJBO-UHFFFAOYSA-N
131763965;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;YLJRMSSFHWLPIF-UHFFFAOYSA-N
131760980;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATKWSHJQYSCESK-UHFFFAOYSA-N
131757378;LPAR3;7;3.362e-55;0.5745;3.9101;97.3471;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;BDPJRENIZGEJEP-UHFFFAOYSA-N
131760987;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UBNYYWZUYOQPFD-UHFFFAOYSA-N
131759766;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SHCRBDGMFUJKHT-UHFFFAOYSA-N
131753901;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OXALJAMNRIYLJO-UHFFFAOYSA-N
131763406;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;OJYRZPXGOAVFNV-UHFFFAOYSA-N
131756460;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;YEMQFZGWRFYGJM-UHFFFAOYSA-N
131753487;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XMQODCFBJXQBDV-UHFFFAOYSA-N
131763646;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XBRGDJCOPAOHAK-UHFFFAOYSA-N
131755162;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QKCZWZMHMPYOPG-UHFFFAOYSA-N
131755163;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZXLEWFIONDQJM-UHFFFAOYSA-N
131759436;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HVIQWNBZDUXPDM-UHFFFAOYSA-N
131759437;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JRNCFIBTWGMRER-UHFFFAOYSA-N
131760492;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PCTKCCIZPRJCIQ-UHFFFAOYSA-N
131760493;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JLRXETBUGMIPJK-UHFFFAOYSA-N
131756459;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;MCIPPLJLYFTODM-UHFFFAOYSA-N
131756458;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;OLZRHDMTTQNXSI-UHFFFAOYSA-N
131759879;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SSKQGMAHQBYKGA-UHFFFAOYSA-N
131753931;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XDAZZLONPIHPNZ-UHFFFAOYSA-N
131758983;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JBTOLUCASDBORC-UHFFFAOYSA-N
131758823;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHQUEWMLMFUPTL-UHFFFAOYSA-N
131756350;LPAR3;7;5.066999999999999e-53;0.5625;3.7538;93.4365;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XTHHRTVNJZAGND-UHFFFAOYSA-N
131765713;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;MQJUYBMLAXVAFU-UHFFFAOYSA-N
131759515;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DFMOOXJLNYMJDV-UHFFFAOYSA-N
131753279;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ABNSWGKFFQUIAR-UHFFFAOYSA-N
131755807;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;PMGLNPPJDNWBFI-UHFFFAOYSA-N
131755806;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;GZBPQMRKEPSOQQ-UHFFFAOYSA-N
131755805;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;DATRBAYWFQZJEM-UHFFFAOYSA-N
131753668;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PZHUYFBIXNXBLU-UHFFFAOYSA-N
131763149;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CVWPTSPATKBGFJ-UHFFFAOYSA-N
131764226;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPRZFYNWCPHLBU-UHFFFAOYSA-N
131759668;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GRFDFSAMUSSDRA-UHFFFAOYSA-N
131763213;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZSEBUOJAFUHWIN-UHFFFAOYSA-N
131757541;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BVJWKPOODLDRIT-UHFFFAOYSA-N
131755296;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HIEDMQDYLJFCPX-UHFFFAOYSA-N
131760281;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AJRSKYARNMVHFT-UHFFFAOYSA-N
131761380;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JDPQRNIORXECGT-UHFFFAOYSA-N
131759564;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SPGXNOUOYUPBSF-UHFFFAOYSA-N
131761637;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MVIQOCPGVCDPJO-UHFFFAOYSA-N
131753408;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BYFGMMQHMLHSEK-UHFFFAOYSA-N
131766112;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DVOPPHNPCKLGLG-UHFFFAOYSA-N
131755348;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QHLALDPTQOIJFG-UHFFFAOYSA-N
131756062;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HAZYEPTWRFLUON-UHFFFAOYSA-N
131758027;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QBIXIQXOQCCVJI-UHFFFAOYSA-N
131763823;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MJTWPTSBGBSEIL-UHFFFAOYSA-N
131755455;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IEXFFVIGQBUXOM-UHFFFAOYSA-N
131755223;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VOQAPCORCIBANS-UHFFFAOYSA-N
131757074;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FUSFZXIXQUQAAT-UHFFFAOYSA-N
131765727;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HBROMTOKCOWBCF-UHFFFAOYSA-N
131753608;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FXCUDDKMKYVUSX-UHFFFAOYSA-N
131760835;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PYMKNYQBVPYQSZ-UHFFFAOYSA-N
131756769;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SNADIPNNRGNXJQ-UHFFFAOYSA-N
131755533;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UZJFJKLCXWYRPN-UHFFFAOYSA-N
131762554;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NGQPUERHGUGMCW-UHFFFAOYSA-N
131760427;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KQHIUWHKRXQFTK-UHFFFAOYSA-N
131760228;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CWWUWOFQAROKCL-UHFFFAOYSA-N
131758057;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RCHRBILGWVSBMD-UHFFFAOYSA-N
131761238;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFNVGGQCIPHTPE-UHFFFAOYSA-N
131764796;LPAR3;6;1.82e-61;0.5778;9.3618;108.5976;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LORJDMOYIBFNHP-UHFFFAOYSA-N
131756573;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;GSYLODJVGAPZPZ-UHFFFAOYSA-N
56940408;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JQGJMNPRHDYYSP-UHFFFAOYSA-N
131755067;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZKXHCZXVCQJSLC-UHFFFAOYSA-N
131759869;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FPWUJNGGVATCPT-UHFFFAOYSA-N
131762596;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YBMSPSGALOVJLN-UHFFFAOYSA-N
131755270;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XWHMTYPOWZWZQD-UHFFFAOYSA-N
131756757;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GYBHIADXUHHABV-UHFFFAOYSA-N
131763725;LPAR3;6;2.445e-62;0.5652;9.4958;110.1626;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FVWBEGMXQQWDMG-UHFFFAOYSA-N
131762193;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VCPLVQPYTVTKNH-UHFFFAOYSA-N
131758049;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;USMSEKIRTKUMEG-UHFFFAOYSA-N
131760108;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZHLYVKHDLPQFD-UHFFFAOYSA-N
131763725;FABP3;7;1.0989999999999999e-54;0.5;1.8013;96.4236;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FVWBEGMXQQWDMG-UHFFFAOYSA-N
131756683;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NIFYGEMZMKSOKK-UHFFFAOYSA-N
131758870;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FDMDMGLROVNITG-UHFFFAOYSA-N
53480584;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PTTJPMSHTWJLSB-UHFFFAOYSA-N
131759360;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKXYRUMPRSILQY-UHFFFAOYSA-N
131760892;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RIWBDVNAXLFKHZ-UHFFFAOYSA-N
131761469;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OQSNLZOBBCMKHQ-UHFFFAOYSA-N
131754036;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KRMCNOVCWGWYHP-UHFFFAOYSA-N
131759069;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SHVMTKJCJPSWEE-UHFFFAOYSA-N
131763691;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NVZVXKRDHFHVPS-UHFFFAOYSA-N
131755986;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NUAAGXVXOLBDRH-UHFFFAOYSA-N
131765459;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VKCIZSSGVHDMAT-UHFFFAOYSA-N
56940398;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;RBNZROQPTPETBJ-UHFFFAOYSA-N
131750421;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131759439;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OAYIGAFUEDTGGM-UHFFFAOYSA-N
131763669;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYKCXKFNRHDBNF-UHFFFAOYSA-N
131760854;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CFXLMSTVSIEEEU-UHFFFAOYSA-N
131753572;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;TXWDWSJYGIFVKP-UHFFFAOYSA-N
131758090;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KGUKXPWFPDKTLO-UHFFFAOYSA-N
131755540;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JLNYLODKIXIHKZ-UHFFFAOYSA-N
131763345;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VZMDAERKCFBEMZ-UHFFFAOYSA-N
131760557;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFPSXJPVXFGDJF-UHFFFAOYSA-N
131760875;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJJRJDAWZMHWKT-UHFFFAOYSA-N
131756037;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTXFYVWYFJNSRG-UHFFFAOYSA-N
131755687;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FPEZLWDATYZAAB-UHFFFAOYSA-N
131756544;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;POSPEMGIHZMKBT-UHFFFAOYSA-N
131753401;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXABCMZUYUPINF-UHFFFAOYSA-N
131755047;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZWYSQWJROGDLIY-UHFFFAOYSA-N
131760283;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BNFYPGSVPNZPRA-UHFFFAOYSA-N
131756851;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UOXUZNWTFAUUEA-UHFFFAOYSA-N
131761399;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTFUIJABEMQZTB-UHFFFAOYSA-N
131761689;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZYGIRJGVMNSFKT-UHFFFAOYSA-N
131757702;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NIHHWECWJIEWCW-UHFFFAOYSA-N
131766133;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPUKBWQAKQTPIK-UHFFFAOYSA-N
131760062;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PBUZOPDSPGPOQS-UHFFFAOYSA-N
131762554;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NGQPUERHGUGMCW-UHFFFAOYSA-N
131763953;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ZEKYFQBFJWUBSX-UHFFFAOYSA-N
56936857;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;AQYRONSXFRXAPZ-UHFFFAOYSA-N
131757037;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBEXOEBBZPQUND-UHFFFAOYSA-N
131759538;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;STEWTUZWAFGDIQ-UHFFFAOYSA-N
131758049;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;USMSEKIRTKUMEG-UHFFFAOYSA-N
131766331;FABP3;7;2.8870000000000002e-56;0.5116;1.8541;99.2612;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KCNBDVGTYULZQA-UHFFFAOYSA-N
131753722;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LTDLQTORSCMBOQ-UHFFFAOYSA-N
131756397;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ORHRYJKHSZANHP-UHFFFAOYSA-N
131765095;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZOOGEVWOZRKOCC-UHFFFAOYSA-N
131761920;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UNYSRSKHDZXMCA-UHFFFAOYSA-N
131763461;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VQFIBNGFXJMOBY-UHFFFAOYSA-N
131756728;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SJSPRNUEKGVEFR-UHFFFAOYSA-N
131760911;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SCBNRRNNYKNHJU-UHFFFAOYSA-N
131756757;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GYBHIADXUHHABV-UHFFFAOYSA-N
131764738;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WJPRJNAUQKKXCZ-UHFFFAOYSA-N
131762024;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFOJMNHTTGBKCU-UHFFFAOYSA-N
131764568;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BTDHRGQFFPYVIV-UHFFFAOYSA-N
131758715;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;VARKWBYIQXSEHP-UHFFFAOYSA-N
53480584;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PTTJPMSHTWJLSB-UHFFFAOYSA-N
131753803;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NTSBQBZSOJXXMZ-UHFFFAOYSA-N
131757907;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CSNMMADQHKSQLN-UHFFFAOYSA-N
131759832;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RZPLQHKENQFELH-UHFFFAOYSA-N
131765280;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZVWNKBXKHWXDGQ-UHFFFAOYSA-N
131759833;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VFQVWRHDXMNZND-UHFFFAOYSA-N
131764597;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZDCGUXVHJZWSQH-UHFFFAOYSA-N
131759544;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJQLIWBFMBNJL-UHFFFAOYSA-N
131762041;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KHYHDLAAJWKMKK-UHFFFAOYSA-N
131760083;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QDMDGODCZNNQBV-UHFFFAOYSA-N
131764065;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;INURSZUTYWHVKL-UHFFFAOYSA-N
131761576;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZLWKCBUKUANMW-UHFFFAOYSA-N
131761582;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HODDFEFUYCPVTQ-UHFFFAOYSA-N
131761989;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YUMXSFGYXZWQHW-UHFFFAOYSA-N
131753601;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UFZBCZHRQDOVGQ-UHFFFAOYSA-N
131765810;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDRIITRYYSNHJE-UHFFFAOYSA-N
131750623;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AKOYMLIOOBZSET-UHFFFAOYSA-N
131753564;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LRUXRFQLJJKABR-UHFFFAOYSA-N
131757286;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NGDYFTHZYYRYJI-UHFFFAOYSA-N
131763469;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BSMCSPHFOOHCPJ-UHFFFAOYSA-N
131756167;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJAVVKUVPSLGBA-UHFFFAOYSA-N
131755402;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RDMSBFYFWYXPOF-UHFFFAOYSA-N
131759223;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVLJROQTWFUTBY-UHFFFAOYSA-N
131761399;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTFUIJABEMQZTB-UHFFFAOYSA-N
131755422;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKJRZMKAIOLLKX-UHFFFAOYSA-N
131761219;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PIMPYDZIXKACMS-UHFFFAOYSA-N
9545910;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTCGGJDDKNMITC-UHFFFAOYSA-N
131760985;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GWUZWGZLGCRJKX-UHFFFAOYSA-N
131763346;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CJMQGODMMNFMOQ-UHFFFAOYSA-N
131763670;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JNZQBLFKGOVDNV-UHFFFAOYSA-N
131755303;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LBDYWQQOJYAVLA-UHFFFAOYSA-N
131756239;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WWQOKYMMBUGAPO-UHFFFAOYSA-N
131765768;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FBORIUPMVVLKEO-UHFFFAOYSA-N
131756238;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QGNLJGRXJOVVCH-UHFFFAOYSA-N
131760341;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SPZFKKCPMIILSL-UHFFFAOYSA-N
131755106;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XASLXNYLAYUVLS-UHFFFAOYSA-N
131762286;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MTZJVBULFGKJAO-UHFFFAOYSA-N
131762257;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LOKPBYPRLSRHNU-UHFFFAOYSA-N
131761602;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;GAQSYHGNKUYUAQ-UHFFFAOYSA-N
131765763;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZOXUQQAZDPHQME-UHFFFAOYSA-N
131764261;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IUKFCSZXWLWVSV-UHFFFAOYSA-N
131762029;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATIWAHXGZHCXGG-UHFFFAOYSA-N
131756212;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDDFZEYQURVBHO-UHFFFAOYSA-N
131762024;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFOJMNHTTGBKCU-UHFFFAOYSA-N
131755098;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;QWFBYRTVWVIXIZ-UHFFFAOYSA-N
131755448;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UGGFEFYRAIPHJW-UHFFFAOYSA-N
131764479;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZMMKASYZFJCWTE-UHFFFAOYSA-N
131763253;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNDHOYSSWMWISN-UHFFFAOYSA-N
131766132;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SOVSZEWJOOZRMD-UHFFFAOYSA-N
131765799;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FOQDWFDQDXPCLA-UHFFFAOYSA-N
131758021;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XXGCNFKQIMIEKF-UHFFFAOYSA-N
131763340;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FJMGCBCMXFEVHK-UHFFFAOYSA-N
131760971;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XOYSWGHQVMLVFO-UHFFFAOYSA-N
131760466;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZTDMXZQXQOEXKZ-UHFFFAOYSA-N
131759558;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OXJWMXOKVXQQKX-UHFFFAOYSA-N
131761184;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RBUWIFMTDWYJEN-UHFFFAOYSA-N
131762391;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VBIJXNNOTQKKMT-UHFFFAOYSA-N
131766171;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PFDVCVWZOWWSHG-UHFFFAOYSA-N
131750619;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JEQMHFPQVKBLLQ-UHFFFAOYSA-N
131758281;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XGRHXRCXVVXNRR-UHFFFAOYSA-N
131764977;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;OTTHDHMHOBYLKO-UHFFFAOYSA-N
131760472;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QQEYPDQDALZZPI-UHFFFAOYSA-N
131764574;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;MCYXMPXRAIMPSS-UHFFFAOYSA-N
131765315;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RAOLZQQBRJPHKT-UHFFFAOYSA-N
131761021;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEPRNBOWRGJCFH-UHFFFAOYSA-N
131760798;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BKWZVJWHAPNDHG-UHFFFAOYSA-N
131756219;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDZSNMGLSOCIKD-UHFFFAOYSA-N
131763429;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PZLNYKRJVKGRCK-UHFFFAOYSA-N
131763880;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NVECGMYENDMAPE-UHFFFAOYSA-N
131762097;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SZEVHZAZCSIMNY-UHFFFAOYSA-N
131761954;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ILYJVOJSUJTWSZ-UHFFFAOYSA-N
131757914;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;XMIDMFLTTPZJFG-UHFFFAOYSA-N
131755324;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NQZTVKYDVUQPPX-UHFFFAOYSA-N
131756084;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VTHDNMHRPKXWMZ-UHFFFAOYSA-N
131763730;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WHDJEGCDDOXKQQ-UHFFFAOYSA-N
131763223;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YKKNGUMBQWFKKB-UHFFFAOYSA-N
131762057;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CUAKEOAMABCXMW-UHFFFAOYSA-N
25240386;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEWUGNNMLZAOCV-UHFFFAOYSA-N
131755661;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XMRBIWWWAIEADV-UHFFFAOYSA-N
131755381;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WHIFVRILMXLGDQ-UHFFFAOYSA-N
131764609;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNMDOQDBXJDBNN-UHFFFAOYSA-N
131765459;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VKCIZSSGVHDMAT-UHFFFAOYSA-N
131760966;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ACBRHMNCXHNUSA-UHFFFAOYSA-N
131756146;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SBHOBWMHSSIWIO-UHFFFAOYSA-N
131753395;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LETIJHNTNHPKEB-UHFFFAOYSA-N
131763470;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GYRBUPBXSBUDIS-UHFFFAOYSA-N
131760856;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WUQZNKAJBDSVTJ-UHFFFAOYSA-N
131766220;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HKWPIEYUIOGMRD-UHFFFAOYSA-N
131753811;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AHYJLIXVIKISHC-UHFFFAOYSA-N
131762062;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YMIBNLBMYGUACK-UHFFFAOYSA-N
131760102;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FTPZUXAMLKYSRC-UHFFFAOYSA-N
56940423;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OXMRRWYQHLBNAT-UHFFFAOYSA-N
131759201;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YAQCQKUWLQDYCJ-UHFFFAOYSA-N
131757906;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;NSRSRNOQDGUIQQ-UHFFFAOYSA-N
9544749;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131765796;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YPKAPKOHLOHKML-UHFFFAOYSA-N
131760472;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QQEYPDQDALZZPI-UHFFFAOYSA-N
131755540;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JLNYLODKIXIHKZ-UHFFFAOYSA-N
131764876;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XPVVJFGULSFCAO-UHFFFAOYSA-N
131753374;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OWUCYMBXHHXZRL-UHFFFAOYSA-N
131762073;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PHZLRGDIBRAISL-UHFFFAOYSA-N
131762603;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYXWSTIICMYXLZ-UHFFFAOYSA-N
131755236;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XYIPDNMNPDTONZ-UHFFFAOYSA-N
9544854;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PKPAOZPHGVIQGC-UHFFFAOYSA-N
131765509;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IZGDWRLRMLPRRH-UHFFFAOYSA-N
131763475;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZWAGVJRENVHFMW-UHFFFAOYSA-N
131760069;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CESSZFUPJUMNNU-UHFFFAOYSA-N
131765399;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FRQQCCLOVFVEJY-UHFFFAOYSA-N
25240386;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEWUGNNMLZAOCV-UHFFFAOYSA-N
131761027;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NWCRHTRUMSZHGL-UHFFFAOYSA-N
131757259;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;XAXCHZWOFLFLPM-UHFFFAOYSA-N
131761503;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JKFVBYVUASWLNU-UHFFFAOYSA-N
131760742;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTSDPTZQCYEEKC-UHFFFAOYSA-N
131760572;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTJRQGPURCBISX-UHFFFAOYSA-N
131766311;LPAR3;6;6.048e-48;0.4464;7.2824;84.322;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KBRCUQIVLUDXJP-UHFFFAOYSA-N
131766000;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FCYZFOKGTFCMBJ-UHFFFAOYSA-N
131755837;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;VBCHYGJCHLNVFC-UHFFFAOYSA-N
131761209;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MEITWFTUQYDSIT-UHFFFAOYSA-N
131761539;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NYDVKQSVKPIZDU-UHFFFAOYSA-N
131756750;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FBQQXRDCPOBIQG-UHFFFAOYSA-N
131757173;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYPCPBKGHFDBQX-UHFFFAOYSA-N
131761022;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GUKADGOJBYUPGU-UHFFFAOYSA-N
131756751;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IRPLNLXEUHFALC-UHFFFAOYSA-N
131765522;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RGDIOAINFQTUAS-UHFFFAOYSA-N
131758090;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KGUKXPWFPDKTLO-UHFFFAOYSA-N
131754064;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NTYQJMMREGDBBU-UHFFFAOYSA-N
131760723;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LQYKKZORBDYUKT-UHFFFAOYSA-N
131759380;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QZEYFZLPYNVHDI-UHFFFAOYSA-N
131764597;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZDCGUXVHJZWSQH-UHFFFAOYSA-N
131756294;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VIGAYEURCPHMGZ-UHFFFAOYSA-N
131756868;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VCXHGFGBKAVNAO-UHFFFAOYSA-N
131760721;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SDWMHLZEAPLCIQ-UHFFFAOYSA-N
131763434;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MQHMZCFDXHXJOZ-UHFFFAOYSA-N
131760952;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KFHZZVYZUWJKQG-UHFFFAOYSA-N
131764685;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XROVXJWVFZVSEH-UHFFFAOYSA-N
131763213;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZSEBUOJAFUHWIN-UHFFFAOYSA-N
131761938;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;CBLVLYIBWALOEM-UHFFFAOYSA-N
131761110;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NIWWYTGJAYUGFA-UHFFFAOYSA-N
131755461;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MEUWGTHLRSIXHV-UHFFFAOYSA-N
131765987;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QOWBFANLOZBMRP-UHFFFAOYSA-N
131759811;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKWQPKBPMIZKRY-UHFFFAOYSA-N
131761503;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JKFVBYVUASWLNU-UHFFFAOYSA-N
56940423;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OXMRRWYQHLBNAT-UHFFFAOYSA-N
131755794;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJRBHONTDZUSAV-UHFFFAOYSA-N
131763753;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JBDVHPYZDOJNKC-UHFFFAOYSA-N
131764489;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZMDJDWQCIRBXLN-UHFFFAOYSA-N
131763332;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WFZRDLLUISIIIZ-UHFFFAOYSA-N
131764938;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TZHCCHGTCLEUNU-UHFFFAOYSA-N
131757868;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;VGJLRVHUGWORNM-UHFFFAOYSA-N
131765399;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FRQQCCLOVFVEJY-UHFFFAOYSA-N
131764238;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DQGFYDHZNGKRQX-UHFFFAOYSA-N
56940415;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHYGFPBNUHVOST-UHFFFAOYSA-N
131758057;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RCHRBILGWVSBMD-UHFFFAOYSA-N
131763455;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OXKWYVLMELYMCF-UHFFFAOYSA-N
56940199;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VTOFANRVVFEBFP-UHFFFAOYSA-N
131757266;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VDFBIEOSCQDYJB-UHFFFAOYSA-N
131753635;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CCKLWBNVDVDCFO-UHFFFAOYSA-N
131760140;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CRAIJEBCCMKULT-UHFFFAOYSA-N
131765821;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQVAELCJJYGSJQ-UHFFFAOYSA-N
131755318;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCXYYNLRWFKNNQ-UHFFFAOYSA-N
131764812;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IYWKHVMWOJKUJQ-UHFFFAOYSA-N
131762408;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DKJQAINPSUNNDI-UHFFFAOYSA-N
131756115;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NWCGBGIXJBNACP-UHFFFAOYSA-N
131755099;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIRHPCGBIJZASY-UHFFFAOYSA-N
131750592;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BHZWQMNOYPGDNF-UHFFFAOYSA-N
131765800;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VFFAIRLXZFVSMW-UHFFFAOYSA-N
131764484;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YUKFMIGMRRYIPC-UHFFFAOYSA-N
131760572;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTJRQGPURCBISX-UHFFFAOYSA-N
131759984;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UEZYCMFLJSEDEB-UHFFFAOYSA-N
131755047;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZWYSQWJROGDLIY-UHFFFAOYSA-N
131755522;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SGSCBPFVSOCVPP-UHFFFAOYSA-N
131765765;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HJZFUASFTDEZRS-UHFFFAOYSA-N
131762045;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FEDXZFODPLHGFU-UHFFFAOYSA-N
131755080;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PTUORBCKDRTJCD-UHFFFAOYSA-N
131760721;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SDWMHLZEAPLCIQ-UHFFFAOYSA-N
131765936;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNYZAFAGHAFCHN-UHFFFAOYSA-N
131765351;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KSUYSWUNWRLYBY-UHFFFAOYSA-N
131765858;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CHOVJZYSPBBQPK-UHFFFAOYSA-N
131764685;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XROVXJWVFZVSEH-UHFFFAOYSA-N
131762724;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PWBWZFOUPAVKBH-UHFFFAOYSA-N
131764937;LPAR3;6;1.054e-52;0.4643;8.0142;92.8655;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YERJMWWEGCCVST-UHFFFAOYSA-N
131761500;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GZYXMJLTMGSMEX-UHFFFAOYSA-N
131757264;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LVHNDABSHOYKAM-UHFFFAOYSA-N
9544925;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UMZMGYWVBWXWDT-UHFFFAOYSA-N
131757219;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;NDIASEVRLBWVRO-UHFFFAOYSA-N
131755968;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QHPYYZFXEDYENT-UHFFFAOYSA-N
131756218;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FTTKNOTUTROZKZ-UHFFFAOYSA-N
9544925;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UMZMGYWVBWXWDT-UHFFFAOYSA-N
53480575;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWSQCBUVZQFFAT-UHFFFAOYSA-N
131766171;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PFDVCVWZOWWSHG-UHFFFAOYSA-N
131765154;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YTMLSQRVRJOZHY-UHFFFAOYSA-N
131759811;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKWQPKBPMIZKRY-UHFFFAOYSA-N
131758708;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PVJPHQHSWUWAQJ-UHFFFAOYSA-N
131760853;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SNZNTALTGPYNEP-UHFFFAOYSA-N
131766433;FABP3;7;2.9169999999999997e-47;0.4355;1.5531;83.0951;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UQAQHCSDUNHUKS-UHFFFAOYSA-N
131764200;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HGVUWOFDDHGBHN-UHFFFAOYSA-N
131760691;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ULBTVPHSXKRJBN-UHFFFAOYSA-N
131763368;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JWYJCPQICGZVHS-UHFFFAOYSA-N
131750626;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HUAVJWUSPIMCRO-UHFFFAOYSA-N
131761238;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFNVGGQCIPHTPE-UHFFFAOYSA-N
131761360;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IHIIZCPGLXUXFB-UHFFFAOYSA-N
131764225;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADUPVYSRXHTHNB-UHFFFAOYSA-N
131766146;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OAINQTZTNKJXAY-UHFFFAOYSA-N
131765591;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MDKFQYLWNPEPSF-UHFFFAOYSA-N
131760090;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;PQNHEABAEPMJMD-UHFFFAOYSA-N
131761931;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORFNHODRKLEDIY-UHFFFAOYSA-N
131756895;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SKWZGEDXJHKPTI-UHFFFAOYSA-N
131765280;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZVWNKBXKHWXDGQ-UHFFFAOYSA-N
131757266;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VDFBIEOSCQDYJB-UHFFFAOYSA-N
131760850;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XRLJXFQOTJPGAY-UHFFFAOYSA-N
131762107;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VMZJSWALUJFVMA-UHFFFAOYSA-N
131750607;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ACBQPKXRQKGWDK-UHFFFAOYSA-N
131757362;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PWCZEZSCMQVPJQ-UHFFFAOYSA-N
131757702;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NIHHWECWJIEWCW-UHFFFAOYSA-N
131760044;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KRNIAXVTJSTDFH-UHFFFAOYSA-N
131764238;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DQGFYDHZNGKRQX-UHFFFAOYSA-N
131756321;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DQHAGOJZQAKIDI-UHFFFAOYSA-N
131759206;LPAR3;6;1.181e-57;0.5417;8.7755;101.7533;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGGVBZZJDDBPJU-UHFFFAOYSA-N
131755795;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;AHTWTNHQUCGAHA-UHFFFAOYSA-N
131760348;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SAHJXIOVXNXTQL-UHFFFAOYSA-N
131753752;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BVDHVRNSAXAACC-UHFFFAOYSA-N
131755533;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UZJFJKLCXWYRPN-UHFFFAOYSA-N
131759941;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DDQPMPZGDGZDLB-UHFFFAOYSA-N
131766304;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XODJUSVIRAYEDA-UHFFFAOYSA-N
131755656;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SJRLCZGQDXBYGK-UHFFFAOYSA-N
131760489;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FJIWLFYCFVEOMI-UHFFFAOYSA-N
131755080;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PTUORBCKDRTJCD-UHFFFAOYSA-N
131755992;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NCJLYHVTMRUDRY-UHFFFAOYSA-N
56940303;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AMKVBHVMCBBXNU-UHFFFAOYSA-N
131756958;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XDOAVAFFHWQIBZ-UHFFFAOYSA-N
131755348;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QHLALDPTQOIJFG-UHFFFAOYSA-N
131755270;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XWHMTYPOWZWZQD-UHFFFAOYSA-N
131764581;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NROTYPBETZBKSI-UHFFFAOYSA-N
131763137;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CYKZBIMIYCZCIP-UHFFFAOYSA-N
131762029;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATIWAHXGZHCXGG-UHFFFAOYSA-N
131755310;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MSRILFYVWJWHRM-UHFFFAOYSA-N
131760566;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;KLPBKIYPIXLUIY-UHFFFAOYSA-N
131755217;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KAAHBDXVVGSEAD-UHFFFAOYSA-N
131766000;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FCYZFOKGTFCMBJ-UHFFFAOYSA-N
131755527;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HSNGDBNPPHCXGS-UHFFFAOYSA-N
131759359;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UOUKSIKNMFLSOA-UHFFFAOYSA-N
131757293;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;PEDXBSVTVPVYSP-UHFFFAOYSA-N
131765161;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LEZCTIQNRDNRPA-UHFFFAOYSA-N
131763383;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RMEHQMVZPZYKQO-UHFFFAOYSA-N
131759359;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UOUKSIKNMFLSOA-UHFFFAOYSA-N
131759978;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RKIWUSSRNOMOHK-UHFFFAOYSA-N
131759558;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OXJWMXOKVXQQKX-UHFFFAOYSA-N
131757220;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HMVLLJGZOCQDFI-UHFFFAOYSA-N
131757441;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNLMGPXMNLVNRF-UHFFFAOYSA-N
131764261;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IUKFCSZXWLWVSV-UHFFFAOYSA-N
131759373;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JNZLJJXCXKXIHT-UHFFFAOYSA-N
131755223;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VOQAPCORCIBANS-UHFFFAOYSA-N
131755277;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZHTYGSYTHOBYHT-UHFFFAOYSA-N
131755276;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XNXYVFSTYMBATM-UHFFFAOYSA-N
131755172;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMCYMWCKOMILQE-UHFFFAOYSA-N
131757265;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QANJMRAWHCWEGS-UHFFFAOYSA-N
131761796;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WNTXQOREERQHJA-UHFFFAOYSA-N
131765805;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZQLZCFZHBCBDQM-UHFFFAOYSA-N
131756050;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UVBMJNGWTCZEQF-UHFFFAOYSA-N
131760764;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZIRJXTDTRZMNMW-UHFFFAOYSA-N
131756745;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GOUXXLWMYYBHCM-UHFFFAOYSA-N
131761938;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;CBLVLYIBWALOEM-UHFFFAOYSA-N
131765958;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WHZABLDEOLRJNE-UHFFFAOYSA-N
131764485;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RYZZITBQUSKDOJ-UHFFFAOYSA-N
131753818;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CVSGTFIHUMEUGC-UHFFFAOYSA-N
131765806;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BBJDEDZNDSLQPM-UHFFFAOYSA-N
131756707;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JWRLQVQWCRUWFY-UHFFFAOYSA-N
131761003;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HJKVTYHGHKPVQF-UHFFFAOYSA-N
131761184;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RBUWIFMTDWYJEN-UHFFFAOYSA-N
131762391;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VBIJXNNOTQKKMT-UHFFFAOYSA-N
131759985;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LAGWHQFUVYNWQJ-UHFFFAOYSA-N
131762192;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCINELBMQVGABE-UHFFFAOYSA-N
131760588;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;IHFWXPSVLCAYTA-UHFFFAOYSA-N
131763758;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AUHAVSXJNUHURT-UHFFFAOYSA-N
131756391;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEHFEWQFZHCTSK-UHFFFAOYSA-N
131761588;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PKYHAMJIVRQXKF-UHFFFAOYSA-N
131763487;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCCCMTCYXQXNLK-UHFFFAOYSA-N
131759723;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DFWFUERTQLGULG-UHFFFAOYSA-N
131764211;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MGEWHJIKKLGUTH-UHFFFAOYSA-N
131762007;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PZHLNSMCTKLDQD-UHFFFAOYSA-N
1080;GRIK3;6;5.26e-46;0.4615;4.1057;80.8401;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C(C(C(=O)O)N)SCC(=O)O;GBFLZEXEOZUWRN-UHFFFAOYSA-N
131765469;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YYUUNOIKGZVQNL-UHFFFAOYSA-N
131761582;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HODDFEFUYCPVTQ-UHFFFAOYSA-N
131763419;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCAVHXJASXMRHH-UHFFFAOYSA-N
131763461;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VQFIBNGFXJMOBY-UHFFFAOYSA-N
131763848;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LEMUUXQSONCZBR-UHFFFAOYSA-N
131759031;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJPANQUZKYHYSG-UHFFFAOYSA-N
131764752;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IKPPMXCWNQRCFS-UHFFFAOYSA-N
131757906;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;NSRSRNOQDGUIQQ-UHFFFAOYSA-N
131763428;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DSFHORXLWDQBME-UHFFFAOYSA-N
131756469;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BEJINFUEKQSHML-UHFFFAOYSA-N
131766080;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AHWAAIWRGKZIQL-UHFFFAOYSA-N
131763785;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEPFYTKJXBZPDF-UHFFFAOYSA-N
131759091;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LMIVETVBRASKSZ-UHFFFAOYSA-N
131758714;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;ZJPRUJQVOSHYAD-UHFFFAOYSA-N
131757293;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;PEDXBSVTVPVYSP-UHFFFAOYSA-N
131764065;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;INURSZUTYWHVKL-UHFFFAOYSA-N
131760728;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;COGBIGLYXFERSM-UHFFFAOYSA-N
131763270;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;IRNARDRWANMWOS-UHFFFAOYSA-N
131760460;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HVOSMRAPGYBTSZ-UHFFFAOYSA-N
131755846;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KDCWAZIMGWULJP-UHFFFAOYSA-N
131753629;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WZCFDZGLFKVTIF-UHFFFAOYSA-N
131761948;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DLVBEOBLMNLHJH-UHFFFAOYSA-N
131761903;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JBOWPSIDPCYDPQ-UHFFFAOYSA-N
131766099;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SUUKHPGWXKPJHR-UHFFFAOYSA-N
131758066;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PAWWFARWOBDKCZ-UHFFFAOYSA-N
131764927;LPAR3;6;9.708e-50;0.4727;7.5584;87.5437;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LHOPPWWFGCZSQE-UHFFFAOYSA-N
131759985;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LAGWHQFUVYNWQJ-UHFFFAOYSA-N
131755656;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SJRLCZGQDXBYGK-UHFFFAOYSA-N
131755381;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WHIFVRILMXLGDQ-UHFFFAOYSA-N
131756566;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KPIFNDIZKFVARX-UHFFFAOYSA-N
131765522;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RGDIOAINFQTUAS-UHFFFAOYSA-N
131759966;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HYPRJUDAMZSDSL-UHFFFAOYSA-N
131763218;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JAGNAZGVBMHJJJ-UHFFFAOYSA-N
131763798;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RRXSURPJVARICW-UHFFFAOYSA-N
131759926;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;QMUSPYPGMAYRTR-UHFFFAOYSA-N
131750370;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AFFQVAIMWFYJJS-UHFFFAOYSA-N
131759926;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;QMUSPYPGMAYRTR-UHFFFAOYSA-N
131755302;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LFNFVWNJHQPLPQ-UHFFFAOYSA-N
131750607;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ACBQPKXRQKGWDK-UHFFFAOYSA-N
131762000;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHFSVCDRQBJIQA-UHFFFAOYSA-N
131765846;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ULMDLWOZXLWNSK-UHFFFAOYSA-N
131763388;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MLBJZKVMDIHXDL-UHFFFAOYSA-N
131761533;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FLTZXTYOVWGLNO-UHFFFAOYSA-N
25240384;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POBQACNRSDFLSN-UHFFFAOYSA-N
131762271;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZQAVPFDERBCAHC-UHFFFAOYSA-N
131764225;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADUPVYSRXHTHNB-UHFFFAOYSA-N
131763433;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UGZBFOQDGPJMST-UHFFFAOYSA-N
131760283;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BNFYPGSVPNZPRA-UHFFFAOYSA-N
131760108;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZHLYVKHDLPQFD-UHFFFAOYSA-N
131759858;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYBNKTCMSXGTGD-UHFFFAOYSA-N
131764811;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RFNMQGVASYUQRC-UHFFFAOYSA-N
131764281;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HMPAWVATDNDSKT-UHFFFAOYSA-N
131763791;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MSTWHTFNNCRHIU-UHFFFAOYSA-N
131757369;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;KJGHSPINRPPFIW-UHFFFAOYSA-N
131759816;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ABRDLWYBZGTCTL-UHFFFAOYSA-N
131755296;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HIEDMQDYLJFCPX-UHFFFAOYSA-N
131764567;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ADCAWKGFWSTGLD-UHFFFAOYSA-N
131761990;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XRUFDENJLIKWQM-UHFFFAOYSA-N
131763675;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UKQWMQSUSAJIDZ-UHFFFAOYSA-N
131760348;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SAHJXIOVXNXTQL-UHFFFAOYSA-N
131761327;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RYKBFFKZQHHFOA-UHFFFAOYSA-N
131764434;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LETCSCFPJVUIQT-UHFFFAOYSA-N
131755940;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLQMLOOMSZNYRJ-UHFFFAOYSA-N
131764792;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDKWOOLRBVQGKK-UHFFFAOYSA-N
131763374;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VQRIXOHBVKMVEL-UHFFFAOYSA-N
131764761;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QXEZXNMXRFVAHQ-UHFFFAOYSA-N
131766116;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BZSQSBHEVLMJAJ-UHFFFAOYSA-N
131755820;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PBWSYTBHNXUZPG-UHFFFAOYSA-N
131765576;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YVMNXNALYLASPR-UHFFFAOYSA-N
131757272;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OWZRRACHZQKQKB-UHFFFAOYSA-N
131758257;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JTAZFPZUAINKAO-UHFFFAOYSA-N
131756707;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JWRLQVQWCRUWFY-UHFFFAOYSA-N
131757434;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OUGBFDBXTPQOJV-UHFFFAOYSA-N
131762642;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ULURBNZZTGHIHV-UHFFFAOYSA-N
131757836;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;DGOPRVUMKXMBBN-UHFFFAOYSA-N
131765987;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QOWBFANLOZBMRP-UHFFFAOYSA-N
131766240;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NUQWVLLCRFOKOU-UHFFFAOYSA-N
131765032;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QZTJDZZOESOVDE-UHFFFAOYSA-N
131763388;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MLBJZKVMDIHXDL-UHFFFAOYSA-N
131754059;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NBPKLINXFYFXMU-UHFFFAOYSA-N
131755048;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRLYDHNYCOCMPB-UHFFFAOYSA-N
131756653;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SBZHRFMQIXHJRW-UHFFFAOYSA-N
9545899;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CHDGNFBVLBELFJ-UHFFFAOYSA-N
131756724;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OEUMFZWSMUCXBP-UHFFFAOYSA-N
131756770;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UBKZOPGBBSBRBG-UHFFFAOYSA-N
131755072;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;XAOHLQFHAMQDGH-UHFFFAOYSA-N
131755310;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MSRILFYVWJWHRM-UHFFFAOYSA-N
131759605;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQBAEHAUBJDGSF-UHFFFAOYSA-N
131760912;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NHHWSKRTYUVOOE-UHFFFAOYSA-N
131765637;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NKHUBYYMFGFTBT-UHFFFAOYSA-N
131753400;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;CUQAJKYGEQUKMM-UHFFFAOYSA-N
131758694;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XORGQMNRBOZGBM-UHFFFAOYSA-N
56940408;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JQGJMNPRHDYYSP-UHFFFAOYSA-N
131766245;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LTRDNXBESBQIQF-UHFFFAOYSA-N
131755048;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRLYDHNYCOCMPB-UHFFFAOYSA-N
131756868;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VCXHGFGBKAVNAO-UHFFFAOYSA-N
131759947;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HJLYLYOJMWMVLA-UHFFFAOYSA-N
131759483;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RFURIDCRDPRIJL-UHFFFAOYSA-N
131757835;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;JAOICCCVVONLHB-UHFFFAOYSA-N
131759544;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJQLIWBFMBNJL-UHFFFAOYSA-N
131757390;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTOBJPAOCFDZJO-UHFFFAOYSA-N
131756864;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZQMWAXRJJGBMX-UHFFFAOYSA-N
131766038;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DIZRZQIIMNNDRW-UHFFFAOYSA-N
131766204;FABP3;7;2.703e-52;0.4681;1.7214;92.1313;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FYMABLMDWJZFIN-UHFFFAOYSA-N
131759727;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STBZEPVDQQTJQY-UHFFFAOYSA-N
131755968;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QHPYYZFXEDYENT-UHFFFAOYSA-N
131757492;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZUYMTPHHKSWXII-UHFFFAOYSA-N
131759374;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CSXWUPDTKWUFDD-UHFFFAOYSA-N
131761009;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZOJYIGVMGHKJI-UHFFFAOYSA-N
131760646;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YEJRDTNJGBHPRE-UHFFFAOYSA-N
131765948;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VGFGAVMFHSHYQQ-UHFFFAOYSA-N
131763810;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SETAFKXUOLRYMX-UHFFFAOYSA-N
131759524;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RVCBRFVHTZWGMW-UHFFFAOYSA-N
131759837;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZGPVKACJWPEIIR-UHFFFAOYSA-N
131764865;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BCNNDWUPEKMMJC-UHFFFAOYSA-N
131764743;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QNUYKUIODKHOPQ-UHFFFAOYSA-N
131765810;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDRIITRYYSNHJE-UHFFFAOYSA-N
131756545;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MPLJLGNREKLWNT-UHFFFAOYSA-N
131759979;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GFFLZJLHLVDXFE-UHFFFAOYSA-N
131753542;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ZIESYZCKIBNJDP-UHFFFAOYSA-N
131761043;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IAKNICPRAKVQME-UHFFFAOYSA-N
131763414;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCWXOZCSQKXLGJ-UHFFFAOYSA-N
131755244;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPAFMXZJSAXNQ-UHFFFAOYSA-N
131756036;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FGOIRQZPYNSNTG-UHFFFAOYSA-N
131757736;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GUBRCOQXLRVIHB-UHFFFAOYSA-N
131765802;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RLGAOLRDHOLJNN-UHFFFAOYSA-N
131764507;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VZTQVMWXBQJQFL-UHFFFAOYSA-N
131755634;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UZFNMPJCAIVEGV-UHFFFAOYSA-N
131764231;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IIRSRGQBHXKFQZ-UHFFFAOYSA-N
131759706;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DOETYUIYWRXHRJ-UHFFFAOYSA-N
131756167;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJAVVKUVPSLGBA-UHFFFAOYSA-N
131757383;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JEEMXKLREVCFGB-UHFFFAOYSA-N
25240383;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MAWRDGRSFXIWKV-UHFFFAOYSA-N
131759439;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OAYIGAFUEDTGGM-UHFFFAOYSA-N
131758694;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XORGQMNRBOZGBM-UHFFFAOYSA-N
131759795;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZGCGJLBXPCKHOS-UHFFFAOYSA-N
131761225;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BHMRNZLOEIYPSM-UHFFFAOYSA-N
131763691;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NVZVXKRDHFHVPS-UHFFFAOYSA-N
131757194;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;FHLGAKXGDKAPGG-UHFFFAOYSA-N
131758044;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RKDUCRGKMCKYTN-UHFFFAOYSA-N
131763389;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IIYFPBRRSIIIPT-UHFFFAOYSA-N
131760905;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OCHXJPHUWMPWLC-UHFFFAOYSA-N
131753833;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCDMPASDBFINOG-UHFFFAOYSA-N
131764553;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VQUDVLRTBZFPSP-UHFFFAOYSA-N
131766304;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XODJUSVIRAYEDA-UHFFFAOYSA-N
131750367;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CCKRHDUCFMOBKX-UHFFFAOYSA-N
131760413;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GLVZNJVSGWGEOW-UHFFFAOYSA-N
131760143;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GXHRHWLAWLLOCF-UHFFFAOYSA-N
131757101;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VWISUFHDQBBLJZ-UHFFFAOYSA-N
131759668;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GRFDFSAMUSSDRA-UHFFFAOYSA-N
131763248;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UGHFVGFGLYJRIY-UHFFFAOYSA-N
131759524;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RVCBRFVHTZWGMW-UHFFFAOYSA-N
131756706;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNFYWKVDGNONSX-UHFFFAOYSA-N
131757441;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNLMGPXMNLVNRF-UHFFFAOYSA-N
131755194;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QBFPWMQTMYVTPZ-UHFFFAOYSA-N
131760985;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GWUZWGZLGCRJKX-UHFFFAOYSA-N
131765688;FABP3;7;6.059e-49;0.4375;1.6094;86.1158;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PBRYRAXZLMVCBK-UHFFFAOYSA-N
131763718;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VVBXWHUJCYWXPS-UHFFFAOYSA-N
131756700;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WHMKXKHZNZAKLF-UHFFFAOYSA-N
131755947;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZLAHDGOWLSOAJ-UHFFFAOYSA-N
131766142;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CKABQJDLXLDWME-UHFFFAOYSA-N
9545002;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WSEOLICCQLXYAB-UHFFFAOYSA-N
131762408;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DKJQAINPSUNNDI-UHFFFAOYSA-N
131756224;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NMZIXCZQAKUEKO-UHFFFAOYSA-N
131760446;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GLIIMTFLXXHIBR-UHFFFAOYSA-N
131762612;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OFHXYQPJQBMTND-UHFFFAOYSA-N
131760489;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FJIWLFYCFVEOMI-UHFFFAOYSA-N
131764791;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEJHTHOZNZVRKD-UHFFFAOYSA-N
131763798;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RRXSURPJVARICW-UHFFFAOYSA-N
25240382;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131760281;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AJRSKYARNMVHFT-UHFFFAOYSA-N
131753374;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OWUCYMBXHHXZRL-UHFFFAOYSA-N
131757369;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;KJGHSPINRPPFIW-UHFFFAOYSA-N
131765529;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FAJMBORGLMHRDE-UHFFFAOYSA-N
131765277;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;WHJRBJJZLJBRBL-UHFFFAOYSA-N
131757041;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XGCJOJLDYHICIU-UHFFFAOYSA-N
131755277;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZHTYGSYTHOBYHT-UHFFFAOYSA-N
131764888;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKHXDEWODXYNLT-UHFFFAOYSA-N
131760966;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ACBRHMNCXHNUSA-UHFFFAOYSA-N
131761589;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYZDQWXRUMWJEF-UHFFFAOYSA-N
131764574;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;MCYXMPXRAIMPSS-UHFFFAOYSA-N
131765528;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GMDHPKIMMXSUTI-UHFFFAOYSA-N
131763462;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FXGQECBIROXLSB-UHFFFAOYSA-N
131756212;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDDFZEYQURVBHO-UHFFFAOYSA-N
131760482;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;AVOGJLBZQNPISG-UHFFFAOYSA-N
131755303;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LBDYWQQOJYAVLA-UHFFFAOYSA-N
131750367;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CCKRHDUCFMOBKX-UHFFFAOYSA-N
131764150;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RYRQCSWRSANYFM-UHFFFAOYSA-N
131756391;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEHFEWQFZHCTSK-UHFFFAOYSA-N
131765591;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MDKFQYLWNPEPSF-UHFFFAOYSA-N
25240384;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POBQACNRSDFLSN-UHFFFAOYSA-N
131766313;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIMKMGTVYYNDEJ-UHFFFAOYSA-N
131757187;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;DPXCUHXDCAZRMD-UHFFFAOYSA-N
131764563;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XRPOIBHTJJIOON-UHFFFAOYSA-N
131755688;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVRSHDOEDJOBJJ-UHFFFAOYSA-N
131758137;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WZTGTJAUXOIVNF-UHFFFAOYSA-N
131762074;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZUWITUYYOHATE-UHFFFAOYSA-N
131756934;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHJNGKVAWYWMEF-UHFFFAOYSA-N
131760892;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RIWBDVNAXLFKHZ-UHFFFAOYSA-N
131760188;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ODZGUPAQUQGEKA-UHFFFAOYSA-N
131755236;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XYIPDNMNPDTONZ-UHFFFAOYSA-N
131756653;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SBZHRFMQIXHJRW-UHFFFAOYSA-N
131756909;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SSWFQDYDESJLBB-UHFFFAOYSA-N
131757057;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPWFSTBTZXCPDN-UHFFFAOYSA-N
131756723;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UKGTYUIMAQPUNI-UHFFFAOYSA-N
131757074;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FUSFZXIXQUQAAT-UHFFFAOYSA-N
131760473;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JHSXEMRTWBYZRI-UHFFFAOYSA-N
131762738;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;DWQHZFVQEBNFQY-UHFFFAOYSA-N
131763791;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MSTWHTFNNCRHIU-UHFFFAOYSA-N
131760742;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTSDPTZQCYEEKC-UHFFFAOYSA-N
131759091;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LMIVETVBRASKSZ-UHFFFAOYSA-N
131762090;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GBVPBBCPTVGLPS-UHFFFAOYSA-N
131759538;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;STEWTUZWAFGDIQ-UHFFFAOYSA-N
131754036;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KRMCNOVCWGWYHP-UHFFFAOYSA-N
131763382;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ODUNWMBZVDPITO-UHFFFAOYSA-N
131755813;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PFPODELEONWMHD-UHFFFAOYSA-N
131756914;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FVMACQWBKCZBMW-UHFFFAOYSA-N
131764216;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HFOUMPWZUOGOLE-UHFFFAOYSA-N
131757492;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZUYMTPHHKSWXII-UHFFFAOYSA-N
131764075;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PNNSMRQLANHRDX-UHFFFAOYSA-N
131763848;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LEMUUXQSONCZBR-UHFFFAOYSA-N
131755682;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BKNNALCUTFKXQS-UHFFFAOYSA-N
131765537;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WIPJLCNBSDRPCH-UHFFFAOYSA-N
131761109;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QOFVOYKNSFNVGG-UHFFFAOYSA-N
131761115;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OMWMADGRZUDBNS-UHFFFAOYSA-N
131761903;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JBOWPSIDPCYDPQ-UHFFFAOYSA-N
131762650;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCNRTBOAVXTQRH-UHFFFAOYSA-N
131766334;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JNWVIGXAZADFPG-UHFFFAOYSA-N
131760681;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLHXDLRLDMFNPU-UHFFFAOYSA-N
131757562;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IGCFSFMLNPLXMG-UHFFFAOYSA-N
131753401;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXABCMZUYUPINF-UHFFFAOYSA-N
131761948;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DLVBEOBLMNLHJH-UHFFFAOYSA-N
131758687;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;DPOKSOYZNAGELJ-UHFFFAOYSA-N
131757844;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KSLLVJBDFZEPTB-UHFFFAOYSA-N
131757259;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;XAXCHZWOFLFLPM-UHFFFAOYSA-N
56940415;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHYGFPBNUHVOST-UHFFFAOYSA-N
131757855;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;MBEHVCHNDQZWCB-UHFFFAOYSA-N
131763342;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LDKWKDUYZWZDBQ-UHFFFAOYSA-N
131764519;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DPVRRBMNBIRJAB-UHFFFAOYSA-N
131756794;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LNRRWLSKAQDUBR-UHFFFAOYSA-N
131765846;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ULMDLWOZXLWNSK-UHFFFAOYSA-N
131757193;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZJDHSVUVYJSBGX-UHFFFAOYSA-N
131756004;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VUMXXMHKLBIICK-UHFFFAOYSA-N
131757860;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;AGHHOFLCBXWHOS-UHFFFAOYSA-N
131764490;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DETNYSOCAKGVMQ-UHFFFAOYSA-N
131756746;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TZJRCHMRWDMDSJ-UHFFFAOYSA-N
131756676;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SQGUGCCVMDVBJZ-UHFFFAOYSA-N
131759978;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RKIWUSSRNOMOHK-UHFFFAOYSA-N
131761588;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PKYHAMJIVRQXKF-UHFFFAOYSA-N
131763810;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SETAFKXUOLRYMX-UHFFFAOYSA-N
9545354;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SPDHJCJAJYRMFV-UHFFFAOYSA-N
131760327;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SBRTXDNWWVUJGY-UHFFFAOYSA-N
131765858;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CHOVJZYSPBBQPK-UHFFFAOYSA-N
131762271;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZQAVPFDERBCAHC-UHFFFAOYSA-N
131765800;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VFFAIRLXZFVSMW-UHFFFAOYSA-N
131766116;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BZSQSBHEVLMJAJ-UHFFFAOYSA-N
131755394;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LJVYQJBNBHGZKG-UHFFFAOYSA-N
131763875;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZTSWHVGWRWKRF-UHFFFAOYSA-N
131765942;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ODSPHNHCZQVDMR-UHFFFAOYSA-N
131765582;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YXCZDJDWMGLROL-UHFFFAOYSA-N
131763770;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FGKAQOCWPYODEA-UHFFFAOYSA-N
131766310;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIZJOPLPAIHRMD-UHFFFAOYSA-N
131750421;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131765170;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HHPKNJJAIMXMJO-UHFFFAOYSA-N
131761778;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YTJVEHDHQJQWGG-UHFFFAOYSA-N
131762041;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KHYHDLAAJWKMKK-UHFFFAOYSA-N
131758044;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RKDUCRGKMCKYTN-UHFFFAOYSA-N
131760413;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GLVZNJVSGWGEOW-UHFFFAOYSA-N
131759795;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZGCGJLBXPCKHOS-UHFFFAOYSA-N
131756447;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HOJKDYMVHKKNHI-UHFFFAOYSA-N
131765293;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CDFXVMNUBYTXIY-UHFFFAOYSA-N
131756851;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UOXUZNWTFAUUEA-UHFFFAOYSA-N
131766241;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MFNNIGPRUSRGSO-UHFFFAOYSA-N
131764867;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FXNFDHYNKSMWLO-UHFFFAOYSA-N
131765799;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FOQDWFDQDXPCLA-UHFFFAOYSA-N
131758043;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WBFSLXIVMFYBJL-UHFFFAOYSA-N
131764075;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PNNSMRQLANHRDX-UHFFFAOYSA-N
131756050;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UVBMJNGWTCZEQF-UHFFFAOYSA-N
131765769;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CDRRGEQBGHUNAB-UHFFFAOYSA-N
131765947;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACXVEKPECUUALE-UHFFFAOYSA-N
131760853;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SNZNTALTGPYNEP-UHFFFAOYSA-N
131760287;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HSALVDSITWQZNS-UHFFFAOYSA-N
56936857;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;AQYRONSXFRXAPZ-UHFFFAOYSA-N
440854;GRIK3;6;7.012e-70;0.5417;6.2684;123.7037;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C(C(C(=O)O)N)C(C(=O)O)O;HBDWQSHEVMSFGY-UHFFFAOYSA-N
131761327;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RYKBFFKZQHHFOA-UHFFFAOYSA-N
131762752;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JQKSTWZRLSFFJF-UHFFFAOYSA-N
131762302;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JINIMSFSEKJDPB-UHFFFAOYSA-N
9545002;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WSEOLICCQLXYAB-UHFFFAOYSA-N
131756676;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SQGUGCCVMDVBJZ-UHFFFAOYSA-N
131755808;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IMVQRDFIBOZOMA-UHFFFAOYSA-N
131758044;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RKDUCRGKMCKYTN-UHFFFAOYSA-N
131756396;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OHSCTPYVQBIXJB-UHFFFAOYSA-N
25240382;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131762089;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UNYKFQXNKAKRPG-UHFFFAOYSA-N
131761815;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GCRBDMOHZRWTQB-UHFFFAOYSA-N
131758665;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XJZRZLMCPQTTIU-UHFFFAOYSA-N
131762250;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;STYLBDUVJOXRMQ-UHFFFAOYSA-N
131766104;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JZOMROZIKMUNRL-UHFFFAOYSA-N
131761823;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YCOZIWGZFLMTFA-UHFFFAOYSA-N
131755107;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LQBZDHKVUKVJGO-UHFFFAOYSA-N
131762316;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WAOXSFHCGYXKMU-UHFFFAOYSA-N
131757836;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;DGOPRVUMKXMBBN-UHFFFAOYSA-N
131757286;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NGDYFTHZYYRYJI-UHFFFAOYSA-N
131755940;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLQMLOOMSZNYRJ-UHFFFAOYSA-N
131759947;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HJLYLYOJMWMVLA-UHFFFAOYSA-N
9544854;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PKPAOZPHGVIQGC-UHFFFAOYSA-N
131753833;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCDMPASDBFINOG-UHFFFAOYSA-N
131764977;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;OTTHDHMHOBYLKO-UHFFFAOYSA-N
131763752;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YPFHJSJMONMNOQ-UHFFFAOYSA-N
131760664;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PDJWMOMYSOZUKA-UHFFFAOYSA-N
131759992;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UGOUYCBMFPBXOX-UHFFFAOYSA-N
445282;BHMT;6;8.89e-65;0.4;1.8949;114.5421;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CS(=O)(=O)CCC(C(=O)O)N;UCUNFLYVYCGDHP-UHFFFAOYSA-N
131760432;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHNZVYBODMKEQT-UHFFFAOYSA-N
131755808;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IMVQRDFIBOZOMA-UHFFFAOYSA-N
131755476;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JEZIXTIQQIPJCZ-UHFFFAOYSA-N
131756958;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XDOAVAFFHWQIBZ-UHFFFAOYSA-N
131757541;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BVJWKPOODLDRIT-UHFFFAOYSA-N
131763739;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DNNIFNOPLBPBJW-UHFFFAOYSA-N
131764816;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HHRQBQZQQLMORJ-UHFFFAOYSA-N
131762028;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VKZDLFFRXVRVQH-UHFFFAOYSA-N
131765598;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BYEYHQIVFWZJHP-UHFFFAOYSA-N
131765350;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LNTDKUBVWIHAKI-UHFFFAOYSA-N
131755394;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LJVYQJBNBHGZKG-UHFFFAOYSA-N
131761830;FABP3;7;3.077e-55;0.4773;1.8198;97.416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;CDGBKFWHRXPNIS-UHFFFAOYSA-N
131756289;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OHFJEIHIIZLXHT-UHFFFAOYSA-N
131764187;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKWUREQRVPUWQW-UHFFFAOYSA-N
131760764;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZIRJXTDTRZMNMW-UHFFFAOYSA-N
131756567;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SALMPXKLCVMTMW-UHFFFAOYSA-N
131766109;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JMXWOODHKZQOTJ-UHFFFAOYSA-N
131762097;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SZEVHZAZCSIMNY-UHFFFAOYSA-N
131761380;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JDPQRNIORXECGT-UHFFFAOYSA-N
131766432;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ITTQJNRRFXILFF-UHFFFAOYSA-N
9544819;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTHQCAZXMMMJNI-UHFFFAOYSA-N
131761209;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MEITWFTUQYDSIT-UHFFFAOYSA-N
131762063;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UUXXVHZKRXILFI-UHFFFAOYSA-N
131756745;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GOUXXLWMYYBHCM-UHFFFAOYSA-N
131763797;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ICVAHKOZRSLUFQ-UHFFFAOYSA-N
131764609;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNMDOQDBXJDBNN-UHFFFAOYSA-N
131760412;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DRHZXOAXOIEMMY-UHFFFAOYSA-N
131757433;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AMDSHUSILZVWMX-UHFFFAOYSA-N
131763341;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PGNPUZLWAYIFAX-UHFFFAOYSA-N
131764162;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PDOINEZJPOJSCI-UHFFFAOYSA-N
131756146;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SBHOBWMHSSIWIO-UHFFFAOYSA-N
131755455;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IEXFFVIGQBUXOM-UHFFFAOYSA-N
131760905;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OCHXJPHUWMPWLC-UHFFFAOYSA-N
131762595;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SDWPVMNEXQULAT-UHFFFAOYSA-N
131757862;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KGCOMYRIEUMHBE-UHFFFAOYSA-N
131766308;LPAR3;6;5.783e-47;0.4815;7.1316;82.5616;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJZUTJRJYIAAKV-UHFFFAOYSA-N
131756042;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BCDRZMKISYSJPP-UHFFFAOYSA-N
131764440;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ISVPYEPJNJNVKN-UHFFFAOYSA-N
131757285;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;ZJYWYCGVUDBWGE-UHFFFAOYSA-N
131756096;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OZEFVBNHXBHBOW-UHFFFAOYSA-N
131763430;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NKUICCQWMVNWPG-UHFFFAOYSA-N
131750420;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131765971;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GFYRVXIUUHCNOX-UHFFFAOYSA-N
131755662;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QVOHTEKWCOOZBV-UHFFFAOYSA-N
131757844;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KSLLVJBDFZEPTB-UHFFFAOYSA-N
131755838;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VXILKXGVHSBSGJ-UHFFFAOYSA-N
131765162;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BFTXLDFELASQJI-UHFFFAOYSA-N
445282;GRIK1;6;3.843e-57;0.5;15.3565;100.8335;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CS(=O)(=O)CCC(C(=O)O)N;UCUNFLYVYCGDHP-UHFFFAOYSA-N
131755991;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IOFQLHPECKLVSM-UHFFFAOYSA-N
131761557;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SKNOESWTOVXVHT-UHFFFAOYSA-N
131760972;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDCWNPRKDZMBHL-UHFFFAOYSA-N
131756441;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JGZAQTBYJIAXMB-UHFFFAOYSA-N
131765982;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VFVJRYCSOQQDRY-UHFFFAOYSA-N
131756107;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QUXKGFALHOZZDI-UHFFFAOYSA-N
131758113;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NXBSSTRUFABJPB-UHFFFAOYSA-N
131760148;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XQLSSUQHKWUYMC-UHFFFAOYSA-N
131760583;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GQNCOCJLEFUUME-UHFFFAOYSA-N
131756115;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NWCGBGIXJBNACP-UHFFFAOYSA-N
131761942;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DZCKFRKMUJZBAT-UHFFFAOYSA-N
131755374;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BRHLVPHCYUHFEL-UHFFFAOYSA-N
131759477;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SFTJTIUAYCUEKQ-UHFFFAOYSA-N
131764281;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HMPAWVATDNDSKT-UHFFFAOYSA-N
131762079;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VBUPWWIRBFWNGJ-UHFFFAOYSA-N
131765806;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BBJDEDZNDSLQPM-UHFFFAOYSA-N
131762028;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VKZDLFFRXVRVQH-UHFFFAOYSA-N
131761885;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SVBUNVHEBALJFL-UHFFFAOYSA-N
131759854;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OFTAFMFOCJTPKP-UHFFFAOYSA-N
131757861;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;CCYKAYZERNIDEA-UHFFFAOYSA-N
131761116;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JAPRMSLBZUSCAD-UHFFFAOYSA-N
131765342;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GWVGQNBVSXPODP-UHFFFAOYSA-N
131764478;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LBPWGTZIEHPYML-UHFFFAOYSA-N
131763149;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CVWPTSPATKBGFJ-UHFFFAOYSA-N
131758050;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LBZONYRNSJMDKD-UHFFFAOYSA-N
131764156;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PICADWPLIJJOOG-UHFFFAOYSA-N
131766103;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HPDGVKHFCTUXLJ-UHFFFAOYSA-N
131758050;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LBZONYRNSJMDKD-UHFFFAOYSA-N
131756560;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IUCQBMBRIJLQCE-UHFFFAOYSA-N
131760583;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GQNCOCJLEFUUME-UHFFFAOYSA-N
131760290;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AAYJVNROXHMWJF-UHFFFAOYSA-N
131760798;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BKWZVJWHAPNDHG-UHFFFAOYSA-N
131766311;FABP3;7;3.03e-47;0.4167;1.5526;83.0654;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KBRCUQIVLUDXJP-UHFFFAOYSA-N
131764867;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FXNFDHYNKSMWLO-UHFFFAOYSA-N
131757420;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;RFWZFNZBJZHWEA-UHFFFAOYSA-N
131760460;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HVOSMRAPGYBTSZ-UHFFFAOYSA-N
131760482;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;AVOGJLBZQNPISG-UHFFFAOYSA-N
131755297;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;XOIYFXHQESLRQT-UHFFFAOYSA-N
131761533;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FLTZXTYOVWGLNO-UHFFFAOYSA-N
131758234;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MLKVMZHDVPFECT-UHFFFAOYSA-N
131756036;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FGOIRQZPYNSNTG-UHFFFAOYSA-N
131763976;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;REPZHTARFKJLGK-UHFFFAOYSA-N
131755340;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GMEJJMCAXRRIOA-UHFFFAOYSA-N
131764243;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XJKZLKNQUBHNFP-UHFFFAOYSA-N
131757413;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UDIKHJQTLDFGFW-UHFFFAOYSA-N
131763468;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SPIMEOJTVCAROF-UHFFFAOYSA-N
131764150;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RYRQCSWRSANYFM-UHFFFAOYSA-N
131760289;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FZKWULPGSLRZTH-UHFFFAOYSA-N
131759965;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MCTZBSNODNYQBM-UHFFFAOYSA-N
131765999;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PTSQXKFHEOEPFF-UHFFFAOYSA-N
131766217;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHVPEYZRZDJCKH-UHFFFAOYSA-N
131756470;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCSMYJQXGWBEFO-UHFFFAOYSA-N
131757200;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;VVNNBLZFSZUXRC-UHFFFAOYSA-N
131757562;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IGCFSFMLNPLXMG-UHFFFAOYSA-N
131755688;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVRSHDOEDJOBJJ-UHFFFAOYSA-N
131759340;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UMQXHZBMMHCUQU-UHFFFAOYSA-N
131764576;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CBCAECZFTIYBLA-UHFFFAOYSA-N
131757285;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;ZJYWYCGVUDBWGE-UHFFFAOYSA-N
131764762;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LBGUIRKHHMWLGW-UHFFFAOYSA-N
131757194;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;FHLGAKXGDKAPGG-UHFFFAOYSA-N
131755276;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XNXYVFSTYMBATM-UHFFFAOYSA-N
131766380;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QPIJJOPUZQDQMA-UHFFFAOYSA-N
131755271;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SMBSCRUSQBQPKE-UHFFFAOYSA-N
131758281;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XGRHXRCXVVXNRR-UHFFFAOYSA-N
131765768;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FBORIUPMVVLKEO-UHFFFAOYSA-N
131760228;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CWWUWOFQAROKCL-UHFFFAOYSA-N
131764519;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DPVRRBMNBIRJAB-UHFFFAOYSA-N
131756043;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JWEMQLKKBMDMSC-UHFFFAOYSA-N
131756091;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AGXFHKUZXQPREM-UHFFFAOYSA-N
131762302;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JINIMSFSEKJDPB-UHFFFAOYSA-N
131764542;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FYXMPUDVYRLIIY-UHFFFAOYSA-N
131758028;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;XDOWEQFXTJXLQK-UHFFFAOYSA-N
131764216;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HFOUMPWZUOGOLE-UHFFFAOYSA-N
131764249;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZEZMNCGRCXZDOR-UHFFFAOYSA-N
131766237;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NEYWOJGVFURBQU-UHFFFAOYSA-N
131761689;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZYGIRJGVMNSFKT-UHFFFAOYSA-N
131761489;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PRTWBFFOFJFSGB-UHFFFAOYSA-N
131755297;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;XOIYFXHQESLRQT-UHFFFAOYSA-N
131755194;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QBFPWMQTMYVTPZ-UHFFFAOYSA-N
131758825;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UVNIPBFYITWPNW-UHFFFAOYSA-N
131758210;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UJXQJJSLQLGCCL-UHFFFAOYSA-N
131756011;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YUPFJKWSOWOCMK-UHFFFAOYSA-N
131757192;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZAQWCHTYSYNWSH-UHFFFAOYSA-N
131760290;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AAYJVNROXHMWJF-UHFFFAOYSA-N
131759984;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UEZYCMFLJSEDEB-UHFFFAOYSA-N
131756729;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ASPJACHPVRBOQP-UHFFFAOYSA-N
131758870;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FDMDMGLROVNITG-UHFFFAOYSA-N
131755963;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RQLZZCKGBZFETM-UHFFFAOYSA-N
131764564;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NSHUKAOTMWTYBG-UHFFFAOYSA-N
131762724;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PWBWZFOUPAVKBH-UHFFFAOYSA-N
131765582;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YXCZDJDWMGLROL-UHFFFAOYSA-N
131764756;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QGITUKCHSUMQKN-UHFFFAOYSA-N
131755558;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JRPWNZDPXIIZOM-UHFFFAOYSA-N
131757265;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QANJMRAWHCWEGS-UHFFFAOYSA-N
131759354;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;WAJPTWUYDRSLNY-UHFFFAOYSA-N
131765793;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ODPDZZJOACRCJQ-UHFFFAOYSA-N
131759374;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CSXWUPDTKWUFDD-UHFFFAOYSA-N
131753774;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AFUMMTADLJXJHO-UHFFFAOYSA-N
131765528;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GMDHPKIMMXSUTI-UHFFFAOYSA-N
131753373;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFQQJRGJJVQGAV-UHFFFAOYSA-N
131755914;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AKJAVHDSGYNHSB-UHFFFAOYSA-N
131763333;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SDLBWDJXBOAFEM-UHFFFAOYSA-N
131763375;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BLKBAXUTLWGPPO-UHFFFAOYSA-N
131764409;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LRVVKNMHUSRKTM-UHFFFAOYSA-N
131750573;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;TUJAWJCRCOOMQU-UHFFFAOYSA-N
131763432;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BHTDMDDGPQHTNH-UHFFFAOYSA-N
131763127;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RLGAQDGPQYEBLL-UHFFFAOYSA-N
131763828;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GBTJDANNDZMCSO-UHFFFAOYSA-N
131757193;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZJDHSVUVYJSBGX-UHFFFAOYSA-N
131750626;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HUAVJWUSPIMCRO-UHFFFAOYSA-N
131757579;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;USAFSLJNOZHCHX-UHFFFAOYSA-N
131765343;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PJNRHMLPSAIXIL-UHFFFAOYSA-N
131755991;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IOFQLHPECKLVSM-UHFFFAOYSA-N
131756706;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNFYWKVDGNONSX-UHFFFAOYSA-N
131758028;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;XDOWEQFXTJXLQK-UHFFFAOYSA-N
131764675;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OJESMNQAHAGSQJ-UHFFFAOYSA-N
131756133;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QPDHZEQJAFYSNE-UHFFFAOYSA-N
131760142;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RSYHUYFRXBMMEW-UHFFFAOYSA-N
131759701;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HRONLDWOZFWEAB-UHFFFAOYSA-N
131757915;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;WAYMRLQEAVIHIN-UHFFFAOYSA-N
131759483;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RFURIDCRDPRIJL-UHFFFAOYSA-N
131764927;FABP3;7;8.167e-49;0.4286;1.605;85.8831;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LHOPPWWFGCZSQE-UHFFFAOYSA-N
131760589;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UCHSMZOZHHHKTN-UHFFFAOYSA-N
131764350;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IYTSSWXSXRRTMI-UHFFFAOYSA-N
131755476;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JEZIXTIQQIPJCZ-UHFFFAOYSA-N
131758687;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;DPOKSOYZNAGELJ-UHFFFAOYSA-N
131760848;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NIPUCULBSQNBSL-UHFFFAOYSA-N
131755634;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UZFNMPJCAIVEGV-UHFFFAOYSA-N
131759334;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MWNZLWBLFRSEKB-UHFFFAOYSA-N
131750619;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JEQMHFPQVKBLLQ-UHFFFAOYSA-N
131762650;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCNRTBOAVXTQRH-UHFFFAOYSA-N
131760571;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WAZXBESWUFNIKC-UHFFFAOYSA-N
131764807;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PSSHOBGHPGDGSV-UHFFFAOYSA-N
131755687;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FPEZLWDATYZAAB-UHFFFAOYSA-N
131763943;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HZEWLUFXEAGEHA-UHFFFAOYSA-N
131764732;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CIFVSTXCBAOUKA-UHFFFAOYSA-N
131763389;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IIYFPBRRSIIIPT-UHFFFAOYSA-N
131758665;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XJZRZLMCPQTTIU-UHFFFAOYSA-N
131765277;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;WHJRBJJZLJBRBL-UHFFFAOYSA-N
131763828;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GBTJDANNDZMCSO-UHFFFAOYSA-N
131757294;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;NEHKBJPTASJPGS-UHFFFAOYSA-N
131760409;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HWIYVWGYVREDBV-UHFFFAOYSA-N
131763792;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZJMZBFZENLUIAF-UHFFFAOYSA-N
131755402;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RDMSBFYFWYXPOF-UHFFFAOYSA-N
131760090;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;PQNHEABAEPMJMD-UHFFFAOYSA-N
131762178;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CNDQFBSWPRXSTI-UHFFFAOYSA-N
131762192;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCINELBMQVGABE-UHFFFAOYSA-N
131755683;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSBAYMYULGHGQO-UHFFFAOYSA-N
131765469;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YYUUNOIKGZVQNL-UHFFFAOYSA-N
131761219;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PIMPYDZIXKACMS-UHFFFAOYSA-N
131759459;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OQYXMWZVMDPNIP-UHFFFAOYSA-N
131761269;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QZSMPWVATGOHPH-UHFFFAOYSA-N
131762286;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MTZJVBULFGKJAO-UHFFFAOYSA-N
131764563;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XRPOIBHTJJIOON-UHFFFAOYSA-N
131764211;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MGEWHJIKKLGUTH-UHFFFAOYSA-N
131758210;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UJXQJJSLQLGCCL-UHFFFAOYSA-N
131765475;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CWMAMCLCHMLZCC-UHFFFAOYSA-N
131756107;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QUXKGFALHOZZDI-UHFFFAOYSA-N
131759959;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;RMYOOEULFAUMKN-UHFFFAOYSA-N
131755837;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;VBCHYGJCHLNVFC-UHFFFAOYSA-N
131759316;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FLMVCURKTYUWQF-UHFFFAOYSA-N
131756750;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FBQQXRDCPOBIQG-UHFFFAOYSA-N
131761202;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SIYFOTCMVVGGPK-UHFFFAOYSA-N
131755067;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZKXHCZXVCQJSLC-UHFFFAOYSA-N
131761116;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JAPRMSLBZUSCAD-UHFFFAOYSA-N
131757843;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KREDKADJJBSZQK-UHFFFAOYSA-N
131765247;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DUQASBXYPRNVES-UHFFFAOYSA-N
131765237;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CZCKEHKZTUAGLH-UHFFFAOYSA-N
131765983;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GYHBJVUQEUTNJK-UHFFFAOYSA-N
131760991;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KDIPBBLLYFDFHC-UHFFFAOYSA-N
131753818;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CVSGTFIHUMEUGC-UHFFFAOYSA-N
131759353;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WJMXDOSYJOVEGP-UHFFFAOYSA-N
131766141;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWTWQURYSLMNII-UHFFFAOYSA-N
131755814;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATLSKDGFHXWZQX-UHFFFAOYSA-N
131753744;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZTYPYYDVEYQFSE-UHFFFAOYSA-N
131756724;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OEUMFZWSMUCXBP-UHFFFAOYSA-N
131750623;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AKOYMLIOOBZSET-UHFFFAOYSA-N
131764796;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LORJDMOYIBFNHP-UHFFFAOYSA-N
131764244;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWHSDMISQPUQKM-UHFFFAOYSA-N
131761003;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HJKVTYHGHKPVQF-UHFFFAOYSA-N
131757389;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NGGZABQJVQPRCU-UHFFFAOYSA-N
131764249;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZEZMNCGRCXZDOR-UHFFFAOYSA-N
131764737;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HLFLGRZVVLYFNK-UHFFFAOYSA-N
131760972;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDCWNPRKDZMBHL-UHFFFAOYSA-N
131761043;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IAKNICPRAKVQME-UHFFFAOYSA-N
131762643;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GBQSFVXSYJLCAE-UHFFFAOYSA-N
131760681;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLHXDLRLDMFNPU-UHFFFAOYSA-N
131759979;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GFFLZJLHLVDXFE-UHFFFAOYSA-N
131759360;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKXYRUMPRSILQY-UHFFFAOYSA-N
131760409;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HWIYVWGYVREDBV-UHFFFAOYSA-N
131764223;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XQBXFBYULTYXBQ-UHFFFAOYSA-N
131755324;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NQZTVKYDVUQPPX-UHFFFAOYSA-N
131758066;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PAWWFARWOBDKCZ-UHFFFAOYSA-N
131764938;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TZHCCHGTCLEUNU-UHFFFAOYSA-N
131759518;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LKBYQEQTTQMXOC-UHFFFAOYSA-N
131765162;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BFTXLDFELASQJI-UHFFFAOYSA-N
131762752;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JQKSTWZRLSFFJF-UHFFFAOYSA-N
131757428;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FTFVPUBFVDVJAU-UHFFFAOYSA-N
131764250;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RTNVVKOTXGJPGJ-UHFFFAOYSA-N
131764485;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RYZZITBQUSKDOJ-UHFFFAOYSA-N
131766293;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KGCRBIMOYHYQPK-UHFFFAOYSA-N
131757860;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;AGHHOFLCBXWHOS-UHFFFAOYSA-N
131757173;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYPCPBKGHFDBQX-UHFFFAOYSA-N
131761897;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IIFYGJBPANGSOD-UHFFFAOYSA-N
131761010;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RFRCPSCGSGYZQU-UHFFFAOYSA-N
131761036;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GJNCCQAILGZQPE-UHFFFAOYSA-N
131755500;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MTPKGLNGVPLRIZ-UHFFFAOYSA-N
131763579;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DNBFQFXWSKRTGJ-UHFFFAOYSA-N
131758897;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NXTVIXLFALVIBZ-UHFFFAOYSA-N
131765088;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TYXIHILEHYUILL-UHFFFAOYSA-N
131750428;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GXWBCAVCOMAOHT-UHFFFAOYSA-N
131760473;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JHSXEMRTWBYZRI-UHFFFAOYSA-N
131761539;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NYDVKQSVKPIZDU-UHFFFAOYSA-N
1080;BHMT;6;3.3530000000000003e-76;0.6071;2.2333;135.0509;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C(C(C(=O)O)N)SCC(=O)O;GBFLZEXEOZUWRN-UHFFFAOYSA-N
131761022;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GUKADGOJBYUPGU-UHFFFAOYSA-N
131764513;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ASSZWZBQIXMMKM-UHFFFAOYSA-N
131763718;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VVBXWHUJCYWXPS-UHFFFAOYSA-N
131759965;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MCTZBSNODNYQBM-UHFFFAOYSA-N
131760856;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WUQZNKAJBDSVTJ-UHFFFAOYSA-N
131753714;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AREMZVRDXOGTHG-UHFFFAOYSA-N
131756140;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YRNOILAKWQZJOO-UHFFFAOYSA-N
131756470;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCSMYJQXGWBEFO-UHFFFAOYSA-N
131765765;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HJZFUASFTDEZRS-UHFFFAOYSA-N
131763250;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DQYDIASSVQDEIU-UHFFFAOYSA-N
131765820;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;UFAIMASITNLXEW-UHFFFAOYSA-N
131764484;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YUKFMIGMRRYIPC-UHFFFAOYSA-N
131761583;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BXABDUMCSIHFIE-UHFFFAOYSA-N
131765550;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HLYYLRJCOCUOTF-UHFFFAOYSA-N
131764512;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KHKICBDLNWOYFV-UHFFFAOYSA-N
131760723;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LQYKKZORBDYUKT-UHFFFAOYSA-N
131761521;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CYFFZIAOTBPWJY-UHFFFAOYSA-N
131750412;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RFMSTHTUAZETPD-UHFFFAOYSA-N
131760588;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;IHFWXPSVLCAYTA-UHFFFAOYSA-N
131762177;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZDZWWVXHKYJJZ-UHFFFAOYSA-N
131766200;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XFKCIJVYTCFMNK-UHFFFAOYSA-N
131760854;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CFXLMSTVSIEEEU-UHFFFAOYSA-N
131757468;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LWKAZICCJBIXBG-UHFFFAOYSA-N
131764223;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XQBXFBYULTYXBQ-UHFFFAOYSA-N
131763363;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFFVNPZNLYTNDK-UHFFFAOYSA-N
131756160;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KXAMFYWJHGZEGH-UHFFFAOYSA-N
131765815;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KAOUTJZLIDQIDJ-UHFFFAOYSA-N
131761055;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;IGNHERGRXWPMJH-UHFFFAOYSA-N
131755947;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZLAHDGOWLSOAJ-UHFFFAOYSA-N
131757101;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VWISUFHDQBBLJZ-UHFFFAOYSA-N
131756545;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MPLJLGNREKLWNT-UHFFFAOYSA-N
131758709;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RQHDZVBUHNJLAI-UHFFFAOYSA-N
131756819;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ALNNHOFYSWAINZ-UHFFFAOYSA-N
131757559;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GVNOVHPRZPBICJ-UHFFFAOYSA-N
131758708;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PVJPHQHSWUWAQJ-UHFFFAOYSA-N
131758891;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;KZTAYHHQGGVNPE-UHFFFAOYSA-N
131759854;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OFTAFMFOCJTPKP-UHFFFAOYSA-N
131763579;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DNBFQFXWSKRTGJ-UHFFFAOYSA-N
131762596;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YBMSPSGALOVJLN-UHFFFAOYSA-N
131764675;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OJESMNQAHAGSQJ-UHFFFAOYSA-N
131761880;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QCIVLXQVYGLERQ-UHFFFAOYSA-N
131759086;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HQPIWUWUVGDNOG-UHFFFAOYSA-N
131760670;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VJJRELRGCGHSSN-UHFFFAOYSA-N
131759701;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HRONLDWOZFWEAB-UHFFFAOYSA-N
131753636;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IGCRUOUEUMSKRE-UHFFFAOYSA-N
131762139;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KVGQCWIIYQFVAZ-UHFFFAOYSA-N
131763468;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SPIMEOJTVCAROF-UHFFFAOYSA-N
131755073;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FYFQGQAMTRIKHO-UHFFFAOYSA-N
131761937;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IGBVZUBJFIUKFA-UHFFFAOYSA-N
131759086;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HQPIWUWUVGDNOG-UHFFFAOYSA-N
131755500;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MTPKGLNGVPLRIZ-UHFFFAOYSA-N
131756210;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KKJGCGBAFKPDGN-UHFFFAOYSA-N
131766217;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHVPEYZRZDJCKH-UHFFFAOYSA-N
131763447;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZPCPPBVETIYFQL-UHFFFAOYSA-N
131765481;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MRTBICLGLIFHGX-UHFFFAOYSA-N
131765951;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;VUTWUCXEPNBATA-UHFFFAOYSA-N
131750408;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QEBMDFMPVYJRFG-UHFFFAOYSA-N
131761099;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OZBDLYCKVSSLBL-UHFFFAOYSA-N
131755813;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PFPODELEONWMHD-UHFFFAOYSA-N
131759605;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQBAEHAUBJDGSF-UHFFFAOYSA-N
131766136;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHJBRHVZLQLMHJ-UHFFFAOYSA-N
131765400;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATZUQFQPFCLNTM-UHFFFAOYSA-N
131765576;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YVMNXNALYLASPR-UHFFFAOYSA-N
131756347;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZQKBJXXQIGRZIX-UHFFFAOYSA-N
131761115;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OMWMADGRZUDBNS-UHFFFAOYSA-N
131758897;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NXTVIXLFALVIBZ-UHFFFAOYSA-N
131762513;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FTYRINBVXMECCW-UHFFFAOYSA-N
131756573;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;GSYLODJVGAPZPZ-UHFFFAOYSA-N
131766240;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NUQWVLLCRFOKOU-UHFFFAOYSA-N
131755422;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKJRZMKAIOLLKX-UHFFFAOYSA-N
131756084;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VTHDNMHRPKXWMZ-UHFFFAOYSA-N
131759340;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UMQXHZBMMHCUQU-UHFFFAOYSA-N
131756043;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JWEMQLKKBMDMSC-UHFFFAOYSA-N
131763792;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZJMZBFZENLUIAF-UHFFFAOYSA-N
131761568;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JJJUMJWQLFBDTL-UHFFFAOYSA-N
131757861;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;CCYKAYZERNIDEA-UHFFFAOYSA-N
131756011;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YUPFJKWSOWOCMK-UHFFFAOYSA-N
131765826;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDMMBNHFKIGUCQ-UHFFFAOYSA-N
131756212;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDDFZEYQURVBHO-UHFFFAOYSA-N
131763253;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNDHOYSSWMWISN-UHFFFAOYSA-N
131757294;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;NEHKBJPTASJPGS-UHFFFAOYSA-N
131764215;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GZIHTRQEPYSJHZ-UHFFFAOYSA-N
131760550;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QFGOYGNOTBVZDL-UHFFFAOYSA-N
131756915;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKEZCTFABVCKSM-UHFFFAOYSA-N
9897805;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AYUYHZRNTHHDTD-UHFFFAOYSA-N
131765154;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YTMLSQRVRJOZHY-UHFFFAOYSA-N
131761360;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IHIIZCPGLXUXFB-UHFFFAOYSA-N
131759837;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZGPVKACJWPEIIR-UHFFFAOYSA-N
131759379;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SZWHHAMLCPVQHZ-UHFFFAOYSA-N
131750593;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIVFDZQIIPHWJN-UHFFFAOYSA-N
131763447;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZPCPPBVETIYFQL-UHFFFAOYSA-N
131755072;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;XAOHLQFHAMQDGH-UHFFFAOYSA-N
131760309;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLHHWPUYZJHBEJ-UHFFFAOYSA-N
131763368;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JWYJCPQICGZVHS-UHFFFAOYSA-N
131756846;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHUKVTWUCRMUNV-UHFFFAOYSA-N
131765575;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDBKGOXLBQIZPU-UHFFFAOYSA-N
131759722;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWAKFXXPMACHCN-UHFFFAOYSA-N
131756037;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTXFYVWYFJNSRG-UHFFFAOYSA-N
131765042;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AEOBRAGXLFVMRE-UHFFFAOYSA-N
131756842;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CGYUWASKRWCFSH-UHFFFAOYSA-N
131750608;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CUDUJMHSCIYKFW-UHFFFAOYSA-N
131756565;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FCHJVBOWMICKJA-UHFFFAOYSA-N
131756448;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RGEZBXPRDPDBNY-UHFFFAOYSA-N
131755366;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BWOWEFRYVHJNEP-UHFFFAOYSA-N
131755276;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XNXYVFSTYMBATM-UHFFFAOYSA-N
131763669;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYKCXKFNRHDBNF-UHFFFAOYSA-N
131760538;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ABSZNRZAXPIPNQ-UHFFFAOYSA-N
131760341;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SPZFKKCPMIILSL-UHFFFAOYSA-N
131760266;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FDBPCQBWBNZEDW-UHFFFAOYSA-N
131756963;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MXJKXYIXCLMTJO-UHFFFAOYSA-N
131756706;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNFYWKVDGNONSX-UHFFFAOYSA-N
131762513;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FTYRINBVXMECCW-UHFFFAOYSA-N
93072;NAALAD2;6;3.087e-49;0.4138;2.8426;86.6415;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);C(C(C(=O)O)NC(=O)N)C(=O)O;HLKXYZVTANABHZ-UHFFFAOYSA-N
131763327;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HIXJBODFVNVVOZ-UHFFFAOYSA-N
131761982;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYVKSOXJHUKFRF-UHFFFAOYSA-N
131762146;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KDKFUFGVHHXTMC-UHFFFAOYSA-N
9544997;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RETPNLDNHGHCKP-UHFFFAOYSA-N
131759354;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;WAJPTWUYDRSLNY-UHFFFAOYSA-N
131760986;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WBYJAVXPGXOYOM-UHFFFAOYSA-N
131762613;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHCVMVYSBUVFNX-UHFFFAOYSA-N
131756683;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NIFYGEMZMKSOKK-UHFFFAOYSA-N
131763137;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CYKZBIMIYCZCIP-UHFFFAOYSA-N
131757836;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;DGOPRVUMKXMBBN-UHFFFAOYSA-N
131765088;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TYXIHILEHYUILL-UHFFFAOYSA-N
131757406;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CDMARTCICGPDST-UHFFFAOYSA-N
131763248;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UGHFVGFGLYJRIY-UHFFFAOYSA-N
131756371;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RXVLBDOYHGQIHF-UHFFFAOYSA-N
131759668;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GRFDFSAMUSSDRA-UHFFFAOYSA-N
131762300;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OKBVCTPHTHIETD-UHFFFAOYSA-N
131763739;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DNNIFNOPLBPBJW-UHFFFAOYSA-N
131764508;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GQUORQBURNYKNQ-UHFFFAOYSA-N
131750423;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131759380;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QZEYFZLPYNVHDI-UHFFFAOYSA-N
131760286;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XPRIEXJXLXJFEI-UHFFFAOYSA-N
9544749;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131764512;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KHKICBDLNWOYFV-UHFFFAOYSA-N
131755845;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MFNWYZFORRXQHT-UHFFFAOYSA-N
131763674;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GYDULBZIXNRXAK-UHFFFAOYSA-N
131763470;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GYRBUPBXSBUDIS-UHFFFAOYSA-N
131766074;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZCTSKQXPXJRBOE-UHFFFAOYSA-N
131756567;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SALMPXKLCVMTMW-UHFFFAOYSA-N
131763836;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KTBQPCJSPGEYHH-UHFFFAOYSA-N
131753744;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZTYPYYDVEYQFSE-UHFFFAOYSA-N
131753608;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FXCUDDKMKYVUSX-UHFFFAOYSA-N
131753402;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZRUKEJWPGFFHOE-UHFFFAOYSA-N
131760228;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CWWUWOFQAROKCL-UHFFFAOYSA-N
131755528;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NDNNXIWBJOKRCM-UHFFFAOYSA-N
131763462;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FXGQECBIROXLSB-UHFFFAOYSA-N
131756187;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PCXVFXRDXMNRHE-UHFFFAOYSA-N
131759663;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WHDYIBJFERAONB-UHFFFAOYSA-N
131765971;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GFYRVXIUUHCNOX-UHFFFAOYSA-N
131763346;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CJMQGODMMNFMOQ-UHFFFAOYSA-N
131757433;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AMDSHUSILZVWMX-UHFFFAOYSA-N
131759379;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SZWHHAMLCPVQHZ-UHFFFAOYSA-N
131759869;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FPWUJNGGVATCPT-UHFFFAOYSA-N
131755814;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATLSKDGFHXWZQX-UHFFFAOYSA-N
131765475;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CWMAMCLCHMLZCC-UHFFFAOYSA-N
131764421;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXTJEHRYNIVMJO-UHFFFAOYSA-N
131755661;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XMRBIWWWAIEADV-UHFFFAOYSA-N
131759852;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CVASUUQYQOXYSJ-UHFFFAOYSA-N
131756889;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGIUZRTVYUQICM-UHFFFAOYSA-N
131755585;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NPGQULUAPOPHIW-UHFFFAOYSA-N
131761110;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NIWWYTGJAYUGFA-UHFFFAOYSA-N
131756683;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NIFYGEMZMKSOKK-UHFFFAOYSA-N
131765688;LPAR3;6;1.054e-52;0.4643;8.0142;92.8655;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PBRYRAXZLMVCBK-UHFFFAOYSA-N
131755838;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VXILKXGVHSBSGJ-UHFFFAOYSA-N
131759360;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKXYRUMPRSILQY-UHFFFAOYSA-N
131761414;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HQDWFERRFHDEEB-UHFFFAOYSA-N
131761557;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SKNOESWTOVXVHT-UHFFFAOYSA-N
131757907;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CSNMMADQHKSQLN-UHFFFAOYSA-N
131764508;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GQUORQBURNYKNQ-UHFFFAOYSA-N
131759373;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JNZLJJXCXKXIHT-UHFFFAOYSA-N
131766142;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CKABQJDLXLDWME-UHFFFAOYSA-N
131759707;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQYVDSPZECGLKR-UHFFFAOYSA-N
131759539;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IDVKFTSFXLYDBH-UHFFFAOYSA-N
131760446;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GLIIMTFLXXHIBR-UHFFFAOYSA-N
131763426;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QEIRJNNKJSBZBN-UHFFFAOYSA-N
131760571;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WAZXBESWUFNIKC-UHFFFAOYSA-N
131756210;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KKJGCGBAFKPDGN-UHFFFAOYSA-N
131763753;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JBDVHPYZDOJNKC-UHFFFAOYSA-N
131765529;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FAJMBORGLMHRDE-UHFFFAOYSA-N
9544997;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RETPNLDNHGHCKP-UHFFFAOYSA-N
131760557;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFPSXJPVXFGDJF-UHFFFAOYSA-N
131760991;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KDIPBBLLYFDFHC-UHFFFAOYSA-N
131763127;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RLGAQDGPQYEBLL-UHFFFAOYSA-N
131760452;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GMVLULHDBJHRNL-UHFFFAOYSA-N
131753401;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXABCMZUYUPINF-UHFFFAOYSA-N
131764128;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YKRAKIKUUNSETH-UHFFFAOYSA-N
131750573;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;TUJAWJCRCOOMQU-UHFFFAOYSA-N
9544818;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131750592;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BHZWQMNOYPGDNF-UHFFFAOYSA-N
131760062;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PBUZOPDSPGPOQS-UHFFFAOYSA-N
131750593;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIVFDZQIIPHWJN-UHFFFAOYSA-N
131757428;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FTFVPUBFVDVJAU-UHFFFAOYSA-N
131758049;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;USMSEKIRTKUMEG-UHFFFAOYSA-N
131763149;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CVWPTSPATKBGFJ-UHFFFAOYSA-N
131763766;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KAUMGZIPYOWTQN-UHFFFAOYSA-N
131762612;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OFHXYQPJQBMTND-UHFFFAOYSA-N
131763218;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JAGNAZGVBMHJJJ-UHFFFAOYSA-N
131760143;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GXHRHWLAWLLOCF-UHFFFAOYSA-N
131759564;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SPGXNOUOYUPBSF-UHFFFAOYSA-N
131750412;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RFMSTHTUAZETPD-UHFFFAOYSA-N
131759852;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CVASUUQYQOXYSJ-UHFFFAOYSA-N
131759538;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;STEWTUZWAFGDIQ-UHFFFAOYSA-N
131763250;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DQYDIASSVQDEIU-UHFFFAOYSA-N
9545846;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KJMSXXMFCOJLJY-UHFFFAOYSA-N
131757907;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CSNMMADQHKSQLN-UHFFFAOYSA-N
131765543;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZQHGMYAPBUGFGH-UHFFFAOYSA-N
131763443;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BTFFOSYFKZTDHX-UHFFFAOYSA-N
131756890;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZHAAEGBTAPSRS-UHFFFAOYSA-N
131759316;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FLMVCURKTYUWQF-UHFFFAOYSA-N
131757219;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;NDIASEVRLBWVRO-UHFFFAOYSA-N
131765514;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;PDVSJXMAWVPRGI-UHFFFAOYSA-N
131750428;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GXWBCAVCOMAOHT-UHFFFAOYSA-N
131762642;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ULURBNZZTGHIHV-UHFFFAOYSA-N
131761244;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UNXLYVQSTSVPKP-UHFFFAOYSA-N
131765778;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WVDRXDBKAJIUGG-UHFFFAOYSA-N
131762039;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GCYPFSFSHPZCIN-UHFFFAOYSA-N
131762193;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VCPLVQPYTVTKNH-UHFFFAOYSA-N
131762257;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LOKPBYPRLSRHNU-UHFFFAOYSA-N
131759206;FABP3;7;2.8870000000000002e-56;0.5116;1.8541;99.2612;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGGVBZZJDDBPJU-UHFFFAOYSA-N
131756219;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDZSNMGLSOCIKD-UHFFFAOYSA-N
131758870;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FDMDMGLROVNITG-UHFFFAOYSA-N
131762107;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VMZJSWALUJFVMA-UHFFFAOYSA-N
131764499;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UTLDFQYGOHSAKY-UHFFFAOYSA-N
131754064;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NTYQJMMREGDBBU-UHFFFAOYSA-N
131763888;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IWTJSOVMTAKRTG-UHFFFAOYSA-N
131757200;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;VVNNBLZFSZUXRC-UHFFFAOYSA-N
131750421;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131763863;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIVPYAHJKISIKY-UHFFFAOYSA-N
25240383;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MAWRDGRSFXIWKV-UHFFFAOYSA-N
131755986;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NUAAGXVXOLBDRH-UHFFFAOYSA-N
131760453;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FQYWDFDUCXHAEX-UHFFFAOYSA-N
131765793;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ODPDZZJOACRCJQ-UHFFFAOYSA-N
131755340;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GMEJJMCAXRRIOA-UHFFFAOYSA-N
131761937;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IGBVZUBJFIUKFA-UHFFFAOYSA-N
131764237;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKSGCJPLSFCQNA-UHFFFAOYSA-N
131765983;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GYHBJVUQEUTNJK-UHFFFAOYSA-N
131765474;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AAQXAMYHTKLRRO-UHFFFAOYSA-N
131763943;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HZEWLUFXEAGEHA-UHFFFAOYSA-N
131761184;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RBUWIFMTDWYJEN-UHFFFAOYSA-N
131763976;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;REPZHTARFKJLGK-UHFFFAOYSA-N
131756037;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTXFYVWYFJNSRG-UHFFFAOYSA-N
131755047;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZWYSQWJROGDLIY-UHFFFAOYSA-N
9544746;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SJKUKFUWJWEPFD-UHFFFAOYSA-N
131757407;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YHILGYSICPKXAA-UHFFFAOYSA-N
131762642;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ULURBNZZTGHIHV-UHFFFAOYSA-N
131763730;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WHDJEGCDDOXKQQ-UHFFFAOYSA-N
131755073;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FYFQGQAMTRIKHO-UHFFFAOYSA-N
131765316;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HAFMBTFFCFVZFH-UHFFFAOYSA-N
131766133;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPUKBWQAKQTPIK-UHFFFAOYSA-N
131758825;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UVNIPBFYITWPNW-UHFFFAOYSA-N
440854;GRIK2;6;1.2579999999999998e-41;0.5417;5.5146;72.979;GRIK2;Ionotropic glutamate receptor subunit GluR6(Q) (pKi >= 6);C(C(C(=O)O)N)C(C(=O)O)O;HBDWQSHEVMSFGY-UHFFFAOYSA-N
131753722;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LTDLQTORSCMBOQ-UHFFFAOYSA-N
131755324;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NQZTVKYDVUQPPX-UHFFFAOYSA-N
131766053;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YFYJXMNGNGSIPY-UHFFFAOYSA-N
131753373;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFQQJRGJJVQGAV-UHFFFAOYSA-N
9544819;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTHQCAZXMMMJNI-UHFFFAOYSA-N
131756728;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SJSPRNUEKGVEFR-UHFFFAOYSA-N
131753811;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AHYJLIXVIKISHC-UHFFFAOYSA-N
131764728;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WAXXYEULPJLQFN-UHFFFAOYSA-N
131761504;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UCHCSQUXSXHUED-UHFFFAOYSA-N
131766421;LPAR3;6;9.708e-50;0.4727;7.5584;87.5437;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZYZCTQBWUMGGIY-UHFFFAOYSA-N
131756397;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ORHRYJKHSZANHP-UHFFFAOYSA-N
131763745;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QKNAYLXEJNZPIP-UHFFFAOYSA-N
131756146;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SBHOBWMHSSIWIO-UHFFFAOYSA-N
131757579;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;USAFSLJNOZHCHX-UHFFFAOYSA-N
131761115;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OMWMADGRZUDBNS-UHFFFAOYSA-N
131760143;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GXHRHWLAWLLOCF-UHFFFAOYSA-N
131764162;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PDOINEZJPOJSCI-UHFFFAOYSA-N
131763823;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MJTWPTSBGBSEIL-UHFFFAOYSA-N
131760102;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FTPZUXAMLKYSRC-UHFFFAOYSA-N
131763674;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GYDULBZIXNRXAK-UHFFFAOYSA-N
131764582;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZKPQCFJMOJCHFM-UHFFFAOYSA-N
131756042;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BCDRZMKISYSJPP-UHFFFAOYSA-N
131757123;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VJVMHCYTENEWNN-UHFFFAOYSA-N
131760083;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QDMDGODCZNNQBV-UHFFFAOYSA-N
131755963;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RQLZZCKGBZFETM-UHFFFAOYSA-N
131761225;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BHMRNZLOEIYPSM-UHFFFAOYSA-N
131763752;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YPFHJSJMONMNOQ-UHFFFAOYSA-N
131753601;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UFZBCZHRQDOVGQ-UHFFFAOYSA-N
131766214;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LQOVUJRZQTZNEJ-UHFFFAOYSA-N
131755402;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RDMSBFYFWYXPOF-UHFFFAOYSA-N
131761244;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UNXLYVQSTSVPKP-UHFFFAOYSA-N
131760286;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XPRIEXJXLXJFEI-UHFFFAOYSA-N
131759992;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UGOUYCBMFPBXOX-UHFFFAOYSA-N
131763804;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWIXODUOTVEHET-UHFFFAOYSA-N
131756723;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UKGTYUIMAQPUNI-UHFFFAOYSA-N
131762192;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCINELBMQVGABE-UHFFFAOYSA-N
131756239;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WWQOKYMMBUGAPO-UHFFFAOYSA-N
131765958;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WHZABLDEOLRJNE-UHFFFAOYSA-N
131764820;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ABVLJQVWYOLQMF-UHFFFAOYSA-N
131757407;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YHILGYSICPKXAA-UHFFFAOYSA-N
131761575;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CALDQAALECKDMI-UHFFFAOYSA-N
131759838;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FBNGTCSJDMTOOZ-UHFFFAOYSA-N
131760572;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTJRQGPURCBISX-UHFFFAOYSA-N
131755683;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSBAYMYULGHGQO-UHFFFAOYSA-N
131750423;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131766074;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZCTSKQXPXJRBOE-UHFFFAOYSA-N
131755837;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;VBCHYGJCHLNVFC-UHFFFAOYSA-N
131761209;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MEITWFTUQYDSIT-UHFFFAOYSA-N
131756750;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FBQQXRDCPOBIQG-UHFFFAOYSA-N
131761602;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;GAQSYHGNKUYUAQ-UHFFFAOYSA-N
131760289;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FZKWULPGSLRZTH-UHFFFAOYSA-N
131756239;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WWQOKYMMBUGAPO-UHFFFAOYSA-N
131755558;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JRPWNZDPXIIZOM-UHFFFAOYSA-N
131756224;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NMZIXCZQAKUEKO-UHFFFAOYSA-N
131755098;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;QWFBYRTVWVIXIZ-UHFFFAOYSA-N
131755448;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UGGFEFYRAIPHJW-UHFFFAOYSA-N
131753803;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NTSBQBZSOJXXMZ-UHFFFAOYSA-N
131758090;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KGUKXPWFPDKTLO-UHFFFAOYSA-N
131762007;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PZHLNSMCTKLDQD-UHFFFAOYSA-N
131765095;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZOOGEVWOZRKOCC-UHFFFAOYSA-N
131760347;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHZFGSBSLITSMO-UHFFFAOYSA-N
131758021;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XXGCNFKQIMIEKF-UHFFFAOYSA-N
131760723;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LQYKKZORBDYUKT-UHFFFAOYSA-N
131759459;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OQYXMWZVMDPNIP-UHFFFAOYSA-N
131759380;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QZEYFZLPYNVHDI-UHFFFAOYSA-N
131757862;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KGCOMYRIEUMHBE-UHFFFAOYSA-N
131756347;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZQKBJXXQIGRZIX-UHFFFAOYSA-N
131763303;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YTTFVSISHNIUJH-UHFFFAOYSA-N
131764440;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ISVPYEPJNJNVKN-UHFFFAOYSA-N
131755098;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;QWFBYRTVWVIXIZ-UHFFFAOYSA-N
131759477;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SFTJTIUAYCUEKQ-UHFFFAOYSA-N
131763744;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NCKGNPQWQKPFIF-UHFFFAOYSA-N
56940401;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OADRPNFNIMRMSJ-UHFFFAOYSA-N
131759960;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RUUBPRONLULDIJ-UHFFFAOYSA-N
131765247;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DUQASBXYPRNVES-UHFFFAOYSA-N
131757407;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YHILGYSICPKXAA-UHFFFAOYSA-N
131758022;LPAR3;6;5.073e-74;0.587;11.2925;131.1373;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;UFISVPDSQMIDGI-UHFFFAOYSA-N
131756219;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDZSNMGLSOCIKD-UHFFFAOYSA-N
131755794;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJRBHONTDZUSAV-UHFFFAOYSA-N
131765944;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;APLBEJJTPVKUEV-UHFFFAOYSA-N
131763270;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;IRNARDRWANMWOS-UHFFFAOYSA-N
131766237;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NEYWOJGVFURBQU-UHFFFAOYSA-N
131764588;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XLHCXTOOFJLBCC-UHFFFAOYSA-N
131762000;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHFSVCDRQBJIQA-UHFFFAOYSA-N
131759387;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCFICBUSORBZMX-UHFFFAOYSA-N
131764499;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UTLDFQYGOHSAKY-UHFFFAOYSA-N
131764938;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TZHCCHGTCLEUNU-UHFFFAOYSA-N
131756914;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FVMACQWBKCZBMW-UHFFFAOYSA-N
131755099;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIRHPCGBIJZASY-UHFFFAOYSA-N
131755381;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WHIFVRILMXLGDQ-UHFFFAOYSA-N
131756566;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KPIFNDIZKFVARX-UHFFFAOYSA-N
131756728;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SJSPRNUEKGVEFR-UHFFFAOYSA-N
131763426;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QEIRJNNKJSBZBN-UHFFFAOYSA-N
131763455;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OXKWYVLMELYMCF-UHFFFAOYSA-N
131755348;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QHLALDPTQOIJFG-UHFFFAOYSA-N
131759832;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RZPLQHKENQFELH-UHFFFAOYSA-N
131750622;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHGBUKYRNKUYSP-UHFFFAOYSA-N
131759838;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FBNGTCSJDMTOOZ-UHFFFAOYSA-N
131764484;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YUKFMIGMRRYIPC-UHFFFAOYSA-N
131764441;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LCJYOCKCVAVOGU-UHFFFAOYSA-N
131762738;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;DWQHZFVQEBNFQY-UHFFFAOYSA-N
131753811;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AHYJLIXVIKISHC-UHFFFAOYSA-N
9544749;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
9544925;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UMZMGYWVBWXWDT-UHFFFAOYSA-N
131763342;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LDKWKDUYZWZDBQ-UHFFFAOYSA-N
131757219;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;NDIASEVRLBWVRO-UHFFFAOYSA-N
131763873;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NPPQAYOZPNHUTJ-UHFFFAOYSA-N
131765936;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNYZAFAGHAFCHN-UHFFFAOYSA-N
131762177;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZDZWWVXHKYJJZ-UHFFFAOYSA-N
131759960;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RUUBPRONLULDIJ-UHFFFAOYSA-N
131765293;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CDFXVMNUBYTXIY-UHFFFAOYSA-N
131761829;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHAQDRDVKDGNJH-UHFFFAOYSA-N
131756302;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYQPRHZKULXQCI-UHFFFAOYSA-N
131760407;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NWTURLYIJSOABO-UHFFFAOYSA-N
131760069;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CESSZFUPJUMNNU-UHFFFAOYSA-N
131764876;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XPVVJFGULSFCAO-UHFFFAOYSA-N
131764434;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LETCSCFPJVUIQT-UHFFFAOYSA-N
25240386;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEWUGNNMLZAOCV-UHFFFAOYSA-N
131763456;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VCJKYSQWTHINNE-UHFFFAOYSA-N
131764128;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YKRAKIKUUNSETH-UHFFFAOYSA-N
131760069;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CESSZFUPJUMNNU-UHFFFAOYSA-N
131760148;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XQLSSUQHKWUYMC-UHFFFAOYSA-N
131760691;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ULBTVPHSXKRJBN-UHFFFAOYSA-N
131763850;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VMOOWSPQGJCOEF-UHFFFAOYSA-N
131761092;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LBXWNIAXYWLNFI-UHFFFAOYSA-N
131756545;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MPLJLGNREKLWNT-UHFFFAOYSA-N
131766146;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OAINQTZTNKJXAY-UHFFFAOYSA-N
131761238;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFNVGGQCIPHTPE-UHFFFAOYSA-N
131755448;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UGGFEFYRAIPHJW-UHFFFAOYSA-N
131765286;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QXKHDQVSKQMTPY-UHFFFAOYSA-N
131756751;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IRPLNLXEUHFALC-UHFFFAOYSA-N
131756895;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SKWZGEDXJHKPTI-UHFFFAOYSA-N
131761489;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PRTWBFFOFJFSGB-UHFFFAOYSA-N
131757362;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PWCZEZSCMQVPJQ-UHFFFAOYSA-N
131757390;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTOBJPAOCFDZJO-UHFFFAOYSA-N
131764513;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ASSZWZBQIXMMKM-UHFFFAOYSA-N
131757389;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NGGZABQJVQPRCU-UHFFFAOYSA-N
131757362;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PWCZEZSCMQVPJQ-UHFFFAOYSA-N
131760433;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NAGOEYAYRYTHKH-UHFFFAOYSA-N
131760044;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KRNIAXVTJSTDFH-UHFFFAOYSA-N
131762073;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PHZLRGDIBRAISL-UHFFFAOYSA-N
131763428;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DSFHORXLWDQBME-UHFFFAOYSA-N
131764572;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UFCXEZKSYAKBPL-UHFFFAOYSA-N
131764761;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QXEZXNMXRFVAHQ-UHFFFAOYSA-N
131753400;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;CUQAJKYGEQUKMM-UHFFFAOYSA-N
131765285;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPNXDPAVMXQTCA-UHFFFAOYSA-N
131765032;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QZTJDZZOESOVDE-UHFFFAOYSA-N
131755461;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MEUWGTHLRSIXHV-UHFFFAOYSA-N
131763757;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZJGPZZWOLFZNJ-UHFFFAOYSA-N
131764762;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LBGUIRKHHMWLGW-UHFFFAOYSA-N
131761955;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTQQCZRZVMTOPI-UHFFFAOYSA-N
131753714;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AREMZVRDXOGTHG-UHFFFAOYSA-N
131753630;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OWCXZEZUQYFXCK-UHFFFAOYSA-N
131755992;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NCJLYHVTMRUDRY-UHFFFAOYSA-N
131766038;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DIZRZQIIMNNDRW-UHFFFAOYSA-N
131757383;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JEEMXKLREVCFGB-UHFFFAOYSA-N
131757037;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBEXOEBBZPQUND-UHFFFAOYSA-N
131757412;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IIJVLTDWMAWLFO-UHFFFAOYSA-N
131760062;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PBUZOPDSPGPOQS-UHFFFAOYSA-N
131764737;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HLFLGRZVVLYFNK-UHFFFAOYSA-N
131760392;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NMBWREWNBSVWGK-UHFFFAOYSA-N
131753636;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IGCRUOUEUMSKRE-UHFFFAOYSA-N
131760596;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MSUBTQPZOUPMQD-UHFFFAOYSA-N
131760428;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GJZAKWNUCSDFIU-UHFFFAOYSA-N
131758137;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WZTGTJAUXOIVNF-UHFFFAOYSA-N
56940199;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VTOFANRVVFEBFP-UHFFFAOYSA-N
131753635;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CCKLWBNVDVDCFO-UHFFFAOYSA-N
131763441;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PVHFYEKHFWFLFZ-UHFFFAOYSA-N
131755318;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCXYYNLRWFKNNQ-UHFFFAOYSA-N
131763223;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YKKNGUMBQWFKKB-UHFFFAOYSA-N
131764441;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LCJYOCKCVAVOGU-UHFFFAOYSA-N
131764215;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GZIHTRQEPYSJHZ-UHFFFAOYSA-N
131759564;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SPGXNOUOYUPBSF-UHFFFAOYSA-N
131755302;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LFNFVWNJHQPLPQ-UHFFFAOYSA-N
131753635;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CCKLWBNVDVDCFO-UHFFFAOYSA-N
131755223;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VOQAPCORCIBANS-UHFFFAOYSA-N
131764837;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CXUAFHKFYPZCJF-UHFFFAOYSA-N
131753630;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OWCXZEZUQYFXCK-UHFFFAOYSA-N
131760412;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DRHZXOAXOIEMMY-UHFFFAOYSA-N
131757264;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LVHNDABSHOYKAM-UHFFFAOYSA-N
131755968;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QHPYYZFXEDYENT-UHFFFAOYSA-N
131757736;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GUBRCOQXLRVIHB-UHFFFAOYSA-N
9544746;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SJKUKFUWJWEPFD-UHFFFAOYSA-N
131756218;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FTTKNOTUTROZKZ-UHFFFAOYSA-N
131756004;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VUMXXMHKLBIICK-UHFFFAOYSA-N
131762316;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WAOXSFHCGYXKMU-UHFFFAOYSA-N
131753722;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LTDLQTORSCMBOQ-UHFFFAOYSA-N
131755522;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SGSCBPFVSOCVPP-UHFFFAOYSA-N
131759706;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DOETYUIYWRXHRJ-UHFFFAOYSA-N
131755914;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AKJAVHDSGYNHSB-UHFFFAOYSA-N
131755820;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PBWSYTBHNXUZPG-UHFFFAOYSA-N
131756963;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MXJKXYIXCLMTJO-UHFFFAOYSA-N
131762300;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OKBVCTPHTHIETD-UHFFFAOYSA-N
131761568;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JJJUMJWQLFBDTL-UHFFFAOYSA-N
131757434;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OUGBFDBXTPQOJV-UHFFFAOYSA-N
131756133;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QPDHZEQJAFYSNE-UHFFFAOYSA-N
131764479;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZMMKASYZFJCWTE-UHFFFAOYSA-N
131760986;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WBYJAVXPGXOYOM-UHFFFAOYSA-N
1080;GRIK1;6;1.4439999999999998e-53;0.4615;14.388;94.4152;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C(C(C(=O)O)N)SCC(=O)O;GBFLZEXEOZUWRN-UHFFFAOYSA-N
131766103;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HPDGVKHFCTUXLJ-UHFFFAOYSA-N
131761582;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HODDFEFUYCPVTQ-UHFFFAOYSA-N
131754059;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NBPKLINXFYFXMU-UHFFFAOYSA-N
131764802;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GWEURXHGUZNRIT-UHFFFAOYSA-N
131756321;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DQHAGOJZQAKIDI-UHFFFAOYSA-N
131765598;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BYEYHQIVFWZJHP-UHFFFAOYSA-N
131760848;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NIPUCULBSQNBSL-UHFFFAOYSA-N
131757906;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;NSRSRNOQDGUIQQ-UHFFFAOYSA-N
131757383;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JEEMXKLREVCFGB-UHFFFAOYSA-N
131760327;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SBRTXDNWWVUJGY-UHFFFAOYSA-N
131757843;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KREDKADJJBSZQK-UHFFFAOYSA-N
131761886;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LTMMYRYQSSNANI-UHFFFAOYSA-N
131765514;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;PDVSJXMAWVPRGI-UHFFFAOYSA-N
131755795;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;AHTWTNHQUCGAHA-UHFFFAOYSA-N
131757420;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;RFWZFNZBJZHWEA-UHFFFAOYSA-N
131761109;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QOFVOYKNSFNVGG-UHFFFAOYSA-N
131764847;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJSRQCYRQHWNOX-UHFFFAOYSA-N
131761931;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORFNHODRKLEDIY-UHFFFAOYSA-N
131765161;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LEZCTIQNRDNRPA-UHFFFAOYSA-N
131753752;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BVDHVRNSAXAACC-UHFFFAOYSA-N
131759941;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DDQPMPZGDGZDLB-UHFFFAOYSA-N
131765414;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LCQVTHMBIKCBPP-UHFFFAOYSA-N
131764250;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RTNVVKOTXGJPGJ-UHFFFAOYSA-N
131762200;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PGNCZCAOFLJMMB-UHFFFAOYSA-N
131760728;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;COGBIGLYXFERSM-UHFFFAOYSA-N
131760489;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FJIWLFYCFVEOMI-UHFFFAOYSA-N
131755172;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMCYMWCKOMILQE-UHFFFAOYSA-N
131765763;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZOXUQQAZDPHQME-UHFFFAOYSA-N
131759966;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HYPRJUDAMZSDSL-UHFFFAOYSA-N
131764123;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BSLYTXPSABCJNS-UHFFFAOYSA-N
131760566;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;KLPBKIYPIXLUIY-UHFFFAOYSA-N
131755585;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NPGQULUAPOPHIW-UHFFFAOYSA-N
131755270;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XWHMTYPOWZWZQD-UHFFFAOYSA-N
131761028;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIHDUURHAHHFSF-UHFFFAOYSA-N
131763405;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CCWQXSQVMPACON-UHFFFAOYSA-N
131755217;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KAAHBDXVVGSEAD-UHFFFAOYSA-N
131757428;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FTFVPUBFVDVJAU-UHFFFAOYSA-N
131764582;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZKPQCFJMOJCHFM-UHFFFAOYSA-N
131760466;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZTDMXZQXQOEXKZ-UHFFFAOYSA-N
131759359;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UOUKSIKNMFLSOA-UHFFFAOYSA-N
131762072;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;USRVRQGAHXFQJK-UHFFFAOYSA-N
131750370;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AFFQVAIMWFYJJS-UHFFFAOYSA-N
131750620;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEWDINSOXAERHQ-UHFFFAOYSA-N
131761092;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LBXWNIAXYWLNFI-UHFFFAOYSA-N
131762068;FABP3;7;3.077e-55;0.4773;1.8198;97.416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHAZOGSUZIJZCI-UHFFFAOYSA-N
131755302;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LFNFVWNJHQPLPQ-UHFFFAOYSA-N
131757627;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CQQRPMOWXSEZTP-UHFFFAOYSA-N
131761288;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGZIYXWMBQUNLC-UHFFFAOYSA-N
131765536;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NEGZJZAROHNABH-UHFFFAOYSA-N
131757220;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HMVLLJGZOCQDFI-UHFFFAOYSA-N
131763675;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UKQWMQSUSAJIDZ-UHFFFAOYSA-N
131759439;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OAYIGAFUEDTGGM-UHFFFAOYSA-N
131764568;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BTDHRGQFFPYVIV-UHFFFAOYSA-N
131765342;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GWVGQNBVSXPODP-UHFFFAOYSA-N
131766293;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KGCRBIMOYHYQPK-UHFFFAOYSA-N
131760108;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZHLYVKHDLPQFD-UHFFFAOYSA-N
131759373;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JNZLJJXCXKXIHT-UHFFFAOYSA-N
131756934;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHJNGKVAWYWMEF-UHFFFAOYSA-N
131765537;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WIPJLCNBSDRPCH-UHFFFAOYSA-N
131755277;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZHTYGSYTHOBYHT-UHFFFAOYSA-N
131753408;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BYFGMMQHMLHSEK-UHFFFAOYSA-N
131756396;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OHSCTPYVQBIXJB-UHFFFAOYSA-N
131764237;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKSGCJPLSFCQNA-UHFFFAOYSA-N
131765237;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CZCKEHKZTUAGLH-UHFFFAOYSA-N
131753608;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FXCUDDKMKYVUSX-UHFFFAOYSA-N
131755172;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMCYMWCKOMILQE-UHFFFAOYSA-N
131763382;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ODUNWMBZVDPITO-UHFFFAOYSA-N
131764123;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BSLYTXPSABCJNS-UHFFFAOYSA-N
131766132;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SOVSZEWJOOZRMD-UHFFFAOYSA-N
131756224;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NMZIXCZQAKUEKO-UHFFFAOYSA-N
131755296;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HIEDMQDYLJFCPX-UHFFFAOYSA-N
131750408;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QEBMDFMPVYJRFG-UHFFFAOYSA-N
131756745;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GOUXXLWMYYBHCM-UHFFFAOYSA-N
131761027;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NWCRHTRUMSZHGL-UHFFFAOYSA-N
131756707;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JWRLQVQWCRUWFY-UHFFFAOYSA-N
131763303;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YTTFVSISHNIUJH-UHFFFAOYSA-N
131757412;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IIJVLTDWMAWLFO-UHFFFAOYSA-N
131759985;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LAGWHQFUVYNWQJ-UHFFFAOYSA-N
131764478;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LBPWGTZIEHPYML-UHFFFAOYSA-N
131760588;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;IHFWXPSVLCAYTA-UHFFFAOYSA-N
131755682;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BKNNALCUTFKXQS-UHFFFAOYSA-N
131762200;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PGNCZCAOFLJMMB-UHFFFAOYSA-N
131763487;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCCCMTCYXQXNLK-UHFFFAOYSA-N
131764163;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONZPXYMTASPSNP-UHFFFAOYSA-N
131765316;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HAFMBTFFCFVZFH-UHFFFAOYSA-N
131756819;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ALNNHOFYSWAINZ-UHFFFAOYSA-N
131758891;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;KZTAYHHQGGVNPE-UHFFFAOYSA-N
131765536;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NEGZJZAROHNABH-UHFFFAOYSA-N
131755048;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRLYDHNYCOCMPB-UHFFFAOYSA-N
9545354;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SPDHJCJAJYRMFV-UHFFFAOYSA-N
131756751;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IRPLNLXEUHFALC-UHFFFAOYSA-N
131760835;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PYMKNYQBVPYQSZ-UHFFFAOYSA-N
131756469;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BEJINFUEKQSHML-UHFFFAOYSA-N
131753400;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;CUQAJKYGEQUKMM-UHFFFAOYSA-N
131756701;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YMNDWXQHOZTTQG-UHFFFAOYSA-N
131765951;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;VUTWUCXEPNBATA-UHFFFAOYSA-N
131750622;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHGBUKYRNKUYSP-UHFFFAOYSA-N
56936895;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;GFKHXQTZIPZMNW-UHFFFAOYSA-N
131763745;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QKNAYLXEJNZPIP-UHFFFAOYSA-N
131764812;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IYWKHVMWOJKUJQ-UHFFFAOYSA-N
131765286;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QXKHDQVSKQMTPY-UHFFFAOYSA-N
131764473;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GRDDVYHFHJYAIG-UHFFFAOYSA-N
131759947;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HJLYLYOJMWMVLA-UHFFFAOYSA-N
131764588;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XLHCXTOOFJLBCC-UHFFFAOYSA-N
131759544;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJQLIWBFMBNJL-UHFFFAOYSA-N
131757390;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTOBJPAOCFDZJO-UHFFFAOYSA-N
131763875;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZTSWHVGWRWKRF-UHFFFAOYSA-N
131756864;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZQMWAXRJJGBMX-UHFFFAOYSA-N
131766099;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SUUKHPGWXKPJHR-UHFFFAOYSA-N
56940014;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBFKGUJFNGJJRX-UHFFFAOYSA-N
131753629;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WZCFDZGLFKVTIF-UHFFFAOYSA-N
131766310;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIZJOPLPAIHRMD-UHFFFAOYSA-N
131753629;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WZCFDZGLFKVTIF-UHFFFAOYSA-N
131763487;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCCCMTCYXQXNLK-UHFFFAOYSA-N
131766204;LPAR3;6;6.092e-70;0.4909;10.6651;123.8133;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FYMABLMDWJZFIN-UHFFFAOYSA-N
131765543;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZQHGMYAPBUGFGH-UHFFFAOYSA-N
131763804;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWIXODUOTVEHET-UHFFFAOYSA-N
131756566;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KPIFNDIZKFVARX-UHFFFAOYSA-N
131759966;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HYPRJUDAMZSDSL-UHFFFAOYSA-N
131765913;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YOIYDGJMKJEXTG-UHFFFAOYSA-N
131764798;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WEMUYPQCMUSKDO-UHFFFAOYSA-N
131759926;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;QMUSPYPGMAYRTR-UHFFFAOYSA-N
131765481;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MRTBICLGLIFHGX-UHFFFAOYSA-N
131756868;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VCXHGFGBKAVNAO-UHFFFAOYSA-N
131755340;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GMEJJMCAXRRIOA-UHFFFAOYSA-N
131755074;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KLBXZRONSATXOR-UHFFFAOYSA-N
131750370;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AFFQVAIMWFYJJS-UHFFFAOYSA-N
131757057;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPWFSTBTZXCPDN-UHFFFAOYSA-N
131763791;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MSTWHTFNNCRHIU-UHFFFAOYSA-N
131763332;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WFZRDLLUISIIIZ-UHFFFAOYSA-N
131763433;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UGZBFOQDGPJMST-UHFFFAOYSA-N
131757915;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;WAYMRLQEAVIHIN-UHFFFAOYSA-N
131765042;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AEOBRAGXLFVMRE-UHFFFAOYSA-N
131764553;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VQUDVLRTBZFPSP-UHFFFAOYSA-N
131760691;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ULBTVPHSXKRJBN-UHFFFAOYSA-N
131763671;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RLKSWIHVEAZROT-UHFFFAOYSA-N
131764503;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LLTRXGBFCHGGPQ-UHFFFAOYSA-N
131760589;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UCHSMZOZHHHKTN-UHFFFAOYSA-N
131760467;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXQABWBASCQTOJ-UHFFFAOYSA-N
131760538;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ABSZNRZAXPIPNQ-UHFFFAOYSA-N
131764116;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IIZFWHKVNJTNPQ-UHFFFAOYSA-N
131764518;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IIGHVRSTPXBBKS-UHFFFAOYSA-N
131763770;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FGKAQOCWPYODEA-UHFFFAOYSA-N
131757835;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;JAOICCCVVONLHB-UHFFFAOYSA-N
131755940;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLQMLOOMSZNYRJ-UHFFFAOYSA-N
131760728;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;COGBIGLYXFERSM-UHFFFAOYSA-N
131761954;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ILYJVOJSUJTWSZ-UHFFFAOYSA-N
131766245;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LTRDNXBESBQIQF-UHFFFAOYSA-N
131764792;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDKWOOLRBVQGKK-UHFFFAOYSA-N
131753833;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCDMPASDBFINOG-UHFFFAOYSA-N
131761955;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTQQCZRZVMTOPI-UHFFFAOYSA-N
131761989;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YUMXSFGYXZWQHW-UHFFFAOYSA-N
56940199;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VTOFANRVVFEBFP-UHFFFAOYSA-N
131761099;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OZBDLYCKVSSLBL-UHFFFAOYSA-N
131757434;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OUGBFDBXTPQOJV-UHFFFAOYSA-N
131763318;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BXLCYHMCRNPYDN-UHFFFAOYSA-N
131758022;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;UFISVPDSQMIDGI-UHFFFAOYSA-N
131764567;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ADCAWKGFWSTGLD-UHFFFAOYSA-N
131757718;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SCMQOOVUTQRBPX-UHFFFAOYSA-N
131756770;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UBKZOPGBBSBRBG-UHFFFAOYSA-N
131762072;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;USRVRQGAHXFQJK-UHFFFAOYSA-N
131766109;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JMXWOODHKZQOTJ-UHFFFAOYSA-N
131759387;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCFICBUSORBZMX-UHFFFAOYSA-N
131764798;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WEMUYPQCMUSKDO-UHFFFAOYSA-N
131750608;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CUDUJMHSCIYKFW-UHFFFAOYSA-N
131756167;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJAVVKUVPSLGBA-UHFFFAOYSA-N
131761902;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XMVHZFQXXQHPFZ-UHFFFAOYSA-N
131759605;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQBAEHAUBJDGSF-UHFFFAOYSA-N
131756700;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WHMKXKHZNZAKLF-UHFFFAOYSA-N
131763785;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEPFYTKJXBZPDF-UHFFFAOYSA-N
131761999;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NSRPQFRLJZJCJC-UHFFFAOYSA-N
131763741;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DSTAYVXFWPAZEZ-UHFFFAOYSA-N
131760188;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ODZGUPAQUQGEKA-UHFFFAOYSA-N
9897805;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AYUYHZRNTHHDTD-UHFFFAOYSA-N
131757264;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LVHNDABSHOYKAM-UHFFFAOYSA-N
131764888;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKHXDEWODXYNLT-UHFFFAOYSA-N
131766218;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HNUYKTOGWYOCHC-UHFFFAOYSA-N
131764752;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IKPPMXCWNQRCFS-UHFFFAOYSA-N
131757835;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;JAOICCCVVONLHB-UHFFFAOYSA-N
131762056;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SZBKZAAACSCYMQ-UHFFFAOYSA-N
131762250;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;STYLBDUVJOXRMQ-UHFFFAOYSA-N
131763836;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KTBQPCJSPGEYHH-UHFFFAOYSA-N
131763254;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RFXAXHWRVMQUCI-UHFFFAOYSA-N
131761829;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHAQDRDVKDGNJH-UHFFFAOYSA-N
131759728;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HCOXAOVJODNXKR-UHFFFAOYSA-N
131762643;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GBQSFVXSYJLCAE-UHFFFAOYSA-N
131756140;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YRNOILAKWQZJOO-UHFFFAOYSA-N
131760971;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XOYSWGHQVMLVFO-UHFFFAOYSA-N
131756851;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UOXUZNWTFAUUEA-UHFFFAOYSA-N
131765302;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MBBWQOJXLONXQW-UHFFFAOYSA-N
131757492;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZUYMTPHHKSWXII-UHFFFAOYSA-N
131765802;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RLGAOLRDHOLJNN-UHFFFAOYSA-N
131758234;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MLKVMZHDVPFECT-UHFFFAOYSA-N
131759223;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVLJROQTWFUTBY-UHFFFAOYSA-N
131755846;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KDCWAZIMGWULJP-UHFFFAOYSA-N
131756187;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PCXVFXRDXMNRHE-UHFFFAOYSA-N
131753752;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BVDHVRNSAXAACC-UHFFFAOYSA-N
131762063;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UUXXVHZKRXILFI-UHFFFAOYSA-N
131760646;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YEJRDTNJGBHPRE-UHFFFAOYSA-N
131755303;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LBDYWQQOJYAVLA-UHFFFAOYSA-N
131760102;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FTPZUXAMLKYSRC-UHFFFAOYSA-N
131753402;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZRUKEJWPGFFHOE-UHFFFAOYSA-N
131761575;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CALDQAALECKDMI-UHFFFAOYSA-N
131765947;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACXVEKPECUUALE-UHFFFAOYSA-N
131764541;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FBVWZRNWVYGXSE-UHFFFAOYSA-N
131756544;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;POSPEMGIHZMKBT-UHFFFAOYSA-N
131753542;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ZIESYZCKIBNJDP-UHFFFAOYSA-N
131764581;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NROTYPBETZBKSI-UHFFFAOYSA-N
131761009;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZOJYIGVMGHKJI-UHFFFAOYSA-N
131766080;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AHWAAIWRGKZIQL-UHFFFAOYSA-N
131760646;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YEJRDTNJGBHPRE-UHFFFAOYSA-N
131763854;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AODBNMOGHKMQLM-UHFFFAOYSA-N
131764244;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWHSDMISQPUQKM-UHFFFAOYSA-N
131764507;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VZTQVMWXBQJQFL-UHFFFAOYSA-N
131764163;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONZPXYMTASPSNP-UHFFFAOYSA-N
131756723;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UKGTYUIMAQPUNI-UHFFFAOYSA-N
131764564;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NSHUKAOTMWTYBG-UHFFFAOYSA-N
131761010;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RFRCPSCGSGYZQU-UHFFFAOYSA-N
131762089;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UNYKFQXNKAKRPG-UHFFFAOYSA-N
131760433;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NAGOEYAYRYTHKH-UHFFFAOYSA-N
131759728;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HCOXAOVJODNXKR-UHFFFAOYSA-N
131757384;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WOHMUGVGZMEZQE-UHFFFAOYSA-N
131761414;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HQDWFERRFHDEEB-UHFFFAOYSA-N
131758027;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QBIXIQXOQCCVJI-UHFFFAOYSA-N
131761015;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZVQFZROUAQXGJM-UHFFFAOYSA-N
131759858;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYBNKTCMSXGTGD-UHFFFAOYSA-N
131762146;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KDKFUFGVHHXTMC-UHFFFAOYSA-N
131759069;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SHVMTKJCJPSWEE-UHFFFAOYSA-N
131756746;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TZJRCHMRWDMDSJ-UHFFFAOYSA-N
25240383;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MAWRDGRSFXIWKV-UHFFFAOYSA-N
131763741;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DSTAYVXFWPAZEZ-UHFFFAOYSA-N
131763254;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RFXAXHWRVMQUCI-UHFFFAOYSA-N
131761225;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BHMRNZLOEIYPSM-UHFFFAOYSA-N
131763805;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WLKYPPYVGVLSFZ-UHFFFAOYSA-N
131761823;LPAR3;6;6.843e-71;0.5778;10.8111;125.518;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YCOZIWGZFLMTFA-UHFFFAOYSA-N
131755107;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LQBZDHKVUKVJGO-UHFFFAOYSA-N
131757855;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;MBEHVCHNDQZWCB-UHFFFAOYSA-N
131762023;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBCQOGPWLGKYNO-UHFFFAOYSA-N
131761109;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QOFVOYKNSFNVGG-UHFFFAOYSA-N
131763662;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HAGZJMAABAPVKG-UHFFFAOYSA-N
131756218;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FTTKNOTUTROZKZ-UHFFFAOYSA-N
131762045;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FEDXZFODPLHGFU-UHFFFAOYSA-N
131756096;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OZEFVBNHXBHBOW-UHFFFAOYSA-N
131760681;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLHXDLRLDMFNPU-UHFFFAOYSA-N
131756265;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HLHOFQHIUQLVAE-UHFFFAOYSA-N
131760911;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SCBNRRNNYKNHJU-UHFFFAOYSA-N
131766433;LPAR3;6;5.783e-47;0.4815;7.1316;82.5616;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UQAQHCSDUNHUKS-UHFFFAOYSA-N
131765796;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YPKAPKOHLOHKML-UHFFFAOYSA-N
131753542;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ZIESYZCKIBNJDP-UHFFFAOYSA-N
131759524;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RVCBRFVHTZWGMW-UHFFFAOYSA-N
131753572;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;TXWDWSJYGIFVKP-UHFFFAOYSA-N
131755947;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZLAHDGOWLSOAJ-UHFFFAOYSA-N
131756789;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IIYQJRSPWUCSDM-UHFFFAOYSA-N
131761028;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIHDUURHAHHFSF-UHFFFAOYSA-N
131763441;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PVHFYEKHFWFLFZ-UHFFFAOYSA-N
131757192;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZAQWCHTYSYNWSH-UHFFFAOYSA-N
131766053;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YFYJXMNGNGSIPY-UHFFFAOYSA-N
131760142;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RSYHUYFRXBMMEW-UHFFFAOYSA-N
131761898;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DOVUUWKFUZDTOP-UHFFFAOYSA-N
131750620;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEWDINSOXAERHQ-UHFFFAOYSA-N
131756746;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TZJRCHMRWDMDSJ-UHFFFAOYSA-N
131762612;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OFHXYQPJQBMTND-UHFFFAOYSA-N
131763419;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCAVHXJASXMRHH-UHFFFAOYSA-N
131761288;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGZIYXWMBQUNLC-UHFFFAOYSA-N
25240382;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131755394;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LJVYQJBNBHGZKG-UHFFFAOYSA-N
131761796;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WNTXQOREERQHJA-UHFFFAOYSA-N
131764542;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FYXMPUDVYRLIIY-UHFFFAOYSA-N
131753374;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OWUCYMBXHHXZRL-UHFFFAOYSA-N
131763434;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MQHMZCFDXHXJOZ-UHFFFAOYSA-N
131765170;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HHPKNJJAIMXMJO-UHFFFAOYSA-N
131756447;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HOJKDYMVHKKNHI-UHFFFAOYSA-N
131760875;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJJRJDAWZMHWKT-UHFFFAOYSA-N
131756091;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AGXFHKUZXQPREM-UHFFFAOYSA-N
131761589;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYZDQWXRUMWJEF-UHFFFAOYSA-N
131765815;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KAOUTJZLIDQIDJ-UHFFFAOYSA-N
131756302;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYQPRHZKULXQCI-UHFFFAOYSA-N
131764222;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AQXUMBSYJVJRPS-UHFFFAOYSA-N
131762193;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VCPLVQPYTVTKNH-UHFFFAOYSA-N
131763754;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MWQHJVNOXOFDGS-UHFFFAOYSA-N
131761880;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QCIVLXQVYGLERQ-UHFFFAOYSA-N
131763163;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PZMSAQJXASOAPE-UHFFFAOYSA-N
131763443;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BTFFOSYFKZTDHX-UHFFFAOYSA-N
131750420;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131756794;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LNRRWLSKAQDUBR-UHFFFAOYSA-N
131759727;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STBZEPVDQQTJQY-UHFFFAOYSA-N
131765769;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CDRRGEQBGHUNAB-UHFFFAOYSA-N
131758043;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WBFSLXIVMFYBJL-UHFFFAOYSA-N
131757559;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GVNOVHPRZPBICJ-UHFFFAOYSA-N
131763329;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZCUCDBKSLMWFIN-UHFFFAOYSA-N
25240384;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POBQACNRSDFLSN-UHFFFAOYSA-N
131757718;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SCMQOOVUTQRBPX-UHFFFAOYSA-N
131756565;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FCHJVBOWMICKJA-UHFFFAOYSA-N
131757187;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;DPXCUHXDCAZRMD-UHFFFAOYSA-N
131763764;LPAR3;6;1.82e-61;0.5778;9.3618;108.5976;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONNMWXZICBDMON-UHFFFAOYSA-N
131763414;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCWXOZCSQKXLGJ-UHFFFAOYSA-N
131761327;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RYKBFFKZQHHFOA-UHFFFAOYSA-N
131762039;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GCYPFSFSHPZCIN-UHFFFAOYSA-N
131764473;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GRDDVYHFHJYAIG-UHFFFAOYSA-N
131760188;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ODZGUPAQUQGEKA-UHFFFAOYSA-N
131756653;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SBZHRFMQIXHJRW-UHFFFAOYSA-N
131761269;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QZSMPWVATGOHPH-UHFFFAOYSA-N
131765521;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IZQCWCMPLLSHHW-UHFFFAOYSA-N
131756469;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BEJINFUEKQSHML-UHFFFAOYSA-N
131756909;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SSWFQDYDESJLBB-UHFFFAOYSA-N
131762056;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SZBKZAAACSCYMQ-UHFFFAOYSA-N
131766331;LPAR3;6;1.181e-57;0.5417;8.7755;101.7533;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KCNBDVGTYULZQA-UHFFFAOYSA-N
131762738;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;DWQHZFVQEBNFQY-UHFFFAOYSA-N
131763861;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VQSBVFWLIMSUKU-UHFFFAOYSA-N
131761920;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UNYSRSKHDZXMCA-UHFFFAOYSA-N
131762068;LPAR3;6;1.1880000000000001e-57;0.5417;8.7751;101.7486;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHAZOGSUZIJZCI-UHFFFAOYSA-N
131755795;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;AHTWTNHQUCGAHA-UHFFFAOYSA-N
131764738;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WJPRJNAUQKKXCZ-UHFFFAOYSA-N
131755813;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PFPODELEONWMHD-UHFFFAOYSA-N
131756914;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FVMACQWBKCZBMW-UHFFFAOYSA-N
131764231;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IIRSRGQBHXKFQZ-UHFFFAOYSA-N
131759353;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WJMXDOSYJOVEGP-UHFFFAOYSA-N
131760453;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FQYWDFDUCXHAEX-UHFFFAOYSA-N
131766141;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWTWQURYSLMNII-UHFFFAOYSA-N
131764199;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WJRHNBWETKCFPT-UHFFFAOYSA-N
131764937;FABP3;7;6.059e-49;0.4375;1.6094;86.1158;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YERJMWWEGCCVST-UHFFFAOYSA-N
131761583;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BXABDUMCSIHFIE-UHFFFAOYSA-N
131760664;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PDJWMOMYSOZUKA-UHFFFAOYSA-N
131765906;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MLCGMLRNSFLNND-UHFFFAOYSA-N
131758714;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;ZJPRUJQVOSHYAD-UHFFFAOYSA-N
131757286;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NGDYFTHZYYRYJI-UHFFFAOYSA-N
131760990;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KGUZSTABAOKSII-UHFFFAOYSA-N
131764432;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XWCJBYCREBJYKA-UHFFFAOYSA-N
131759722;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWAKFXXPMACHCN-UHFFFAOYSA-N
56940014;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBFKGUJFNGJJRX-UHFFFAOYSA-N
131762613;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHCVMVYSBUVFNX-UHFFFAOYSA-N
131753803;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NTSBQBZSOJXXMZ-UHFFFAOYSA-N
131763469;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BSMCSPHFOOHCPJ-UHFFFAOYSA-N
9545899;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CHDGNFBVLBELFJ-UHFFFAOYSA-N
131756794;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LNRRWLSKAQDUBR-UHFFFAOYSA-N
131760162;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZNRJZRRGRJDRMD-UHFFFAOYSA-N
131755318;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCXYYNLRWFKNNQ-UHFFFAOYSA-N
131755476;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JEZIXTIQQIPJCZ-UHFFFAOYSA-N
56936895;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;GFKHXQTZIPZMNW-UHFFFAOYSA-N
131757384;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WOHMUGVGZMEZQE-UHFFFAOYSA-N
131756676;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SQGUGCCVMDVBJZ-UHFFFAOYSA-N
131763456;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VCJKYSQWTHINNE-UHFFFAOYSA-N
131759978;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RKIWUSSRNOMOHK-UHFFFAOYSA-N
131761588;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PKYHAMJIVRQXKF-UHFFFAOYSA-N
131764503;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LLTRXGBFCHGGPQ-UHFFFAOYSA-N
131759959;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;RMYOOEULFAUMKN-UHFFFAOYSA-N
131762271;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZQAVPFDERBCAHC-UHFFFAOYSA-N
131764129;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LLRMOUDUDWTCRD-UHFFFAOYSA-N
131761576;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZLWKCBUKUANMW-UHFFFAOYSA-N
131763340;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FJMGCBCMXFEVHK-UHFFFAOYSA-N
131765913;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YOIYDGJMKJEXTG-UHFFFAOYSA-N
131764837;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CXUAFHKFYPZCJF-UHFFFAOYSA-N
131763764;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONNMWXZICBDMON-UHFFFAOYSA-N
131753601;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UFZBCZHRQDOVGQ-UHFFFAOYSA-N
131766308;FABP3;7;2.9169999999999997e-47;0.4355;1.5531;83.0951;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJZUTJRJYIAAKV-UHFFFAOYSA-N
131756042;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BCDRZMKISYSJPP-UHFFFAOYSA-N
131760309;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLHHWPUYZJHBEJ-UHFFFAOYSA-N
131757123;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VJVMHCYTENEWNN-UHFFFAOYSA-N
131763880;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NVECGMYENDMAPE-UHFFFAOYSA-N
131763863;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIVPYAHJKISIKY-UHFFFAOYSA-N
131761999;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NSRPQFRLJZJCJC-UHFFFAOYSA-N
131750420;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
56936857;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;AQYRONSXFRXAPZ-UHFFFAOYSA-N
131761898;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DOVUUWKFUZDTOP-UHFFFAOYSA-N
445282;GRIK3;6;3.972e-52;0.5;4.6603;91.8311;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CS(=O)(=O)CCC(C(=O)O)N;UCUNFLYVYCGDHP-UHFFFAOYSA-N
131760162;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZNRJZRRGRJDRMD-UHFFFAOYSA-N
131764820;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ABVLJQVWYOLQMF-UHFFFAOYSA-N
131758113;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NXBSSTRUFABJPB-UHFFFAOYSA-N
131756889;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGIUZRTVYUQICM-UHFFFAOYSA-N
131761036;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GJNCCQAILGZQPE-UHFFFAOYSA-N
131755527;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HSNGDBNPPHCXGS-UHFFFAOYSA-N
131764199;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WJRHNBWETKCFPT-UHFFFAOYSA-N
131755374;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BRHLVPHCYUHFEL-UHFFFAOYSA-N
131755528;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NDNNXIWBJOKRCM-UHFFFAOYSA-N
131759477;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SFTJTIUAYCUEKQ-UHFFFAOYSA-N
131764281;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HMPAWVATDNDSKT-UHFFFAOYSA-N
131762062;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YMIBNLBMYGUACK-UHFFFAOYSA-N
131763219;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NRDVYSIZCMNJBW-UHFFFAOYSA-N
131766334;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JNWVIGXAZADFPG-UHFFFAOYSA-N
56940303;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AMKVBHVMCBBXNU-UHFFFAOYSA-N
131765315;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RAOLZQQBRJPHKT-UHFFFAOYSA-N
56940401;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OADRPNFNIMRMSJ-UHFFFAOYSA-N
131759663;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WHDYIBJFERAONB-UHFFFAOYSA-N
131766104;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JZOMROZIKMUNRL-UHFFFAOYSA-N
131761116;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JAPRMSLBZUSCAD-UHFFFAOYSA-N
131763329;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZCUCDBKSLMWFIN-UHFFFAOYSA-N
131760952;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KFHZZVYZUWJKQG-UHFFFAOYSA-N
131758050;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LBZONYRNSJMDKD-UHFFFAOYSA-N
131764870;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RLBRHSVOQORXKJ-UHFFFAOYSA-N
131764587;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BFHIXYFKXXDKJA-UHFFFAOYSA-N
131765474;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AAQXAMYHTKLRRO-UHFFFAOYSA-N
131760290;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AAYJVNROXHMWJF-UHFFFAOYSA-N
9544854;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PKPAOZPHGVIQGC-UHFFFAOYSA-N
131755963;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RQLZZCKGBZFETM-UHFFFAOYSA-N
131759334;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MWNZLWBLFRSEKB-UHFFFAOYSA-N
131760798;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BKWZVJWHAPNDHG-UHFFFAOYSA-N
131758043;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WBFSLXIVMFYBJL-UHFFFAOYSA-N
131764243;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XJKZLKNQUBHNFP-UHFFFAOYSA-N
131763752;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YPFHJSJMONMNOQ-UHFFFAOYSA-N
131766220;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HKWPIEYUIOGMRD-UHFFFAOYSA-N
131764409;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LRVVKNMHUSRKTM-UHFFFAOYSA-N
131760664;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PDJWMOMYSOZUKA-UHFFFAOYSA-N
131760482;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;AVOGJLBZQNPISG-UHFFFAOYSA-N
131762178;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CNDQFBSWPRXSTI-UHFFFAOYSA-N
131763874;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LVLWZYJYVIWLMX-UHFFFAOYSA-N
131764541;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FBVWZRNWVYGXSE-UHFFFAOYSA-N
131763803;FABP3;7;1.0989999999999999e-54;0.5;1.8013;96.4236;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QADBLNHWOKOYDH-UHFFFAOYSA-N
131764518;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IIGHVRSTPXBBKS-UHFFFAOYSA-N
131757265;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QANJMRAWHCWEGS-UHFFFAOYSA-N
131763383;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RMEHQMVZPZYKQO-UHFFFAOYSA-N
131758234;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MLKVMZHDVPFECT-UHFFFAOYSA-N
131757541;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BVJWKPOODLDRIT-UHFFFAOYSA-N
131761521;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CYFFZIAOTBPWJY-UHFFFAOYSA-N
131759707;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQYVDSPZECGLKR-UHFFFAOYSA-N
131764576;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CBCAECZFTIYBLA-UHFFFAOYSA-N
131757041;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XGCJOJLDYHICIU-UHFFFAOYSA-N
131757413;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UDIKHJQTLDFGFW-UHFFFAOYSA-N
131762023;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBCQOGPWLGKYNO-UHFFFAOYSA-N
131756700;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WHMKXKHZNZAKLF-UHFFFAOYSA-N
131755271;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SMBSCRUSQBQPKE-UHFFFAOYSA-N
131765906;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MLCGMLRNSFLNND-UHFFFAOYSA-N
131757433;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AMDSHUSILZVWMX-UHFFFAOYSA-N
131764816;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HHRQBQZQQLMORJ-UHFFFAOYSA-N
131753774;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AFUMMTADLJXJHO-UHFFFAOYSA-N
131765350;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LNTDKUBVWIHAKI-UHFFFAOYSA-N
131755455;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IEXFFVIGQBUXOM-UHFFFAOYSA-N
131753954;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JXLIWOMLOAXJKY-UHFFFAOYSA-N
131762250;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;STYLBDUVJOXRMQ-UHFFFAOYSA-N
131756890;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZHAAEGBTAPSRS-UHFFFAOYSA-N
131757285;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;ZJYWYCGVUDBWGE-UHFFFAOYSA-N
131756096;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OZEFVBNHXBHBOW-UHFFFAOYSA-N
131761469;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OQSNLZOBBCMKHQ-UHFFFAOYSA-N
131755217;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KAAHBDXVVGSEAD-UHFFFAOYSA-N
131760452;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GMVLULHDBJHRNL-UHFFFAOYSA-N
131760990;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KGUZSTABAOKSII-UHFFFAOYSA-N
131756544;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;POSPEMGIHZMKBT-UHFFFAOYSA-N
131762302;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JINIMSFSEKJDPB-UHFFFAOYSA-N
131764865;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BCNNDWUPEKMMJC-UHFFFAOYSA-N
131756265;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HLHOFQHIUQLVAE-UHFFFAOYSA-N
131758709;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RQHDZVBUHNJLAI-UHFFFAOYSA-N
131763766;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KAUMGZIPYOWTQN-UHFFFAOYSA-N
131762074;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZUWITUYYOHATE-UHFFFAOYSA-N
131759031;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJPANQUZKYHYSG-UHFFFAOYSA-N
131760287;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HSALVDSITWQZNS-UHFFFAOYSA-N
131763953;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ZEKYFQBFJWUBSX-UHFFFAOYSA-N
131763803;LPAR3;6;2.445e-62;0.5652;9.4958;110.1626;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QADBLNHWOKOYDH-UHFFFAOYSA-N
131755297;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;XOIYFXHQESLRQT-UHFFFAOYSA-N
131755194;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QBFPWMQTMYVTPZ-UHFFFAOYSA-N
131764870;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RLBRHSVOQORXKJ-UHFFFAOYSA-N
131761055;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;IGNHERGRXWPMJH-UHFFFAOYSA-N
131764587;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BFHIXYFKXXDKJA-UHFFFAOYSA-N
131757192;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZAQWCHTYSYNWSH-UHFFFAOYSA-N
131756062;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HAZYEPTWRFLUON-UHFFFAOYSA-N
131759984;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UEZYCMFLJSEDEB-UHFFFAOYSA-N
131756895;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SKWZGEDXJHKPTI-UHFFFAOYSA-N
131762050;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWGVIIKYSFUCLF-UHFFFAOYSA-N
131764791;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEJHTHOZNZVRKD-UHFFFAOYSA-N
131760148;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XQLSSUQHKWUYMC-UHFFFAOYSA-N
131756789;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IIYQJRSPWUCSDM-UHFFFAOYSA-N
131765826;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDMMBNHFKIGUCQ-UHFFFAOYSA-N
131756115;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NWCGBGIXJBNACP-UHFFFAOYSA-N
131765590;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYZQQKYMCQJKTA-UHFFFAOYSA-N
131757627;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CQQRPMOWXSEZTP-UHFFFAOYSA-N
131761990;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XRUFDENJLIKWQM-UHFFFAOYSA-N
131755374;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BRHLVPHCYUHFEL-UHFFFAOYSA-N
131765302;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MBBWQOJXLONXQW-UHFFFAOYSA-N
131765285;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPNXDPAVMXQTCA-UHFFFAOYSA-N
131766136;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHJBRHVZLQLMHJ-UHFFFAOYSA-N
131766421;FABP3;7;8.167e-49;0.4286;1.605;85.8831;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZYZCTQBWUMGGIY-UHFFFAOYSA-N
131764129;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LLRMOUDUDWTCRD-UHFFFAOYSA-N
131764156;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PICADWPLIJJOOG-UHFFFAOYSA-N
131761500;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GZYXMJLTMGSMEX-UHFFFAOYSA-N
131757861;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;CCYKAYZERNIDEA-UHFFFAOYSA-N
131756864;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZQMWAXRJJGBMX-UHFFFAOYSA-N
9545846;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KJMSXXMFCOJLJY-UHFFFAOYSA-N
131759374;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CSXWUPDTKWUFDD-UHFFFAOYSA-N
131755992;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NCJLYHVTMRUDRY-UHFFFAOYSA-N
131760583;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GQNCOCJLEFUUME-UHFFFAOYSA-N
131755914;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AKJAVHDSGYNHSB-UHFFFAOYSA-N
131759201;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YAQCQKUWLQDYCJ-UHFFFAOYSA-N
131756890;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZHAAEGBTAPSRS-UHFFFAOYSA-N
9544818;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131766108;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGOXOYQAVRXXMO-UHFFFAOYSA-N
131756729;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ASPJACHPVRBOQP-UHFFFAOYSA-N
131763754;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MWQHJVNOXOFDGS-UHFFFAOYSA-N
53480575;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWSQCBUVZQFFAT-UHFFFAOYSA-N
131764200;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HGVUWOFDDHGBHN-UHFFFAOYSA-N
131763344;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MHQQXKMTIMDITH-UHFFFAOYSA-N
9545910;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTCGGJDDKNMITC-UHFFFAOYSA-N
131762050;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWGVIIKYSFUCLF-UHFFFAOYSA-N
131765575;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDBKGOXLBQIZPU-UHFFFAOYSA-N
131756160;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KXAMFYWJHGZEGH-UHFFFAOYSA-N
131764350;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IYTSSWXSXRRTMI-UHFFFAOYSA-N
131759941;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DDQPMPZGDGZDLB-UHFFFAOYSA-N
131757193;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZJDHSVUVYJSBGX-UHFFFAOYSA-N
131760044;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KRNIAXVTJSTDFH-UHFFFAOYSA-N
131765999;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PTSQXKFHEOEPFF-UHFFFAOYSA-N
131753954;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JXLIWOMLOAXJKY-UHFFFAOYSA-N
131764811;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RFNMQGVASYUQRC-UHFFFAOYSA-N
131756133;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QPDHZEQJAFYSNE-UHFFFAOYSA-N
131763432;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BHTDMDDGPQHTNH-UHFFFAOYSA-N
131763797;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ICVAHKOZRSLUFQ-UHFFFAOYSA-N
131759965;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MCTZBSNODNYQBM-UHFFFAOYSA-N
131760589;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UCHSMZOZHHHKTN-UHFFFAOYSA-N
131760467;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXQABWBASCQTOJ-UHFFFAOYSA-N
131764728;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WAXXYEULPJLQFN-UHFFFAOYSA-N
131756422;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QAMWFCYOJWMYOC-UHFFFAOYSA-N
131766380;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QPIJJOPUZQDQMA-UHFFFAOYSA-N
131757562;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IGCFSFMLNPLXMG-UHFFFAOYSA-N
131758687;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;DPOKSOYZNAGELJ-UHFFFAOYSA-N
131763861;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VQSBVFWLIMSUKU-UHFFFAOYSA-N
131760764;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZIRJXTDTRZMNMW-UHFFFAOYSA-N
131764756;LPAR3;6;6.843e-71;0.5778;10.8111;125.518;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QGITUKCHSUMQKN-UHFFFAOYSA-N
131759340;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UMQXHZBMMHCUQU-UHFFFAOYSA-N
131761982;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYVKSOXJHUKFRF-UHFFFAOYSA-N
131760912;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NHHWSKRTYUVOOE-UHFFFAOYSA-N
131765667;FABP3;7;8.167e-49;0.4286;1.605;85.8831;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SXUJRBNGKRSZMK-UHFFFAOYSA-N
131757194;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;FHLGAKXGDKAPGG-UHFFFAOYSA-N
131765590;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYZQQKYMCQJKTA-UHFFFAOYSA-N
131761043;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IAKNICPRAKVQME-UHFFFAOYSA-N
131760083;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QDMDGODCZNNQBV-UHFFFAOYSA-N
131756448;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RGEZBXPRDPDBNY-UHFFFAOYSA-N
440854;GRIK1;6;7.87e-96;0.5417;25.8383;170.292;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C(C(C(=O)O)N)C(C(=O)O)O;HBDWQSHEVMSFGY-UHFFFAOYSA-N
131763943;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HZEWLUFXEAGEHA-UHFFFAOYSA-N
131758665;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XJZRZLMCPQTTIU-UHFFFAOYSA-N
131756091;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AGXFHKUZXQPREM-UHFFFAOYSA-N
131760596;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MSUBTQPZOUPMQD-UHFFFAOYSA-N
131755244;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPAFMXZJSAXNQ-UHFFFAOYSA-N
56940398;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;RBNZROQPTPETBJ-UHFFFAOYSA-N
131760090;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;PQNHEABAEPMJMD-UHFFFAOYSA-N
131765942;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ODSPHNHCZQVDMR-UHFFFAOYSA-N
131758825;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UVNIPBFYITWPNW-UHFFFAOYSA-N
131763874;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LVLWZYJYVIWLMX-UHFFFAOYSA-N
131759459;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OQYXMWZVMDPNIP-UHFFFAOYSA-N
131756729;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ASPJACHPVRBOQP-UHFFFAOYSA-N
131753886;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ISVYJGODJAFSSA-UHFFFAOYSA-N
131756107;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QUXKGFALHOZZDI-UHFFFAOYSA-N
131759959;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;RMYOOEULFAUMKN-UHFFFAOYSA-N
131764743;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QNUYKUIODKHOPQ-UHFFFAOYSA-N
131758021;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XXGCNFKQIMIEKF-UHFFFAOYSA-N
131761202;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SIYFOTCMVVGGPK-UHFFFAOYSA-N
131766112;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DVOPPHNPCKLGLG-UHFFFAOYSA-N
131761504;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UCHCSQUXSXHUED-UHFFFAOYSA-N
131761021;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEPRNBOWRGJCFH-UHFFFAOYSA-N
131753818;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CVSGTFIHUMEUGC-UHFFFAOYSA-N
131764140;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFTGNQCYADESFM-UHFFFAOYSA-N
131755814;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATLSKDGFHXWZQX-UHFFFAOYSA-N
131753373;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFQQJRGJJVQGAV-UHFFFAOYSA-N
131765948;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VGFGAVMFHSHYQQ-UHFFFAOYSA-N
131750573;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;TUJAWJCRCOOMQU-UHFFFAOYSA-N
131763333;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SDLBWDJXBOAFEM-UHFFFAOYSA-N
131764421;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXTJEHRYNIVMJO-UHFFFAOYSA-N
131762643;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GBQSFVXSYJLCAE-UHFFFAOYSA-N
131761815;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GCRBDMOHZRWTQB-UHFFFAOYSA-N
131761902;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XMVHZFQXXQHPFZ-UHFFFAOYSA-N
131764226;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPRZFYNWCPHLBU-UHFFFAOYSA-N
131757860;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;AGHHOFLCBXWHOS-UHFFFAOYSA-N
131763405;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CCWQXSQVMPACON-UHFFFAOYSA-N
131755991;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IOFQLHPECKLVSM-UHFFFAOYSA-N
131763341;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PGNPUZLWAYIFAX-UHFFFAOYSA-N
131761202;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SIYFOTCMVVGGPK-UHFFFAOYSA-N
131760142;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RSYHUYFRXBMMEW-UHFFFAOYSA-N
131765343;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PJNRHMLPSAIXIL-UHFFFAOYSA-N
131761036;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GJNCCQAILGZQPE-UHFFFAOYSA-N
131759483;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RFURIDCRDPRIJL-UHFFFAOYSA-N
131753886;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ISVYJGODJAFSSA-UHFFFAOYSA-N
131765400;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATZUQFQPFCLNTM-UHFFFAOYSA-N
131761540;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JAFDAKTXILVQMT-UHFFFAOYSA-N
131765727;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HBROMTOKCOWBCF-UHFFFAOYSA-N
131762527;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DCYWSDMCLMGYLN-UHFFFAOYSA-N
131764140;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFTGNQCYADESFM-UHFFFAOYSA-N
131758715;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;VARKWBYIQXSEHP-UHFFFAOYSA-N
131755099;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIRHPCGBIJZASY-UHFFFAOYSA-N
131756140;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YRNOILAKWQZJOO-UHFFFAOYSA-N
131756470;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCSMYJQXGWBEFO-UHFFFAOYSA-N
131763127;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RLGAQDGPQYEBLL-UHFFFAOYSA-N
131765550;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HLYYLRJCOCUOTF-UHFFFAOYSA-N
131765944;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;APLBEJJTPVKUEV-UHFFFAOYSA-N
131766432;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ITTQJNRRFXILFF-UHFFFAOYSA-N
131750412;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RFMSTHTUAZETPD-UHFFFAOYSA-N
131760571;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WAZXBESWUFNIKC-UHFFFAOYSA-N
131762177;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZDZWWVXHKYJJZ-UHFFFAOYSA-N
131765820;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;UFAIMASITNLXEW-UHFFFAOYSA-N
131766108;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGOXOYQAVRXXMO-UHFFFAOYSA-N
131758963;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QAVLFIAVSWNWOP-UHFFFAOYSA-N
131764732;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CIFVSTXCBAOUKA-UHFFFAOYSA-N
131764187;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKWUREQRVPUWQW-UHFFFAOYSA-N
131763744;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NCKGNPQWQKPFIF-UHFFFAOYSA-N
131761055;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;IGNHERGRXWPMJH-UHFFFAOYSA-N
131765982;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VFVJRYCSOQQDRY-UHFFFAOYSA-N
131765821;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQVAELCJJYGSJQ-UHFFFAOYSA-N
131762178;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CNDQFBSWPRXSTI-UHFFFAOYSA-N
131763219;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NRDVYSIZCMNJBW-UHFFFAOYSA-N
131756819;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ALNNHOFYSWAINZ-UHFFFAOYSA-N
131765517;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYDNDHADQTVNOZ-UHFFFAOYSA-N
131756842;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CGYUWASKRWCFSH-UHFFFAOYSA-N
131766241;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MFNNIGPRUSRGSO-UHFFFAOYSA-N
131756238;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QGNLJGRXJOVVCH-UHFFFAOYSA-N
131757220;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HMVLLJGZOCQDFI-UHFFFAOYSA-N
131763430;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NKUICCQWMVNWPG-UHFFFAOYSA-N
131763854;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AODBNMOGHKMQLM-UHFFFAOYSA-N
131758891;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;KZTAYHHQGGVNPE-UHFFFAOYSA-N
131761219;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PIMPYDZIXKACMS-UHFFFAOYSA-N
131765509;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IZGDWRLRMLPRRH-UHFFFAOYSA-N
131761949;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MXSSKIVWHBHDLS-UHFFFAOYSA-N
131757406;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CDMARTCICGPDST-UHFFFAOYSA-N
131763850;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VMOOWSPQGJCOEF-UHFFFAOYSA-N
131758210;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UJXQJJSLQLGCCL-UHFFFAOYSA-N
131760557;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFPSXJPVXFGDJF-UHFFFAOYSA-N
131755461;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MEUWGTHLRSIXHV-UHFFFAOYSA-N
131759316;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FLMVCURKTYUWQF-UHFFFAOYSA-N
131750408;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QEBMDFMPVYJRFG-UHFFFAOYSA-N
131761099;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OZBDLYCKVSSLBL-UHFFFAOYSA-N
131760140;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CRAIJEBCCMKULT-UHFFFAOYSA-N
131762527;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DCYWSDMCLMGYLN-UHFFFAOYSA-N
131763953;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ZEKYFQBFJWUBSX-UHFFFAOYSA-N
131758877;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;RIPMVOUZKWTQDO-UHFFFAOYSA-N
131759869;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FPWUJNGGVATCPT-UHFFFAOYSA-N
131759353;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WJMXDOSYJOVEGP-UHFFFAOYSA-N
131764274;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNLUHLHHOCNFLS-UHFFFAOYSA-N
131761885;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SVBUNVHEBALJFL-UHFFFAOYSA-N
131758963;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QAVLFIAVSWNWOP-UHFFFAOYSA-N
131764489;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZMDJDWQCIRBXLN-UHFFFAOYSA-N
131756294;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VIGAYEURCPHMGZ-UHFFFAOYSA-N
131760266;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FDBPCQBWBNZEDW-UHFFFAOYSA-N
131759816;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ABRDLWYBZGTCTL-UHFFFAOYSA-N
131753744;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZTYPYYDVEYQFSE-UHFFFAOYSA-N
131757868;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;VGJLRVHUGWORNM-UHFFFAOYSA-N
131761015;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZVQFZROUAQXGJM-UHFFFAOYSA-N
131757272;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OWZRRACHZQKQKB-UHFFFAOYSA-N
131756560;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IUCQBMBRIJLQCE-UHFFFAOYSA-N
131756043;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JWEMQLKKBMDMSC-UHFFFAOYSA-N
131757389;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NGGZABQJVQPRCU-UHFFFAOYSA-N
131764222;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AQXUMBSYJVJRPS-UHFFFAOYSA-N
131760538;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ABSZNRZAXPIPNQ-UHFFFAOYSA-N
131766313;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIMKMGTVYYNDEJ-UHFFFAOYSA-N
131763873;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NPPQAYOZPNHUTJ-UHFFFAOYSA-N
131759979;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GFFLZJLHLVDXFE-UHFFFAOYSA-N
131762079;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VBUPWWIRBFWNGJ-UHFFFAOYSA-N
131765351;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KSUYSWUNWRLYBY-UHFFFAOYSA-N
131756915;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKEZCTFABVCKSM-UHFFFAOYSA-N
131758066;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PAWWFARWOBDKCZ-UHFFFAOYSA-N
131759518;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LKBYQEQTTQMXOC-UHFFFAOYSA-N
131758257;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JTAZFPZUAINKAO-UHFFFAOYSA-N
131756915;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKEZCTFABVCKSM-UHFFFAOYSA-N
131765517;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYDNDHADQTVNOZ-UHFFFAOYSA-N
131760407;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NWTURLYIJSOABO-UHFFFAOYSA-N
131756701;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YMNDWXQHOZTTQG-UHFFFAOYSA-N
131764572;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UFCXEZKSYAKBPL-UHFFFAOYSA-N
131760432;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHNZVYBODMKEQT-UHFFFAOYSA-N
131759833;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VFQVWRHDXMNZND-UHFFFAOYSA-N
131761244;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UNXLYVQSTSVPKP-UHFFFAOYSA-N
131763374;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VQRIXOHBVKMVEL-UHFFFAOYSA-N
131761897;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IIFYGJBPANGSOD-UHFFFAOYSA-N
131758877;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;RIPMVOUZKWTQDO-UHFFFAOYSA-N
131765521;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IZQCWCMPLLSHHW-UHFFFAOYSA-N
131762090;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GBVPBBCPTVGLPS-UHFFFAOYSA-N
131765805;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZQLZCFZHBCBDQM-UHFFFAOYSA-N
131764490;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DETNYSOCAKGVMQ-UHFFFAOYSA-N
131756842;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CGYUWASKRWCFSH-UHFFFAOYSA-N
131756565;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FCHJVBOWMICKJA-UHFFFAOYSA-N
131755074;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KLBXZRONSATXOR-UHFFFAOYSA-N
131760850;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XRLJXFQOTJPGAY-UHFFFAOYSA-N
131763888;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IWTJSOVMTAKRTG-UHFFFAOYSA-N
131753395;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LETIJHNTNHPKEB-UHFFFAOYSA-N
131760856;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WUQZNKAJBDSVTJ-UHFFFAOYSA-N
131753714;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AREMZVRDXOGTHG-UHFFFAOYSA-N
131755366;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BWOWEFRYVHJNEP-UHFFFAOYSA-N
131763671;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RLKSWIHVEAZROT-UHFFFAOYSA-N
131757413;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UDIKHJQTLDFGFW-UHFFFAOYSA-N
131763670;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JNZQBLFKGOVDNV-UHFFFAOYSA-N
131757468;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LWKAZICCJBIXBG-UHFFFAOYSA-N
131761583;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BXABDUMCSIHFIE-UHFFFAOYSA-N
9544818;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131756963;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MXJKXYIXCLMTJO-UHFFFAOYSA-N
131764116;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IIZFWHKVNJTNPQ-UHFFFAOYSA-N
131763163;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PZMSAQJXASOAPE-UHFFFAOYSA-N
131760550;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QFGOYGNOTBVZDL-UHFFFAOYSA-N
131763344;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MHQQXKMTIMDITH-UHFFFAOYSA-N
131760392;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NMBWREWNBSVWGK-UHFFFAOYSA-N
131756160;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KXAMFYWJHGZEGH-UHFFFAOYSA-N
131760428;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GJZAKWNUCSDFIU-UHFFFAOYSA-N
9544997;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RETPNLDNHGHCKP-UHFFFAOYSA-N
131762613;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHCVMVYSBUVFNX-UHFFFAOYSA-N
131760427;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KQHIUWHKRXQFTK-UHFFFAOYSA-N
131760289;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FZKWULPGSLRZTH-UHFFFAOYSA-N
131765637;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NKHUBYYMFGFTBT-UHFFFAOYSA-N
131763137;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CYKZBIMIYCZCIP-UHFFFAOYSA-N
131761092;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LBXWNIAXYWLNFI-UHFFFAOYSA-N
131756289;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OHFJEIHIIZLXHT-UHFFFAOYSA-N
131758708;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PVJPHQHSWUWAQJ-UHFFFAOYSA-N
131755106;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XASLXNYLAYUVLS-UHFFFAOYSA-N
131761830;LPAR3;6;1.1880000000000001e-57;0.5417;8.7751;101.7486;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;CDGBKFWHRXPNIS-UHFFFAOYSA-N
131759518;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LKBYQEQTTQMXOC-UHFFFAOYSA-N
131756036;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FGOIRQZPYNSNTG-UHFFFAOYSA-N
131762596;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YBMSPSGALOVJLN-UHFFFAOYSA-N
131760670;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VJJRELRGCGHSSN-UHFFFAOYSA-N
131753636;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IGCRUOUEUMSKRE-UHFFFAOYSA-N
131755845;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MFNWYZFORRXQHT-UHFFFAOYSA-N
131750632;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MDADRLWXQATSON-UHFFFAOYSA-N
131762139;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KVGQCWIIYQFVAZ-UHFFFAOYSA-N
131755073;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FYFQGQAMTRIKHO-UHFFFAOYSA-N
131756371;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RXVLBDOYHGQIHF-UHFFFAOYSA-N
131750423;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131758113;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NXBSSTRUFABJPB-UHFFFAOYSA-N
56940014;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBFKGUJFNGJJRX-UHFFFAOYSA-N
131761540;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JAFDAKTXILVQMT-UHFFFAOYSA-N
131763429;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PZLNYKRJVKGRCK-UHFFFAOYSA-N
131755366;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BWOWEFRYVHJNEP-UHFFFAOYSA-N
131757412;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IIJVLTDWMAWLFO-UHFFFAOYSA-N
131762139;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KVGQCWIIYQFVAZ-UHFFFAOYSA-N
131761886;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LTMMYRYQSSNANI-UHFFFAOYSA-N
131764262;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IIRNIPXWMCLIGN-UHFFFAOYSA-N
131766218;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HNUYKTOGWYOCHC-UHFFFAOYSA-N
131756062;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HAZYEPTWRFLUON-UHFFFAOYSA-N
131761778;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YTJVEHDHQJQWGG-UHFFFAOYSA-N
131756084;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VTHDNMHRPKXWMZ-UHFFFAOYSA-N
131763345;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VZMDAERKCFBEMZ-UHFFFAOYSA-N
131762057;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CUAKEOAMABCXMW-UHFFFAOYSA-N
131765667;LPAR3;6;9.708e-50;0.4727;7.5584;87.5437;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SXUJRBNGKRSZMK-UHFFFAOYSA-N
131765778;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WVDRXDBKAJIUGG-UHFFFAOYSA-N
131756422;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QAMWFCYOJWMYOC-UHFFFAOYSA-N
131764802;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GWEURXHGUZNRIT-UHFFFAOYSA-N
131759379;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SZWHHAMLCPVQHZ-UHFFFAOYSA-N
131760550;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QFGOYGNOTBVZDL-UHFFFAOYSA-N
131758401;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JCQPLTYLLRMKIQ-UHFFFAOYSA-N
131763375;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BLKBAXUTLWGPPO-UHFFFAOYSA-N
131766214;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LQOVUJRZQTZNEJ-UHFFFAOYSA-N
131762595;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SDWPVMNEXQULAT-UHFFFAOYSA-N
131755072;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;XAOHLQFHAMQDGH-UHFFFAOYSA-N
131756889;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGIUZRTVYUQICM-UHFFFAOYSA-N
131764847;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJSRQCYRQHWNOX-UHFFFAOYSA-N
131755838;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VXILKXGVHSBSGJ-UHFFFAOYSA-N
131756846;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHUKVTWUCRMUNV-UHFFFAOYSA-N
131761949;LPAR3;6;6.843e-71;0.5778;10.8111;125.518;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MXSSKIVWHBHDLS-UHFFFAOYSA-N
131750632;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MDADRLWXQATSON-UHFFFAOYSA-N
131760347;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHZFGSBSLITSMO-UHFFFAOYSA-N
131757914;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;XMIDMFLTTPZJFG-UHFFFAOYSA-N
131764262;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IIRNIPXWMCLIGN-UHFFFAOYSA-N
131759539;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IDVKFTSFXLYDBH-UHFFFAOYSA-N
131764274;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNLUHLHHOCNFLS-UHFFFAOYSA-N
131763318;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BXLCYHMCRNPYDN-UHFFFAOYSA-N
131755662;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QVOHTEKWCOOZBV-UHFFFAOYSA-N
131765414;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LCQVTHMBIKCBPP-UHFFFAOYSA-N
131756846;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHUKVTWUCRMUNV-UHFFFAOYSA-N
131763475;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZWAGVJRENVHFMW-UHFFFAOYSA-N
131759334;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MWNZLWBLFRSEKB-UHFFFAOYSA-N
131763662;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HAGZJMAABAPVKG-UHFFFAOYSA-N
131761637;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MVIQOCPGVCDPJO-UHFFFAOYSA-N
131756769;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SNADIPNNRGNXJQ-UHFFFAOYSA-N
131763805;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WLKYPPYVGVLSFZ-UHFFFAOYSA-N
131759539;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IDVKFTSFXLYDBH-UHFFFAOYSA-N
131762603;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYXWSTIICMYXLZ-UHFFFAOYSA-N
131763363;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFFVNPZNLYTNDK-UHFFFAOYSA-N
131763757;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZJGPZZWOLFZNJ-UHFFFAOYSA-N
131762286;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MTZJVBULFGKJAO-UHFFFAOYSA-N
131764807;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PSSHOBGHPGDGSV-UHFFFAOYSA-N
131764432;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XWCJBYCREBJYKA-UHFFFAOYSA-N
131761942;LPAR3;6;6.843e-71;0.5778;10.8111;125.518;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DZCKFRKMUJZBAT-UHFFFAOYSA-N
131761589;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYZDQWXRUMWJEF-UHFFFAOYSA-N
131753564;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LRUXRFQLJJKABR-UHFFFAOYSA-N
131762146;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KDKFUFGVHHXTMC-UHFFFAOYSA-N
131755794;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJRBHONTDZUSAV-UHFFFAOYSA-N
131766200;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XFKCIJVYTCFMNK-UHFFFAOYSA-N
131758401;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JCQPLTYLLRMKIQ-UHFFFAOYSA-N
131763758;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AUHAVSXJNUHURT-UHFFFAOYSA-N
131762595;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SDWPVMNEXQULAT-UHFFFAOYSA-N
76406;KDM2A;6;1.524e-45;0.44;1.8106;80.011;KDM2A;Lysine-specific demethylase 2A (pKi >= 6);CC(=O)NCCC(=O)O;LJLLAWRMBZNPMO-UHFFFAOYSA-N
131759723;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DFWFUERTQLGULG-UHFFFAOYSA-N
131757406;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CDMARTCICGPDST-UHFFFAOYSA-N
131760670;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VJJRELRGCGHSSN-UHFFFAOYSA-N
131756441;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JGZAQTBYJIAXMB-UHFFFAOYSA-N
131763327;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HIXJBODFVNVVOZ-UHFFFAOYSA-N
131757187;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;DPXCUHXDCAZRMD-UHFFFAOYSA-N
445282;GRIK1;7;1.7889999999999998e-47;0.4286;7.9891;83.4762;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 7);CS(=O)(=O)CCC(C(=O)O)N;UCUNFLYVYCGDHP-UHFFFAOYSA-N
440854;GRIK1;7;2.921e-74;0.5417;12.5516;131.5678;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 7);C(C(C(=O)O)N)C(C(=O)O)O;HBDWQSHEVMSFGY-UHFFFAOYSA-N
440854;GRIK3;7;1.443e-45;0.5417;1.6578;80.0532;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 7);C(C(C(=O)O)N)C(C(=O)O)O;HBDWQSHEVMSFGY-UHFFFAOYSA-N
131758022;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;UFISVPDSQMIDGI-UHFFFAOYSA-N
131750622;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHGBUKYRNKUYSP-UHFFFAOYSA-N
131756676;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SQGUGCCVMDVBJZ-UHFFFAOYSA-N
131758027;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;QBIXIQXOQCCVJI-UHFFFAOYSA-N
131757413;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;UDIKHJQTLDFGFW-UHFFFAOYSA-N
131756573;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;GSYLODJVGAPZPZ-UHFFFAOYSA-N
131758028;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;XDOWEQFXTJXLQK-UHFFFAOYSA-N
131756469;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BEJINFUEKQSHML-UHFFFAOYSA-N
131758021;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;XXGCNFKQIMIEKF-UHFFFAOYSA-N
131764123;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BSLYTXPSABCJNS-UHFFFAOYSA-N
131764128;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YKRAKIKUUNSETH-UHFFFAOYSA-N
131764129;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LLRMOUDUDWTCRD-UHFFFAOYSA-N
131755107;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LQBZDHKVUKVJGO-UHFFFAOYSA-N
131759728;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HCOXAOVJODNXKR-UHFFFAOYSA-N
131764116;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IIZFWHKVNJTNPQ-UHFFFAOYSA-N
131753395;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LETIJHNTNHPKEB-UHFFFAOYSA-N
131760143;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GXHRHWLAWLLOCF-UHFFFAOYSA-N
131760140;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CRAIJEBCCMKULT-UHFFFAOYSA-N
131759722;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWAKFXXPMACHCN-UHFFFAOYSA-N
131759723;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DFWFUERTQLGULG-UHFFFAOYSA-N
131756683;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NIFYGEMZMKSOKK-UHFFFAOYSA-N
131757074;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FUSFZXIXQUQAAT-UHFFFAOYSA-N
131759727;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;STBZEPVDQQTJQY-UHFFFAOYSA-N
131760148;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XQLSSUQHKWUYMC-UHFFFAOYSA-N
131766116;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BZSQSBHEVLMJAJ-UHFFFAOYSA-N
131757173;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYPCPBKGHFDBQX-UHFFFAOYSA-N
131763434;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MQHMZCFDXHXJOZ-UHFFFAOYSA-N
131763433;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UGZBFOQDGPJMST-UHFFFAOYSA-N
131763432;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BHTDMDDGPQHTNH-UHFFFAOYSA-N
131763430;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NKUICCQWMVNWPG-UHFFFAOYSA-N
131757562;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IGCFSFMLNPLXMG-UHFFFAOYSA-N
131758709;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RQHDZVBUHNJLAI-UHFFFAOYSA-N
131758708;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PVJPHQHSWUWAQJ-UHFFFAOYSA-N
131763757;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZJGPZZWOLFZNJ-UHFFFAOYSA-N
131763754;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MWQHJVNOXOFDGS-UHFFFAOYSA-N
131757541;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BVJWKPOODLDRIT-UHFFFAOYSA-N
131763752;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YPFHJSJMONMNOQ-UHFFFAOYSA-N
131759316;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FLMVCURKTYUWQF-UHFFFAOYSA-N
131756701;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YMNDWXQHOZTTQG-UHFFFAOYSA-N
131756700;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WHMKXKHZNZAKLF-UHFFFAOYSA-N
131765667;LPAR3;7;5.318e-45;0.4727;3.1782;79.0363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SXUJRBNGKRSZMK-UHFFFAOYSA-N
131761360;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IHIIZCPGLXUXFB-UHFFFAOYSA-N
131756707;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JWRLQVQWCRUWFY-UHFFFAOYSA-N
131756706;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNFYWKVDGNONSX-UHFFFAOYSA-N
131761539;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NYDVKQSVKPIZDU-UHFFFAOYSA-N
131755276;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XNXYVFSTYMBATM-UHFFFAOYSA-N
131755277;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZHTYGSYTHOBYHT-UHFFFAOYSA-N
131755270;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;XWHMTYPOWZWZQD-UHFFFAOYSA-N
131755271;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SMBSCRUSQBQPKE-UHFFFAOYSA-N
131761244;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UNXLYVQSTSVPKP-UHFFFAOYSA-N
131755374;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BRHLVPHCYUHFEL-UHFFFAOYSA-N
131761533;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FLTZXTYOVWGLNO-UHFFFAOYSA-N
131758090;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KGUKXPWFPDKTLO-UHFFFAOYSA-N
131755072;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;XAOHLQFHAMQDGH-UHFFFAOYSA-N
131764150;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RYRQCSWRSANYFM-UHFFFAOYSA-N
131761920;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UNYSRSKHDZXMCA-UHFFFAOYSA-N
131759869;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FPWUJNGGVATCPT-UHFFFAOYSA-N
131757259;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;XAXCHZWOFLFLPM-UHFFFAOYSA-N
131755074;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KLBXZRONSATXOR-UHFFFAOYSA-N
131764156;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PICADWPLIJJOOG-UHFFFAOYSA-N
131759852;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CVASUUQYQOXYSJ-UHFFFAOYSA-N
131764409;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LRVVKNMHUSRKTM-UHFFFAOYSA-N
131762752;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JQKSTWZRLSFFJF-UHFFFAOYSA-N
131762050;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWGVIIKYSFUCLF-UHFFFAOYSA-N
131759941;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;DDQPMPZGDGZDLB-UHFFFAOYSA-N
131762056;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SZBKZAAACSCYMQ-UHFFFAOYSA-N
131759947;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;HJLYLYOJMWMVLA-UHFFFAOYSA-N
131762193;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VCPLVQPYTVTKNH-UHFFFAOYSA-N
131762192;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCINELBMQVGABE-UHFFFAOYSA-N
131759978;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RKIWUSSRNOMOHK-UHFFFAOYSA-N
131756770;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UBKZOPGBBSBRBG-UHFFFAOYSA-N
131760446;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GLIIMTFLXXHIBR-UHFFFAOYSA-N
131759544;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJQLIWBFMBNJL-UHFFFAOYSA-N
131760566;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;KLPBKIYPIXLUIY-UHFFFAOYSA-N
131757420;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;RFWZFNZBJZHWEA-UHFFFAOYSA-N
131758897;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NXTVIXLFALVIBZ-UHFFFAOYSA-N
131758891;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;KZTAYHHQGGVNPE-UHFFFAOYSA-N
131765316;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HAFMBTFFCFVZFH-UHFFFAOYSA-N
131759387;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCFICBUSORBZMX-UHFFFAOYSA-N
131759380;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QZEYFZLPYNVHDI-UHFFFAOYSA-N
131765971;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GFYRVXIUUHCNOX-UHFFFAOYSA-N
131765277;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;WHJRBJJZLJBRBL-UHFFFAOYSA-N
131760452;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GMVLULHDBJHRNL-UHFFFAOYSA-N
131765906;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MLCGMLRNSFLNND-UHFFFAOYSA-N
131750632;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MDADRLWXQATSON-UHFFFAOYSA-N
131760090;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;PQNHEABAEPMJMD-UHFFFAOYSA-N
131765575;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDBKGOXLBQIZPU-UHFFFAOYSA-N
131765576;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YVMNXNALYLASPR-UHFFFAOYSA-N
131757855;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;MBEHVCHNDQZWCB-UHFFFAOYSA-N
131757492;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZUYMTPHHKSWXII-UHFFFAOYSA-N
131757559;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GVNOVHPRZPBICJ-UHFFFAOYSA-N
131765475;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CWMAMCLCHMLZCC-UHFFFAOYSA-N
131764499;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UTLDFQYGOHSAKY-UHFFFAOYSA-N
131762271;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZQAVPFDERBCAHC-UHFFFAOYSA-N
131757220;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;HMVLLJGZOCQDFI-UHFFFAOYSA-N
131764490;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DETNYSOCAKGVMQ-UHFFFAOYSA-N
131764876;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XPVVJFGULSFCAO-UHFFFAOYSA-N
131762408;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DKJQAINPSUNNDI-UHFFFAOYSA-N
131764870;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RLBRHSVOQORXKJ-UHFFFAOYSA-N
131755991;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IOFQLHPECKLVSM-UHFFFAOYSA-N
131763804;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWIXODUOTVEHET-UHFFFAOYSA-N
131755992;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NCJLYHVTMRUDRY-UHFFFAOYSA-N
131756914;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FVMACQWBKCZBMW-UHFFFAOYSA-N
131756915;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKEZCTFABVCKSM-UHFFFAOYSA-N
131760691;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ULBTVPHSXKRJBN-UHFFFAOYSA-N
131756851;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UOXUZNWTFAUUEA-UHFFFAOYSA-N
131756107;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QUXKGFALHOZZDI-UHFFFAOYSA-N
131758963;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QAVLFIAVSWNWOP-UHFFFAOYSA-N
131760142;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RSYHUYFRXBMMEW-UHFFFAOYSA-N
131756084;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VTHDNMHRPKXWMZ-UHFFFAOYSA-N
131760596;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MSUBTQPZOUPMQD-UHFFFAOYSA-N
131753601;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UFZBCZHRQDOVGQ-UHFFFAOYSA-N
131764572;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UFCXEZKSYAKBPL-UHFFFAOYSA-N
131761109;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QOFVOYKNSFNVGG-UHFFFAOYSA-N
131764576;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CBCAECZFTIYBLA-UHFFFAOYSA-N
131753608;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FXCUDDKMKYVUSX-UHFFFAOYSA-N
131765999;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PTSQXKFHEOEPFF-UHFFFAOYSA-N
131764274;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNLUHLHHOCNFLS-UHFFFAOYSA-N
131762554;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NGQPUERHGUGMCW-UHFFFAOYSA-N
131755296;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HIEDMQDYLJFCPX-UHFFFAOYSA-N
131755297;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;XOIYFXHQESLRQT-UHFFFAOYSA-N
131759374;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CSXWUPDTKWUFDD-UHFFFAOYSA-N
131758694;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;XORGQMNRBOZGBM-UHFFFAOYSA-N
131760664;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PDJWMOMYSOZUKA-UHFFFAOYSA-N
131763383;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RMEHQMVZPZYKQO-UHFFFAOYSA-N
131763382;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ODUNWMBZVDPITO-UHFFFAOYSA-N
131763389;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IIYFPBRRSIIIPT-UHFFFAOYSA-N
131763388;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MLBJZKVMDIHXDL-UHFFFAOYSA-N
131760875;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJJRJDAWZMHWKT-UHFFFAOYSA-N
131756294;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VIGAYEURCPHMGZ-UHFFFAOYSA-N
131760188;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ODZGUPAQUQGEKA-UHFFFAOYSA-N
131760742;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTSDPTZQCYEEKC-UHFFFAOYSA-N
131757037;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBEXOEBBZPQUND-UHFFFAOYSA-N
131763475;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZWAGVJRENVHFMW-UHFFFAOYSA-N
131756160;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KXAMFYWJHGZEGH-UHFFFAOYSA-N
131763374;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VQRIXOHBVKMVEL-UHFFFAOYSA-N
131756036;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FGOIRQZPYNSNTG-UHFFFAOYSA-N
131760453;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FQYWDFDUCXHAEX-UHFFFAOYSA-N
131755476;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JEZIXTIQQIPJCZ-UHFFFAOYSA-N
131760990;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KGUZSTABAOKSII-UHFFFAOYSA-N
131765727;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HBROMTOKCOWBCF-UHFFFAOYSA-N
131766112;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DVOPPHNPCKLGLG-UHFFFAOYSA-N
131756745;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GOUXXLWMYYBHCM-UHFFFAOYSA-N
131758113;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NXBSSTRUFABJPB-UHFFFAOYSA-N
131756746;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TZJRCHMRWDMDSJ-UHFFFAOYSA-N
131760473;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JHSXEMRTWBYZRI-UHFFFAOYSA-N
9897805;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AYUYHZRNTHHDTD-UHFFFAOYSA-N
131761202;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SIYFOTCMVVGGPK-UHFFFAOYSA-N
131759524;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RVCBRFVHTZWGMW-UHFFFAOYSA-N
131761575;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CALDQAALECKDMI-UHFFFAOYSA-N
131761576;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BZLWKCBUKUANMW-UHFFFAOYSA-N
131754036;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KRMCNOVCWGWYHP-UHFFFAOYSA-N
131758137;LPAR3;7;3.498e-45;0.587;3.1912;79.3629;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WZTGTJAUXOIVNF-UHFFFAOYSA-N
131757293;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;PEDXBSVTVPVYSP-UHFFFAOYSA-N
131757294;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;NEHKBJPTASJPGS-UHFFFAOYSA-N
131750412;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RFMSTHTUAZETPD-UHFFFAOYSA-N
131761778;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;YTJVEHDHQJQWGG-UHFFFAOYSA-N
131755963;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RQLZZCKGBZFETM-UHFFFAOYSA-N
131766432;LPAR3;7;1.756e-50;0.5;3.5715;88.877;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ITTQJNRRFXILFF-UHFFFAOYSA-N
131766433;LPAR3;7;1.013e-43;0.4815;3.0863;76.7383;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UQAQHCSDUNHUKS-UHFFFAOYSA-N
131757041;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XGCJOJLDYHICIU-UHFFFAOYSA-N
131761027;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NWCRHTRUMSZHGL-UHFFFAOYSA-N
131758066;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PAWWFARWOBDKCZ-UHFFFAOYSA-N
131766293;LPAR3;7;2.322e-51;0.5094;3.6346;90.4542;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KGCRBIMOYHYQPK-UHFFFAOYSA-N
131759223;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVLJROQTWFUTBY-UHFFFAOYSA-N
53480584;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PTTJPMSHTWJLSB-UHFFFAOYSA-N
131761982;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYVKSOXJHUKFRF-UHFFFAOYSA-N
131759340;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UMQXHZBMMHCUQU-UHFFFAOYSA-N
131750620;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEWDINSOXAERHQ-UHFFFAOYSA-N
131763725;LPAR3;7;5.165e-43;0.5652;3.0356;75.4685;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FVWBEGMXQQWDMG-UHFFFAOYSA-N
131758234;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MLKVMZHDVPFECT-UHFFFAOYSA-N
131761989;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YUMXSFGYXZWQHW-UHFFFAOYSA-N
131759477;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SFTJTIUAYCUEKQ-UHFFFAOYSA-N
131765948;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VGFGAVMFHSHYQQ-UHFFFAOYSA-N
131765944;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;APLBEJJTPVKUEV-UHFFFAOYSA-N
131755244;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FEPAFMXZJSAXNQ-UHFFFAOYSA-N
131765947;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ACXVEKPECUUALE-UHFFFAOYSA-N
131757860;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;AGHHOFLCBXWHOS-UHFFFAOYSA-N
131763753;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JBDVHPYZDOJNKC-UHFFFAOYSA-N
131761500;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GZYXMJLTMGSMEX-UHFFFAOYSA-N
131765820;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;UFAIMASITNLXEW-UHFFFAOYSA-N
131765537;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WIPJLCNBSDRPCH-UHFFFAOYSA-N
131765826;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;CDMMBNHFKIGUCQ-UHFFFAOYSA-N
131761504;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UCHCSQUXSXHUED-UHFFFAOYSA-N
131755324;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NQZTVKYDVUQPPX-UHFFFAOYSA-N
25240386;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEWUGNNMLZAOCV-UHFFFAOYSA-N
25240384;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;POBQACNRSDFLSN-UHFFFAOYSA-N
131755080;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PTUORBCKDRTJCD-UHFFFAOYSA-N
25240382;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
25240383;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MAWRDGRSFXIWKV-UHFFFAOYSA-N
131759832;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RZPLQHKENQFELH-UHFFFAOYSA-N
131759833;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VFQVWRHDXMNZND-UHFFFAOYSA-N
131763791;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MSTWHTFNNCRHIU-UHFFFAOYSA-N
131759837;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZGPVKACJWPEIIR-UHFFFAOYSA-N
131759838;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FBNGTCSJDMTOOZ-UHFFFAOYSA-N
131765942;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ODSPHNHCZQVDMR-UHFFFAOYSA-N
131763127;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;RLGAQDGPQYEBLL-UHFFFAOYSA-N
131759086;LPAR3;7;2.387e-44;0.5745;3.1314;77.8656;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HQPIWUWUVGDNOG-UHFFFAOYSA-N
131756819;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ALNNHOFYSWAINZ-UHFFFAOYSA-N
131755688;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LVRSHDOEDJOBJJ-UHFFFAOYSA-N
131764752;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IKPPMXCWNQRCFS-UHFFFAOYSA-N
131755687;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FPEZLWDATYZAAB-UHFFFAOYSA-N
131760413;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GLVZNJVSGWGEOW-UHFFFAOYSA-N
131756958;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XDOAVAFFHWQIBZ-UHFFFAOYSA-N
131762527;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DCYWSDMCLMGYLN-UHFFFAOYSA-N
131755683;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LSBAYMYULGHGQO-UHFFFAOYSA-N
131755682;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BKNNALCUTFKXQS-UHFFFAOYSA-N
131760550;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QFGOYGNOTBVZDL-UHFFFAOYSA-N
131765821;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NQVAELCJJYGSJQ-UHFFFAOYSA-N
131755500;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MTPKGLNGVPLRIZ-UHFFFAOYSA-N
131760557;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IFPSXJPVXFGDJF-UHFFFAOYSA-N
131761948;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DLVBEOBLMNLHJH-UHFFFAOYSA-N
131753954;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JXLIWOMLOAXJKY-UHFFFAOYSA-N
131766313;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIMKMGTVYYNDEJ-UHFFFAOYSA-N
131759539;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IDVKFTSFXLYDBH-UHFFFAOYSA-N
131759538;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;STEWTUZWAFGDIQ-UHFFFAOYSA-N
131756212;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDDFZEYQURVBHO-UHFFFAOYSA-N
131756210;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KKJGCGBAFKPDGN-UHFFFAOYSA-N
131761022;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GUKADGOJBYUPGU-UHFFFAOYSA-N
131760489;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FJIWLFYCFVEOMI-UHFFFAOYSA-N
131761021;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEPRNBOWRGJCFH-UHFFFAOYSA-N
131753774;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AFUMMTADLJXJHO-UHFFFAOYSA-N
131756219;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QDZSNMGLSOCIKD-UHFFFAOYSA-N
131756218;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FTTKNOTUTROZKZ-UHFFFAOYSA-N
131764231;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IIRSRGQBHXKFQZ-UHFFFAOYSA-N
131761028;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIHDUURHAHHFSF-UHFFFAOYSA-N
131760228;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CWWUWOFQAROKCL-UHFFFAOYSA-N
131765543;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZQHGMYAPBUGFGH-UHFFFAOYSA-N
131757468;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LWKAZICCJBIXBG-UHFFFAOYSA-N
131755394;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LJVYQJBNBHGZKG-UHFFFAOYSA-N
131762057;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CUAKEOAMABCXMW-UHFFFAOYSA-N
131760835;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PYMKNYQBVPYQSZ-UHFFFAOYSA-N
131762097;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SZEVHZAZCSIMNY-UHFFFAOYSA-N
131763976;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;REPZHTARFKJLGK-UHFFFAOYSA-N
131764802;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GWEURXHGUZNRIT-UHFFFAOYSA-N
131763875;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZTSWHVGWRWKRF-UHFFFAOYSA-N
131763874;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LVLWZYJYVIWLMX-UHFFFAOYSA-N
131763873;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NPPQAYOZPNHUTJ-UHFFFAOYSA-N
131755194;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QBFPWMQTMYVTPZ-UHFFFAOYSA-N
131761219;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PIMPYDZIXKACMS-UHFFFAOYSA-N
131763405;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CCWQXSQVMPACON-UHFFFAOYSA-N
131755820;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PBWSYTBHNXUZPG-UHFFFAOYSA-N
131766214;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LQOVUJRZQTZNEJ-UHFFFAOYSA-N
131757265;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QANJMRAWHCWEGS-UHFFFAOYSA-N
131766217;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NHVPEYZRZDJCKH-UHFFFAOYSA-N
131756448;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RGEZBXPRDPDBNY-UHFFFAOYSA-N
131757264;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LVHNDABSHOYKAM-UHFFFAOYSA-N
131756447;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HOJKDYMVHKKNHI-UHFFFAOYSA-N
131766218;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HNUYKTOGWYOCHC-UHFFFAOYSA-N
131756441;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JGZAQTBYJIAXMB-UHFFFAOYSA-N
131765765;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;HJZFUASFTDEZRS-UHFFFAOYSA-N
131765095;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZOOGEVWOZRKOCC-UHFFFAOYSA-N
131757266;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;VDFBIEOSCQDYJB-UHFFFAOYSA-N
131756289;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OHFJEIHIIZLXHT-UHFFFAOYSA-N
131765763;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZOXUQQAZDPHQME-UHFFFAOYSA-N
131760905;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OCHXJPHUWMPWLC-UHFFFAOYSA-N
131755814;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATLSKDGFHXWZQX-UHFFFAOYSA-N
131765315;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RAOLZQQBRJPHKT-UHFFFAOYSA-N
131764243;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XJKZLKNQUBHNFP-UHFFFAOYSA-N
131764244;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWHSDMISQPUQKM-UHFFFAOYSA-N
131756096;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OZEFVBNHXBHBOW-UHFFFAOYSA-N
131763797;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ICVAHKOZRSLUFQ-UHFFFAOYSA-N
131765088;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;TYXIHILEHYUILL-UHFFFAOYSA-N
131761269;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QZSMPWVATGOHPH-UHFFFAOYSA-N
131755073;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FYFQGQAMTRIKHO-UHFFFAOYSA-N
131755986;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NUAAGXVXOLBDRH-UHFFFAOYSA-N
131756545;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MPLJLGNREKLWNT-UHFFFAOYSA-N
131756544;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;POSPEMGIHZMKBT-UHFFFAOYSA-N
56940408;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JQGJMNPRHDYYSP-UHFFFAOYSA-N
131765400;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATZUQFQPFCLNTM-UHFFFAOYSA-N
131763669;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QYKCXKFNRHDBNF-UHFFFAOYSA-N
131757390;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTOBJPAOCFDZJO-UHFFFAOYSA-N
56940401;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OADRPNFNIMRMSJ-UHFFFAOYSA-N
131766108;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGOXOYQAVRXXMO-UHFFFAOYSA-N
131763429;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PZLNYKRJVKGRCK-UHFFFAOYSA-N
131756140;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YRNOILAKWQZJOO-UHFFFAOYSA-N
131755106;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XASLXNYLAYUVLS-UHFFFAOYSA-N
131758715;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;VARKWBYIQXSEHP-UHFFFAOYSA-N
131763426;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QEIRJNNKJSBZBN-UHFFFAOYSA-N
131758049;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;USMSEKIRTKUMEG-UHFFFAOYSA-N
131763341;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PGNPUZLWAYIFAX-UHFFFAOYSA-N
131763340;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FJMGCBCMXFEVHK-UHFFFAOYSA-N
131753542;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ZIESYZCKIBNJDP-UHFFFAOYSA-N
131763342;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LDKWKDUYZWZDBQ-UHFFFAOYSA-N
131763345;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VZMDAERKCFBEMZ-UHFFFAOYSA-N
131763344;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MHQQXKMTIMDITH-UHFFFAOYSA-N
131763346;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CJMQGODMMNFMOQ-UHFFFAOYSA-N
131765162;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BFTXLDFELASQJI-UHFFFAOYSA-N
131765161;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LEZCTIQNRDNRPA-UHFFFAOYSA-N
131756728;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SJSPRNUEKGVEFR-UHFFFAOYSA-N
131755533;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UZJFJKLCXWYRPN-UHFFFAOYSA-N
131757627;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CQQRPMOWXSEZTP-UHFFFAOYSA-N
131766080;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AHWAAIWRGKZIQL-UHFFFAOYSA-N
131763805;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WLKYPPYVGVLSFZ-UHFFFAOYSA-N
131755366;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BWOWEFRYVHJNEP-UHFFFAOYSA-N
131761540;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JAFDAKTXILVQMT-UHFFFAOYSA-N
131757915;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;WAYMRLQEAVIHIN-UHFFFAOYSA-N
131757914;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;XMIDMFLTTPZJFG-UHFFFAOYSA-N
131755047;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZWYSQWJROGDLIY-UHFFFAOYSA-N
131764140;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFTGNQCYADESFM-UHFFFAOYSA-N
131761937;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IGBVZUBJFIUKFA-UHFFFAOYSA-N
131761931;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ORFNHODRKLEDIY-UHFFFAOYSA-N
131755348;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;QHLALDPTQOIJFG-UHFFFAOYSA-N
131761938;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;CBLVLYIBWALOEM-UHFFFAOYSA-N
131761830;LPAR3;7;1.1689999999999998e-47;0.5417;3.3689;83.8081;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;CDGBKFWHRXPNIS-UHFFFAOYSA-N
131755048;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LRLYDHNYCOCMPB-UHFFFAOYSA-N
131762063;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UUXXVHZKRXILFI-UHFFFAOYSA-N
131762062;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YMIBNLBMYGUACK-UHFFFAOYSA-N
131763691;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NVZVXKRDHFHVPS-UHFFFAOYSA-N
131756789;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IIYQJRSPWUCSDM-UHFFFAOYSA-N
131757718;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SCMQOOVUTQRBPX-UHFFFAOYSA-N
131758401;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JCQPLTYLLRMKIQ-UHFFFAOYSA-N
131759979;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GFFLZJLHLVDXFE-UHFFFAOYSA-N
131762068;LPAR3;7;1.1689999999999998e-47;0.5417;3.3689;83.8081;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHAZOGSUZIJZCI-UHFFFAOYSA-N
131757433;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AMDSHUSILZVWMX-UHFFFAOYSA-N
131757434;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OUGBFDBXTPQOJV-UHFFFAOYSA-N
131765590;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYZQQKYMCQJKTA-UHFFFAOYSA-N
131765591;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MDKFQYLWNPEPSF-UHFFFAOYSA-N
131761184;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;RBUWIFMTDWYJEN-UHFFFAOYSA-N
131762643;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GBQSFVXSYJLCAE-UHFFFAOYSA-N
131758877;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;RIPMVOUZKWTQDO-UHFFFAOYSA-N
131765598;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BYEYHQIVFWZJHP-UHFFFAOYSA-N
131760309;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLHHWPUYZJHBEJ-UHFFFAOYSA-N
131759373;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JNZLJJXCXKXIHT-UHFFFAOYSA-N
131753833;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCDMPASDBFINOG-UHFFFAOYSA-N
131760266;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FDBPCQBWBNZEDW-UHFFFAOYSA-N
131753722;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LTDLQTORSCMBOQ-UHFFFAOYSA-N
131759379;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SZWHHAMLCPVQHZ-UHFFFAOYSA-N
131756566;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KPIFNDIZKFVARX-UHFFFAOYSA-N
131760798;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BKWZVJWHAPNDHG-UHFFFAOYSA-N
131758870;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FDMDMGLROVNITG-UHFFFAOYSA-N
131765913;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YOIYDGJMKJEXTG-UHFFFAOYSA-N
131760062;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;PBUZOPDSPGPOQS-UHFFFAOYSA-N
131765509;LPAR3;7;2.387e-44;0.5745;3.1314;77.8656;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;IZGDWRLRMLPRRH-UHFFFAOYSA-N
131755217;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KAAHBDXVVGSEAD-UHFFFAOYSA-N
131757868;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;VGJLRVHUGWORNM-UHFFFAOYSA-N
131760069;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CESSZFUPJUMNNU-UHFFFAOYSA-N
131750626;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HUAVJWUSPIMCRO-UHFFFAOYSA-N
131755968;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QHPYYZFXEDYENT-UHFFFAOYSA-N
131757862;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;KGCOMYRIEUMHBE-UHFFFAOYSA-N
131757861;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;CCYKAYZERNIDEA-UHFFFAOYSA-N
131750623;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AKOYMLIOOBZSET-UHFFFAOYSA-N
131761942;LPAR3;7;4.3879999999999996e-60;0.5778;4.2606;106.116;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DZCKFRKMUJZBAT-UHFFFAOYSA-N
131761949;LPAR3;7;4.3879999999999996e-60;0.5778;4.2606;106.116;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MXSSKIVWHBHDLS-UHFFFAOYSA-N
131766310;LPAR3;7;1.649e-55;0.5;3.9323;97.9026;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIZJOPLPAIHRMD-UHFFFAOYSA-N
131765469;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YYUUNOIKGZVQNL-UHFFFAOYSA-N
131763766;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KAUMGZIPYOWTQN-UHFFFAOYSA-N
131763764;LPAR3;7;7.768999999999999e-44;0.5778;3.0946;76.9455;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONNMWXZICBDMON-UHFFFAOYSA-N
131763836;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KTBQPCJSPGEYHH-UHFFFAOYSA-N
131759605;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQBAEHAUBJDGSF-UHFFFAOYSA-N
131765280;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZVWNKBXKHWXDGQ-UHFFFAOYSA-N
131765286;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QXKHDQVSKQMTPY-UHFFFAOYSA-N
131756963;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MXJKXYIXCLMTJO-UHFFFAOYSA-N
131765285;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPNXDPAVMXQTCA-UHFFFAOYSA-N
131756842;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CGYUWASKRWCFSH-UHFFFAOYSA-N
131755402;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RDMSBFYFWYXPOF-UHFFFAOYSA-N
131756846;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FHUKVTWUCRMUNV-UHFFFAOYSA-N
131760427;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KQHIUWHKRXQFTK-UHFFFAOYSA-N
131760428;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GJZAKWNUCSDFIU-UHFFFAOYSA-N
131760589;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UCHSMZOZHHHKTN-UHFFFAOYSA-N
131761116;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JAPRMSLBZUSCAD-UHFFFAOYSA-N
131756321;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DQHAGOJZQAKIDI-UHFFFAOYSA-N
131765793;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ODPDZZJOACRCJQ-UHFFFAOYSA-N
131764568;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BTDHRGQFFPYVIV-UHFFFAOYSA-N
131760583;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GQNCOCJLEFUUME-UHFFFAOYSA-N
131761110;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NIWWYTGJAYUGFA-UHFFFAOYSA-N
131757736;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GUBRCOQXLRVIHB-UHFFFAOYSA-N
131764564;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NSHUKAOTMWTYBG-UHFFFAOYSA-N
131761055;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;IGNHERGRXWPMJH-UHFFFAOYSA-N
131764567;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ADCAWKGFWSTGLD-UHFFFAOYSA-N
131760588;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;IHFWXPSVLCAYTA-UHFFFAOYSA-N
131764563;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XRPOIBHTJJIOON-UHFFFAOYSA-N
131755914;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;AKJAVHDSGYNHSB-UHFFFAOYSA-N
131757285;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;ZJYWYCGVUDBWGE-UHFFFAOYSA-N
131764200;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HGVUWOFDDHGBHN-UHFFFAOYSA-N
131760412;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DRHZXOAXOIEMMY-UHFFFAOYSA-N
131758687;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;DPOKSOYZNAGELJ-UHFFFAOYSA-N
131760848;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NIPUCULBSQNBSL-UHFFFAOYSA-N
131765032;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;QZTJDZZOESOVDE-UHFFFAOYSA-N
131763739;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DNNIFNOPLBPBJW-UHFFFAOYSA-N
131764238;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DQGFYDHZNGKRQX-UHFFFAOYSA-N
131756187;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PCXVFXRDXMNRHE-UHFFFAOYSA-N
131766146;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OAINQTZTNKJXAY-UHFFFAOYSA-N
131762023;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBCQOGPWLGKYNO-UHFFFAOYSA-N
131763461;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VQFIBNGFXJMOBY-UHFFFAOYSA-N
131763462;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FXGQECBIROXLSB-UHFFFAOYSA-N
131761602;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;GAQSYHGNKUYUAQ-UHFFFAOYSA-N
131759459;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OQYXMWZVMDPNIP-UHFFFAOYSA-N
131763468;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SPIMEOJTVCAROF-UHFFFAOYSA-N
131757123;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VJVMHCYTENEWNN-UHFFFAOYSA-N
131755661;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XMRBIWWWAIEADV-UHFFFAOYSA-N
131764519;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DPVRRBMNBIRJAB-UHFFFAOYSA-N
131764518;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IIGHVRSTPXBBKS-UHFFFAOYSA-N
131760281;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AJRSKYARNMVHFT-UHFFFAOYSA-N
131760283;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BNFYPGSVPNZPRA-UHFFFAOYSA-N
131764512;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KHKICBDLNWOYFV-UHFFFAOYSA-N
131764847;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XJSRQCYRQHWNOX-UHFFFAOYSA-N
131760287;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HSALVDSITWQZNS-UHFFFAOYSA-N
131760286;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XPRIEXJXLXJFEI-UHFFFAOYSA-N
131756757;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GYBHIADXUHHABV-UHFFFAOYSA-N
131764237;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKSGCJPLSFCQNA-UHFFFAOYSA-N
131756750;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FBQQXRDCPOBIQG-UHFFFAOYSA-N
131756751;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IRPLNLXEUHFALC-UHFFFAOYSA-N
131761238;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IFNVGGQCIPHTPE-UHFFFAOYSA-N
131763487;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SCCCMTCYXQXNLK-UHFFFAOYSA-N
131763798;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RRXSURPJVARICW-UHFFFAOYSA-N
131762595;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;SDWPVMNEXQULAT-UHFFFAOYSA-N
131761469;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OQSNLZOBBCMKHQ-UHFFFAOYSA-N
131761380;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JDPQRNIORXECGT-UHFFFAOYSA-N
9545899;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CHDGNFBVLBELFJ-UHFFFAOYSA-N
131765769;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CDRRGEQBGHUNAB-UHFFFAOYSA-N
131766038;LPAR3;7;2.322e-51;0.5094;3.6346;90.4542;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DIZRZQIIMNNDRW-UHFFFAOYSA-N
131760392;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NMBWREWNBSVWGK-UHFFFAOYSA-N
131762024;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;RFOJMNHTTGBKCU-UHFFFAOYSA-N
131753373;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFQQJRGJJVQGAV-UHFFFAOYSA-N
131762029;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ATIWAHXGZHCXGG-UHFFFAOYSA-N
131762028;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VKZDLFFRXVRVQH-UHFFFAOYSA-N
131750408;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;QEBMDFMPVYJRFG-UHFFFAOYSA-N
131762146;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KDKFUFGVHHXTMC-UHFFFAOYSA-N
131753374;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OWUCYMBXHHXZRL-UHFFFAOYSA-N
9545002;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WSEOLICCQLXYAB-UHFFFAOYSA-N
131766133;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CPUKBWQAKQTPIK-UHFFFAOYSA-N
131758050;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LBZONYRNSJMDKD-UHFFFAOYSA-N
131758057;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;RCHRBILGWVSBMD-UHFFFAOYSA-N
131763414;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VCWXOZCSQKXLGJ-UHFFFAOYSA-N
131766136;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KHJBRHVZLQLMHJ-UHFFFAOYSA-N
131757193;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZJDHSVUVYJSBGX-UHFFFAOYSA-N
131757192;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;ZAQWCHTYSYNWSH-UHFFFAOYSA-N
131753572;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;TXWDWSJYGIFVKP-UHFFFAOYSA-N
131757194;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;FHLGAKXGDKAPGG-UHFFFAOYSA-N
131763730;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WHDJEGCDDOXKQQ-UHFFFAOYSA-N
131761990;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XRUFDENJLIKWQM-UHFFFAOYSA-N
131759701;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HRONLDWOZFWEAB-UHFFFAOYSA-N
131759334;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;MWNZLWBLFRSEKB-UHFFFAOYSA-N
131755448;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UGGFEFYRAIPHJW-UHFFFAOYSA-N
131757579;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;USAFSLJNOZHCHX-UHFFFAOYSA-N
131761999;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NSRPQFRLJZJCJC-UHFFFAOYSA-N
131760347;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHZFGSBSLITSMO-UHFFFAOYSA-N
131760341;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SPZFKKCPMIILSL-UHFFFAOYSA-N
131765958;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WHZABLDEOLRJNE-UHFFFAOYSA-N
131760348;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SAHJXIOVXNXTQL-UHFFFAOYSA-N
131765951;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;VUTWUCXEPNBATA-UHFFFAOYSA-N
131762286;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MTZJVBULFGKJAO-UHFFFAOYSA-N
131765815;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KAOUTJZLIDQIDJ-UHFFFAOYSA-N
131755098;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;QWFBYRTVWVIXIZ-UHFFFAOYSA-N
131755099;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GIRHPCGBIJZASY-UHFFFAOYSA-N
131755310;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MSRILFYVWJWHRM-UHFFFAOYSA-N
131755455;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IEXFFVIGQBUXOM-UHFFFAOYSA-N
131750573;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;TUJAWJCRCOOMQU-UHFFFAOYSA-N
131764421;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXTJEHRYNIVMJO-UHFFFAOYSA-N
131761903;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JBOWPSIDPCYDPQ-UHFFFAOYSA-N
131755318;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCXYYNLRWFKNNQ-UHFFFAOYSA-N
131757272;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;OWZRRACHZQKQKB-UHFFFAOYSA-N
131764743;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QNUYKUIODKHOPQ-UHFFFAOYSA-N
131759353;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;WJMXDOSYJOVEGP-UHFFFAOYSA-N
131762200;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PGNCZCAOFLJMMB-UHFFFAOYSA-N
131763137;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CYKZBIMIYCZCIP-UHFFFAOYSA-N
131762738;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;DWQHZFVQEBNFQY-UHFFFAOYSA-N
131759483;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;RFURIDCRDPRIJL-UHFFFAOYSA-N
131761092;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;LBXWNIAXYWLNFI-UHFFFAOYSA-N
131760467;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HXQABWBASCQTOJ-UHFFFAOYSA-N
131760466;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZTDMXZQXQOEXKZ-UHFFFAOYSA-N
131762513;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FTYRINBVXMECCW-UHFFFAOYSA-N
131760460;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HVOSMRAPGYBTSZ-UHFFFAOYSA-N
131757407;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YHILGYSICPKXAA-UHFFFAOYSA-N
131757406;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CDMARTCICGPDST-UHFFFAOYSA-N
131764187;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKWUREQRVPUWQW-UHFFFAOYSA-N
131753714;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AREMZVRDXOGTHG-UHFFFAOYSA-N
131753803;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NTSBQBZSOJXXMZ-UHFFFAOYSA-N
131761010;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RFRCPSCGSGYZQU-UHFFFAOYSA-N
131765582;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YXCZDJDWMGLROL-UHFFFAOYSA-N
131761015;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZVQFZROUAQXGJM-UHFFFAOYSA-N
131766311;LPAR3;7;6.621e-44;0.4464;3.0996;77.0702;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KBRCUQIVLUDXJP-UHFFFAOYSA-N
131761399;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTFUIJABEMQZTB-UHFFFAOYSA-N
131753886;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ISVYJGODJAFSSA-UHFFFAOYSA-N
131765399;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FRQQCCLOVFVEJY-UHFFFAOYSA-N
131754064;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NTYQJMMREGDBBU-UHFFFAOYSA-N
131755381;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;WHIFVRILMXLGDQ-UHFFFAOYSA-N
131765550;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HLYYLRJCOCUOTF-UHFFFAOYSA-N
131764732;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CIFVSTXCBAOUKA-UHFFFAOYSA-N
131755236;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XYIPDNMNPDTONZ-UHFFFAOYSA-N
131764737;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HLFLGRZVVLYFNK-UHFFFAOYSA-N
131764738;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WJPRJNAUQKKXCZ-UHFFFAOYSA-N
131750619;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JEQMHFPQVKBLLQ-UHFFFAOYSA-N
131765474;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AAQXAMYHTKLRRO-UHFFFAOYSA-N
131763943;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HZEWLUFXEAGEHA-UHFFFAOYSA-N
131764811;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RFNMQGVASYUQRC-UHFFFAOYSA-N
131764812;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IYWKHVMWOJKUJQ-UHFFFAOYSA-N
131766380;LPAR3;7;2.322e-51;0.5094;3.6346;90.4542;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QPIJJOPUZQDQMA-UHFFFAOYSA-N
131755656;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SJRLCZGQDXBYGK-UHFFFAOYSA-N
131764816;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HHRQBQZQQLMORJ-UHFFFAOYSA-N
131763861;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VQSBVFWLIMSUKU-UHFFFAOYSA-N
131763863;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FIVPYAHJKISIKY-UHFFFAOYSA-N
131759795;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZGCGJLBXPCKHOS-UHFFFAOYSA-N
131756934;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHJNGKVAWYWMEF-UHFFFAOYSA-N
131762603;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RYXWSTIICMYXLZ-UHFFFAOYSA-N
131759069;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SHVMTKJCJPSWEE-UHFFFAOYSA-N
131766141;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWTWQURYSLMNII-UHFFFAOYSA-N
9544997;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RETPNLDNHGHCKP-UHFFFAOYSA-N
131762642;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ULURBNZZTGHIHV-UHFFFAOYSA-N
131756470;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FCSMYJQXGWBEFO-UHFFFAOYSA-N
131766142;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CKABQJDLXLDWME-UHFFFAOYSA-N
131753629;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WZCFDZGLFKVTIF-UHFFFAOYSA-N
131756371;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RXVLBDOYHGQIHF-UHFFFAOYSA-N
9544854;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PKPAOZPHGVIQGC-UHFFFAOYSA-N
131763223;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YKKNGUMBQWFKKB-UHFFFAOYSA-N
9545354;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SPDHJCJAJYRMFV-UHFFFAOYSA-N
131758825;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UVNIPBFYITWPNW-UHFFFAOYSA-N
131764553;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VQUDVLRTBZFPSP-UHFFFAOYSA-N
131759091;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LMIVETVBRASKSZ-UHFFFAOYSA-N
131764250;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RTNVVKOTXGJPGJ-UHFFFAOYSA-N
131764927;LPAR3;7;5.318e-45;0.4727;3.1782;79.0363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LHOPPWWFGCZSQE-UHFFFAOYSA-N
131765778;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WVDRXDBKAJIUGG-UHFFFAOYSA-N
131764888;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DKHXDEWODXYNLT-UHFFFAOYSA-N
9545910;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTCGGJDDKNMITC-UHFFFAOYSA-N
131765350;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;LNTDKUBVWIHAKI-UHFFFAOYSA-N
131764685;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XROVXJWVFZVSEH-UHFFFAOYSA-N
131765351;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KSUYSWUNWRLYBY-UHFFFAOYSA-N
131755662;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QVOHTEKWCOOZBV-UHFFFAOYSA-N
131759668;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GRFDFSAMUSSDRA-UHFFFAOYSA-N
56940415;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PHYGFPBNUHVOST-UHFFFAOYSA-N
131763303;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YTTFVSISHNIUJH-UHFFFAOYSA-N
131757389;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;NGGZABQJVQPRCU-UHFFFAOYSA-N
131759663;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WHDYIBJFERAONB-UHFFFAOYSA-N
131757384;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WOHMUGVGZMEZQE-UHFFFAOYSA-N
131757383;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;JEEMXKLREVCFGB-UHFFFAOYSA-N
131760162;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZNRJZRRGRJDRMD-UHFFFAOYSA-N
131766074;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZCTSKQXPXJRBOE-UHFFFAOYSA-N
131760289;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FZKWULPGSLRZTH-UHFFFAOYSA-N
131762107;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VMZJSWALUJFVMA-UHFFFAOYSA-N
131756729;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ASPJACHPVRBOQP-UHFFFAOYSA-N
131759706;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DOETYUIYWRXHRJ-UHFFFAOYSA-N
131759707;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQYVDSPZECGLKR-UHFFFAOYSA-N
131763455;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OXKWYVLMELYMCF-UHFFFAOYSA-N
131763456;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VCJKYSQWTHINNE-UHFFFAOYSA-N
131766171;LPAR3;7;3.417e-42;0.5106;2.9767;73.9952;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PFDVCVWZOWWSHG-UHFFFAOYSA-N
131756265;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HLHOFQHIUQLVAE-UHFFFAOYSA-N
131760764;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;ZIRJXTDTRZMNMW-UHFFFAOYSA-N
131764977;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;OTTHDHMHOBYLKO-UHFFFAOYSA-N
131761288;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGZIYXWMBQUNLC-UHFFFAOYSA-N
131756011;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YUPFJKWSOWOCMK-UHFFFAOYSA-N
131762302;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JINIMSFSEKJDPB-UHFFFAOYSA-N
131765170;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HHPKNJJAIMXMJO-UHFFFAOYSA-N
131765293;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CDFXVMNUBYTXIY-UHFFFAOYSA-N
131763675;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UKQWMQSUSAJIDZ-UHFFFAOYSA-N
131763674;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GYDULBZIXNRXAK-UHFFFAOYSA-N
131763579;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DNBFQFXWSKRTGJ-UHFFFAOYSA-N
131763671;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RLKSWIHVEAZROT-UHFFFAOYSA-N
131763670;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JNZQBLFKGOVDNV-UHFFFAOYSA-N
131755522;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SGSCBPFVSOCVPP-UHFFFAOYSA-N
131759992;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UGOUYCBMFPBXOX-UHFFFAOYSA-N
131755528;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NDNNXIWBJOKRCM-UHFFFAOYSA-N
131756724;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OEUMFZWSMUCXBP-UHFFFAOYSA-N
131762089;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UNYKFQXNKAKRPG-UHFFFAOYSA-N
131763803;LPAR3;7;5.165e-43;0.5652;3.0356;75.4685;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QADBLNHWOKOYDH-UHFFFAOYSA-N
131757219;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;NDIASEVRLBWVRO-UHFFFAOYSA-N
131761557;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SKNOESWTOVXVHT-UHFFFAOYSA-N
131757906;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;NSRSRNOQDGUIQQ-UHFFFAOYSA-N
131757907;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CSNMMADQHKSQLN-UHFFFAOYSA-N
131764513;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ASSZWZBQIXMMKM-UHFFFAOYSA-N
131762079;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VBUPWWIRBFWNGJ-UHFFFAOYSA-N
131761414;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HQDWFERRFHDEEB-UHFFFAOYSA-N
131755067;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZKXHCZXVCQJSLC-UHFFFAOYSA-N
131761829;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DHAQDRDVKDGNJH-UHFFFAOYSA-N
131759960;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RUUBPRONLULDIJ-UHFFFAOYSA-N
131761880;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QCIVLXQVYGLERQ-UHFFFAOYSA-N
131761796;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WNTXQOREERQHJA-UHFFFAOYSA-N
131762073;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PHZLRGDIBRAISL-UHFFFAOYSA-N
131762074;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FZUWITUYYOHATE-UHFFFAOYSA-N
131759965;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MCTZBSNODNYQBM-UHFFFAOYSA-N
131759966;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HYPRJUDAMZSDSL-UHFFFAOYSA-N
131757702;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NIHHWECWJIEWCW-UHFFFAOYSA-N
131766000;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FCYZFOKGTFCMBJ-UHFFFAOYSA-N
131765042;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AEOBRAGXLFVMRE-UHFFFAOYSA-N
131756794;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LNRRWLSKAQDUBR-UHFFFAOYSA-N
131759811;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YKWQPKBPMIZKRY-UHFFFAOYSA-N
131756653;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;SBZHRFMQIXHJRW-UHFFFAOYSA-N
131753752;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BVDHVRNSAXAACC-UHFFFAOYSA-N
131762650;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;QCNRTBOAVXTQRH-UHFFFAOYSA-N
9544925;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UMZMGYWVBWXWDT-UHFFFAOYSA-N
131757441;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HNLMGPXMNLVNRF-UHFFFAOYSA-N
131755795;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;AHTWTNHQUCGAHA-UHFFFAOYSA-N
131755794;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;KJRBHONTDZUSAV-UHFFFAOYSA-N
131758210;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;UJXQJJSLQLGCCL-UHFFFAOYSA-N
131759206;LPAR3;7;4.926e-48;0.5417;3.3958;84.4821;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SGGVBZZJDDBPJU-UHFFFAOYSA-N
131759201;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YAQCQKUWLQDYCJ-UHFFFAOYSA-N
131759360;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKXYRUMPRSILQY-UHFFFAOYSA-N
131759816;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ABRDLWYBZGTCTL-UHFFFAOYSA-N
131765688;LPAR3;7;2.9209999999999996e-45;0.4643;3.1968;79.5036;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PBRYRAXZLMVCBK-UHFFFAOYSA-N
131755558;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JRPWNZDPXIIZOM-UHFFFAOYSA-N
131756889;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MGIUZRTVYUQICM-UHFFFAOYSA-N
131764281;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;HMPAWVATDNDSKT-UHFFFAOYSA-N
131764249;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZEZMNCGRCXZDOR-UHFFFAOYSA-N
131764075;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PNNSMRQLANHRDX-UHFFFAOYSA-N
131755223;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VOQAPCORCIBANS-UHFFFAOYSA-N
131765517;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UYDNDHADQTVNOZ-UHFFFAOYSA-N
131765514;LPAR3;7;3.8619999999999996e-51;0.54;3.6187;90.0576;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;PDVSJXMAWVPRGI-UHFFFAOYSA-N
131762257;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LOKPBYPRLSRHNU-UHFFFAOYSA-N
131762250;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;STYLBDUVJOXRMQ-UHFFFAOYSA-N
131756769;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SNADIPNNRGNXJQ-UHFFFAOYSA-N
131763163;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;PZMSAQJXASOAPE-UHFFFAOYSA-N
131764473;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GRDDVYHFHJYAIG-UHFFFAOYSA-N
131766308;LPAR3;7;1.013e-43;0.4815;3.0863;76.7383;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJZUTJRJYIAAKV-UHFFFAOYSA-N
131761898;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;DOVUUWKFUZDTOP-UHFFFAOYSA-N
131761954;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ILYJVOJSUJTWSZ-UHFFFAOYSA-N
131761955;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PTQQCZRZVMTOPI-UHFFFAOYSA-N
131761489;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;PRTWBFFOFJFSGB-UHFFFAOYSA-N
131764478;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LBPWGTZIEHPYML-UHFFFAOYSA-N
131764479;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZMMKASYZFJCWTE-UHFFFAOYSA-N
131761897;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IIFYGJBPANGSOD-UHFFFAOYSA-N
131765459;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VKCIZSSGVHDMAT-UHFFFAOYSA-N
131757200;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;VVNNBLZFSZUXRC-UHFFFAOYSA-N
131755837;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;VBCHYGJCHLNVFC-UHFFFAOYSA-N
131763823;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MJTWPTSBGBSEIL-UHFFFAOYSA-N
131763828;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GBTJDANNDZMCSO-UHFFFAOYSA-N
131750367;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CCKRHDUCFMOBKX-UHFFFAOYSA-N
131760432;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHNZVYBODMKEQT-UHFFFAOYSA-N
131760433;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NAGOEYAYRYTHKH-UHFFFAOYSA-N
131766204;LPAR3;7;1.106e-50;0.4909;3.5859;89.2375;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FYMABLMDWJZFIN-UHFFFAOYSA-N
131759518;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;LKBYQEQTTQMXOC-UHFFFAOYSA-N
9544818;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131761689;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZYGIRJGVMNSFKT-UHFFFAOYSA-N
131757428;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;FTFVPUBFVDVJAU-UHFFFAOYSA-N
131764807;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PSSHOBGHPGDGSV-UHFFFAOYSA-N
131760972;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDCWNPRKDZMBHL-UHFFFAOYSA-N
131760971;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XOYSWGHQVMLVFO-UHFFFAOYSA-N
131761043;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;IAKNICPRAKVQME-UHFFFAOYSA-N
131756239;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WWQOKYMMBUGAPO-UHFFFAOYSA-N
131760892;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RIWBDVNAXLFKHZ-UHFFFAOYSA-N
131753744;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZTYPYYDVEYQFSE-UHFFFAOYSA-N
131764937;LPAR3;7;2.9209999999999996e-45;0.4643;3.1968;79.5036;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YERJMWWEGCCVST-UHFFFAOYSA-N
131765637;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NKHUBYYMFGFTBT-UHFFFAOYSA-N
131750592;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BHZWQMNOYPGDNF-UHFFFAOYSA-N
131765768;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FBORIUPMVVLKEO-UHFFFAOYSA-N
131764216;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HFOUMPWZUOGOLE-UHFFFAOYSA-N
131764215;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GZIHTRQEPYSJHZ-UHFFFAOYSA-N
131764609;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XNMDOQDBXJDBNN-UHFFFAOYSA-N
131755813;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PFPODELEONWMHD-UHFFFAOYSA-N
131762072;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;USRVRQGAHXFQJK-UHFFFAOYSA-N
131764350;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IYTSSWXSXRRTMI-UHFFFAOYSA-N
131760850;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XRLJXFQOTJPGAY-UHFFFAOYSA-N
131760853;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SNZNTALTGPYNEP-UHFFFAOYSA-N
131760854;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CFXLMSTVSIEEEU-UHFFFAOYSA-N
131760856;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WUQZNKAJBDSVTJ-UHFFFAOYSA-N
131760991;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KDIPBBLLYFDFHC-UHFFFAOYSA-N
131764820;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ABVLJQVWYOLQMF-UHFFFAOYSA-N
131764938;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TZHCCHGTCLEUNU-UHFFFAOYSA-N
131761823;LPAR3;7;4.3879999999999996e-60;0.5778;4.2606;106.116;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YCOZIWGZFLMTFA-UHFFFAOYSA-N
131763850;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VMOOWSPQGJCOEF-UHFFFAOYSA-N
131765799;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FOQDWFDQDXPCLA-UHFFFAOYSA-N
131763854;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AODBNMOGHKMQLM-UHFFFAOYSA-N
131756224;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NMZIXCZQAKUEKO-UHFFFAOYSA-N
131755172;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AMCYMWCKOMILQE-UHFFFAOYSA-N
131760952;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KFHZZVYZUWJKQG-UHFFFAOYSA-N
131762007;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PZHLNSMCTKLDQD-UHFFFAOYSA-N
131760723;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;LQYKKZORBDYUKT-UHFFFAOYSA-N
131763318;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BXLCYHMCRNPYDN-UHFFFAOYSA-N
131760721;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SDWMHLZEAPLCIQ-UHFFFAOYSA-N
131761637;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;MVIQOCPGVCDPJO-UHFFFAOYSA-N
131766237;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NEYWOJGVFURBQU-UHFFFAOYSA-N
131756422;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QAMWFCYOJWMYOC-UHFFFAOYSA-N
131764798;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WEMUYPQCMUSKDO-UHFFFAOYSA-N
131760482;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;AVOGJLBZQNPISG-UHFFFAOYSA-N
131760728;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;COGBIGLYXFERSM-UHFFFAOYSA-N
131764508;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GQUORQBURNYKNQ-UHFFFAOYSA-N
131763254;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RFXAXHWRVMQUCI-UHFFFAOYSA-N
131763253;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HNDHOYSSWMWISN-UHFFFAOYSA-N
131756347;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZQKBJXXQIGRZIX-UHFFFAOYSA-N
131763250;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DQYDIASSVQDEIU-UHFFFAOYSA-N
131763792;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZJMZBFZENLUIAF-UHFFFAOYSA-N
131764503;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LLTRXGBFCHGGPQ-UHFFFAOYSA-N
131760290;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AAYJVNROXHMWJF-UHFFFAOYSA-N
131764507;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VZTQVMWXBQJQFL-UHFFFAOYSA-N
131761225;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BHMRNZLOEIYPSM-UHFFFAOYSA-N
131755302;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LFNFVWNJHQPLPQ-UHFFFAOYSA-N
131762177;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZDZWWVXHKYJJZ-UHFFFAOYSA-N
131756560;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IUCQBMBRIJLQCE-UHFFFAOYSA-N
131756565;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;FCHJVBOWMICKJA-UHFFFAOYSA-N
131756567;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SALMPXKLCVMTMW-UHFFFAOYSA-N
131761503;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JKFVBYVUASWLNU-UHFFFAOYSA-N
131761036;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;GJNCCQAILGZQPE-UHFFFAOYSA-N
131762178;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CNDQFBSWPRXSTI-UHFFFAOYSA-N
131764211;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MGEWHJIKKLGUTH-UHFFFAOYSA-N
56940423;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OXMRRWYQHLBNAT-UHFFFAOYSA-N
131755303;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;LBDYWQQOJYAVLA-UHFFFAOYSA-N
56940199;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VTOFANRVVFEBFP-UHFFFAOYSA-N
131759926;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;QMUSPYPGMAYRTR-UHFFFAOYSA-N
131762139;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KVGQCWIIYQFVAZ-UHFFFAOYSA-N
131762039;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GCYPFSFSHPZCIN-UHFFFAOYSA-N
131758044;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RKDUCRGKMCKYTN-UHFFFAOYSA-N
131756167;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJAVVKUVPSLGBA-UHFFFAOYSA-N
131753401;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZXABCMZUYUPINF-UHFFFAOYSA-N
131753400;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;CUQAJKYGEQUKMM-UHFFFAOYSA-N
131753402;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZRUKEJWPGFFHOE-UHFFFAOYSA-N
131756042;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;BCDRZMKISYSJPP-UHFFFAOYSA-N
131756043;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JWEMQLKKBMDMSC-UHFFFAOYSA-N
131757187;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;DPXCUHXDCAZRMD-UHFFFAOYSA-N
131753408;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BYFGMMQHMLHSEK-UHFFFAOYSA-N
131753564;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LRUXRFQLJJKABR-UHFFFAOYSA-N
131760572;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PTJRQGPURCBISX-UHFFFAOYSA-N
131763745;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QKNAYLXEJNZPIP-UHFFFAOYSA-N
131763744;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NCKGNPQWQKPFIF-UHFFFAOYSA-N
131758257;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JTAZFPZUAINKAO-UHFFFAOYSA-N
131763741;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DSTAYVXFWPAZEZ-UHFFFAOYSA-N
131750593;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DIVFDZQIIPHWJN-UHFFFAOYSA-N
131755527;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HSNGDBNPPHCXGS-UHFFFAOYSA-N
9544749;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
9544746;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SJKUKFUWJWEPFD-UHFFFAOYSA-N
131761099;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;OZBDLYCKVSSLBL-UHFFFAOYSA-N
131766053;LPAR3;7;1.649e-55;0.5;3.9323;97.9026;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YFYJXMNGNGSIPY-UHFFFAOYSA-N
131764574;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;MCYXMPXRAIMPSS-UHFFFAOYSA-N
56936895;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;GFKHXQTZIPZMNW-UHFFFAOYSA-N
131765800;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VFFAIRLXZFVSMW-UHFFFAOYSA-N
131757057;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPWFSTBTZXCPDN-UHFFFAOYSA-N
131765802;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RLGAOLRDHOLJNN-UHFFFAOYSA-N
131760646;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;YEJRDTNJGBHPRE-UHFFFAOYSA-N
131765805;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZQLZCFZHBCBDQM-UHFFFAOYSA-N
131765806;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BBJDEDZNDSLQPM-UHFFFAOYSA-N
131761589;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYZDQWXRUMWJEF-UHFFFAOYSA-N
131757835;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;JAOICCCVVONLHB-UHFFFAOYSA-N
131761521;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CYFFZIAOTBPWJY-UHFFFAOYSA-N
131765414;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LCQVTHMBIKCBPP-UHFFFAOYSA-N
131764756;LPAR3;7;4.3879999999999996e-60;0.5778;4.2606;106.116;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QGITUKCHSUMQKN-UHFFFAOYSA-N
131764434;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LETCSCFPJVUIQT-UHFFFAOYSA-N
131762724;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;PWBWZFOUPAVKBH-UHFFFAOYSA-N
131759564;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SPGXNOUOYUPBSF-UHFFFAOYSA-N
131762041;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KHYHDLAAJWKMKK-UHFFFAOYSA-N
131757362;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;PWCZEZSCMQVPJQ-UHFFFAOYSA-N
131766132;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SOVSZEWJOOZRMD-UHFFFAOYSA-N
131762045;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;FEDXZFODPLHGFU-UHFFFAOYSA-N
131765810;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDRIITRYYSNHJE-UHFFFAOYSA-N
131759959;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;RMYOOEULFAUMKN-UHFFFAOYSA-N
131757369;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;KJGHSPINRPPFIW-UHFFFAOYSA-N
131756115;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;NWCGBGIXJBNACP-UHFFFAOYSA-N
131760670;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VJJRELRGCGHSSN-UHFFFAOYSA-N
131757836;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;DGOPRVUMKXMBBN-UHFFFAOYSA-N
131759558;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OXJWMXOKVXQQKX-UHFFFAOYSA-N
131766109;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JMXWOODHKZQOTJ-UHFFFAOYSA-N
131757412;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IIJVLTDWMAWLFO-UHFFFAOYSA-N
131764796;LPAR3;7;7.768999999999999e-44;0.5778;3.0946;76.9455;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LORJDMOYIBFNHP-UHFFFAOYSA-N
131764792;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VDKWOOLRBVQGKK-UHFFFAOYSA-N
131764791;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IEJHTHOZNZVRKD-UHFFFAOYSA-N
131763419;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RCAVHXJASXMRHH-UHFFFAOYSA-N
131753818;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CVSGTFIHUMEUGC-UHFFFAOYSA-N
131755422;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QKJRZMKAIOLLKX-UHFFFAOYSA-N
131761009;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WZOJYIGVMGHKJI-UHFFFAOYSA-N
131760571;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WAZXBESWUFNIKC-UHFFFAOYSA-N
131756050;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UVBMJNGWTCZEQF-UHFFFAOYSA-N
131753811;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AHYJLIXVIKISHC-UHFFFAOYSA-N
131759031;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XJPANQUZKYHYSG-UHFFFAOYSA-N
131761003;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HJKVTYHGHKPVQF-UHFFFAOYSA-N
131755585;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NPGQULUAPOPHIW-UHFFFAOYSA-N
131760327;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SBRTXDNWWVUJGY-UHFFFAOYSA-N
131754059;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NBPKLINXFYFXMU-UHFFFAOYSA-N
131763469;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BSMCSPHFOOHCPJ-UHFFFAOYSA-N
131760083;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QDMDGODCZNNQBV-UHFFFAOYSA-N
131755947;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OZLAHDGOWLSOAJ-UHFFFAOYSA-N
131757843;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KREDKADJJBSZQK-UHFFFAOYSA-N
131757844;LPAR3;7;1.645e-56;0.5094;4.0041;99.6997;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;KSLLVJBDFZEPTB-UHFFFAOYSA-N
131755940;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLQMLOOMSZNYRJ-UHFFFAOYSA-N
131756238;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QGNLJGRXJOVVCH-UHFFFAOYSA-N
131762596;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YBMSPSGALOVJLN-UHFFFAOYSA-N
131764489;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZMDJDWQCIRBXLN-UHFFFAOYSA-N
131765247;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DUQASBXYPRNVES-UHFFFAOYSA-N
131764728;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WAXXYEULPJLQFN-UHFFFAOYSA-N
131765481;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MRTBICLGLIFHGX-UHFFFAOYSA-N
131764485;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RYZZITBQUSKDOJ-UHFFFAOYSA-N
131764484;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YUKFMIGMRRYIPC-UHFFFAOYSA-N
131756396;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OHSCTPYVQBIXJB-UHFFFAOYSA-N
131756397;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ORHRYJKHSZANHP-UHFFFAOYSA-N
131764867;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FXNFDHYNKSMWLO-UHFFFAOYSA-N
131766103;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HPDGVKHFCTUXLJ-UHFFFAOYSA-N
131756391;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEHFEWQFZHCTSK-UHFFFAOYSA-N
131766104;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JZOMROZIKMUNRL-UHFFFAOYSA-N
131755845;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MFNWYZFORRXQHT-UHFFFAOYSA-N
131760681;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MLHXDLRLDMFNPU-UHFFFAOYSA-N
131763810;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SETAFKXUOLRYMX-UHFFFAOYSA-N
131756146;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SBHOBWMHSSIWIO-UHFFFAOYSA-N
131755634;LPAR3;7;1.9849999999999998e-41;0.551;2.9218;72.6233;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UZFNMPJCAIVEGV-UHFFFAOYSA-N
131763428;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DSFHORXLWDQBME-UHFFFAOYSA-N
9544819;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KTHQCAZXMMMJNI-UHFFFAOYSA-N
131756091;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AGXFHKUZXQPREM-UHFFFAOYSA-N
131756909;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SSWFQDYDESJLBB-UHFFFAOYSA-N
131760472;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QQEYPDQDALZZPI-UHFFFAOYSA-N
131753630;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OWCXZEZUQYFXCK-UHFFFAOYSA-N
131753636;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IGCRUOUEUMSKRE-UHFFFAOYSA-N
131764597;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZDCGUXVHJZWSQH-UHFFFAOYSA-N
131750607;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ACBQPKXRQKGWDK-UHFFFAOYSA-N
131763219;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NRDVYSIZCMNJBW-UHFFFAOYSA-N
131763218;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JAGNAZGVBMHJJJ-UHFFFAOYSA-N
131756062;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HAZYEPTWRFLUON-UHFFFAOYSA-N
131756302;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYQPRHZKULXQCI-UHFFFAOYSA-N
131750428;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GXWBCAVCOMAOHT-UHFFFAOYSA-N
131764542;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FYXMPUDVYRLIIY-UHFFFAOYSA-N
131764541;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FBVWZRNWVYGXSE-UHFFFAOYSA-N
131763333;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SDLBWDJXBOAFEM-UHFFFAOYSA-N
131765983;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GYHBJVUQEUTNJK-UHFFFAOYSA-N
131765982;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VFVJRYCSOQQDRY-UHFFFAOYSA-N
131764262;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IIRNIPXWMCLIGN-UHFFFAOYSA-N
9545846;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KJMSXXMFCOJLJY-UHFFFAOYSA-N
56936857;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;AQYRONSXFRXAPZ-UHFFFAOYSA-N
131766099;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SUUKHPGWXKPJHR-UHFFFAOYSA-N
131764675;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OJESMNQAHAGSQJ-UHFFFAOYSA-N
131763332;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WFZRDLLUISIIIZ-UHFFFAOYSA-N
131764837;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CXUAFHKFYPZCJF-UHFFFAOYSA-N
131761568;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JJJUMJWQLFBDTL-UHFFFAOYSA-N
131763470;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GYRBUPBXSBUDIS-UHFFFAOYSA-N
131762300;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OKBVCTPHTHIETD-UHFFFAOYSA-N
56940014;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IBFKGUJFNGJJRX-UHFFFAOYSA-N
131757101;LPAR3;7;2.854e-52;0.5192;3.6999;92.0887;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VWISUFHDQBBLJZ-UHFFFAOYSA-N
56940398;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;RBNZROQPTPETBJ-UHFFFAOYSA-N
131763880;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NVECGMYENDMAPE-UHFFFAOYSA-N
131763149;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CVWPTSPATKBGFJ-UHFFFAOYSA-N
131763447;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZPCPPBVETIYFQL-UHFFFAOYSA-N
131763443;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BTFFOSYFKZTDHX-UHFFFAOYSA-N
131763888;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IWTJSOVMTAKRTG-UHFFFAOYSA-N
131763441;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PVHFYEKHFWFLFZ-UHFFFAOYSA-N
131766245;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LTRDNXBESBQIQF-UHFFFAOYSA-N
131763363;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NFFVNPZNLYTNDK-UHFFFAOYSA-N
131750608;LPAR3;7;3.417e-42;0.5106;2.9767;73.9952;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CUDUJMHSCIYKFW-UHFFFAOYSA-N
131766241;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MFNNIGPRUSRGSO-UHFFFAOYSA-N
131766240;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NUQWVLLCRFOKOU-UHFFFAOYSA-N
131762613;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XHCVMVYSBUVFNX-UHFFFAOYSA-N
131763368;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JWYJCPQICGZVHS-UHFFFAOYSA-N
56940303;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AMKVBHVMCBBXNU-UHFFFAOYSA-N
131764865;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BCNNDWUPEKMMJC-UHFFFAOYSA-N
131759984;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UEZYCMFLJSEDEB-UHFFFAOYSA-N
131759985;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;LAGWHQFUVYNWQJ-UHFFFAOYSA-N
131763662;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HAGZJMAABAPVKG-UHFFFAOYSA-N
131756895;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;SKWZGEDXJHKPTI-UHFFFAOYSA-N
131762090;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GBVPBBCPTVGLPS-UHFFFAOYSA-N
131756037;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HTXFYVWYFJNSRG-UHFFFAOYSA-N
131763375;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BLKBAXUTLWGPPO-UHFFFAOYSA-N
131765846;LPAR3;7;3.417e-42;0.5106;2.9767;73.9952;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ULMDLWOZXLWNSK-UHFFFAOYSA-N
131755340;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GMEJJMCAXRRIOA-UHFFFAOYSA-N
131758665;LPAR3;7;7.368000000000001e-65;0.6429;4.6033;114.6884;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;XJZRZLMCPQTTIU-UHFFFAOYSA-N
131765796;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YPKAPKOHLOHKML-UHFFFAOYSA-N
131764162;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PDOINEZJPOJSCI-UHFFFAOYSA-N
131764163;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ONZPXYMTASPSNP-UHFFFAOYSA-N
131762391;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;VBIJXNNOTQKKMT-UHFFFAOYSA-N
131759854;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OFTAFMFOCJTPKP-UHFFFAOYSA-N
131757286;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NGDYFTHZYYRYJI-UHFFFAOYSA-N
131760108;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;BZHLYVKHDLPQFD-UHFFFAOYSA-N
131766220;LPAR3;7;5.275e-47;0.5745;3.3219;82.6334;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HKWPIEYUIOGMRD-UHFFFAOYSA-N
131761815;LPAR3;7;6.310000000000001e-56;0.54;3.9622;98.6515;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GCRBDMOHZRWTQB-UHFFFAOYSA-N
131763270;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;IRNARDRWANMWOS-UHFFFAOYSA-N
131760102;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;FTPZUXAMLKYSRC-UHFFFAOYSA-N
131766421;LPAR3;7;5.318e-45;0.4727;3.1782;79.0363;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZYZCTQBWUMGGIY-UHFFFAOYSA-N
131763953;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;ZEKYFQBFJWUBSX-UHFFFAOYSA-N
131759858;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JYBNKTCMSXGTGD-UHFFFAOYSA-N
131762000;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GHFSVCDRQBJIQA-UHFFFAOYSA-N
131750420;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;VYGDFJHLNCSFJZ-UHFFFAOYSA-N
131750421;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WYUNJFXMLHILJN-UHFFFAOYSA-N
131762316;LPAR3;7;7.177e-56;0.587;3.9582;98.5511;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WAOXSFHCGYXKMU-UHFFFAOYSA-N
131755846;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;KDCWAZIMGWULJP-UHFFFAOYSA-N
131756133;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QPDHZEQJAFYSNE-UHFFFAOYSA-N
131765858;LPAR3;7;3.417e-42;0.5106;2.9767;73.9952;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CHOVJZYSPBBQPK-UHFFFAOYSA-N
131763718;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VVBXWHUJCYWXPS-UHFFFAOYSA-N
131765343;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PJNRHMLPSAIXIL-UHFFFAOYSA-N
131760538;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ABSZNRZAXPIPNQ-UHFFFAOYSA-N
131755461;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;MEUWGTHLRSIXHV-UHFFFAOYSA-N
131765342;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GWVGQNBVSXPODP-UHFFFAOYSA-N
131755540;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JLNYLODKIXIHKZ-UHFFFAOYSA-N
131759354;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;WAJPTWUYDRSLNY-UHFFFAOYSA-N
131761327;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RYKBFFKZQHHFOA-UHFFFAOYSA-N
131765936;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LNYZAFAGHAFCHN-UHFFFAOYSA-N
131765522;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RGDIOAINFQTUAS-UHFFFAOYSA-N
131765521;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IZQCWCMPLLSHHW-UHFFFAOYSA-N
131760044;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KRNIAXVTJSTDFH-UHFFFAOYSA-N
131764432;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XWCJBYCREBJYKA-UHFFFAOYSA-N
131763770;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FGKAQOCWPYODEA-UHFFFAOYSA-N
131765529;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FAJMBORGLMHRDE-UHFFFAOYSA-N
131765528;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GMDHPKIMMXSUTI-UHFFFAOYSA-N
131764762;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LBGUIRKHHMWLGW-UHFFFAOYSA-N
131758714;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;ZJPRUJQVOSHYAD-UHFFFAOYSA-N
131764761;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QXEZXNMXRFVAHQ-UHFFFAOYSA-N
131763785;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WEPFYTKJXBZPDF-UHFFFAOYSA-N
131766304;LPAR3;7;2.322e-51;0.5094;3.6346;90.4542;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XODJUSVIRAYEDA-UHFFFAOYSA-N
131764441;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LCJYOCKCVAVOGU-UHFFFAOYSA-N
131764440;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ISVPYEPJNJNVKN-UHFFFAOYSA-N
131761885;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SVBUNVHEBALJFL-UHFFFAOYSA-N
131761886;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LTMMYRYQSSNANI-UHFFFAOYSA-N
131766334;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JNWVIGXAZADFPG-UHFFFAOYSA-N
131764199;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WJRHNBWETKCFPT-UHFFFAOYSA-N
131766331;LPAR3;7;4.926e-48;0.5417;3.3958;84.4821;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KCNBDVGTYULZQA-UHFFFAOYSA-N
131756868;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;VCXHGFGBKAVNAO-UHFFFAOYSA-N
131759359;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;UOUKSIKNMFLSOA-UHFFFAOYSA-N
131750423;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYDPSWDUKLRDNF-UHFFFAOYSA-N
131762612;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OFHXYQPJQBMTND-UHFFFAOYSA-N
131750370;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AFFQVAIMWFYJJS-UHFFFAOYSA-N
131764261;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IUKFCSZXWLWVSV-UHFFFAOYSA-N
131756864;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZQMWAXRJJGBMX-UHFFFAOYSA-N
131760407;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NWTURLYIJSOABO-UHFFFAOYSA-N
131764065;LPAR3;7;6.146e-57;0.551;4.0348;100.4673;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;INURSZUTYWHVKL-UHFFFAOYSA-N
131756004;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VUMXXMHKLBIICK-UHFFFAOYSA-N
131761902;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XMVHZFQXXQHPFZ-UHFFFAOYSA-N
131760409;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HWIYVWGYVREDBV-UHFFFAOYSA-N
131764582;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZKPQCFJMOJCHFM-UHFFFAOYSA-N
131760966;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ACBRHMNCXHNUSA-UHFFFAOYSA-N
131764581;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NROTYPBETZBKSI-UHFFFAOYSA-N
131764587;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BFHIXYFKXXDKJA-UHFFFAOYSA-N
131764223;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;XQBXFBYULTYXBQ-UHFFFAOYSA-N
131764222;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;AQXUMBSYJVJRPS-UHFFFAOYSA-N
131764588;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XLHCXTOOFJLBCC-UHFFFAOYSA-N
131761209;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MEITWFTUQYDSIT-UHFFFAOYSA-N
131764226;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;BPRZFYNWCPHLBU-UHFFFAOYSA-N
131764225;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ADUPVYSRXHTHNB-UHFFFAOYSA-N
131765237;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CZCKEHKZTUAGLH-UHFFFAOYSA-N
131761588;LPAR3;7;2.545e-61;0.54;4.3494;108.3362;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PKYHAMJIVRQXKF-UHFFFAOYSA-N
131755808;LPAR3;7;1.456e-49;0.6;3.5056;87.2275;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;IMVQRDFIBOZOMA-UHFFFAOYSA-N
131765536;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NEGZJZAROHNABH-UHFFFAOYSA-N
131761583;LPAR3;7;3.247e-60;0.5294;4.27;106.3508;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BXABDUMCSIHFIE-UHFFFAOYSA-N
131761582;LPAR3;7;3.0640000000000005e-72;0.5745;5.133;127.9397;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HODDFEFUYCPVTQ-UHFFFAOYSA-N
131756723;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UKGTYUIMAQPUNI-UHFFFAOYSA-N
131763213;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZSEBUOJAFUHWIN-UHFFFAOYSA-N
131765154;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YTMLSQRVRJOZHY-UHFFFAOYSA-N
131760986;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WBYJAVXPGXOYOM-UHFFFAOYSA-N
131758281;LPAR3;7;5.86e-50;0.6;3.534;87.9372;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XGRHXRCXVVXNRR-UHFFFAOYSA-N
131760985;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GWUZWGZLGCRJKX-UHFFFAOYSA-N
131755838;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;VXILKXGVHSBSGJ-UHFFFAOYSA-N
131763848;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LEMUUXQSONCZBR-UHFFFAOYSA-N
131763248;LPAR3;7;5.665e-44;0.5745;3.1044;77.1917;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UGHFVGFGLYJRIY-UHFFFAOYSA-N
131766200;LPAR3;7;1.756e-50;0.5;3.5715;88.877;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XFKCIJVYTCFMNK-UHFFFAOYSA-N
131763327;LPAR3;7;8.489999999999999e-45;0.587;3.1636;78.6716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HIXJBODFVNVVOZ-UHFFFAOYSA-N
131756890;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZHAAEGBTAPSRS-UHFFFAOYSA-N
131758043;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WBFSLXIVMFYBJL-UHFFFAOYSA-N
131761115;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OMWMADGRZUDBNS-UHFFFAOYSA-N
131763329;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZCUCDBKSLMWFIN-UHFFFAOYSA-N
131753635;LPAR3;7;2.311e-66;0.6136;4.7112;117.3878;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;CCKLWBNVDVDCFO-UHFFFAOYSA-N
131763758;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;AUHAVSXJNUHURT-UHFFFAOYSA-N
53480575;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KWSQCBUVZQFFAT-UHFFFAOYSA-N
131759439;LPAR3;7;9.328e-66;0.6585;4.6677;116.2999;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OAYIGAFUEDTGGM-UHFFFAOYSA-N
131760911;LPAR3;7;1.049e-51;0.551;3.6593;91.074;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SCBNRRNNYKNHJU-UHFFFAOYSA-N
131760912;LPAR3;7;8.624e-51;0.54;3.5937;89.4313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NHHWSKRTYUVOOE-UHFFFAOYSA-N
131765302;LPAR3;7;1.177e-52;0.5625;3.7275;92.7792;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MBBWQOJXLONXQW-UHFFFAOYSA-N
131765987;LPAR3;7;1.214e-53;0.5745;3.7983;94.5505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;QOWBFANLOZBMRP-UHFFFAOYSA-N
131760306;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LQORAQJGEORWLS-UHFFFAOYSA-N
131761302;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SPUJFJNWFPTYCI-UHFFFAOYSA-N
131763777;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WVKSRKGAZQQBAE-UHFFFAOYSA-N
131756070;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NXVPBQKOQAHIQZ-UHFFFAOYSA-N
9545582;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PMEABGYOVGWCSQ-UHFFFAOYSA-N
131765905;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AOTFUYDDGGOHGP-UHFFFAOYSA-N
131757747;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RXEXVUVFJRTYMW-UHFFFAOYSA-N
131756917;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYOOKRFWFUJQTP-UHFFFAOYSA-N
131760706;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;AKQAUMVOMMKMTF-UHFFFAOYSA-N
131760439;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GYCKKRXENHOTFF-UHFFFAOYSA-N
131761422;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QYFDEAFYRXDHQK-UHFFFAOYSA-N
131758098;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BLEZXNLVEWZCRH-UHFFFAOYSA-N
131761301;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;AXZAPIACNHHVNU-UHFFFAOYSA-N
131757030;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AMLVLGGTLWUONM-UHFFFAOYSA-N
131760757;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AQXPAPMULLSBQL-UHFFFAOYSA-N
131760781;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ORQMNWAGMCHUBN-UHFFFAOYSA-N
131764669;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XLTFKKGEFQUZDB-UHFFFAOYSA-N
131760574;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BHETTXDAZXCFKF-UHFFFAOYSA-N
131760847;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YMGSOCWJHLMLQM-UHFFFAOYSA-N
131764615;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DSBMDFNAANRIOD-UHFFFAOYSA-N
131764836;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VRQORPMJTGLJIF-UHFFFAOYSA-N
131756022;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MQTQRKAUZZYKLD-UHFFFAOYSA-N
131763556;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PTMJQDBEENYEHE-UHFFFAOYSA-N
131756810;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZVAZRCNQDGGHIY-UHFFFAOYSA-N
131756589;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ZKCPJGUEGWADAV-UHFFFAOYSA-N
131762181;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YHKXBBUZMDPXSA-UHFFFAOYSA-N
131762547;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HUNYHNIYIYCFKC-UHFFFAOYSA-N
131760807;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PIZKEXJUEDRGCV-UHFFFAOYSA-N
131764143;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PUCACZUVSXLWRS-UHFFFAOYSA-N
131764062;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QJLUNEFXQRDKLC-UHFFFAOYSA-N
131757146;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FGCRNQQTWMCHBU-UHFFFAOYSA-N
131761228;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SLNSNTKFZUABKK-UHFFFAOYSA-N
131762447;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NFYYDFZZKBBWRC-UHFFFAOYSA-N
131757733;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GWECERDTBORDQQ-UHFFFAOYSA-N
131764530;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WKMJVPNNZRZPKK-UHFFFAOYSA-N
131760119;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GSHKNZZOMWCMJO-UHFFFAOYSA-N
131764731;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LFLKOLLXMXUPMJ-UHFFFAOYSA-N
131764790;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IMMKDABJSSZNBN-UHFFFAOYSA-N
131757653;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZOOFCAJPCUMJET-UHFFFAOYSA-N
131757109;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GEHPSFWUFSXURT-UHFFFAOYSA-N
131765659;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BPAMRGTXFLHKIB-UHFFFAOYSA-N
131765029;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SOXFSPJIIHJCEP-UHFFFAOYSA-N
131754043;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZFXPLVLFBHYGSN-UHFFFAOYSA-N
131758060;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;BSPIFBZEPCECGT-UHFFFAOYSA-N
131761670;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IALRONIRWRXXFJ-UHFFFAOYSA-N
131760898;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DSDYHEOLLZDDPO-UHFFFAOYSA-N
131764973;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YOYHAKULCQGNIT-UHFFFAOYSA-N
131762289;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLWQYLIHICZAQN-UHFFFAOYSA-N
9545747;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MNOSBSFAFCETAL-UHFFFAOYSA-N
131763310;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JJVQIAHLUNUXIN-UHFFFAOYSA-N
131756759;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JCKZVXSFNAILPO-UHFFFAOYSA-N
131756400;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DSTCTJRXZHFEEO-UHFFFAOYSA-N
131760339;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PFCDUEXIIFGNON-UHFFFAOYSA-N
131760984;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VVRZBMYJHVBGAQ-UHFFFAOYSA-N
131765279;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;QSAZQWUZAGCDBS-UHFFFAOYSA-N
9545524;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YOUSHAZSTHBEJI-UHFFFAOYSA-N
131764929;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OIZPCGDUHJZSMK-UHFFFAOYSA-N
131756777;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KJJSZLIZMYZLOM-UHFFFAOYSA-N
131755312;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;BVHNZHCDCIVCNP-UHFFFAOYSA-N
131766324;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UVGDFMKGDHVPHK-UHFFFAOYSA-N
131757678;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XFCIPVYPNCSGSK-UHFFFAOYSA-N
131756854;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LUAVDZZOBREHQN-UHFFFAOYSA-N
131765814;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VRDFIQSWUACISW-UHFFFAOYSA-N
131763564;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTYYWBNWBIXRST-UHFFFAOYSA-N
131763247;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GATBTSFSXXAQAW-UHFFFAOYSA-N
131761771;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VUABVSDTWKAGBK-UHFFFAOYSA-N
131763360;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CDFSSVIAZNGTBZ-UHFFFAOYSA-N
131763849;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IWQXPFWRVPSQSD-UHFFFAOYSA-N
131765487;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PDOJEFKZWZWMCQ-UHFFFAOYSA-N
131760439;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GYCKKRXENHOTFF-UHFFFAOYSA-N
131756426;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NFFNDBLEGQCYOX-UHFFFAOYSA-N
131756288;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RBJAIGDUPAACLQ-UHFFFAOYSA-N
131762282;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;CEJOBDUANZCCOB-UHFFFAOYSA-N
131757437;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YFHMHPUWCPHBQO-UHFFFAOYSA-N
131759547;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PKTUULQXDIEYDT-UHFFFAOYSA-N
131758449;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BDAAUVXVYYGPNU-UHFFFAOYSA-N
131756255;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;QEBZICHWOFBWMS-UHFFFAOYSA-N
131762653;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OYZCTROWQJHDDM-UHFFFAOYSA-N
131758249;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GSINXERSHYXLOO-UHFFFAOYSA-N
131761795;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SSPNCRHVPPGOSG-UHFFFAOYSA-N
131765556;LPAR3;6;5.66e-57;0.5;8.6709;100.5316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IPPJSXWXPGLCQK-UHFFFAOYSA-N
131757073;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VOIUMMLAPMMRMR-UHFFFAOYSA-N
131762203;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MODPITGELPIGOT-UHFFFAOYSA-N
131755995;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DWIFUTKZBKIVIO-UHFFFAOYSA-N
131758900;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NZGZMFGERFXOQI-UHFFFAOYSA-N
131761347;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IFRXOEIIKSFQOO-UHFFFAOYSA-N
131756364;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IRFCZQIIPLGSKZ-UHFFFAOYSA-N
131756261;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZFXYDOMFBWQZNA-UHFFFAOYSA-N
131763153;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CBQQNGMIEQUSNE-UHFFFAOYSA-N
131756178;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LQGJLTQDXJLJGB-UHFFFAOYSA-N
131762319;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UHCRYPFJSBIIRR-UHFFFAOYSA-N
131761567;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JVXVUTIOKONCJQ-UHFFFAOYSA-N
131760809;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MJNRQPAXIWANBB-UHFFFAOYSA-N
131758082;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNTKADGAFKNKPP-UHFFFAOYSA-N
131757549;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WLCMTXXFZMOMHZ-UHFFFAOYSA-N
131760885;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VBYQUDJISXINCX-UHFFFAOYSA-N
131762727;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;HUFAUCRKBKDFDP-UHFFFAOYSA-N
131760112;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MNFJIZPZFDFSHT-UHFFFAOYSA-N
131755077;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GQAUQPCQRVYUQF-UHFFFAOYSA-N
9545351;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LYUOZIPQCKXNPX-UHFFFAOYSA-N
131761460;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GIYUPPWUIAUMIZ-UHFFFAOYSA-N
131764562;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VLEBBCZZNDWVCE-UHFFFAOYSA-N
131760996;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MIAFRKAYTHDWRE-UHFFFAOYSA-N
131758053;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTCDSFDXNQAUJF-UHFFFAOYSA-N
131762379;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SZJQKGFMCYFPGP-UHFFFAOYSA-N
131758908;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IBUWOVXDFGLFPQ-UHFFFAOYSA-N
131762865;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;APLABQCESRGFRN-UHFFFAOYSA-N
131760765;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DSSFNWQQTMLKJD-UHFFFAOYSA-N
131764413;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKJYIRPZZWLYSB-UHFFFAOYSA-N
131764341;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMJSZQBPVUGYMY-UHFFFAOYSA-N
131760694;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AKPFCWNOANKGPU-UHFFFAOYSA-N
131764137;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VLMFXQRKOXVLPZ-UHFFFAOYSA-N
131761664;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GPZNPRSWWAGAKP-UHFFFAOYSA-N
131759677;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QETBIRGBJSNBME-UHFFFAOYSA-N
131764032;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;NOLCSFQLXSPJBG-UHFFFAOYSA-N
131763983;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JQHWRRJYPOHAKD-UHFFFAOYSA-N
131763312;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VTKNVVRESNLLGP-UHFFFAOYSA-N
131756149;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GNKDSUNTVMVVBM-UHFFFAOYSA-N
131760765;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DSSFNWQQTMLKJD-UHFFFAOYSA-N
131762742;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PQVAMULAOIDXID-UHFFFAOYSA-N
131760904;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XGMRMYUHVURNEO-UHFFFAOYSA-N
131763568;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TWIVSQOXNBXDFW-UHFFFAOYSA-N
131763238;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;TZEDWJDIOLCDJN-UHFFFAOYSA-N
131764339;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KDRWOUSNZBDXFR-UHFFFAOYSA-N
131763654;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PEHSTCKPKBMSBQ-UHFFFAOYSA-N
131764056;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BODCPTKZTGBALI-UHFFFAOYSA-N
131756899;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CQJJJRSFXVFAMI-UHFFFAOYSA-N
131756439;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FTHLMZICSLNUNG-UHFFFAOYSA-N
131757197;FABP3;7;9.821999999999999e-53;0.5;1.7361;92.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;XTVWCEQQMYEOJZ-UHFFFAOYSA-N
131757742;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GEGMUTTVHLZEBG-UHFFFAOYSA-N
131761822;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PEIWINCKWDTWRA-UHFFFAOYSA-N
131755403;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LEYNPNMAFNJINO-UHFFFAOYSA-N
131757102;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZFWLBSAZUANAAS-UHFFFAOYSA-N
131755431;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ULQBTSOLBSLCJS-UHFFFAOYSA-N
131761672;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;XHEAJMDJLPMZEK-UHFFFAOYSA-N
131756862;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JIWBKNDEFSQJBT-UHFFFAOYSA-N
131762850;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DVVXILVDNWEYLR-UHFFFAOYSA-N
131762502;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GITBOGBAISSPME-UHFFFAOYSA-N
131760237;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UQXVRDHAZYQOSA-UHFFFAOYSA-N
131760748;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MIQNEBSSVNEWHY-UHFFFAOYSA-N
131762130;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DBABQSZDEPAQMJ-UHFFFAOYSA-N
9545554;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;VHWHMIVHTCKTPQ-UHFFFAOYSA-N
131756028;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZAABBQKBBZHIKW-UHFFFAOYSA-N
131758402;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MSQOAJJKBRJHKC-UHFFFAOYSA-N
131763784;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PEHCCWRKDIRZAZ-UHFFFAOYSA-N
131758242;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MOFDKHZXLRZVOO-UHFFFAOYSA-N
131766170;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;POBZIGDMHISRHS-UHFFFAOYSA-N
131756947;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QHKBTFROAVQQIT-UHFFFAOYSA-N
131756203;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MBYYMZUVLLYROS-UHFFFAOYSA-N
131759781;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MXQGPSRZEDBAOD-UHFFFAOYSA-N
131763777;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WVKSRKGAZQQBAE-UHFFFAOYSA-N
131761343;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HATPVFYQRUFDTP-UHFFFAOYSA-N
131761442;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ADKLGQHKFMGSDC-UHFFFAOYSA-N
131756221;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IDAQDJPLYHWOKS-UHFFFAOYSA-N
131757555;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NUARLQSDFGRENY-UHFFFAOYSA-N
131764347;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHWNHSAKNIOPPW-UHFFFAOYSA-N
131756955;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NPDFCHHIYFJVGQ-UHFFFAOYSA-N
131760693;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NTSBPGZUJBXBSL-UHFFFAOYSA-N
131758138;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WICCDJPCCTZLBO-UHFFFAOYSA-N
131763152;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;INDPJVIDKWBQSJ-UHFFFAOYSA-N
131761562;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IHAZFQHVOPNHHB-UHFFFAOYSA-N
131763765;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CRKRCBKIBIHXFP-UHFFFAOYSA-N
131762779;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPNUDVKOGAAXPS-UHFFFAOYSA-N
131764797;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GOBSVYLENLQESQ-UHFFFAOYSA-N
131754022;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MFBJAFVRSRFNBT-UHFFFAOYSA-N
131764433;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SGITZBIAHRILMB-UHFFFAOYSA-N
9545386;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JNDBWTLJGLLSAK-UHFFFAOYSA-N
131756303;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYQSHOWOAIDEJS-UHFFFAOYSA-N
131757036;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQXBXQMXXNQSMI-UHFFFAOYSA-N
131761821;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BWXJGGJFPJYWNA-UHFFFAOYSA-N
131760903;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AJANAYCEBNGXKY-UHFFFAOYSA-N
131761368;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTTAXJGEXQSTCM-UHFFFAOYSA-N
131759541;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OXIPRMUYAGLPPY-UHFFFAOYSA-N
131764192;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JFCUMDGUAUVTSM-UHFFFAOYSA-N
131765426;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KKPFEVCEWGVILK-UHFFFAOYSA-N
131765814;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VRDFIQSWUACISW-UHFFFAOYSA-N
131766076;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VPOZOJSGWJGLAC-UHFFFAOYSA-N
131757016;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GEYBFTLZFGOMLS-UHFFFAOYSA-N
131761929;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JHWBUXSCSIHAAE-UHFFFAOYSA-N
131758032;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;DZKPWYXJQNAJRE-UHFFFAOYSA-N
131762646;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QSWDCFMAGFRFLB-UHFFFAOYSA-N
131759382;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HEMRKPYNFGQFML-UHFFFAOYSA-N
131758138;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;WICCDJPCCTZLBO-UHFFFAOYSA-N
131761276;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QHLATCHOBPMICE-UHFFFAOYSA-N
131760297;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OYFSLUROHDMBJJ-UHFFFAOYSA-N
131764347;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SHWNHSAKNIOPPW-UHFFFAOYSA-N
9545524;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;YOUSHAZSTHBEJI-UHFFFAOYSA-N
131763258;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ASHDSIZMSUYRGL-UHFFFAOYSA-N
131762196;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OIMOXMXEHNPADS-UHFFFAOYSA-N
131764062;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QJLUNEFXQRDKLC-UHFFFAOYSA-N
131762388;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QPELGHLJZRAEJZ-UHFFFAOYSA-N
131763359;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JBDJDXZTHMTVDR-UHFFFAOYSA-N
131755816;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WRPAVJZVCFOMOP-UHFFFAOYSA-N
131756575;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;YJBBKAQEXQATDN-UHFFFAOYSA-N
131763688;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QSKROXVIZWMLAM-UHFFFAOYSA-N
131764751;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QUQKNNJGHQORGA-UHFFFAOYSA-N
131764074;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SXLSGVHVTGSALG-UHFFFAOYSA-N
131755464;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AIJZDCRCOWFNRQ-UHFFFAOYSA-N
131755594;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FYMHLHDVPWTCCO-UHFFFAOYSA-N
131760732;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YXUAESIHENABSF-UHFFFAOYSA-N
131756176;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MEIGPYFQXNHGCJ-UHFFFAOYSA-N
131756221;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IDAQDJPLYHWOKS-UHFFFAOYSA-N
131760319;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IAFMACZCBGOYAR-UHFFFAOYSA-N
131761138;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YFMDCVKFNONJOO-UHFFFAOYSA-N
131757715;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HGSNEKPPSIBDLE-UHFFFAOYSA-N
131757268;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CYEYMUIZHDCNEQ-UHFFFAOYSA-N
131764132;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VIIWKEJLCOZGMH-UHFFFAOYSA-N
131757016;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GEYBFTLZFGOMLS-UHFFFAOYSA-N
131757017;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XIMVAXPQXRCQDC-UHFFFAOYSA-N
131762275;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZNAJMOCCTZFALW-UHFFFAOYSA-N
9545385;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PDCZMYYCRMCWTG-UHFFFAOYSA-N
131761400;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WMJYOPWQUYFVJJ-UHFFFAOYSA-N
131756322;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NIUHSZFZGDYMCJ-UHFFFAOYSA-N
131756022;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MQTQRKAUZZYKLD-UHFFFAOYSA-N
131755305;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DHTOKABCIVEDQY-UHFFFAOYSA-N
131757613;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MEEWQDGSGNOSQP-UHFFFAOYSA-N
131755823;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NDODQCHGZSBDMO-UHFFFAOYSA-N
131761353;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RBASRMKCLNNORI-UHFFFAOYSA-N
131764085;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XTPPLMSBGCFPTO-UHFFFAOYSA-N
131761746;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZNDLKGOPISOCOU-UHFFFAOYSA-N
131756971;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;YNIZWWNPCWHUTQ-UHFFFAOYSA-N
131760598;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QZXIVAFCGWISDS-UHFFFAOYSA-N
131756204;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VKCTUXDPTHSMPZ-UHFFFAOYSA-N
131762404;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LQJPCYRTCWFLFO-UHFFFAOYSA-N
131766362;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;QUHURZUDLDDFJM-UHFFFAOYSA-N
131762762;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;RUSCMJMSQIOWQE-UHFFFAOYSA-N
131761301;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;AXZAPIACNHHVNU-UHFFFAOYSA-N
131763259;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JWUGOBDQRTWQDM-UHFFFAOYSA-N
131765909;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MLBXOOYHYHHLQI-UHFFFAOYSA-N
131757146;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FGCRNQQTWMCHBU-UHFFFAOYSA-N
131761430;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HHZNVRUBXAYDCQ-UHFFFAOYSA-N
131755613;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XNRMSBDDILQLRG-UHFFFAOYSA-N
131764751;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QUQKNNJGHQORGA-UHFFFAOYSA-N
131762447;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NFYYDFZZKBBWRC-UHFFFAOYSA-N
131756348;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NZDXNWLXUJHQDW-UHFFFAOYSA-N
131757728;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OWJXGNJNFGGSAF-UHFFFAOYSA-N
131765039;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YDXADNGEUYJWKH-UHFFFAOYSA-N
131756169;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJEBHXWSLTWPCM-UHFFFAOYSA-N
131764864;LPAR3;6;5.66e-57;0.5;8.6709;100.5316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DIBYWIYZKDKTEL-UHFFFAOYSA-N
131765015;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LLFPJINNFLWCHE-UHFFFAOYSA-N
131754043;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZFXPLVLFBHYGSN-UHFFFAOYSA-N
56940217;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BJOKYLJMABAHNL-UHFFFAOYSA-N
131760617;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ZZTHPXVKEQEQDW-UHFFFAOYSA-N
131760884;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FJFQEYNMGJSGOC-UHFFFAOYSA-N
131755817;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QCIAAKBWAXWFOI-UHFFFAOYSA-N
131758031;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VHXPQJFOLJPCQU-UHFFFAOYSA-N
131760863;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JXSMIMXHJNFSLE-UHFFFAOYSA-N
131761520;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WBENLJREAPLIFI-UHFFFAOYSA-N
131761449;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JZQYMINNIQSBMO-UHFFFAOYSA-N
131761119;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JOXVEMDPPLURBQ-UHFFFAOYSA-N
131758218;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SYCPSWRZYSSYMM-UHFFFAOYSA-N
131756877;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HHWHJJSODCDUKU-UHFFFAOYSA-N
131761812;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BINYJEJVCIPSFI-UHFFFAOYSA-N
131757098;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NTQFVICUXZMCHT-UHFFFAOYSA-N
131763454;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NVCFQTAXRDDMLZ-UHFFFAOYSA-N
131760357;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YAVAVSMMSRUIQM-UHFFFAOYSA-N
131758427;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QYSAZPWQWDQBMK-UHFFFAOYSA-N
131765780;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DDMIXISYNHIHGW-UHFFFAOYSA-N
131755431;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ULQBTSOLBSLCJS-UHFFFAOYSA-N
131763326;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZUFGRRVTVKEBJI-UHFFFAOYSA-N
131761020;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WWNWPBUPVCWJHV-UHFFFAOYSA-N
131753639;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HVJIYFSRIYNDPL-UHFFFAOYSA-N
131765054;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KUWKDKKFKVFAGR-UHFFFAOYSA-N
131766420;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HPSNFWYKNKZZRH-UHFFFAOYSA-N
131757274;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;YXFXBGQKOCWXIW-UHFFFAOYSA-N
9545669;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATYQADYSFQGJBV-UHFFFAOYSA-N
131756116;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XZCFLUUMROMSAR-UHFFFAOYSA-N
131758719;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LOQLDSZRHWTGNQ-UHFFFAOYSA-N
131756996;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ACGHXTVLDFHATI-UHFFFAOYSA-N
131760312;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SYOMGTNMWHLBFV-UHFFFAOYSA-N
131761400;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WMJYOPWQUYFVJJ-UHFFFAOYSA-N
131761119;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JOXVEMDPPLURBQ-UHFFFAOYSA-N
131765243;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JYHMTHDHJBNVQX-UHFFFAOYSA-N
131762994;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SBHVXVGIUJBNSJ-UHFFFAOYSA-N
131757678;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XFCIPVYPNCSGSK-UHFFFAOYSA-N
131758032;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;DZKPWYXJQNAJRE-UHFFFAOYSA-N
131756778;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DIKJEMPGNQDBCI-UHFFFAOYSA-N
131758306;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LWZVEKQNTUNOHB-UHFFFAOYSA-N
131757030;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AMLVLGGTLWUONM-UHFFFAOYSA-N
131755477;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKXVFDJOYACJHJ-UHFFFAOYSA-N
131765548;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PUZHVGYKYYGDMS-UHFFFAOYSA-N
131760840;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SNIRWKWYRGYYKI-UHFFFAOYSA-N
131764414;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BDCZEXNOCSGQCL-UHFFFAOYSA-N
131755647;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DTGWBWNZTSFJEB-UHFFFAOYSA-N
131763233;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FZVSVPNSNPCVJK-UHFFFAOYSA-N
131764221;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;WDFUGSQAEFPRPL-UHFFFAOYSA-N
131760731;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HWLVTNCWIOTLSO-UHFFFAOYSA-N
131756169;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJEBHXWSLTWPCM-UHFFFAOYSA-N
131764053;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GAWBNAJJRJBPMU-UHFFFAOYSA-N
131763567;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UEFBXDIEVPQCTF-UHFFFAOYSA-N
131761701;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OSSYIJMBFKKOMK-UHFFFAOYSA-N
131757708;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NPZLRDCOUNCXDT-UHFFFAOYSA-N
131753834;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MIRRUHDLDQABSJ-UHFFFAOYSA-N
131763159;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UOQDSEPRWVVBKV-UHFFFAOYSA-N
131755822;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IPHODDSCNVBUSO-UHFFFAOYSA-N
131764493;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;TXWFFTTYLKQWRO-UHFFFAOYSA-N
131761120;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RXMAXLLPNKWYHJ-UHFFFAOYSA-N
131763656;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SXYJOWDBRRCLFA-UHFFFAOYSA-N
131755666;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PTSDZIVZWSSOQV-UHFFFAOYSA-N
131756990;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GIMZLHBKBDWKNT-UHFFFAOYSA-N
131760713;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XNFUACYEWNBQLH-UHFFFAOYSA-N
131763367;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HXTSHFBTAPQXOE-UHFFFAOYSA-N
131758282;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JPJMXAFPVUPHGK-UHFFFAOYSA-N
131763272;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GUXKXSATTNLTNC-UHFFFAOYSA-N
131763661;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GHFWFQHLLHELBA-UHFFFAOYSA-N
131761556;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DPAGBXUISVSPAM-UHFFFAOYSA-N
131756733;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;NLINQQFDCCGNFE-UHFFFAOYSA-N
131765420;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LTJUTLQBAKGEKJ-UHFFFAOYSA-N
131757567;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FEJZLHABNKUOEC-UHFFFAOYSA-N
131761014;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PMTUBLSDRVNMGS-UHFFFAOYSA-N
131759606;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZUPXIIFMWPFTKM-UHFFFAOYSA-N
131765718;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UVKBBNGIOHOUEE-UHFFFAOYSA-N
131761929;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JHWBUXSCSIHAAE-UHFFFAOYSA-N
131764210;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WTQILBUQTSQKMT-UHFFFAOYSA-N
9545459;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VGUNDIMKOJFCKY-UHFFFAOYSA-N
131761777;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;UYCTVQQBNMEKIQ-UHFFFAOYSA-N
131760814;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UNPHSNFHDIZVSI-UHFFFAOYSA-N
131761389;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PCDJUEAPQQHKQV-UHFFFAOYSA-N
131758217;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MENKUUOOQRGDSS-UHFFFAOYSA-N
131757393;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UNUYEOWBNOUCHI-UHFFFAOYSA-N
131750418;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GGNMBNAJWKYLBB-UHFFFAOYSA-N
25240392;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ANCUFEBJPNGQKK-UHFFFAOYSA-N
131759546;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZULRYZCUNGPAHY-UHFFFAOYSA-N
131761879;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KIJAVMZBMCLIEW-UHFFFAOYSA-N
131760133;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VHPUITUUEXRCGU-UHFFFAOYSA-N
131758352;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RBAXJCVLSUEXJH-UHFFFAOYSA-N
131763656;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SXYJOWDBRRCLFA-UHFFFAOYSA-N
131758217;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MENKUUOOQRGDSS-UHFFFAOYSA-N
131763738;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MXOQAYBYRAGVQT-UHFFFAOYSA-N
131763239;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AHTTULMKWLTZHP-UHFFFAOYSA-N
131762666;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;OKMPYBUPDFDIHC-UHFFFAOYSA-N
131760151;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXNYWQGAKRABHA-UHFFFAOYSA-N
131755305;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DHTOKABCIVEDQY-UHFFFAOYSA-N
131761247;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KYMZBLBKJMZRJX-UHFFFAOYSA-N
131760878;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XMMKMNSZBLWXRZ-UHFFFAOYSA-N
131762606;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IEOSRVGEECHXBY-UHFFFAOYSA-N
131763968;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NIEMKAQPFODPCE-UHFFFAOYSA-N
131761139;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YWMXFRKULOXAPT-UHFFFAOYSA-N
131762305;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LDQMUQGHUBNDTF-UHFFFAOYSA-N
131760592;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LMGNSHHFYGGMOJ-UHFFFAOYSA-N
131761670;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IALRONIRWRXXFJ-UHFFFAOYSA-N
131754014;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UAZSECASKQJKIA-UHFFFAOYSA-N
131764930;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QYDUYXRVYKJXAF-UHFFFAOYSA-N
131761352;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CZCGMLNCRPSJDT-UHFFFAOYSA-N
131762187;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FFRUWMSJKGSWRM-UHFFFAOYSA-N
9545676;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PBKAVJDINREZJK-UHFFFAOYSA-N
131760334;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BJLRZHNJFQMOIR-UHFFFAOYSA-N
131760465;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIGNKIDTFFNZDL-UHFFFAOYSA-N
131763366;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DXAZBFYXLZYUIG-UHFFFAOYSA-N
56940383;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TUZZBILRHPBTHW-UHFFFAOYSA-N
9545533;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KNVSDJVHRPAOCP-UHFFFAOYSA-N
9545554;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;VHWHMIVHTCKTPQ-UHFFFAOYSA-N
131763679;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZZNQEKZITOQVEU-UHFFFAOYSA-N
131753872;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DJOOHJRCQZSQJS-UHFFFAOYSA-N
131760014;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AMXNXQFOJFMVAP-UHFFFAOYSA-N
131763247;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GATBTSFSXXAQAW-UHFFFAOYSA-N
131764115;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QTYYFJGKWKUBSQ-UHFFFAOYSA-N
131760872;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WMLPUCUGYDVCLW-UHFFFAOYSA-N
56940238;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NZPQLKPAJMTADW-UHFFFAOYSA-N
131757139;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BPDREBISDHEJBG-UHFFFAOYSA-N
131765020;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MLKZMSXRVHKPIC-UHFFFAOYSA-N
131756710;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YIENLPUFSVQUCG-UHFFFAOYSA-N
131756408;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BRPUMZUOUUAVGA-UHFFFAOYSA-N
131764403;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XBJZPTQZKFLWMM-UHFFFAOYSA-N
131760013;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;ZVECOVJZJMOJSN-UHFFFAOYSA-N
131762138;FABP3;7;6.059e-49;0.4375;1.6094;86.1158;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NNNMVNSALGUZNQ-UHFFFAOYSA-N
131761763;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JIAJTOHVOZEPJW-UHFFFAOYSA-N
131758081;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMWSXQSMSFDAB-UHFFFAOYSA-N
131761423;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IKPYKXHCUXCJHN-UHFFFAOYSA-N
131764280;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFYKQFUOADHDTL-UHFFFAOYSA-N
131758402;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;MSQOAJJKBRJHKC-UHFFFAOYSA-N
131760169;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CFGOOLOMBIOEGG-UHFFFAOYSA-N
131760609;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;XMFRBOAHYIOZTK-UHFFFAOYSA-N
131765449;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XJRZLDVBOKCGHX-UHFFFAOYSA-N
131765362;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XWSIPXKDOXVBDJ-UHFFFAOYSA-N
131758226;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AQUHVGHTBSILQP-UHFFFAOYSA-N
131765230;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BVJYLMXQFAHMGO-UHFFFAOYSA-N
131758718;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PPKIZYUIIFPNOZ-UHFFFAOYSA-N
131761368;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTTAXJGEXQSTCM-UHFFFAOYSA-N
9545767;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GHVVXAAHMOLTMW-UHFFFAOYSA-N
131756370;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VGDHPALBZNZOAN-UHFFFAOYSA-N
131755102;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZFHHHJBRXGVHEW-UHFFFAOYSA-N
131755423;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SCXZWEQDFMQHJA-UHFFFAOYSA-N
131762209;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DFWJNSRUGPXPNK-UHFFFAOYSA-N
131766284;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MULMEUBOKZKCAH-UHFFFAOYSA-N
131763152;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;INDPJVIDKWBQSJ-UHFFFAOYSA-N
131756947;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QHKBTFROAVQQIT-UHFFFAOYSA-N
131761020;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WWNWPBUPVCWJHV-UHFFFAOYSA-N
131757063;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QMDVGDLZLSCJAH-UHFFFAOYSA-N
131755076;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFESPFKKWBRMFJ-UHFFFAOYSA-N
131763351;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZNOAWGZVSGWABO-UHFFFAOYSA-N
131764433;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;SGITZBIAHRILMB-UHFFFAOYSA-N
131759700;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BTOBAOSWLQZTFQ-UHFFFAOYSA-N
131765612;LPAR3;6;5.66e-57;0.5;8.6709;100.5316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HEPCVJBIBIAOMD-UHFFFAOYSA-N
56940375;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;CVLWWEVOWKHNNO-UHFFFAOYSA-N
131760134;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JQVMDWCSJIMBFA-UHFFFAOYSA-N
131764494;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AUJUYSXBGAUAGJ-UHFFFAOYSA-N
131763271;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;POKWAFRJAZNFSU-UHFFFAOYSA-N
131757747;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RXEXVUVFJRTYMW-UHFFFAOYSA-N
131761763;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JIAJTOHVOZEPJW-UHFFFAOYSA-N
131765967;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RHQBRHXLEMVAPU-UHFFFAOYSA-N
131764356;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;UZIKBSYQATZXML-UHFFFAOYSA-N
131762388;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QPELGHLJZRAEJZ-UHFFFAOYSA-N
131760903;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AJANAYCEBNGXKY-UHFFFAOYSA-N
131762203;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MODPITGELPIGOT-UHFFFAOYSA-N
131756979;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBFKNCWBKFPUIY-UHFFFAOYSA-N
131760398;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LZQXDMQLLSQLDI-UHFFFAOYSA-N
131759721;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VFICNLJKIFKMLD-UHFFFAOYSA-N
131756990;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GIMZLHBKBDWKNT-UHFFFAOYSA-N
131758408;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FJCZNIRVTYQYOI-UHFFFAOYSA-N
131760230;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AJOYUENGEJHXFT-UHFFFAOYSA-N
131755465;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BTKBYBXKJGMWMW-UHFFFAOYSA-N
131757870;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;LTKCBUMGVCUVPG-UHFFFAOYSA-N
131763687;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UYULDZRZDPVLFT-UHFFFAOYSA-N
131761488;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBYYUOFBHJZJDM-UHFFFAOYSA-N
131763139;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WUPOLOVISVVRIA-UHFFFAOYSA-N
131764292;FABP3;7;2.703e-52;0.4681;1.7214;92.1313;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIZPZYVVCLXNRY-UHFFFAOYSA-N
131763968;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NIEMKAQPFODPCE-UHFFFAOYSA-N
131759369;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FNBKULXEHXAYLR-UHFFFAOYSA-N
131755102;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZFHHHJBRXGVHEW-UHFFFAOYSA-N
131760406;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TWDVZQIJTRNOQN-UHFFFAOYSA-N
131755082;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RGTDFTBQSPVDLT-UHFFFAOYSA-N
131753645;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;FHNSFDXXUNMFHU-UHFFFAOYSA-N
131756786;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;USSQANBAQNQTNC-UHFFFAOYSA-N
131764959;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RHYBXYWAECNXSA-UHFFFAOYSA-N
131760984;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VVRZBMYJHVBGAQ-UHFFFAOYSA-N
131764333;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FJUCHGYLVVMEGA-UHFFFAOYSA-N
131755621;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OQTQYHCFGCOUPR-UHFFFAOYSA-N
56940238;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NZPQLKPAJMTADW-UHFFFAOYSA-N
131756267;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MWJBYDLBNUIUKI-UHFFFAOYSA-N
131766284;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MULMEUBOKZKCAH-UHFFFAOYSA-N
131764747;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HRTPJAKAPLEWKW-UHFFFAOYSA-N
131761229;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AZCFJOQBPCTUJB-UHFFFAOYSA-N
9545747;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MNOSBSFAFCETAL-UHFFFAOYSA-N
131758037;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;BZZJVZIMQHLYFH-UHFFFAOYSA-N
131760170;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NVTGKNBTUCFOOC-UHFFFAOYSA-N
131763231;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFTFKKKNMJLXFT-UHFFFAOYSA-N
131765967;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RHQBRHXLEMVAPU-UHFFFAOYSA-N
131764420;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SINMBGNDNFVNCB-UHFFFAOYSA-N
131764067;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LFYKWGODUKKZEK-UHFFFAOYSA-N
131762380;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CUSUSJFFOGKHBB-UHFFFAOYSA-N
131765914;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XBZRFWSSSDXNCN-UHFFFAOYSA-N
131760814;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UNPHSNFHDIZVSI-UHFFFAOYSA-N
131761592;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CRPGFZTUFREYFV-UHFFFAOYSA-N
131760864;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XXAWZPPLHQUSBP-UHFFFAOYSA-N
131760617;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ZZTHPXVKEQEQDW-UHFFFAOYSA-N
131763564;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTYYWBNWBIXRST-UHFFFAOYSA-N
131760864;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XXAWZPPLHQUSBP-UHFFFAOYSA-N
131764674;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UCROWURDULDTCP-UHFFFAOYSA-N
131760756;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PVXKEKCIFSZOTE-UHFFFAOYSA-N
131764451;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;BEAIEHHBBTZBNH-UHFFFAOYSA-N
131761871;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FFVISGZUNRMRSS-UHFFFAOYSA-N
131760609;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;XMFRBOAHYIOZTK-UHFFFAOYSA-N
131756077;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RWHDQXUEVMMABX-UHFFFAOYSA-N
131763233;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FZVSVPNSNPCVJK-UHFFFAOYSA-N
131760827;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTNGQUGKMONWEF-UHFFFAOYSA-N
131762762;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;RUSCMJMSQIOWQE-UHFFFAOYSA-N
131764573;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VBNCHMHZHLSEKN-UHFFFAOYSA-N
131762616;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FRJVUQNOKPPWFF-UHFFFAOYSA-N
131761919;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XPPOOLOXNKODLX-UHFFFAOYSA-N
9545669;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATYQADYSFQGJBV-UHFFFAOYSA-N
131755082;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RGTDFTBQSPVDLT-UHFFFAOYSA-N
131765774;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HKIUNKJCPJLXAN-UHFFFAOYSA-N
131763360;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CDFSSVIAZNGTBZ-UHFFFAOYSA-N
131764402;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VNYZFOSXECUIIP-UHFFFAOYSA-N
131758236;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZYOAWXKTIAAOD-UHFFFAOYSA-N
131763984;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XOYMYYRTVUGSGP-UHFFFAOYSA-N
131760840;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SNIRWKWYRGYYKI-UHFFFAOYSA-N
131755245;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UDLIAKHQDWRPKP-UHFFFAOYSA-N
131758376;LPAR3;6;3.236e-71;0.5745;10.8612;126.102;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DXLAYYUDUQMJEA-UHFFFAOYSA-N
131753405;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LJKKMUUFGNOAAL-UHFFFAOYSA-N
131758724;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RDIKTUSAPKAQOH-UHFFFAOYSA-N
131759535;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LXYLTKFBCPXRRN-UHFFFAOYSA-N
131762013;LPAR3;6;5.66e-57;0.5;8.6709;100.5316;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZGUFPHBIMQTUKT-UHFFFAOYSA-N
131764959;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RHYBXYWAECNXSA-UHFFFAOYSA-N
131764559;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VCEGRHVWRBJANM-UHFFFAOYSA-N
131761002;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;URZQPRIHMQKXHC-UHFFFAOYSA-N
131760125;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;NZLWAKCEBADZQI-UHFFFAOYSA-N
131757910;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MASGOWIBHUPTSI-UHFFFAOYSA-N
9545582;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PMEABGYOVGWCSQ-UHFFFAOYSA-N
131760800;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CZCNBEOJWUHLJB-UHFFFAOYSA-N
131764472;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BNQJQBHYOORHQK-UHFFFAOYSA-N
131760170;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NVTGKNBTUCFOOC-UHFFFAOYSA-N
131750380;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZZUYNPSYAPCHJT-UHFFFAOYSA-N
131757864;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SWJAOFQRGQDADV-UHFFFAOYSA-N
131763267;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QNNMKCWGRUYNED-UHFFFAOYSA-N
131765169;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZENQZFFVOIAMBA-UHFFFAOYSA-N
131755822;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IPHODDSCNVBUSO-UHFFFAOYSA-N
131759684;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GKWLUOVARMAZKA-UHFFFAOYSA-N
131756576;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;APPYUQSCODMKIN-UHFFFAOYSA-N
131755299;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;UOOXHVUYFGFXKJ-UHFFFAOYSA-N
131763353;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GQFRMDOUNSKSDC-UHFFFAOYSA-N
131762770;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;NFYLWGALGFJXKV-UHFFFAOYSA-N
131756027;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LRLJXQHYZIWUEY-UHFFFAOYSA-N
131763964;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PHFDIFRFKJJMBV-UHFFFAOYSA-N
131765312;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LQIVLMSRFUNROM-UHFFFAOYSA-N
131760426;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;TUXUSRKEZCBDLD-UHFFFAOYSA-N
131764929;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OIZPCGDUHJZSMK-UHFFFAOYSA-N
131766111;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DSEZAKGJLUPKSF-UHFFFAOYSA-N
131764186;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WFZKPKXMTUTJCU-UHFFFAOYSA-N
131757115;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JUJSCXCFHLKMAG-UHFFFAOYSA-N
131756183;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;CGTDWZHIXKXGNM-UHFFFAOYSA-N
131765604;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UJIIPOJJWNIRHW-UHFFFAOYSA-N
131760112;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MNFJIZPZFDFSHT-UHFFFAOYSA-N
131761803;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;KHTCDNIANMRTHD-UHFFFAOYSA-N
131764424;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PPBRPZLEEGPJRP-UHFFFAOYSA-N
131762379;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SZJQKGFMCYFPGP-UHFFFAOYSA-N
131756262;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PAKBTZYUUDHYDL-UHFFFAOYSA-N
131764339;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KDRWOUSNZBDXFR-UHFFFAOYSA-N
131763751;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYDZOUJCPUDLC-UHFFFAOYSA-N
131756228;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HCLNENGBRCSTJE-UHFFFAOYSA-N
131760756;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PVXKEKCIFSZOTE-UHFFFAOYSA-N
131756716;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;QYDFSMCMLCRFHQ-UHFFFAOYSA-N
131755994;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IEMDRUBCZRDUKX-UHFFFAOYSA-N
131764408;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OPWCVQYBFRNZGW-UHFFFAOYSA-N
131760694;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AKPFCWNOANKGPU-UHFFFAOYSA-N
131764681;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GSUWRMPMDCWVTH-UHFFFAOYSA-N
131763311;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WMCZIAXAQXLFKB-UHFFFAOYSA-N
56940228;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PPOURTVWTVHRMU-UHFFFAOYSA-N
131764668;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WDEZMXSFPUWTDB-UHFFFAOYSA-N
131757070;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JRUAJAMOWZTEMR-UHFFFAOYSA-N
131755083;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YDUCJNVMKCLMRK-UHFFFAOYSA-N
131761474;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CJXBOQIATYJBPZ-UHFFFAOYSA-N
131756882;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BFPUBWJKTOCMTE-UHFFFAOYSA-N
131761672;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;XHEAJMDJLPMZEK-UHFFFAOYSA-N
131762306;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UFGDTAVYJRCYSY-UHFFFAOYSA-N
131763568;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TWIVSQOXNBXDFW-UHFFFAOYSA-N
131756234;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FSLGMQVJEHZUPJ-UHFFFAOYSA-N
131761014;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PMTUBLSDRVNMGS-UHFFFAOYSA-N
131757476;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;OHGHFOMCCWAMGO-UHFFFAOYSA-N
131761567;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JVXVUTIOKONCJQ-UHFFFAOYSA-N
131765542;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FTPIEUFVUCYXLP-UHFFFAOYSA-N
131762405;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ITLCIQWCSXSTJO-UHFFFAOYSA-N
131760326;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWOXYLRRGFBQMC-UHFFFAOYSA-N
131761879;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KIJAVMZBMCLIEW-UHFFFAOYSA-N
131761781;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ULRKYPIVIHSCGJ-UHFFFAOYSA-N
131762430;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SAWHJLXGHUDEDK-UHFFFAOYSA-N
131762526;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GAGJGQSTFRQNAT-UHFFFAOYSA-N
131758416;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NVDYXXAEDSIYNY-UHFFFAOYSA-N
131760693;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NTSBPGZUJBXBSL-UHFFFAOYSA-N
131759679;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ADSZQKQPUVZHRL-UHFFFAOYSA-N
131766362;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;QUHURZUDLDDFJM-UHFFFAOYSA-N
131762379;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SZJQKGFMCYFPGP-UHFFFAOYSA-N
131765021;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UJZZUTNWRYJMTF-UHFFFAOYSA-N
131760111;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FWPCKKOAEAIPKJ-UHFFFAOYSA-N
131762558;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DUYBKOXPEWXVRC-UHFFFAOYSA-N
56940238;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NZPQLKPAJMTADW-UHFFFAOYSA-N
131761638;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;QCRGSRJHSCHLOD-UHFFFAOYSA-N
131756363;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XJEUXSCURWSZSQ-UHFFFAOYSA-N
9545351;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LYUOZIPQCKXNPX-UHFFFAOYSA-N
131756716;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;QYDFSMCMLCRFHQ-UHFFFAOYSA-N
131756898;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DTHQVLKUDRJNSH-UHFFFAOYSA-N
131766203;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LGGGUGHTVQPVHX-UHFFFAOYSA-N
131760749;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QTXQZWXXJFNSGW-UHFFFAOYSA-N
131757865;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;ISJUEJIQJNPESE-UHFFFAOYSA-N
131755521;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DFOPDYSQCRFMDS-UHFFFAOYSA-N
131765542;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FTPIEUFVUCYXLP-UHFFFAOYSA-N
131764055;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VLYQASCCDNGEQJ-UHFFFAOYSA-N
131764420;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SINMBGNDNFVNCB-UHFFFAOYSA-N
131764108;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HWOAMJMEVLUICF-UHFFFAOYSA-N
131762411;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VDRHQUDGPLPDPR-UHFFFAOYSA-N
131756202;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YJELIPRHDFZGTI-UHFFFAOYSA-N
131755816;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WRPAVJZVCFOMOP-UHFFFAOYSA-N
131762617;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DKFCABSRSLZDFF-UHFFFAOYSA-N
131763311;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WMCZIAXAQXLFKB-UHFFFAOYSA-N
131756922;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UCBIXYZFPRNBNY-UHFFFAOYSA-N
131764637;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PYEBEEUWKLPYJF-UHFFFAOYSA-N
131761912;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QJHAAKMJLURPNY-UHFFFAOYSA-N
131761789;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SXPQPXRSBLSSAC-UHFFFAOYSA-N
131762763;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;WPTDLSWTVUJAOX-UHFFFAOYSA-N
56940375;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;CVLWWEVOWKHNNO-UHFFFAOYSA-N
131757476;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;OHGHFOMCCWAMGO-UHFFFAOYSA-N
131760265;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYIPWEDEDCENLJ-UHFFFAOYSA-N
131766420;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HPSNFWYKNKZZRH-UHFFFAOYSA-N
131765055;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YHQURYLTBPXJMG-UHFFFAOYSA-N
131763153;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CBQQNGMIEQUSNE-UHFFFAOYSA-N
131760297;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OYFSLUROHDMBJJ-UHFFFAOYSA-N
131761906;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CFDDNXGICWHOFE-UHFFFAOYSA-N
131760292;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FSUMMHYNEFRCKJ-UHFFFAOYSA-N
131757083;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MVZVFFWLMVHSMR-UHFFFAOYSA-N
131761255;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;KPJGNTJVQXQHJJ-UHFFFAOYSA-N
131760313;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UDICYIUJKLODAB-UHFFFAOYSA-N
131761461;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IRUNKUKWFHXBGR-UHFFFAOYSA-N
131761483;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SNJFTPQXHGPDEX-UHFFFAOYSA-N
131763668;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;STQPITNFYWWCFX-UHFFFAOYSA-N
131756440;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QWLKJDKJCFMSGB-UHFFFAOYSA-N
131758236;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZYOAWXKTIAAOD-UHFFFAOYSA-N
131760828;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATCRUZMUPRXROY-UHFFFAOYSA-N
131761294;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OZIVOOHFGACURK-UHFFFAOYSA-N
131764669;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XLTFKKGEFQUZDB-UHFFFAOYSA-N
131764691;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XATFYFLKYAULHM-UHFFFAOYSA-N
131761777;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;UYCTVQQBNMEKIQ-UHFFFAOYSA-N
131763580;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;JIILIEPJZCAPPZ-UHFFFAOYSA-N
56940387;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PQMAOFUFIMHGKV-UHFFFAOYSA-N
131755306;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QEVBZWCDAZFBQV-UHFFFAOYSA-N
131757269;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LOUYJPLUAGKBFG-UHFFFAOYSA-N
131764356;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;UZIKBSYQATZXML-UHFFFAOYSA-N
131760749;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QTXQZWXXJFNSGW-UHFFFAOYSA-N
131757268;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CYEYMUIZHDCNEQ-UHFFFAOYSA-N
131765301;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LVEHFFLNEWVVQL-UHFFFAOYSA-N
131756253;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DHFHFDYQWHOMJO-UHFFFAOYSA-N
131761270;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SPCLMIMPBVSZFZ-UHFFFAOYSA-N
131757023;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MOPJMQJQXVNKMM-UHFFFAOYSA-N
131750418;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GGNMBNAJWKYLBB-UHFFFAOYSA-N
131760258;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WMGBXZPFBDGEGE-UHFFFAOYSA-N
131755613;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XNRMSBDDILQLRG-UHFFFAOYSA-N
131764401;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMKPIBYZJMFWDC-UHFFFAOYSA-N
131765480;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RQCPUHOLUCPXJR-UHFFFAOYSA-N
131764109;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BLUODYRHIPCAQS-UHFFFAOYSA-N
131753640;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SFMSLZCWXHIABM-UHFFFAOYSA-N
131757437;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;YFHMHPUWCPHBQO-UHFFFAOYSA-N
131756941;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;COPQYDANMKTRTJ-UHFFFAOYSA-N
131764529;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;OBIZTMOHZKQECQ-UHFFFAOYSA-N
131766073;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NQBFZMRNBOGVBN-UHFFFAOYSA-N
56940413;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YKVDFZOAUOIXCA-UHFFFAOYSA-N
131758059;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;NWCKRGICIKHKFU-UHFFFAOYSA-N
131761335;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QRQHIENJPWVWCM-UHFFFAOYSA-N
131761156;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SAVXWGBSAALXPY-UHFFFAOYSA-N
131757726;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZDIIFMFAQBMYEV-UHFFFAOYSA-N
131756052;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WFKRBGOCZSKULO-UHFFFAOYSA-N
131765909;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MLBXOOYHYHHLQI-UHFFFAOYSA-N
131758403;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AHYOFQHJCROZHS-UHFFFAOYSA-N
131760720;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YCULQDJFVHNAEQ-UHFFFAOYSA-N
131756875;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;AXLMYDXBLLUOLF-UHFFFAOYSA-N
131764338;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NUEYLMZDBXYDET-UHFFFAOYSA-N
131763082;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HMRLAHOLCLZNNW-UHFFFAOYSA-N
131759527;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;BOXFXXYECNCIFC-UHFFFAOYSA-N
131756759;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JCKZVXSFNAILPO-UHFFFAOYSA-N
131760738;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RYSFVHSTLPOBIB-UHFFFAOYSA-N
131760251;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDJRCOJFDNTSGV-UHFFFAOYSA-N
131760152;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IBRKGGWUQIZSKI-UHFFFAOYSA-N
131760996;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MIAFRKAYTHDWRE-UHFFFAOYSA-N
131761972;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QARMSZHUPFDIOQ-UHFFFAOYSA-N
131755108;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SPLSVCLRKCVCTG-UHFFFAOYSA-N
131760189;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVZCIRATOLVRIA-UHFFFAOYSA-N
131757055;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XIQRFKNFMFEAKD-UHFFFAOYSA-N
131759547;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PKTUULQXDIEYDT-UHFFFAOYSA-N
131756196;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXSFIMVOIADAFE-UHFFFAOYSA-N
131755280;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZNKMPMMJCRJCG-UHFFFAOYSA-N
131762137;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;YXNSTAIJZPYOPN-UHFFFAOYSA-N
131760006;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RVALMDYIOYYMPN-UHFFFAOYSA-N
131764136;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NJJRJRJTWCCNNE-UHFFFAOYSA-N
131757543;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RNCIUDLIXBXAFK-UHFFFAOYSA-N
131762396;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PKRMTWZVLNHVCA-UHFFFAOYSA-N
131764047;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LZZJAKQUDMTSMD-UHFFFAOYSA-N
131759846;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AEDDMHLQFFOWDJ-UHFFFAOYSA-N
131757165;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JASRGXRLHMKFMV-UHFFFAOYSA-N
131761896;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CANUGJFNUXQJNT-UHFFFAOYSA-N
131762138;LPAR3;6;1.054e-52;0.4643;8.0142;92.8655;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NNNMVNSALGUZNQ-UHFFFAOYSA-N
131761846;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LKEFQOSBUFGTFE-UHFFFAOYSA-N
131763164;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WDLBTJHWGYBSCW-UHFFFAOYSA-N
131764401;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMKPIBYZJMFWDC-UHFFFAOYSA-N
131755492;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FHLCKJOBUHAURH-UHFFFAOYSA-N
131763172;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PULVRMWMRNJUAS-UHFFFAOYSA-N
131765230;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BVJYLMXQFAHMGO-UHFFFAOYSA-N
131758426;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YHXPJGXXXHDEDU-UHFFFAOYSA-N
131760715;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VACJTARUJZHQTP-UHFFFAOYSA-N
131758074;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LSSCZEINTKPCRU-UHFFFAOYSA-N
131764632;LPAR3;6;5.564000000000001e-78;0.5192;11.9014;138.2466;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWJJJBNSUPZYSM-UHFFFAOYSA-N
131757732;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QULNTIICGQLJOS-UHFFFAOYSA-N
131761401;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NUTGEMDNMRDLIN-UHFFFAOYSA-N
131765486;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OVIVEYNLEWNFJB-UHFFFAOYSA-N
131761549;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DYELJOCDTBVSIU-UHFFFAOYSA-N
131761352;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CZCGMLNCRPSJDT-UHFFFAOYSA-N
131761395;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSJPFKLHZHQUSD-UHFFFAOYSA-N
131763326;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZUFGRRVTVKEBJI-UHFFFAOYSA-N
131758059;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;NWCKRGICIKHKFU-UHFFFAOYSA-N
9545523;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IKHPWHNVYZLELL-UHFFFAOYSA-N
131762132;LPAR3;6;7.43e-62;0.4906;9.4216;109.296;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AXXALZKBFIPMAS-UHFFFAOYSA-N
131760272;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XBGZGJVIPABSJH-UHFFFAOYSA-N
131760827;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTNGQUGKMONWEF-UHFFFAOYSA-N
131757707;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NMHPZWRTPAPYOL-UHFFFAOYSA-N
131762874;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WVWWFHQLYDZJNM-UHFFFAOYSA-N
131760158;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DDZGDBPXBWPREM-UHFFFAOYSA-N
131766256;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FZXHRPROYXAPTJ-UHFFFAOYSA-N
131763967;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CDUVBPWCCZLKBZ-UHFFFAOYSA-N
131763139;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WUPOLOVISVVRIA-UHFFFAOYSA-N
131762599;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BPRIEDPMPZRCDU-UHFFFAOYSA-N
131761236;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;VXEUWHHXKKJFHJ-UHFFFAOYSA-N
131762850;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DVVXILVDNWEYLR-UHFFFAOYSA-N
131765153;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZGVRHASAEPOUMI-UHFFFAOYSA-N
131755108;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SPLSVCLRKCVCTG-UHFFFAOYSA-N
131760713;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XNFUACYEWNBQLH-UHFFFAOYSA-N
131756738;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HLJUWCMJURHSAS-UHFFFAOYSA-N
131760280;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXMYNXNZICUHSI-UHFFFAOYSA-N
131761354;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CQPAGPNRJFQHMN-UHFFFAOYSA-N
131763312;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VTKNVVRESNLLGP-UHFFFAOYSA-N
131761803;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;KHTCDNIANMRTHD-UHFFFAOYSA-N
131764966;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YQSGKRMNUSQKEC-UHFFFAOYSA-N
9545677;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QGLJFPIPRSJLBD-UHFFFAOYSA-N
131764331;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QNCBCQOFCIRMDR-UHFFFAOYSA-N
131756390;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FUFCCGBYLOBWHP-UHFFFAOYSA-N
131763082;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HMRLAHOLCLZNNW-UHFFFAOYSA-N
131764055;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VLYQASCCDNGEQJ-UHFFFAOYSA-N
131761790;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PFLHGEYNZZRPBP-UHFFFAOYSA-N
131762617;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DKFCABSRSLZDFF-UHFFFAOYSA-N
131761247;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KYMZBLBKJMZRJX-UHFFFAOYSA-N
131763140;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKRSQYQLQNSHTO-UHFFFAOYSA-N
131754022;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MFBJAFVRSRFNBT-UHFFFAOYSA-N
131761930;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XJKUBRHQRPUPNX-UHFFFAOYSA-N
131756434;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SXAAWCNXDWGCLB-UHFFFAOYSA-N
131760320;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIUYJEVBYIQITA-UHFFFAOYSA-N
131762296;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;BICJWANPZUYADQ-UHFFFAOYSA-N
131763956;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;GPDKESGJHAJPPZ-UHFFFAOYSA-N
131761805;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FNVXDAXZGGBYJV-UHFFFAOYSA-N
131763687;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UYULDZRZDPVLFT-UHFFFAOYSA-N
56940371;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;LAYMMGQEJTZXHH-UHFFFAOYSA-N
131759781;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MXQGPSRZEDBAOD-UHFFFAOYSA-N
131760877;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQGJZWLEVUCIQR-UHFFFAOYSA-N
131763567;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UEFBXDIEVPQCTF-UHFFFAOYSA-N
131758235;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KZYYSJQGDAJSBI-UHFFFAOYSA-N
131756000;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RPRUIZWBGFJFML-UHFFFAOYSA-N
131764632;FABP3;7;9.821999999999999e-53;0.5;1.7361;92.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HWJJJBNSUPZYSM-UHFFFAOYSA-N
131763558;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MLHPCHDXLJOHRM-UHFFFAOYSA-N
131766165;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XLLNNVMYNIGFGO-UHFFFAOYSA-N
131763353;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GQFRMDOUNSKSDC-UHFFFAOYSA-N
131759528;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CHXNIWLFFFQXQY-UHFFFAOYSA-N
131756855;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MYYKNWKDBLPJRV-UHFFFAOYSA-N
131765450;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MKKNEWLMPQPSGJ-UHFFFAOYSA-N
131761549;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DYELJOCDTBVSIU-UHFFFAOYSA-N
131762326;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RMAOBGGCPVHDLB-UHFFFAOYSA-N
131762659;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NNBFKLFMPMDQEJ-UHFFFAOYSA-N
131756407;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DWQZBCMNGWIPJK-UHFFFAOYSA-N
131757108;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WIMOTPNOOSOQHS-UHFFFAOYSA-N
131756440;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QWLKJDKJCFMSGB-UHFFFAOYSA-N
131761381;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDVIBBNZDQDULN-UHFFFAOYSA-N
131760319;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IAFMACZCBGOYAR-UHFFFAOYSA-N
131764142;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKKZTOWNYBYTMN-UHFFFAOYSA-N
131763173;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;IMMYAYNDFJZVBZ-UHFFFAOYSA-N
131761395;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;RSJPFKLHZHQUSD-UHFFFAOYSA-N
131757023;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MOPJMQJQXVNKMM-UHFFFAOYSA-N
131756408;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BRPUMZUOUUAVGA-UHFFFAOYSA-N
131756569;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NZBRMZMLPIKHLK-UHFFFAOYSA-N
131764451;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;BEAIEHHBBTZBNH-UHFFFAOYSA-N
131755492;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FHLCKJOBUHAURH-UHFFFAOYSA-N
131764108;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HWOAMJMEVLUICF-UHFFFAOYSA-N
131761278;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DMRCFTQNQMIGTD-UHFFFAOYSA-N
131762874;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;WVWWFHQLYDZJNM-UHFFFAOYSA-N
131756732;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MRZUKESUWGFNGN-UHFFFAOYSA-N
131760725;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;XODZXKPANKDXHP-UHFFFAOYSA-N
131761598;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OHDFRISQFVTZCL-UHFFFAOYSA-N
131761913;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWUSALQTKNQHQD-UHFFFAOYSA-N
131760151;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXNYWQGAKRABHA-UHFFFAOYSA-N
131764415;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WOEWLVSANLVPBT-UHFFFAOYSA-N
131764777;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;PVIAPLQIFDZWHV-UHFFFAOYSA-N
131761455;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BNRUJXMUWHJABI-UHFFFAOYSA-N
131765719;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DSKCDSMBKQZQNR-UHFFFAOYSA-N
131755493;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LZMYQBXIIPFGAL-UHFFFAOYSA-N
131757393;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UNUYEOWBNOUCHI-UHFFFAOYSA-N
131755281;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ANGPTMIQAOFQBH-UHFFFAOYSA-N
131755485;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YZYLLQDFUYUJGF-UHFFFAOYSA-N
131765492;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WZUOZWXCEUQTRE-UHFFFAOYSA-N
131753404;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZBAKDZKUJDNKLJ-UHFFFAOYSA-N
9545386;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JNDBWTLJGLLSAK-UHFFFAOYSA-N
131760748;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MIQNEBSSVNEWHY-UHFFFAOYSA-N
131756303;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYQSHOWOAIDEJS-UHFFFAOYSA-N
56940373;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PNWARPKMZYMSHQ-UHFFFAOYSA-N
131762306;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;UFGDTAVYJRCYSY-UHFFFAOYSA-N
131755594;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FYMHLHDVPWTCCO-UHFFFAOYSA-N
131756370;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VGDHPALBZNZOAN-UHFFFAOYSA-N
131764040;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YOEYZADNHRXJJT-UHFFFAOYSA-N
131756070;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NXVPBQKOQAHIQZ-UHFFFAOYSA-N
131764682;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FFAOLBOCMJSXFL-UHFFFAOYSA-N
131761694;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UHDCEJARBRUIDB-UHFFFAOYSA-N
131763351;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZNOAWGZVSGWABO-UHFFFAOYSA-N
131765420;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LTJUTLQBAKGEKJ-UHFFFAOYSA-N
131761781;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;ULRKYPIVIHSCGJ-UHFFFAOYSA-N
131756322;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NIUHSZFZGDYMCJ-UHFFFAOYSA-N
131756202;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YJELIPRHDFZGTI-UHFFFAOYSA-N
131765175;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KUKXRUGYPUGLNB-UHFFFAOYSA-N
131764677;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KOHORHCCLQOXCS-UHFFFAOYSA-N
131760258;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WMGBXZPFBDGEGE-UHFFFAOYSA-N
131764772;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YFGCWKHYYCNTFA-UHFFFAOYSA-N
131759988;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GPRNIHMMZUKOCG-UHFFFAOYSA-N
131760178;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;OGZYWHBWXAJJRP-UHFFFAOYSA-N
131756046;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;VRRPYVKHLUMVJX-UHFFFAOYSA-N
131757548;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOFFTNBYEWWFON-UHFFFAOYSA-N
131760260;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;QREKKIRJSWBZTL-UHFFFAOYSA-N
131756282;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WDAMDABFGGIOBB-UHFFFAOYSA-N
131756363;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XJEUXSCURWSZSQ-UHFFFAOYSA-N
131753411;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SYMRDJKPDMMRLM-UHFFFAOYSA-N
131760169;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CFGOOLOMBIOEGG-UHFFFAOYSA-N
131755109;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NWYRSEXEDYEEFM-UHFFFAOYSA-N
131764149;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MHNHYVCCWTUPKM-UHFFFAOYSA-N
131756078;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;JLGWZFFBMBENJB-UHFFFAOYSA-N
131762380;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CUSUSJFFOGKHBB-UHFFFAOYSA-N
131757728;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OWJXGNJNFGGSAF-UHFFFAOYSA-N
131757132;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFBNXRASQCUYMI-UHFFFAOYSA-N
131761964;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GAOSCGSBKHEEEX-UHFFFAOYSA-N
131758496;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HTYGMBXFTNEZHO-UHFFFAOYSA-N
131762771;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKTQVQIRLRPGDR-UHFFFAOYSA-N
131756150;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKQWVJHGQMXCFY-UHFFFAOYSA-N
131756931;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DEGARZFHWKYSKY-UHFFFAOYSA-N
131756415;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XOMMIQREYDPKRF-UHFFFAOYSA-N
131763688;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QSKROXVIZWMLAM-UHFFFAOYSA-N
131763957;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LEDZXTFKKPRATN-UHFFFAOYSA-N
131762380;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CUSUSJFFOGKHBB-UHFFFAOYSA-N
131764472;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BNQJQBHYOORHQK-UHFFFAOYSA-N
131760272;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XBGZGJVIPABSJH-UHFFFAOYSA-N
131761285;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HTHXCXIQIAMNEI-UHFFFAOYSA-N
131766111;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DSEZAKGJLUPKSF-UHFFFAOYSA-N
131759831;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MVZLNTWQSMVSCH-UHFFFAOYSA-N
131765962;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;NSAPJHVXFFFJJZ-UHFFFAOYSA-N
131756954;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AYHWSRWXZGTAJR-UHFFFAOYSA-N
131764638;FABP3;7;2.703e-52;0.4681;1.7214;92.1313;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFUPLKNUYGXDCB-UHFFFAOYSA-N
131756255;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;QEBZICHWOFBWMS-UHFFFAOYSA-N
131765020;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MLKZMSXRVHKPIC-UHFFFAOYSA-N
131762055;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ULRVJSBXYDGFRT-UHFFFAOYSA-N
131762181;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YHKXBBUZMDPXSA-UHFFFAOYSA-N
131761531;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QRHBKDZWDQJGCP-UHFFFAOYSA-N
131761593;LPAR3;6;5.564000000000001e-78;0.5192;11.9014;138.2466;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WDXAQMAKFLAOHN-UHFFFAOYSA-N
131763661;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GHFWFQHLLHELBA-UHFFFAOYSA-N
131762319;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UHCRYPFJSBIIRR-UHFFFAOYSA-N
131757423;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZGKZBSSBZQXPKF-UHFFFAOYSA-N
131762605;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JIJSROMUTDPOMJ-UHFFFAOYSA-N
131759670;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FMHGBFIQGMDKBC-UHFFFAOYSA-N
131762599;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BPRIEDPMPZRCDU-UHFFFAOYSA-N
131761229;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AZCFJOQBPCTUJB-UHFFFAOYSA-N
131761795;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SSPNCRHVPPGOSG-UHFFFAOYSA-N
131761484;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GTMNASXROGIQBF-UHFFFAOYSA-N
131756778;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DIKJEMPGNQDBCI-UHFFFAOYSA-N
131759628;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KMLLHGHUQWACBE-UHFFFAOYSA-N
131764122;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MGEAOKJODZKTKX-UHFFFAOYSA-N
131755995;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;DWIFUTKZBKIVIO-UHFFFAOYSA-N
131760340;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FHRLUJKJKYLPIE-UHFFFAOYSA-N
131764742;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MDNOGAANWQBLFP-UHFFFAOYSA-N
131761924;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NTEFIKMFLCQZKQ-UHFFFAOYSA-N
131761002;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;URZQPRIHMQKXHC-UHFFFAOYSA-N
131762622;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OCZVBYXRRPOZFY-UHFFFAOYSA-N
131765243;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JYHMTHDHJBNVQX-UHFFFAOYSA-N
131760575;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FIEHEEYBLZIFLG-UHFFFAOYSA-N
131761964;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GAOSCGSBKHEEEX-UHFFFAOYSA-N
131761248;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WPTIBZNSPMSWML-UHFFFAOYSA-N
9545523;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IKHPWHNVYZLELL-UHFFFAOYSA-N
131757203;FABP3;7;7.536000000000001e-49;0.4255;1.6062;85.9458;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;DPGIVBQTWYXEKO-UHFFFAOYSA-N
131762274;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KGIVQHRXQYBBBF-UHFFFAOYSA-N
131755485;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YZYLLQDFUYUJGF-UHFFFAOYSA-N
131762645;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XZWHNXBAQKSDHH-UHFFFAOYSA-N
131765426;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KKPFEVCEWGVILK-UHFFFAOYSA-N
131766195;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OYGFWCBFWGFRGF-UHFFFAOYSA-N
131764413;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKJYIRPZZWLYSB-UHFFFAOYSA-N
131763778;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HMWYLDUUJNYCNU-UHFFFAOYSA-N
131757069;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QOVOXGFLQUWOCD-UHFFFAOYSA-N
131759369;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FNBKULXEHXAYLR-UHFFFAOYSA-N
131757048;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IGGJZLJGRRYFIM-UHFFFAOYSA-N
131764853;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IWAAHSCTDZFCMG-UHFFFAOYSA-N
131756020;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MCTXTKYETLGMSB-UHFFFAOYSA-N
131763159;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UOQDSEPRWVVBKV-UHFFFAOYSA-N
131761257;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NAZBWUYFIUKAKG-UHFFFAOYSA-N
9545778;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SCZUAPBFQIKQCZ-UHFFFAOYSA-N
131762442;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WFNPIEVTDGQDNF-UHFFFAOYSA-N
131762509;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FSGZYGYLCKMUKP-UHFFFAOYSA-N
131762442;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WFNPIEVTDGQDNF-UHFFFAOYSA-N
131757122;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HBEVIJGDUHOPDQ-UHFFFAOYSA-N
131757132;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFBNXRASQCUYMI-UHFFFAOYSA-N
131764155;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MOTVJOAHEUKKRZ-UHFFFAOYSA-N
131756407;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DWQZBCMNGWIPJK-UHFFFAOYSA-N
131765085;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NFXBUAHCKPMYSD-UHFFFAOYSA-N
131765910;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PWMCWAZYXBHOKR-UHFFFAOYSA-N
131757483;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;COTBIHOOVUEBLQ-UHFFFAOYSA-N
131760847;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YMGSOCWJHLMLQM-UHFFFAOYSA-N
131760245;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OQVOEILLAWEJJU-UHFFFAOYSA-N
131757055;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XIQRFKNFMFEAKD-UHFFFAOYSA-N
131760244;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFAOTZPCSYQOED-UHFFFAOYSA-N
131756991;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFCDSMPUWNZUFI-UHFFFAOYSA-N
131761493;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CHPUIFFVSPQGIH-UHFFFAOYSA-N
131761337;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KNVXBCMILXVLTA-UHFFFAOYSA-N
131757871;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;AOEMOZQBRAJCGN-UHFFFAOYSA-N
9545449;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FRWFMVSCXNKUPX-UHFFFAOYSA-N
131756275;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JLSNFGORYGPKQA-UHFFFAOYSA-N
131756854;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LUAVDZZOBREHQN-UHFFFAOYSA-N
131762121;LPAR3;6;9.708e-50;0.4727;7.5584;87.5437;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OTLKOLCCRBJOBU-UHFFFAOYSA-N
131760720;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YCULQDJFVHNAEQ-UHFFFAOYSA-N
131760820;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NHNBHJTVRJQCPP-UHFFFAOYSA-N
131757165;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JASRGXRLHMKFMV-UHFFFAOYSA-N
131763972;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AAARRLVSWMMLIL-UHFFFAOYSA-N
131760251;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDJRCOJFDNTSGV-UHFFFAOYSA-N
131757416;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NBAGACYNMBHBAX-UHFFFAOYSA-N
131755848;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PFQZTTBUBNIVPK-UHFFFAOYSA-N
131759677;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QETBIRGBJSNBME-UHFFFAOYSA-N
131757203;LPAR3;6;8.244999999999999e-53;0.4545;8.0306;93.057;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;DPGIVBQTWYXEKO-UHFFFAOYSA-N
131762312;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;SWRZTLLFJSEQMV-UHFFFAOYSA-N
131756183;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;CGTDWZHIXKXGNM-UHFFFAOYSA-N
131761526;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FJSDZEUICFMRSA-UHFFFAOYSA-N
131763700;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;UBRMSPGQEBRUJH-UHFFFAOYSA-N
131764958;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TXHGTEXFFQXVMR-UHFFFAOYSA-N
131757197;LPAR3;6;5.564000000000001e-78;0.5192;11.9014;138.2466;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;XTVWCEQQMYEOJZ-UHFFFAOYSA-N
131761788;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DBOXIHBAINITHH-UHFFFAOYSA-N
131757576;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MPNBJXUQYBYLAM-UHFFFAOYSA-N
131763147;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SRVIIJLKVZLBAK-UHFFFAOYSA-N
131763381;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BALVTBGXOJRZCI-UHFFFAOYSA-N
131755299;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;UOOXHVUYFGFXKJ-UHFFFAOYSA-N
131761906;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CFDDNXGICWHOFE-UHFFFAOYSA-N
131765718;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UVKBBNGIOHOUEE-UHFFFAOYSA-N
131756150;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKQWVJHGQMXCFY-UHFFFAOYSA-N
131762771;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKTQVQIRLRPGDR-UHFFFAOYSA-N
131765604;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UJIIPOJJWNIRHW-UHFFFAOYSA-N
131766394;FABP3;7;7.302e-49;0.4667;1.6067;85.9704;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEARNUYKYUAPTL-UHFFFAOYSA-N
131757774;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LNEGIXKHOVJBCA-UHFFFAOYSA-N
9545533;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;KNVSDJVHRPAOCP-UHFFFAOYSA-N
131759364;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WBUNYBCPBJAPRX-UHFFFAOYSA-N
131755403;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LEYNPNMAFNJINO-UHFFFAOYSA-N
131757097;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OSJAITDJSAAPCD-UHFFFAOYSA-N
131760139;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IGHPWMZALJOYAV-UHFFFAOYSA-N
131765910;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PWMCWAZYXBHOKR-UHFFFAOYSA-N
131758052;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MPULJGAMFCKYGH-UHFFFAOYSA-N
131757054;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZBIXPXAIQGNOJR-UHFFFAOYSA-N
131761662;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LHTAXCCUUDIJJC-UHFFFAOYSA-N
131764155;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MOTVJOAHEUKKRZ-UHFFFAOYSA-N
131764916;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OUDIBODAEFRRMK-UHFFFAOYSA-N
131761389;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PCDJUEAPQQHKQV-UHFFFAOYSA-N
131756732;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MRZUKESUWGFNGN-UHFFFAOYSA-N
131759677;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QETBIRGBJSNBME-UHFFFAOYSA-N
131763972;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AAARRLVSWMMLIL-UHFFFAOYSA-N
131762202;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VFWNWLUEZNPXHB-UHFFFAOYSA-N
131761678;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UAJDOZFIHLGIOJ-UHFFFAOYSA-N
131764864;FABP3;7;3.99e-49;0.45;1.6154;86.4416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DIBYWIYZKDKTEL-UHFFFAOYSA-N
131759376;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZNLDPPZYMIYAKR-UHFFFAOYSA-N
131764045;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PRNZTHLFVCDZAV-UHFFFAOYSA-N
131762121;FABP3;7;8.167e-49;0.4286;1.605;85.8831;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OTLKOLCCRBJOBU-UHFFFAOYSA-N
131762216;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HSOJKQPYAKFWOR-UHFFFAOYSA-N
131761669;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ABQXBTBXGFBZIV-UHFFFAOYSA-N
131757469;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;GKSQQYCZRSBFKG-UHFFFAOYSA-N
131755083;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YDUCJNVMKCLMRK-UHFFFAOYSA-N
131762411;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VDRHQUDGPLPDPR-UHFFFAOYSA-N
131757917;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;CSXWGAYDXHHFDH-UHFFFAOYSA-N
131761482;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HESVTHZAJFHPDB-UHFFFAOYSA-N
131760748;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;MIQNEBSSVNEWHY-UHFFFAOYSA-N
131758282;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JPJMXAFPVUPHGK-UHFFFAOYSA-N
9545627;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;IMKJVBUOLHLZAH-UHFFFAOYSA-N
131762405;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ITLCIQWCSXSTJO-UHFFFAOYSA-N
131760574;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BHETTXDAZXCFKF-UHFFFAOYSA-N
131765094;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ONWVKDMOWWRYKJ-UHFFFAOYSA-N
131760298;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SRARWQZTRDRWIY-UHFFFAOYSA-N
131757443;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;CZMBTAPVPVKAEQ-UHFFFAOYSA-N
131761662;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LHTAXCCUUDIJJC-UHFFFAOYSA-N
131763339;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZYYSWIRPQRDPKM-UHFFFAOYSA-N
131755423;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SCXZWEQDFMQHJA-UHFFFAOYSA-N
131764142;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKKZTOWNYBYTMN-UHFFFAOYSA-N
131762275;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZNAJMOCCTZFALW-UHFFFAOYSA-N
131764916;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OUDIBODAEFRRMK-UHFFFAOYSA-N
131764630;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FLCCFUGFGCCGBK-UHFFFAOYSA-N
131761981;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WOJXCZKSQBKVOE-UHFFFAOYSA-N
131756917;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZYOOKRFWFUJQTP-UHFFFAOYSA-N
131760725;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;XODZXKPANKDXHP-UHFFFAOYSA-N
131764483;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IJCNKBUZXXINLK-UHFFFAOYSA-N
131763576;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OAHFSXGNMDGFOX-UHFFFAOYSA-N
131757864;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SWJAOFQRGQDADV-UHFFFAOYSA-N
131763165;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DYXIHLFAMCSWDP-UHFFFAOYSA-N
131761450;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XFAWUHKFJSCOCU-UHFFFAOYSA-N
131757005;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UJZIJWWJEILDEY-UHFFFAOYSA-N
131753842;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KKWGNAXIJLGZIW-UHFFFAOYSA-N
131764186;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WFZKPKXMTUTJCU-UHFFFAOYSA-N
131761125;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ROEPCWTWFLVVNE-UHFFFAOYSA-N
131764929;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OIZPCGDUHJZSMK-UHFFFAOYSA-N
131758241;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JFSBSLVFROLCLU-UHFFFAOYSA-N
131766324;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UVGDFMKGDHVPHK-UHFFFAOYSA-N
131766195;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OYGFWCBFWGFRGF-UHFFFAOYSA-N
131763258;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ASHDSIZMSUYRGL-UHFFFAOYSA-N
131765449;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XJRZLDVBOKCGHX-UHFFFAOYSA-N
131765015;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LLFPJINNFLWCHE-UHFFFAOYSA-N
131764414;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BDCZEXNOCSGQCL-UHFFFAOYSA-N
131756883;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FKRMVRADOUUIPO-UHFFFAOYSA-N
131757109;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GEHPSFWUFSXURT-UHFFFAOYSA-N
131759528;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CHXNIWLFFFQXQY-UHFFFAOYSA-N
131756877;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;HHWHJJSODCDUKU-UHFFFAOYSA-N
131762103;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CMEILRZMJFZODR-UHFFFAOYSA-N
131758449;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BDAAUVXVYYGPNU-UHFFFAOYSA-N
131760828;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATCRUZMUPRXROY-UHFFFAOYSA-N
131766343;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GDUXUDRMHCHQQG-UHFFFAOYSA-N
131761125;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ROEPCWTWFLVVNE-UHFFFAOYSA-N
131756390;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FUFCCGBYLOBWHP-UHFFFAOYSA-N
131753842;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KKWGNAXIJLGZIW-UHFFFAOYSA-N
131766363;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KFAMHFBUUJEDFQ-UHFFFAOYSA-N
131760260;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;QREKKIRJSWBZTL-UHFFFAOYSA-N
131759363;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HSNAKNZDCUCCNE-UHFFFAOYSA-N
131761526;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FJSDZEUICFMRSA-UHFFFAOYSA-N
9545376;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWQYUQPMOLYBJW-UHFFFAOYSA-N
131756288;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RBJAIGDUPAACLQ-UHFFFAOYSA-N
131756078;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;JLGWZFFBMBENJB-UHFFFAOYSA-N
131755493;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LZMYQBXIIPFGAL-UHFFFAOYSA-N
131764731;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LFLKOLLXMXUPMJ-UHFFFAOYSA-N
131761342;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BMSWKYPCZHQOJH-UHFFFAOYSA-N
9545375;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZABKADJKVACIK-UHFFFAOYSA-N
131761359;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;AILHDVOWAUJGKA-UHFFFAOYSA-N
131761270;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;SPCLMIMPBVSZFZ-UHFFFAOYSA-N
131753411;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SYMRDJKPDMMRLM-UHFFFAOYSA-N
131757470;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BGIMVPIMTCDTIR-UHFFFAOYSA-N
131766073;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NQBFZMRNBOGVBN-UHFFFAOYSA-N
131761871;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FFVISGZUNRMRSS-UHFFFAOYSA-N
131764493;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;TXWFFTTYLKQWRO-UHFFFAOYSA-N
131760378;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HLZUZYCNWDXIET-UHFFFAOYSA-N
131757178;LPAR3;6;6.267e-50;0.5192;7.5876;87.8849;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HLBJXGSSXOWJNK-UHFFFAOYSA-N
131757564;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYRLXLPLLFAUHZ-UHFFFAOYSA-N
131763700;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;UBRMSPGQEBRUJH-UHFFFAOYSA-N
131757098;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NTQFVICUXZMCHT-UHFFFAOYSA-N
131753639;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HVJIYFSRIYNDPL-UHFFFAOYSA-N
131764747;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HRTPJAKAPLEWKW-UHFFFAOYSA-N
131765244;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RVQQPBSTHIVINE-UHFFFAOYSA-N
131761335;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QRQHIENJPWVWCM-UHFFFAOYSA-N
131759692;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KTSYFYGEYMWJBJ-UHFFFAOYSA-N
131762520;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NWUKMNBNRHWGKD-UHFFFAOYSA-N
131760006;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RVALMDYIOYYMPN-UHFFFAOYSA-N
131761261;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YYDMKYRCWRXENW-UHFFFAOYSA-N
131765301;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LVEHFFLNEWVVQL-UHFFFAOYSA-N
131763238;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;TZEDWJDIOLCDJN-UHFFFAOYSA-N
9545450;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HRJKHHJODKNNJK-UHFFFAOYSA-N
131763983;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;JQHWRRJYPOHAKD-UHFFFAOYSA-N
131763165;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DYXIHLFAMCSWDP-UHFFFAOYSA-N
131760781;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ORQMNWAGMCHUBN-UHFFFAOYSA-N
131762755;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FQOOBZWSSFBGRJ-UHFFFAOYSA-N
131763681;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DGYTXSNHLHPLMV-UHFFFAOYSA-N
131759055;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FZZMMDPBSSQSEG-UHFFFAOYSA-N
131762849;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LEISCWOXEYMOAG-UHFFFAOYSA-N
56940413;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YKVDFZOAUOIXCA-UHFFFAOYSA-N
131756188;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VLOCCOVTRWLMEU-UHFFFAOYSA-N
131764930;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QYDUYXRVYKJXAF-UHFFFAOYSA-N
131764494;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AUJUYSXBGAUAGJ-UHFFFAOYSA-N
131761677;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LKMYGIJKNMNLDQ-UHFFFAOYSA-N
131766363;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KFAMHFBUUJEDFQ-UHFFFAOYSA-N
56940406;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;OEKRRUNWWAUSPT-UHFFFAOYSA-N
131758235;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KZYYSJQGDAJSBI-UHFFFAOYSA-N
9545459;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VGUNDIMKOJFCKY-UHFFFAOYSA-N
131759548;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MYSDZTIORDWFIW-UHFFFAOYSA-N
131762977;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NAYLGIBYZIJGJI-UHFFFAOYSA-N
131765957;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;FHLRXHATKQNMKA-UHFFFAOYSA-N
131756991;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFCDSMPUWNZUFI-UHFFFAOYSA-N
131757598;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MIDOZDIGHHQOQX-UHFFFAOYSA-N
131763679;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZZNQEKZITOQVEU-UHFFFAOYSA-N
131759389;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KVBRKDKYGMSEEX-UHFFFAOYSA-N
131756733;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;NLINQQFDCCGNFE-UHFFFAOYSA-N
131757122;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HBEVIJGDUHOPDQ-UHFFFAOYSA-N
131757147;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PUGGWLRJISRKED-UHFFFAOYSA-N
131758098;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BLEZXNLVEWZCRH-UHFFFAOYSA-N
131756020;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MCTXTKYETLGMSB-UHFFFAOYSA-N
131761401;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NUTGEMDNMRDLIN-UHFFFAOYSA-N
131763784;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PEHCCWRKDIRZAZ-UHFFFAOYSA-N
131760820;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NHNBHJTVRJQCPP-UHFFFAOYSA-N
131762741;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZAMSJHWTYQXQPY-UHFFFAOYSA-N
131760701;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YNFNQTHMVAZPPY-UHFFFAOYSA-N
131761506;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PRQIXVRXFROCMF-UHFFFAOYSA-N
131765114;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XPHRYTCVIDCWOL-UHFFFAOYSA-N
131763681;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DGYTXSNHLHPLMV-UHFFFAOYSA-N
131762857;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HMLHWNHLFKBMRY-UHFFFAOYSA-N
131757567;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FEJZLHABNKUOEC-UHFFFAOYSA-N
131764280;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFYKQFUOADHDTL-UHFFFAOYSA-N
131756116;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XZCFLUUMROMSAR-UHFFFAOYSA-N
131757613;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MEEWQDGSGNOSQP-UHFFFAOYSA-N
131766170;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;POBZIGDMHISRHS-UHFFFAOYSA-N
56940421;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FGBZKVMJCSLMNT-UHFFFAOYSA-N
131762305;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LDQMUQGHUBNDTF-UHFFFAOYSA-N
131761387;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GWYYYKLEOYWXOZ-UHFFFAOYSA-N
131763279;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YLZNOVLTDCHRND-UHFFFAOYSA-N
131762398;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YOKRIONVIOTDSJ-UHFFFAOYSA-N
131757722;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LGZWDESXZRQBOV-UHFFFAOYSA-N
131761387;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GWYYYKLEOYWXOZ-UHFFFAOYSA-N
131757050;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BHRCZYGYXNQZMA-UHFFFAOYSA-N
131762040;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OYJUCBWWULREPL-UHFFFAOYSA-N
131757568;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LABYNSUZQGFKHQ-UHFFFAOYSA-N
131763956;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;GPDKESGJHAJPPZ-UHFFFAOYSA-N
131760320;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IIUYJEVBYIQITA-UHFFFAOYSA-N
131764039;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RWRADNFFPOHHEA-UHFFFAOYSA-N
131765376;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XSUFNQFSNOZPJJ-UHFFFAOYSA-N
131760237;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UQXVRDHAZYQOSA-UHFFFAOYSA-N
131756227;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUUMBKHGQRFUNQ-UHFFFAOYSA-N
131762132;FABP3;7;3.184e-49;0.4667;1.6187;86.6175;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AXXALZKBFIPMAS-UHFFFAOYSA-N
131760863;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JXSMIMXHJNFSLE-UHFFFAOYSA-N
131761407;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KTYNBLWPJGUGJJ-UHFFFAOYSA-N
131765962;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;NSAPJHVXFFFJJZ-UHFFFAOYSA-N
131756434;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SXAAWCNXDWGCLB-UHFFFAOYSA-N
131765556;FABP3;7;3.99e-49;0.45;1.6154;86.4416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IPPJSXWXPGLCQK-UHFFFAOYSA-N
131763777;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;WVKSRKGAZQQBAE-UHFFFAOYSA-N
131756855;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MYYKNWKDBLPJRV-UHFFFAOYSA-N
131766227;LPAR3;6;3.3260000000000004e-57;0.5192;8.7064;100.9461;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MPOVRWPOBWYLDM-UHFFFAOYSA-N
131761422;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QYFDEAFYRXDHQK-UHFFFAOYSA-N
131758098;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BLEZXNLVEWZCRH-UHFFFAOYSA-N
131758427;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QYSAZPWQWDQBMK-UHFFFAOYSA-N
131756262;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PAKBTZYUUDHYDL-UHFFFAOYSA-N
131760815;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YUCHRXJXJUSLFQ-UHFFFAOYSA-N
131761265;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJEKPAAJOOGLSW-UHFFFAOYSA-N
131761354;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CQPAGPNRJFQHMN-UHFFFAOYSA-N
9545834;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VJKRHAUTZWFBOQ-UHFFFAOYSA-N
131761912;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QJHAAKMJLURPNY-UHFFFAOYSA-N
131761506;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PRQIXVRXFROCMF-UHFFFAOYSA-N
131760781;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ORQMNWAGMCHUBN-UHFFFAOYSA-N
131760957;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RMJXWEMBRPTSKD-UHFFFAOYSA-N
131756247;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GTTMZICIVQUFGN-UHFFFAOYSA-N
131763279;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YLZNOVLTDCHRND-UHFFFAOYSA-N
131753410;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IYXYOIWMWJMTGN-UHFFFAOYSA-N
131764055;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VLYQASCCDNGEQJ-UHFFFAOYSA-N
131760134;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JQVMDWCSJIMBFA-UHFFFAOYSA-N
131759969;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYEMGSOIPJXIHT-UHFFFAOYSA-N
131761369;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZZPHZVWOGZYNAO-UHFFFAOYSA-N
9545834;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VJKRHAUTZWFBOQ-UHFFFAOYSA-N
131762754;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OQDCWOUJNQSYMR-UHFFFAOYSA-N
131757865;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;ISJUEJIQJNPESE-UHFFFAOYSA-N
131763556;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PTMJQDBEENYEHE-UHFFFAOYSA-N
131757756;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CQRHWLBMFHTPSF-UHFFFAOYSA-N
131755586;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MEUKCWGKFGAXPK-UHFFFAOYSA-N
131764483;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IJCNKBUZXXINLK-UHFFFAOYSA-N
131765612;FABP3;7;3.99e-49;0.45;1.6154;86.4416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HEPCVJBIBIAOMD-UHFFFAOYSA-N
131760807;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PIZKEXJUEDRGCV-UHFFFAOYSA-N
131760139;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IGHPWMZALJOYAV-UHFFFAOYSA-N
131762742;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PQVAMULAOIDXID-UHFFFAOYSA-N
131763007;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;STBHWPRLUZOAIJ-UHFFFAOYSA-N
131762022;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XJAXPYSHJDNMEP-UHFFFAOYSA-N
131762778;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;CGQLVCFUDCESMV-UHFFFAOYSA-N
131764638;LPAR3;6;6.092e-70;0.4909;10.6651;123.8133;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFUPLKNUYGXDCB-UHFFFAOYSA-N
131760230;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AJOYUENGEJHXFT-UHFFFAOYSA-N
131758242;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MOFDKHZXLRZVOO-UHFFFAOYSA-N
131763002;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HGDIZRAUCJKNGD-UHFFFAOYSA-N
131757939;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;OBQQBOPIPFQDPJ-UHFFFAOYSA-N
131757653;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZOOFCAJPCUMJET-UHFFFAOYSA-N
9545376;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YWQYUQPMOLYBJW-UHFFFAOYSA-N
131765029;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SOXFSPJIIHJCEP-UHFFFAOYSA-N
131757910;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;MASGOWIBHUPTSI-UHFFFAOYSA-N
131760599;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HAVPVXRAONEJBL-UHFFFAOYSA-N
131763751;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYDZOUJCPUDLC-UHFFFAOYSA-N
131755464;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AIJZDCRCOWFNRQ-UHFFFAOYSA-N
131761981;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WOJXCZKSQBKVOE-UHFFFAOYSA-N
131756204;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VKCTUXDPTHSMPZ-UHFFFAOYSA-N
131760406;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TWDVZQIJTRNOQN-UHFFFAOYSA-N
131760210;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CIQHDYHPBGLGRY-UHFFFAOYSA-N
131753404;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZBAKDZKUJDNKLJ-UHFFFAOYSA-N
131763580;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;JIILIEPJZCAPPZ-UHFFFAOYSA-N
131760872;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WMLPUCUGYDVCLW-UHFFFAOYSA-N
131757475;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGXUDWBHHLLXEY-UHFFFAOYSA-N
131760714;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RBFZLZMJOWEYIX-UHFFFAOYSA-N
131756862;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JIWBKNDEFSQJBT-UHFFFAOYSA-N
131761353;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RBASRMKCLNNORI-UHFFFAOYSA-N
131760858;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWEUKYATQHHVDX-UHFFFAOYSA-N
131761430;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HHZNVRUBXAYDCQ-UHFFFAOYSA-N
131761548;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZDPAUWXMIGMKJP-UHFFFAOYSA-N
131757394;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;REOIMVZEISKUHF-UHFFFAOYSA-N
131757764;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YPOPSJNSJQLQSC-UHFFFAOYSA-N
131760445;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RDYPQHGKLGNVNR-UHFFFAOYSA-N
131760938;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RFYJOAKKTIXXJD-UHFFFAOYSA-N
131761477;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CGVICJWXMHXXSP-UHFFFAOYSA-N
131755817;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QCIAAKBWAXWFOI-UHFFFAOYSA-N
131759547;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PKTUULQXDIEYDT-UHFFFAOYSA-N
131761423;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IKPYKXHCUXCJHN-UHFFFAOYSA-N
56940228;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PPOURTVWTVHRMU-UHFFFAOYSA-N
131759628;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KMLLHGHUQWACBE-UHFFFAOYSA-N
131764428;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QOCFTCUMNUGLBB-UHFFFAOYSA-N
131755513;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WGDZLZAQMLWOIG-UHFFFAOYSA-N
131764174;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GSLBJFYKPXLMFL-UHFFFAOYSA-N
131762652;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BXVJGJVJSKVGMC-UHFFFAOYSA-N
56940217;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BJOKYLJMABAHNL-UHFFFAOYSA-N
131759994;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZGUXKEKZSSEOPN-UHFFFAOYSA-N
131764772;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YFGCWKHYYCNTFA-UHFFFAOYSA-N
131761228;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SLNSNTKFZUABKK-UHFFFAOYSA-N
131761816;LPAR3;6;6.843e-71;0.5778;10.8111;125.518;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XWDKUUOKCJGHBE-UHFFFAOYSA-N
131756046;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;VRRPYVKHLUMVJX-UHFFFAOYSA-N
131756364;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IRFCZQIIPLGSKZ-UHFFFAOYSA-N
131756971;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;YNIZWWNPCWHUTQ-UHFFFAOYSA-N
131756711;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OUVOMMBEDVUBQG-UHFFFAOYSA-N
131759975;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PNELOFAUJCQISE-UHFFFAOYSA-N
131764045;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PRNZTHLFVCDZAV-UHFFFAOYSA-N
131756922;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UCBIXYZFPRNBNY-UHFFFAOYSA-N
131760145;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BUVNBWSDDBJEIH-UHFFFAOYSA-N
9545582;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PMEABGYOVGWCSQ-UHFFFAOYSA-N
131761156;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SAVXWGBSAALXPY-UHFFFAOYSA-N
131759831;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MVZLNTWQSMVSCH-UHFFFAOYSA-N
131761468;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QMLRKHJLBXYXOH-UHFFFAOYSA-N
131759527;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;BOXFXXYECNCIFC-UHFFFAOYSA-N
131766394;LPAR3;6;6.267e-50;0.5192;7.5876;87.8849;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PEARNUYKYUAPTL-UHFFFAOYSA-N
131765492;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WZUOZWXCEUQTRE-UHFFFAOYSA-N
131762182;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YSPOTOBPQXVIKH-UHFFFAOYSA-N
131761294;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OZIVOOHFGACURK-UHFFFAOYSA-N
131757296;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;LFKOJNRPJDKRCS-UHFFFAOYSA-N
131757097;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OSJAITDJSAAPCD-UHFFFAOYSA-N
9545709;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AMPLXUVROQRPNY-UHFFFAOYSA-N
131764413;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JKJYIRPZZWLYSB-UHFFFAOYSA-N
131760757;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AQXPAPMULLSBQL-UHFFFAOYSA-N
131760765;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DSSFNWQQTMLKJD-UHFFFAOYSA-N
131756261;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZFXYDOMFBWQZNA-UHFFFAOYSA-N
131762857;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HMLHWNHLFKBMRY-UHFFFAOYSA-N
131755513;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WGDZLZAQMLWOIG-UHFFFAOYSA-N
131760694;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AKPFCWNOANKGPU-UHFFFAOYSA-N
131762181;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YHKXBBUZMDPXSA-UHFFFAOYSA-N
131756941;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;COPQYDANMKTRTJ-UHFFFAOYSA-N
131764529;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;OBIZTMOHZKQECQ-UHFFFAOYSA-N
131764032;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;NOLCSFQLXSPJBG-UHFFFAOYSA-N
131757422;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JMEDNPXWSUSBMW-UHFFFAOYSA-N
131764402;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VNYZFOSXECUIIP-UHFFFAOYSA-N
131763140;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKRSQYQLQNSHTO-UHFFFAOYSA-N
131758074;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LSSCZEINTKPCRU-UHFFFAOYSA-N
131762216;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;HSOJKQPYAKFWOR-UHFFFAOYSA-N
131765231;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AVHSMRVNDALZFQ-UHFFFAOYSA-N
131759685;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RECDMXVWMLBZBY-UHFFFAOYSA-N
131763790;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WHRYWMDHNOKZCV-UHFFFAOYSA-N
131765480;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RQCPUHOLUCPXJR-UHFFFAOYSA-N
131761701;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OSSYIJMBFKKOMK-UHFFFAOYSA-N
131757732;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QULNTIICGQLJOS-UHFFFAOYSA-N
131759684;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GKWLUOVARMAZKA-UHFFFAOYSA-N
131760132;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;WODOUFGUYBJSCG-UHFFFAOYSA-N
131757031;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DIKFYIAWOURXLG-UHFFFAOYSA-N
131764958;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TXHGTEXFFQXVMR-UHFFFAOYSA-N
131764068;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SATBWAXPKBXLEF-UHFFFAOYSA-N
131762289;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLWQYLIHICZAQN-UHFFFAOYSA-N
131764221;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;WDFUGSQAEFPRPL-UHFFFAOYSA-N
131759975;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PNELOFAUJCQISE-UHFFFAOYSA-N
131763310;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JJVQIAHLUNUXIN-UHFFFAOYSA-N
131764056;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BODCPTKZTGBALI-UHFFFAOYSA-N
131761919;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XPPOOLOXNKODLX-UHFFFAOYSA-N
131762438;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FPHMGBWHJXWNSY-UHFFFAOYSA-N
131765279;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;QSAZQWUZAGCDBS-UHFFFAOYSA-N
131755280;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZNKMPMMJCRJCG-UHFFFAOYSA-N
131763367;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HXTSHFBTAPQXOE-UHFFFAOYSA-N
56940394;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QIGRMYCCQMEGIU-UHFFFAOYSA-N
9545450;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;HRJKHHJODKNNJK-UHFFFAOYSA-N
131756979;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBFKNCWBKFPUIY-UHFFFAOYSA-N
131756854;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LUAVDZZOBREHQN-UHFFFAOYSA-N
131766077;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YQTVDMDWRIUVLK-UHFFFAOYSA-N
131756875;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;AXLMYDXBLLUOLF-UHFFFAOYSA-N
131761284;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JRLHDZGAHDVBNN-UHFFFAOYSA-N
131755305;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DHTOKABCIVEDQY-UHFFFAOYSA-N
131756028;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZAABBQKBBZHIKW-UHFFFAOYSA-N
131763654;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PEHSTCKPKBMSBQ-UHFFFAOYSA-N
131757422;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JMEDNPXWSUSBMW-UHFFFAOYSA-N
131761811;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PYHYTXIIXWEHSC-UHFFFAOYSA-N
131762137;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;YXNSTAIJZPYOPN-UHFFFAOYSA-N
131760158;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DDZGDBPXBWPREM-UHFFFAOYSA-N
131756414;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FFMPGKXDJNLCRV-UHFFFAOYSA-N
9545385;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PDCZMYYCRMCWTG-UHFFFAOYSA-N
131761343;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HATPVFYQRUFDTP-UHFFFAOYSA-N
131764331;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QNCBCQOFCIRMDR-UHFFFAOYSA-N
131757483;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;COTBIHOOVUEBLQ-UHFFFAOYSA-N
131760245;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OQVOEILLAWEJJU-UHFFFAOYSA-N
131762130;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DBABQSZDEPAQMJ-UHFFFAOYSA-N
131756149;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GNKDSUNTVMVVBM-UHFFFAOYSA-N
131758242;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MOFDKHZXLRZVOO-UHFFFAOYSA-N
131759546;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZULRYZCUNGPAHY-UHFFFAOYSA-N
9545449;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FRWFMVSCXNKUPX-UHFFFAOYSA-N
131761513;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MHYXIAUVXQNGQB-UHFFFAOYSA-N
131757133;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HMRPHEFZYARYNZ-UHFFFAOYSA-N
131759700;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BTOBAOSWLQZTFQ-UHFFFAOYSA-N
56940396;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZLBFDCQURCAMRP-UHFFFAOYSA-N
131761442;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ADKLGQHKFMGSDC-UHFFFAOYSA-N
131764424;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PPBRPZLEEGPJRP-UHFFFAOYSA-N
131758249;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GSINXERSHYXLOO-UHFFFAOYSA-N
131757202;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;JSBGTMPZZRTBBA-UHFFFAOYSA-N
131760693;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NTSBPGZUJBXBSL-UHFFFAOYSA-N
131763152;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;INDPJVIDKWBQSJ-UHFFFAOYSA-N
131761449;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JZQYMINNIQSBMO-UHFFFAOYSA-N
131761677;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LKMYGIJKNMNLDQ-UHFFFAOYSA-N
131764842;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWZUXHAVUFTVEK-UHFFFAOYSA-N
131762735;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;QIPKPBOQLFJNQW-UHFFFAOYSA-N
131763259;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JWUGOBDQRTWQDM-UHFFFAOYSA-N
131762666;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;OKMPYBUPDFDIHC-UHFFFAOYSA-N
131766160;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SQBQHLQBUHBYQJ-UHFFFAOYSA-N
131756905;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NFLOZGHSXUQYSV-UHFFFAOYSA-N
131759692;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KTSYFYGEYMWJBJ-UHFFFAOYSA-N
131757070;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JRUAJAMOWZTEMR-UHFFFAOYSA-N
131762334;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RHAIVLSTPJTGRI-UHFFFAOYSA-N
131765236;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BXTYKLWEJMYKID-UHFFFAOYSA-N
131763563;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;JJABVFOQBZMQSC-UHFFFAOYSA-N
131757164;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GJTXTGACCVJFCY-UHFFFAOYSA-N
9545676;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PBKAVJDINREZJK-UHFFFAOYSA-N
131762865;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;APLABQCESRGFRN-UHFFFAOYSA-N
131757764;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YPOPSJNSJQLQSC-UHFFFAOYSA-N
131761686;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BBGDVLRKNFSFTF-UHFFFAOYSA-N
131764132;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VIIWKEJLCOZGMH-UHFFFAOYSA-N
131761284;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JRLHDZGAHDVBNN-UHFFFAOYSA-N
131756227;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUUMBKHGQRFUNQ-UHFFFAOYSA-N
131762187;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FFRUWMSJKGSWRM-UHFFFAOYSA-N
131766203;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LGGGUGHTVQPVHX-UHFFFAOYSA-N
131759363;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HSNAKNZDCUCCNE-UHFFFAOYSA-N
131762526;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GAGJGQSTFRQNAT-UHFFFAOYSA-N
131761119;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JOXVEMDPPLURBQ-UHFFFAOYSA-N
131763738;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MXOQAYBYRAGVQT-UHFFFAOYSA-N
131761455;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BNRUJXMUWHJABI-UHFFFAOYSA-N
56940228;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PPOURTVWTVHRMU-UHFFFAOYSA-N
131756149;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GNKDSUNTVMVVBM-UHFFFAOYSA-N
131766379;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KIUFCROTWBUMMM-UHFFFAOYSA-N
131761407;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KTYNBLWPJGUGJJ-UHFFFAOYSA-N
131763568;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TWIVSQOXNBXDFW-UHFFFAOYSA-N
131763790;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WHRYWMDHNOKZCV-UHFFFAOYSA-N
131763790;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WHRYWMDHNOKZCV-UHFFFAOYSA-N
131762558;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DUYBKOXPEWXVRC-UHFFFAOYSA-N
131761422;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QYFDEAFYRXDHQK-UHFFFAOYSA-N
131763654;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PEHSTCKPKBMSBQ-UHFFFAOYSA-N
131761468;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;QMLRKHJLBXYXOH-UHFFFAOYSA-N
131763172;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;PULVRMWMRNJUAS-UHFFFAOYSA-N
131755464;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;AIJZDCRCOWFNRQ-UHFFFAOYSA-N
131765312;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LQIVLMSRFUNROM-UHFFFAOYSA-N
131758060;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;BSPIFBZEPCECGT-UHFFFAOYSA-N
131760111;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FWPCKKOAEAIPKJ-UHFFFAOYSA-N
131759969;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYEMGSOIPJXIHT-UHFFFAOYSA-N
131762748;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;PJDOXWVMHBYGBX-UHFFFAOYSA-N
131759216;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UYTLNZBFEBCSPM-UHFFFAOYSA-N
131757017;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XIMVAXPQXRCQDC-UHFFFAOYSA-N
131756176;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MEIGPYFQXNHGCJ-UHFFFAOYSA-N
131765362;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XWSIPXKDOXVBDJ-UHFFFAOYSA-N
131762547;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HUNYHNIYIYCFKC-UHFFFAOYSA-N
131757444;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;ICZNVYWIBUJKRO-UHFFFAOYSA-N
131764429;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HCNIXAHXARQCOB-UHFFFAOYSA-N
131760298;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SRARWQZTRDRWIY-UHFFFAOYSA-N
131763984;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XOYMYYRTVUGSGP-UHFFFAOYSA-N
131762033;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZJKYRERUNOYMDL-UHFFFAOYSA-N
131757704;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WZSWCHGXBYZHMA-UHFFFAOYSA-N
131760732;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YXUAESIHENABSF-UHFFFAOYSA-N
131764242;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XCCCZEHGAYDWGO-UHFFFAOYSA-N
131762326;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RMAOBGGCPVHDLB-UHFFFAOYSA-N
131762275;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZNAJMOCCTZFALW-UHFFFAOYSA-N
131764931;LPAR3;6;7.43e-62;0.4906;9.4216;109.296;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YOFWQYCRZFTOKW-UHFFFAOYSA-N
131755477;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKXVFDJOYACJHJ-UHFFFAOYSA-N
131761771;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;VUABVSDTWKAGBK-UHFFFAOYSA-N
131757870;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;LTKCBUMGVCUVPG-UHFFFAOYSA-N
131764230;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XBOGPRFREBREQV-UHFFFAOYSA-N
9545709;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AMPLXUVROQRPNY-UHFFFAOYSA-N
131757083;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MVZVFFWLMVHSMR-UHFFFAOYSA-N
131762404;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LQJPCYRTCWFLFO-UHFFFAOYSA-N
131757164;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GJTXTGACCVJFCY-UHFFFAOYSA-N
131758106;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWLALMGEVBJBJV-UHFFFAOYSA-N
131764674;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UCROWURDULDTCP-UHFFFAOYSA-N
131761693;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ANGCSMRUARXHTN-UHFFFAOYSA-N
131765039;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YDXADNGEUYJWKH-UHFFFAOYSA-N
131763576;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OAHFSXGNMDGFOX-UHFFFAOYSA-N
131760965;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GZUMPLARGPROGA-UHFFFAOYSA-N
131761532;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RRXDJYNFSRXVNG-UHFFFAOYSA-N
131764670;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NTFIQEWZDSXEJP-UHFFFAOYSA-N
131761347;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IFRXOEIIKSFQOO-UHFFFAOYSA-N
131758441;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JNWUZJVVSINCRU-UHFFFAOYSA-N
131760878;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XMMKMNSZBLWXRZ-UHFFFAOYSA-N
131757005;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UJZIJWWJEILDEY-UHFFFAOYSA-N
131761837;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;HYQDCVGUIPYREC-UHFFFAOYSA-N
131756027;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;LRLJXQHYZIWUEY-UHFFFAOYSA-N
131761499;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;WTGRDQWTZSUSQB-UHFFFAOYSA-N
56940255;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FJSARSYJKVJQHG-UHFFFAOYSA-N
131750419;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BZPDQOHIKFKCEV-UHFFFAOYSA-N
131763668;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;STQPITNFYWWCFX-UHFFFAOYSA-N
131756786;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;USSQANBAQNQTNC-UHFFFAOYSA-N
131757089;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NEVHLARDZQWNDN-UHFFFAOYSA-N
131764472;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BNQJQBHYOORHQK-UHFFFAOYSA-N
131761001;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UNEKYBHIZJBCFN-UHFFFAOYSA-N
131759389;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KVBRKDKYGMSEEX-UHFFFAOYSA-N
131760863;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JXSMIMXHJNFSLE-UHFFFAOYSA-N
131762033;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZJKYRERUNOYMDL-UHFFFAOYSA-N
131765687;LPAR3;6;6.092e-70;0.4909;10.6651;123.8133;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PETWQBFAHCQEHD-UHFFFAOYSA-N
131757399;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;LGMIHDFKAMFZFO-UHFFFAOYSA-N
131758053;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;PTCDSFDXNQAUJF-UHFFFAOYSA-N
131758408;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FJCZNIRVTYQYOI-UHFFFAOYSA-N
131761483;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SNJFTPQXHGPDEX-UHFFFAOYSA-N
131754014;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UAZSECASKQJKIA-UHFFFAOYSA-N
131756589;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;ZKCPJGUEGWADAV-UHFFFAOYSA-N
131764535;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ROYJPPZMPGNTCP-UHFFFAOYSA-N
131763002;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HGDIZRAUCJKNGD-UHFFFAOYSA-N
131764637;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PYEBEEUWKLPYJF-UHFFFAOYSA-N
56940394;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;QIGRMYCCQMEGIU-UHFFFAOYSA-N
131764109;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BLUODYRHIPCAQS-UHFFFAOYSA-N
131753639;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;HVJIYFSRIYNDPL-UHFFFAOYSA-N
131760189;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVZCIRATOLVRIA-UHFFFAOYSA-N
131757444;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;ICZNVYWIBUJKRO-UHFFFAOYSA-N
131763317;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BETJPUOQASBYOQ-UHFFFAOYSA-N
9545374;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GDSOHLLQXYEIDF-UHFFFAOYSA-N
131756996;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ACGHXTVLDFHATI-UHFFFAOYSA-N
131760465;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIGNKIDTFFNZDL-UHFFFAOYSA-N
131766346;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MRBYYUNTUNMTMA-UHFFFAOYSA-N
131759382;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HEMRKPYNFGQFML-UHFFFAOYSA-N
131764668;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WDEZMXSFPUWTDB-UHFFFAOYSA-N
131762755;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FQOOBZWSSFBGRJ-UHFFFAOYSA-N
131764429;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HCNIXAHXARQCOB-UHFFFAOYSA-N
131757548;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOFFTNBYEWWFON-UHFFFAOYSA-N
131756882;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BFPUBWJKTOCMTE-UHFFFAOYSA-N
131764790;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IMMKDABJSSZNBN-UHFFFAOYSA-N
131759499;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KGQWRGYSBBEKHB-UHFFFAOYSA-N
131766409;LPAR3;6;9.708e-50;0.4727;7.5584;87.5437;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FHTDYIDIOVTTCF-UHFFFAOYSA-N
131755494;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BQPFRDZWJNSTCS-UHFFFAOYSA-N
131765169;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZENQZFFVOIAMBA-UHFFFAOYSA-N
131764403;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XBJZPTQZKFLWMM-UHFFFAOYSA-N
131765486;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OVIVEYNLEWNFJB-UHFFFAOYSA-N
131758218;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SYCPSWRZYSSYMM-UHFFFAOYSA-N
131755465;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BTKBYBXKJGMWMW-UHFFFAOYSA-N
131761772;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SPIHSNCGRXGHRO-UHFFFAOYSA-N
131763001;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DIQHRWHXSVXJHW-UHFFFAOYSA-N
131760152;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;IBRKGGWUQIZSKI-UHFFFAOYSA-N
56940255;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FJSARSYJKVJQHG-UHFFFAOYSA-N
131762055;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ULRVJSBXYDGFRT-UHFFFAOYSA-N
131761477;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CGVICJWXMHXXSP-UHFFFAOYSA-N
131760145;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BUVNBWSDDBJEIH-UHFFFAOYSA-N
131757102;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZFWLBSAZUANAAS-UHFFFAOYSA-N
131761257;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NAZBWUYFIUKAKG-UHFFFAOYSA-N
131755639;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YQESTRXWSPZNHW-UHFFFAOYSA-N
131755655;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UEPGRXMBZHCOGK-UHFFFAOYSA-N
131756196;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXSFIMVOIADAFE-UHFFFAOYSA-N
131761896;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CANUGJFNUXQJNT-UHFFFAOYSA-N
131760259;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FERRYQPGBTWCLI-UHFFFAOYSA-N
9545385;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PDCZMYYCRMCWTG-UHFFFAOYSA-N
131757063;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QMDVGDLZLSCJAH-UHFFFAOYSA-N
131753410;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IYXYOIWMWJMTGN-UHFFFAOYSA-N
131760829;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NTCOYOBXIUTQIE-UHFFFAOYSA-N
131765659;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BPAMRGTXFLHKIB-UHFFFAOYSA-N
131765085;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NFXBUAHCKPMYSD-UHFFFAOYSA-N
131763259;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JWUGOBDQRTWQDM-UHFFFAOYSA-N
131763317;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BETJPUOQASBYOQ-UHFFFAOYSA-N
131761353;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;RBASRMKCLNNORI-UHFFFAOYSA-N
131757068;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OIBLFFKYXAHRDW-UHFFFAOYSA-N
131756971;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;YNIZWWNPCWHUTQ-UHFFFAOYSA-N
131764136;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NJJRJRJTWCCNNE-UHFFFAOYSA-N
131762519;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCZNYKXKMTUJGT-UHFFFAOYSA-N
131764402;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VNYZFOSXECUIIP-UHFFFAOYSA-N
131762130;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DBABQSZDEPAQMJ-UHFFFAOYSA-N
131764047;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LZZJAKQUDMTSMD-UHFFFAOYSA-N
131760834;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DRJWUSGKQPKDTB-UHFFFAOYSA-N
131761342;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BMSWKYPCZHQOJH-UHFFFAOYSA-N
131763738;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;MXOQAYBYRAGVQT-UHFFFAOYSA-N
131756274;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FOIBEFNGSFFBMC-UHFFFAOYSA-N
131760334;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BJLRZHNJFQMOIR-UHFFFAOYSA-N
131756169;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MJEBHXWSLTWPCM-UHFFFAOYSA-N
131761347;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IFRXOEIIKSFQOO-UHFFFAOYSA-N
131757598;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MIDOZDIGHHQOQX-UHFFFAOYSA-N
56940217;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;BJOKYLJMABAHNL-UHFFFAOYSA-N
131756013;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VRWLAKNBXGYTIC-UHFFFAOYSA-N
131760731;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HWLVTNCWIOTLSO-UHFFFAOYSA-N
131760731;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HWLVTNCWIOTLSO-UHFFFAOYSA-N
131760884;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FJFQEYNMGJSGOC-UHFFFAOYSA-N
131760014;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AMXNXQFOJFMVAP-UHFFFAOYSA-N
131762986;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XMEDZNCDBPSROA-UHFFFAOYSA-N
131761520;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WBENLJREAPLIFI-UHFFFAOYSA-N
131759670;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FMHGBFIQGMDKBC-UHFFFAOYSA-N
131758218;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;SYCPSWRZYSSYMM-UHFFFAOYSA-N
131759541;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;OXIPRMUYAGLPPY-UHFFFAOYSA-N
131761821;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BWXJGGJFPJYWNA-UHFFFAOYSA-N
131764931;FABP3;7;3.184e-49;0.4667;1.6187;86.6175;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YOFWQYCRZFTOKW-UHFFFAOYSA-N
131760829;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NTCOYOBXIUTQIE-UHFFFAOYSA-N
131756178;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LQGJLTQDXJLJGB-UHFFFAOYSA-N
131757274;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;YXFXBGQKOCWXIW-UHFFFAOYSA-N
131762438;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FPHMGBWHJXWNSY-UHFFFAOYSA-N
131762411;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VDRHQUDGPLPDPR-UHFFFAOYSA-N
131762740;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SBNMRUIGCHPGON-UHFFFAOYSA-N
131763679;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;ZZNQEKZITOQVEU-UHFFFAOYSA-N
131765013;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ABQOBDXXEGCQPI-UHFFFAOYSA-N
131764292;LPAR3;6;6.092e-70;0.4909;10.6651;123.8133;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIZPZYVVCLXNRY-UHFFFAOYSA-N
131760312;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SYOMGTNMWHLBFV-UHFFFAOYSA-N
131764285;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RKZJFNKVHZZJGE-UHFFFAOYSA-N
131762502;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GITBOGBAISSPME-UHFFFAOYSA-N
131756267;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MWJBYDLBNUIUKI-UHFFFAOYSA-N
131760357;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;YAVAVSMMSRUIQM-UHFFFAOYSA-N
131761285;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;HTHXCXIQIAMNEI-UHFFFAOYSA-N
131758226;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;AQUHVGHTBSILQP-UHFFFAOYSA-N
131756209;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VDTUMEBCKWSEJW-UHFFFAOYSA-N
131757470;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;BGIMVPIMTCDTIR-UHFFFAOYSA-N
131764067;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;LFYKWGODUKKZEK-UHFFFAOYSA-N
131758306;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LWZVEKQNTUNOHB-UHFFFAOYSA-N
131762296;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;BICJWANPZUYADQ-UHFFFAOYSA-N
131763567;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;UEFBXDIEVPQCTF-UHFFFAOYSA-N
131762209;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DFWJNSRUGPXPNK-UHFFFAOYSA-N
131753834;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MIRRUHDLDQABSJ-UHFFFAOYSA-N
131764053;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GAWBNAJJRJBPMU-UHFFFAOYSA-N
131762770;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;NFYLWGALGFJXKV-UHFFFAOYSA-N
131757068;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OIBLFFKYXAHRDW-UHFFFAOYSA-N
131759994;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZGUXKEKZSSEOPN-UHFFFAOYSA-N
131763147;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SRVIIJLKVZLBAK-UHFFFAOYSA-N
131760013;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;ZVECOVJZJMOJSN-UHFFFAOYSA-N
131760169;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;CFGOOLOMBIOEGG-UHFFFAOYSA-N
131760609;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;XMFRBOAHYIOZTK-UHFFFAOYSA-N
131760459;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;INWPHLCORRPJIM-UHFFFAOYSA-N
131764842;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWZUXHAVUFTVEK-UHFFFAOYSA-N
131756899;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CQJJJRSFXVFAMI-UHFFFAOYSA-N
131761488;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BBYYUOFBHJZJDM-UHFFFAOYSA-N
131762504;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZTJYQIYMUQWSOC-UHFFFAOYSA-N
131756990;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GIMZLHBKBDWKNT-UHFFFAOYSA-N
131761368;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CTTAXJGEXQSTCM-UHFFFAOYSA-N
131756421;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IUMDGPNWURWSCV-UHFFFAOYSA-N
131755499;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GCOQNBYYCRADMG-UHFFFAOYSA-N
131764866;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KZMACVQAHWYDMM-UHFFFAOYSA-N
131762209;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DFWJNSRUGPXPNK-UHFFFAOYSA-N
131763272;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GUXKXSATTNLTNC-UHFFFAOYSA-N
131756978;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUDWFYHOJFIKDR-UHFFFAOYSA-N
131756157;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XLDJIGJUYLTKCW-UHFFFAOYSA-N
131763272;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;GUXKXSATTNLTNC-UHFFFAOYSA-N
131761513;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MHYXIAUVXQNGQB-UHFFFAOYSA-N
131761120;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RXMAXLLPNKWYHJ-UHFFFAOYSA-N
131755312;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;BVHNZHCDCIVCNP-UHFFFAOYSA-N
131763231;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFTFKKKNMJLXFT-UHFFFAOYSA-N
131756000;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RPRUIZWBGFJFML-UHFFFAOYSA-N
131766160;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SQBQHLQBUHBYQJ-UHFFFAOYSA-N
131761265;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OJEKPAAJOOGLSW-UHFFFAOYSA-N
131760809;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MJNRQPAXIWANBB-UHFFFAOYSA-N
131761377;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BZOZGDYJRRGPNI-UHFFFAOYSA-N
131765013;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ABQOBDXXEGCQPI-UHFFFAOYSA-N
131761746;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZNDLKGOPISOCOU-UHFFFAOYSA-N
131758376;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DXLAYYUDUQMJEA-UHFFFAOYSA-N
131763271;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;POKWAFRJAZNFSU-UHFFFAOYSA-N
131756184;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KWKOUCDAAANDPY-UHFFFAOYSA-N
131758217;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MENKUUOOQRGDSS-UHFFFAOYSA-N
131765292;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LNYTYUIVGJVPBU-UHFFFAOYSA-N
131762398;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;YOKRIONVIOTDSJ-UHFFFAOYSA-N
131759546;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;ZULRYZCUNGPAHY-UHFFFAOYSA-N
131760807;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PIZKEXJUEDRGCV-UHFFFAOYSA-N
131766125;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;COHAHZFRWDOLFS-UHFFFAOYSA-N
131765236;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BXTYKLWEJMYKID-UHFFFAOYSA-N
131755505;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZWDRUMGFLNADOE-UHFFFAOYSA-N
56940373;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PNWARPKMZYMSHQ-UHFFFAOYSA-N
131760312;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SYOMGTNMWHLBFV-UHFFFAOYSA-N
131757048;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IGGJZLJGRRYFIM-UHFFFAOYSA-N
131760592;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;LMGNSHHFYGGMOJ-UHFFFAOYSA-N
131762754;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OQDCWOUJNQSYMR-UHFFFAOYSA-N
131759383;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YYVDCJLPCNWCCR-UHFFFAOYSA-N
131755521;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DFOPDYSQCRFMDS-UHFFFAOYSA-N
131765055;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;YHQURYLTBPXJMG-UHFFFAOYSA-N
131760230;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AJOYUENGEJHXFT-UHFFFAOYSA-N
131755465;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BTKBYBXKJGMWMW-UHFFFAOYSA-N
131753864;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NKIGKQWLBIPYDK-UHFFFAOYSA-N
131760292;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FSUMMHYNEFRCKJ-UHFFFAOYSA-N
131761302;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;SPUJFJNWFPTYCI-UHFFFAOYSA-N
131756760;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IULQMBPZWYNZEZ-UHFFFAOYSA-N
131762622;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OCZVBYXRRPOZFY-UHFFFAOYSA-N
131766077;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YQTVDMDWRIUVLK-UHFFFAOYSA-N
131756421;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IUMDGPNWURWSCV-UHFFFAOYSA-N
131763655;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YWXCEMWZELUBSX-UHFFFAOYSA-N
131758496;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HTYGMBXFTNEZHO-UHFFFAOYSA-N
131757555;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NUARLQSDFGRENY-UHFFFAOYSA-N
131756810;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZVAZRCNQDGGHIY-UHFFFAOYSA-N
131761352;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CZCGMLNCRPSJDT-UHFFFAOYSA-N
131757568;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LABYNSUZQGFKHQ-UHFFFAOYSA-N
131763366;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DXAZBFYXLZYUIG-UHFFFAOYSA-N
131755077;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GQAUQPCQRVYUQF-UHFFFAOYSA-N
131763556;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;PTMJQDBEENYEHE-UHFFFAOYSA-N
131765122;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;REAXNFSVDUNGRG-UHFFFAOYSA-N
131761229;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AZCFJOQBPCTUJB-UHFFFAOYSA-N
131759670;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FMHGBFIQGMDKBC-UHFFFAOYSA-N
131766418;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GYVVNJNAXWYMSI-UHFFFAOYSA-N
131759650;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FFSBYDWZGXLHOR-UHFFFAOYSA-N
131755666;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PTSDZIVZWSSOQV-UHFFFAOYSA-N
131764966;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YQSGKRMNUSQKEC-UHFFFAOYSA-N
131760616;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;SEGAFXOOJWNDFX-UHFFFAOYSA-N
56940383;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;TUZZBILRHPBTHW-UHFFFAOYSA-N
131757091;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FACDAQXMPKTFRQ-UHFFFAOYSA-N
131756710;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YIENLPUFSVQUCG-UHFFFAOYSA-N
131753640;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;SFMSLZCWXHIABM-UHFFFAOYSA-N
131761947;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HBMNWHFLFHOFFZ-UHFFFAOYSA-N
131763359;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JBDJDXZTHMTVDR-UHFFFAOYSA-N
131761592;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CRPGFZTUFREYFV-UHFFFAOYSA-N
131762182;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YSPOTOBPQXVIKH-UHFFFAOYSA-N
131761423;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IKPYKXHCUXCJHN-UHFFFAOYSA-N
131758106;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;OWLALMGEVBJBJV-UHFFFAOYSA-N
131765060;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YKIKYETUKYLZGC-UHFFFAOYSA-N
131762196;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OIMOXMXEHNPADS-UHFFFAOYSA-N
131761972;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;QARMSZHUPFDIOQ-UHFFFAOYSA-N
131757715;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HGSNEKPPSIBDLE-UHFFFAOYSA-N
131758409;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FKDVIQPHQIWBSH-UHFFFAOYSA-N
131763957;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LEDZXTFKKPRATN-UHFFFAOYSA-N
131757726;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;ZDIIFMFAQBMYEV-UHFFFAOYSA-N
131759032;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XVGWHPBTFCPJEQ-UHFFFAOYSA-N
131763778;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HMWYLDUUJNYCNU-UHFFFAOYSA-N
131762616;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FRJVUQNOKPPWFF-UHFFFAOYSA-N
131761531;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QRHBKDZWDQJGCP-UHFFFAOYSA-N
131756772;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;OUVCXSDTWMPGJT-UHFFFAOYSA-N
131757423;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZGKZBSSBZQXPKF-UHFFFAOYSA-N
131761001;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UNEKYBHIZJBCFN-UHFFFAOYSA-N
131763849;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IWQXPFWRVPSQSD-UHFFFAOYSA-N
131762534;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TWMZUNYBAPKPNZ-UHFFFAOYSA-N
131761396;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UJRJCLHLHPOJDC-UHFFFAOYSA-N
131765774;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HKIUNKJCPJLXAN-UHFFFAOYSA-N
131755286;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WWQOCPZHIQRZNO-UHFFFAOYSA-N
131760339;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PFCDUEXIIFGNON-UHFFFAOYSA-N
131755076;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFESPFKKWBRMFJ-UHFFFAOYSA-N
131761363;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OFRMFQDZUZWUCZ-UHFFFAOYSA-N
131764034;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ULRJOCSDJZFMFY-UHFFFAOYSA-N
131757073;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VOIUMMLAPMMRMR-UHFFFAOYSA-N
131764559;LPAR3;6;1.124e-70;0.5294;10.778;125.1313;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VCEGRHVWRBJANM-UHFFFAOYSA-N
131762653;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OYZCTROWQJHDDM-UHFFFAOYSA-N
131755076;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFESPFKKWBRMFJ-UHFFFAOYSA-N
131759055;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FZZMMDPBSSQSEG-UHFFFAOYSA-N
131757564;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;UYRLXLPLLFAUHZ-UHFFFAOYSA-N
131763139;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WUPOLOVISVVRIA-UHFFFAOYSA-N
131756356;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WGJIHWLKJGCRQX-UHFFFAOYSA-N
131761977;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLZIAWKRCIQGBQ-UHFFFAOYSA-N
131756710;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;YIENLPUFSVQUCG-UHFFFAOYSA-N
131756955;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NPDFCHHIYFJVGQ-UHFFFAOYSA-N
131762770;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;NFYLWGALGFJXKV-UHFFFAOYSA-N
131765153;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZGVRHASAEPOUMI-UHFFFAOYSA-N
131764285;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RKZJFNKVHZZJGE-UHFFFAOYSA-N
131757567;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FEJZLHABNKUOEC-UHFFFAOYSA-N
131761562;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IHAZFQHVOPNHHB-UHFFFAOYSA-N
131761493;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CHPUIFFVSPQGIH-UHFFFAOYSA-N
131759032;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XVGWHPBTFCPJEQ-UHFFFAOYSA-N
131757916;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;MLAAGFLYGGJEIR-UHFFFAOYSA-N
131763001;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DIQHRWHXSVXJHW-UHFFFAOYSA-N
131764229;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LDWACUWXECAMNZ-UHFFFAOYSA-N
131759721;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VFICNLJKIFKMLD-UHFFFAOYSA-N
131758719;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LOQLDSZRHWTGNQ-UHFFFAOYSA-N
131756365;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AKYYZUWPIITYAK-UHFFFAOYSA-N
131760426;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;TUXUSRKEZCBDLD-UHFFFAOYSA-N
131756738;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;HLJUWCMJURHSAS-UHFFFAOYSA-N
131758900;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;NZGZMFGERFXOQI-UHFFFAOYSA-N
9545374;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GDSOHLLQXYEIDF-UHFFFAOYSA-N
131756923;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KRGKEXOYBMAEQS-UHFFFAOYSA-N
131755994;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IEMDRUBCZRDUKX-UHFFFAOYSA-N
131756923;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KRGKEXOYBMAEQS-UHFFFAOYSA-N
131761460;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GIYUPPWUIAUMIZ-UHFFFAOYSA-N
131755994;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IEMDRUBCZRDUKX-UHFFFAOYSA-N
131765292;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LNYTYUIVGJVPBU-UHFFFAOYSA-N
131764285;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RKZJFNKVHZZJGE-UHFFFAOYSA-N
131765487;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PDOJEFKZWZWMCQ-UHFFFAOYSA-N
131761790;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PFLHGEYNZZRPBP-UHFFFAOYSA-N
131761377;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BZOZGDYJRRGPNI-UHFFFAOYSA-N
131757054;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZBIXPXAIQGNOJR-UHFFFAOYSA-N
131764333;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FJUCHGYLVVMEGA-UHFFFAOYSA-N
131762645;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XZWHNXBAQKSDHH-UHFFFAOYSA-N
131755647;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DTGWBWNZTSFJEB-UHFFFAOYSA-N
131761363;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OFRMFQDZUZWUCZ-UHFFFAOYSA-N
131757722;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;LGZWDESXZRQBOV-UHFFFAOYSA-N
131760864;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XXAWZPPLHQUSBP-UHFFFAOYSA-N
131757576;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MPNBJXUQYBYLAM-UHFFFAOYSA-N
131758441;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JNWUZJVVSINCRU-UHFFFAOYSA-N
131762728;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LIBQPQCZEFGZPS-UHFFFAOYSA-N
131764331;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;QNCBCQOFCIRMDR-UHFFFAOYSA-N
131765548;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;PUZHVGYKYYGDMS-UHFFFAOYSA-N
131761664;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GPZNPRSWWAGAKP-UHFFFAOYSA-N
131760919;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WCNZFQBWVLERSB-UHFFFAOYSA-N
131761592;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CRPGFZTUFREYFV-UHFFFAOYSA-N
131763442;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QRAYXPKVQDNMMF-UHFFFAOYSA-N
131763173;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;IMMYAYNDFJZVBZ-UHFFFAOYSA-N
131763366;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DXAZBFYXLZYUIG-UHFFFAOYSA-N
131760701;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YNFNQTHMVAZPPY-UHFFFAOYSA-N
131760738;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RYSFVHSTLPOBIB-UHFFFAOYSA-N
131762334;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RHAIVLSTPJTGRI-UHFFFAOYSA-N
131763563;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;JJABVFOQBZMQSC-UHFFFAOYSA-N
131764573;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VBNCHMHZHLSEKN-UHFFFAOYSA-N
131765728;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YZQJJIWXQVTOPY-UHFFFAOYSA-N
131757108;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WIMOTPNOOSOQHS-UHFFFAOYSA-N
131756274;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FOIBEFNGSFFBMC-UHFFFAOYSA-N
131761638;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;QCRGSRJHSCHLOD-UHFFFAOYSA-N
131765084;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DSHWDOGQDLMJNI-UHFFFAOYSA-N
131757202;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;JSBGTMPZZRTBBA-UHFFFAOYSA-N
131762652;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BXVJGJVJSKVGMC-UHFFFAOYSA-N
131755245;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UDLIAKHQDWRPKP-UHFFFAOYSA-N
131762735;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;QIPKPBOQLFJNQW-UHFFFAOYSA-N
131764137;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VLMFXQRKOXVLPZ-UHFFFAOYSA-N
131760957;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;RMJXWEMBRPTSKD-UHFFFAOYSA-N
131756356;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WGJIHWLKJGCRQX-UHFFFAOYSA-N
131763239;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AHTTULMKWLTZHP-UHFFFAOYSA-N
131761381;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDVIBBNZDQDULN-UHFFFAOYSA-N
131760749;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;QTXQZWXXJFNSGW-UHFFFAOYSA-N
131764959;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RHYBXYWAECNXSA-UHFFFAOYSA-N
131761369;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZZPHZVWOGZYNAO-UHFFFAOYSA-N
131757469;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;GKSQQYCZRSBFKG-UHFFFAOYSA-N
131756898;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DTHQVLKUDRJNSH-UHFFFAOYSA-N
131758225;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NCTGMGBJXWCUSU-UHFFFAOYSA-N
131760340;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FHRLUJKJKYLPIE-UHFFFAOYSA-N
131764627;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DVJHAUACNCKWHY-UHFFFAOYSA-N
131762202;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VFWNWLUEZNPXHB-UHFFFAOYSA-N
131764498;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QANZEVFDXQPYRW-UHFFFAOYSA-N
131760800;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CZCNBEOJWUHLJB-UHFFFAOYSA-N
131760133;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VHPUITUUEXRCGU-UHFFFAOYSA-N
131762022;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XJAXPYSHJDNMEP-UHFFFAOYSA-N
131760170;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NVTGKNBTUCFOOC-UHFFFAOYSA-N
131760904;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XGMRMYUHVURNEO-UHFFFAOYSA-N
131764142;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LKKZTOWNYBYTMN-UHFFFAOYSA-N
131755494;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BQPFRDZWJNSTCS-UHFFFAOYSA-N
131756330;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UGSOYIWJZWSYGO-UHFFFAOYSA-N
131755816;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WRPAVJZVCFOMOP-UHFFFAOYSA-N
131761278;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;DMRCFTQNQMIGTD-UHFFFAOYSA-N
131756209;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VDTUMEBCKWSEJW-UHFFFAOYSA-N
131760125;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;NZLWAKCEBADZQI-UHFFFAOYSA-N
131765719;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DSKCDSMBKQZQNR-UHFFFAOYSA-N
131761255;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;KPJGNTJVQXQHJJ-UHFFFAOYSA-N
131757846;FABP3;7;1.3719999999999998e-51;0.4565;1.6978;90.8644;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;HAAANVHPHRLRPS-UHFFFAOYSA-N
131755281;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ANGPTMIQAOFQBH-UHFFFAOYSA-N
131761507;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XFQJFJLWOIVLOP-UHFFFAOYSA-N
131764777;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;PVIAPLQIFDZWHV-UHFFFAOYSA-N
131758473;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YERFYJOKWWABQO-UHFFFAOYSA-N
131765775;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AXNLZGZTFCFLJT-UHFFFAOYSA-N
131760112;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MNFJIZPZFDFSHT-UHFFFAOYSA-N
131755313;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IAQHPRCGXYWKRC-UHFFFAOYSA-N
131759853;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FXJCGDYWDDAGPZ-UHFFFAOYSA-N
131757704;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WZSWCHGXBYZHMA-UHFFFAOYSA-N
131760297;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OYFSLUROHDMBJJ-UHFFFAOYSA-N
9545351;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;LYUOZIPQCKXNPX-UHFFFAOYSA-N
131760706;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;AKQAUMVOMMKMTF-UHFFFAOYSA-N
9545374;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GDSOHLLQXYEIDF-UHFFFAOYSA-N
131756570;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XYNZLONPOFRLJB-UHFFFAOYSA-N
131764154;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NBIMQFDILFVFBB-UHFFFAOYSA-N
131761686;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BBGDVLRKNFSFTF-UHFFFAOYSA-N
131760714;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RBFZLZMJOWEYIX-UHFFFAOYSA-N
131756772;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;OUVCXSDTWMPGJT-UHFFFAOYSA-N
131760178;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;OGZYWHBWXAJJRP-UHFFFAOYSA-N
131758236;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZYOAWXKTIAAOD-UHFFFAOYSA-N
131761337;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;KNVXBCMILXVLTA-UHFFFAOYSA-N
131760828;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ATCRUZMUPRXROY-UHFFFAOYSA-N
131757269;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;LOUYJPLUAGKBFG-UHFFFAOYSA-N
131763580;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;JIILIEPJZCAPPZ-UHFFFAOYSA-N
131763311;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;WMCZIAXAQXLFKB-UHFFFAOYSA-N
131761770;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XWBXEKHMDWEGSR-UHFFFAOYSA-N
131759383;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YYVDCJLPCNWCCR-UHFFFAOYSA-N
131759995;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WZCUNFYCFDLHNZ-UHFFFAOYSA-N
131757268;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;CYEYMUIZHDCNEQ-UHFFFAOYSA-N
131756157;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XLDJIGJUYLTKCW-UHFFFAOYSA-N
131755586;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MEUKCWGKFGAXPK-UHFFFAOYSA-N
131757939;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;OBQQBOPIPFQDPJ-UHFFFAOYSA-N
131762519;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QCZNYKXKMTUJGT-UHFFFAOYSA-N
131761474;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CJXBOQIATYJBPZ-UHFFFAOYSA-N
131756760;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IULQMBPZWYNZEZ-UHFFFAOYSA-N
131755639;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YQESTRXWSPZNHW-UHFFFAOYSA-N
131757708;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NPZLRDCOUNCXDT-UHFFFAOYSA-N
131766076;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VPOZOJSGWJGLAC-UHFFFAOYSA-N
131764341;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMJSZQBPVUGYMY-UHFFFAOYSA-N
131762510;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NLIRMXKSZFVANY-UHFFFAOYSA-N
131762646;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QSWDCFMAGFRFLB-UHFFFAOYSA-N
131757741;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XDLVHAQCGLBAQF-UHFFFAOYSA-N
131757031;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DIKFYIAWOURXLG-UHFFFAOYSA-N
131761138;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YFMDCVKFNONJOO-UHFFFAOYSA-N
131758416;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NVDYXXAEDSIYNY-UHFFFAOYSA-N
131760580;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BOHGMMGUVPUWFF-UHFFFAOYSA-N
131756281;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CDFAJARHNVKXPZ-UHFFFAOYSA-N
131756931;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DEGARZFHWKYSKY-UHFFFAOYSA-N
131763558;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MLHPCHDXLJOHRM-UHFFFAOYSA-N
131757089;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NEVHLARDZQWNDN-UHFFFAOYSA-N
131760378;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HLZUZYCNWDXIET-UHFFFAOYSA-N
131760326;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UWOXYLRRGFBQMC-UHFFFAOYSA-N
131759527;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;BOXFXXYECNCIFC-UHFFFAOYSA-N
131760111;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;FWPCKKOAEAIPKJ-UHFFFAOYSA-N
9545767;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GHVVXAAHMOLTMW-UHFFFAOYSA-N
131757543;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RNCIUDLIXBXAFK-UHFFFAOYSA-N
131763655;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YWXCEMWZELUBSX-UHFFFAOYSA-N
131758724;LPAR3;6;8.015000000000001e-69;0.5625;10.493;121.8041;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RDIKTUSAPKAQOH-UHFFFAOYSA-N
131762659;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NNBFKLFMPMDQEJ-UHFFFAOYSA-N
131761593;FABP3;7;9.821999999999999e-53;0.5;1.7361;92.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WDXAQMAKFLAOHN-UHFFFAOYSA-N
131762605;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JIJSROMUTDPOMJ-UHFFFAOYSA-N
131762520;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NWUKMNBNRHWGKD-UHFFFAOYSA-N
131764085;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;XTPPLMSBGCFPTO-UHFFFAOYSA-N
131755280;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MZNKMPMMJCRJCG-UHFFFAOYSA-N
131757152;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FXPIYBNAKLGETL-UHFFFAOYSA-N
131765687;FABP3;7;2.703e-52;0.4681;1.7214;92.1313;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PETWQBFAHCQEHD-UHFFFAOYSA-N
131758426;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YHXPJGXXXHDEDU-UHFFFAOYSA-N
131756570;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XYNZLONPOFRLJB-UHFFFAOYSA-N
131759535;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LXYLTKFBCPXRRN-UHFFFAOYSA-N
131758105;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;AGZNGMZBQPKGJK-UHFFFAOYSA-N
131762013;FABP3;7;3.99e-49;0.45;1.6154;86.4416;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZGUFPHBIMQTUKT-UHFFFAOYSA-N
131763427;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YXMZAVWGCYZIAF-UHFFFAOYSA-N
131755681;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RKCXETNTKLONSQ-UHFFFAOYSA-N
131764032;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;NOLCSFQLXSPJBG-UHFFFAOYSA-N
131761276;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;QHLATCHOBPMICE-UHFFFAOYSA-N
131764108;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;HWOAMJMEVLUICF-UHFFFAOYSA-N
131760398;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LZQXDMQLLSQLDI-UHFFFAOYSA-N
131756426;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NFFNDBLEGQCYOX-UHFFFAOYSA-N
131764401;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMKPIBYZJMFWDC-UHFFFAOYSA-N
131765208;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JWOUNOKQOBGPPN-UHFFFAOYSA-N
131753645;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;FHNSFDXXUNMFHU-UHFFFAOYSA-N
131760119;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GSHKNZZOMWCMJO-UHFFFAOYSA-N
131766409;FABP3;7;8.167e-49;0.4286;1.605;85.8831;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;FHTDYIDIOVTTCF-UHFFFAOYSA-N
131759995;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WZCUNFYCFDLHNZ-UHFFFAOYSA-N
131765021;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UJZZUTNWRYJMTF-UHFFFAOYSA-N
131756281;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CDFAJARHNVKXPZ-UHFFFAOYSA-N
131764242;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XCCCZEHGAYDWGO-UHFFFAOYSA-N
131760715;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VACJTARUJZHQTP-UHFFFAOYSA-N
131766256;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FZXHRPROYXAPTJ-UHFFFAOYSA-N
131761396;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UJRJCLHLHPOJDC-UHFFFAOYSA-N
131757443;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;CZMBTAPVPVKAEQ-UHFFFAOYSA-N
131762509;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FSGZYGYLCKMUKP-UHFFFAOYSA-N
131760827;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HTNGQUGKMONWEF-UHFFFAOYSA-N
131763765;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;CRKRCBKIBIHXFP-UHFFFAOYSA-N
131756777;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KJJSZLIZMYZLOM-UHFFFAOYSA-N
131758432;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DZRDCZBPJFZULK-UHFFFAOYSA-N
131763967;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CDUVBPWCCZLKBZ-UHFFFAOYSA-N
131765376;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XSUFNQFSNOZPJJ-UHFFFAOYSA-N
131761294;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;OZIVOOHFGACURK-UHFFFAOYSA-N
131762850;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DVVXILVDNWEYLR-UHFFFAOYSA-N
131760444;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ICXGNYXLZAKZKP-UHFFFAOYSA-N
131765780;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;DDMIXISYNHIHGW-UHFFFAOYSA-N
131755823;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NDODQCHGZSBDMO-UHFFFAOYSA-N
131755873;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;VGHLSLRDNJIASC-UHFFFAOYSA-N
131757172;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IILFLPTWCQUCBF-UHFFFAOYSA-N
131757139;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BPDREBISDHEJBG-UHFFFAOYSA-N
131762541;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IWLAXAPEIGUTCB-UHFFFAOYSA-N
131760258;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WMGBXZPFBDGEGE-UHFFFAOYSA-N
131760259;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FERRYQPGBTWCLI-UHFFFAOYSA-N
131760132;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;WODOUFGUYBJSCG-UHFFFAOYSA-N
131764109;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BLUODYRHIPCAQS-UHFFFAOYSA-N
131758081;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;JTMWSXQSMSFDAB-UHFFFAOYSA-N
131755848;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PFQZTTBUBNIVPK-UHFFFAOYSA-N
131761247;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;KYMZBLBKJMZRJX-UHFFFAOYSA-N
131763007;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;STBHWPRLUZOAIJ-UHFFFAOYSA-N
131758473;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YERFYJOKWWABQO-UHFFFAOYSA-N
131763164;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WDLBTJHWGYBSCW-UHFFFAOYSA-N
56940406;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;OEKRRUNWWAUSPT-UHFFFAOYSA-N
131759364;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WBUNYBCPBJAPRX-UHFFFAOYSA-N
131764056;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BODCPTKZTGBALI-UHFFFAOYSA-N
131760877;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQGJZWLEVUCIQR-UHFFFAOYSA-N
131757133;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HMRPHEFZYARYNZ-UHFFFAOYSA-N
131759554;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GCZJDCKDLSIPSW-UHFFFAOYSA-N
131756875;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;AXLMYDXBLLUOLF-UHFFFAOYSA-N
131764535;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ROYJPPZMPGNTCP-UHFFFAOYSA-N
131760239;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XHZZGLXWFJMTMZ-UHFFFAOYSA-N
131756415;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XOMMIQREYDPKRF-UHFFFAOYSA-N
131760251;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDJRCOJFDNTSGV-UHFFFAOYSA-N
131756077;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RWHDQXUEVMMABX-UHFFFAOYSA-N
131765114;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XPHRYTCVIDCWOL-UHFFFAOYSA-N
131759528;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;CHXNIWLFFFQXQY-UHFFFAOYSA-N
131760189;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RVZCIRATOLVRIA-UHFFFAOYSA-N
131756855;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MYYKNWKDBLPJRV-UHFFFAOYSA-N
131753872;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DJOOHJRCQZSQJS-UHFFFAOYSA-N
131760800;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;CZCNBEOJWUHLJB-UHFFFAOYSA-N
131762659;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;NNBFKLFMPMDQEJ-UHFFFAOYSA-N
131762541;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;IWLAXAPEIGUTCB-UHFFFAOYSA-N
131763381;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BALVTBGXOJRZCI-UHFFFAOYSA-N
131764122;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MGEAOKJODZKTKX-UHFFFAOYSA-N
131761381;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JDVIBBNZDQDULN-UHFFFAOYSA-N
131756923;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KRGKEXOYBMAEQS-UHFFFAOYSA-N
131762741;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZAMSJHWTYQXQPY-UHFFFAOYSA-N
131761556;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DPAGBXUISVSPAM-UHFFFAOYSA-N
131763231;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFTFKKKNMJLXFT-UHFFFAOYSA-N
131757172;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IILFLPTWCQUCBF-UHFFFAOYSA-N
131762396;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PKRMTWZVLNHVCA-UHFFFAOYSA-N
131758352;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RBAXJCVLSUEXJH-UHFFFAOYSA-N
131760891;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TUYQXUBNEYRCJG-UHFFFAOYSA-N
131750380;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZZUYNPSYAPCHJT-UHFFFAOYSA-N
131760151;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;MXNYWQGAKRABHA-UHFFFAOYSA-N
131756892;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BTSUUUCAWHHMAG-UHFFFAOYSA-N
131762510;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NLIRMXKSZFVANY-UHFFFAOYSA-N
131753834;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MIRRUHDLDQABSJ-UHFFFAOYSA-N
131755492;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FHLCKJOBUHAURH-UHFFFAOYSA-N
131753405;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LJKKMUUFGNOAAL-UHFFFAOYSA-N
131757115;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JUJSCXCFHLKMAG-UHFFFAOYSA-N
131757741;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XDLVHAQCGLBAQF-UHFFFAOYSA-N
131757917;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;CSXWGAYDXHHFDH-UHFFFAOYSA-N
131763964;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PHFDIFRFKJJMBV-UHFFFAOYSA-N
131761442;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ADKLGQHKFMGSDC-UHFFFAOYSA-N
131755493;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LZMYQBXIIPFGAL-UHFFFAOYSA-N
131761548;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZDPAUWXMIGMKJP-UHFFFAOYSA-N
9545627;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;IMKJVBUOLHLZAH-UHFFFAOYSA-N
131761413;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FBEGIWCDARDTAH-UHFFFAOYSA-N
131760459;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;INWPHLCORRPJIM-UHFFFAOYSA-N
131765013;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ABQOBDXXEGCQPI-UHFFFAOYSA-N
131763587;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SLHARRPKIAUULE-UHFFFAOYSA-N
9545522;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IMWXKSCYQVBGON-UHFFFAOYSA-N
131763326;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZUFGRRVTVKEBJI-UHFFFAOYSA-N
131756176;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MEIGPYFQXNHGCJ-UHFFFAOYSA-N
131765084;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;DSHWDOGQDLMJNI-UHFFFAOYSA-N
131762606;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IEOSRVGEECHXBY-UHFFFAOYSA-N
131764630;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FLCCFUGFGCCGBK-UHFFFAOYSA-N
131758225;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;NCTGMGBJXWCUSU-UHFFFAOYSA-N
131756070;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NXVPBQKOQAHIQZ-UHFFFAOYSA-N
131763339;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZYYSWIRPQRDPKM-UHFFFAOYSA-N
131757152;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FXPIYBNAKLGETL-UHFFFAOYSA-N
131759216;LPAR3;6;6.568e-65;0.54;9.8912;114.778;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UYTLNZBFEBCSPM-UHFFFAOYSA-N
131755286;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WWQOCPZHIQRZNO-UHFFFAOYSA-N
9545522;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IMWXKSCYQVBGON-UHFFFAOYSA-N
131762754;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OQDCWOUJNQSYMR-UHFFFAOYSA-N
131761134;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UEUMJNZAUWBSAC-UHFFFAOYSA-N
131764110;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;COZVSHKROVOQOP-UHFFFAOYSA-N
131765728;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;YZQJJIWXQVTOPY-UHFFFAOYSA-N
131756253;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DHFHFDYQWHOMJO-UHFFFAOYSA-N
131756188;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VLOCCOVTRWLMEU-UHFFFAOYSA-N
131761450;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XFAWUHKFJSCOCU-UHFFFAOYSA-N
9545448;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XTFHDFLJLDMULJ-UHFFFAOYSA-N
131757756;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CQRHWLBMFHTPSF-UHFFFAOYSA-N
131765724;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RTQRXFBDRZBVFU-UHFFFAOYSA-N
131764415;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WOEWLVSANLVPBT-UHFFFAOYSA-N
131760877;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DQGJZWLEVUCIQR-UHFFFAOYSA-N
131756228;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HCLNENGBRCSTJE-UHFFFAOYSA-N
131762667;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MWLKTPCHSMXLLY-UHFFFAOYSA-N
131760306;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LQORAQJGEORWLS-UHFFFAOYSA-N
131761139;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YWMXFRKULOXAPT-UHFFFAOYSA-N
131757178;FABP3;7;7.302e-49;0.4667;1.6067;85.9704;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HLBJXGSSXOWJNK-UHFFFAOYSA-N
131760210;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CIQHDYHPBGLGRY-UHFFFAOYSA-N
56940421;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FGBZKVMJCSLMNT-UHFFFAOYSA-N
131759548;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MYSDZTIORDWFIW-UHFFFAOYSA-N
131755477;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKXVFDJOYACJHJ-UHFFFAOYSA-N
131756150;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NKQWVJHGQMXCFY-UHFFFAOYSA-N
131764192;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JFCUMDGUAUVTSM-UHFFFAOYSA-N
131765279;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;QSAZQWUZAGCDBS-UHFFFAOYSA-N
131757147;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PUGGWLRJISRKED-UHFFFAOYSA-N
131762849;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LEISCWOXEYMOAG-UHFFFAOYSA-N
131764615;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DSBMDFNAANRIOD-UHFFFAOYSA-N
131760575;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FIEHEEYBLZIFLG-UHFFFAOYSA-N
131762319;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;UHCRYPFJSBIIRR-UHFFFAOYSA-N
131760259;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FERRYQPGBTWCLI-UHFFFAOYSA-N
131760319;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IAFMACZCBGOYAR-UHFFFAOYSA-N
131757394;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;REOIMVZEISKUHF-UHFFFAOYSA-N
131761947;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HBMNWHFLFHOFFZ-UHFFFAOYSA-N
131761507;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XFQJFJLWOIVLOP-UHFFFAOYSA-N
131762599;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BPRIEDPMPZRCDU-UHFFFAOYSA-N
131756569;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NZBRMZMLPIKHLK-UHFFFAOYSA-N
131756732;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;MRZUKESUWGFNGN-UHFFFAOYSA-N
9545448;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XTFHDFLJLDMULJ-UHFFFAOYSA-N
131765724;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RTQRXFBDRZBVFU-UHFFFAOYSA-N
131759628;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KMLLHGHUQWACBE-UHFFFAOYSA-N
131759970;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GNQOPFBPJFYLEN-UHFFFAOYSA-N
131761678;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UAJDOZFIHLGIOJ-UHFFFAOYSA-N
131765762;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GGWFIQWJEZZPGR-UHFFFAOYSA-N
131760965;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GZUMPLARGPROGA-UHFFFAOYSA-N
131760265;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NYIPWEDEDCENLJ-UHFFFAOYSA-N
131764973;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YOYHAKULCQGNIT-UHFFFAOYSA-N
131760580;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BOHGMMGUVPUWFF-UHFFFAOYSA-N
131760938;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RFYJOAKKTIXXJD-UHFFFAOYSA-N
131761924;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NTEFIKMFLCQZKQ-UHFFFAOYSA-N
131760598;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QZXIVAFCGWISDS-UHFFFAOYSA-N
131764052;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QKUJSLKNYNFMCG-UHFFFAOYSA-N
131761772;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SPIHSNCGRXGHRO-UHFFFAOYSA-N
131765230;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BVJYLMXQFAHMGO-UHFFFAOYSA-N
131750419;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BZPDQOHIKFKCEV-UHFFFAOYSA-N
131757296;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;LFKOJNRPJDKRCS-UHFFFAOYSA-N
131756374;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UGESMJAODJVYKL-UHFFFAOYSA-N
131761816;FABP3;7;6.754e-56;0.5122;1.8418;98.5984;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XWDKUUOKCJGHBE-UHFFFAOYSA-N
131756400;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DSTCTJRXZHFEEO-UHFFFAOYSA-N
131756348;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NZDXNWLXUJHQDW-UHFFFAOYSA-N
131765060;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;YKIKYETUKYLZGC-UHFFFAOYSA-N
131757778;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KFTJSRDBWLUZAR-UHFFFAOYSA-N
131766343;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;GDUXUDRMHCHQQG-UHFFFAOYSA-N
131761236;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;VXEUWHHXKKJFHJ-UHFFFAOYSA-N
131761598;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OHDFRISQFVTZCL-UHFFFAOYSA-N
9545532;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BQXCEUPRWWRHCG-UHFFFAOYSA-N
131758037;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCC;BZZJVZIMQHLYFH-UHFFFAOYSA-N
131759988;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GPRNIHMMZUKOCG-UHFFFAOYSA-N
131763351;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZNOAWGZVSGWABO-UHFFFAOYSA-N
131756991;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RFCDSMPUWNZUFI-UHFFFAOYSA-N
131756996;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ACGHXTVLDFHATI-UHFFFAOYSA-N
131760313;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UDICYIUJKLODAB-UHFFFAOYSA-N
131756575;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;YJBBKAQEXQATDN-UHFFFAOYSA-N
131761413;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FBEGIWCDARDTAH-UHFFFAOYSA-N
131766346;LPAR3;6;3.613e-62;0.5094;9.4697;109.858;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;MRBYYUNTUNMTMA-UHFFFAOYSA-N
131757548;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FOFFTNBYEWWFON-UHFFFAOYSA-N
131764341;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZMJSZQBPVUGYMY-UHFFFAOYSA-N
131761977;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;BLZIAWKRCIQGBQ-UHFFFAOYSA-N
131761461;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IRUNKUKWFHXBGR-UHFFFAOYSA-N
131762778;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;CGQLVCFUDCESMV-UHFFFAOYSA-N
131758052;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MPULJGAMFCKYGH-UHFFFAOYSA-N
131762274;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KGIVQHRXQYBBBF-UHFFFAOYSA-N
131764936;FABP3;7;2.3779999999999997e-53;0.4783;1.7567;94.0263;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PYQKFCMZOTWMNG-UHFFFAOYSA-N
9545375;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZABKADJKVACIK-UHFFFAOYSA-N
131757416;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;NBAGACYNMBHBAX-UHFFFAOYSA-N
131764040;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YOEYZADNHRXJJT-UHFFFAOYSA-N
131764771;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GOCVRJSMLHXZOM-UHFFFAOYSA-N
131763140;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HKRSQYQLQNSHTO-UHFFFAOYSA-N
131764630;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;FLCCFUGFGCCGBK-UHFFFAOYSA-N
131757846;LPAR3;6;1.9580000000000002e-58;0.4815;8.8955;103.1545;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;HAAANVHPHRLRPS-UHFFFAOYSA-N
131762430;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SAWHJLXGHUDEDK-UHFFFAOYSA-N
131758105;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;AGZNGMZBQPKGJK-UHFFFAOYSA-N
131759685;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;RECDMXVWMLBZBY-UHFFFAOYSA-N
131763957;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;LEDZXTFKKPRATN-UHFFFAOYSA-N
131762977;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NAYLGIBYZIJGJI-UHFFFAOYSA-N
131764498;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QANZEVFDXQPYRW-UHFFFAOYSA-N
131759390;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LXMOBIJJRVVOQR-UHFFFAOYSA-N
9545532;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BQXCEUPRWWRHCG-UHFFFAOYSA-N
131764149;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MHNHYVCCWTUPKM-UHFFFAOYSA-N
131756414;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;FFMPGKXDJNLCRV-UHFFFAOYSA-N
131762771;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKTQVQIRLRPGDR-UHFFFAOYSA-N
131757774;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LNEGIXKHOVJBCA-UHFFFAOYSA-N
131761812;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BINYJEJVCIPSFI-UHFFFAOYSA-N
131762343;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PFJYUMJZKKKZDO-UHFFFAOYSA-N
131762542;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CEDIQWAKNMQFHR-UHFFFAOYSA-N
131764154;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;NBIMQFDILFVFBB-UHFFFAOYSA-N
131756365;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AKYYZUWPIITYAK-UHFFFAOYSA-N
131762740;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SBNMRUIGCHPGON-UHFFFAOYSA-N
131755472;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SUSVIZFJFDUVRG-UHFFFAOYSA-N
131762986;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;XMEDZNCDBPSROA-UHFFFAOYSA-N
131762994;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;SBHVXVGIUJBNSJ-UHFFFAOYSA-N
131762727;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;HUFAUCRKBKDFDP-UHFFFAOYSA-N
131755403;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;LEYNPNMAFNJINO-UHFFFAOYSA-N
131755499;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GCOQNBYYCRADMG-UHFFFAOYSA-N
9545778;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SCZUAPBFQIKQCZ-UHFFFAOYSA-N
131755873;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;VGHLSLRDNJIASC-UHFFFAOYSA-N
131756954;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AYHWSRWXZGTAJR-UHFFFAOYSA-N
131756052;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;WFKRBGOCZSKULO-UHFFFAOYSA-N
131757778;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KFTJSRDBWLUZAR-UHFFFAOYSA-N
131761261;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YYDMKYRCWRXENW-UHFFFAOYSA-N
131764229;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LDWACUWXECAMNZ-UHFFFAOYSA-N
131758432;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;DZRDCZBPJFZULK-UHFFFAOYSA-N
131764866;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KZMACVQAHWYDMM-UHFFFAOYSA-N
131762290;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SEYKPSIUYHSDMB-UHFFFAOYSA-N
131760834;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;DRJWUSGKQPKDTB-UHFFFAOYSA-N
131763442;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QRAYXPKVQDNMMF-UHFFFAOYSA-N
131760445;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RDYPQHGKLGNVNR-UHFFFAOYSA-N
131757916;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;MLAAGFLYGGJEIR-UHFFFAOYSA-N
131758046;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IRMUTXUYWRLUGE-UHFFFAOYSA-N
131760444;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ICXGNYXLZAKZKP-UHFFFAOYSA-N
131762779;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;XPNUDVKOGAAXPS-UHFFFAOYSA-N
131756892;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BTSUUUCAWHHMAG-UHFFFAOYSA-N
131760858;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FWEUKYATQHHVDX-UHFFFAOYSA-N
131764428;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QOCFTCUMNUGLBB-UHFFFAOYSA-N
131761248;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WPTIBZNSPMSWML-UHFFFAOYSA-N
131760884;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FJFQEYNMGJSGOC-UHFFFAOYSA-N
131762274;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;KGIVQHRXQYBBBF-UHFFFAOYSA-N
131755485;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YZYLLQDFUYUJGF-UHFFFAOYSA-N
56940387;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;PQMAOFUFIMHGKV-UHFFFAOYSA-N
131762645;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;XZWHNXBAQKSDHH-UHFFFAOYSA-N
131756576;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;APPYUQSCODMKIN-UHFFFAOYSA-N
131761846;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;LKEFQOSBUFGTFE-UHFFFAOYSA-N
131758901;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZULICJDFTKHDTK-UHFFFAOYSA-N
131763655;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;YWXCEMWZELUBSX-UHFFFAOYSA-N
131761482;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;HESVTHZAJFHPDB-UHFFFAOYSA-N
131757275;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;PSQNMLIGVNKGBS-UHFFFAOYSA-N
131762616;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;FRJVUQNOKPPWFF-UHFFFAOYSA-N
131759554;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GCZJDCKDLSIPSW-UHFFFAOYSA-N
131764408;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OPWCVQYBFRNZGW-UHFFFAOYSA-N
131760815;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;YUCHRXJXJUSLFQ-UHFFFAOYSA-N
131762040;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;OYJUCBWWULREPL-UHFFFAOYSA-N
131758282;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;JPJMXAFPVUPHGK-UHFFFAOYSA-N
131765094;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ONWVKDMOWWRYKJ-UHFFFAOYSA-N
131760298;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SRARWQZTRDRWIY-UHFFFAOYSA-N
131755472;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;SUSVIZFJFDUVRG-UHFFFAOYSA-N
131761514;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NLHGMVZOEGWXJR-UHFFFAOYSA-N
131760244;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFAOTZPCSYQOED-UHFFFAOYSA-N
131758046;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;IRMUTXUYWRLUGE-UHFFFAOYSA-N
131759390;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LXMOBIJJRVVOQR-UHFFFAOYSA-N
131764936;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;PYQKFCMZOTWMNG-UHFFFAOYSA-N
131763271;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;POKWAFRJAZNFSU-UHFFFAOYSA-N
131756253;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;DHFHFDYQWHOMJO-UHFFFAOYSA-N
131762282;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;CEJOBDUANZCCOB-UHFFFAOYSA-N
131765175;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KUKXRUGYPUGLNB-UHFFFAOYSA-N
131762290;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SEYKPSIUYHSDMB-UHFFFAOYSA-N
131756330;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UGSOYIWJZWSYGO-UHFFFAOYSA-N
131760280;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RXMYNXNZICUHSI-UHFFFAOYSA-N
131760177;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RERKVVZYIAVMKL-UHFFFAOYSA-N
131761805;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FNVXDAXZGGBYJV-UHFFFAOYSA-N
131757864;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;SWJAOFQRGQDADV-UHFFFAOYSA-N
131756053;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MAHQPVANDQGZIN-UHFFFAOYSA-N
131766379;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KIUFCROTWBUMMM-UHFFFAOYSA-N
131763165;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;DYXIHLFAMCSWDP-UHFFFAOYSA-N
131757707;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;NMHPZWRTPAPYOL-UHFFFAOYSA-N
131756203;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MBYYMZUVLLYROS-UHFFFAOYSA-N
131763164;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WDLBTJHWGYBSCW-UHFFFAOYSA-N
131762728;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;LIBQPQCZEFGZPS-UHFFFAOYSA-N
131757275;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCC;PSQNMLIGVNKGBS-UHFFFAOYSA-N
131764670;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NTFIQEWZDSXEJP-UHFFFAOYSA-N
131765905;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;AOTFUYDDGGOHGP-UHFFFAOYSA-N
9545449;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FRWFMVSCXNKUPX-UHFFFAOYSA-N
131765231;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AVHSMRVNDALZFQ-UHFFFAOYSA-N
131758241;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JFSBSLVFROLCLU-UHFFFAOYSA-N
131764414;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BDCZEXNOCSGQCL-UHFFFAOYSA-N
131755109;LPAR3;6;1.184e-61;0.5745;9.3905;108.9324;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NWYRSEXEDYEEFM-UHFFFAOYSA-N
131759679;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ADSZQKQPUVZHRL-UHFFFAOYSA-N
131758718;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PPKIZYUIIFPNOZ-UHFFFAOYSA-N
131757036;FABP3;7;1.846e-52;0.4746;1.7269;92.4287;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQXBXQMXXNQSMI-UHFFFAOYSA-N
131755313;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;IAQHPRCGXYWKRC-UHFFFAOYSA-N
131763258;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ASHDSIZMSUYRGL-UHFFFAOYSA-N
131764958;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;TXHGTEXFFQXVMR-UHFFFAOYSA-N
131756234;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FSLGMQVJEHZUPJ-UHFFFAOYSA-N
131758901;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZULICJDFTKHDTK-UHFFFAOYSA-N
131762504;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;ZTJYQIYMUQWSOC-UHFFFAOYSA-N
131758403;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;AHYOFQHJCROZHS-UHFFFAOYSA-N
131756978;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;OUDWFYHOJFIKDR-UHFFFAOYSA-N
131760599;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HAVPVXRAONEJBL-UHFFFAOYSA-N
131759606;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZUPXIIFMWPFTKM-UHFFFAOYSA-N
131764797;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;GOBSVYLENLQESQ-UHFFFAOYSA-N
131761811;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PYHYTXIIXWEHSC-UHFFFAOYSA-N
131759853;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FXJCGDYWDDAGPZ-UHFFFAOYSA-N
131762103;FABP3;7;5.41e-53;0.459;1.7447;93.3855;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CMEILRZMJFZODR-UHFFFAOYSA-N
131757733;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;GWECERDTBORDQQ-UHFFFAOYSA-N
131756184;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;KWKOUCDAAANDPY-UHFFFAOYSA-N
131759700;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BTOBAOSWLQZTFQ-UHFFFAOYSA-N
131756227;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LUUMBKHGQRFUNQ-UHFFFAOYSA-N
131765775;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AXNLZGZTFCFLJT-UHFFFAOYSA-N
131759650;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FFSBYDWZGXLHOR-UHFFFAOYSA-N
131766125;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;COHAHZFRWDOLFS-UHFFFAOYSA-N
131760616;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;SEGAFXOOJWNDFX-UHFFFAOYSA-N
131762396;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PKRMTWZVLNHVCA-UHFFFAOYSA-N
131756711;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OUVOMMBEDVUBQG-UHFFFAOYSA-N
131759363;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HSNAKNZDCUCCNE-UHFFFAOYSA-N
131764122;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;MGEAOKJODZKTKX-UHFFFAOYSA-N
131755505;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZWDRUMGFLNADOE-UHFFFAOYSA-N
131761913;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;AWUSALQTKNQHQD-UHFFFAOYSA-N
131764110;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;COZVSHKROVOQOP-UHFFFAOYSA-N
131759376;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ZNLDPPZYMIYAKR-UHFFFAOYSA-N
131763367;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HXTSHFBTAPQXOE-UHFFFAOYSA-N
131760898;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DSDYHEOLLZDDPO-UHFFFAOYSA-N
56940396;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZLBFDCQURCAMRP-UHFFFAOYSA-N
9545375;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DZABKADJKVACIK-UHFFFAOYSA-N
131756053;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MAHQPVANDQGZIN-UHFFFAOYSA-N
131764771;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GOCVRJSMLHXZOM-UHFFFAOYSA-N
131753864;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NKIGKQWLBIPYDK-UHFFFAOYSA-N
131763427;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YXMZAVWGCYZIAF-UHFFFAOYSA-N
131761669;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ABQXBTBXGFBZIV-UHFFFAOYSA-N
131757069;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;QOVOXGFLQUWOCD-UHFFFAOYSA-N
131762763;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;WPTDLSWTVUJAOX-UHFFFAOYSA-N
131761499;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;WTGRDQWTZSUSQB-UHFFFAOYSA-N
131761359;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;AILHDVOWAUJGKA-UHFFFAOYSA-N
131760574;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;BHETTXDAZXCFKF-UHFFFAOYSA-N
131764143;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;PUCACZUVSXLWRS-UHFFFAOYSA-N
131766418;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GYVVNJNAXWYMSI-UHFFFAOYSA-N
131759692;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KTSYFYGEYMWJBJ-UHFFFAOYSA-N
131757871;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCC;AOEMOZQBRAJCGN-UHFFFAOYSA-N
131761789;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;SXPQPXRSBLSSAC-UHFFFAOYSA-N
131756275;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JLSNFGORYGPKQA-UHFFFAOYSA-N
131760006;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;RVALMDYIOYYMPN-UHFFFAOYSA-N
131757091;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FACDAQXMPKTFRQ-UHFFFAOYSA-N
131764677;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KOHORHCCLQOXCS-UHFFFAOYSA-N
131762740;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;SBNMRUIGCHPGON-UHFFFAOYSA-N
131759382;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;HEMRKPYNFGQFML-UHFFFAOYSA-N
131759970;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GNQOPFBPJFYLEN-UHFFFAOYSA-N
131760891;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;TUYQXUBNEYRCJG-UHFFFAOYSA-N
131755306;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QEVBZWCDAZFBQV-UHFFFAOYSA-N
131762755;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FQOOBZWSSFBGRJ-UHFFFAOYSA-N
131759499;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;KGQWRGYSBBEKHB-UHFFFAOYSA-N
131765762;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GGWFIQWJEZZPGR-UHFFFAOYSA-N
131764074;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SXLSGVHVTGSALG-UHFFFAOYSA-N
131762748;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;PJDOXWVMHBYGBX-UHFFFAOYSA-N
131762849;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;LEISCWOXEYMOAG-UHFFFAOYSA-N
131764682;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FFAOLBOCMJSXFL-UHFFFAOYSA-N
131764930;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QYDUYXRVYKJXAF-UHFFFAOYSA-N
131761930;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XJKUBRHQRPUPNX-UHFFFAOYSA-N
131753842;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KKWGNAXIJLGZIW-UHFFFAOYSA-N
131758082;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCC;WNTKADGAFKNKPP-UHFFFAOYSA-N
131757393;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;UNUYEOWBNOUCHI-UHFFFAOYSA-N
131756282;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WDAMDABFGGIOBB-UHFFFAOYSA-N
131764530;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WKMJVPNNZRZPKK-UHFFFAOYSA-N
131758908;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IBUWOVXDFGLFPQ-UHFFFAOYSA-N
131755681;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RKCXETNTKLONSQ-UHFFFAOYSA-N
131756374;FABP3;7;5.132e-56;0.4821;1.8458;98.8126;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UGESMJAODJVYKL-UHFFFAOYSA-N
131758409;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FKDVIQPHQIWBSH-UHFFFAOYSA-N
131756382;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHSZPPTYGRFCSI-UHFFFAOYSA-N
131757116;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KBDPPMIATBCOMG-UHFFFAOYSA-N
9545459;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VGUNDIMKOJFCKY-UHFFFAOYSA-N
131764039;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;RWRADNFFPOHHEA-UHFFFAOYSA-N
131757598;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;MIDOZDIGHHQOQX-UHFFFAOYSA-N
131759606;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZUPXIIFMWPFTKM-UHFFFAOYSA-N
131762289;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ZLWQYLIHICZAQN-UHFFFAOYSA-N
131763454;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NVCFQTAXRDDMLZ-UHFFFAOYSA-N
131764068;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;SATBWAXPKBXLEF-UHFFFAOYSA-N
131761484;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;GTMNASXROGIQBF-UHFFFAOYSA-N
131761514;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NLHGMVZOEGWXJR-UHFFFAOYSA-N
131757475;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;XGXUDWBHHLLXEY-UHFFFAOYSA-N
131762305;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LDQMUQGHUBNDTF-UHFFFAOYSA-N
131758031;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VHXPQJFOLJPCQU-UHFFFAOYSA-N
131764338;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NUEYLMZDBXYDET-UHFFFAOYSA-N
131762550;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ODFCEYTWBQSXQC-UHFFFAOYSA-N
131760820;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;NHNBHJTVRJQCPP-UHFFFAOYSA-N
131764052;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QKUJSLKNYNFMCG-UHFFFAOYSA-N
131764691;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XATFYFLKYAULHM-UHFFFAOYSA-N
131764681;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GSUWRMPMDCWVTH-UHFFFAOYSA-N
131763267;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QNNMKCWGRUYNED-UHFFFAOYSA-N
131757549;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;WLCMTXXFZMOMHZ-UHFFFAOYSA-N
131756883;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FKRMVRADOUUIPO-UHFFFAOYSA-N
131755655;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;UEPGRXMBZHCOGK-UHFFFAOYSA-N
131760885;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;VBYQUDJISXINCX-UHFFFAOYSA-N
131761971;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KIWZLPDMTTVSIN-UHFFFAOYSA-N
131764836;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;VRQORPMJTGLJIF-UHFFFAOYSA-N
131765914;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XBZRFWSSSDXNCN-UHFFFAOYSA-N
25240392;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;ANCUFEBJPNGQKK-UHFFFAOYSA-N
131765208;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;JWOUNOKQOBGPPN-UHFFFAOYSA-N
131760177;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;RERKVVZYIAVMKL-UHFFFAOYSA-N
131761387;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;GWYYYKLEOYWXOZ-UHFFFAOYSA-N
131757050;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;BHRCZYGYXNQZMA-UHFFFAOYSA-N
131762312;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCCCC;SWRZTLLFJSEQMV-UHFFFAOYSA-N
9545532;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BQXCEUPRWWRHCG-UHFFFAOYSA-N
131761770;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;XWBXEKHMDWEGSR-UHFFFAOYSA-N
131764493;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;TXWFFTTYLKQWRO-UHFFFAOYSA-N
131761822;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PEIWINCKWDTWRA-UHFFFAOYSA-N
131758241;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JFSBSLVFROLCLU-UHFFFAOYSA-N
131760237;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UQXVRDHAZYQOSA-UHFFFAOYSA-N
131760919;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WCNZFQBWVLERSB-UHFFFAOYSA-N
131755621;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OQTQYHCFGCOUPR-UHFFFAOYSA-N
131762343;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PFJYUMJZKKKZDO-UHFFFAOYSA-N
131757742;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;GEGMUTTVHLZEBG-UHFFFAOYSA-N
131761335;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QRQHIENJPWVWCM-UHFFFAOYSA-N
131757399;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCCCCCC;LGMIHDFKAMFZFO-UHFFFAOYSA-N
131756905;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NFLOZGHSXUQYSV-UHFFFAOYSA-N
131761694;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;UHDCEJARBRUIDB-UHFFFAOYSA-N
131757116;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;KBDPPMIATBCOMG-UHFFFAOYSA-N
131762534;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TWMZUNYBAPKPNZ-UHFFFAOYSA-N
131761261;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YYDMKYRCWRXENW-UHFFFAOYSA-N
131762542;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CEDIQWAKNMQFHR-UHFFFAOYSA-N
131759846;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AEDDMHLQFFOWDJ-UHFFFAOYSA-N
131756247;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GTTMZICIVQUFGN-UHFFFAOYSA-N
131759969;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UYEMGSOIPJXIHT-UHFFFAOYSA-N
131761369;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZZPHZVWOGZYNAO-UHFFFAOYSA-N
131761971;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KIWZLPDMTTVSIN-UHFFFAOYSA-N
131764210;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;WTQILBUQTSQKMT-UHFFFAOYSA-N
131764045;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PRNZTHLFVCDZAV-UHFFFAOYSA-N
131764483;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;IJCNKBUZXXINLK-UHFFFAOYSA-N
131762865;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;APLABQCESRGFRN-UHFFFAOYSA-N
9545677;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QGLJFPIPRSJLBD-UHFFFAOYSA-N
131763587;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;SLHARRPKIAUULE-UHFFFAOYSA-N
131758235;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;KZYYSJQGDAJSBI-UHFFFAOYSA-N
131763310;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JJVQIAHLUNUXIN-UHFFFAOYSA-N
131761788;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;DBOXIHBAINITHH-UHFFFAOYSA-N
131765957;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;FHLRXHATKQNMKA-UHFFFAOYSA-N
131764742;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MDNOGAANWQBLFP-UHFFFAOYSA-N
131760239;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XHZZGLXWFJMTMZ-UHFFFAOYSA-N
131757653;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZOOFCAJPCUMJET-UHFFFAOYSA-N
131764115;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCCCCC;QTYYFJGKWKUBSQ-UHFFFAOYSA-N
131763751;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZFYDZOUJCPUDLC-UHFFFAOYSA-N
131765450;LPAR3;6;5.539e-71;0.5;10.8253;125.6829;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MKKNEWLMPQPSGJ-UHFFFAOYSA-N
131761248;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WPTIBZNSPMSWML-UHFFFAOYSA-N
131763967;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;CDUVBPWCCZLKBZ-UHFFFAOYSA-N
131764562;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VLEBBCZZNDWVCE-UHFFFAOYSA-N
131760210;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;CIQHDYHPBGLGRY-UHFFFAOYSA-N
131762741;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZAMSJHWTYQXQPY-UHFFFAOYSA-N
131753404;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZBAKDZKUJDNKLJ-UHFFFAOYSA-N
131756569;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;NZBRMZMLPIKHLK-UHFFFAOYSA-N
131764230;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XBOGPRFREBREQV-UHFFFAOYSA-N
131765054;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;KUWKDKKFKVFAGR-UHFFFAOYSA-N
131761837;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;HYQDCVGUIPYREC-UHFFFAOYSA-N
131756116;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;XZCFLUUMROMSAR-UHFFFAOYSA-N
131758074;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;LSSCZEINTKPCRU-UHFFFAOYSA-N
131766227;FABP3;7;2.1669999999999998e-51;0.4667;1.6912;90.5081;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MPOVRWPOBWYLDM-UHFFFAOYSA-N
131764627;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DVJHAUACNCKWHY-UHFFFAOYSA-N
131761693;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;ANGCSMRUARXHTN-UHFFFAOYSA-N
131761134;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UEUMJNZAUWBSAC-UHFFFAOYSA-N
131756898;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DTHQVLKUDRJNSH-UHFFFAOYSA-N
131756247;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GTTMZICIVQUFGN-UHFFFAOYSA-N
131757568;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;LABYNSUZQGFKHQ-UHFFFAOYSA-N
131763956;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;GPDKESGJHAJPPZ-UHFFFAOYSA-N
131758052;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;MPULJGAMFCKYGH-UHFFFAOYSA-N
131764034;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ULRJOCSDJZFMFY-UHFFFAOYSA-N
56940371;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;LAYMMGQEJTZXHH-UHFFFAOYSA-N
131762667;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;MWLKTPCHSMXLLY-UHFFFAOYSA-N
131761228;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;SLNSNTKFZUABKK-UHFFFAOYSA-N
131764174;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;GSLBJFYKPXLMFL-UHFFFAOYSA-N
131756439;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FTHLMZICSLNUNG-UHFFFAOYSA-N
131765244;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RVQQPBSTHIVINE-UHFFFAOYSA-N
131761532;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RRXDJYNFSRXVNG-UHFFFAOYSA-N
131756013;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;VRWLAKNBXGYTIC-UHFFFAOYSA-N
131764853;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;IWAAHSCTDZFCMG-UHFFFAOYSA-N
131756922;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UCBIXYZFPRNBNY-UHFFFAOYSA-N
131765122;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;REAXNFSVDUNGRG-UHFFFAOYSA-N
131756382;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BHSZPPTYGRFCSI-UHFFFAOYSA-N
131762550;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ODFCEYTWBQSXQC-UHFFFAOYSA-N
131766165;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XLLNNVMYNIGFGO-UHFFFAOYSA-N
131756725;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKGFMQTYNRBSTK-UHFFFAOYSA-N
131755272;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QVXASAXDWWFXGC-UHFFFAOYSA-N
131765143;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;TVJQOPIRMZCJFH-UHFFFAOYSA-N
131765593;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YHLFOSOEMRNPRK-UHFFFAOYSA-N
131763465;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GCDGRCYQBMTTFW-UHFFFAOYSA-N
131760665;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DJUZUKMVZZOHPA-UHFFFAOYSA-N
94180;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(C(=O)O)O;JKRDADVRIYVCCY-UHFFFAOYSA-N
131753594;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ABGAPQWSCYUSJV-UHFFFAOYSA-N
131759986;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PJUDTLQEZCEYBU-UHFFFAOYSA-N
131761832;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;NGIXVWBHYCBVSU-UHFFFAOYSA-N
131762078;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DZEYBXMCOFPWNY-UHFFFAOYSA-N
131765402;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FOJHZEOEWLJWDV-UHFFFAOYSA-N
131762288;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHZYTFVUDKSYSQ-UHFFFAOYSA-N
439377;NAALAD2;6;2.773e-92;0.6154;5.3657;163.9239;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CNC(CCC(=O)O)C(=O)O;XLBVNMSMFQMKEY-UHFFFAOYSA-N
131761831;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RAEGSWCAOPPSJQ-UHFFFAOYSA-N
131756694;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBGIIZRJUJAGJD-UHFFFAOYSA-N
10976;CQSS;6;1.356e-62;0.4231;1.8302;110.622;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(C)O;CETWDUZRCINIHU-UHFFFAOYSA-N
131762117;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MKUDSHOEWNCTAU-UHFFFAOYSA-N
131753403;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NDJUOSGUPZFLID-UHFFFAOYSA-N
131756597;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;VZNQKMLGTXDQIH-UHFFFAOYSA-N
131764616;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PSZIJFDVVSPFBG-UHFFFAOYSA-N
131766161;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PZCPGKGPFMHJBX-UHFFFAOYSA-N
131755449;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HKLUOMJYFGCDTK-UHFFFAOYSA-N
131757908;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QMUANRQBCWCFMK-UHFFFAOYSA-N
131761132;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OOPMCEWTZJHXQW-UHFFFAOYSA-N
131766354;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LTXHHOPKPPDABQ-UHFFFAOYSA-N
131761951;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QVOYWQYGRGLLAY-UHFFFAOYSA-N
53480588;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZUNWODIBMWYUGB-UHFFFAOYSA-N
12587;NAALAD2;6;1.418e-47;0.4444;2.7452;83.6576;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C)CCC(=O)O;FGKJLKRYENPLQH-UHFFFAOYSA-N
131766154;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HJRKYUCSRVBURI-UHFFFAOYSA-N
131757392;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZUIIFSXSZSIBCK-UHFFFAOYSA-N
131763809;LPAR3;6;2.445e-62;0.5652;9.4958;110.1626;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SSHNUYNODGSBKZ-UHFFFAOYSA-N
131756568;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNBLIASYUOJINW-UHFFFAOYSA-N
131756220;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CMYGJOFGWDPRGY-UHFFFAOYSA-N
131762066;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HLHLXVHKMTYBSS-UHFFFAOYSA-N
66141;ACE;6;1.14e-66;0.5455;66.2403;117.939;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(=O)N1CCCC1C(=O)O;GNMSLDIYJOSUSW-UHFFFAOYSA-N
131756709;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MJLWCZOZMFQAGA-UHFFFAOYSA-N
131757409;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HOOIWTKANHPAOR-UHFFFAOYSA-N
131766114;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AHELIOBCROQGBQ-UHFFFAOYSA-N
25240391;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AVPYORJSIJFEAZ-UHFFFAOYSA-N
131765347;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JGJNMFUCXCXAKE-UHFFFAOYSA-N
131757408;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WTCMNORLXBIXAX-UHFFFAOYSA-N
131756038;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MRYNICMNUGGZAJ-UHFFFAOYSA-N
131766166;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BCFZUYAFWFJZJJ-UHFFFAOYSA-N
131760455;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LVFGCKMHIYKCGK-UHFFFAOYSA-N
131756694;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBGIIZRJUJAGJD-UHFFFAOYSA-N
131765106;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OWSJQXBTEYLBML-UHFFFAOYSA-N
131757195;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;KBOXWJNBWNAPDL-UHFFFAOYSA-N
131763593;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CVMGFHNEUZQYDT-UHFFFAOYSA-N
131757058;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;PPUMGRJWTDYAJJ-UHFFFAOYSA-N
131756134;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEPNNQMHGKLSKK-UHFFFAOYSA-N
131756891;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IPHBLBUBXCJBLT-UHFFFAOYSA-N
131757902;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;WOZPSEZFVJBYJL-UHFFFAOYSA-N
131755987;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYNGPKGJSNVQOS-UHFFFAOYSA-N
25240389;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LEZBCWXJJZZACU-UHFFFAOYSA-N
131764696;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UTBRCBMCCLRNPB-UHFFFAOYSA-N
131756561;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UXJYWOFCVLKPDF-UHFFFAOYSA-N
131753396;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KWBNOUOFUVIQGL-UHFFFAOYSA-N
131756671;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HGCINVBTERQPJG-UHFFFAOYSA-N
131764509;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VIBIIAUIZFMPDA-UHFFFAOYSA-N
131766277;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GWPFCSILQUPTKP-UHFFFAOYSA-N
131762003;LPAR3;6;6.1270000000000005e-56;0.5532;8.5118;98.6744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SPANQEOGZHFPCM-UHFFFAOYSA-N
131762644;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QUQYRBGCIMSPCK-UHFFFAOYSA-N
131756092;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PEXSAAMYDXHXJR-UHFFFAOYSA-N
88454;CES2C;6;3.068e-60;0.4375;1.987;106.3949;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCOC(=O)CC;GOKKOFHHJFGZHW-UHFFFAOYSA-N
131760762;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QIKLHWHYLOODPL-UHFFFAOYSA-N
131756865;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZYPBECLJEJXDCU-UHFFFAOYSA-N
131766154;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HJRKYUCSRVBURI-UHFFFAOYSA-N
131762288;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHZYTFVUDKSYSQ-UHFFFAOYSA-N
131762251;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KTCYPQYXMMRSJQ-UHFFFAOYSA-N
131756764;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PVLPTPLTYBYKPQ-UHFFFAOYSA-N
165527;GRIK1;6;1.054e-45;0.5926;12.2576;80.2982;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C(CC(=O)NCC(=O)O)C(C(=O)O)N;ACIJGUBIMXQCMF-UHFFFAOYSA-N
131763386;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BRYGUDCZVRWORF-UHFFFAOYSA-N
131756795;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LDNPYIZUVHLDLV-UHFFFAOYSA-N
131756753;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JXVMBJGBROTCFP-UHFFFAOYSA-N
131758092;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OZGHAUBMNCOWIH-UHFFFAOYSA-N
131760144;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NMJIAWZBGZFPMZ-UHFFFAOYSA-N
4369021;ACE;6;4.4630000000000004e-71;0.7429;70.6174;125.8512;ACE;Angiotensin-converting enzyme (pKi >= 6);C1CC(N(C1)C(=O)C(CO)N)C(=O)O;WBAXJMCUFIXCNI-UHFFFAOYSA-N
7015695;ANPEP;6;7.634e-49;0.5116;17.0954;85.9357;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
131764892;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MHUAVEYSFKXLTQ-UHFFFAOYSA-N
131762140;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;YSHCWMWSRVVMKQ-UHFFFAOYSA-N
131761203;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LZYPGVKOHKHDAD-UHFFFAOYSA-N
131757903;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;VPGFYQNSTYPTAI-UHFFFAOYSA-N
131766188;LPAR3;6;3.0189999999999997e-41;0.5;6.2523;72.2965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XTSIRSMGWJZXCI-UHFFFAOYSA-N
131764442;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GBMUQJHBAYXLFF-UHFFFAOYSA-N
131764362;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;YCGDLABDDKGWQV-UHFFFAOYSA-N
53480597;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SBPDLKMUDWDEFF-UHFFFAOYSA-N
131765533;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MFXICCJOWPGOMM-UHFFFAOYSA-N
131762348;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JMSQUIMJQZICKW-UHFFFAOYSA-N
96799;HLA-A;6;9.213e-56;0.5641;8.5783;98.3564;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(C)N;LIWMQSWFLXEGMA-UHFFFAOYSA-N
57449;GRIK3;6;1.5699999999999998e-54;0.52;4.8779;96.1453;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C(CCN)CC(C(=O)O)N;KDXKERNSBIXSRK-UHFFFAOYSA-N
131762422;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFINDNIYLCOJHX-UHFFFAOYSA-N
7826;EST1_PIG;7;2.2180000000000002e-69;0.4643;4.5769;122.8059;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCC(=O)OC;XNCNNDVCAUWAIT-UHFFFAOYSA-N
131761132;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OOPMCEWTZJHXQW-UHFFFAOYSA-N
131757379;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RWKYSZZMYDKMMP-UHFFFAOYSA-N
131759335;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PJZNQCVWKSDFQV-UHFFFAOYSA-N
131763879;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LZBCYJATWXCMHP-UHFFFAOYSA-N
131762092;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GEPBFCHPEPGUAQ-UHFFFAOYSA-N
131757925;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XZEKHDQNQNUYCG-UHFFFAOYSA-N
131756444;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UURRRKGAHHCVSI-UHFFFAOYSA-N
23847;CQSS;6;1.74e-62;0.4231;1.827;110.428;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCC(=O)C(C)C;HIGGFWFRAWSMBR-UHFFFAOYSA-N
131755941;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ALEWSTMZONDAQL-UHFFFAOYSA-N
131758073;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;RVRTUMVPHQBOPW-UHFFFAOYSA-N
131763885;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KHTDSTVVANVHFF-UHFFFAOYSA-N
131756598;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KIOWNTIUPBZKFY-UHFFFAOYSA-N
131764269;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JAYITAIAYFOYRP-UHFFFAOYSA-N
131763893;FABP3;7;4.2649999999999996e-54;0.4667;1.7816;95.3661;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VHGVPSYDWFOMRD-UHFFFAOYSA-N
131760084;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CFASHVJHKJIKRY-UHFFFAOYSA-N
7824;CQSS;6;3.2e-70;0.4286;2.0562;124.3153;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)OC;NUKZAGXMHTUAFE-UHFFFAOYSA-N
131757547;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCOSJHHIEGDUHK-UHFFFAOYSA-N
96757;NOD1;9;3.095e-85;0.4;6.0656;151.271;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CSCCC(C(=O)O)NC(=O)CN;PFMUCCYYAAFKTH-UHFFFAOYSA-N
131755375;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZLDDMZGQIOQJK-UHFFFAOYSA-N
131761133;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IDGIWWVXFKHRCG-UHFFFAOYSA-N
131761147;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XEGBEKAAVUQJRL-UHFFFAOYSA-N
131761037;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FRRIXNAAJYOQAA-UHFFFAOYSA-N
131762078;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;DZEYBXMCOFPWNY-UHFFFAOYSA-N
656979;FURIN;6;1.3699999999999999e-67;0.5;12.3713;119.5908;FURIN;Furin (pKi >= 6);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
131755839;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MIWJGWAISDNXBZ-UHFFFAOYSA-N
3621685;LAP3;6;6.564e-42;0.5556;4.7699;73.4862;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(CO)C(=O)O)N;XGDCYUQSFDQISZ-UHFFFAOYSA-N
131762002;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZCVSDPAGUYLRRT-UHFFFAOYSA-N
131764758;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AHQZELFLVJXKCX-UHFFFAOYSA-N
131762099;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VZNTVOPNTJTOID-UHFFFAOYSA-N
131758023;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;ABLVQVNHRJIDDA-UHFFFAOYSA-N
131761093;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JLQZYULPGPGUBH-UHFFFAOYSA-N
7020902;HLA-A;6;7.705e-60;0.4545;9.2123;105.6771;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(C(C)O)N;CKHWEVXPLJBEOZ-UHFFFAOYSA-N
131765824;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MULNUHSRKPNWLL-UHFFFAOYSA-N
131765409;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RHFXHYXWJVPZPR-UHFFFAOYSA-N
131762010;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HXSQHIRLTXCUEB-UHFFFAOYSA-N
131758553;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;MNBYMCVZZONTET-UHFFFAOYSA-N
131762598;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMGBYZOKWLAVIY-UHFFFAOYSA-N
131763459;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZZAFJHQNDZMPDX-UHFFFAOYSA-N
131762784;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RVMQNMKFUZZTPY-UHFFFAOYSA-N
131758023;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;ABLVQVNHRJIDDA-UHFFFAOYSA-N
7797;CQSS;6;7.424e-77;0.5;2.2527;136.2264;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)OCC;TVQGDYNRXLTQAP-UHFFFAOYSA-N
131757595;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NJFXQBUHWRCFMV-UHFFFAOYSA-N
81721;LAP3;6;7.741e-44;0.4722;4.9928;76.9483;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)NC(C)C(=O)O)N;HSQGMTRYSIHDAC-UHFFFAOYSA-N
131757414;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GBUWYEPDQKOYKY-UHFFFAOYSA-N
131766267;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ACAFAPUIJTWQJQ-UHFFFAOYSA-N
131764257;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ONLNESNWMKDEPS-UHFFFAOYSA-N
5312860;CQSS;6;1.1740000000000002e-78;0.5172;2.306;139.4595;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(C(=O)O)O;JKRDADVRIYVCCY-UHFFFAOYSA-N
131765156;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IBRVYWQBLHWNLY-UHFFFAOYSA-N
131761541;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATZGVMKFUWGRQG-UHFFFAOYSA-N
131755993;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NSFHGSMSKWUULJ-UHFFFAOYSA-N
131756449;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OTFHEYIENBSGTP-UHFFFAOYSA-N
131763884;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IRNKBTPNXMDLBH-UHFFFAOYSA-N
128841;NOD1;9;3.272e-96;0.4318;6.8532;170.9762;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C(=O)NC(CCC(=O)O)C(=O)O)N;VYZAGTDAHUIRQA-UHFFFAOYSA-N
131762267;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WCCRVFFTKSGKIN-UHFFFAOYSA-N
131764860;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KBIZWAIRBWIMJH-UHFFFAOYSA-N
131756843;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEZPDJIPJQTNAB-UHFFFAOYSA-N
131756226;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KWEJHHHDBVLFPL-UHFFFAOYSA-N
131765344;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MYJWWYIUFIBLJK-UHFFFAOYSA-N
131764810;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AKGKDADGQVDJFQ-UHFFFAOYSA-N
131756611;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UXLOFYOLOKXYAP-UHFFFAOYSA-N
131755075;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;VBRUDSKZQDCRGT-UHFFFAOYSA-N
131756910;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WHPQOGDRBOSGRN-UHFFFAOYSA-N
131756935;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MUIBFWWHJKHTDU-UHFFFAOYSA-N
131761957;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KSQBRKREYMTJTD-UHFFFAOYSA-N
131756538;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MYQZXEILKZNHFK-UHFFFAOYSA-N
131764077;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LGZBYVCHRDGVGD-UHFFFAOYSA-N
131756731;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BWVMXRNTJKNLIG-UHFFFAOYSA-N
131758710;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PASXLGNHMHBIKZ-UHFFFAOYSA-N
131760603;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OAJSPZUBFWYCCY-UHFFFAOYSA-N
131760470;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;TYDXDNLOHMRFIS-UHFFFAOYSA-N
131757832;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;FCFBMPGFGZPIBY-UHFFFAOYSA-N
131766222;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QLWBFLGZPZRYRJ-UHFFFAOYSA-N
131760551;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BGOSCAYGIGBWAZ-UHFFFAOYSA-N
131765545;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PKOCESNOUDACBL-UHFFFAOYSA-N
131760291;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GDWVKMUJAYQRMH-UHFFFAOYSA-N
131763814;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LZINVXSWUNMSJK-UHFFFAOYSA-N
131760449;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XKLODESLCLIXEV-UHFFFAOYSA-N
69602;MTNR1A;6;8.862e-45;0.4082;31.5845;78.6381;MTNR1A;Melatonin receptor type 1A (pKi >= 6);CC(=O)NCCC1=CN=CN1;XJWPISBUKWZALE-UHFFFAOYSA-N
131756424;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NHOONBFZUMWOFW-UHFFFAOYSA-N
131761221;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BTOBYBZBYYITRI-UHFFFAOYSA-N
131761958;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GVAIQYMZMOVIIO-UHFFFAOYSA-N
9546272;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PRNTVSSKPYNQFB-UHFFFAOYSA-N
131762587;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BXWJNVALZYFZLM-UHFFFAOYSA-N
6131;POLB;6;8.508e-72;0.569;2.1028;127.1435;POLB;DNA polymerase beta (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131762109;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SFYYMWCCKFQDEZ-UHFFFAOYSA-N
131761436;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JOGFTXNSXUJXOG-UHFFFAOYSA-N
131755980;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XXNKCKKMSRHNDQ-UHFFFAOYSA-N
131766267;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ACAFAPUIJTWQJQ-UHFFFAOYSA-N
131760857;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBRLOBPZVDQAEA-UHFFFAOYSA-N
131758067;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HSADKDIVCWSNKY-UHFFFAOYSA-N
70912;CAPN1;6;5.912e-42;0.6176;24.223;73.5678;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C;WXNXCEHXYPACJF-UHFFFAOYSA-N
131755272;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QVXASAXDWWFXGC-UHFFFAOYSA-N
7408079;ACE2;7;1.959e-44;0.4444;5.4849;78.0197;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C)N;ZSOICJZJSRWNHX-UHFFFAOYSA-N
131764602;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QFZJQQLNNQGHMX-UHFFFAOYSA-N
131765317;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AAAUQAJYMBAEDN-UHFFFAOYSA-N
439377;FOLH1;7;1.793e-80;0.6154;18.6002;142.7202;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CNC(CCC(=O)O)C(=O)O;XLBVNMSMFQMKEY-UHFFFAOYSA-N
131763464;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DHGPOFOBMYEFSV-UHFFFAOYSA-N
131763465;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GCDGRCYQBMTTFW-UHFFFAOYSA-N
5312860;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCC(C(=O)O)O;JKRDADVRIYVCCY-UHFFFAOYSA-N
131765438;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MIQPWXAIHLQOQB-UHFFFAOYSA-N
528;GRIK3;6;1.261e-60;0.4815;5.4301;107.0881;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CC(=O)OCCC(C(=O)O)N;FCXZBWSIAGGPCB-UHFFFAOYSA-N
131758553;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;MNBYMCVZZONTET-UHFFFAOYSA-N
131766251;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MFUCZQQHHGYRHL-UHFFFAOYSA-N
131765430;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QWKVFDZMGWNXNH-UHFFFAOYSA-N
131763898;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZDGDOUDXXGCMIS-UHFFFAOYSA-N
131760470;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;TYDXDNLOHMRFIS-UHFFFAOYSA-N
131765353;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MJRMGSNLYWPJLO-UHFFFAOYSA-N
131755858;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RUXLBRZLBVLBFV-UHFFFAOYSA-N
131757832;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;FCFBMPGFGZPIBY-UHFFFAOYSA-N
131756731;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BWVMXRNTJKNLIG-UHFFFAOYSA-N
131762529;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HHDZLCQDAWUVBO-UHFFFAOYSA-N
131761436;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JOGFTXNSXUJXOG-UHFFFAOYSA-N
131764263;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XPIVVSMKOZXPFD-UHFFFAOYSA-N
131755094;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;MGBYDKAHDISQBC-UHFFFAOYSA-N
101543;P2RY6;6;3.203e-157;0.6;25.9172;280.5074;P2RY6;P2Y purinoceptor 6 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
131755211;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OWXSQMIDLXAPIW-UHFFFAOYSA-N
6131;P2RY1;6;2.556e-51;0.5156;25.0226;90.3794;P2RY1;P2Y purinoceptor 1 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131762065;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KKTHCSVXQUWJBT-UHFFFAOYSA-N
131757542;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CYNDYCIRXVVTMS-UHFFFAOYSA-N
131765402;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FOJHZEOEWLJWDV-UHFFFAOYSA-N
131755042;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KXNZZVRMSWHVPA-UHFFFAOYSA-N
131764765;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFVJCEBDOJPSTJ-UHFFFAOYSA-N
131765641;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SNTGZWYCTMYTOD-UHFFFAOYSA-N
131765397;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KDBNEOPSJYQWQS-UHFFFAOYSA-N
9025;CYP1B1;6;6.4109999999999996e-52;0.4516;10.2622;91.4578;CYP1B1;Cytochrome P450 1B1 (pKi >= 6);COC1=CC(=CC=C1)OC;DPZNOMCNRMUKPS-UHFFFAOYSA-N
131762991;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UQQUTEPSRVSYRH-UHFFFAOYSA-N
8094;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
101122;GRIK3;6;4.998e-55;0.6957;4.923;97.0379;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C(CCC(=O)O)CC(C(=O)O)N;JUQLUIFNNFIIKC-UHFFFAOYSA-N
131762615;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZXIGPBPGGKUILK-UHFFFAOYSA-N
131761129;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PQCPSTGNGBQVPR-UHFFFAOYSA-N
131766355;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LUOCHSUVELFRQV-UHFFFAOYSA-N
13187;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131758552;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OTARVUCVZUWLOP-UHFFFAOYSA-N
131757332;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;JJHAIYBALUXLAQ-UHFFFAOYSA-N
131756069;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ACFCSXYEAINHFR-UHFFFAOYSA-N
131757582;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZDIISHVVPLAVCQ-UHFFFAOYSA-N
131762251;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KTCYPQYXMMRSJQ-UHFFFAOYSA-N
131764522;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XMWUXAVIWIDJNZ-UHFFFAOYSA-N
131763376;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AAAULIDICJVAGC-UHFFFAOYSA-N
131760150;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;DFPNCBSXNOPJHY-UHFFFAOYSA-N
131759986;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PJUDTLQEZCEYBU-UHFFFAOYSA-N
131760894;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YFDGJODCMWVLKK-UHFFFAOYSA-N
131765690;FABP3;7;2.889e-50;0.4565;1.6536;88.4886;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LZIIYBKRUWDFGC-UHFFFAOYSA-N
131756463;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WITFBADACYFOQN-UHFFFAOYSA-N
131761991;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XAOROXTUFKKLJS-UHFFFAOYSA-N
131757415;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;INCHZKMNHLHTMY-UHFFFAOYSA-N
131760730;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OSQJHCZDNGROLT-UHFFFAOYSA-N
131755068;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;CTOZRWCYXGCCPP-UHFFFAOYSA-N
131758688;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;MYYDVRKVUNECKQ-UHFFFAOYSA-N
56940205;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SRFZZMHOMJJKRR-UHFFFAOYSA-N
7015695;HLA-A;6;5.841000000000001e-84;0.4906;12.9624;148.9806;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
131756604;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HRIZOSOLJUQKSO-UHFFFAOYSA-N
131756134;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEPNNQMHGKLSKK-UHFFFAOYSA-N
131766427;FABP3;7;5.64e-50;0.4286;1.6438;87.9671;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BDGPXFOSOLYLHH-UHFFFAOYSA-N
131761707;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RYAUACKFYWJJEY-UHFFFAOYSA-N
131756450;LPAR3;6;4.1129999999999997e-47;0.5745;7.1544;82.8273;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;POVKTGOFOJWXMA-UHFFFAOYSA-N
131756916;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHBLSXUEUXTLMG-UHFFFAOYSA-N
131764516;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OSKYXBRDUUVYGA-UHFFFAOYSA-N
131766402;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTKJUGSNYRWBGG-UHFFFAOYSA-N
131757356;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;NIPVPXGEDBBOMK-UHFFFAOYSA-N
131758030;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VQFSLGRGKYUSSR-UHFFFAOYSA-N
9545225;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SEOQXFHPWMVJJP-UHFFFAOYSA-N
131766042;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KGMWBODWUGOVSS-UHFFFAOYSA-N
131756108;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JTJZUFAYMWLIGR-UHFFFAOYSA-N
131757289;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;JUAQGNVWXOALQO-UHFFFAOYSA-N
131764442;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GBMUQJHBAYXLFF-UHFFFAOYSA-N
131759520;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZZBKGDIMYDDPOX-UHFFFAOYSA-N
131758091;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GVCWIXNHGLSALQ-UHFFFAOYSA-N
131760608;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZRZVISWZVARYCM-UHFFFAOYSA-N
131765545;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;PKOCESNOUDACBL-UHFFFAOYSA-N
9545117;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XKXYLRHFXANGHG-UHFFFAOYSA-N
9546315;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NOARWYBQRHYNAX-UHFFFAOYSA-N
131753367;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NSFHIRVYTDSVSD-UHFFFAOYSA-N
101543;P2RY2;6;8.095e-173;0.5818;42.1874;308.5094;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
131763989;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;DZWPMQPSPOGAGG-UHFFFAOYSA-N
131756603;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YITUAXAQLSWWNX-UHFFFAOYSA-N
9545294;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;JRIJXKUOTQILAX-UHFFFAOYSA-N
131764818;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QZKVXJMSEGENRO-UHFFFAOYSA-N
131755841;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;TVQFPEHRCSMMRD-UHFFFAOYSA-N
131762077;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AUZXYDGDYWCTNI-UHFFFAOYSA-N
8051;CQSS;6;3.505e-78;0.48;2.292;138.6068;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)C;CATSNJVOTSVZJV-UHFFFAOYSA-N
131764903;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MLGSATAFRBQCQT-UHFFFAOYSA-N
131764611;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HBSUKMPAVQMSND-UHFFFAOYSA-N
101122;GRM8;7;3.5819999999999996e-41;0.6957;1.1957;72.1631;GRM8;Metabotropic glutamate receptor 8 (pKi >= 7);C(CCC(=O)O)CC(C(=O)O)N;JUQLUIFNNFIIKC-UHFFFAOYSA-N
131753623;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PJQSYBAZIMBSRZ-UHFFFAOYSA-N
13187;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131757038;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;LPFMURDWEDJXOF-UHFFFAOYSA-N
131762111;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KAZJZSGQAUEXAS-UHFFFAOYSA-N
131763893;LPAR3;6;1.747e-52;0.5306;7.9805;92.4716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VHGVPSYDWFOMRD-UHFFFAOYSA-N
131757430;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QQXNBQNXQFZRPW-UHFFFAOYSA-N
9545299;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQGCOHUTHPKJNA-UHFFFAOYSA-N
131760063;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CPMVPDLVOWSSKE-UHFFFAOYSA-N
131766253;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JDNDOXXFGNHEBN-UHFFFAOYSA-N
131765119;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HIASQOMGPHBNCJ-UHFFFAOYSA-N
167627;CQSS;6;4.14e-60;0.4;1.7566;106.1613;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CC(CCCCCC(=O)O)O;OFCMTSZRXXFMBQ-UHFFFAOYSA-N
131757489;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PLJUCVWMUHTXMN-UHFFFAOYSA-N
131757582;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZDIISHVVPLAVCQ-UHFFFAOYSA-N
131758688;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;MYYDVRKVUNECKQ-UHFFFAOYSA-N
131758114;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WLQOSKFMJPLCIL-UHFFFAOYSA-N
131757493;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UHIRVISANDDFQO-UHFFFAOYSA-N
131763479;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RBFFADLAIHOKCA-UHFFFAOYSA-N
131757287;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CUYWPWQOJRQSCW-UHFFFAOYSA-N
131755264;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ANOUVNADVQFHPD-UHFFFAOYSA-N
13945;P2RY6;6;1.573e-112;0.6406;18.523;200.2724;P2RY6;P2Y purinoceptor 6 (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131757908;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QMUANRQBCWCFMK-UHFFFAOYSA-N
131761707;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;RYAUACKFYWJJEY-UHFFFAOYSA-N
131757761;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDNSSVJJLZBKEO-UHFFFAOYSA-N
131757385;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOPFKAUVUXZXGV-UHFFFAOYSA-N
131750634;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NZZPEUWLSFJAKQ-UHFFFAOYSA-N
131760164;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NNCFNVDCMOKBFC-UHFFFAOYSA-N
131755839;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MIWJGWAISDNXBZ-UHFFFAOYSA-N
131756897;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GPIFUYLJOSZBCL-UHFFFAOYSA-N
131756063;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KCZXAMVZIWNRAA-UHFFFAOYSA-N
182230;NAALAD2;6;4.3280000000000003e-69;0.4839;4.0063;122.2846;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(=O)NC(CCC(=O)N)C(=O)O;KSMRODHGGIIXDV-UHFFFAOYSA-N
96384;FFAR1;6;8.688e-62;0.4524;34.5446;109.1741;FFAR1;Free fatty acid receptor 1 (pKi >= 6);C1=CC(=C(C=C1O)O)CCC(=O)O;HMCMTJPPXSGYJY-UHFFFAOYSA-N
131756752;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IBYMEWUNOCTTRG-UHFFFAOYSA-N
131756702;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ONAJSAYDJRBCNQ-UHFFFAOYSA-N
131761293;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UBHZXNRDMRSIPS-UHFFFAOYSA-N
131761832;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;NGIXVWBHYCBVSU-UHFFFAOYSA-N
131758111;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OIXSAFSNRKDPLC-UHFFFAOYSA-N
131760680;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;PHZQINHSUNAFFE-UHFFFAOYSA-N
18218188;HLA-A;6;3.3089999999999996e-51;0.4655;7.8701;90.1782;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CC(=O)N)N;KWBQPGIYEZKDEG-UHFFFAOYSA-N
131757610;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FATDEJIPCRXHBE-UHFFFAOYSA-N
131760000;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADBUUCLFUXNJAT-UHFFFAOYSA-N
131753812;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JWNQPWOMEKFYMA-UHFFFAOYSA-N
131764912;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PWGSYNKICGOQAF-UHFFFAOYSA-N
8093;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131764456;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GQESZZRPJKPSPA-UHFFFAOYSA-N
131750377;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;PORGMKLTIBAGKT-UHFFFAOYSA-N
131760665;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DJUZUKMVZZOHPA-UHFFFAOYSA-N
131762615;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZXIGPBPGGKUILK-UHFFFAOYSA-N
9545150;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;QMGVAYGHMZTSEF-UHFFFAOYSA-N
131762111;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KAZJZSGQAUEXAS-UHFFFAOYSA-N
131756801;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SBRSQEIFWNUOMV-UHFFFAOYSA-N
9545226;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;PXBQCSMXBDELKI-UHFFFAOYSA-N
7408079;HLA-A;6;1.494e-61;0.5532;9.4785;108.7512;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(C)N;ZSOICJZJSRWNHX-UHFFFAOYSA-N
131763800;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GLNXLYRBLGFBLW-UHFFFAOYSA-N
131763178;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJZLKIOUYEPDB-UHFFFAOYSA-N
131763151;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ADPNGIWOVLEKOB-UHFFFAOYSA-N
13945;RNASE1;6;5.22e-53;0.4268;1.5463;93.4134;RNASE1;Ribonuclease pancreatic (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131765339;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GASSAAYRXQQJLB-UHFFFAOYSA-N
131761471;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NHGYEISCODGQRT-UHFFFAOYSA-N
131757831;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;CAOCEUZJFODCFY-UHFFFAOYSA-N
131765344;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MYJWWYIUFIBLJK-UHFFFAOYSA-N
131761129;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;PQCPSTGNGBQVPR-UHFFFAOYSA-N
131760590;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGLCIQWPEJNTLF-UHFFFAOYSA-N
131757408;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WTCMNORLXBIXAX-UHFFFAOYSA-N
131762140;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;YSHCWMWSRVVMKQ-UHFFFAOYSA-N
131766191;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IGPSCPPINAFEKC-UHFFFAOYSA-N
131759355;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;CISSBQIGKKYEPB-UHFFFAOYSA-N
21117855;NOD1;9;8.471e-89;0.4359;6.3213;157.6674;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCC(=O)NC(CCSC)C(=O)O;RBAAEQRITQHPJM-UHFFFAOYSA-N
131761655;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AONZFAXPHFTHIO-UHFFFAOYSA-N
131757332;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;JJHAIYBALUXLAQ-UHFFFAOYSA-N
131764165;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WJUAWPOIGFVUDB-UHFFFAOYSA-N
132862;NOD1;9;2.866e-68;0.4082;4.848;120.8106;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CN=C(N)NCCCC(C(=O)O)N;NTNWOCRCBQPEKQ-UHFFFAOYSA-N
131764548;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NWKWBJNWUOYDEU-UHFFFAOYSA-N
131764263;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XPIVVSMKOZXPFD-UHFFFAOYSA-N
131759375;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FNHNIQYRALAOKL-UHFFFAOYSA-N
131764759;FABP3;7;1.584e-53;0.4884;1.7626;94.3434;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YLUCRQKSSLJBCX-UHFFFAOYSA-N
31234;SLC18A2;6;1.872e-46;0.4483;9.4432;81.6456;SLC18A2;Synaptic vesicular amine transporter (pKi >= 6);C1=CC=C(C=C1)CCCO;VAJVDSVGBWFCLW-UHFFFAOYSA-N
131757839;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;WKEWFXQSALSQCQ-UHFFFAOYSA-N
14878381;BHMT;6;1.8119999999999998e-60;0.425;1.7672;106.8055;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CC(C(=O)O)NC(=O)C(CCSC)N;JHKXZYLNVJRAAJ-UHFFFAOYSA-N
131765823;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WFPDDMWARPVGSU-UHFFFAOYSA-N
7015695;FPR1;6;1.4150000000000002e-69;0.4444;13.163;123.156;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
131756213;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LPELEKIVSWFLKI-UHFFFAOYSA-N
13187;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131753631;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;UISYJGKZKOFBCP-UHFFFAOYSA-N
8093;PAOX;6;2.664e-54;0.4643;2.1649;95.7331;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131760183;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PMFLTJZDQUHUAB-UHFFFAOYSA-N
131755449;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HKLUOMJYFGCDTK-UHFFFAOYSA-N
9546271;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PYADCGOWWCWTFV-UHFFFAOYSA-N
131765197;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PWILPMVZTCKVTA-UHFFFAOYSA-N
131765623;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LAHSEWDJIRFXHL-UHFFFAOYSA-N
131764898;LPAR3;6;1.086e-44;0.5;6.782;78.4797;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RQKHMPSZDUHCED-UHFFFAOYSA-N
131764276;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GBIRFFFMSPKFEB-UHFFFAOYSA-N
53481030;P2RY2;6;5.369e-62;0.4478;15.058;109.5492;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C3C(C(O2)CO)OP(=O)(O3)O;NMPZCCZXCOMSDQ-UHFFFAOYSA-N
131760591;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PFBXBGIBHLCMFX-UHFFFAOYSA-N
8908;CES2C;6;5.207e-62;0.4516;2.0461;109.5732;CES2C;Acylcarnitine hydrolase (pKi >= 6);CCCCCCOC(=O)C;AOGQPLXWSUTHQB-UHFFFAOYSA-N
131756450;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;POVKTGOFOJWXMA-UHFFFAOYSA-N
131762879;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FIXNXVIJNBXNSK-UHFFFAOYSA-N
131766148;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ACSPQPSYQCNVOM-UHFFFAOYSA-N
131760584;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;DWPNGNRTDXKEOG-UHFFFAOYSA-N
131764509;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;VIBIIAUIZFMPDA-UHFFFAOYSA-N
131766167;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZDNJPUPRXOSVID-UHFFFAOYSA-N
131765430;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QWKVFDZMGWNXNH-UHFFFAOYSA-N
131762060;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CLLKZXQFVMCGDJ-UHFFFAOYSA-N
131763459;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZZAFJHQNDZMPDX-UHFFFAOYSA-N
131760590;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGLCIQWPEJNTLF-UHFFFAOYSA-N
131755964;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFCLJNCTQYJPGS-UHFFFAOYSA-N
13945;P2RY2;6;2.8799999999999997e-137;0.6406;33.4844;244.6837;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131763989;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;DZWPMQPSPOGAGG-UHFFFAOYSA-N
131757282;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SSQXIJLQGIDAIS-UHFFFAOYSA-N
81721;NPR;6;3.242e-66;0.4314;9.5249;117.1239;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)NC(C)C(=O)O)N;HSQGMTRYSIHDAC-UHFFFAOYSA-N
131760913;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LSMSLBOQWAMLMY-UHFFFAOYSA-N
439378;NOD1;9;2.121e-114;0.5385;8.1585;203.6301;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCNC(=O)CCC(C(=O)O)N;DATAGRPVKZEWHA-UHFFFAOYSA-N
131765423;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BSPLHTLQAWNASH-UHFFFAOYSA-N
131755291;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OGQHBMYPMDPMNU-UHFFFAOYSA-N
131761161;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;PQLKPQSCLYKAEF-UHFFFAOYSA-N
131757838;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;NROZTINCWPRCMV-UHFFFAOYSA-N
131764819;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YJMGXZYEPBQBAS-UHFFFAOYSA-N
131759986;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;PJUDTLQEZCEYBU-UHFFFAOYSA-N
131762658;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFUYTFWOBBTMIA-UHFFFAOYSA-N
7478;RXRA;6;5.133e-45;0.4146;21.8902;79.0639;RXRA;Retinoic acid receptor RXR-alpha (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131761416;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AZRGVQKDBWALBZ-UHFFFAOYSA-N
131765345;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HZVGBFLSCGEAAE-UHFFFAOYSA-N
131758051;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RHKGVUCWKLHRQP-UHFFFAOYSA-N
131759981;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;WSXKYZANGLDIKE-UHFFFAOYSA-N
131756802;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RRCHFUDCOMJONU-UHFFFAOYSA-N
131763480;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NVRVRYSEUZDNFH-UHFFFAOYSA-N
131760567;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WZWIOTYITIUOCJ-UHFFFAOYSA-N
131756870;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZMNYGXVOKIZHI-UHFFFAOYSA-N
131764234;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XEDWMKBQXWAUCP-UHFFFAOYSA-N
131765530;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HHHZTIJSFLQUDN-UHFFFAOYSA-N
131764556;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VMXDSQGCSDZBPH-UHFFFAOYSA-N
131755864;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WVBWJULBZBNZMZ-UHFFFAOYSA-N
7036275;ENPEP;7;7.222e-69;0.4419;5.3911;121.8854;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C;JDTWZSUNGHMMJM-UHFFFAOYSA-N
131758068;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FXXAUAAYIAECGB-UHFFFAOYSA-N
131762991;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UQQUTEPSRVSYRH-UHFFFAOYSA-N
131766192;FABP3;7;3.0409999999999997e-53;0.5366;1.7531;93.8346;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFVWVELECLSMOM-UHFFFAOYSA-N
131761578;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FFYFDHSACVXNGJ-UHFFFAOYSA-N
131764549;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GYKIUAHHSLWRCC-UHFFFAOYSA-N
131766355;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LUOCHSUVELFRQV-UHFFFAOYSA-N
131760584;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;DWPNGNRTDXKEOG-UHFFFAOYSA-N
131755298;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZLRZWJGBXVBWHP-UHFFFAOYSA-N
131765397;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;KDBNEOPSJYQWQS-UHFFFAOYSA-N
131757332;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;JJHAIYBALUXLAQ-UHFFFAOYSA-N
131765406;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JSMIDOASADIYEB-UHFFFAOYSA-N
131762597;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VRADBIPNMXGYIT-UHFFFAOYSA-N
131759961;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;BDNLTRKYOYVEEN-UHFFFAOYSA-N
131765734;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MGVLRAKEBILBAC-UHFFFAOYSA-N
131764195;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UHTSPOGAADMXJF-UHFFFAOYSA-N
131757947;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;XXHFTCACPARCGZ-UHFFFAOYSA-N
131759362;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JKTCMEHHQOHFEA-UHFFFAOYSA-N
131757188;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;ZIDPGXBTSKOGRO-UHFFFAOYSA-N
131762221;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;DUEKVDIAQKILOH-UHFFFAOYSA-N
131765623;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LAHSEWDJIRFXHL-UHFFFAOYSA-N
131759375;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FNHNIQYRALAOKL-UHFFFAOYSA-N
5312965;NOD1;9;1.154e-120;0.5405;8.6081;214.8766;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCC(C(=O)O)N;RDFMDVXONNIGBC-UHFFFAOYSA-N
131764923;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YQBJSWUNYSIELN-UHFFFAOYSA-N
131766192;LPAR3;6;3.0189999999999997e-41;0.5;6.2523;72.2965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFVWVELECLSMOM-UHFFFAOYSA-N
131760551;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BGOSCAYGIGBWAZ-UHFFFAOYSA-N
131762110;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LQSCSTJZOROWON-UHFFFAOYSA-N
131766184;FABP3;7;4.085e-52;0.5238;1.7154;91.8091;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;NJFNAWKYWBXFMY-UHFFFAOYSA-N
13945;POLA1;6;1.1100000000000001e-57;0.6491;2.1063;101.8016;POLA1;DNA polymerase alpha catalytic subunit (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131757924;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PDFGKXGOWBDITR-UHFFFAOYSA-N
131760743;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YGGZFQWCIRKMIF-UHFFFAOYSA-N
131762104;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WBTOGGRLPHBVAX-UHFFFAOYSA-N
131765345;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HZVGBFLSCGEAAE-UHFFFAOYSA-N
131755933;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OSVPTBUSNXGUED-UHFFFAOYSA-N
131760163;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;JHWDCGVOVZRWAF-UHFFFAOYSA-N
8051;CES2;7;4.969999999999999e-52;0.48;3.0063;91.6563;CES2;Cocaine esterase (pKi >= 7);CCCCCC(=O)C;CATSNJVOTSVZJV-UHFFFAOYSA-N
131765366;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OHRISHQDSVLHIL-UHFFFAOYSA-N
7478;PLA2G4B;7;4.1e-55;0.4324;3.3365;97.1922;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 7);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131755298;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZLRZWJGBXVBWHP-UHFFFAOYSA-N
131764903;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MLGSATAFRBQCQT-UHFFFAOYSA-N
131756801;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SBRSQEIFWNUOMV-UHFFFAOYSA-N
131761006;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;INEXMIRTZIHZMF-UHFFFAOYSA-N
131758871;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;USJFTUJSTHNKJJ-UHFFFAOYSA-N
131761111;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;ZROXJHNMTWXXSU-UHFFFAOYSA-N
131757076;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ALYVJOCNZCAWSV-UHFFFAOYSA-N
131765539;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LBZFYZRIVKZJJE-UHFFFAOYSA-N
131756965;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLVBPNSIUBYKIC-UHFFFAOYSA-N
131762267;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WCCRVFFTKSGKIN-UHFFFAOYSA-N
131755815;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFPSXYRYGSJWEL-UHFFFAOYSA-N
131757517;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KDBXLBUVLNGKSH-UHFFFAOYSA-N
161368;ITPR1;9;1.7489999999999998e-94;0.8421;3.1317;167.8742;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 9);C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O;INAPMGSXUVUWAF-UHFFFAOYSA-N
131757379;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RWKYSZZMYDKMMP-UHFFFAOYSA-N
131763480;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NVRVRYSEUZDNFH-UHFFFAOYSA-N
131761934;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BWOCMKYCXIXQRR-UHFFFAOYSA-N
131764913;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GWSGWHHWROFTDI-UHFFFAOYSA-N
131765863;FABP3;7;4.085e-52;0.5238;1.7154;91.8091;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HDRSBEGKBHLZCW-UHFFFAOYSA-N
131756677;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WPQGJCCBOJSBDL-UHFFFAOYSA-N
131763878;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BQWOVZWVJFRMTK-UHFFFAOYSA-N
131764247;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XEOSAHGABTVYIL-UHFFFAOYSA-N
131750625;FABP3;7;1.522e-50;0.4348;1.6629;88.9883;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BOXFBDURIZMSKQ-UHFFFAOYSA-N
656979;POLG_WNV;6;2.554e-45;0.4118;3.9433;79.6081;POLG_WNV;Genome polyprotein (pKi >= 6);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
131764893;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UBWVHRBREHBARK-UHFFFAOYSA-N
131757415;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;INCHZKMNHLHTMY-UHFFFAOYSA-N
131755291;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OGQHBMYPMDPMNU-UHFFFAOYSA-N
131761584;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NYVBOEBPAQPUMA-UHFFFAOYSA-N
131759968;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZDRCFAZKFWDKNW-UHFFFAOYSA-N
131760104;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NMGROZCBZQQOSP-UHFFFAOYSA-N
131764165;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;WJUAWPOIGFVUDB-UHFFFAOYSA-N
131759362;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JKTCMEHHQOHFEA-UHFFFAOYSA-N
131757429;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SLCSZUMZGXHZBR-UHFFFAOYSA-N
131764584;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OPQWTAFOYCFRKH-UHFFFAOYSA-N
131756044;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QXOPDZOQHIVILD-UHFFFAOYSA-N
96801;ANPEP;6;3.724e-55;0.55;19.3221;97.2672;ANPEP;Aminopeptidase N (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131766013;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JBTCSEUULKOTDN-UHFFFAOYSA-N
131764764;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BXLAGUWZJCEHDF-UHFFFAOYSA-N
131755279;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HCEFBTFVOASXGI-UHFFFAOYSA-N
131757260;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LHPFBXJMLHBPAN-UHFFFAOYSA-N
131761128;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HIBOOXQOVDHKOV-UHFFFAOYSA-N
131755395;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SYHQDCMTVVZJSW-UHFFFAOYSA-N
131756295;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CCTFWKNIQDIFGW-UHFFFAOYSA-N
131756870;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZMNYGXVOKIZHI-UHFFFAOYSA-N
131765197;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PWILPMVZTCKVTA-UHFFFAOYSA-N
131766250;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JEWIRWPDJGIKLP-UHFFFAOYSA-N
131758560;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;JNIVZFHKRHKLRF-UHFFFAOYSA-N
131765862;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;TZHNFARYORXAOO-UHFFFAOYSA-N
131757287;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CUYWPWQOJRQSCW-UHFFFAOYSA-N
131764443;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NCZKUPMKYLKXLD-UHFFFAOYSA-N
131761542;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PAKZJLDJBGQIRN-UHFFFAOYSA-N
96801;NPR;6;7.191e-80;0.4146;11.507;141.6372;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131765553;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WAPIAFALOIFIDE-UHFFFAOYSA-N
131759540;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AQYFFCAUDMUBEY-UHFFFAOYSA-N
131765649;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UWQFVORTWFKSOT-UHFFFAOYSA-N
131761831;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;RAEGSWCAOPPSJQ-UHFFFAOYSA-N
131766386;FABP3;7;2.703e-52;0.4681;1.7214;92.1313;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XPPRNVKNFMZXDO-UHFFFAOYSA-N
131766436;FABP3;7;1.048e-46;0.413;1.5346;82.0981;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SLNZHQMWTFFEGB-UHFFFAOYSA-N
131756741;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VNTAEBMTULPOLY-UHFFFAOYSA-N
131764605;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VLIZDRAULWCXJB-UHFFFAOYSA-N
131758422;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;LHGYPMLTLDHXRM-UHFFFAOYSA-N
131761584;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NYVBOEBPAQPUMA-UHFFFAOYSA-N
131764839;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WUOIZTCKOHESSM-UHFFFAOYSA-N
131757931;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;GIPQJGVRFPTGNE-UHFFFAOYSA-N
131759540;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AQYFFCAUDMUBEY-UHFFFAOYSA-N
131765592;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UOFWKNNJKYNSGN-UHFFFAOYSA-N
131765785;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RROULMIXESFVQQ-UHFFFAOYSA-N
131760005;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OKYXKQWJBHHXBC-UHFFFAOYSA-N
246728;CES2;7;2.159e-50;0.4615;2.9103;88.7157;CES2;Cocaine esterase (pKi >= 7);CCCCCC(=O)CC;RHLVCLIPMVJYKS-UHFFFAOYSA-N
131760449;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XKLODESLCLIXEV-UHFFFAOYSA-N
131755987;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYNGPKGJSNVQOS-UHFFFAOYSA-N
131765391;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZZTADPGUNQYDJV-UHFFFAOYSA-N
439198;P2RY2;6;2.666e-110;0.4118;26.8829;196.2704;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O;NBSCHQHZLSJFNQ-UHFFFAOYSA-N
131763809;FABP3;7;1.0989999999999999e-54;0.5;1.8013;96.4236;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SSHNUYNODGSBKZ-UHFFFAOYSA-N
131756161;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZPZAEIZDMKHCGA-UHFFFAOYSA-N
131765919;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XQQJAGYYEVRLNX-UHFFFAOYSA-N
131763474;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VSVPMUHPOFOMTE-UHFFFAOYSA-N
131766434;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MEODBAFRLCEHNV-UHFFFAOYSA-N
131760591;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PFBXBGIBHLCMFX-UHFFFAOYSA-N
131756597;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;VZNQKMLGTXDQIH-UHFFFAOYSA-N
131756583;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IURMBXSVKSWAOA-UHFFFAOYSA-N
131765179;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QKFVWYDUZMSNAI-UHFFFAOYSA-N
131764917;FABP3;7;1.522e-50;0.4348;1.6629;88.9883;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DXMMCRIFBAEJJI-UHFFFAOYSA-N
131761111;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;ZROXJHNMTWXXSU-UHFFFAOYSA-N
131756588;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;JVDSXKOHBLWGIM-UHFFFAOYSA-N
131764543;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OIHKRHQEBBJGMC-UHFFFAOYSA-N
131757837;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;SXKDYXAVNJJKQE-UHFFFAOYSA-N
131757947;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;XXHFTCACPARCGZ-UHFFFAOYSA-N
131762768;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MVFBCZDAWPPNMN-UHFFFAOYSA-N
131763705;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MRTCVGSSQXQTAY-UHFFFAOYSA-N
131761293;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UBHZXNRDMRSIPS-UHFFFAOYSA-N
131764839;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;WUOIZTCKOHESSM-UHFFFAOYSA-N
70912;RIR1_HHV11;6;9.239e-62;0.4468;4.0689;109.1261;RIR1_HHV11;Ribonucleoside-diphosphate reductase large subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C;WXNXCEHXYPACJF-UHFFFAOYSA-N
131766118;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XPUDKPRPIYUKFD-UHFFFAOYSA-N
131763391;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OGDZZJXPNSIRGH-UHFFFAOYSA-N
131761655;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AONZFAXPHFTHIO-UHFFFAOYSA-N
131765670;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HGLWRMSTDIUKPJ-UHFFFAOYSA-N
131756220;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CMYGJOFGWDPRGY-UHFFFAOYSA-N
131766354;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LTXHHOPKPPDABQ-UHFFFAOYSA-N
131761155;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UTZVSOSRMZACPL-UHFFFAOYSA-N
131761260;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IXONFDDCPAVLRA-UHFFFAOYSA-N
131756538;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MYQZXEILKZNHFK-UHFFFAOYSA-N
131755865;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;KOGFJPQTJBKODN-UHFFFAOYSA-N
131759999;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;NZJOZQGTEOIRPE-UHFFFAOYSA-N
131759381;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;IKNAMSQXQLOJII-UHFFFAOYSA-N
131753367;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NSFHIRVYTDSVSD-UHFFFAOYSA-N
656979;C3AR1;6;1.775e-96;0.4286;16.0241;171.4532;C3AR1;C3a anaphylatoxin chemotactic receptor (pKi >= 6);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
131766270;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RXYZBWALOSVYDB-UHFFFAOYSA-N
25240391;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AVPYORJSIJFEAZ-UHFFFAOYSA-N
131762110;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LQSCSTJZOROWON-UHFFFAOYSA-N
131757260;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LHPFBXJMLHBPAN-UHFFFAOYSA-N
131756039;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HBMHHUTWSLFSBG-UHFFFAOYSA-N
131755094;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;MGBYDKAHDISQBC-UHFFFAOYSA-N
131765366;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OHRISHQDSVLHIL-UHFFFAOYSA-N
131755833;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;UMQZVBBPQUGNIW-UHFFFAOYSA-N
131756044;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QXOPDZOQHIVILD-UHFFFAOYSA-N
131761591;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JQFYUNTYJPUUBW-UHFFFAOYSA-N
131760000;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADBUUCLFUXNJAT-UHFFFAOYSA-N
131764246;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CQNHRJUJTGXQQC-UHFFFAOYSA-N
131758161;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LQUXSTRECRGYRZ-UHFFFAOYSA-N
131761329;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MQKXAZDGXABSQN-UHFFFAOYSA-N
131764152;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IYWYZXDESMKWHJ-UHFFFAOYSA-N
131764270;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJFWEPAZVRIOOH-UHFFFAOYSA-N
9025;CYP1A1;6;8.050999999999999e-47;0.4545;10.2545;82.3036;CYP1A1;Cytochrome P450 1A1 (pKi >= 6);COC1=CC(=CC=C1)OC;DPZNOMCNRMUKPS-UHFFFAOYSA-N
131760687;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AOIVCCSFBIWNFL-UHFFFAOYSA-N
131765410;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CGHXVHJHWSVBCD-UHFFFAOYSA-N
131756584;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SKYYKLLKGOJLMR-UHFFFAOYSA-N
131755457;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IMIRBNJSIWDVSA-UHFFFAOYSA-N
445238;FIMH;6;2.736e-116;0.5588;14.9152;207.0221;FIMH;FimH (pKi >= 6);COC1C(C(C(C(O1)CO)O)O)O;HOVAGTYPODGVJG-UHFFFAOYSA-N
131756809;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SFWGKPGCJSVXCM-UHFFFAOYSA-N
131764264;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XAEFFNXDYZHTNN-UHFFFAOYSA-N
131755815;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFPSXYRYGSJWEL-UHFFFAOYSA-N
131765669;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SYWBOISBWLVQRM-UHFFFAOYSA-N
131755457;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IMIRBNJSIWDVSA-UHFFFAOYSA-N
131756916;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHBLSXUEUXTLMG-UHFFFAOYSA-N
107737;ITPR3;6;3.1320000000000003e-147;0.8421;7.7518;262.5716;ITPR3;Inositol 1,4,5-trisphosphate receptor type 3 (pKi >= 6);C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O;INAPMGSXUVUWAF-UHFFFAOYSA-N
131759999;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;NZJOZQGTEOIRPE-UHFFFAOYSA-N
131757043;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DKUNFLKMWAUNDY-UHFFFAOYSA-N
131759968;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZDRCFAZKFWDKNW-UHFFFAOYSA-N
131756865;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZYPBECLJEJXDCU-UHFFFAOYSA-N
131766386;LPAR3;6;6.092e-70;0.4909;10.6651;123.8133;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XPPRNVKNFMZXDO-UHFFFAOYSA-N
131764985;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NOYWGHLJUCUPFJ-UHFFFAOYSA-N
131762060;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CLLKZXQFVMCGDJ-UHFFFAOYSA-N
131765636;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UPVISHBUYMKHRG-UHFFFAOYSA-N
131761161;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;PQLKPQSCLYKAEF-UHFFFAOYSA-N
131755100;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OLEXXKUUZGHGOQ-UHFFFAOYSA-N
131766270;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RXYZBWALOSVYDB-UHFFFAOYSA-N
131764253;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LVULGVDFRMCAJP-UHFFFAOYSA-N
131757925;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XZEKHDQNQNUYCG-UHFFFAOYSA-N
131755304;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VPQTUUYLDJYFBX-UHFFFAOYSA-N
131765869;FABP3;7;4.085e-52;0.5238;1.7154;91.8091;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DKVBIZBAPFCQCD-UHFFFAOYSA-N
131756725;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKGFMQTYNRBSTK-UHFFFAOYSA-N
9545299;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQGCOHUTHPKJNA-UHFFFAOYSA-N
131766149;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XLZYBLQWGQKJPH-UHFFFAOYSA-N
131757450;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;CFOWRVBCJCEHTO-UHFFFAOYSA-N
31234;FAAH;8;2.134e-48;0.4146;32.2147;85.1343;FAAH;Fatty-acid amide hydrolase 1 (pKi >= 8);C1=CC=C(C=C1)CCCO;VAJVDSVGBWFCLW-UHFFFAOYSA-N
131756820;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DIWDNTROQQFMKS-UHFFFAOYSA-N
99824;CQSS;6;3.1059999999999995e-67;0.4483;1.9677;118.9526;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCC(C(=O)O)O;NYHNVHGFPZAZGA-UHFFFAOYSA-N
131759981;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;WSXKYZANGLDIKE-UHFFFAOYSA-N
131764510;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XXDBJHDRECUBNX-UHFFFAOYSA-N
131755859;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CRRULBZKNVQXFP-UHFFFAOYSA-N
131762086;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BTQCGDSXYRWJGJ-UHFFFAOYSA-N
131763801;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JYUPBLUIDGVNML-UHFFFAOYSA-N
131756964;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZTFSXTDCVHSWOS-UHFFFAOYSA-N
131756622;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FOUWGWGSPVWLRF-UHFFFAOYSA-N
131765365;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UNPSHEGDLDGHSI-UHFFFAOYSA-N
131757450;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;CFOWRVBCJCEHTO-UHFFFAOYSA-N
131756584;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SKYYKLLKGOJLMR-UHFFFAOYSA-N
131757517;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KDBXLBUVLNGKSH-UHFFFAOYSA-N
131755933;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OSVPTBUSNXGUED-UHFFFAOYSA-N
131760476;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LIWGBSUBZQSLON-UHFFFAOYSA-N
131765592;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UOFWKNNJKYNSGN-UHFFFAOYSA-N
131760913;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LSMSLBOQWAMLMY-UHFFFAOYSA-N
131762180;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FVDYYPMNUFXGPD-UHFFFAOYSA-N
96801;FPR1;6;8.574000000000001e-78;0.4762;14.73;137.9094;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131763885;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KHTDSTVVANVHFF-UHFFFAOYSA-N
131765409;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;RHFXHYXWJVPZPR-UHFFFAOYSA-N
131755809;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;APCPZQYJQIVCIQ-UHFFFAOYSA-N
96801;ACE2;7;7.172999999999999e-45;0.4;5.5395;78.803;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131762194;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VVFRIVIQQBOTDF-UHFFFAOYSA-N
131753594;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ABGAPQWSCYUSJV-UHFFFAOYSA-N
131762672;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;MJAVAMAWXATTJN-UHFFFAOYSA-N
131764202;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GZVGKSYTMGJZSJ-UHFFFAOYSA-N
131763473;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OMPXEBMHVBYGHO-UHFFFAOYSA-N
131761329;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MQKXAZDGXABSQN-UHFFFAOYSA-N
131760573;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YNHHZPAROZOHCY-UHFFFAOYSA-N
131765179;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QKFVWYDUZMSNAI-UHFFFAOYSA-N
131762086;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BTQCGDSXYRWJGJ-UHFFFAOYSA-N
131763074;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TVASWGWPZXLFFR-UHFFFAOYSA-N
131760475;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PONZKPRWQCDCFJ-UHFFFAOYSA-N
131762123;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NTBWBNOELFPOOM-UHFFFAOYSA-N
131764611;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HBSUKMPAVQMSND-UHFFFAOYSA-N
131757356;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;NIPVPXGEDBBOMK-UHFFFAOYSA-N
131756965;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLVBPNSIUBYKIC-UHFFFAOYSA-N
131757267;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;RTYVZERQRRRYNE-UHFFFAOYSA-N
439198;P2RY14;6;5.532e-65;0.451;11.8903;114.9119;P2RY14;P2Y purinoceptor 14 (pKi >= 6);C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O;NBSCHQHZLSJFNQ-UHFFFAOYSA-N
131766222;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QLWBFLGZPZRYRJ-UHFFFAOYSA-N
131760350;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WMBVQZLMMZWHJG-UHFFFAOYSA-N
131761148;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FRAQRWVCMZTLGK-UHFFFAOYSA-N
131757703;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYVPIHBHFXEWIN-UHFFFAOYSA-N
131750634;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NZZPEUWLSFJAKQ-UHFFFAOYSA-N
131761006;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;INEXMIRTZIHZMF-UHFFFAOYSA-N
131760150;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;DFPNCBSXNOPJHY-UHFFFAOYSA-N
131757924;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PDFGKXGOWBDITR-UHFFFAOYSA-N
131761991;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;XAOROXTUFKKLJS-UHFFFAOYSA-N
131755100;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OLEXXKUUZGHGOQ-UHFFFAOYSA-N
131763892;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NGXAXCIWISQEQF-UHFFFAOYSA-N
131760743;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YGGZFQWCIRKMIF-UHFFFAOYSA-N
131765254;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KDPNULICSKUKOB-UHFFFAOYSA-N
131761939;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FCVBQNIGVMCKAH-UHFFFAOYSA-N
458;GRIK1;6;1.3660000000000001e-56;0.5;15.2073;99.8446;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C[S+](C)CCC(C(=O)O)N;YDBYJHTYSHBBAU-UHFFFAOYSA-O
131762597;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VRADBIPNMXGYIT-UHFFFAOYSA-N
131756583;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IURMBXSVKSWAOA-UHFFFAOYSA-N
131760914;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SVVFWKBAVUDOCH-UHFFFAOYSA-N
131761591;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JQFYUNTYJPUUBW-UHFFFAOYSA-N
131765359;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LTEIYJACFBPHLT-UHFFFAOYSA-N
131750376;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;YNDXXWKSWMKVGO-UHFFFAOYSA-N
7478;RARB;6;4.5e-77;0.4571;24.2364;136.6168;RARB;Retinoic acid receptor beta (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131762194;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VVFRIVIQQBOTDF-UHFFFAOYSA-N
131764861;FABP3;7;1.522e-50;0.4348;1.6629;88.9883;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UFZCYUBETGBVRN-UHFFFAOYSA-N
131764823;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JZCOYMPHNKEFBL-UHFFFAOYSA-N
439378;GRIK1;6;1.4229999999999998e-59;0.7188;16.0152;105.1986;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CCNC(=O)CCC(C(=O)O)N;DATAGRPVKZEWHA-UHFFFAOYSA-N
128841;FOLH1;9;4.1300000000000003e-85;0.5714;6.6757;151.0462;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CC(C(=O)NC(CCC(=O)O)C(=O)O)N;VYZAGTDAHUIRQA-UHFFFAOYSA-N
131763371;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HFGHKKLRXFEOCY-UHFFFAOYSA-N
131761851;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZWNLCOBYNICJOK-UHFFFAOYSA-N
131765525;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HYHGLDLBWNUGPI-UHFFFAOYSA-N
131753623;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PJQSYBAZIMBSRZ-UHFFFAOYSA-N
131765862;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;TZHNFARYORXAOO-UHFFFAOYSA-N
131757196;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OIZMVBWGKIPHII-UHFFFAOYSA-N
31265;LPAR3;6;2.809e-48;0.4722;7.3336;84.92;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC(=O)OCC;SHZIWNPUGXLXDT-UHFFFAOYSA-N
131758111;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OIXSAFSNRKDPLC-UHFFFAOYSA-N
131764830;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RBZWPWOMYYQLGS-UHFFFAOYSA-N
131756891;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IPHBLBUBXCJBLT-UHFFFAOYSA-N
131765655;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SRBSGDVVPHPNDO-UHFFFAOYSA-N
131761957;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KSQBRKREYMTJTD-UHFFFAOYSA-N
7009608;ENPEP;7;4.1690000000000004e-85;0.4468;6.6754;151.0388;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CC(C)C(C(=O)NC(CC(=O)O)C(=O)O)N;OBTCMSPFOITUIJ-UHFFFAOYSA-N
131750635;FABP3;7;4.085e-52;0.5238;1.7154;91.8091;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HWXPLSJBUFNUQA-UHFFFAOYSA-N
131760019;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZCWCOELIGJYADE-UHFFFAOYSA-N
131766143;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;AWRYVSSWZIIKCV-UHFFFAOYSA-N
131753403;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NDJUOSGUPZFLID-UHFFFAOYSA-N
131765831;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJQLMNLOMYMQTG-UHFFFAOYSA-N
182230;NOD1;9;2.734e-88;0.4186;6.2847;156.7537;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(=O)NC(CCC(=O)N)C(=O)O;KSMRODHGGIIXDV-UHFFFAOYSA-N
131765830;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XWQYOJPOKGTBNZ-UHFFFAOYSA-N
131756085;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUYKNMGGFRUDSS-UHFFFAOYSA-N
131755211;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OWXSQMIDLXAPIW-UHFFFAOYSA-N
131765348;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UHJHJZHWOBUIFZ-UHFFFAOYSA-N
131760483;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;LISACBAHGCRQCQ-UHFFFAOYSA-N
7824;LPAR3;6;2.936e-45;0.4054;6.8693;79.4995;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC(=O)OC;NUKZAGXMHTUAFE-UHFFFAOYSA-N
131763966;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;APGLXYXZBPDMPJ-UHFFFAOYSA-N
131757213;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;HEROZXQJPBVFAZ-UHFFFAOYSA-N
131753602;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JOLAYFVNYLLIOH-UHFFFAOYSA-N
131762083;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LYMIXKGUZOITPL-UHFFFAOYSA-N
131762173;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBSHSSBEIAVWOU-UHFFFAOYSA-N
131756897;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GPIFUYLJOSZBCL-UHFFFAOYSA-N
439715;P2RY6;6;2.9630000000000003e-65;0.4912;10.7014;115.3987;P2RY6;P2Y purinoceptor 6 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C3C(C(O2)CO)OP(=O)(O3)O;HWDMHJDYMFRXOX-UHFFFAOYSA-N
131766144;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QIZRQVJXILJOKI-UHFFFAOYSA-N
131757288;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IJOXAPFYWITIHW-UHFFFAOYSA-N
131756885;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBEVRNHIOSXUJJ-UHFFFAOYSA-N
96801;CAPN1;6;1.031e-80;0.5122;46.7159;143.1515;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131757295;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;WAWGLAWANXTROF-UHFFFAOYSA-N
131763074;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TVASWGWPZXLFFR-UHFFFAOYSA-N
444718;CPA1;6;1.342e-113;0.5517;14.1447;202.1917;CPA1;Carboxypeptidase A1 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131764617;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OCHVKWRHOIARSR-UHFFFAOYSA-N
131763371;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HFGHKKLRXFEOCY-UHFFFAOYSA-N
131764822;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KAEODHZECKFAMI-UHFFFAOYSA-N
131763787;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KUBPNGBHPOVPIW-UHFFFAOYSA-N
131763392;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MORRKBVQDCCUAG-UHFFFAOYSA-N
131766143;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;AWRYVSSWZIIKCV-UHFFFAOYSA-N
131762173;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBSHSSBEIAVWOU-UHFFFAOYSA-N
131760591;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;PFBXBGIBHLCMFX-UHFFFAOYSA-N
131765354;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VQQAYQWXQXRZHI-UHFFFAOYSA-N
131757563;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PEOBDAPKUYNJDB-UHFFFAOYSA-N
6131;GPR17;7;1.105e-66;0.4189;1.9513;117.9632;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 7);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131761037;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FRRIXNAAJYOQAA-UHFFFAOYSA-N
8094;FABP3;7;6.518e-57;0.7391;1.8757;100.4214;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131755367;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DWYQYYDRIUNZMR-UHFFFAOYSA-N
131766427;LPAR3;6;5.3899999999999994e-55;0.463;8.3666;96.9791;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BDGPXFOSOLYLHH-UHFFFAOYSA-N
131765403;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FGEZHGZQXJRSDZ-UHFFFAOYSA-N
131761240;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IIVRPCVURYXRKJ-UHFFFAOYSA-N
131760724;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OTXDGHXQYRYHDV-UHFFFAOYSA-N
81721;GRIK3;6;2.025e-43;0.4194;3.8715;76.1984;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CC(C)CC(C(=O)NC(C)C(=O)O)N;HSQGMTRYSIHDAC-UHFFFAOYSA-N
131765390;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YXJDHTLWZURQQQ-UHFFFAOYSA-N
131765552;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OIOGHITYHSZJFT-UHFFFAOYSA-N
131755858;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RUXLBRZLBVLBFV-UHFFFAOYSA-N
131765587;LPAR3;6;1.747e-52;0.5306;7.9805;92.4716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTWXUMBXWXULHV-UHFFFAOYSA-N
131765439;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZHVAYMYWTOVIQC-UHFFFAOYSA-N
131766119;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OCKZCSGVPDLCOR-UHFFFAOYSA-N
131757385;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOPFKAUVUXZXGV-UHFFFAOYSA-N
440103;GRIK3;6;1.137e-51;0.5357;4.6189;91.0111;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CC(C(=O)O)NC(=O)CCC(C(=O)O)N;WQXXXVRAFAKQJM-UHFFFAOYSA-N
131757363;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;MEEQUTNYZOELIE-UHFFFAOYSA-N
13945;POLB;6;1.177e-95;0.8039;2.8096;169.9784;POLB;DNA polymerase beta (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131755987;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OYNGPKGJSNVQOS-UHFFFAOYSA-N
131758546;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;KGEVQMGAUYEWTD-UHFFFAOYSA-N
131765405;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HWLTXKYHRROFDD-UHFFFAOYSA-N
131765143;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;TVJQOPIRMZCJFH-UHFFFAOYSA-N
131757938;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;URBAOCZNEPINCX-UHFFFAOYSA-N
131763376;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AAAULIDICJVAGC-UHFFFAOYSA-N
131758212;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MDAOMPFQZJLFBG-UHFFFAOYSA-N
7015695;LAP3;6;5.2899999999999997e-45;0.697;5.1275;79.0404;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
11920;AKR1C2;6;4.805e-44;0.4194;4.7566;77.3201;AKR1C2;Aldo-keto reductase family 1 member C2 (pKi >= 6);C1=CC=C(C(=C1)CO)C(=O)O;MGMNPSAERQZUIM-UHFFFAOYSA-N
131756142;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VFMVVXVFRDLZMQ-UHFFFAOYSA-N
68662;GRIK3;6;8.704e-64;0.7;5.7164;112.7632;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);COC(=O)CCC(C(=O)O)N;ZGEYCCHDTIDZAE-UHFFFAOYSA-N
131764159;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ANLTWDYCKOTMFG-UHFFFAOYSA-N
131765403;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;FGEZHGZQXJRSDZ-UHFFFAOYSA-N
131758871;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;USJFTUJSTHNKJJ-UHFFFAOYSA-N
131765533;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MFXICCJOWPGOMM-UHFFFAOYSA-N
131756848;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BMLXKVIKPFXMLY-UHFFFAOYSA-N
131753396;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KWBNOUOFUVIQGL-UHFFFAOYSA-N
8908;EST1_PIG;7;1.176e-68;0.4516;4.5286;121.5052;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCOC(=O)C;AOGQPLXWSUTHQB-UHFFFAOYSA-N
131764521;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ILKSJOCYCMKEPF-UHFFFAOYSA-N
165527;GLO1;6;1.4319999999999998e-59;0.4694;5.2024;105.1937;GLO1;Lactoylglutathione lyase (pKi >= 6);C(CC(=O)NCC(=O)O)C(C(=O)O)N;ACIJGUBIMXQCMF-UHFFFAOYSA-N
131756622;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FOUWGWGSPVWLRF-UHFFFAOYSA-N
131758211;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IYSLCAKQDCKAPA-UHFFFAOYSA-N
131766161;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;PZCPGKGPFMHJBX-UHFFFAOYSA-N
131757703;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;JYVPIHBHFXEWIN-UHFFFAOYSA-N
131760349;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CRTLUTSDOWTFCK-UHFFFAOYSA-N
131761118;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QDWJAQSRCULWCC-UHFFFAOYSA-N
131760350;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WMBVQZLMMZWHJG-UHFFFAOYSA-N
131760590;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KGLCIQWPEJNTLF-UHFFFAOYSA-N
131760622;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KADMYKMUQFNYTD-UHFFFAOYSA-N
131756720;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GTQFAXDJIANZMD-UHFFFAOYSA-N
131756809;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SFWGKPGCJSVXCM-UHFFFAOYSA-N
131765655;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SRBSGDVVPHPNDO-UHFFFAOYSA-N
131765163;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NNGSXHAOHVGQLQ-UHFFFAOYSA-N
131757837;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;SXKDYXAVNJJKQE-UHFFFAOYSA-N
9546172;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZZHQPHMTXYHRIT-UHFFFAOYSA-N
131755375;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZLDDMZGQIOQJK-UHFFFAOYSA-N
68662;NOD1;9;9.980000000000001e-79;0.4222;5.5985;139.5864;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);COC(=O)CCC(C(=O)O)N;ZGEYCCHDTIDZAE-UHFFFAOYSA-N
131765615;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OUNRRJRLGQQCQC-UHFFFAOYSA-N
131765578;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OYSOIAGVLQBDQC-UHFFFAOYSA-N
131760144;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NMJIAWZBGZFPMZ-UHFFFAOYSA-N
101543;P2RY14;6;1.751e-103;0.6;18.9951;184.0308;P2RY14;P2Y purinoceptor 14 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
9545117;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XKXYLRHFXANGHG-UHFFFAOYSA-N
131756796;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FOOGDTKNQFZILE-UHFFFAOYSA-N
131761362;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VQFVTSXDLUDVAR-UHFFFAOYSA-N
53480590;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CJLFAMUPGLSRFA-UHFFFAOYSA-N
9545294;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;JRIJXKUOTQILAX-UHFFFAOYSA-N
131766157;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GFNWPYUGWYDNER-UHFFFAOYSA-N
7015695;NPR;6;3.598e-84;0.4151;12.1313;149.3584;NPR;Thermolysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
131764555;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UBRHQUSYUSSYQB-UHFFFAOYSA-N
131763801;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JYUPBLUIDGVNML-UHFFFAOYSA-N
131756291;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FRFQSYRDVBGUBF-UHFFFAOYSA-N
131760455;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LVFGCKMHIYKCGK-UHFFFAOYSA-N
131762863;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GCHDZYLUKSEHHL-UHFFFAOYSA-N
131766008;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HUYCOKLLYZTFEE-UHFFFAOYSA-N
131765644;FABP3;7;4.2649999999999996e-54;0.4667;1.7816;95.3661;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NZGAHETUOKYLSV-UHFFFAOYSA-N
135398660;PNP;6;1.2980000000000001e-76;0.5;28.7356;135.791;PNP;Purine nucleoside phosphorylase (pKi >= 6);C1=CN=C2C(=N1)C(=O)NC(=N2)N;HNXQXTQTPAJEJL-UHFFFAOYSA-N
131757435;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QYYNNMGUOXLSIN-UHFFFAOYSA-N
131763815;LPAR3;6;1.747e-52;0.5306;7.9805;92.4716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZINMHJGMXNZUON-UHFFFAOYSA-N
131764549;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GYKIUAHHSLWRCC-UHFFFAOYSA-N
131760724;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OTXDGHXQYRYHDV-UHFFFAOYSA-N
131764506;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SQNFAMFCWLTXBP-UHFFFAOYSA-N
8094;NOD1;9;1.62e-69;0.4242;4.9375;123.0506;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
96384;TYR;6;2.45e-45;0.6538;2.3595;79.6404;TYR;Tyrosinase (pKi >= 6);C1=CC(=C(C=C1O)O)CCC(=O)O;HMCMTJPPXSGYJY-UHFFFAOYSA-N
131758547;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;HQQQOQMFXJYUMG-UHFFFAOYSA-N
131765622;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XYNXIKDBPCXNIZ-UHFFFAOYSA-N
131756031;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YENXZCWCIMKQCY-UHFFFAOYSA-N
31234;CES1;6;9.355000000000001e-63;0.4375;14.0462;110.9116;CES1;Liver carboxylesterase 1 (pKi >= 6);C1=CC=C(C=C1)CCCO;VAJVDSVGBWFCLW-UHFFFAOYSA-N
131764612;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YMJYQRKUQPYKQY-UHFFFAOYSA-N
131764601;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZNNSZCOJOITELJ-UHFFFAOYSA-N
131755101;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BDAPQXURZQCHLV-UHFFFAOYSA-N
131764277;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XKOVFTWOPGPYGI-UHFFFAOYSA-N
131757038;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;LPFMURDWEDJXOF-UHFFFAOYSA-N
131755790;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RMGUQZSFJCIQCW-UHFFFAOYSA-N
131765318;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SXLJFLPUYAAMSI-UHFFFAOYSA-N
131753638;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;GKMLPMONLVGROY-UHFFFAOYSA-N
131759961;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;BDNLTRKYOYVEEN-UHFFFAOYSA-N
131766001;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WSUKABRGISKTKI-UHFFFAOYSA-N
131763966;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;APGLXYXZBPDMPJ-UHFFFAOYSA-N
131763073;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FMMAGCQSTTUUOF-UHFFFAOYSA-N
131764252;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OUUACZFEHKKSHC-UHFFFAOYSA-N
444718;ANPEP;8;7.795e-105;0.4146;14.2031;186.4573;ANPEP;Aminopeptidase N (pKi >= 8);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131762304;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JTHJRVKYZXTUQN-UHFFFAOYSA-N
131764818;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QZKVXJMSEGENRO-UHFFFAOYSA-N
131757414;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GBUWYEPDQKOYKY-UHFFFAOYSA-N
131764091;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UWHCZBAFYYHHRB-UHFFFAOYSA-N
131764202;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GZVGKSYTMGJZSJ-UHFFFAOYSA-N
6427004;HLA-A;6;4.47e-44;0.4419;6.7615;77.3764;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(C(=O)O)NC(=O)C(C)N)O;BUQICHWNXBIBOG-UHFFFAOYSA-N
131766144;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QIZRQVJXILJOKI-UHFFFAOYSA-N
131759961;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;BDNLTRKYOYVEEN-UHFFFAOYSA-N
131765373;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FSGXRGDLAOPONC-UHFFFAOYSA-N
131756820;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DIWDNTROQQFMKS-UHFFFAOYSA-N
131757175;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QSDDUOAVUDULFV-UHFFFAOYSA-N
81721;HLA-A;6;2.102e-64;0.4773;9.9219;113.8709;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(C)C(=O)O)N;HSQGMTRYSIHDAC-UHFFFAOYSA-N
131755075;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;VBRUDSKZQDCRGT-UHFFFAOYSA-N
131762092;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GEPBFCHPEPGUAQ-UHFFFAOYSA-N
131758258;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XKLBAGAZJABNLI-UHFFFAOYSA-N
131755218;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YADRKXZELPOCPI-UHFFFAOYSA-N
131758045;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QYDPSHIZJLSVKM-UHFFFAOYSA-N
131756702;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ONAJSAYDJRBCNQ-UHFFFAOYSA-N
131760084;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CFASHVJHKJIKRY-UHFFFAOYSA-N
131764843;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZCXFXSOZEDCKII-UHFFFAOYSA-N
131756038;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MRYNICMNUGGZAJ-UHFFFAOYSA-N
131763473;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OMPXEBMHVBYGHO-UHFFFAOYSA-N
131766295;LPAR3;6;3.0189999999999997e-41;0.5;6.2523;72.2965;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FCKLIAZZLDXSJY-UHFFFAOYSA-N
8093;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131756935;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;MUIBFWWHJKHTDU-UHFFFAOYSA-N
131759980;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;CCPVIYZRYMYSQZ-UHFFFAOYSA-N
131750378;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QPNVLDQSHXVPMG-UHFFFAOYSA-N
70912;FPR1;6;4.332e-62;0.4048;11.7356;109.7167;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C;WXNXCEHXYPACJF-UHFFFAOYSA-N
131764854;FABP3;7;5.965e-51;0.4651;1.6765;89.7187;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BOCXQLMOUDZMLY-UHFFFAOYSA-N
131764239;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DOKOWFJDKWKLFD-UHFFFAOYSA-N
131765552;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OIOGHITYHSZJFT-UHFFFAOYSA-N
131757302;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;MFTJGJJGQONILX-UHFFFAOYSA-N
131756064;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DKLOEZUJIXIVSU-UHFFFAOYSA-N
12101;HSD17B1;6;3.3509999999999996e-41;0.4231;14.6727;72.2151;HSD17B1;Estradiol 17-beta-dehydrogenase 1 (pKi >= 6);CCC1=CC(=CC=C1)O;HMNKTRSOROOSPP-UHFFFAOYSA-N
131755790;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RMGUQZSFJCIQCW-UHFFFAOYSA-N
131758255;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BTMVDFIHILPGTB-UHFFFAOYSA-N
8093;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131760914;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SVVFWKBAVUDOCH-UHFFFAOYSA-N
131755964;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFCLJNCTQYJPGS-UHFFFAOYSA-N
131763178;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;HQJZLKIOUYEPDB-UHFFFAOYSA-N
131758258;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XKLBAGAZJABNLI-UHFFFAOYSA-N
440103;BHMT;6;3.565e-64;0.4324;1.877;113.4592;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CC(C(=O)O)NC(=O)CCC(C(=O)O)N;WQXXXVRAFAKQJM-UHFFFAOYSA-N
131763151;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ADPNGIWOVLEKOB-UHFFFAOYSA-N
131759987;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;KBTUAEPMBMZEAT-UHFFFAOYSA-N
101122;NOD1;9;5.171e-81;0.425;5.7625;143.6896;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CCC(=O)O)CC(C(=O)O)N;JUQLUIFNNFIIKC-UHFFFAOYSA-N
131755840;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JQOSLGXBJPERKJ-UHFFFAOYSA-N
131760469;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AKWRLSBPYGLHDM-UHFFFAOYSA-N
101122;BHMT;6;5.129e-85;0.6552;2.4944;150.8773;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C(CCC(=O)O)CC(C(=O)O)N;JUQLUIFNNFIIKC-UHFFFAOYSA-N
5312965;GRIK3;6;2.772e-51;0.5;4.5838;90.3164;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CCCCCC(C(=O)O)N;RDFMDVXONNIGBC-UHFFFAOYSA-N
83525;XIAP;6;3.8600000000000003e-56;0.4423;22.9683;99.0348;XIAP;E3 ubiquitin-protein ligase XIAP (pKi >= 6);CC(C(=O)N1CCCC1C(=O)O)N;WPWUFUBLGADILS-UHFFFAOYSA-N
131760687;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AOIVCCSFBIWNFL-UHFFFAOYSA-N
131764537;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MUNBPCWOOXLCTN-UHFFFAOYSA-N
131756848;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BMLXKVIKPFXMLY-UHFFFAOYSA-N
131765359;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LTEIYJACFBPHLT-UHFFFAOYSA-N
131761307;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AUNUZTMVWMIQKY-UHFFFAOYSA-N
131761148;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FRAQRWVCMZTLGK-UHFFFAOYSA-N
131765187;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BDXWRENUBFQIOU-UHFFFAOYSA-N
56940205;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SRFZZMHOMJJKRR-UHFFFAOYSA-N
131765960;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CHGDDVGRAUDGCG-UHFFFAOYSA-N
131764596;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UPFPFVNSYAIZPP-UHFFFAOYSA-N
131761471;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NHGYEISCODGQRT-UHFFFAOYSA-N
131761155;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UTZVSOSRMZACPL-UHFFFAOYSA-N
96801;HLA-A;6;1.479e-76;0.625;11.8114;135.6891;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131756970;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XIXBCMGXHNLMTN-UHFFFAOYSA-N
131762304;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JTHJRVKYZXTUQN-UHFFFAOYSA-N
131763808;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DOCRXAVOQFBILA-UHFFFAOYSA-N
131764253;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LVULGVDFRMCAJP-UHFFFAOYSA-N
131765295;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PICREIZFJYZKAV-UHFFFAOYSA-N
440103;NOD1;9;1.428e-111;0.5385;7.9555;198.5526;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(C(=O)O)NC(=O)CCC(C(=O)O)N;WQXXXVRAFAKQJM-UHFFFAOYSA-N
156908028;HLA-A;6;3.0069999999999997e-44;0.4038;6.7882;77.6855;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)NC(C(C)O)C(=O)O)N;GVRKWABULJAONN-UHFFFAOYSA-N
131758097;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LZWYQOUXYAEBEU-UHFFFAOYSA-N
131765438;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MIQPWXAIHLQOQB-UHFFFAOYSA-N
131757628;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WHBOQNGVRPUVKB-UHFFFAOYSA-N
131757392;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZUIIFSXSZSIBCK-UHFFFAOYSA-N
131762100;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ASFUCJFATRUISW-UHFFFAOYSA-N
131760573;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YNHHZPAROZOHCY-UHFFFAOYSA-N
131765348;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UHJHJZHWOBUIFZ-UHFFFAOYSA-N
131755993;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NSFHGSMSKWUULJ-UHFFFAOYSA-N
246728;EST1_PIG;7;2.656e-70;0.4615;4.6383;124.4606;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCC(=O)CC;RHLVCLIPMVJYKS-UHFFFAOYSA-N
656979;NOD1;9;6.244999999999999e-88;0.4082;6.259;156.1097;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
101543;ITPR1;6;5.081e-84;0.7593;6.3891;149.0893;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
131755395;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SYHQDCMTVVZJSW-UHFFFAOYSA-N
131755304;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VPQTUUYLDJYFBX-UHFFFAOYSA-N
131765416;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VTBYNMGNJUWKGK-UHFFFAOYSA-N
131764896;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MIHUZKOKUAIBTL-UHFFFAOYSA-N
131765531;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HFBJTSRFGJNOKC-UHFFFAOYSA-N
9545226;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;PXBQCSMXBDELKI-UHFFFAOYSA-N
12293;NOD1;9;1.0780000000000001e-43;0.4;3.0844;76.69;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCC(=O)OCCC;HTUIWRWYYVBCFT-UHFFFAOYSA-N
131756039;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HBMHHUTWSLFSBG-UHFFFAOYSA-N
131753804;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NUEDPKJRKOIZSG-UHFFFAOYSA-N
131762084;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YQJWRLLYQMZFTD-UHFFFAOYSA-N
131755980;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XXNKCKKMSRHNDQ-UHFFFAOYSA-N
131764624;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WVRQIMKZDXPCPD-UHFFFAOYSA-N
131766374;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KUKWVVBXEOUVSA-UHFFFAOYSA-N
131757863;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VYZRRPSXSDYNCO-UHFFFAOYSA-N
131756561;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UXJYWOFCVLKPDF-UHFFFAOYSA-N
246728;CQSS;6;2.476e-75;0.4615;2.2076;133.4919;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)CC;RHLVCLIPMVJYKS-UHFFFAOYSA-N
131763285;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;JECSEZDUELWFJD-UHFFFAOYSA-N
6131;P2RY4;6;2.9830000000000005e-160;0.6;23.1756;285.9488;P2RY4;P2Y purinoceptor 4 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
128841;NAALAD2;6;7.179e-92;0.6;5.3415;163.1823;NAALAD2;N-acetylated-alpha-linked acidic dipeptidase 2 (pKi >= 6);CC(C(=O)NC(CCC(=O)O)C(=O)O)N;VYZAGTDAHUIRQA-UHFFFAOYSA-N
131761093;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JLQZYULPGPGUBH-UHFFFAOYSA-N
131757464;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XFSRNVJYWCLUGE-UHFFFAOYSA-N
131762597;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VRADBIPNMXGYIT-UHFFFAOYSA-N
131758161;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LQUXSTRECRGYRZ-UHFFFAOYSA-N
131764892;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;MHUAVEYSFKXLTQ-UHFFFAOYSA-N
131757970;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;FWVLOXKUQLDETR-UHFFFAOYSA-N
131758087;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AEWUIILVPVQOTF-UHFFFAOYSA-N
131757195;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;KBOXWJNBWNAPDL-UHFFFAOYSA-N
131757281;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RDDJZUXEKOBRLD-UHFFFAOYSA-N
131758030;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCC;VQFSLGRGKYUSSR-UHFFFAOYSA-N
131755095;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;GKUAJCNVJMNRAV-UHFFFAOYSA-N
131766435;LPAR3;6;9.664e-46;0.4808;6.9435;80.3659;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NBCFODXTSOUUIN-UHFFFAOYSA-N
131762658;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFUYTFWOBBTMIA-UHFFFAOYSA-N
131757188;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;ZIDPGXBTSKOGRO-UHFFFAOYSA-N
131762180;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FVDYYPMNUFXGPD-UHFFFAOYSA-N
131765196;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ICUVDUDMLHWGHD-UHFFFAOYSA-N
131756449;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OTFHEYIENBSGTP-UHFFFAOYSA-N
131763794;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RXECQHPSJFVNPL-UHFFFAOYSA-N
131764252;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;OUUACZFEHKKSHC-UHFFFAOYSA-N
131761826;LPAR3;6;6.1270000000000005e-56;0.5532;8.5118;98.6744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;GOMWYYIOHUUNDY-UHFFFAOYSA-N
131762221;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;DUEKVDIAQKILOH-UHFFFAOYSA-N
131756240;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YFYCCMUWMOKMGJ-UHFFFAOYSA-N
131750633;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PKSYBCOQZZXUCU-UHFFFAOYSA-N
131759478;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WNUCOTRZBRFTHH-UHFFFAOYSA-N
131761571;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CIGMJNJLEJRUAW-UHFFFAOYSA-N
131757043;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;DKUNFLKMWAUNDY-UHFFFAOYSA-N
131764754;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SDAUBXOTWVTLJM-UHFFFAOYSA-N
131762077;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;AUZXYDGDYWCTNI-UHFFFAOYSA-N
131757493;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UHIRVISANDDFQO-UHFFFAOYSA-N
131766246;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JULKBNHHCMDQPB-UHFFFAOYSA-N
131755834;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BNEOBBHFUOWGMG-UHFFFAOYSA-N
7797;LPAR3;6;2.1619999999999997e-53;0.5;8.12;94.1007;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)OCC;TVQGDYNRXLTQAP-UHFFFAOYSA-N
131764830;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;RBZWPWOMYYQLGS-UHFFFAOYSA-N
131765410;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;CGHXVHJHWSVBCD-UHFFFAOYSA-N
131765416;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;VTBYNMGNJUWKGK-UHFFFAOYSA-N
131765365;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;UNPSHEGDLDGHSI-UHFFFAOYSA-N
444718;LAP3;6;5.436e-69;0.4516;7.9002;122.1068;LAP3;Cytosol aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131765531;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HFBJTSRFGJNOKC-UHFFFAOYSA-N
131765304;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIMIHFHVOVPOHU-UHFFFAOYSA-N
131765050;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KQSNLSIDQBGKLE-UHFFFAOYSA-N
131758546;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;KGEVQMGAUYEWTD-UHFFFAOYSA-N
131765417;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TXCFTFLDXVMEJI-UHFFFAOYSA-N
131756709;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MJLWCZOZMFQAGA-UHFFFAOYSA-N
131764906;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YXINJZXUPUXLPR-UHFFFAOYSA-N
131758211;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IYSLCAKQDCKAPA-UHFFFAOYSA-N
131764850;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LOHAZCBURLHRGA-UHFFFAOYSA-N
9545225;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SEOQXFHPWMVJJP-UHFFFAOYSA-N
131756240;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YFYCCMUWMOKMGJ-UHFFFAOYSA-N
131761940;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UITJRAHHHRPZTP-UHFFFAOYSA-N
131765824;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MULNUHSRKPNWLL-UHFFFAOYSA-N
131762644;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QUQYRBGCIMSPCK-UHFFFAOYSA-N
131761826;FABP3;7;1.584e-53;0.4884;1.7626;94.3434;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;GOMWYYIOHUUNDY-UHFFFAOYSA-N
131753602;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JOLAYFVNYLLIOH-UHFFFAOYSA-N
131758073;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;RVRTUMVPHQBOPW-UHFFFAOYSA-N
53480597;FABP3;7;4.0849999999999995e-53;0.4821;1.7488;93.6045;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SBPDLKMUDWDEFF-UHFFFAOYSA-N
131757856;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PPUWOQZPYWAPRO-UHFFFAOYSA-N
131764521;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ILKSJOCYCMKEPF-UHFFFAOYSA-N
131761541;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ATZGVMKFUWGRQG-UHFFFAOYSA-N
131757845;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;ZWRVHEJEANYSRU-UHFFFAOYSA-N
131756720;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GTQFAXDJIANZMD-UHFFFAOYSA-N
131755958;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JCJXSYIZXLFKNX-UHFFFAOYSA-N
131764284;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OYMCEAZYNJCWPE-UHFFFAOYSA-N
131755068;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;CTOZRWCYXGCCPP-UHFFFAOYSA-N
131765683;LPAR3;6;5.3899999999999994e-55;0.463;8.3666;96.9791;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XDSCVFTUKLPIHC-UHFFFAOYSA-N
131760104;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NMGROZCBZQQOSP-UHFFFAOYSA-N
131764601;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZNNSZCOJOITELJ-UHFFFAOYSA-N
131765615;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OUNRRJRLGQQCQC-UHFFFAOYSA-N
131764754;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SDAUBXOTWVTLJM-UHFFFAOYSA-N
131753594;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ABGAPQWSCYUSJV-UHFFFAOYSA-N
131766274;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BJEWOFVVPFFTJS-UHFFFAOYSA-N
131765119;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;HIASQOMGPHBNCJ-UHFFFAOYSA-N
131758893;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;RZHKUNBPKZZKQV-UHFFFAOYSA-N
131766008;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HUYCOKLLYZTFEE-UHFFFAOYSA-N
131762288;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;IHZYTFVUDKSYSQ-UHFFFAOYSA-N
131763815;FABP3;7;4.2649999999999996e-54;0.4667;1.7816;95.3661;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZINMHJGMXNZUON-UHFFFAOYSA-N
131764164;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YKAWRFAUPATMGP-UHFFFAOYSA-N
131750378;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QPNVLDQSHXVPMG-UHFFFAOYSA-N
131757267;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;RTYVZERQRRRYNE-UHFFFAOYSA-N
131765630;LPAR3;6;1.747e-52;0.5306;7.9805;92.4716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SELGUPPPTRUQAL-UHFFFAOYSA-N
131765960;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CHGDDVGRAUDGCG-UHFFFAOYSA-N
131756677;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WPQGJCCBOJSBDL-UHFFFAOYSA-N
131755264;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ANOUVNADVQFHPD-UHFFFAOYSA-N
131755449;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HKLUOMJYFGCDTK-UHFFFAOYSA-N
6131;P2RX4;6;3.674e-43;0.4559;1.7143;75.734;P2RX4;P2X purinoceptor 4 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131765390;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YXJDHTLWZURQQQ-UHFFFAOYSA-N
131764605;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VLIZDRAULWCXJB-UHFFFAOYSA-N
131758893;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;RZHKUNBPKZZKQV-UHFFFAOYSA-N
8094;CES2;7;5.0560000000000005e-57;0.52;3.2989;100.6195;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131757909;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ABFACKHFNWRLBN-UHFFFAOYSA-N
131756085;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUYKNMGGFRUDSS-UHFFFAOYSA-N
131766183;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UWFFSPMTISZWAL-UHFFFAOYSA-N
131757125;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NGKSSGSZKCGACO-UHFFFAOYSA-N
131755840;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JQOSLGXBJPERKJ-UHFFFAOYSA-N
131764240;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZOBKWRBFUOHRSY-UHFFFAOYSA-N
131757392;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;ZUIIFSXSZSIBCK-UHFFFAOYSA-N
71429009;HLA-A;6;1.979e-62;0.5686;9.615;110.3274;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)C(CO)N;BXLYSRPHVMCOPS-UHFFFAOYSA-N
131756568;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNBLIASYUOJINW-UHFFFAOYSA-N
131756220;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;CMYGJOFGWDPRGY-UHFFFAOYSA-N
131765050;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;KQSNLSIDQBGKLE-UHFFFAOYSA-N
131756709;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MJLWCZOZMFQAGA-UHFFFAOYSA-N
131757302;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;MFTJGJJGQONILX-UHFFFAOYSA-N
131761577;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MLYNKZHILBDXAA-UHFFFAOYSA-N
131765254;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KDPNULICSKUKOB-UHFFFAOYSA-N
131757408;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;WTCMNORLXBIXAX-UHFFFAOYSA-N
131760603;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OAJSPZUBFWYCCY-UHFFFAOYSA-N
131764823;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JZCOYMPHNKEFBL-UHFFFAOYSA-N
131756038;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;MRYNICMNUGGZAJ-UHFFFAOYSA-N
131756815;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;CLLQMHIUPLJSCO-UHFFFAOYSA-N
131765373;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;FSGXRGDLAOPONC-UHFFFAOYSA-N
131756753;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JXVMBJGBROTCFP-UHFFFAOYSA-N
131757213;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;HEROZXQJPBVFAZ-UHFFFAOYSA-N
131766338;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YXIRZGODZXSBEF-UHFFFAOYSA-N
5312965;CQSS;6;2.4549999999999998e-67;0.4667;1.9707;119.136;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(C(=O)O)N;RDFMDVXONNIGBC-UHFFFAOYSA-N
131756891;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IPHBLBUBXCJBLT-UHFFFAOYSA-N
131764595;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;REAOSGOGZMYBES-UHFFFAOYSA-N
131766007;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ZJDPMLJZMVILST-UHFFFAOYSA-N
131757931;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;GIPQJGVRFPTGNE-UHFFFAOYSA-N
131764854;LPAR3;6;6.990999999999999e-45;0.5319;6.8114;78.8231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BOCXQLMOUDZMLY-UHFFFAOYSA-N
131761221;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BTOBYBZBYYITRI-UHFFFAOYSA-N
131755958;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JCJXSYIZXLFKNX-UHFFFAOYSA-N
131764544;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ITQKGJSZZRFPGO-UHFFFAOYSA-N
131766384;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SLFGGSZZABSPQJ-UHFFFAOYSA-N
131753804;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NUEDPKJRKOIZSG-UHFFFAOYSA-N
66535;P2RY4;6;1.398e-118;0.4861;17.1265;211.1361;P2RY4;P2Y purinoceptor 4 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131760344;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CPPRQORZWKTODT-UHFFFAOYSA-N
131756561;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;UXJYWOFCVLKPDF-UHFFFAOYSA-N
131756580;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;HQKSQUGAHISWQN-UHFFFAOYSA-N
131756671;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HGCINVBTERQPJG-UHFFFAOYSA-N
131766246;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JULKBNHHCMDQPB-UHFFFAOYSA-N
131756045;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NKVPAWUMBWESJM-UHFFFAOYSA-N
131766042;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KGMWBODWUGOVSS-UHFFFAOYSA-N
131756063;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KCZXAMVZIWNRAA-UHFFFAOYSA-N
131764456;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;GQESZZRPJKPSPA-UHFFFAOYSA-N
131756741;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VNTAEBMTULPOLY-UHFFFAOYSA-N
131765483;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BJLJPRPQCIEYGL-UHFFFAOYSA-N
131762768;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;MVFBCZDAWPPNMN-UHFFFAOYSA-N
440103;GLO1;6;1.9539999999999999e-47;0.4118;4.1303;83.4077;GLO1;Lactoylglutathione lyase (pKi >= 6);CC(C(=O)O)NC(=O)CCC(C(=O)O)N;WQXXXVRAFAKQJM-UHFFFAOYSA-N
131765317;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;AAAUQAJYMBAEDN-UHFFFAOYSA-N
131756865;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZYPBECLJEJXDCU-UHFFFAOYSA-N
131762251;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;KTCYPQYXMMRSJQ-UHFFFAOYSA-N
131765601;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LJBBIXZYENZZID-UHFFFAOYSA-N
131764585;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QVXNVPNSDDBRRI-UHFFFAOYSA-N
131756045;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NKVPAWUMBWESJM-UHFFFAOYSA-N
131765608;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WYTOCNZJJQVMPR-UHFFFAOYSA-N
131765609;LPAR3;6;1.086e-44;0.5;6.782;78.4797;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;POOWIGVTDSCWSD-UHFFFAOYSA-N
131760762;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;QIKLHWHYLOODPL-UHFFFAOYSA-N
131756611;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;UXLOFYOLOKXYAP-UHFFFAOYSA-N
131756771;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PTBZUJYXYHDLML-UHFFFAOYSA-N
131765429;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QNPUPYHMCYOMNH-UHFFFAOYSA-N
131763787;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;KUBPNGBHPOVPIW-UHFFFAOYSA-N
131757624;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JDBIUXJWGUOYCR-UHFFFAOYSA-N
131757856;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PPUWOQZPYWAPRO-UHFFFAOYSA-N
131756161;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZPZAEIZDMKHCGA-UHFFFAOYSA-N
7015695;CAPN1;6;2.909e-82;0.5116;47.6152;145.9335;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(CO)N;NFDYGNFETJVMSE-UHFFFAOYSA-N
131760730;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OSQJHCZDNGROLT-UHFFFAOYSA-N
131758231;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RIVUGQBNZQXMMO-UHFFFAOYSA-N
131762140;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;YSHCWMWSRVVMKQ-UHFFFAOYSA-N
131761203;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LZYPGVKOHKHDAD-UHFFFAOYSA-N
131764860;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;KBIZWAIRBWIMJH-UHFFFAOYSA-N
131763391;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OGDZZJXPNSIRGH-UHFFFAOYSA-N
131760469;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AKWRLSBPYGLHDM-UHFFFAOYSA-N
131757863;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VYZRRPSXSDYNCO-UHFFFAOYSA-N
131766271;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GQHFKUZFVPRUHC-UHFFFAOYSA-N
131758067;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HSADKDIVCWSNKY-UHFFFAOYSA-N
131764201;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IIAFUSNBHNDBCQ-UHFFFAOYSA-N
57449;GRIK1;6;1.0759999999999999e-54;0.52;14.6936;96.4403;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C(CCN)CC(C(=O)O)N;KDXKERNSBIXSRK-UHFFFAOYSA-N
131756597;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;VZNQKMLGTXDQIH-UHFFFAOYSA-N
131757908;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;QMUANRQBCWCFMK-UHFFFAOYSA-N
131765601;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LJBBIXZYENZZID-UHFFFAOYSA-N
131761132;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OOPMCEWTZJHXQW-UHFFFAOYSA-N
131761260;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IXONFDDCPAVLRA-UHFFFAOYSA-N
61346;CQSS;6;6.4039999999999995e-68;0.4138;1.988;120.1837;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)C=C;KLTVSWGXIAYTHO-UHFFFAOYSA-N
131762348;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;JMSQUIMJQZICKW-UHFFFAOYSA-N
131758097;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LZWYQOUXYAEBEU-UHFFFAOYSA-N
131766007;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ZJDPMLJZMVILST-UHFFFAOYSA-N
131765579;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZBZSGHOSBYKFMH-UHFFFAOYSA-N
131762117;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MKUDSHOEWNCTAU-UHFFFAOYSA-N
131765417;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;TXCFTFLDXVMEJI-UHFFFAOYSA-N
131765669;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;SYWBOISBWLVQRM-UHFFFAOYSA-N
131757924;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;PDFGKXGOWBDITR-UHFFFAOYSA-N
131764623;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DFVIEKPXGADLNT-UHFFFAOYSA-N
131765156;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;IBRVYWQBLHWNLY-UHFFFAOYSA-N
131761024;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YMGJAUNSLVNGOU-UHFFFAOYSA-N
131766162;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FFDWEAUVNKQUFW-UHFFFAOYSA-N
131765347;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JGJNMFUCXCXAKE-UHFFFAOYSA-N
131756424;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;NHOONBFZUMWOFW-UHFFFAOYSA-N
131764152;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IYWYZXDESMKWHJ-UHFFFAOYSA-N
131761559;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JETOMRNEPWRNPU-UHFFFAOYSA-N
131757282;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;SSQXIJLQGIDAIS-UHFFFAOYSA-N
131758231;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;RIVUGQBNZQXMMO-UHFFFAOYSA-N
131765690;LPAR3;6;2.591e-56;0.4545;8.5693;99.3453;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LZIIYBKRUWDFGC-UHFFFAOYSA-N
131756598;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KIOWNTIUPBZKFY-UHFFFAOYSA-N
131760084;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;CFASHVJHKJIKRY-UHFFFAOYSA-N
131765677;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PJUXPSZIAMGJNO-UHFFFAOYSA-N
131756694;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;JBGIIZRJUJAGJD-UHFFFAOYSA-N
131761147;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XEGBEKAAVUQJRL-UHFFFAOYSA-N
131764758;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AHQZELFLVJXKCX-UHFFFAOYSA-N
131756134;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;UEPNNQMHGKLSKK-UHFFFAOYSA-N
131757838;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;NROZTINCWPRCMV-UHFFFAOYSA-N
131757902;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;WOZPSEZFVJBYJL-UHFFFAOYSA-N
9546272;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PRNTVSSKPYNQFB-UHFFFAOYSA-N
131765683;FABP3;7;5.64e-50;0.4286;1.6438;87.9671;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XDSCVFTUKLPIHC-UHFFFAOYSA-N
131762435;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IDBSAKGNYNUSJB-UHFFFAOYSA-N
131764501;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LXJFDHZCAKDNRX-UHFFFAOYSA-N
131766149;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XLZYBLQWGQKJPH-UHFFFAOYSA-N
131764822;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KAEODHZECKFAMI-UHFFFAOYSA-N
131763285;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;JECSEZDUELWFJD-UHFFFAOYSA-N
131764179;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GAGJUGUZOUXSIF-UHFFFAOYSA-N
131764827;FABP3;7;5.965e-51;0.4651;1.6765;89.7187;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KRLQJAOQAHGFBW-UHFFFAOYSA-N
131757058;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;PPUMGRJWTDYAJJ-UHFFFAOYSA-N
9545301;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;JJWIHFDQAUJTKM-UHFFFAOYSA-N
131756142;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VFMVVXVFRDLZMQ-UHFFFAOYSA-N
131765670;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;HGLWRMSTDIUKPJ-UHFFFAOYSA-N
131765785;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;RROULMIXESFVQQ-UHFFFAOYSA-N
131766404;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FMKKRMHWNRHGQT-UHFFFAOYSA-N
131765439;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZHVAYMYWTOVIQC-UHFFFAOYSA-N
131760608;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZRZVISWZVARYCM-UHFFFAOYSA-N
131762598;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMGBYZOKWLAVIY-UHFFFAOYSA-N
131756092;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PEXSAAMYDXHXJR-UHFFFAOYSA-N
131755941;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ALEWSTMZONDAQL-UHFFFAOYSA-N
131766281;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HGYFSGLNNNHPHI-UHFFFAOYSA-N
131760476;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LIWGBSUBZQSLON-UHFFFAOYSA-N
131757429;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SLCSZUMZGXHZBR-UHFFFAOYSA-N
131766002;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;TXXAAMLWYFWSKB-UHFFFAOYSA-N
131758561;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;FAAHFCOXNIGEMO-UHFFFAOYSA-N
131764240;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZOBKWRBFUOHRSY-UHFFFAOYSA-N
165527;GRIK3;6;6.301999999999999e-54;0.5926;4.8233;95.0618;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C(CC(=O)NCC(=O)O)C(C(=O)O)N;ACIJGUBIMXQCMF-UHFFFAOYSA-N
131756057;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KUKLTLNSTKLWOK-UHFFFAOYSA-N
131765406;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;JSMIDOASADIYEB-UHFFFAOYSA-N
131756795;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LDNPYIZUVHLDLV-UHFFFAOYSA-N
131757414;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;GBUWYEPDQKOYKY-UHFFFAOYSA-N
131755864;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WVBWJULBZBNZMZ-UHFFFAOYSA-N
131761024;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YMGJAUNSLVNGOU-UHFFFAOYSA-N
131756753;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;JXVMBJGBROTCFP-UHFFFAOYSA-N
131757542;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CYNDYCIRXVVTMS-UHFFFAOYSA-N
131755993;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NSFHGSMSKWUULJ-UHFFFAOYSA-N
131761559;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;JETOMRNEPWRNPU-UHFFFAOYSA-N
131764591;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WEIYGRYZWZVJNM-UHFFFAOYSA-N
131758092;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OZGHAUBMNCOWIH-UHFFFAOYSA-N
13945;GPR17;6;2.7139999999999997e-44;0.4328;2.3042;77.7656;GPR17;Uracil nucleotide/cysteinyl leukotriene receptor (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131760144;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NMJIAWZBGZFPMZ-UHFFFAOYSA-N
131765656;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWYPDEYRJRCIAW-UHFFFAOYSA-N
131761012;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QUWRGMOSPKXQJN-UHFFFAOYSA-N
8093;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131755834;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;BNEOBBHFUOWGMG-UHFFFAOYSA-N
131756910;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WHPQOGDRBOSGRN-UHFFFAOYSA-N
131756226;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KWEJHHHDBVLFPL-UHFFFAOYSA-N
131766153;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LAGVAZJEYLYEQL-UHFFFAOYSA-N
439353;FIMH;6;1.2460000000000002e-72;0.4242;9.2855;128.6413;FIMH;FimH (pKi >= 6);C(C1C(C(C(C(O1)O)O)O)O)O;WQZGKKKJIJFFOK-UHFFFAOYSA-N
131761996;FABP3;7;1.584e-53;0.4884;1.7626;94.3434;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZYIATLWLTAHQNK-UHFFFAOYSA-N
131766002;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;TXXAAMLWYFWSKB-UHFFFAOYSA-N
131757379;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RWKYSZZMYDKMMP-UHFFFAOYSA-N
131762009;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZGXGANOLCKKLJU-UHFFFAOYSA-N
131801690;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UBOALFOWVHLTCP-UHFFFAOYSA-N
131757832;LPAR1;6;2.977e-42;0.5294;7.889;74.1027;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;FCFBMPGFGZPIBY-UHFFFAOYSA-N
131755941;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ALEWSTMZONDAQL-UHFFFAOYSA-N
131758073;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;RVRTUMVPHQBOPW-UHFFFAOYSA-N
131758561;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;FAAHFCOXNIGEMO-UHFFFAOYSA-N
131762100;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ASFUCJFATRUISW-UHFFFAOYSA-N
131765164;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VRDKJPIBXLZYBB-UHFFFAOYSA-N
131756291;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FRFQSYRDVBGUBF-UHFFFAOYSA-N
131757547;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCOSJHHIEGDUHK-UHFFFAOYSA-N
131760291;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GDWVKMUJAYQRMH-UHFFFAOYSA-N
131763479;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RBFFADLAIHOKCA-UHFFFAOYSA-N
131762598;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;DMGBYZOKWLAVIY-UHFFFAOYSA-N
131761221;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;BTOBYBZBYYITRI-UHFFFAOYSA-N
131760894;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YFDGJODCMWVLKK-UHFFFAOYSA-N
131758717;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;JVIIPAKFIVOQGP-UHFFFAOYSA-N
131756964;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZTFSXTDCVHSWOS-UHFFFAOYSA-N
20057289;MAG;6;1.567e-53;0.4569;1.7627;94.3515;MAG;Myelin-associated glycoprotein (pKi >= 6);CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)OC3(CC(C(C(O3)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)CCCCCCCCCCCCC=CCCCCCCCCC)O;BGMMKNTYKZAIDF-UHFFFAOYSA-N
131761523;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZYJWXFJPEXYPPD-UHFFFAOYSA-N
131760475;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PONZKPRWQCDCFJ-UHFFFAOYSA-N
439583;FIMH;6;1.2460000000000002e-72;0.4242;9.2855;128.6413;FIMH;FimH (pKi >= 6);C(C1C(C(C(C(O1)O)O)O)O)O;WQZGKKKJIJFFOK-UHFFFAOYSA-N
131758546;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OCCCCCCCCCCCCCCCCCC;KGEVQMGAUYEWTD-UHFFFAOYSA-N
131765525;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HYHGLDLBWNUGPI-UHFFFAOYSA-N
131765530;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HHHZTIJSFLQUDN-UHFFFAOYSA-N
131757076;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ALYVJOCNZCAWSV-UHFFFAOYSA-N
131765586;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XKMBJWDOLOADJZ-UHFFFAOYSA-N
131764814;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PPOTXXPYDKRBFX-UHFFFAOYSA-N
53480586;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XRIGAJUVDRNXQG-UHFFFAOYSA-N
444718;MME;6;4.127000000000001e-143;0.5278;122.4731;255.1752;MME;Neprilysin (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131761031;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PTACBPKQWASVGS-UHFFFAOYSA-N
131755272;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QVXASAXDWWFXGC-UHFFFAOYSA-N
131757289;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;JUAQGNVWXOALQO-UHFFFAOYSA-N
131765831;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJQLMNLOMYMQTG-UHFFFAOYSA-N
131766085;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SLYLFMOSDCVRJE-UHFFFAOYSA-N
131761958;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;GVAIQYMZMOVIIO-UHFFFAOYSA-N
131766251;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MFUCZQQHHGYRHL-UHFFFAOYSA-N
528;GRIK1;6;4.5060000000000003e-72;0.4815;19.4017;127.6392;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CC(=O)OCCC(C(=O)O)N;FCXZBWSIAGGPCB-UHFFFAOYSA-N
131758023;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;ABLVQVNHRJIDDA-UHFFFAOYSA-N
131761996;LPAR3;6;6.1270000000000005e-56;0.5532;8.5118;98.6744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZYIATLWLTAHQNK-UHFFFAOYSA-N
131762118;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HACBAOINPHYNST-UHFFFAOYSA-N
131755075;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;VBRUDSKZQDCRGT-UHFFFAOYSA-N
131756731;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;BWVMXRNTJKNLIG-UHFFFAOYSA-N
131758446;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YRIBGJSBLCTVJS-UHFFFAOYSA-N
131763081;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MGIADBDESXZBTF-UHFFFAOYSA-N
131764257;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ONLNESNWMKDEPS-UHFFFAOYSA-N
131756463;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WITFBADACYFOQN-UHFFFAOYSA-N
131757281;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RDDJZUXEKOBRLD-UHFFFAOYSA-N
131755211;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;OWXSQMIDLXAPIW-UHFFFAOYSA-N
131765164;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;VRDKJPIBXLZYBB-UHFFFAOYSA-N
131756795;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LDNPYIZUVHLDLV-UHFFFAOYSA-N
131761030;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YEPSKQSRIFNCPW-UHFFFAOYSA-N
131762435;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;IDBSAKGNYNUSJB-UHFFFAOYSA-N
131756843;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEZPDJIPJQTNAB-UHFFFAOYSA-N
9545226;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;PXBQCSMXBDELKI-UHFFFAOYSA-N
131757542;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;CYNDYCIRXVVTMS-UHFFFAOYSA-N
131761577;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MLYNKZHILBDXAA-UHFFFAOYSA-N
7826;CQSS;6;5.2580000000000004e-76;0.4643;2.2275;134.7;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCC(=O)OC;XNCNNDVCAUWAIT-UHFFFAOYSA-N
131766434;FABP3;7;5.296e-52;0.4516;1.7116;91.6068;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MEODBAFRLCEHNV-UHFFFAOYSA-N
131756226;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;KWEJHHHDBVLFPL-UHFFFAOYSA-N
131755042;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KXNZZVRMSWHVPA-UHFFFAOYSA-N
131765600;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RISPPOANHRVJCG-UHFFFAOYSA-N
131765586;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XKMBJWDOLOADJZ-UHFFFAOYSA-N
131763705;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;MRTCVGSSQXQTAY-UHFFFAOYSA-N
131764604;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MELJTHJAZJCCBG-UHFFFAOYSA-N
131756538;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;MYQZXEILKZNHFK-UHFFFAOYSA-N
131761992;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KABLDRAFWYQMHA-UHFFFAOYSA-N
131756580;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;HQKSQUGAHISWQN-UHFFFAOYSA-N
56936906;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MGQQPWQKHKOPLE-UHFFFAOYSA-N
131762010;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;HXSQHIRLTXCUEB-UHFFFAOYSA-N
131757489;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PLJUCVWMUHTXMN-UHFFFAOYSA-N
101122;GRIK1;6;9.391e-58;0.6957;15.5223;101.9321;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);C(CCC(=O)O)CC(C(=O)O)N;JUQLUIFNNFIIKC-UHFFFAOYSA-N
131758710;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PASXLGNHMHBIKZ-UHFFFAOYSA-N
165527;NOD1;9;4.3020000000000004e-76;0.4286;5.4094;134.8565;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);C(CC(=O)NCC(=O)O)C(C(=O)O)N;ACIJGUBIMXQCMF-UHFFFAOYSA-N
131766085;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;SLYLFMOSDCVRJE-UHFFFAOYSA-N
131766148;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ACSPQPSYQCNVOM-UHFFFAOYSA-N
131761952;LPAR3;6;6.1270000000000005e-56;0.5532;8.5118;98.6744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JEYAIOVCJUFECT-UHFFFAOYSA-N
131761416;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;AZRGVQKDBWALBZ-UHFFFAOYSA-N
131765817;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PHBPVJUUYJZCOS-UHFFFAOYSA-N
131758097;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;LZWYQOUXYAEBEU-UHFFFAOYSA-N
439378;GLO1;6;8.579e-46;0.4118;3.9852;80.4588;GLO1;Lactoylglutathione lyase (pKi >= 6);CCNC(=O)CCC(C(=O)O)N;DATAGRPVKZEWHA-UHFFFAOYSA-N
131761985;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HVTFPWMQNVTIML-UHFFFAOYSA-N
131760551;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;BGOSCAYGIGBWAZ-UHFFFAOYSA-N
131765429;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QNPUPYHMCYOMNH-UHFFFAOYSA-N
131765160;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KDZYWQNMBRTHNK-UHFFFAOYSA-N
165527;BHMT;6;1.5830000000000002e-65;0.4054;1.9171;115.8876;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C(CC(=O)NCC(=O)O)C(C(=O)O)N;ACIJGUBIMXQCMF-UHFFFAOYSA-N
131756671;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;HGCINVBTERQPJG-UHFFFAOYSA-N
131756463;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WITFBADACYFOQN-UHFFFAOYSA-N
131763377;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JQULTLMUUUQRFY-UHFFFAOYSA-N
131765608;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WYTOCNZJJQVMPR-UHFFFAOYSA-N
131765347;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JGJNMFUCXCXAKE-UHFFFAOYSA-N
131755980;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XXNKCKKMSRHNDQ-UHFFFAOYSA-N
131756747;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RONZIXSUBRLVHU-UHFFFAOYSA-N
131766374;LPAR3;6;6.369e-44;0.5106;6.6638;77.1003;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;KUKWVVBXEOUVSA-UHFFFAOYSA-N
131764602;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;QFZJQQLNNQGHMX-UHFFFAOYSA-N
131765097;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZXNJPPFMHXBJOZ-UHFFFAOYSA-N
131758067;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HSADKDIVCWSNKY-UHFFFAOYSA-N
131756604;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HRIZOSOLJUQKSO-UHFFFAOYSA-N
131757563;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PEOBDAPKUYNJDB-UHFFFAOYSA-N
131766119;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OCKZCSGVPDLCOR-UHFFFAOYSA-N
131765593;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YHLFOSOEMRNPRK-UHFFFAOYSA-N
131765398;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UAMGOVBFCPESRD-UHFFFAOYSA-N
131759987;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;KBTUAEPMBMZEAT-UHFFFAOYSA-N
131758553;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;MNBYMCVZZONTET-UHFFFAOYSA-N
131758091;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GVCWIXNHGLSALQ-UHFFFAOYSA-N
131760608;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ZRZVISWZVARYCM-UHFFFAOYSA-N
131766162;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FFDWEAUVNKQUFW-UHFFFAOYSA-N
131763458;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OGIYWYULRPCZFI-UHFFFAOYSA-N
131766247;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QXPZZKNNVUFTEO-UHFFFAOYSA-N
101543;P2RY4;6;1.987e-155;0.5818;22.4754;277.2891;P2RY4;P2Y purinoceptor 4 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
131756598;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KIOWNTIUPBZKFY-UHFFFAOYSA-N
131766277;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GWPFCSILQUPTKP-UHFFFAOYSA-N
131765663;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XPNIGQULVQXNOR-UHFFFAOYSA-N
131764501;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LXJFDHZCAKDNRX-UHFFFAOYSA-N
444718;AMP1_PLAFQ;6;1.836e-49;0.4167;6.2979;87.0468;AMP1_PLAFQ;M1 family aminopeptidase (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131765629;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FBADKMOCWQAFRV-UHFFFAOYSA-N
66535;POLB;6;3.0050000000000003e-65;0.5161;1.9089;115.3877;POLB;DNA polymerase beta (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131756603;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YITUAXAQLSWWNX-UHFFFAOYSA-N
131766253;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JDNDOXXFGNHEBN-UHFFFAOYSA-N
131763878;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BQWOVZWVJFRMTK-UHFFFAOYSA-N
7478;AKR1C2;6;4.704e-54;0.5429;5.8537;95.2899;AKR1C2;Aldo-keto reductase family 1 member C2 (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131750633;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PKSYBCOQZZXUCU-UHFFFAOYSA-N
131765823;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;WFPDDMWARPVGSU-UHFFFAOYSA-N
131762863;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;GCHDZYLUKSEHHL-UHFFFAOYSA-N
131760163;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;JHWDCGVOVZRWAF-UHFFFAOYSA-N
131764362;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;YCGDLABDDKGWQV-UHFFFAOYSA-N
131753812;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JWNQPWOMEKFYMA-UHFFFAOYSA-N
131757909;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ABFACKHFNWRLBN-UHFFFAOYSA-N
131760063;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CPMVPDLVOWSSKE-UHFFFAOYSA-N
131764887;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LTIDJEYLTBXYLE-UHFFFAOYSA-N
131764179;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GAGJUGUZOUXSIF-UHFFFAOYSA-N
9545299;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;JQGCOHUTHPKJNA-UHFFFAOYSA-N
131765622;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;XYNXIKDBPCXNIZ-UHFFFAOYSA-N
131766118;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XPUDKPRPIYUKFD-UHFFFAOYSA-N
131760063;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;CPMVPDLVOWSSKE-UHFFFAOYSA-N
131758552;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OTARVUCVZUWLOP-UHFFFAOYSA-N
131756069;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ACFCSXYEAINHFR-UHFFFAOYSA-N
131758688;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;MYYDVRKVUNECKQ-UHFFFAOYSA-N
131765578;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;OYSOIAGVLQBDQC-UHFFFAOYSA-N
131764850;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LOHAZCBURLHRGA-UHFFFAOYSA-N
92843;HLA-A;6;4.1009999999999996e-53;0.4615;8.1666;93.6014;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)CN;DKEXFJVMVGETOO-UHFFFAOYSA-N
131756057;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KUKLTLNSTKLWOK-UHFFFAOYSA-N
13945;P2RY4;6;1.103e-106;0.6406;15.3995;189.7774;P2RY4;P2Y purinoceptor 4 (pKi >= 6);C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O;NCMVOABPESMRCP-UHFFFAOYSA-N
131760150;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;DFPNCBSXNOPJHY-UHFFFAOYSA-N
131755839;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;MIWJGWAISDNXBZ-UHFFFAOYSA-N
131758045;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QYDPSHIZJLSVKM-UHFFFAOYSA-N
131765663;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XPNIGQULVQXNOR-UHFFFAOYSA-N
131758092;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;OZGHAUBMNCOWIH-UHFFFAOYSA-N
131766153;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LAGVAZJEYLYEQL-UHFFFAOYSA-N
131760730;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OSQJHCZDNGROLT-UHFFFAOYSA-N
6054;SLC18A2;6;6.687e-52;0.4242;10.5632;91.4249;SLC18A2;Synaptic vesicular amine transporter (pKi >= 6);C1=CC=C(C=C1)CCO;WRMNZCZEMHIOCP-UHFFFAOYSA-N
131755068;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;CTOZRWCYXGCCPP-UHFFFAOYSA-N
131761578;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FFYFDHSACVXNGJ-UHFFFAOYSA-N
131761992;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;KABLDRAFWYQMHA-UHFFFAOYSA-N
131753812;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JWNQPWOMEKFYMA-UHFFFAOYSA-N
131764584;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OPQWTAFOYCFRKH-UHFFFAOYSA-N
131765097;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;ZXNJPPFMHXBJOZ-UHFFFAOYSA-N
131763464;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;DHGPOFOBMYEFSV-UHFFFAOYSA-N
131766013;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;JBTCSEUULKOTDN-UHFFFAOYSA-N
9545225;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;SEOQXFHPWMVJJP-UHFFFAOYSA-N
131750377;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;PORGMKLTIBAGKT-UHFFFAOYSA-N
131764906;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YXINJZXUPUXLPR-UHFFFAOYSA-N
131756108;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JTJZUFAYMWLIGR-UHFFFAOYSA-N
131763151;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;ADPNGIWOVLEKOB-UHFFFAOYSA-N
131759520;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZZBKGDIMYDDPOX-UHFFFAOYSA-N
131765573;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MOBYCDUVYHPIKW-UHFFFAOYSA-N
131753367;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;NSFHIRVYTDSVSD-UHFFFAOYSA-N
14426033;ENPEP;7;1.8089999999999998e-90;0.42;7.0995;160.6663;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)NC(CO)C(=O)O)N;TWVKGYNQQAUNRN-UHFFFAOYSA-N
131759355;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;CISSBQIGKKYEPB-UHFFFAOYSA-N
131764091;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UWHCZBAFYYHHRB-UHFFFAOYSA-N
131755279;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HCEFBTFVOASXGI-UHFFFAOYSA-N
79025;FIMH;6;1.2460000000000002e-72;0.4242;9.2855;128.6413;FIMH;FimH (pKi >= 6);C(C1C(C(C(C(O1)O)O)O)O)O;WQZGKKKJIJFFOK-UHFFFAOYSA-N
131766435;FABP3;7;9.912999999999999e-47;0.4333;1.5354;82.1414;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NBCFODXTSOUUIN-UHFFFAOYSA-N
7478;RARG;6;1.6169999999999998e-66;0.4474;18.3165;117.6662;RARG;Retinoic acid receptor gamma (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131756603;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;YITUAXAQLSWWNX-UHFFFAOYSA-N
7020159;HLA-A;6;1.289e-60;0.4808;9.3331;107.0713;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)C(CO)N;ILVGMCVCQBJPSH-UHFFFAOYSA-N
131761025;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RUSGNCLMYHYYHV-UHFFFAOYSA-N
8051;EST1_PIG;6;4.004e-73;0.48;5.7277;129.5265;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCC(=O)C;CATSNJVOTSVZJV-UHFFFAOYSA-N
5312965;BHMT;6;1.8809999999999997e-67;0.4118;1.9741;119.3436;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);CCCCCC(C(=O)O)N;RDFMDVXONNIGBC-UHFFFAOYSA-N
458;BHMT;6;8.89e-65;0.4;1.8949;114.5421;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C[S+](C)CCC(C(=O)O)N;YDBYJHTYSHBBAU-UHFFFAOYSA-O
131766247;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QXPZZKNNVUFTEO-UHFFFAOYSA-N
131764276;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GBIRFFFMSPKFEB-UHFFFAOYSA-N
131753623;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PJQSYBAZIMBSRZ-UHFFFAOYSA-N
131756213;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LPELEKIVSWFLKI-UHFFFAOYSA-N
31265;CQSS;6;3.476e-71;0.4643;2.0847;126.0461;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)OCC;SHZIWNPUGXLXDT-UHFFFAOYSA-N
131760005;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OKYXKQWJBHHXBC-UHFFFAOYSA-N
131760454;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LRBIDJYFWXUQGA-UHFFFAOYSA-N
7478;RARA;6;8.754e-49;0.4324;12.211;85.8289;RARA;Retinoic acid receptor alpha (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131753631;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;UISYJGKZKOFBCP-UHFFFAOYSA-N
101543;RNASE1;6;8.603e-80;0.5195;2.3397;141.4974;RNASE1;Ribonuclease pancreatic (pKi >= 6);C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=O)(O)O)O;FOGRQMPFHUHIGU-UHFFFAOYSA-N
131757582;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;ZDIISHVVPLAVCQ-UHFFFAOYSA-N
131758114;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WLQOSKFMJPLCIL-UHFFFAOYSA-N
131760584;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;DWPNGNRTDXKEOG-UHFFFAOYSA-N
131763081;LPAR3;6;5.32e-74;0.5094;11.2893;131.1002;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MGIADBDESXZBTF-UHFFFAOYSA-N
131757287;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CUYWPWQOJRQSCW-UHFFFAOYSA-N
131755264;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ANOUVNADVQFHPD-UHFFFAOYSA-N
131755964;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;AFCLJNCTQYJPGS-UHFFFAOYSA-N
131757430;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QQXNBQNXQFZRPW-UHFFFAOYSA-N
131760164;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NNCFNVDCMOKBFC-UHFFFAOYSA-N
131763891;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UIGZHQJJRVXCAK-UHFFFAOYSA-N
9546271;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PYADCGOWWCWTFV-UHFFFAOYSA-N
131763385;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FOEXFNVACTZKNE-UHFFFAOYSA-N
131756897;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;GPIFUYLJOSZBCL-UHFFFAOYSA-N
8093;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCC(=O)C;ZPVFWPFBNIEHGJ-UHFFFAOYSA-N
131760164;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;NNCFNVDCMOKBFC-UHFFFAOYSA-N
131764269;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;JAYITAIAYFOYRP-UHFFFAOYSA-N
131755291;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;OGQHBMYPMDPMNU-UHFFFAOYSA-N
131755218;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YADRKXZELPOCPI-UHFFFAOYSA-N
131756752;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IBYMEWUNOCTTRG-UHFFFAOYSA-N
131756702;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;ONAJSAYDJRBCNQ-UHFFFAOYSA-N
75619;ACE2;6;2.912e-55;0.5082;7.7418;97.4591;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);CC(=O)NC(CC1=CN=CN1)C(=O)O;KBOJOGQFRVVWBH-UHFFFAOYSA-N
131765573;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MOBYCDUVYHPIKW-UHFFFAOYSA-N
131764604;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MELJTHJAZJCCBG-UHFFFAOYSA-N
131760680;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;PHZQINHSUNAFFE-UHFFFAOYSA-N
131761037;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;FRRIXNAAJYOQAA-UHFFFAOYSA-N
7478;RXRG;6;2.055e-50;0.4444;14.1659;88.7544;RXRG;Retinoic acid receptor RXR-gamma (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
445238;SLC5A2;6;4.477e-62;0.4348;46.0835;109.6909;SLC5A2;Sodium/glucose cotransporter 2 (pKi >= 6);COC1C(C(C(C(O1)CO)O)O)O;HOVAGTYPODGVJG-UHFFFAOYSA-N
131763593;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;CVMGFHNEUZQYDT-UHFFFAOYSA-N
131762109;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SFYYMWCCKFQDEZ-UHFFFAOYSA-N
88454;LPAR3;6;9.869e-43;0.4483;6.4808;74.9636;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCOC(=O)CC;GOKKOFHHJFGZHW-UHFFFAOYSA-N
131758717;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCC;JVIIPAKFIVOQGP-UHFFFAOYSA-N
131760329;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZDZGRFOKLODFJJ-UHFFFAOYSA-N
56936906;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MGQQPWQKHKOPLE-UHFFFAOYSA-N
131761133;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IDGIWWVXFKHRCG-UHFFFAOYSA-N
131755298;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ZLRZWJGBXVBWHP-UHFFFAOYSA-N
131760687;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;AOIVCCSFBIWNFL-UHFFFAOYSA-N
131757930;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CLPGGZLOXDCDRW-UHFFFAOYSA-N
131763800;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;GLNXLYRBLGFBLW-UHFFFAOYSA-N
131757831;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;CAOCEUZJFODCFY-UHFFFAOYSA-N
131760454;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LRBIDJYFWXUQGA-UHFFFAOYSA-N
131763884;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IRNKBTPNXMDLBH-UHFFFAOYSA-N
96801;RNPEP;6;7.344e-42;0.55;2.0533;73.3987;RNPEP;Aminopeptidase B (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131757188;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;ZIDPGXBTSKOGRO-UHFFFAOYSA-N
131760585;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AOUHOSSCVUKSAD-UHFFFAOYSA-N
131765372;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZAXBGJFTPBBLPV-UHFFFAOYSA-N
131764590;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AJBJMZWRBVANHW-UHFFFAOYSA-N
131760680;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;PHZQINHSUNAFFE-UHFFFAOYSA-N
7797;CES2;7;3.9539999999999995e-51;0.4483;2.9535;90.0394;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)OCC;TVQGDYNRXLTQAP-UHFFFAOYSA-N
131759375;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FNHNIQYRALAOKL-UHFFFAOYSA-N
131758068;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FXXAUAAYIAECGB-UHFFFAOYSA-N
131763386;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BRYGUDCZVRWORF-UHFFFAOYSA-N
131758051;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RHKGVUCWKLHRQP-UHFFFAOYSA-N
131760908;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JDVMRQCFIMNFEV-UHFFFAOYSA-N
131757839;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;WKEWFXQSALSQCQ-UHFFFAOYSA-N
131755933;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;OSVPTBUSNXGUED-UHFFFAOYSA-N
656979;FOLH1;7;3.464e-64;0.5122;14.8125;113.4817;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 7);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
131756885;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBEVRNHIOSXUJJ-UHFFFAOYSA-N
7826;CES2;7;2.65e-53;0.4643;3.0809;93.942;CES2;Cocaine esterase (pKi >= 7);CCCCCCC(=O)OC;XNCNNDVCAUWAIT-UHFFFAOYSA-N
131761851;LPAR3;6;1.362e-73;0.54;11.2265;130.3672;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZWNLCOBYNICJOK-UHFFFAOYSA-N
131761203;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;LZYPGVKOHKHDAD-UHFFFAOYSA-N
131762879;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;FIXNXVIJNBXNSK-UHFFFAOYSA-N
131764849;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JMDOVHGZTAWIRS-UHFFFAOYSA-N
131755859;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CRRULBZKNVQXFP-UHFFFAOYSA-N
131756747;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;RONZIXSUBRLVHU-UHFFFAOYSA-N
131762615;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZXIGPBPGGKUILK-UHFFFAOYSA-N
131766167;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZDNJPUPRXOSVID-UHFFFAOYSA-N
131764893;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UBWVHRBREHBARK-UHFFFAOYSA-N
131764543;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;OIHKRHQEBBJGMC-UHFFFAOYSA-N
131757902;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;WOZPSEZFVJBYJL-UHFFFAOYSA-N
57449;BHMT;6;7.822e-67;0.4242;1.9558;118.2325;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C(CCN)CC(C(=O)O)N;KDXKERNSBIXSRK-UHFFFAOYSA-N
131755101;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BDAPQXURZQCHLV-UHFFFAOYSA-N
6131;P2RX1;7;1.942e-58;0.4559;1.7071;103.1608;P2RX1;P2X purinoceptor 1 (pKi >= 7);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131762672;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;MJAVAMAWXATTJN-UHFFFAOYSA-N
131764189;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JHULUDGYWIJGEI-UHFFFAOYSA-N
131756444;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UURRRKGAHHCVSI-UHFFFAOYSA-N
131757415;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;INCHZKMNHLHTMY-UHFFFAOYSA-N
131758552;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OTARVUCVZUWLOP-UHFFFAOYSA-N
131761584;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;NYVBOEBPAQPUMA-UHFFFAOYSA-N
131757838;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;NROZTINCWPRCMV-UHFFFAOYSA-N
131765656;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZWYPDEYRJRCIAW-UHFFFAOYSA-N
131764556;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;VMXDSQGCSDZBPH-UHFFFAOYSA-N
131758051;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCC;RHKGVUCWKLHRQP-UHFFFAOYSA-N
131756843;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;OEZPDJIPJQTNAB-UHFFFAOYSA-N
131756213;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;LPELEKIVSWFLKI-UHFFFAOYSA-N
131756802;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RRCHFUDCOMJONU-UHFFFAOYSA-N
131760567;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WZWIOTYITIUOCJ-UHFFFAOYSA-N
182230;FOLH1;9;5.9880000000000005e-58;0.45;4.5276;102.283;FOLH1;Glutamate carboxypeptidase 2 (pKi >= 9);CC(=O)NC(CCC(=O)N)C(=O)O;KSMRODHGGIIXDV-UHFFFAOYSA-N
131764849;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JMDOVHGZTAWIRS-UHFFFAOYSA-N
131762002;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZCVSDPAGUYLRRT-UHFFFAOYSA-N
131761128;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HIBOOXQOVDHKOV-UHFFFAOYSA-N
131764506;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SQNFAMFCWLTXBP-UHFFFAOYSA-N
131756870;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JZMNYGXVOKIZHI-UHFFFAOYSA-N
131755864;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;WVBWJULBZBNZMZ-UHFFFAOYSA-N
131758068;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;FXXAUAAYIAECGB-UHFFFAOYSA-N
131760908;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JDVMRQCFIMNFEV-UHFFFAOYSA-N
18218230;HLA-A;6;1.144e-46;0.4603;7.1644;82.0295;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C(C(=O)O)NC(=O)C(CCSC)N)O;KAKJTZWHIUWTTD-UHFFFAOYSA-N
131766402;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTKJUGSNYRWBGG-UHFFFAOYSA-N
131764437;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQOHWEWPDQAKRD-UHFFFAOYSA-N
66535;P2RY1;6;1.806e-43;0.4026;21.1746;76.2876;P2RY1;P2Y purinoceptor 1 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131764515;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YEWJAWDCDPEWJL-UHFFFAOYSA-N
131764239;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;DOKOWFJDKWKLFD-UHFFFAOYSA-N
131765391;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZZTADPGUNQYDJV-UHFFFAOYSA-N
131766281;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;HGYFSGLNNNHPHI-UHFFFAOYSA-N
131765172;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LSBRSPXRXGIWSM-UHFFFAOYSA-N
131764861;LPAR3;6;1.086e-44;0.5;6.782;78.4797;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UFZCYUBETGBVRN-UHFFFAOYSA-N
131758255;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;BTMVDFIHILPGTB-UHFFFAOYSA-N
131761940;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;UITJRAHHHRPZTP-UHFFFAOYSA-N
131756069;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;ACFCSXYEAINHFR-UHFFFAOYSA-N
131759520;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;ZZBKGDIMYDDPOX-UHFFFAOYSA-N
7797;EST1_PIG;7;7.052e-67;0.4483;4.4101;118.3133;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCC(=O)OCC;TVQGDYNRXLTQAP-UHFFFAOYSA-N
131764887;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LTIDJEYLTBXYLE-UHFFFAOYSA-N
131757595;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;NJFXQBUHWRCFMV-UHFFFAOYSA-N
131760163;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;JHWDCGVOVZRWAF-UHFFFAOYSA-N
131766266;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VWIONIBYRJYTDI-UHFFFAOYSA-N
131766337;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFGCAZDDZSPQTA-UHFFFAOYSA-N
131758547;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;HQQQOQMFXJYUMG-UHFFFAOYSA-N
131756801;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;SBRSQEIFWNUOMV-UHFFFAOYSA-N
131756583;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;IURMBXSVKSWAOA-UHFFFAOYSA-N
131765579;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZBZSGHOSBYKFMH-UHFFFAOYSA-N
131761307;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;AUNUZTMVWMIQKY-UHFFFAOYSA-N
131759980;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;CCPVIYZRYMYSQZ-UHFFFAOYSA-N
131761111;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;ZROXJHNMTWXXSU-UHFFFAOYSA-N
131762267;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WCCRVFFTKSGKIN-UHFFFAOYSA-N
161368;ITPR3;6;3.1320000000000003e-147;0.8421;7.7518;262.5716;ITPR3;Inositol 1,4,5-trisphosphate receptor type 3 (pKi >= 6);C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O;INAPMGSXUVUWAF-UHFFFAOYSA-N
131766338;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YXIRZGODZXSBEF-UHFFFAOYSA-N
131764437;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;BQOHWEWPDQAKRD-UHFFFAOYSA-N
131764284;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OYMCEAZYNJCWPE-UHFFFAOYSA-N
131761293;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UBHZXNRDMRSIPS-UHFFFAOYSA-N
131764077;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LGZBYVCHRDGVGD-UHFFFAOYSA-N
131750625;LPAR3;6;1.086e-44;0.5;6.782;78.4797;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BOXFBDURIZMSKQ-UHFFFAOYSA-N
131757947;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;XXHFTCACPARCGZ-UHFFFAOYSA-N
131755865;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;KOGFJPQTJBKODN-UHFFFAOYSA-N
131761922;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BAVCCPMFLDZBDC-UHFFFAOYSA-N
8094;EST1_PIG;6;1.432e-79;0.52;6.2376;141.1001;EST1_PIG;Liver carboxylesterase (pKi >= 6);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131759381;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;IKNAMSQXQLOJII-UHFFFAOYSA-N
131756815;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;CLLQMHIUPLJSCO-UHFFFAOYSA-N
9545150;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;QMGVAYGHMZTSEF-UHFFFAOYSA-N
656979;WDR5;6;8.673999999999999e-54;0.4667;2.8067;94.8128;WDR5;WD repeat-containing protein 5 (pKi >= 6);CC(=O)NC(CCCNC(=O)N)C(=O)O;WMQMIOYQXNRROC-UHFFFAOYSA-N
444718;ACE2;6;1.98e-70;0.4103;9.8902;124.6895;ACE2;Angiotensin-converting enzyme 2 (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131759968;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZDRCFAZKFWDKNW-UHFFFAOYSA-N
131765372;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZAXBGJFTPBBLPV-UHFFFAOYSA-N
53480590;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CJLFAMUPGLSRFA-UHFFFAOYSA-N
131759362;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;JKTCMEHHQOHFEA-UHFFFAOYSA-N
131756612;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ALFAYLAQUMDHCM-UHFFFAOYSA-N
131764596;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UPFPFVNSYAIZPP-UHFFFAOYSA-N
131755279;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;HCEFBTFVOASXGI-UHFFFAOYSA-N
131757493;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;UHIRVISANDDFQO-UHFFFAOYSA-N
131755395;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;SYHQDCMTVVZJSW-UHFFFAOYSA-N
131765106;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;OWSJQXBTEYLBML-UHFFFAOYSA-N
131760000;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;ADBUUCLFUXNJAT-UHFFFAOYSA-N
131764284;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OYMCEAZYNJCWPE-UHFFFAOYSA-N
8094;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131765641;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;SNTGZWYCTMYTOD-UHFFFAOYSA-N
9545117;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XKXYLRHFXANGHG-UHFFFAOYSA-N
131765734;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;MGVLRAKEBILBAC-UHFFFAOYSA-N
131755858;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;RUXLBRZLBVLBFV-UHFFFAOYSA-N
131756057;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KUKLTLNSTKLWOK-UHFFFAOYSA-N
131756752;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IBYMEWUNOCTTRG-UHFFFAOYSA-N
131755457;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IMIRBNJSIWDVSA-UHFFFAOYSA-N
131759540;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;AQYFFCAUDMUBEY-UHFFFAOYSA-N
131755815;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;HFPSXYRYGSJWEL-UHFFFAOYSA-N
131763814;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;LZINVXSWUNMSJK-UHFFFAOYSA-N
131753631;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;UISYJGKZKOFBCP-UHFFFAOYSA-N
131765405;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HWLTXKYHRROFDD-UHFFFAOYSA-N
131756741;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;VNTAEBMTULPOLY-UHFFFAOYSA-N
107737;ITPR1;9;1.7489999999999998e-94;0.8421;3.1317;167.8742;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 9);C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O;INAPMGSXUVUWAF-UHFFFAOYSA-N
131757931;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;GIPQJGVRFPTGNE-UHFFFAOYSA-N
88454;EST1_PIG;7;9.582999999999999e-67;0.4375;4.4012;118.0742;EST1_PIG;Liver carboxylesterase (pKi >= 7);CCCCCCOC(=O)CC;GOKKOFHHJFGZHW-UHFFFAOYSA-N
131762118;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HACBAOINPHYNST-UHFFFAOYSA-N
131760005;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;OKYXKQWJBHHXBC-UHFFFAOYSA-N
131763808;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;DOCRXAVOQFBILA-UHFFFAOYSA-N
131764759;LPAR3;6;6.1270000000000005e-56;0.5532;8.5118;98.6744;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YLUCRQKSSLJBCX-UHFFFAOYSA-N
131756612;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;ALFAYLAQUMDHCM-UHFFFAOYSA-N
131757938;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;URBAOCZNEPINCX-UHFFFAOYSA-N
131764548;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;NWKWBJNWUOYDEU-UHFFFAOYSA-N
131761133;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;IDGIWWVXFKHRCG-UHFFFAOYSA-N
131755872;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;BJGXENBEKNJTIW-UHFFFAOYSA-N
14426033;HLA-A;6;2.304e-70;0.4464;10.8486;124.5714;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)NC(CO)C(=O)O)N;TWVKGYNQQAUNRN-UHFFFAOYSA-N
131763794;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RXECQHPSJFVNPL-UHFFFAOYSA-N
131762084;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;YQJWRLLYQMZFTD-UHFFFAOYSA-N
131764897;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IFFCQSDSZZCHHD-UHFFFAOYSA-N
131756796;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FOOGDTKNQFZILE-UHFFFAOYSA-N
131765339;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;GASSAAYRXQQJLB-UHFFFAOYSA-N
131756161;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;ZPZAEIZDMKHCGA-UHFFFAOYSA-N
131761536;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UAOGGKZVARSZGZ-UHFFFAOYSA-N
131764898;FABP3;7;1.522e-50;0.4348;1.6629;88.9883;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;RQKHMPSZDUHCED-UHFFFAOYSA-N
131762065;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;KKTHCSVXQUWJBT-UHFFFAOYSA-N
92843;FPR1;6;1.907e-49;0.4091;9.3247;87.0172;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)CN;DKEXFJVMVGETOO-UHFFFAOYSA-N
131763474;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VSVPMUHPOFOMTE-UHFFFAOYSA-N
131755859;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;CRRULBZKNVQXFP-UHFFFAOYSA-N
131757837;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;SXKDYXAVNJJKQE-UHFFFAOYSA-N
131756970;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XIXBCMGXHNLMTN-UHFFFAOYSA-N
131760019;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZCWCOELIGJYADE-UHFFFAOYSA-N
131757970;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;FWVLOXKUQLDETR-UHFFFAOYSA-N
131762003;FABP3;7;1.584e-53;0.4884;1.7626;94.3434;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SPANQEOGZHFPCM-UHFFFAOYSA-N
131757517;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KDBXLBUVLNGKSH-UHFFFAOYSA-N
131757628;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WHBOQNGVRPUVKB-UHFFFAOYSA-N
131756984;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IYNVHYKXELZPNC-UHFFFAOYSA-N
13187;CQSS;6;1.25e-84;0.52;2.483;150.1825;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131762331;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;CTLXHWRJDCSACX-UHFFFAOYSA-N
131756588;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;JVDSXKOHBLWGIM-UHFFFAOYSA-N
131762180;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;FVDYYPMNUFXGPD-UHFFFAOYSA-N
131761260;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;IXONFDDCPAVLRA-UHFFFAOYSA-N
131755865;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;KOGFJPQTJBKODN-UHFFFAOYSA-N
131759999;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;NZJOZQGTEOIRPE-UHFFFAOYSA-N
7478;RXRB;6;6.624e-51;0.4146;14.4941;89.637;RXRB;Retinoic acid receptor RXR-beta (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131755809;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;APCPZQYJQIVCIQ-UHFFFAOYSA-N
131764522;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;XMWUXAVIWIDJNZ-UHFFFAOYSA-N
131759335;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PJZNQCVWKSDFQV-UHFFFAOYSA-N
131764623;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DFVIEKPXGADLNT-UHFFFAOYSA-N
25240391;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;AVPYORJSIJFEAZ-UHFFFAOYSA-N
131757260;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;LHPFBXJMLHBPAN-UHFFFAOYSA-N
131760585;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;AOUHOSSCVUKSAD-UHFFFAOYSA-N
131764819;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;YJMGXZYEPBQBAS-UHFFFAOYSA-N
131761329;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MQKXAZDGXABSQN-UHFFFAOYSA-N
131757547;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;JCOSJHHIEGDUHK-UHFFFAOYSA-N
131755094;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;MGBYDKAHDISQBC-UHFFFAOYSA-N
96801;LAP3;6;3.7200000000000004e-47;0.7097;5.3763;82.9055;LAP3;Cytosol aminopeptidase (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131755833;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;UMQZVBBPQUGNIW-UHFFFAOYSA-N
131766001;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;WSUKABRGISKTKI-UHFFFAOYSA-N
131756044;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;QXOPDZOQHIVILD-UHFFFAOYSA-N
131761591;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JQFYUNTYJPUUBW-UHFFFAOYSA-N
444718;ACE;6;1.4270000000000002e-46;0.475;46.2793;81.8573;ACE;Angiotensin-converting enzyme (pKi >= 6);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131761571;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;CIGMJNJLEJRUAW-UHFFFAOYSA-N
25240389;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LEZBCWXJJZZACU-UHFFFAOYSA-N
57449;RNPEP;8;2.044e-44;0.5769;1.458;77.9866;RNPEP;Aminopeptidase B (pKi >= 8);C(CCN)CC(C(=O)O)N;KDXKERNSBIXSRK-UHFFFAOYSA-N
131766266;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;VWIONIBYRJYTDI-UHFFFAOYSA-N
131766337;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IFGCAZDDZSPQTA-UHFFFAOYSA-N
131764590;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;AJBJMZWRBVANHW-UHFFFAOYSA-N
131757356;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;NIPVPXGEDBBOMK-UHFFFAOYSA-N
131757175;LPAR3;6;2.2909999999999998e-54;0.551;8.2699;95.8507;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;QSDDUOAVUDULFV-UHFFFAOYSA-N
131761147;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;XEGBEKAAVUQJRL-UHFFFAOYSA-N
131757267;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;RTYVZERQRRRYNE-UHFFFAOYSA-N
131762099;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;VZNTVOPNTJTOID-UHFFFAOYSA-N
131759987;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;KBTUAEPMBMZEAT-UHFFFAOYSA-N
131763392;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;MORRKBVQDCCUAG-UHFFFAOYSA-N
7408079;ENPEP;7;9.048e-95;0.5476;7.4396;168.3878;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(C)N;ZSOICJZJSRWNHX-UHFFFAOYSA-N
131756916;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;HHBLSXUEUXTLMG-UHFFFAOYSA-N
439715;P2RY14;6;6.103e-74;0.4667;13.5433;130.9932;P2RY14;P2Y purinoceptor 14 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C3C(C(O2)CO)OP(=O)(O3)O;HWDMHJDYMFRXOX-UHFFFAOYSA-N
131765630;FABP3;7;4.2649999999999996e-54;0.4667;1.7816;95.3661;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;SELGUPPPTRUQAL-UHFFFAOYSA-N
53480598;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MEIOXTFWWGQLIM-UHFFFAOYSA-N
131762093;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CQKHWQRBCVXSJK-UHFFFAOYSA-N
7826;LPAR3;6;1.198e-48;0.4324;7.3905;85.5845;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC(=O)OC;XNCNNDVCAUWAIT-UHFFFAOYSA-N
131765304;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;HIMIHFHVOVPOHU-UHFFFAOYSA-N
131759942;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZKVCIPCWALLPQC-UHFFFAOYSA-N
131765318;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;SXLJFLPUYAAMSI-UHFFFAOYSA-N
131760743;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YGGZFQWCIRKMIF-UHFFFAOYSA-N
131756005;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IMFARGSEPLYKKO-UHFFFAOYSA-N
131753638;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;GKMLPMONLVGROY-UHFFFAOYSA-N
131757925;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;XZEKHDQNQNUYCG-UHFFFAOYSA-N
131765644;LPAR3;6;1.747e-52;0.5306;7.9805;92.4716;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NZGAHETUOKYLSV-UHFFFAOYSA-N
131764813;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KVYXNXVDUNZWSJ-UHFFFAOYSA-N
131756725;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;WKGFMQTYNRBSTK-UHFFFAOYSA-N
131758091;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GVCWIXNHGLSALQ-UHFFFAOYSA-N
131764591;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;WEIYGRYZWZVJNM-UHFFFAOYSA-N
131756910;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;WHPQOGDRBOSGRN-UHFFFAOYSA-N
131750376;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;YNDXXWKSWMKVGO-UHFFFAOYSA-N
131761934;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;BWOCMKYCXIXQRR-UHFFFAOYSA-N
131764814;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PPOTXXPYDKRBFX-UHFFFAOYSA-N
131764826;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DLGNQYNTHSLLTF-UHFFFAOYSA-N
131760183;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;PMFLTJZDQUHUAB-UHFFFAOYSA-N
259613;ENPEP;7;1.438e-77;0.4444;6.0792;137.5061;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)CN;KGVHCTWYMPWEGN-UHFFFAOYSA-N
131756964;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;ZTFSXTDCVHSWOS-UHFFFAOYSA-N
131757196;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OIZMVBWGKIPHII-UHFFFAOYSA-N
131757450;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;CFOWRVBCJCEHTO-UHFFFAOYSA-N
131756584;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SKYYKLLKGOJLMR-UHFFFAOYSA-N
131762784;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;RVMQNMKFUZZTPY-UHFFFAOYSA-N
131765538;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CBWHWKJXJAEZSY-UHFFFAOYSA-N
131760344;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CPPRQORZWKTODT-UHFFFAOYSA-N
131765539;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LBZFYZRIVKZJJE-UHFFFAOYSA-N
131753403;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NDJUOSGUPZFLID-UHFFFAOYSA-N
131765172;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;LSBRSPXRXGIWSM-UHFFFAOYSA-N
131765398;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UAMGOVBFCPESRD-UHFFFAOYSA-N
131762059;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CNELLNYZVHIXGC-UHFFFAOYSA-N
6131;ATIC;6;1.497e-42;0.4839;1.2365;74.6385;ATIC;Bifunctional purine biosynthesis protein PURH (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131764247;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XEOSAHGABTVYIL-UHFFFAOYSA-N
131756005;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;IMFARGSEPLYKKO-UHFFFAOYSA-N
131756085;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;FUYKNMGGFRUDSS-UHFFFAOYSA-N
131762194;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;VVFRIVIQQBOTDF-UHFFFAOYSA-N
131764813;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KVYXNXVDUNZWSJ-UHFFFAOYSA-N
131757213;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;HEROZXQJPBVFAZ-UHFFFAOYSA-N
131759381;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCC;IKNAMSQXQLOJII-UHFFFAOYSA-N
131764896;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;MIHUZKOKUAIBTL-UHFFFAOYSA-N
131757436;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QFXWHSAPDFXYOG-UHFFFAOYSA-N
131757409;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;HOOIWTKANHPAOR-UHFFFAOYSA-N
131757288;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IJOXAPFYWITIHW-UHFFFAOYSA-N
131763074;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;TVASWGWPZXLFFR-UHFFFAOYSA-N
131762123;LPAR3;6;7.11e-81;0.5294;12.3464;143.4414;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NTBWBNOELFPOOM-UHFFFAOYSA-N
131761542;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;PAKZJLDJBGQIRN-UHFFFAOYSA-N
94180;NOD1;9;6.907000000000001e-85;0.4167;6.0406;150.6452;NOD1;Nucleotide-binding oligomerization domain-containing protein 1 (pKi >= 9);CCCCCCC(C(=O)O)O;JKRDADVRIYVCCY-UHFFFAOYSA-N
31236;LTA4H;6;5.061e-42;0.5;23.0434;73.689;LTA4H;Leukotriene A-4 hydrolase (pKi >= 6);C1=CC=C(C=C1)OCCO;QCDWFXQBSFUVSP-UHFFFAOYSA-N
131756965;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JLVBPNSIUBYKIC-UHFFFAOYSA-N
131755809;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;APCPZQYJQIVCIQ-UHFFFAOYSA-N
131764544;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ITQKGJSZZRFPGO-UHFFFAOYSA-N
131757610;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FATDEJIPCRXHBE-UHFFFAOYSA-N
131765642;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VXWOYIMCGZLATM-UHFFFAOYSA-N
131761952;FABP3;7;1.584e-53;0.4884;1.7626;94.3434;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JEYAIOVCJUFECT-UHFFFAOYSA-N
131757930;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CLPGGZLOXDCDRW-UHFFFAOYSA-N
8373;AKR1C2;6;1.594e-68;0.5484;7.4398;121.2681;AKR1C2;Aldo-keto reductase family 1 member C2 (pKi >= 6);CC1=CC=CC=C1C(=O)O;ZWLPBLYKEWSWPD-UHFFFAOYSA-N
131757563;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;PEOBDAPKUYNJDB-UHFFFAOYSA-N
131764277;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;XKOVFTWOPGPYGI-UHFFFAOYSA-N
131765354;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;VQQAYQWXQXRZHI-UHFFFAOYSA-N
131761118;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QDWJAQSRCULWCC-UHFFFAOYSA-N
131758114;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WLQOSKFMJPLCIL-UHFFFAOYSA-N
131764595;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;REAOSGOGZMYBES-UHFFFAOYSA-N
8094;PLA2G4B;6;2.175e-68;0.4595;5.9815;121.0259;PLA2G4B;Cytosolic phospholipase A2 beta (pKi >= 6);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131764810;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;AKGKDADGQVDJFQ-UHFFFAOYSA-N
131761951;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;QVOYWQYGRGLLAY-UHFFFAOYSA-N
131766295;FABP3;7;3.0409999999999997e-53;0.5366;1.7531;93.8346;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;FCKLIAZZLDXSJY-UHFFFAOYSA-N
131761148;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;FRAQRWVCMZTLGK-UHFFFAOYSA-N
131764612;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;YMJYQRKUQPYKQY-UHFFFAOYSA-N
131765817;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PHBPVJUUYJZCOS-UHFFFAOYSA-N
131766157;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;GFNWPYUGWYDNER-UHFFFAOYSA-N
131758560;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;JNIVZFHKRHKLRF-UHFFFAOYSA-N
131757761;FABP3;7;5.0469999999999995e-54;0.4667;1.7792;95.235;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;YDNSSVJJLZBKEO-UHFFFAOYSA-N
131757385;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;XOPFKAUVUXZXGV-UHFFFAOYSA-N
131755100;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;OLEXXKUUZGHGOQ-UHFFFAOYSA-N
131764585;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;QVXNVPNSDDBRRI-UHFFFAOYSA-N
440103;GRIK1;6;1.3499999999999999e-52;0.5357;14.125;92.6725;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CC(C(=O)O)NC(=O)CCC(C(=O)O)N;WQXXXVRAFAKQJM-UHFFFAOYSA-N
131764189;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JHULUDGYWIJGEI-UHFFFAOYSA-N
131766114;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;AHELIOBCROQGBQ-UHFFFAOYSA-N
131757363;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;MEEQUTNYZOELIE-UHFFFAOYSA-N
458;GRIK3;6;2.924e-51;0.5;4.5817;90.2745;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);C[S+](C)CCC(C(=O)O)N;YDBYJHTYSHBBAU-UHFFFAOYSA-O
131763892;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NGXAXCIWISQEQF-UHFFFAOYSA-N
131756771;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PTBZUJYXYHDLML-UHFFFAOYSA-N
131766166;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;BCFZUYAFWFJZJJ-UHFFFAOYSA-N
131756764;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;PVLPTPLTYBYKPQ-UHFFFAOYSA-N
131757295;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCC;WAWGLAWANXTROF-UHFFFAOYSA-N
131765636;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;UPVISHBUYMKHRG-UHFFFAOYSA-N
6131;P2RY2;6;5.706e-208;0.6842;50.7927;371.6183;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131758212;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MDAOMPFQZJLFBG-UHFFFAOYSA-N
131764696;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;UTBRCBMCCLRNPB-UHFFFAOYSA-N
4133;TRPA1;9;1.706e-42;0.4146;1.957;74.5367;TRPA1;Transient receptor potential cation channel subfamily A member 1 (pKi >= 9);COC(=O)C1=CC=CC=C1O;OSWPMRLSEDHDFF-UHFFFAOYSA-N
439378;GRIK3;6;3.6740000000000005e-55;0.5357;4.9351;97.2779;GRIK3;Glutamate receptor ionotropic, kainate 3 (pKi >= 6);CCNC(=O)CCC(C(=O)O)N;DATAGRPVKZEWHA-UHFFFAOYSA-N
131761922;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;BAVCCPMFLDZBDC-UHFFFAOYSA-N
131757196;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;OIZMVBWGKIPHII-UHFFFAOYSA-N
131764159;LPAR3;6;4.843e-71;0.5745;10.8342;125.7875;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ANLTWDYCKOTMFG-UHFFFAOYSA-N
131756142;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VFMVVXVFRDLZMQ-UHFFFAOYSA-N
131766274;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BJEWOFVVPFFTJS-UHFFFAOYSA-N
131758871;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;USJFTUJSTHNKJJ-UHFFFAOYSA-N
131765196;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ICUVDUDMLHWGHD-UHFFFAOYSA-N
9546172;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;ZZHQPHMTXYHRIT-UHFFFAOYSA-N
131757288;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;IJOXAPFYWITIHW-UHFFFAOYSA-N
131753396;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;KWBNOUOFUVIQGL-UHFFFAOYSA-N
131762093;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;CQKHWQRBCVXSJK-UHFFFAOYSA-N
131764917;LPAR3;6;1.086e-44;0.5;6.782;78.4797;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;DXMMCRIFBAEJJI-UHFFFAOYSA-N
8908;CES2;7;1.767e-52;0.4516;3.0326;92.4627;CES2;Cocaine esterase (pKi >= 7);CCCCCCOC(=O)C;AOGQPLXWSUTHQB-UHFFFAOYSA-N
131756622;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;FOUWGWGSPVWLRF-UHFFFAOYSA-N
131755367;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DWYQYYDRIUNZMR-UHFFFAOYSA-N
131756064;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DKLOEZUJIXIVSU-UHFFFAOYSA-N
131765919;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCC=CCC;XQQJAGYYEVRLNX-UHFFFAOYSA-N
131763891;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UIGZHQJJRVXCAK-UHFFFAOYSA-N
131760483;LPAR1;6;2.7979999999999998e-45;0.5745;8.4616;79.5371;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;LISACBAHGCRQCQ-UHFFFAOYSA-N
131763966;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;APGLXYXZBPDMPJ-UHFFFAOYSA-N
131765581;LPAR3;6;2.445e-62;0.5652;9.4958;110.1626;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JDZAHEZYIGRMEL-UHFFFAOYSA-N
7668;SLC18A2;6;1.484e-46;0.4242;9.464;81.8268;SLC18A2;Synaptic vesicular amine transporter (pKi >= 6);CCCC1=CC=CC=C1;ODLMAHJVESYWTB-UHFFFAOYSA-N
131757363;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCC;MEEQUTNYZOELIE-UHFFFAOYSA-N
9546315;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NOARWYBQRHYNAX-UHFFFAOYSA-N
131764270;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RJFWEPAZVRIOOH-UHFFFAOYSA-N
131756796;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;FOOGDTKNQFZILE-UHFFFAOYSA-N
131765160;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;KDZYWQNMBRTHNK-UHFFFAOYSA-N
439715;P2RY4;6;6.757e-99;0.4912;14.269;175.7968;P2RY4;P2Y purinoceptor 4 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C3C(C(O2)CO)OP(=O)(O3)O;HWDMHJDYMFRXOX-UHFFFAOYSA-N
131757125;FABP3;7;9.578e-54;0.4655;1.7699;94.7354;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;NGKSSGSZKCGACO-UHFFFAOYSA-N
131761011;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PMDBBHISOXQRJA-UHFFFAOYSA-N
131756885;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;IBEVRNHIOSXUJJ-UHFFFAOYSA-N
131764537;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;MUNBPCWOOXLCTN-UHFFFAOYSA-N
131764827;LPAR3;6;6.990999999999999e-45;0.5319;6.8114;78.8231;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;KRLQJAOQAHGFBW-UHFFFAOYSA-N
131764826;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;DLGNQYNTHSLLTF-UHFFFAOYSA-N
13187;LPAR3;6;2.503e-41;0.4;6.2649;72.4427;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131764264;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XAEFFNXDYZHTNN-UHFFFAOYSA-N
131757435;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QYYNNMGUOXLSIN-UHFFFAOYSA-N
131762083;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;LYMIXKGUZOITPL-UHFFFAOYSA-N
131757909;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCC;ABFACKHFNWRLBN-UHFFFAOYSA-N
131756802;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;RRCHFUDCOMJONU-UHFFFAOYSA-N
131762173;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC;UBSHSSBEIAVWOU-UHFFFAOYSA-N
131764234;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;XEDWMKBQXWAUCP-UHFFFAOYSA-N
131762422;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;PFINDNIYLCOJHX-UHFFFAOYSA-N
131756031;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YENXZCWCIMKQCY-UHFFFAOYSA-N
131756604;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCCCC)COC(=O)CCCCC=CCC=CCC=CCCCCC;HRIZOSOLJUQKSO-UHFFFAOYSA-N
131755367;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;DWYQYYDRIUNZMR-UHFFFAOYSA-N
131761240;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IIVRPCVURYXRKJ-UHFFFAOYSA-N
131762059;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;CNELLNYZVHIXGC-UHFFFAOYSA-N
131760724;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OTXDGHXQYRYHDV-UHFFFAOYSA-N
131759335;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;PJZNQCVWKSDFQV-UHFFFAOYSA-N
131763385;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FOEXFNVACTZKNE-UHFFFAOYSA-N
131757010;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SFRHUFVHFRPPOS-UHFFFAOYSA-N
3621685;CAPN1;6;9.588000000000001e-57;0.4444;32.8062;100.1206;CAPN1;Calpain-1 catalytic subunit (pKi >= 6);CC(C)CC(C(=O)NC(CO)C(=O)O)N;XGDCYUQSFDQISZ-UHFFFAOYSA-N
131765538;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CBWHWKJXJAEZSY-UHFFFAOYSA-N
131753638;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;GKMLPMONLVGROY-UHFFFAOYSA-N
131764923;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YQBJSWUNYSIELN-UHFFFAOYSA-N
83525;ACE;6;3.441e-82;0.6389;81.6548;145.8025;ACE;Angiotensin-converting enzyme (pKi >= 6);CC(C(=O)N1CCCC1C(=O)O)N;WPWUFUBLGADILS-UHFFFAOYSA-N
131756108;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCCCCC;JTJZUFAYMWLIGR-UHFFFAOYSA-N
131761012;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;QUWRGMOSPKXQJN-UHFFFAOYSA-N
131756820;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DIWDNTROQQFMKS-UHFFFAOYSA-N
131765609;FABP3;7;1.522e-50;0.4348;1.6629;88.9883;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;POOWIGVTDSCWSD-UHFFFAOYSA-N
131757839;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;WKEWFXQSALSQCQ-UHFFFAOYSA-N
131758258;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;XKLBAGAZJABNLI-UHFFFAOYSA-N
131757436;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QFXWHSAPDFXYOG-UHFFFAOYSA-N
131758045;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;QYDPSHIZJLSVKM-UHFFFAOYSA-N
6131;P2RY6;6;1.553e-175;0.6;28.9474;313.3876;P2RY6;P2Y purinoceptor 6 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131762331;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;CTLXHWRJDCSACX-UHFFFAOYSA-N
66535;RNASE1;6;1.3800000000000002e-66;0.4337;1.9485;117.7897;RNASE1;Ribonuclease pancreatic (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131765677;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PJUXPSZIAMGJNO-UHFFFAOYSA-N
68662;GRIK1;6;1.68e-64;0.7;17.3504;114.0459;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);COC(=O)CCC(C(=O)O)N;ZGEYCCHDTIDZAE-UHFFFAOYSA-N
131764164;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YKAWRFAUPATMGP-UHFFFAOYSA-N
131763795;LPAR3;6;3.946e-74;0.587;11.3092;131.3333;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PLAOSKWDTZUAOS-UHFFFAOYSA-N
7478;AKR1C3;6;1.954e-52;0.5429;19.9606;92.3842;AKR1C3;Aldo-keto reductase family 1 member C3 (pKi >= 6);COC1=CC=C(C=C1)C(=O)O;ZEYHEAKUIGZSGI-UHFFFAOYSA-N
131764510;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;XXDBJHDRECUBNX-UHFFFAOYSA-N
131755847;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OLGCAYHSBQAASU-UHFFFAOYSA-N
131761523;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;ZYJWXFJPEXYPPD-UHFFFAOYSA-N
131766404;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;FMKKRMHWNRHGQT-UHFFFAOYSA-N
131764913;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;GWSGWHHWROFTDI-UHFFFAOYSA-N
131760622;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;KADMYKMUQFNYTD-UHFFFAOYSA-N
131759942;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZKVCIPCWALLPQC-UHFFFAOYSA-N
131766191;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;IGPSCPPINAFEKC-UHFFFAOYSA-N
131758211;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;IYSLCAKQDCKAPA-UHFFFAOYSA-N
131755833;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;UMQZVBBPQUGNIW-UHFFFAOYSA-N
6131;P2RY14;6;7.122e-93;0.5345;17.0372;164.9838;P2RY14;P2Y purinoceptor 14 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O;IERHLVCPSMICTF-UHFFFAOYSA-N
131757302;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;MFTJGJJGQONILX-UHFFFAOYSA-N
14426033;ACE2;7;1.5760000000000001e-71;0.4474;8.8773;126.6629;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(CO)C(=O)O)N;TWVKGYNQQAUNRN-UHFFFAOYSA-N
131761118;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;QDWJAQSRCULWCC-UHFFFAOYSA-N
131761031;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PTACBPKQWASVGS-UHFFFAOYSA-N
131756083;LPAR3;6;1.549e-81;0.587;12.4482;144.6295;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WIUBICRACXYXHV-UHFFFAOYSA-N
131756720;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;GTQFAXDJIANZMD-UHFFFAOYSA-N
131760857;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBRLOBPZVDQAEA-UHFFFAOYSA-N
131755375;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;MZLDDMZGQIOQJK-UHFFFAOYSA-N
439715;P2RY2;6;4.974e-91;0.4912;22.1654;161.6731;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1=CN(C(=O)NC1=O)C2C3C(C(O2)CO)OP(=O)(O3)O;HWDMHJDYMFRXOX-UHFFFAOYSA-N
131766320;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UYGYJZMSBAQEGR-UHFFFAOYSA-N
2724807;HLA-A;6;1.088e-49;0.451;7.6343;87.4548;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)C(C(=O)O)NC(=O)CN;STKYPAFSDFAEPH-UHFFFAOYSA-N
131764515;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;YEWJAWDCDPEWJL-UHFFFAOYSA-N
131760483;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;LISACBAHGCRQCQ-UHFFFAOYSA-N
131761362;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VQFVTSXDLUDVAR-UHFFFAOYSA-N
12293;LPAR3;6;6.984000000000001e-48;0.4595;7.2728;84.2098;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC(=O)OCCC;HTUIWRWYYVBCFT-UHFFFAOYSA-N
131757429;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;SLCSZUMZGXHZBR-UHFFFAOYSA-N
9545294;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;JRIJXKUOTQILAX-UHFFFAOYSA-N
131765553;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;WAPIAFALOIFIDE-UHFFFAOYSA-N
131765187;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;BDXWRENUBFQIOU-UHFFFAOYSA-N
131764616;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PSZIJFDVVSPFBG-UHFFFAOYSA-N
131766183;FABP3;7;2.011e-54;0.55;1.7925;95.9524;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;UWFFSPMTISZWAL-UHFFFAOYSA-N
131764617;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;OCHVKWRHOIARSR-UHFFFAOYSA-N
131760329;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;ZDZGRFOKLODFJJ-UHFFFAOYSA-N
131765581;FABP3;7;1.0989999999999999e-54;0.5;1.8013;96.4236;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;JDZAHEZYIGRMEL-UHFFFAOYSA-N
131761025;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;RUSGNCLMYHYYHV-UHFFFAOYSA-N
131755304;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;VPQTUUYLDJYFBX-UHFFFAOYSA-N
3621685;HLA-A;6;3.001e-73;0.5192;11.2972;129.7514;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CC(C)CC(C(=O)NC(CO)C(=O)O)N;XGDCYUQSFDQISZ-UHFFFAOYSA-N
131756848;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;BMLXKVIKPFXMLY-UHFFFAOYSA-N
131758547;LPAR3;6;7.284e-97;0.5745;14.8053;172.1475;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;HQQQOQMFXJYUMG-UHFFFAOYSA-N
53480586;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XRIGAJUVDRNXQG-UHFFFAOYSA-N
96801;MME;6;7.775000000000001e-48;0.5263;40.9097;84.1261;MME;Neprilysin (pKi >= 6);CC(C)CC(C(=O)O)NC(=O)C(C)N;RDIKFPRVLJLMER-UHFFFAOYSA-N
131755101;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;BDAPQXURZQCHLV-UHFFFAOYSA-N
131760665;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;DJUZUKMVZZOHPA-UHFFFAOYSA-N
131763073;FABP3;7;5.184e-55;0.5238;1.8122;97.0094;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FMMAGCQSTTUUOF-UHFFFAOYSA-N
25240389;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;LEZBCWXJJZZACU-UHFFFAOYSA-N
131755790;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RMGUQZSFJCIQCW-UHFFFAOYSA-N
131758710;FABP3;7;2.459e-56;0.5294;1.8565;99.3864;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;PASXLGNHMHBIKZ-UHFFFAOYSA-N
131766271;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;GQHFKUZFVPRUHC-UHFFFAOYSA-N
131766250;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;JEWIRWPDJGIKLP-UHFFFAOYSA-N
131765649;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;UWQFVORTWFKSOT-UHFFFAOYSA-N
131763073;LPAR1;6;8.595e-43;0.54;7.9911;75.0714;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;FMMAGCQSTTUUOF-UHFFFAOYSA-N
131766384;LPAR3;6;3.7829999999999996e-61;0.5;9.3129;108.027;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SLFGGSZZABSPQJ-UHFFFAOYSA-N
131765587;FABP3;7;4.2649999999999996e-54;0.4667;1.7816;95.3661;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BTWXUMBXWXULHV-UHFFFAOYSA-N
131755237;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UJMUINYNSNMHQZ-UHFFFAOYSA-N
131762304;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JTHJRVKYZXTUQN-UHFFFAOYSA-N
131764985;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NOYWGHLJUCUPFJ-UHFFFAOYSA-N
88454;CES2;7;5.603999999999999e-51;0.4375;2.9446;89.7674;CES2;Cocaine esterase (pKi >= 7);CCCCCCOC(=O)CC;GOKKOFHHJFGZHW-UHFFFAOYSA-N
131761011;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PMDBBHISOXQRJA-UHFFFAOYSA-N
131766196;FABP3;7;4.085e-52;0.5238;1.7154;91.8091;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;IAMKAVOVYRCLJE-UHFFFAOYSA-N
131761985;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;HVTFPWMQNVTIML-UHFFFAOYSA-N
131763898;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;ZDGDOUDXXGCMIS-UHFFFAOYSA-N
131755218;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;YADRKXZELPOCPI-UHFFFAOYSA-N
131757195;LPAR3;6;8.583e-88;0.54;13.4103;155.8618;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OCCCCCCCCCCCCCCCCCC;KBOXWJNBWNAPDL-UHFFFAOYSA-N
131759355;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCC;CISSBQIGKKYEPB-UHFFFAOYSA-N
131764912;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;PWGSYNKICGOQAF-UHFFFAOYSA-N
131762123;FABP3;7;7.554e-54;0.5116;1.7733;94.9205;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;NTBWBNOELFPOOM-UHFFFAOYSA-N
131758446;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;YRIBGJSBLCTVJS-UHFFFAOYSA-N
131762066;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;HLHLXVHKMTYBSS-UHFFFAOYSA-N
131761030;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;YEPSKQSRIFNCPW-UHFFFAOYSA-N
131757930;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;CLPGGZLOXDCDRW-UHFFFAOYSA-N
131762587;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BXWJNVALZYFZLM-UHFFFAOYSA-N
131759980;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;CCPVIYZRYMYSQZ-UHFFFAOYSA-N
131765642;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;VXWOYIMCGZLATM-UHFFFAOYSA-N
13187;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCCC(=O)C;VKCYHJWLYTUGCC-UHFFFAOYSA-N
131765830;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;XWQYOJPOKGTBNZ-UHFFFAOYSA-N
131750378;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;QPNVLDQSHXVPMG-UHFFFAOYSA-N
131753804;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;NUEDPKJRKOIZSG-UHFFFAOYSA-N
131757863;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCC;VYZRRPSXSDYNCO-UHFFFAOYSA-N
131764886;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FHXGXFQTGPOXHY-UHFFFAOYSA-N
131763879;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;LZBCYJATWXCMHP-UHFFFAOYSA-N
131764195;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UHTSPOGAADMXJF-UHFFFAOYSA-N
131756064;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;DKLOEZUJIXIVSU-UHFFFAOYSA-N
131765353;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;MJRMGSNLYWPJLO-UHFFFAOYSA-N
131761093;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;JLQZYULPGPGUBH-UHFFFAOYSA-N
131758161;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;LQUXSTRECRGYRZ-UHFFFAOYSA-N
53480598;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;MEIOXTFWWGQLIM-UHFFFAOYSA-N
131761240;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;IIVRPCVURYXRKJ-UHFFFAOYSA-N
131764624;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WVRQIMKZDXPCPD-UHFFFAOYSA-N
131757970;LPAR1;6;3.0129999999999997e-41;0.6429;7.6989;72.2981;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC;FWVLOXKUQLDETR-UHFFFAOYSA-N
131762529;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;HHDZLCQDAWUVBO-UHFFFAOYSA-N
128841;ENPEP;6;7.923999999999999e-90;0.4681;10.8286;159.5147;ENPEP;Glutamyl aminopeptidase (pKi >= 6);CC(C(=O)NC(CCC(=O)O)C(=O)O)N;VYZAGTDAHUIRQA-UHFFFAOYSA-N
444718;CAPN1;7;1.5139999999999998e-41;0.4211;15.2055;72.8344;CAPN1;Calpain-1 catalytic subunit (pKi >= 7);C1=CC=C(C=C1)CC(C(=O)O)O;VOXXWSYKYCBWHO-UHFFFAOYSA-N
131761128;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCCCC;HIBOOXQOVDHKOV-UHFFFAOYSA-N
20057289;SELP;6;2.883e-43;0.5521;3.3664;75.9232;SELP;P-selectin (pKi >= 6);CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)OC3(CC(C(C(O3)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)CCCCCCCCCCCCC=CCCCCCCCCC)O;BGMMKNTYKZAIDF-UHFFFAOYSA-N
131757010;LPAR3;6;1.12e-76;0.551;11.7009;135.9054;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;SFRHUFVHFRPPOS-UHFFFAOYSA-N
8094;CES1;8;1.354e-56;0.52;6.2449;99.8515;CES1;Liver carboxylesterase 1 (pKi >= 8);CCCCCCC(=O)O;MNWFXJYAOYHMED-UHFFFAOYSA-N
131762009;FABP3;7;1.8460000000000003e-55;0.4783;1.8272;97.8143;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;ZGXGANOLCKKLJU-UHFFFAOYSA-N
131764201;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;IIAFUSNBHNDBCQ-UHFFFAOYSA-N
131758212;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;MDAOMPFQZJLFBG-UHFFFAOYSA-N
9545301;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCCCCCCCCC;JJWIHFDQAUJTKM-UHFFFAOYSA-N
131764897;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;IFFCQSDSZZCHHD-UHFFFAOYSA-N
131757831;FABP3;7;1.348e-52;0.4872;1.7315;92.6738;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OCCCCCCCCCCCCCCCCCC;CAOCEUZJFODCFY-UHFFFAOYSA-N
131763794;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;RXECQHPSJFVNPL-UHFFFAOYSA-N
5246010;ACE2;7;1.967e-48;0.625;5.9854;85.1977;ACE2;Angiotensin-converting enzyme 2 (pKi >= 7);CCC(C)C(C(=O)NC(C)C(=O)O)N;RCFDOSNHHZGBOY-UHFFFAOYSA-N
131759478;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WNUCOTRZBRFTHH-UHFFFAOYSA-N
131759478;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;WNUCOTRZBRFTHH-UHFFFAOYSA-N
5312965;GRIK1;6;8.12e-61;0.6786;16.3522;107.4314;GRIK1;Glutamate receptor ionotropic, kainate 1 (pKi >= 6);CCCCCC(C(=O)O)N;RDFMDVXONNIGBC-UHFFFAOYSA-N
131756092;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC;PEXSAAMYDXHXJR-UHFFFAOYSA-N
9545150;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;QMGVAYGHMZTSEF-UHFFFAOYSA-N
131766436;LPAR3;6;1.718e-48;0.4182;7.3664;85.3031;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCOC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;SLNZHQMWTFFEGB-UHFFFAOYSA-N
131763377;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;JQULTLMUUUQRFY-UHFFFAOYSA-N
66535;P2RY6;6;3.0520000000000005e-122;0.4861;20.1299;217.7089;P2RY6;P2Y purinoceptor 6 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131766188;FABP3;7;3.0409999999999997e-53;0.5366;1.7531;93.8346;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCC=CCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;XTSIRSMGWJZXCI-UHFFFAOYSA-N
56940205;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;SRFZZMHOMJJKRR-UHFFFAOYSA-N
131756295;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;CCTFWKNIQDIFGW-UHFFFAOYSA-N
131755042;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KXNZZVRMSWHVPA-UHFFFAOYSA-N
131756984;FABP3;7;1.363e-54;0.4912;1.7982;96.2557;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;IYNVHYKXELZPNC-UHFFFAOYSA-N
131765295;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCC=CCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;PICREIZFJYZKAV-UHFFFAOYSA-N
131756970;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;XIXBCMGXHNLMTN-UHFFFAOYSA-N
66535;P2RY2;6;1.528e-147;0.5231;35.9998;263.1312;P2RY2;P2Y purinoceptor 2 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131801690;LPAR3;6;5.287e-79;0.6;12.0586;140.0817;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;UBOALFOWVHLTCP-UHFFFAOYSA-N
12293;CQSS;6;2.902e-67;0.4194;1.9685;119.0056;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCC(=O)OCCC;HTUIWRWYYVBCFT-UHFFFAOYSA-N
131766320;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;UYGYJZMSBAQEGR-UHFFFAOYSA-N
131761536;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;UAOGGKZVARSZGZ-UHFFFAOYSA-N
131762104;FABP3;7;5.300999999999999e-53;0.4565;1.745;93.4013;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;WBTOGGRLPHBVAX-UHFFFAOYSA-N
131765423;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;BSPLHTLQAWNASH-UHFFFAOYSA-N
131761939;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCC=CCC=CCC=CCCCCC;FCVBQNIGVMCKAH-UHFFFAOYSA-N
131756083;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCOCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;WIUBICRACXYXHV-UHFFFAOYSA-N
131757628;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;WHBOQNGVRPUVKB-UHFFFAOYSA-N
131765629;FABP3;7;1.3180000000000001e-56;0.4889;1.8655;99.8727;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;FBADKMOCWQAFRV-UHFFFAOYSA-N
131753602;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;JOLAYFVNYLLIOH-UHFFFAOYSA-N
131760573;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;YNHHZPAROZOHCY-UHFFFAOYSA-N
131763458;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;OGIYWYULRPCZFI-UHFFFAOYSA-N
131757856;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCC;PPUWOQZPYWAPRO-UHFFFAOYSA-N
131764246;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCC=CCC;CQNHRJUJTGXQQC-UHFFFAOYSA-N
131755958;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;JCJXSYIZXLFKNX-UHFFFAOYSA-N
131764843;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;ZCXFXSOZEDCKII-UHFFFAOYSA-N
131760104;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;NMGROZCBZQQOSP-UHFFFAOYSA-N
131760567;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;WZWIOTYITIUOCJ-UHFFFAOYSA-N
131765600;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;RISPPOANHRVJCG-UHFFFAOYSA-N
131758893;LPAR3;6;4.31e-86;0.6429;13.1487;152.8083;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCC;RZHKUNBPKZZKQV-UHFFFAOYSA-N
131758087;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCC;AEWUIILVPVQOTF-UHFFFAOYSA-N
131756677;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCC;WPQGJCCBOJSBDL-UHFFFAOYSA-N
131755095;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCCCCCCCC;GKUAJCNVJMNRAV-UHFFFAOYSA-N
131760291;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;GDWVKMUJAYQRMH-UHFFFAOYSA-N
131755237;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCCCCCCCC;UJMUINYNSNMHQZ-UHFFFAOYSA-N
131764516;FABP3;7;4.204e-56;0.5116;1.8487;98.9681;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;OSKYXBRDUUVYGA-UHFFFAOYSA-N
131759942;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCCCCCC;ZKVCIPCWALLPQC-UHFFFAOYSA-N
131762658;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC;UFUYTFWOBBTMIA-UHFFFAOYSA-N
131755841;LPAR3;6;8.085000000000001e-79;0.6;12.0302;139.7505;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;TVQFPEHRCSMMRD-UHFFFAOYSA-N
131760349;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;CRTLUTSDOWTFCK-UHFFFAOYSA-N
131755840;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCCCCC;JQOSLGXBJPERKJ-UHFFFAOYSA-N
131757464;FABP3;7;1.905e-52;0.5185;1.7265;92.4039;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC=CCCCCCCCC;XFSRNVJYWCLUGE-UHFFFAOYSA-N
71429009;ENPEP;7;1.802e-89;0.5111;7.0205;158.8739;ENPEP;Glutamyl aminopeptidase (pKi >= 7);CCC(C)C(C(=O)O)NC(=O)C(CO)N;BXLYSRPHVMCOPS-UHFFFAOYSA-N
131760603;LPAR1;6;1.744e-43;0.6585;8.1221;76.3149;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC;OAJSPZUBFWYCCY-UHFFFAOYSA-N
131755872;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCC=CCC=CCC;BJGXENBEKNJTIW-UHFFFAOYSA-N
131764764;LPAR3;6;1.188e-68;0.5625;10.4667;121.4973;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCC=CCC=CCC=CCC=CCCCCC;BXLAGUWZJCEHDF-UHFFFAOYSA-N
131757845;FABP3;7;1.888e-54;0.4889;1.7934;96.0017;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OCCCCCCCCCCCCCCCCCC;ZWRVHEJEANYSRU-UHFFFAOYSA-N
131756031;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;YENXZCWCIMKQCY-UHFFFAOYSA-N
66535;ITPR1;6;3.527e-76;0.4923;5.7878;135.0114;ITPR1;Inositol 1,4,5-trisphosphate receptor type 1 (pKi >= 6);C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OP(=O)(O)O)O;UOOOPKANIPLQPU-UHFFFAOYSA-N
131765163;FABP3;7;4.726e-59;0.5116;1.9473;104.2628;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCC=CCC=CCC=CCC=CCC;NNGSXHAOHVGQLQ-UHFFFAOYSA-N
131750376;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC;YNDXXWKSWMKVGO-UHFFFAOYSA-N
259613;HLA-A;6;4.699999999999999e-43;0.4808;6.6026;75.5419;HLA-A;HLA class I histocompatibility antigen, A-3 alpha chain (pKi >= 6);CCC(C)C(C(=O)O)NC(=O)CN;KGVHCTWYMPWEGN-UHFFFAOYSA-N
131763795;FABP3;7;2.557e-57;0.5238;1.8893;101.1512;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCCCCC(=O)OCC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;PLAOSKWDTZUAOS-UHFFFAOYSA-N
131764765;LPAR3;6;3.123e-50;0.52;7.6341;88.4279;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;LFVJCEBDOJPSTJ-UHFFFAOYSA-N
131755847;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC=CCC=CCC=CCC=CCC;OLGCAYHSBQAASU-UHFFFAOYSA-N
131764886;FABP3;7;8.388e-58;0.5;1.9055;102.0202;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCC=CCC=CCC=CCC=CCC;FHXGXFQTGPOXHY-UHFFFAOYSA-N
131765483;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;BJLJPRPQCIEYGL-UHFFFAOYSA-N
131761362;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC;VQFVTSXDLUDVAR-UHFFFAOYSA-N
131764443;LPAR3;6;9.556e-65;0.54;9.8661;114.4857;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCC=CCC=CCCCC(=O)OC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)COC(=O)CCC=CCC=CCC=CCC=CCC=CCC=CCC;NCZKUPMKYLKXLD-UHFFFAOYSA-N
131757903;FABP3;7;1.369e-58;0.5366;1.9318;103.4335;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC;VPGFYQNSTYPTAI-UHFFFAOYSA-N
131764555;LPAR3;6;1.049e-67;0.551;10.3212;119.7988;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCC=CCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCC=CCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC;UBRHQUSYUSSYQB-UHFFFAOYSA-N
131757281;FABP3;7;1.1750000000000001e-57;0.54;1.9006;101.7572;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;RDDJZUXEKOBRLD-UHFFFAOYSA-N
131756045;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC;NKVPAWUMBWESJM-UHFFFAOYSA-N
131757435;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QYYNNMGUOXLSIN-UHFFFAOYSA-N
131756063;LPAR3;6;2.034e-89;0.6585;13.6602;158.7796;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCC=CCCCCCC)OC(=O)CCCCCCCCCCCCCC=CCCCCCCCC;KCZXAMVZIWNRAA-UHFFFAOYSA-N
131758422;LPAR3;6;6.763999999999999e-67;0.5192;10.1968;118.3457;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCC=CCC=CCC;LHGYPMLTLDHXRM-UHFFFAOYSA-N
53480588;LPAR3;6;2.199e-75;0.5745;11.5021;133.5843;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCC=CCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC)COC(=O)CCCCCC=CCC=CCC=CCC=CCC=CCC;ZUNWODIBMWYUGB-UHFFFAOYSA-N
131756568;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC;DNBLIASYUOJINW-UHFFFAOYSA-N
131756240;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC;YFYCCMUWMOKMGJ-UHFFFAOYSA-N
131757436;FABP3;7;6.395e-60;0.55;1.9763;105.8223;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC;QFXWHSAPDFXYOG-UHFFFAOYSA-N
131757624;FABP3;7;1.6669999999999999e-53;0.4828;1.7618;94.3032;FABP3;Fatty acid-binding protein, heart (pKi >= 7);CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COCCCCCCCCCCCCCCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC;JDBIUXJWGUOYCR-UHFFFAOYSA-N
8051;PAOX;6;3.028e-50;0.4286;2.0008;88.452;PAOX;Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (pKi >= 6);CCCCCC(=O)C;CATSNJVOTSVZJV-UHFFFAOYSA-N
3621685;FPR1;6;3.848e-55;0.413;10.4106;97.2417;FPR1;fMet-Leu-Phe receptor (pKi >= 6);CC(C)CC(C(=O)NC(CO)C(=O)O)N;XGDCYUQSFDQISZ-UHFFFAOYSA-N
131760857;LPAR3;6;1.733e-89;0.6136;13.6709;158.9045;LPAR3;Lysophosphatidic acid receptor 3 (pKi >= 6);CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCCCCCC=CCC=CCCCCC;JBRLOBPZVDQAEA-UHFFFAOYSA-N
131762644;LPAR1;6;7.328e-44;0.6136;8.1933;76.991;LPAR1;Lysophosphatidic acid receptor 1 (pKi >= 6);CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCC=CCC=CCCCCC;QUQYRBGCIMSPCK-UHFFFAOYSA-N
53481912;BHMT;6;4.656e-53;0.4737;1.5478;93.5026;BHMT;Betaine--homocysteine S-methyltransferase 1 (pKi >= 6);C(CCC(=O)O)CC(CCSCN)S;YNZQCBXDUUGFIX-UHFFFAOYSA-N
12367;CQSS;6;1.2349999999999999e-68;0.4615;2.0092;121.4668;CQSS;CAI-1 autoinducer sensor kinase/phosphatase CqsS (pKi >= 6);CCCCCCCC(C)O;NGDNVOAEIVQRFH-UHFFFAOYSA-N
